Citrus Sinensis ID: 046544

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640------
Protein Sequence
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED
Secondary Structure (PSIPRED)
cccHHHcccccccEEEcccccccccccHHHHcccccccccccccccEEcccHHHHHcccccccEEccccEEEEcccHHHHHcccccEEcccccEEEccccccccccccccEEEccccccccccccccccccccccccccEEEccccccccccccccHHcccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccccccccccccccHHHHHcccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccEEccccccccccccHHHHcccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHccccccccccEEEEEccccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHHHHcHcccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccccccccccccHHHccccccEEEEcccccccccccHHHHcccHHHccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHcccccccEEEEccccEEccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccccccHHHccHHHcccccEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccHHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
eipleisnlqnleeldLRHNKLVGTVPAAIFNMSMLKLLHLQnnsllgclssiadvrlPNLEALLLwgnnfsgtiprfiFNASKLSILELSQnsfsgfipntfgnlrnlewlnlrdnyltsstpelsflsslsncksltfihlsdnpldgilsktsignlSHSLKDFYmsncnvsggipeeitnltnsitidlggnklngsipITLSKLQKLqglglddnklegsipdsiCRLTELYELelggnklfgsipaCFSNLASLRILSlssneltsipltfWNLKDILQlnfssnfltgplpleigNLKVLIGIDfsmnnfssvipteigglknlEYLFLGYnrlegsipdsfgdlISLKFLNlsnnnlsgaiptsleklSYLEDLNLSFNklegeiprggsfgnfaaesfegnellcgsptlqvlpcktsihhtswKNSLLLGIVLPLSTTLLIVVIWLILRYrkrgkqpsndanmplvATWRTFSYLELCratngfsennligrggfgsvykarlgdGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEykphgslekylyssnCILDIFQRLNIMIDVASALEYLhfgclapvihcdlkpdnvllddnLVAYLSDFGIAKLLIGED
Flexible Loop (DISEMBL)
eipleisnLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYrkrgkqpsndanmplVATWRTFSYLELCRATNgfsennligrgGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED
Low Complexity Region (SEG)
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMlkllhlqnnsllgclSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSklqklqglglddNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIslkflnlsnnnlsGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPlsttllivviwlilRYRKRGKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED
Disordered region (IsUnstruct)
***********LEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKR*******ANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI***
Disordered Region (DISOPRED)
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP*********************LGIVLPLSTTLLIVVIWLIL********************WRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG**
Disordered Region (DISEMBL)
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED
Disordered Region (DISPRO)
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGK*******MPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	646	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.992	0.634	0.407	1e-115
C0LGT6	1031	LRR receptor-like serine/	no	no	0.996	0.624	0.393	1e-110
Q9SD62	1025	Putative receptor-like pr	no	no	0.996	0.628	0.400	1e-102
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.978	0.644	0.364	3e-98
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.984	0.509	0.334	4e-87
Q9FL28	1173	LRR receptor-like serine/	no	no	0.982	0.541	0.340	1e-86
Q9LJF3	1164	Receptor-like protein kin	no	no	0.984	0.546	0.336	8e-85
Q42371	976	LRR receptor-like serine/	no	no	0.976	0.646	0.332	6e-83
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.978	0.574	0.339	1e-82
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.944	0.583	0.327	2e-82

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 274/673 (40%), Positives = 382/673 (56%), Gaps = 32/673 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP +++ L  +  L L  N   G  P A++N+S LKLL +  N   G L     + LPN
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L +  + GN F+G+IP  + N S L  L +++N+ +G IP TFGN+ NL+ L L  N L 
Sbjct: 261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLG 319

Query: 121 S-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           S S+ +L FL+SL+NC  L  + +  N L G L   SI NLS  L    +    +SG IP
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDL-PISIANLSAKLVTLDLGGTLISGSIP 378

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
            +I NL N   + L  N L+G +P +L KL  L+ L L  N+L G IP  I  +T L  L
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
           +L  N   G +P    N + L  L +  N+L  +IPL    ++ +L+L+ S N L G LP
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLP 498

Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            +IG L+ L  +    N  S  +P  +G    +E LFL  N   G IPD  G L+ +K +
Sbjct: 499 QDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEV 557

Query: 359 NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
           +LSNN+LSG+IP      S LE LNLSFN LEG++P  G F N    S  GN  LCG   
Sbjct: 558 DLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIM 617

Query: 419 -LQVLPCKTSI-----HHTSWKNSLLLGIVLPLSTTLL-----IVVIWLILRYRKRGKQP 467
             Q+ PC +        H+S    +++G+ + ++  LL     + +IW  LR RK+ K+ 
Sbjct: 618 GFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW--LRKRKKNKET 675

Query: 468 SNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNL 526
           +N     L       SY +L  ATNGFS +N++G G FG+VYKA  L +   VAVKV N+
Sbjct: 676 NNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNM 735

Query: 527 QCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLYS 581
           Q   A KSF  ECE +K IRHRNL+K++++CS+      EF+AL+ E+ P+GSL+ +L+ 
Sbjct: 736 QRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP 795

Query: 582 SNC--------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL 633
                       L + +RLNI IDVAS L+YLH  C  P+ HCDLKP NVLLDD+L A++
Sbjct: 796 EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHV 855

Query: 634 SDFGIAKLLIGED 646
           SDFG+A+LL+  D
Sbjct: 856 SDFGLARLLLKFD 868

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  400 bits (1029), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 265/673 (39%), Positives = 375/673 (55%), Gaps = 29/673 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP E++ L  +    +  N   G  P A++N+S L+ L L +NS  G L +     LPN
Sbjct: 208 EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPN 267

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR-DNYL 119
           L  LLL  N F+G IP+ + N S L   ++S N  SG IP +FG LRNL WL +R ++  
Sbjct: 268 LRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLG 327

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
            +S+  L F+ +++NC  L ++ +  N L G L   SI NLS +L   ++    +SG IP
Sbjct: 328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGEL-PASIANLSTTLTSLFLGQNLISGTIP 386

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
            +I NL +   + L  N L+G +P++  KL  LQ + L  N + G IP     +T L +L
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
            L  N   G IP        L  L + +N L  +IP     +  +  ++ S+NFLTG  P
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFP 506

Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            E+G L++L+G+  S N  S  +P  IGG  ++E+LF+  N  +G+IPD    L+SLK +
Sbjct: 507 EEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNV 565

Query: 359 NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
           + SNNNLSG IP  L  L  L +LNLS NK EG +P  G F N  A S  GN  +CG   
Sbjct: 566 DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVR 625

Query: 418 TLQVLPCKTSIHHT-----SWKNSLLLGIVLPLSTTLLIVVI----WLILRYRKRGKQPS 468
            +Q+ PC            S +  ++ GI + +++ LLI+++    W + R +K      
Sbjct: 626 EMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDG 685

Query: 469 NDANMPLVATWR-TFSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNL 526
           N ++   +  +    SY EL  AT+ FS  NLIG G FG+V+K  LG +   VAVKV NL
Sbjct: 686 NPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNL 745

Query: 527 QCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY- 580
               A KSF  ECE  K IRHRNL+K+I+ CS+      +F+ALV E+ P GSL+ +L  
Sbjct: 746 LKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQL 805

Query: 581 -------SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL 633
                    +  L   ++LNI IDVASALEYLH  C  PV HCD+KP N+LLDD+L A++
Sbjct: 806 EDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHV 865

Query: 634 SDFGIAKLLIGED 646
           SDFG+A+LL   D
Sbjct: 866 SDFGLAQLLYKYD 878

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  372 bits (956), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 269/672 (40%), Positives = 378/672 (56%), Gaps = 28/672 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP +I+ L+ +    +  NK  G  P  I+N+S L  L +  NS  G L       LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+ L +  N+F+GTIP  + N S L  L++  N  +G IP +FG L+NL  L L +N L 
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query: 121 S-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           + S+ +L FL +L+NC  L ++++  N L G L    I NLS  L +  +    +SG IP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQL-PVFIANLSTQLTELSLGGNLISGSIP 394

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
             I NL +  T+DLG N L G +P +L +L +L+ + L  N L G IP S+  ++ L  L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
            L  N   GSIP+   + + L  L+L +N+L  SIP     L  ++ LN S N L GPL 
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLR 514

Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            +IG LK L+ +D S N  S  IP  +    +LE+L L  N   G IPD  G L  L+FL
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFL 573

Query: 359 NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
           +LS NNLSG IP  +   S L++LNLS N  +G +P  G F N +A S  GN  LCG  P
Sbjct: 574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633

Query: 418 TLQVLPCKTSI--HHTSWKNSLLLGI-----VLPLSTTLLIVVIWLILRYRK-RGKQPSN 469
           +LQ+ PC   +   H+S +  + + +      L L    ++ + W  LR +  R     N
Sbjct: 634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693

Query: 470 DANM-PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ 527
           D +  P+ + +   SY EL + T GFS +NLIG G FG+V+K  LG     VA+KV NL 
Sbjct: 694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753

Query: 528 CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYKPHGSLEKYLYSS 582
              A KSF  ECE +  IRHRNL+K+++ CS+ +F     +ALV E+ P+G+L+ +L+  
Sbjct: 754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPD 813

Query: 583 NC--------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS 634
                      L +F RLNI IDVASAL YLH  C  P+ HCD+KP N+LLD +L A++S
Sbjct: 814 EIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVS 873

Query: 635 DFGIAKLLIGED 646
           DFG+A+LL+  D
Sbjct: 874 DFGLAQLLLKFD 885

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  360 bits (923), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 254/696 (36%), Positives = 371/696 (53%), Gaps = 64/696 (9%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIF---NMSMLKLLHLQNNSLLGCLSSIADVRL 58
           IP E+  L  L  LDL  N+L G++P  +F   + S L+ + L NNSL G +       L
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDN 117
             L  LLLW N  +GT+P  + N++ L  ++L  N  SG +P      +  L++L L  N
Sbjct: 191 KELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYN 250

Query: 118 YLTS---STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNV 174
           +  S   +T    F +SL+N   L  + L+ N L G ++ +S+ +LS +L   ++    +
Sbjct: 251 HFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEIT-SSVRHLSVNLVQIHLDQNRI 309

Query: 175 SGGIPEEIT------------------------NLTNSITIDLGGNKLNGSIPITLSKLQ 210
            G IP EI+                         L+    + L  N L G IP+ L  + 
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369

Query: 211 KLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNEL 270
           +L  L +  N L GSIPDS   L++L  L L GN L G++P       +L IL LS N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429

Query: 271 T-SIPL-TFWNLKDI-LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGG 327
           T +IP+    NL+++ L LN SSN L+GP+PLE+  + +++ +D S N  S  IP ++G 
Sbjct: 430 TGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGS 489

Query: 328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
              LE+L L  N    ++P S G L  LK L++S N L+GAIP S ++ S L+ LN SFN
Sbjct: 490 CIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFN 549

Query: 388 KLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLST 447
            L G +   GSF     ESF G+ LLCGS    +  CK       + + LL  ++  ++T
Sbjct: 550 LLSGNVSDKGSFSKLTIESFLGDSLLCGS-IKGMQACKKK---HKYPSVLLPVLLSLIAT 605

Query: 448 TLLIVVIWLILRYRKRG---------------KQPSNDANMPLVATWRTFSYLELCRATN 492
            +L V  + +++  + G               KQ  ND   P +      SY +L  AT 
Sbjct: 606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI------SYQQLIAATG 659

Query: 493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLI 551
           GF+ ++LIG G FG VYK  L +  +VAVKV + +    F  SF  EC+++K  RHRNLI
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFG 608
           ++I++CS   F ALVL   P+GSLE++LY    S+  LD+ Q +NI  DVA  + YLH  
Sbjct: 720 RIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHY 779

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
               V+HCDLKP N+LLDD + A ++DFGI++L+ G
Sbjct: 780 SPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQG 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  322 bits (826), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 256/765 (33%), Positives = 374/765 (48%), Gaps = 129/765 (16%)

Query: 1    EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLS-SIADV--- 56
            EIP+E+S  Q+L++LDL +N L G++P A+F +  L  L+L NN+L G LS SI+++   
Sbjct: 351  EIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNL 410

Query: 57   ------------RLPN-------LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG 97
                        +LP        LE L L+ N FSG IP+ I N + L ++++  N F G
Sbjct: 411  QWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEG 470

Query: 98   FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSI 157
             IP + G L+ L  L+LR N L    P     +SL NC  L  + L+DN L G +  +S 
Sbjct: 471  EIPPSIGRLKELNLLHLRQNELVGGLP-----ASLGNCHQLNILDLADNQLSGSI-PSSF 524

Query: 158  G--------------------------------NLSH--------------SLKDFYMSN 171
            G                                NLSH              S   F ++N
Sbjct: 525  GFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN 584

Query: 172  CNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC 231
                  IP E+ N  N   + LG N+L G IP TL K+++L  L +  N L G+IP  + 
Sbjct: 585  NGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLV 644

Query: 232  RLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNE-LTSIPLTFWNLKDILQLNFSS 290
               +L  ++L  N L G IP     L+ L  L LSSN+ + S+P   +N   +L L+   
Sbjct: 645  LCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDG 704

Query: 291  NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFG 350
            N L G +P EIGNL  L  ++   N FS  +P  +G L  L  L L  N L G IP   G
Sbjct: 705  NSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIG 764

Query: 351  DLISLK-FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR-------------- 395
             L  L+  L+LS NN +G IP+++  LS LE L+LS N+L GE+P               
Sbjct: 765  QLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVS 824

Query: 396  ----GG----SFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHT--SWKNSLLLGIVLPL 445
                GG     F  + A+SF GN  LCGSP  +    +++      S ++ +++  +  L
Sbjct: 825  FNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISAL 884

Query: 446  STT-LLIVVIWLILRYR-----KRGKQPS---------NDANMPLV---ATWRTFSYLEL 487
            +   L+I+VI L  + R     K G   +            + PL    A+     + ++
Sbjct: 885  TAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDI 944

Query: 488  CRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIR 546
              AT+  SE  +IG GG G VYKA L +G  VAVK    +    + KSF+ E + +  IR
Sbjct: 945  MEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIR 1004

Query: 547  HRNLIKVISSCSN--EEFKALVLEYKPHGSLEKYLYSSNCIL-------DIFQRLNIMID 597
            HR+L+K++  CS+  E    L+ EY  +GS+  +L+    +L       D   RL I + 
Sbjct: 1005 HRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVG 1064

Query: 598  VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +A  +EYLH  C+ P++H D+K  NVLLD N+ A+L DFG+AK+L
Sbjct: 1065 LAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL 1109

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  321 bits (823), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 256/751 (34%), Positives = 377/751 (50%), Gaps = 116/751 (15%)

Query: 1    EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +IP E+ NL  L+ L +  NKL  ++P+++F ++ L  L L  N L+G +S      L +
Sbjct: 279  KIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGF-LES 337

Query: 61   LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
            LE L L  NNF+G  P+ I N   L++L +  N+ SG +P   G L NL  L+  DN LT
Sbjct: 338  LEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLT 397

Query: 121  SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSK---------TSIG------------- 158
               P     SS+SNC  L  + LS N + G + +          SIG             
Sbjct: 398  GPIP-----SSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFTGEIPDDIF 452

Query: 159  -------------NLSHSLKDF----------YMSNCNVSGGIPEEITNLTNSITIDLGG 195
                         NL+ +LK             +S  +++G IP EI NL +   + L  
Sbjct: 453  NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHS 512

Query: 196  NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFS 255
            N   G IP  +S L  LQGL +  N LEG IP+ +  +  L  L+L  NK  G IPA FS
Sbjct: 513  NGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFS 572

Query: 256  NLASLRILSLSSNELT-SIP-----LTFWNLKDI---------------------LQLNF 288
             L SL  LSL  N+   SIP     L+  N  DI                     L LNF
Sbjct: 573  KLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNF 632

Query: 289  SSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD- 347
            S+N LTG +P E+G L+++  ID S N FS  IP  +   KN+  L    N L G IPD 
Sbjct: 633  SNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDE 692

Query: 348  ------------------------SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLN 383
                                    SFG++  L  L+LS+NNL+G IP SL  LS L+ L 
Sbjct: 693  VFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLK 752

Query: 384  LSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPC--KTSIHHTSWKNS---LL 438
            L+ N L+G +P  G F N  A    GN  LCGS    + PC  K    H S +     ++
Sbjct: 753  LASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILII 811

Query: 439  LGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVAT---WRTFSYLELCRATNGFS 495
            LG    L   LL+V+I    + +++  + S+++++P + +    + F   EL +AT+ F+
Sbjct: 812  LGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFN 871

Query: 496  ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKV 553
              N+IG     +VYK +L DG  +AVKV NL+     + K F  E + +  ++HRNL+K+
Sbjct: 872  SANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKI 931

Query: 554  IS-SCSNEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLA 611
            +  +  + + KALVL +  +G+LE  ++ S   I  + +++++ + +AS ++YLH G   
Sbjct: 932  LGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF 991

Query: 612  PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            P++HCDLKP N+LLD + VA++SDFG A++L
Sbjct: 992  PIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  315 bits (807), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 247/733 (33%), Positives = 353/733 (48%), Gaps = 97/733 (13%)

Query: 1    EIPLEISNL-QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLP 59
            EIP E+S L + LE LDL  N L G +P +  +   L+ L+L NN L G   S    +L 
Sbjct: 292  EIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLS 351

Query: 60   NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRN---LEWLNLRD 116
             +  L L  NN SG++P  + N S L +L+LS N F+G +P+ F +L++   LE L + +
Sbjct: 352  RITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIAN 411

Query: 117  NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
            NYL+ + P       L  CKSL  I LS N L G++ K  I  L   L D  M   N++G
Sbjct: 412  NYLSGTVP-----VELGKCKSLKTIDLSFNALTGLIPK-EIWTLPK-LSDLVMWANNLTG 464

Query: 177  GIPEEI-------------------------TNLTNSITIDLGGNKLNGSIPITLSKLQK 211
            GIPE I                         +  TN + I L  N L G IP+ + KL+K
Sbjct: 465  GIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEK 524

Query: 212  LQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL-SLSSNEL 270
            L  L L +N L G+IP  +     L  L+L  N L G++P   ++ A L +  S+S  + 
Sbjct: 525  LAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQF 584

Query: 271  TSIP-------------LTFWNLKDILQLNF-------SSNFLTGPLPLEIGNLKVLIGI 310
              +              + F  ++     +F        +   +G       +   +I +
Sbjct: 585  AFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYL 644

Query: 311  DFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
            D S N  S  IP   G +  L+ L LG+N L G+IPDSFG L ++  L+LS+N+L G +P
Sbjct: 645  DLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLP 704

Query: 371  TSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCK----- 425
             SL  LS+L DL++S N L G IP GG    F    +  N  LCG P   + PC      
Sbjct: 705  GSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPCSSGSRP 761

Query: 426  TSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSND--------------- 470
            T  H    K S+  G+   +  + + +V+ ++  YR R  Q                   
Sbjct: 762  TRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSS 821

Query: 471  ------ANMPL---VATW----RTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGM 517
                   + PL   VAT+    R  ++  L  ATNGFS +++IG GGFG VYKA+L DG 
Sbjct: 822  SWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGS 881

Query: 518  EVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEK 577
             VA+K      G+  + F  E E +  I+HRNL+ ++  C   E + LV EY  +GSLE 
Sbjct: 882  VVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLET 941

Query: 578  YLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL 633
             L+         LD   R  I I  A  L +LH  C+  +IH D+K  NVLLD + VA +
Sbjct: 942  VLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARV 1001

Query: 634  SDFGIAKLLIGED 646
            SDFG+A+L+   D
Sbjct: 1002 SDFGMARLVSALD 1014

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  308 bits (790), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 234/703 (33%), Positives = 345/703 (49%), Gaps = 72/703 (10%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           +IP EI +  +L+ LDL  N+L G +P +I  +  L+ L L+NN L+G + S    ++PN
Sbjct: 107 QIPDEIGDCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLS-QIPN 165

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+ L L  N  SG IPR I+    L  L L  N+  G I      L  L + ++R+N LT
Sbjct: 166 LKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLT 225

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGIL---------------------SKTSIGN 159
            S PE     ++ NC +   + LS N L G +                        S+  
Sbjct: 226 GSIPE-----TIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVATLSLQGNQLSGKIPSVIG 280

Query: 160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD 219
           L  +L    +S   +SG IP  + NLT +  + L  NKL GSIP  L  + KL  L L+D
Sbjct: 281 LMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELND 340

Query: 220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFW 278
           N L G IP  + +LT+L++L +  N L G IP   S+  +L  L++  N+ + +IP  F 
Sbjct: 341 NHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQ 400

Query: 279 NLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGY 338
            L+ +  LN SSN + GP+P+E+  +  L  +D S N  + +IP+ +G L++L  + L  
Sbjct: 401 KLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSR 460

Query: 339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS--------------------- 377
           N + G +P  FG+L S+  ++LSNN++SG IP  L +L                      
Sbjct: 461 NHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLAN 520

Query: 378 --YLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIH--HTSW 433
              L  LN+S N L G+IP+  +F  F+ +SF GN  LCGS      PC  S      S 
Sbjct: 521 CLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNS--PCHDSRRTVRVSI 578

Query: 434 KNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWRT------------ 481
             + +LGI +     L+I+++ LI   R     P  D ++    T+ T            
Sbjct: 579 SRAAILGIAI---GGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMAL 635

Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM 541
             Y ++ R T   SE  +IG G   +VYK  L +   VA+K       ++ K F  E EM
Sbjct: 636 HVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEM 695

Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY--SSNCILDIFQRLNIMIDVA 599
           + SI+HRNL+ + +   +     L  +Y  +GSL   L+  +    LD   RL I    A
Sbjct: 696 LSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAA 755

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             L YLH  C   +IH D+K  N+LLD +L A L+DFGIAK L
Sbjct: 756 QGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSL 798

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  308 bits (788), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 249/734 (33%), Positives = 351/734 (47%), Gaps = 102/734 (13%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           +P ++  LQNL +L L  N+L G +P ++ N+S L++L L  N   G +      +L  +
Sbjct: 227 LPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIG-KLTKM 285

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           + L L+ N  +G IPR I N    + ++ S+N  +GFIP  FG++ NL+ L+L +N L  
Sbjct: 286 KRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLG 345

Query: 122 STP----ELSFLSSL---------SNCKSLTFI------HLSDNPLDGILSKTSIGNLSH 162
             P    EL+ L  L         +  + L F+       L DN L+G +    IG  S+
Sbjct: 346 PIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPL-IGFYSN 404

Query: 163 -SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
            S+ D  MS  ++SG IP         I + LG NKL+G+IP  L   + L  L L DN+
Sbjct: 405 FSVLD--MSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQ 462

Query: 222 LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNL 280
           L GS+P  +  L  L  LEL  N L G+I A    L +L  L L++N  T  IP    NL
Sbjct: 463 LTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNL 522

Query: 281 KDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR 340
             I+  N SSN LTG +P E+G+   +  +D S N FS  I  E+G L  LE L L  NR
Sbjct: 523 TKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNR 582

Query: 341 LEGSIPDSFGDLISLK-------------------------FLNLSNNNLSGAIPTSLEK 375
           L G IP SFGDL  L                           LN+S+NNLSG IP SL  
Sbjct: 583 LTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGN 642

Query: 376 LSYLEDLNLSFNKLEGEIPRG------------------------GSFGNFAAESFEGNE 411
           L  LE L L+ NKL GEIP                            F    + +F GN 
Sbjct: 643 LQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH 702

Query: 412 LLCGSPTLQVLPCKTSIHHT----------SWKNSLLLGIVLPLSTTLLIVVIWLILRYR 461
            LC S   Q   C+  + H+          S +  +L    + + +  LI  + L    +
Sbjct: 703 GLCNS---QRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIK 759

Query: 462 KRGKQPS----NDANMPLVAT-----WRTFSYLELCRATNGFSENNLIGRGGFGSVYKAR 512
           +R  +P+     D   P V        + F+Y  L  AT  FSE+ ++GRG  G+VYKA 
Sbjct: 760 RR--EPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAE 817

Query: 513 LGDGMEVAVKVFNLQCGRAFK--SFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK 570
           +  G  +AVK  N +   A    SF  E   +  IRHRN++K+   C ++    L+ EY 
Sbjct: 818 MSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYM 877

Query: 571 PHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN 628
             GSL + L     NC+LD   R  I +  A  L YLH  C   ++H D+K +N+LLD+ 
Sbjct: 878 SKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDER 937

Query: 629 LVAYLSDFGIAKLL 642
             A++ DFG+AKL+
Sbjct: 938 FQAHVGDFGLAKLI 951

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  306 bits (785), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 225/686 (32%), Positives = 339/686 (49%), Gaps = 76/686 (11%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSL-------LGCLSSI 53
           EIP EI N+  L+ L L  NKL G +P+ + N+  L +LHL  N L       LG + S+
Sbjct: 277 EIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESM 336

Query: 54  ADV----------------RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG 97
            D+                +L  LE L L  N  SG IP  I N+++L++L+L  N+F+G
Sbjct: 337 IDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTG 396

Query: 98  FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSI 157
           F+P+T      LE L L DN+     P+     SL +CKSL  +    N           
Sbjct: 397 FLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIRVRFKGN----------- 440

Query: 158 GNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL 217
                          + SG I E          IDL  N  +G +     + QKL    L
Sbjct: 441 ---------------SFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFIL 485

Query: 218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLT 276
            +N + G+IP  I  +T+L +L+L  N++ G +P   SN+  +  L L+ N L+  IP  
Sbjct: 486 SNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSG 545

Query: 277 FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
              L ++  L+ SSN  +  +P  + NL  L  ++ S N+    IP  +  L  L+ L L
Sbjct: 546 IRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDL 605

Query: 337 GYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
            YN+L+G I   F  L +L+ L+LS+NNLSG IP S + +  L  +++S N L+G IP  
Sbjct: 606 SYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDN 665

Query: 397 GSFGNFAAESFEGNELLCGS--PTLQVLPCKTSIHHTSWKN-SLLLGIVLPLSTTLLI-- 451
            +F N   ++FEGN+ LCGS   T  + PC  +    S K+ +L++ I++P+   ++I  
Sbjct: 666 AAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILS 725

Query: 452 VVIWLILRYRKRGKQ-------PSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGG 504
           V   + + +RKR KQ        S    + + +      Y E+ +AT  F    LIG GG
Sbjct: 726 VCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGG 785

Query: 505 FGSVYKARLGDGMEVAVKVFNLQCGRAF------KSFAVECEMMKSIRHRNLIKVISSCS 558
            G VYKA+L + + +AVK  N     +       + F  E   +  IRHRN++K+   CS
Sbjct: 786 HGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCS 844

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
           +     LV EY   GSL K L + +    LD  +R+N++  VA AL Y+H      ++H 
Sbjct: 845 HRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHR 904

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLL 642
           D+   N+LL ++  A +SDFG AKLL
Sbjct: 905 DISSGNILLGEDYEAKISDFGTAKLL 930

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	646
255585401	843	serine-threonine protein kinase, plant-t	0.984	0.754	0.551	1e-180
255572272	1089	serine-threonine protein kinase, plant-t	0.996	0.591	0.531	1e-176
224116832	1061	predicted protein [Populus trichocarpa]	0.990	0.603	0.526	1e-175
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.987	0.438	0.530	1e-172
359485453	1202	PREDICTED: probable LRR receptor-like se	0.993	0.534	0.533	1e-170
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.987	0.519	0.529	1e-170
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.993	0.452	0.525	1e-169
224139658	1019	predicted protein [Populus trichocarpa]	0.995	0.631	0.516	1e-169
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.987	0.510	0.527	1e-168
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.987	0.609	0.519	1e-168

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 354/642 (55%), Positives = 447/642 (69%), Gaps = 6/642 (0%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           IP EI  L NL  L LR+N L G++P+ + N+S +K + +  N L G L S     LPNL
Sbjct: 67  IPTEIGKLSNLVHLLLRYNFLTGSIPSTLLNISAIKTISINVNQLSGHLPSTLGYGLPNL 126

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           E L +  N F GT+P  I NASKL+ILE S NS SG IP+T  NL+NL+ LNL DN   S
Sbjct: 127 EELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIPDTLCNLKNLKRLNLADN---S 183

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
            T EL FL+SL+ CK L  + L  NPL+  L  TSIGNLS S++ F + +CN+ G IP E
Sbjct: 184 FTDELGFLASLARCKELRRLVLIGNPLNSTL-PTSIGNLS-SIEYFNVQSCNIKGNIPSE 241

Query: 182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
           I  L+N IT+ L  N+L GSIP+T+  LQKLQ L L  N L GSIP  IC L+ L EL L
Sbjct: 242 IGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFL 301

Query: 242 GGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPLPLE 300
             N LFG +PACF +L SLRIL L SN  TS IP + W+LKD+L+LN SSN L+G +PL 
Sbjct: 302 SNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLS 361

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
           IGNLKVL  +DFS N+ S +IP  IG L+NL  L L +NR EG IP+ FG+LISL+ L+L
Sbjct: 362 IGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDL 421

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQ 420
           S+NNLSG IP SLE+L YL+ LN+SFN L+GE+P  G+F NF+A SF GN  LCGS  L 
Sbjct: 422 SSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLP 481

Query: 421 VLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWR 480
           ++PCK + H  S  ++ LL I +  ++ L I  I + LR +K   +  N  ++  V TWR
Sbjct: 482 LMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIITVGTWR 541

Query: 481 TFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECE 540
             S+ EL +AT+GF  +NL+G GG+GSVYK RL DG  VA+KVFNL    AFK F  ECE
Sbjct: 542 RISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECE 601

Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
           +M SIRHRNL+K+IS CSN++FKA+VLEY P+GSLEK+LYS N  L+I QRL +MIDVAS
Sbjct: 602 VMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVAS 661

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ALEYLH G  AP++HCDLKP NVLLD ++V +++DFG+AKLL
Sbjct: 662 ALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL 703

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  624 bits (1609), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 347/653 (53%), Positives = 452/653 (69%), Gaps = 9/653 (1%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            IPLEI NLQNL+ + L  N L G++P A+FN+S +K + + +N+LLG L +   + LPN
Sbjct: 303 RIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPN 362

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  L L  N  SG IP +I NASKL+ILEL  NSF+GFIP++ G+LRNL+ L L  N L+
Sbjct: 363 LIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLS 422

Query: 121 S--STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           S  ++ EL+  SSL NC++L ++ LS NPLDG L   S+GNLS+SL+ F  S+  + G +
Sbjct: 423 SKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPH-SVGNLSNSLESFLASDGLIKGSV 481

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
            E I NL++   ++LG N L G IP T+  L+ LQGL L  N L+GSIP  +C L  LY 
Sbjct: 482 HESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYN 541

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPL 297
           LEL GNKL GSIP CFSNL SLR L L+SN   S I  T W LKDILQ+N +SN+LTG L
Sbjct: 542 LELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSL 601

Query: 298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKF 357
           P EI NL+ +  I+ S N  S  IP  IGGL++L  L+L  N+L+G IP S GD+ SL+F
Sbjct: 602 PSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEF 661

Query: 358 LNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP 417
           L+LS+NNLSG IP SL+ L YL+  N+SFN L+GEIP GGSF NF+A+SF GNE LCGS 
Sbjct: 662 LDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSA 721

Query: 418 TLQVLPCK--TSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLIL--RYRKRGKQPSNDANM 473
            LQV PCK   S    +  + ++L  VLP     + V+ ++I+  RY +R  + S + + 
Sbjct: 722 RLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDF 781

Query: 474 PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK 533
             + T R  SY EL  ATNGF E+N +G G FGSVYK  L DG  +A KVFNLQ  RAFK
Sbjct: 782 LALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFK 841

Query: 534 SFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN 593
           SF  ECE+++++RHRNL+K+I+SCS   FKALVLE+ P+ SLEK+LYS +  L+  QRLN
Sbjct: 842 SFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLN 901

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           IM+DVAS LEYLH G   P+ HCD+KP NVLL++++VA+L+DFGI+KLL GE+
Sbjct: 902 IMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEE 953

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  622 bits (1603), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 340/646 (52%), Positives = 437/646 (67%), Gaps = 6/646 (0%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           IP E+ NL  L+ELDL  N + G++P+  FN S+L+ +++  N L G L S   + LPNL
Sbjct: 275 IPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNL 334

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           E L L  N  SG IP  I NASKL +L+LS NSFSG IP+  GNLRNL+ LNL +N LTS
Sbjct: 335 EELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTS 394

Query: 122 STPELSFLSSLS--NCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
            +         S  NC+SL ++  + NPL G L   SIGNLS SL++ Y  +C + G IP
Sbjct: 395 KSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRL-PVSIGNLSASLEELYAFDCRIIGNIP 453

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
             I NL+N I + L  N+L G+IP  + +L+ LQ   L  NKL+G IP+ IC L  L  L
Sbjct: 454 RGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYL 513

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPL 299
            L  N   GS+PAC SN+ SLR L L SN  TSIP TFW+LKD+LQ+N S N LTG LPL
Sbjct: 514 YLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPL 573

Query: 300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLN 359
           EIGNLKV+  IDFS N  S  IPT I  L+NL +  L  NR++G IP SFGDL+SL+FL+
Sbjct: 574 EIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLD 633

Query: 360 LSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTL 419
           LS N+LSGAIP SLEKL +L+  N+SFN+L+GEI  GG F NF+  SF  NE LCG   +
Sbjct: 634 LSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRM 693

Query: 420 QVLPCKT-SIHHTSWK-NSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPL-V 476
           QV PCK+ S H  S +    ++  ++P    +++V+   ++ +R+  K+  +    PL  
Sbjct: 694 QVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPP 753

Query: 477 ATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFA 536
           ATWR  SY EL RAT GF+E NL+G G  GSVYK  L DG+ +AVKVF+LQ       F 
Sbjct: 754 ATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFD 813

Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            ECE+++ +RHRNL+K+ISSC N +FKAL+LE+ PHGSLEK+LYS N  LDI QRLNIMI
Sbjct: 814 SECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMI 873

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           DVASALEYLH GC  PV+HCDLKP NVL+++++VA++SDFGI++LL
Sbjct: 874 DVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL 919

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  611 bits (1575), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 344/648 (53%), Positives = 438/648 (67%), Gaps = 10/648 (1%)

Query: 2    IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            IP E+ NL NL+ L L  N L G +P AIFN+S L+ L L  N   G L S    +LP+L
Sbjct: 678  IPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDL 737

Query: 62   EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            E L +  N FSG IP  I N S+L+ L++  N F+G +P   GNLR LE+LNL  N LT 
Sbjct: 738  EGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTD 797

Query: 122  --STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
              S  E+ FL+SL+NC  L  + + DNPL GIL   S+GNLS SL+ F  S C   G IP
Sbjct: 798  EHSASEVGFLTSLTNCNFLRTLWIEDNPLKGIL-PNSLGNLSISLESFDASACQFRGTIP 856

Query: 180  EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
              I NLT+ I+++LG N L G IP TL +L+KLQ LG+  N+L GSIP+ +CRL  L  L
Sbjct: 857  TGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYL 916

Query: 240  ELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPLP 298
             L  N+L GSIP+C   L  LR L L SN L S IP + W L+ +L LN SSNFLTG LP
Sbjct: 917  FLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLP 976

Query: 299  LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
             E+GN+K +  +D S N  S  IP  +G L+NLE L L  NRL+G IP  FGDL+SLKFL
Sbjct: 977  PEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFL 1036

Query: 359  NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            +LS NNLSG IP SL+ L+YL+ LN+SFNKL+GEIP GG F NF AESF  NE LCG+P 
Sbjct: 1037 DLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPH 1096

Query: 419  LQVLPCKTSIHHTSWKNSL-LLGIVLPLSTTLLIVVIWLIL--RYRKRGKQPSN-DANMP 474
             QV+ C  S    SW+  L +L  +LP   +++ +V++L+L  R RK  + P+  D+ +P
Sbjct: 1097 FQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP 1156

Query: 475  LVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS 534
               +    S+ +L  ATN F E+NLIG+G    VYK  L +G+ VAVKVFNL+   AF+S
Sbjct: 1157 --GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRS 1214

Query: 535  FAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
            F  ECE+M+SIRHRNL+K+I+ CSN +FKALVLEY P GSL+K+LYS N  LD+ QRLNI
Sbjct: 1215 FDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNI 1274

Query: 595  MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            MIDVASALEYLH  C + V+HCDLKP+N+LLDD++VA++ DFGIA+LL
Sbjct: 1275 MIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLL 1322

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 347/651 (53%), Positives = 437/651 (67%), Gaps = 9/651 (1%)

Query: 2    IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            IP E+ NL NL+ L L  N L G VP AIFN+S L++L L  N L G L S     LPNL
Sbjct: 423  IPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNL 482

Query: 62   EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            E LL+ GN FSG IP  I N S L  L++S N F G +P   GNLR L+ L L  N LT+
Sbjct: 483  EQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTN 542

Query: 122  --STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
              S  EL+FL+SL+NC  L  + +SDNPL G++   S+GNLS SL+  Y S+C + G IP
Sbjct: 543  EHSASELAFLTSLTNCIFLRTLSISDNPLKGMI-PNSLGNLSISLEIIYASDCQLRGTIP 601

Query: 180  EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
              I+NLTN I + L  N L G IP    +LQKLQ L +  N++ GSIP  +C LT L  L
Sbjct: 602  TGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFL 661

Query: 240  ELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPLP 298
            +L  NKL G+IP+C  NL  LR + L SN L S IP +  NL+ +L LN SSNFL   LP
Sbjct: 662  DLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLP 721

Query: 299  LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            L++GN+K L+ +D S N FS  IP+ I  L+NL  L+L +N+L+G IP +FGDL+SL+ L
Sbjct: 722  LQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESL 781

Query: 359  NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            +LS NNLSG IP SLE L YLE LN+SFNKL+GEIP GG F NF AESF  N  LCG+P 
Sbjct: 782  DLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPR 841

Query: 419  LQVLPCKTSIHHTSWKNSLLLGIVLPLS---TTLLIVVIWLILRYRKRGKQPSNDANMPL 475
             QV+ C+      +   SLLL  ++PLS   +T+++VV+++  + R+   +     ++ L
Sbjct: 842  FQVMACEKDSRKNT--KSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSL 899

Query: 476  VATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSF 535
                R   + EL  ATN F E+NLIG+G  G VYK  L DG+ VAVKVFNL+   AFKSF
Sbjct: 900  PRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSF 959

Query: 536  AVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
             VECE+M++IRHRNL K+ISSCSN +FKALVLEY P+GSLEK+LYS N  LD  QRL IM
Sbjct: 960  EVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIM 1019

Query: 596  IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            IDVAS LEYLH     PV+HCDLKP NVLLDD++VA++SDFGIAKLL+G +
Sbjct: 1020 IDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSE 1070

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  604 bits (1557), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 343/648 (52%), Positives = 432/648 (66%), Gaps = 10/648 (1%)

Query: 2    IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            IP    NL+ L+ L L  N L GT+P  IFN+S L+ L L  N L G L S     LP+L
Sbjct: 452  IPTSFGNLKALKFLQLGSNNLTGTIPEDIFNISKLQTLALAQNHLSGGLPSSIGTWLPDL 511

Query: 62   EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            E L + GN FSGTIP  I N SKL  L +S N F+G +P    NLR LE LNL  N LT 
Sbjct: 512  EGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTD 571

Query: 122  S--TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
               T E+ FL+SL+NCK L  + +  NPL G L   S+GNLS +L+ F  S C+  G IP
Sbjct: 572  EHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTL-PNSLGNLSVALESFTASACHFRGTIP 630

Query: 180  EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
              I NLTN I +DLG N L GSIP TL  LQKLQ L +  N+++GSIP+ +C L  L  L
Sbjct: 631  TGIGNLTNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYL 690

Query: 240  ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
             L  NKL GSIP+CF +L +LR LSL SN L  +IP++FW+L+D++ L+ SSNFLTG LP
Sbjct: 691  HLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLP 750

Query: 299  LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
             E+GN+K +  +D S N  S  IP  +G L+NL  L L  N+L+GSIP  FGDL+SL+ +
Sbjct: 751  PEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESM 810

Query: 359  NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            +LS NNL G IP SLE L YL+ LN+SFNKL+GEIP GG F NF AESF  NE LCG+P 
Sbjct: 811  DLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPH 870

Query: 419  LQVLPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRKRGKQPSN-DANMP 474
             QV+ C  +    SWK    +L  I+LP+ S   L+  I L +R R   + P+  D+ +P
Sbjct: 871  FQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP 930

Query: 475  LVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS 534
                    S  +L  ATNGF E+NLIG+G  G VYK  L +G+ VA+KVFNL+   A +S
Sbjct: 931  --GAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRS 988

Query: 535  FAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
            F  ECE+M+ I HRNLI++I+ CSN +FKALVLEY P GSL+K+LYS N  LD+FQRLNI
Sbjct: 989  FDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNI 1048

Query: 595  MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            MIDVASALEYLH  C + V+HCDLKP NVLLD+N+VA+++DFGIA+LL
Sbjct: 1049 MIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLL 1096

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  601 bits (1550), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 342/651 (52%), Positives = 434/651 (66%), Gaps = 9/651 (1%)

Query: 2    IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            IP E+ NL NL+ L L  N L G +P AIFN+S L+ L L  N   G L S    +LP+L
Sbjct: 424  IPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDL 483

Query: 62   EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            E L +  N FSG IP  I N S+L++L++  N F+G +P   GNLR LE+LNL  N LT 
Sbjct: 484  EGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTD 543

Query: 122  --STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
              ST E+ FL+SL+NCK L  + + DNPL GIL   S+GNLS SL+ F  S C   G IP
Sbjct: 544  EHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGIL-PNSLGNLSISLESFDASACQFKGTIP 602

Query: 180  EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
              I NL N I + L  N L G IPI+   LQKLQ   +  N++ GSIP  +C L  L  L
Sbjct: 603  TGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYL 662

Query: 240  ELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPLP 298
            +L  NKL G+IP CF NL +LR +SL SN L S IP + W L+D+L LN SSNFL   LP
Sbjct: 663  DLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLP 722

Query: 299  LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            LE+GN+K L+ +D S N FS  IP+ I  L+NL  L+L +N+L+G +P +FG L+SL++L
Sbjct: 723  LEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYL 782

Query: 359  NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            +LS NN SG IPTSLE L YL+ LN+SFNKL+GEIP  G F NF AESF  N  LCG+P 
Sbjct: 783  DLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPR 842

Query: 419  LQVLPCKTSIHHTSWKNSLLLGIVLPLS---TTLLIVVIWLILRYRKRGKQPSNDANMPL 475
             QV+ C+      +   SLLL  ++PLS   +T+++VV++ + + R+   +     ++ L
Sbjct: 843  FQVMACEKDARRNT--KSLLLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQVDLLL 900

Query: 476  VATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSF 535
                R  S+ EL  AT+ F E NLIG+G  G VYK  L DG+ VAVKVFNL+   AFKSF
Sbjct: 901  PRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSF 960

Query: 536  AVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
             VECE+M++IRHRNL K+ISSCSN +FKALVLEY P+ SLEK+LYS N  LD  QRL IM
Sbjct: 961  EVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIM 1020

Query: 596  IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            IDVAS LEYLH     PV+HCDLKP NVLLDD++VA++SDFGIAKLL+G +
Sbjct: 1021 IDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSE 1071

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 336/650 (51%), Positives = 432/650 (66%), Gaps = 7/650 (1%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           IP E+  L  LE L+L  N L G +P +IFNM+ L+ + +  N+L G +     + LPNL
Sbjct: 235 IPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNL 294

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           E L L  N  +G++PRF+ N S+L IL+LS N  +G +   FGNLR L+ L+L+ N  T+
Sbjct: 295 EELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTN 354

Query: 122 --STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
             S+  L+F++SL+N + L  +H+ DNPLDG+L   S+GNLS  L  FY+    + G IP
Sbjct: 355 HPSSQTLNFITSLTNSRQLKELHIGDNPLDGML-PNSVGNLSSFLTKFYVYASKLKGNIP 413

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
            EI NL+N I + L  N L G IP T+  L+K+Q L L  N L GSIP  IC    L ++
Sbjct: 414 GEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDI 473

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPLP 298
            L  N L G IP+C  NL SLR L L  N L+S IP+  W+LKD+L LN  SNFL G LP
Sbjct: 474 TLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLP 533

Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
            ++G ++  IGI  S N  S  IP+ IG L+NL    L  N  +GSIP++FG L+SL+ L
Sbjct: 534 SQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELL 593

Query: 359 NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
           +LS NNLSG IP SLE L YLE  ++SFN L+GEIPRGG F NF A SF  N+ LCG   
Sbjct: 594 DLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSR 653

Query: 419 LQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVV--IWLILRYRKRGKQPSNDANMPLV 476
           LQV PC       S   S LL   LP   ++L+VV  I+L++  R+R ++      +P+ 
Sbjct: 654 LQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVT 713

Query: 477 ATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFA 536
           A  R  SYLEL  ATN F E+NL+G G FGSVY+ RL DG+ VAVK+FNLQ  RAF+SF 
Sbjct: 714 AIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFD 773

Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            ECE+M++IRHRNL+K+I SCSN +FKALVLEY P GSLEK+LYS N  LDI QR+NIMI
Sbjct: 774 TECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMI 833

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           DVASALEYLH G  +PV+HCDLKP NVLLD+++VA++ DFGIAKLL GE+
Sbjct: 834 DVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GEN 882

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  599 bits (1545), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 342/648 (52%), Positives = 432/648 (66%), Gaps = 10/648 (1%)

Query: 2    IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            IP    NL+ L+ L L  N L+GT+P  IFN+S L+ L L  N L G L S     LP+L
Sbjct: 452  IPTSFGNLKALKFLQLGSNNLIGTIPEDIFNISKLQTLALAQNHLSGGLPSSISTWLPDL 511

Query: 62   EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            E L + GN FSGTIP  I N SKL  L +S N F G +P    NLR LE LNL  N LT 
Sbjct: 512  EGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFIGNVPKDLSNLRKLEVLNLAGNQLTD 571

Query: 122  S--TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
               T E+ FL+SL+NCK L  + +  NPL G L   S+GNLS +L+ F  S C+  G IP
Sbjct: 572  EHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTL-PNSLGNLSVALESFTASACHFRGTIP 630

Query: 180  EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
              I NLTN I +DLG N L GSIP TL +LQKLQ L +  N+++GSIP+ +  L  L  L
Sbjct: 631  TGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYL 690

Query: 240  ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
             L  NKL GSIP+CF +L +LR LSL SN L  +IP++FW+L+D+L L+ SSNFLTG LP
Sbjct: 691  HLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLP 750

Query: 299  LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
             E+GN+K +  +D S N  S  IP  +G L+NL  L L  N+L+GSIP  FGDL+SL+ +
Sbjct: 751  PEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESM 810

Query: 359  NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            +LS NNLSG IP SLE L YL+ LN+SFNKL+GEIP GG F NF AESF  NE LCG+P 
Sbjct: 811  DLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPH 870

Query: 419  LQVLPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRKRGKQPSN-DANMP 474
             QV+ C  + H  SWK    +L  I+LP+ S   L+  I L +R +   + P+  D+ +P
Sbjct: 871  FQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDNTEIPAPIDSWLP 930

Query: 475  LVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS 534
                    S  +L  ATN F E+NLIG+G  G VYK  L +G+ VA+KVFNL+   A +S
Sbjct: 931  --GAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRS 988

Query: 535  FAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
            F  ECE+M+ I HRNLI++I+ CSN +FKALVLEY P GSL+K+LYS N  LD+FQRLNI
Sbjct: 989  FDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNI 1048

Query: 595  MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            MIDVA ALEYLH  C + V+HCDLKP NVLLD+N+VA+++DFGIA+LL
Sbjct: 1049 MIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLL 1096

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  598 bits (1542), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 342/658 (51%), Positives = 436/658 (66%), Gaps = 20/658 (3%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAI----------FNMSMLKLLHLQNNSLLGCLS 51
           IP EI NL  LEE+DL  N L+G++P +           FN+S L+ L L  N L G L 
Sbjct: 260 IPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQTLGLVQNHLSGSLP 319

Query: 52  SIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEW 111
           S     LP+LE L +  N FSGTIP  I N SKL++L LS NSF+G +P    NL  L++
Sbjct: 320 SSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLQF 379

Query: 112 LNLRDNYLTSS--TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
           L+L  N LT       + FL+SL+NCK L  + +  NPL G L   S+GNL  +L+ F  
Sbjct: 380 LDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTL-PNSLGNLPIALEIFIA 438

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDS 229
           S C   G IP  I NLTN I +DLG N L GSIP TL +LQKLQ L +  N++ GSIP+ 
Sbjct: 439 SACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPND 498

Query: 230 ICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNF 288
           +C L  L  L L  NKL GSIP+CF +L +LR LSL SN L  +IP++FW+L+D+L LN 
Sbjct: 499 LCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNL 558

Query: 289 SSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS 348
           SSNFLTG LP E+GN+K +  +D S N  S  IP+ +G L+NL  L L  N+L+G IP  
Sbjct: 559 SSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVE 618

Query: 349 FGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFE 408
           FGDL+SL+ L+LS NNLSG IP +LE L YL+ LN+SFNKL+GEIP GG F  F AESF 
Sbjct: 619 FGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFM 678

Query: 409 GNELLCGSPTLQVLPCKTSIHHTSWKNS--LLLGIVLPL-STTLLIVVIWLILRYRKRGK 465
            NE LCG+P  QV+ C  +    SWK    +L  I+LP+ ST  L+V I L +R R   +
Sbjct: 679 FNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNME 738

Query: 466 QPSN-DANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF 524
            P+  D+ +P   T    S+ +L  ATN F E+NLIG+G  G VYK  L +G+ VA+KVF
Sbjct: 739 IPTPIDSWLP--GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVF 796

Query: 525 NLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC 584
           NL+   A +SF  ECE+M+ IRHRNL+++I+ CSN +FKALVL+Y P+GSLEK LYS   
Sbjct: 797 NLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYY 856

Query: 585 ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            LD+ QRLNIMIDVASALEYLH  C + V+HCDLKP NVLLDD++VA+++DFGIAKLL
Sbjct: 857 FLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLL 914

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	646
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.981	0.618	0.367	1.9e-99
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.893	0.571	0.356	1.2e-81
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.975	0.642	0.345	3.6e-82
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.893	0.562	0.355	4.1e-81
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.885	0.703	0.334	2.3e-78
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.893	0.570	0.327	3.6e-73
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.862	0.540	0.347	7.9e-78
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.976	0.537	0.312	5.6e-77
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.894	0.572	0.336	1.1e-76
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.597	0.308	0.337	1.3e-76

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
 Identities = 243/661 (36%), Positives = 352/661 (53%)

Query:     2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPNL 61
             IP  +  L +L  ++L  N L G +P +I+N+S                 + A   L  L
Sbjct:   216 IPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLL 275

Query:    62 EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL-RDNYLT 120
             E + +  N F G IP  + NAS L+++++  N FSG I + FG LRNL  L L R+ + T
Sbjct:   276 EVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQT 335

Query:   121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
                 +  F+S L+NC  L  ++L +N L G+L   S  NLS SL    +    ++G IP+
Sbjct:   336 REQDDWGFISDLTNCSKLQTLNLGENNLGGVLPN-SFSNLSTSLSFLALELNKITGSIPK 394

Query:   181 EITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELE 240
             +I NL     + L  N   GS+P +L             N L GSIP +I  LTEL  L 
Sbjct:   395 DIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILL 454

Query:   241 LGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDI-LQLNFSSNFLTGPLP 298
             LG NK  G IP   SNL +L  L LS+N L+  IP   +N++ + + +N S N L G +P
Sbjct:   455 LGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIP 514

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              EIG+LK L+      N  S  IP  +G  + L YL+L  N L GSIP + G L      
Sbjct:   515 QEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETL 574

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
                     G IPTSL  ++ L  LNLSFN   GE+P  G+F   +  S +GN  LCG  P
Sbjct:   575 DLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIP 634

Query:   418 TLQVLPCKTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXXXRYRKRGKQ--PSNDA--NM 473
              L +  C   + +      L + + L                + KR K+  PS  +    
Sbjct:   635 DLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLIT-WHKRTKKGAPSRTSMKGH 693

Query:   474 PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK 533
             PLV      SY +L +AT+GF+  NL+G G FGSVYK +L     VAVKV  L+  +A K
Sbjct:   694 PLV------SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALK 747

Query:   534 SFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY------SS 582
             SF  ECE ++++RHRNL+K+++ CS+      +FKA+V ++ P+GSLE +++      + 
Sbjct:   748 SFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQAD 807

Query:   583 NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                L++ +R+ I++DVA AL+YLH     PV+HCD+K  NVLLD ++VA++ DFG+A++L
Sbjct:   808 QRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARIL 867

Query:   643 I 643
             +
Sbjct:   868 V 868

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 213/597 (35%), Positives = 302/597 (50%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             EIP +++ L  +  L L  N   G  P A++N+S                     + LPN
Sbjct:   201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
             L +  + GN F+G+IP  + N S L  L +++N+ +G IP TFGN+ NL+ L L  N L 
Sbjct:   261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLG 319

Query:   121 S-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
             S S+ +L FL+SL+NC  L  + +  N L G L   SI NLS  L    +    +SG IP
Sbjct:   320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIP 378

Query:   180 EEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYEL 239
              +I NL N   + L  N L+G +P +L             N+L G IP  I  +T L  L
Sbjct:   379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438

Query:   240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
             +L  N   G +P    N + L  L +  N+L  +IPL    ++ +L+L+ S N L G LP
Sbjct:   439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLP 498

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              +IG L+ L  +    N  S  +P  +G    +E LFL  N   G IPD  G L+     
Sbjct:   499 QDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEV 557

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
                     G+IP      S LE LNLSFN LEG++P  G F N    S  GN  LCG   
Sbjct:   558 DLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIM 617

Query:   419 -LQVLPCKT---SI--HHTSWKNSLLLGIVLPXXXXXXXXXXXXXX---RYRKRGKQPSN 469
               Q+ PC +   S+   H+S    +++G+ +                  R RK+ K+ +N
Sbjct:   618 GFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNN 677

Query:   470 DANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC 528
                  L       SY +L  ATNGFS +N++G G FG+VYKA L  +   VAVKV N+Q 
Sbjct:   678 PTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQR 737

Query:   529 GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY 580
               A KSF  ECE +K IRHRNL+K++++CS+      EF+AL+ E+ P+GSL+ +L+
Sbjct:   738 RGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 824 (295.1 bits), Expect = 3.6e-82, P = 3.6e-82
 Identities = 233/674 (34%), Positives = 335/674 (49%)

Query:     2 IPLEI---SNLQNLEELDLRHNKLVGTVPAAIFN--MSMXXXXXXXXXXXXXXXSSIADV 56
             IP+++    +  +L+ +DL +N L G +P         +               SS+++ 
Sbjct:   155 IPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNS 214

Query:    57 RLPNLEALLLWGNNFSGTIP-RFIFNASKLSILELSQNSFSGFIPNT-----FGNLRNLE 110
                NL+ + L  N  SG +P + I    +L  L LS N F     NT     F +L N  
Sbjct:   215 T--NLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSS 272

Query:   111 WLNLRDNYLTSSTPELSFLSSLSNCK-SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
               +L++  L  ++      SS+ +   +L  IHL  N + G +    I NL + L    +
Sbjct:   273 --DLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPP-EISNLLN-LTLLNL 328

Query:   170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDS 229
             S+  +SG IP E+  L+    + L  N L G IP+ L             N L GSIPDS
Sbjct:   329 SSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDS 388

Query:   230 ICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPL-TFWNLKDI-LQL 286
                L++L  L L GN L G++P       +L IL LS N LT +IP+    NL+++ L L
Sbjct:   389 FGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYL 448

Query:   287 NFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP 346
             N SSN L+GP+PLE+  + +++ +D S N  S  IP ++G    LE+L L  N    ++P
Sbjct:   449 NLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLP 508

Query:   347 DSFGDLIXXXXXXXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAES 406
              S G L              GAIP S ++ S L+ LN SFN L G +   GSF     ES
Sbjct:   509 SSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIES 568

Query:   407 FEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXXXRYRKR--- 463
             F G+ LLCGS    +  CK    + S    +LL ++                R+ K    
Sbjct:   569 FLGDSLLCGS-IKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTV 627

Query:   464 ---------GKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG 514
                       KQ  ND   P +      SY +L  AT GF+ ++LIG G FG VYK  L 
Sbjct:   628 YAKEEVEDEEKQNQNDPKYPRI------SYQQLIAATGGFNASSLIGSGRFGHVYKGVLR 681

Query:   515 DGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG 573
             +  +VAVKV + +    F  SF  EC+++K  RHRNLI++I++CS   F ALVL   P+G
Sbjct:   682 NNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNG 741

Query:   574 SLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV 630
             SLE++LY    S+  LD+ Q +NI  DVA  + YLH      V+HCDLKP N+LLDD + 
Sbjct:   742 SLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMT 801

Query:   631 AYLSDFGIAKLLIG 644
             A ++DFGI++L+ G
Sbjct:   802 ALVTDFGISRLVQG 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
 Identities = 213/599 (35%), Positives = 305/599 (50%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             EIP +I+ L+ +    +  NK  G  P  I+N+S                       LPN
Sbjct:   216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
             L+ L +  N+F+GTIP  + N S L  L++  N  +G IP +FG L+NL  L L +N L 
Sbjct:   276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query:   121 S-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
             + S+ +L FL +L+NC  L ++++  N L G L    I NLS  L +  +    +SG IP
Sbjct:   336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIP 394

Query:   180 EEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYEL 239
               I NL +  T+DLG N L G +P +L             N L G IP S+  ++ L  L
Sbjct:   395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454

Query:   240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
              L  N   GSIP+   + + L  L+L +N+L  SIP     L  ++ LN S N L GPL 
Sbjct:   455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLR 514

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              +IG LK L+ +D S N  S  IP  +    +LE+L L  N   G IPD  G L      
Sbjct:   515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFL 573

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
                     G IP  +   S L++LNLS N  +G +P  G F N +A S  GN  LCG  P
Sbjct:   574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633

Query:   418 TLQVLPCKTSI--HHTSWKNSLLLGI-VLPXXXXXXXXXXXXXXRYRKRGK--QPSNDAN 472
             +LQ+ PC   +   H+S +  + + +  +                Y+ R K  + +N+ N
Sbjct:   634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693

Query:   473 ----MPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ 527
                  P+ + +   SY EL + T GFS +NLIG G FG+V+K  LG     VA+KV NL 
Sbjct:   694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL- 752

Query:   528 CGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYKPHGSLEKYLY 580
             C R A KSF  ECE +  IRHRNL+K+++ CS+ +F     +ALV E+ P+G+L+ +L+
Sbjct:   753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
 Identities = 200/598 (33%), Positives = 298/598 (49%)

Query:     2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPNL 61
             IP     L+ L  L L  N L G +P  I+N+S                 + A   LP+L
Sbjct:   190 IPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSL 249

Query:    62 EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
             + + ++ N F G IP  I NAS +SI  +  NSFSG +P   G +RNL+ L L +    +
Sbjct:   250 QEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEA 309

Query:   122 S-TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
               T +  F+++L+NC +L  + L      G+L   S+ NLS SL    + +  +SG +P 
Sbjct:   310 EETNDWKFMTALTNCSNLQEVELGGCKFGGVLPD-SVSNLSSSLVSLSIRDNKISGSLPR 368

Query:   181 EITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELE 240
             +I NL N   + L  N L GS+P + S            NKL GS+P +I  LT+L  +E
Sbjct:   369 DIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNME 428

Query:   241 LGGNKLFGSIPACFSNLASLRILSLSSNE-LTSIPLTFWNLKDILQ-LNFSSNFLTGPLP 298
             +  N   G+IP+   NL  L  ++L  N  +  IP+  +++  + + L+ S N L G +P
Sbjct:   429 VQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIP 488

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              EIG LK ++      N  S   P+ IG  + L++LFL  N L GSIP +   L      
Sbjct:   489 KEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTL 548

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
                     G IP SL  +  L  LNLSFN   GE+P  G F N +    +GN  +CG  P
Sbjct:   549 DLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIP 608

Query:   418 TLQVLPCKTSIHHTSWKNSLLLGIV--LPXXXXXXXXXXXXXXRYRKRGKQPSNDANM-- 473
              L +  C            LLL +V  L                +++R K+     +M  
Sbjct:   609 ELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQG 668

Query:   474 -PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG--DG---MEVAVKVFNLQ 527
              P++      +Y +L +AT+GFS ++L+G G FGSVYK      DG     VAV+V  L+
Sbjct:   669 HPMI------TYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLE 722

Query:   528 CGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY 580
               +A KSF  ECE +++ RHRNL+K+++ CS+      +FKA+V ++ P+GSLE +L+
Sbjct:   723 TPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
 Identities = 196/598 (32%), Positives = 292/598 (48%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             E+P E++ L  +  L L  NK  G  P AI+N+S                       LPN
Sbjct:   201 EVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPN 260

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
             +  L L  N+  G IP  + N S L    +++N  +G I   FG + +L++L+L +N L 
Sbjct:   261 IRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLG 320

Query:   121 SST-PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
             S T  +L F+ SL+NC  L  + +    L G L  TSI N+S  L    +   +  G IP
Sbjct:   321 SYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALP-TSIANMSTELISLNLIGNHFFGSIP 379

Query:   180 EEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYEL 239
             ++I NL     + LG N L G +P +L             N++ G IP  I  LT+L  L
Sbjct:   380 QDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEIL 439

Query:   240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
              L  N   G +P      + +  L +  N+L  +IP     +  ++ L+   N L+G LP
Sbjct:   440 YLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLP 499

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              +IG+L+ L+ +    N FS  +P  +G    +E LFL  N  +G+IP+  G L+     
Sbjct:   500 NDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRV 558

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
                     G+IP      S LE LNLS N   G++P  G+F N       GN+ LCG   
Sbjct:   559 DLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIK 618

Query:   418 TLQVLPC-----KTSIHHTSW--KNSLL--LGIVLPXXXXXXXXXXXXXXRYRKRGKQPS 468
              L++ PC          H+S   K ++L  +GI L               R R++ +Q +
Sbjct:   619 DLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIAL-LLLLVIASMVLCWFRKRRKNQQTN 677

Query:   469 NDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ 527
             N     L       SY +L  ATNGFS +N++G G FG+V+KA L  +   VAVKV N+Q
Sbjct:   678 NLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQ 737

Query:   528 CGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY 580
                A KSF  ECE +K  RHRNL+K++++C++      EF+AL+ EY P+GS++ +L+
Sbjct:   738 RRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 783 (280.7 bits), Expect = 7.9e-78, P = 7.9e-78
 Identities = 199/573 (34%), Positives = 281/573 (49%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             EIP E++ L  +    +  N   G  P A++N+S                 +     LPN
Sbjct:   208 EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPN 267

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL- 119
             L  LLL  N F+G IP+ + N S L   ++S N  SG IP +FG LRNL WL +R+N L 
Sbjct:   268 LRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLG 327

Query:   120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
              +S+  L F+ +++NC  L ++ +  N L G L   SI NLS +L   ++    +SG IP
Sbjct:   328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIP 386

Query:   180 EEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYEL 239
              +I NL +   + L  N L+G +P++              N + G IP     +T L +L
Sbjct:   387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446

Query:   240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
              L  N   G IP        L  L + +N L  +IP     +  +  ++ S+NFLTG  P
Sbjct:   447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFP 506

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              E+G L++L+G+  S N  S  +P  IGG  ++E+LF+  N  +G+IPD    L+     
Sbjct:   507 EEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNV 565

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
                     G IP  L  L  L +LNLS NK EG +P  G F N  A S  GN  +CG   
Sbjct:   566 DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVR 625

Query:   419 -LQVLPC--KTSIHHT---SWKNSLLLGIVLPXXXXXXXXXXXXXXRYRKRGKQPS-NDA 471
              +Q+ PC  + S       S +  ++ GI +                + KR K+ + +D 
Sbjct:   626 EMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDG 685

Query:   472 NMPLVATWRTF----SYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNL 526
             N     T   F    SY EL  AT+ FS  NLIG G FG+V+K  LG +   VAVKV NL
Sbjct:   686 NPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNL 745

Query:   527 QCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
                 A KSF  ECE  K IRHRNL+K+I+ CS+
Sbjct:   746 LKHGATKSFMAECETFKGIRHRNLVKLITVCSS 778

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 780 (279.6 bits), Expect = 5.6e-77, P = 5.6e-77
 Identities = 206/659 (31%), Positives = 333/659 (50%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             E+P ++  L NL  L    N L G +P++I N +                      R+ N
Sbjct:   375 ELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPR-GFGRM-N 432

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
             L  + +  N+F+G IP  IFN S L  L ++ N+ +G +    G L+ L  L +  N LT
Sbjct:   433 LTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLT 492

Query:   121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
                P       + N K L  ++L  N   G + +  + NL+  L+   M + ++ G IPE
Sbjct:   493 GPIPR-----EIGNLKDLNILYLHSNGFTGRIPR-EMSNLT-LLQGLRMYSNDLEGPIPE 545

Query:   181 EITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELE 240
             E+ ++     +DL  NK +G IP   S            NK  GSIP S+  L+ L   +
Sbjct:   546 EMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFD 605

Query:   241 LGGNKLFGSIPA-CFSNLASLRI-LSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPL 297
             +  N L G+IP    ++L ++++ L+ S+N LT +IP     L+ + +++ S+N  +G +
Sbjct:   606 ISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSI 665

Query:   298 PLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFGDLIXXX 356
             P  +   K +  +DFS NN S  IP E+  G+  +  L L  N   G IP SFG++    
Sbjct:   666 PRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLV 725

Query:   357 XXXXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS 416
                       G IP SL  LS L+ L L+ N L+G +P  G F N  A    GN  LCGS
Sbjct:   726 SLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGS 785

Query:   417 PTLQVLPC--KTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXXXRY--RKRGK--QPSND 470
                 + PC  K    H S +  ++L I+L                   +K+ K  + S++
Sbjct:   786 KK-PLKPCTIKQKSSHFSKRTRVIL-IILGSAAALLLVLLLVLILTCCKKKEKKIENSSE 843

Query:   471 ANMPLVAT---WRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ 527
             +++P + +    + F   EL +AT+ F+  N+IG     +VYK +L DG  +AVKV NL+
Sbjct:   844 SSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK 903

Query:   528 --CGRAFKSFAVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYKPHGSLEKYLYSSNC 584
                  + K F  E + +  ++HRNL+K++  +  + + KALVL +  +G+LE  ++ S  
Sbjct:   904 EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAA 963

Query:   585 -ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              I  + +++++ + +AS ++YLH G   P++HCDLKP N+LLD + VA++SDFG A++L
Sbjct:   964 PIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
 Identities = 200/595 (33%), Positives = 292/595 (49%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLPN 60
             EIP +I+ L  +  L L  N   G  P A +N+S                       LPN
Sbjct:   201 EIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPN 260

Query:    61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
             +  L L GN  +G IP  + N S L +  + +N  +G I   FG L NL +L L +N L 
Sbjct:   261 IHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLG 320

Query:   121 S-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
             S S  +L+FL +L+NC  L  + +S N L G L  TSI N+S  L    +    + G IP
Sbjct:   321 SYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALP-TSIVNMSTELTVLNLKGNLIYGSIP 379

Query:   180 EEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYEL 239
              +I NL    ++ L  N L G +P +L             N+  G IP  I  LT+L +L
Sbjct:   380 HDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKL 439

Query:   240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLP 298
              L  N   G +P    + + +  L +  N+L  +IP     +  ++ LN  SN L+G LP
Sbjct:   440 YLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLP 499

Query:   299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXX 358
              +IG L+ L+ +    NN S  +P  +G   ++E ++L  N  +G+IPD  G L+     
Sbjct:   500 NDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNV 558

Query:   359 XXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS-P 417
                     G+I    E  S LE LNLS N  EG +P  G F N    S  GN+ LCGS  
Sbjct:   559 DLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIK 618

Query:   418 TLQVLPC-----KTSIHHTSWKNSLLLGIVLPXXXXXXXXXXXXX-XRYRKRGKQPSNDA 471
              L++ PC          H S    + +G+ +                + RK  ++ +N A
Sbjct:   619 ELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSA 678

Query:   472 NMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR 530
                L       SY +L  AT+GFS +N++G G FG+V+KA L  +   VAVKV N+Q   
Sbjct:   679 PFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRG 738

Query:   531 AFKSFAVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYKPHGSLEKYLY 580
             A KSF  ECE +K IRHRNL+K++++C++      EF+AL+ E+ P+GSL+K+L+
Sbjct:   739 AMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 1.3e-76, Sum P(2) = 1.3e-76
 Identities = 141/418 (33%), Positives = 211/418 (50%)

Query:     1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNM-SMXXXXXXXXXXXXXXXSSIADV--- 56
             EIP EISN Q+L+ LDL +N L G +P ++F +  +               SSI+++   
Sbjct:   352 EIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNL 411

Query:    57 ------------RLPN-------LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG 97
                         ++P        LE + L+ N FSG +P  I N ++L  ++   N  SG
Sbjct:   412 QEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSG 471

Query:    98 FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSI 157
              IP++ G L++L  L+LR+N L  + P     +SL NC  +T I L+DN L G +  +S 
Sbjct:   472 EIPSSIGRLKDLTRLHLRENELVGNIP-----ASLGNCHQMTVIDLADNQLSGSIP-SSF 525

Query:   158 GNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXX 217
             G L+ +L+ F + N ++ G +P+ + NL N   I+   NK NGSI   L           
Sbjct:   526 GFLT-ALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSIS-PLCGSSSYLSFDV 583

Query:   218 XXNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLT 276
               N  EG IP  + + T L  L LG N+  G IP  F  ++ L +L +S N L+ I P+ 
Sbjct:   584 TENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVE 643

Query:   277 FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
                 K +  ++ ++N+L+G +P  +G L +L  +  S N F   +PTEI  L N+  LFL
Sbjct:   644 LGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFL 703

Query:   337 GYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
               N L GSIP   G+L              G +P+++ KLS L +L LS N L GEIP
Sbjct:   704 DGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIP 761

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	646
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-68
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-53
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-32
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.001
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.001
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.001
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.002
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.002
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.002
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.002
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.003
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.003
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.004
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.004
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  240 bits (615), Expect = 1e-68
 Identities = 196/639 (30%), Positives = 309/639 (48%), Gaps = 37/639 (5%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCL-SSIADVRLP 59
           +IP E+  +++L+ + L +N L G +P  I  ++ L  L L  N+L G + SS+ +  L 
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN--LK 260

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           NL+ L L+ N  SG IP  IF+  KL  L+LS NS SG IP     L+NLE L+L  N  
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           T   P      +L++   L  + L  N   G + K ++G   ++L    +S  N++G IP
Sbjct: 321 TGKIPV-----ALTSLPRLQVLQLWSNKFSGEIPK-NLGK-HNNLTVLDLSTNNLTGEIP 373

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
           E + +  N   + L  N L G IP +L   + L+ + L DN   G +P    +L  +Y L
Sbjct: 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPL 299
           ++  N L G I +   ++ SL++LSL+ N+        +  K +  L+ S N  +G +P 
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR 493

Query: 300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLN 359
           ++G+L  L+ +  S N  S  IP E+   K L  L L +N+L G IP SF ++  L  L+
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553

Query: 360 LSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTL 419
           LS N LSG IP +L  +  L  +N+S N L G +P  G+F    A +  GN  LCG  T 
Sbjct: 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT 613

Query: 420 QVL-PCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVAT 478
             L PCK      SW     +   L     L +V    +    +   +     N     T
Sbjct: 614 SGLPPCKRVRKTPSW--WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED--GT 669

Query: 479 W----------RTFSYLELCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 527
           W          ++ +  ++  +     E N+I RG  G+ YK + + +GM+  VK  N  
Sbjct: 670 WELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN-D 725

Query: 528 CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD 587
                 S   +   M  ++H N++K+I  C +E+   L+ EY    +L + L +    L 
Sbjct: 726 VNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LS 778

Query: 588 IFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD 626
             +R  I I +A AL +LH  C   V+  +L P+ +++D
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  197 bits (502), Expect = 2e-53
 Identities = 146/389 (37%), Positives = 202/389 (51%), Gaps = 12/389 (3%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
           +N   +  +DL    + G + +AIF +  ++ ++L NN L G +         +L  L L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 67  WGNNFSGTIPR-FIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
             NNF+G+IPR  I N   L  L+LS N  SG IPN  G+  +L+ L+L  N L    P 
Sbjct: 126 SNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP- 181

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
               +SL+N  SL F+ L+ N L G + +  +G +  SLK  Y+   N+SG IP EI  L
Sbjct: 182 ----NSLTNLTSLEFLTLASNQLVGQIPR-ELGQMK-SLKWIYLGYNNLSGEIPYEIGGL 235

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK 245
           T+   +DL  N L G IP +L  L+ LQ L L  NKL G IP SI  L +L  L+L  N 
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295

Query: 246 LFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
           L G IP     L +L IL L SN  T  IP+   +L  +  L   SN  +G +P  +G  
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355

Query: 305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN 364
             L  +D S NN +  IP  +    NL  L L  N LEG IP S G   SL+ + L +N+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415

Query: 365 LSGAIPTSLEKLSYLEDLNLSFNKLEGEI 393
            SG +P+   KL  +  L++S N L+G I
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  178 bits (452), Expect = 6e-47
 Identities = 119/317 (37%), Positives = 172/317 (54%), Gaps = 9/317 (2%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
           N+S++  ++LS  + SG I +    L  ++ +NL +N L+   P+  F +      SL +
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRY 122

Query: 141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG 200
           ++LS+N   G + + SI N    L+   +SN  +SG IP +I + ++   +DLGGN L G
Sbjct: 123 LNLSNNNFTGSIPRGSIPN----LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL 260
            IP +L+ L  L+ L L  N+L G IP  + ++  L  + LG N L G IP     L SL
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238

Query: 261 RILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS 319
             L L  N LT  IP +  NLK++  L    N L+GP+P  I +L+ LI +D S N+ S 
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298

Query: 320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
            IP  +  L+NLE L L  N   G IP +   L  L+ L L +N  SG IP +L K + L
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358

Query: 380 EDLNLSFNKLEGEIPRG 396
             L+LS N L GEIP G
Sbjct: 359 TVLDLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (344), Expect = 1e-36
 Identities = 55/146 (37%), Positives = 82/146 (56%), Gaps = 6/146 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           +G GGFG+VY AR    G +VA+K+   +      +    E E++K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            +E    LV+EY   GSL+  L  +   L   + L I++ +   LEYLH      +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 618 LKPDNVLLD-DNLVAYLSDFGIAKLL 642
           LKP+N+LLD DN    L+DFG++KLL
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL 143

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  125 bits (317), Expect = 1e-32
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLIKVIS 555
             +G G FG VY AR    G  VA+KV   +  +   +    E +++K ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +E+   LV+EY   G L   L      L   +    +  + SALEYLH      ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD++    L+DFG+A+ L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL 147

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  125 bits (315), Expect = 4e-32
 Identities = 52/151 (34%), Positives = 82/151 (54%), Gaps = 9/151 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR---AFKSFAVECEMMKSIRHRNLIKVIS 555
           +G G FG+VYKA+  G G  VAVK+            ++   E  +++ + H N++++I 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +  +++   LV+EY   G L  YL S    L   +   I + +   LEYLH      +IH
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIH 121

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            DLKP+N+LLD+N V  ++DFG+AK L+   
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSS 152

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (296), Expect = 1e-29
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG VYK  L     G   +VAVK           + F  E  +MK + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           +  C+  E   +V EY P G L  +L      L +   L + + +A  +EYL        
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H DL   N L+ +NLV  +SDFG+++ +  +D
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  117 bits (295), Expect = 1e-29
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 9/152 (5%)

Query: 497 NNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNL 550
              +G G FG VYK +L        +EVAVK           + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++  C+ EE   +V+EY   G L  YL  +   L +   L+  + +A  +EYL     
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK-- 121

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              IH DL   N L+ +NLV  +SDFG+++ L
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDL 152

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (286), Expect = 3e-28
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 10/153 (6%)

Query: 497 NNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNL 550
              +G G FG VYK  L        +EVAVK        +  + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           +K++  C+ EE   +V+EY P G L  YL  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               IH DL   N L+ +NLV  +SDFG+++ L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 53/156 (33%), Positives = 74/156 (47%), Gaps = 21/156 (13%)

Query: 498 NLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECE--MMKSIRHRNLIKVI 554
            L+GRG FGSVY A   D G  +AVK   L      +  A+E E  ++ S++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 555 SSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNI------MIDVASALEYLH 606
            S  +EE   L   LEY   GSL   L         F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 ++H D+K  N+L+D + V  L+DFG AK L
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 16/162 (9%)

Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIK 552
             +G G FG VYK +L    G   EVAVK          +  F  E  +MK + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEY 604
           ++  C+ EE   LVLEY   G L  YL  S           L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           L        +H DL   N L+ ++LV  +SDFG+++ +  +D
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 50/142 (35%), Positives = 76/142 (53%), Gaps = 4/142 (2%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+GGFG VYKAR    G EVA+KV  L+     +    E +++K  +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            ++   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH      +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDI 124

Query: 619 KPDNVLLDDNLVAYLSDFGIAK 640
           K  N+LL  +    L DFG++ 
Sbjct: 125 KAANILLTSDGEVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVI 554
             IG+G FG VY  R   DG    +K  +L       +  A+ E +++K + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCLA 611
            S   +    +V+EY   G L + +         F   Q L+  + +  AL+YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
            ++H D+KP N+ L  N +  L DFGI+K+L 
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.1 bits (221), Expect = 7e-20
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 4/143 (2%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLIKVISSC 557
            IG+G FG VYK  L    EVAVK          K  F  E E++K   H N++K+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             ++   +V+E  P GSL  +L      L + + L + +D A+ +EYL        IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118

Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           L   N L+ +N V  +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 54/146 (36%), Positives = 79/146 (54%), Gaps = 12/146 (8%)

Query: 499 LIGRGGFGSVYKARLGD--GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVIS 555
            IG+G FG V    LGD  G +VAVK   L+    A ++F  E  +M ++RH NL++++ 
Sbjct: 13  TIGKGEFGDVM---LGDYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
                    +V EY   GSL  YL S    ++ + Q+L   +DV   +EYL        +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           H DL   NVL+ ++LVA +SDFG+AK
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 11/153 (7%)

Query: 498 NLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLI 551
             +G G FG V   R        G +VAVK  N       +S F  E E+++++ H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 552 KVISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           K    C     ++  L++EY P GSL  YL      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               IH DL   N+L++   +  +SDFG+AK+L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 29/164 (17%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V+           D   VAVK         A K F  E E++ + +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYS------------SNCI-LDIFQRLNIMIDVA 599
               C+  +   +V EY  HG L K+L S            S    L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 600 SALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           S + YL   HF      +H DL   N L+  +LV  + DFG+++
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 48/144 (33%), Positives = 68/144 (47%), Gaps = 5/144 (3%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G VYKA     G EVA+K   L+     +    E  +MK  +H N++    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   +  +   ++  Q   +  +V   LEYLH      VIH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 619 KPDNVLLDDNLVAYLSDFGIAKLL 642
           K DN+LL  +    L+DFG A  L
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQL 166

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 52/151 (34%), Positives = 79/151 (52%), Gaps = 13/151 (8%)

Query: 499 LIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCGRAFKSFAVECE-MMKSIRHRNLIKV 553
           +IG G F +V  A+      E A+K+ +   L   +  K   +E E + +   H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             +  +EE    VLEY P+G L +Y+  Y S   LD         ++  ALEYLH     
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +IH DLKP+N+LLD ++   ++DFG AK+L
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 13/148 (8%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+        +VAVK   L+ G  + ++F  E ++MK +RH  L+++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID----VASALEYLHFGCLAPVI 614
            EE   +V EY   GSL  +L S         RL  ++D    +A  + YL        I
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DL   N+L+ +NLV  ++DFG+A+L+
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 19/158 (12%)

Query: 498 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +LIGRG FG VYK   L  G  VA+K  +L+     A KS   E +++K+++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFG 608
            S    +   ++LEY  +GSL + +            + ++Q       V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH-- 116

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               VIH D+K  N+L   + V  L+DFG+A  L    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 83.3 bits (206), Expect = 1e-16
 Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 9/160 (5%)

Query: 306 VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNL 365
            + G+          IP +I  L++L+ + L  N + G+IP S G + SL+ L+LS N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 366 SGAIPTSLEKLSYLEDLNLSFNKLEGEIPR--GGSFGNFAAESFEGNELLCGSPTLQVLP 423
           +G+IP SL +L+ L  LNL+ N L G +P   GG   + A+ +F  N  LCG P L+   
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--A 536

Query: 424 CKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRKR 463
           C     H S      +GI   +S   L +VI  +  +++R
Sbjct: 537 CGP---HLS--VGAKIGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 81.7 bits (200), Expect = 1e-16
 Identities = 57/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRH-RNLIKVI 554
            +G G FG VY AR  D   VA+KV   +     +  + F  E +++ S+ H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
               +E    LV+EY   GSLE  L        L   + L I+  + SALEYLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 613 VIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGED 646
           +IH D+KP+N+LLD +  V  L DFG+AKLL    
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 52/149 (34%), Positives = 80/149 (53%), Gaps = 8/149 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V++    +   VAVK   L+ G    K F  E ++MK +RH  LI++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            EE   +V E   +GSL +YL       L + Q +++   VAS + YL        IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           L   NVL+ +N +  ++DFG+A+ +I ED
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 4/150 (2%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           F+    +G G FG V++    + + VA+K+         + F  E + +K +RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAP 612
            + CS  E   ++ E    GSL  +L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            IH DL   N+L+ ++LV  ++DFG+A+L+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 14/165 (8%)

Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKS 544
           E+ R     +  + +G G +G VY+       + VAVK    +     + F  E  +MK 
Sbjct: 2   EMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 58

Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 603
           I+H NL++++  C+ E    ++ E+  +G+L  YL   N   ++    L +   ++SA+E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 604 YL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           YL   +F      IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 119 YLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSIRHRNLIK---- 552
           IG G +G VYKAR    G  VA+K   ++  +  F   A+ E ++++ +RH N+++    
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           V S      +  +V EY  H  L   L S        Q    M  +   L+YLH      
Sbjct: 67  VTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NG 120

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++H D+K  N+L++++ V  L+DFG+A+
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 16/156 (10%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG+G FG+V K  R  DG  +  K  +        K   V E  +++ ++H N+++    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 557 CSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLHFG 608
             +   + L  V+EY   G L + +    C  +  + +       I+  +  AL   H  
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEEFIWRILTQLLLALYECHNR 124

Query: 609 CLAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 V+H DLKP N+ LD N    L DFG+AK+L
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 26/168 (15%)

Query: 499 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIK 552
           ++G G FGSV + +L    G  ++VAVK   L        + F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 553 VISSC----SNEEFKA--LVLEYKPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 601
           +I  C    S ++     ++L +  HG L  +L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 602 LEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +EYL   +F      IH DL   N +L +++   ++DFG++K +   D
Sbjct: 126 MEYLSNRNF------IHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 4/143 (2%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLIKVISSC 557
           L+G+G FG V+K  L D   VAVK       +  K  F  E  ++K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           +  +   +V+E  P G    +L      L   Q +   +D A+ + YL        IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           L   N L+ +N V  +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 8e-15
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 22/158 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMK-------SIRHR 548
           +G+G FG V   R    G   A+KV         K   +   E E           I H 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHP 53

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
            ++K+  +   EE   LVLEY P G L  +L       +   R     ++  ALEYLH  
Sbjct: 54  FIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH-- 110

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +I+ DLKP+N+LLD +    L+DFG+AK L  E 
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 51/150 (34%), Positives = 73/150 (48%), Gaps = 11/150 (7%)

Query: 498 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGR--AFKSFAVECEMMKSIRHRNLIKVI 554
           N IG G FG VY A  L  G  +AVK   +Q       K  A E ++++ ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD--IFQRLNIMIDVASALEYLHFGCLAP 612
               + E   + +EY   G+LE+ L     ILD  + +   + +     L YLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H D+KP N+ LD N V  L DFG A  L
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 51/149 (34%), Positives = 73/149 (48%), Gaps = 13/149 (8%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK    +CG+   S +  E  ++K++ H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              CS +  K   L++EY P GSL  YL      L++ Q L     +   + YLH     
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 9/148 (6%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG G    VY A  L +  +VA+K  +L +C  +      E + M    H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 558 SNEEFKALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              +   LV+ Y   GSL    K  Y     LD      ++ +V   LEYLH       I
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLHSNGQ---I 124

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+K  N+LL ++    ++DFG++  L
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASL 152

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 23/163 (14%)

Query: 498 NLIGRGGFGSVYKARL---GDGMEVAVKVFN-LQCGRAFKSFAVECEMM-KSIRHRNLIK 552
           ++IG G FG V +A +   G  M  A+K+          + FA E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 597
           ++ +C N  +  + +EY P+G+L  +L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           VA+ ++YL        IH DL   NVL+ +NL + ++DFG+++
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 50/155 (32%), Positives = 72/155 (46%), Gaps = 26/155 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G +G VYKAR +  G  VA+KV  L+ G  F+    E  M+K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASALEYLH-F 607
             +   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           G     IH D+K  N+LL ++    L+DFG++  L
Sbjct: 121 G----KIHRDIKGANILLTEDGDVKLADFGVSAQL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 8e-14
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRAFKSFAVECEMMKSIRHRNL 550
             IG G +G V  A     G +VA+K  +      +   R  +    E ++++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 551 IK---VISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           I    ++   S E+F  +  V E      L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           H    A VIH DLKP N+L++ N    + DFG+A+
Sbjct: 120 HS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 23/163 (14%)

Query: 498 NLIGRGGFGSVYKARL-GDG--MEVAVKVFNLQCGRA-FKSFAVECEMMKSI-RHRNLIK 552
           ++IG G FG V KAR+  DG  M+ A+K       +   + FA E E++  +  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 597
           ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 500 IGRGGFGSVYKAR---LGDG--MEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG+VYK      G+   + VA+KV   +    A K    E  +M S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           +  C + +   L+ +  P G L  Y+ +    +     LN  + +A  + YL    L   
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL--- 130

Query: 614 IHCDLKPDNVLLDD-NLVAYLSDFGIAKLL-IGED 646
           +H DL   NVL+     V  ++DFG+AKLL + E 
Sbjct: 131 VHRDLAARNVLVKTPQHVK-ITDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 45/142 (31%), Positives = 78/142 (54%), Gaps = 8/142 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG+V +     G +VAVK  N++C    ++F  E  +M  + H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 560 EEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
                +V+E    G+L  +L +    ++ + Q L   +DVA  +EYL    L   +H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL---VHRDL 126

Query: 619 KPDNVLLDDNLVAYLSDFGIAK 640
              N+L+ ++ VA +SDFG+A+
Sbjct: 127 AARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 8/156 (5%)

Query: 492 NGFSENNLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRAFKS---FAVECEMMKSIR 546
           +  ++  +IG G FG V++   ++    EVAV +  L+ G   K    F  E  +M    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           H N+I++    +  +   ++ EY  +G+L+KYL   +     +Q + ++  +A+ ++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL- 123

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                  +H DL   N+L++ NL   +SDFG++++L
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLIKVISSC 557
           +G+G  G VYK R    G   A+K  ++     F K    E + ++S     ++K    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 558 SNEEFK----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
               +K    ++VLEY   GSL   L     I +      I   +   L+YLH      +
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHTK--RHI 121

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           IH D+KP N+L++      ++DFGI+K+L
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 26/165 (15%)

Query: 499 LIGRGGFGSVYKARLGD------GMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNL 550
            +G G FG V KA             VAVK+       +       E EMMK I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NIM 595
           I ++  C+ E    +V+EY  HG+L  +L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             VA  +E+L        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 19/161 (11%)

Query: 493 GFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRN 549
            F     +G+G +GSVYK  RL D    A+K  +L    +  +  AV E  ++ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 550 LIKVISSCSNEEF-----KALVLEYKPHGSLEKYLYSSNCILDIFQR---LNIMIDVASA 601
           +I        E F       +V+EY P G L K +        +        I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+ LH      ++H DLK  N+LL  N +  + D GI+K+L
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL 153

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 12/145 (8%)

Query: 500 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 558 SNEEFKA-LVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF---VH 125

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 14/148 (9%)

Query: 500 IGRGGFGSVYKAR---LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           I +G +G V+ A+    GD    A+KV     +           E +++   +   ++K+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLAP 612
             S   ++   LV+EY P G L   L +    LD       + ++  ALEYLH  G    
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI--- 114

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            IH DLKPDN+L+D N    L+DFG++K
Sbjct: 115 -IHRDLKPDNILIDSNGHLKLTDFGLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 4/141 (2%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+  +    ++VA+K+   +   +   F  E ++M  + H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    +V EY  +G L  YL      L     L++  DV  A+EYL        IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127

Query: 620 PDNVLLDDNLVAYLSDFGIAK 640
             N L+ ++ V  +SDFG+A+
Sbjct: 128 ARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 4e-13
 Identities = 34/81 (41%), Positives = 46/81 (56%)

Query: 191 IDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI 250
           + L    L G IP  +SKL+ LQ + L  N + G+IP S+  +T L  L+L  N   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 251 PACFSNLASLRILSLSSNELT 271
           P     L SLRIL+L+ N L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 5e-13
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 1/90 (1%)

Query: 214 GLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-S 272
           GLGLD+  L G IP+ I +L  L  + L GN + G+IP    ++ SL +L LS N    S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 273 IPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
           IP +   L  +  LN + N L+G +P  +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 10/159 (6%)

Query: 491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRAFKSFAVECEMMKSIR 546
              F     IG+G F  VYKA  L DG  VA   V++F +   +A +    E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALE 603
           H N+IK ++S        +VLE    G L    K+      ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H      ++H D+KP NV +    V  L D G+ +  
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 30/171 (17%)

Query: 500 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 598
              C + +   +V EY  HG L K+L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 599 ASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           AS + YL   HF      +H DL   N L+  NL+  + DFG+++ +   D
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 45/149 (30%), Positives = 80/149 (53%), Gaps = 8/149 (5%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           ++GRG FG V+   R  D   V +K   ++        +   EC+++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           +   ++   +V+EY P G+L +Y+    N +LD    L+  + +  AL ++H      ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 615 HCDLKPDNVLLDDN-LVAYLSDFGIAKLL 642
           H DLK  N+LLD + +V  + DFGI+K+L
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 8/154 (5%)

Query: 493 GFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--GRAFKSFAVECEMMKSIRHR 548
            F    +IG+G FG V   +  D  ++ A+K  N Q C    + ++   E  +++ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
            L+ +  S  +EE   LV++    G L +Y  S        Q    + ++  ALEYLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               +IH D+KPDN+LLD+    +++DF IA  +
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.4 bits (167), Expect = 9e-13
 Identities = 41/156 (26%), Positives = 80/156 (51%), Gaps = 12/156 (7%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRH 547
           +++  ++G+G +G+VY      G  +AVK   L         + ++    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYLH 606
            N+++ + +C ++   ++ +E+ P GS+   L     + +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             C   V+H D+K +NV+L  N +  L DFG A+ L
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 5/143 (3%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKVISSC 557
           IGRG FG V+  RL  D   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           + ++   +V+E    G    +L +    L + + + ++ + A+ +EYL        IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           L   N L+ +  V  +SDFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 24/155 (15%)

Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF---NLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FGSV    Y  + G  +EVAVK     ++  G+  K F  E  +M  + H  +++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL---HF 607
           +I  C  E    LV+E  P G L KYL       + D+     +   VA  + YL   HF
Sbjct: 61  LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 +H DL   NVLL +   A +SDFG+++ L
Sbjct: 117 ------VHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 45/145 (31%), Positives = 79/145 (54%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            EE   +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 29/170 (17%)

Query: 500 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNC---ILD-----------IFQRLNIMIDVA 599
              C+      +V EY  HG L ++L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 600 SALEY---LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           S + Y   LHF      +H DL   N L+   LV  + DFG+++ +   D
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 4/144 (2%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
                LV E+  HG L  YL +          L + +DV   + YL       VIH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127

Query: 620 PDNVLLDDNLVAYLSDFGIAKLLI 643
             N L+ +N V  +SDFG+ + ++
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL 151

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 50/148 (33%), Positives = 72/148 (48%), Gaps = 10/148 (6%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGR-AFKSFAVECEMMKSIRHRNLIK 552
           L+G G FGSVY+   L DG   AVK  +L    Q G+ A K    E  ++  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
            + +   E+   + LE  P GSL K L                  +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHD---RN 122

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +H D+K  N+L+D N V  L+DFG+AK
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.5 bits (166), Expect = 2e-12
 Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 7/144 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G +G VYKAR    G  VA+K   L        S A+ E  ++K ++H N++K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E    LV EY     L+KYL      L      +IM  +   L Y H      ++H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHR 122

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L++ + V  L+DFG+A+
Sbjct: 123 DLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 12/150 (8%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVK------VFNLQCGRAFKSFAVECEMMKSIRHRNL 550
             +G G +  VYKAR    G  VA+K          + G  F +   E ++++ ++H N+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           I ++    ++    LV E+     LEK +   + +L      + M+     LEYLH    
Sbjct: 65  IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---S 120

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             ++H DLKP+N+L+  + V  L+DFG+A+
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 499 LIGRGGFGSVYKARL---GDGME--VAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIK 552
           L+G G FG+V+K      GD ++  VA+K    + GR  F+        M S+ H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           ++  C     + LV +  P GSL  ++      LD  + LN  + +A  + YL    +  
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV- 131

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             H +L   N+LL  + +  ++DFG+A LL  +D
Sbjct: 132 --HRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 20/170 (11%)

Query: 494 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCGRAFKSFAVECEMMKSIRH 547
           F+   ++G+G FGSV +A+L    G   +VAVK+   ++      + F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 548 RNLIKVISSCSNEEFKA------LVLEYKPHGSLEKYLYSSNC-----ILDIFQRLNIMI 596
            N+IK+I        K       ++L +  HG L  +L  S        L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           D+AS +EYL        IH DL   N +L++N+   ++DFG++K +   D
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 26/163 (15%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           F     +G G +GSVYKA     G  VA+KV  +      +    E  ++K      ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASAL 602
              S        +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           EYLH       IH D+K  N+LL++   A L+DFG++  L   
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 29/171 (16%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG VYK  L          +V +  L+     +  + F  E E+M  ++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMID 597
           ++  C+ E+   ++ EY  HG L ++L  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 598 VASALEYL--HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +A+ +EYL  H       +H DL   N L+ + L   +SDFG+++ +   D
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)

Query: 497 NNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V + RL       ++VA+K        +    F  E  +M    H N+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++    +      ++ EY  +GSL+K+L  ++    + Q + ++  +AS ++YL      
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 8/149 (5%)

Query: 499 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKV 553
           +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
               +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++YL        
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 7/147 (4%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHRNLIKVIS 555
           ++G G +G V K R    G  VA+K F   +     K  A+ E ++++ +RH N++ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +   +    LV EY     LE  L +S   L      + +  +  A+ Y H      +IH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            D+KP+N+L+ ++ V  L DFG A+ L
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 23/163 (14%)

Query: 498 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRA-FKSFAVECEMM-KSIRHRNLIK 552
           ++IG G FG V KAR+   G  M+ A+K       +   + FA E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 597
           ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 494 FSENNLI-----GRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L      G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 544 SIRHRNLIK---VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
           S++H N++K   V  S      + LV+EY P+GSL  YL      LD  + L     +  
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +EYL        +H DL   N+L++      + DFG+ K+L
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 15/150 (10%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ------CGRAFKSFAVECEMMKSIRHRNLIK 552
           IG G +G VYKAR    G  VA+K   L+         A +    E +++K + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           ++    ++    LV E+     L K +      L      + +  +   L + H      
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H DLKP+N+L++   V  L+DFG+A+  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF 148

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 6/139 (4%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA+K  NLQ     +    E  +M+  +H N++  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   +  +   +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 141

Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K DN+LL  +    L+DFG
Sbjct: 142 KSDNILLGMDGSVKLTDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHRNLIKVIS 555
           L+G G +G V K +  + G  VA+K F   +  +  K  A+ E  M+K +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 556 SCSNEEFKALVLEYKPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
               ++   LV E+  H     LEKY       LD  +    +  +   +E+ H      
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
           +IH D+KP+N+L+  + V  L DFG A+ L  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 4/148 (2%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  + G+  A K+  ++     + F VE +++   +H N++ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            E    +++E+   G+L+  +      L   Q   +   +  AL +LH      VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           K  N+LL  +    L+DFG++       
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTL 157

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 20/157 (12%)

Query: 499 LIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRA---------FKSFAVECEMMKSI 545
           LIG G FGSVY   LG     G  +AVK   L    A           + A E  ++K +
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           +H N+++ + S  + +   + LEY P GS+   L +     +   R N +  +   L YL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H      +IH D+K  N+L+D+     +SDFGI+K L
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)

Query: 494 FSENN---LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN 549
           + EN    ++G+G +G VY AR L   + +A+K    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI----DVASALEYL 605
           +++ + S S   F  + +E  P GSL   L S    L   +    +I     +   L+YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124

Query: 606 HFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIG 644
           H      ++H D+K DNVL++  + V  +SDFG +K L G
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 5/141 (3%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G +G VYKAR +  G   A+KV  L+ G  F     E  MMK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   + +E+   GSL+  +Y     L   Q   +  +    L YLH       +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDI 132

Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+LL DN    L+DFG++
Sbjct: 133 KGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 48/141 (34%), Positives = 68/141 (48%), Gaps = 5/141 (3%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VYKAR L  G   AVK+  L+ G  F     E  M+K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
           + E   + +EY   GSL+  +Y     L   Q   +  +    L YLH       +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+LL DN    L+DFG+A
Sbjct: 133 KGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 10/150 (6%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRAFKSFAVECEMMKSIRHRNLIK 552
           L+G+G FG VY     D G E+AVK         +  +   +   E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
                 ++E  ++ +EY P GS++  L +   + +   R      +   +EYLH      
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN---M 124

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H D+K  N+L D      L DFG +K L
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 500 IGRGGFGSVYKARLGDG---MEVAVKVFNLQ-CGRA-FKSFAVECEMMKSIRHRNLIKVI 554
           +G G FGSV + +L      ++VAVK   +  C R+  + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 555 SSC----SNEEFKA--LVLEYKPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALE 603
             C     +E + +  ++L +  HG L  +L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL        IH DL   N +L++N+   ++DFG++K +   D
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 34/84 (40%), Positives = 50/84 (59%)

Query: 169 MSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD 228
           + N  + G IP +I+ L +  +I+L GN + G+IP +L  +  L+ L L  N   GSIP+
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 229 SICRLTELYELELGGNKLFGSIPA 252
           S+ +LT L  L L GN L G +PA
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 53/173 (30%), Positives = 79/173 (45%), Gaps = 32/173 (18%)

Query: 498 NLIGRGGFGSVYKAR----LGDGME---VAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           N +G G FG VY+      LG G     VAVK   L+ G   +  K F  E  +M +  H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASA 601
            N++K++  C   E + +++E    G L  YL  +        +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 602 LEYL---HFGCLAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLLIGED 646
             YL   HF      IH DL   N L+     D + V  + DFG+A+ +   D
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 4/146 (2%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVISSC 557
           +G G  G V K      G  +AVK   L+   A  K    E +++       ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            N    ++ +EY   GSL+K L      +       I + V   L YLH      +IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRD 126

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLI 643
           +KP N+L++      L DFG++  L+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV 152

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 27/168 (16%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASA 601
              C   +   +V EY  HG L K+L +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 602 LEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + YL   HF      +H DL   N L+ +NL+  + DFG+++ +   D
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 39/149 (26%), Positives = 75/149 (50%), Gaps = 8/149 (5%)

Query: 499 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKV 553
           +IG G FG V + RL      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
               +      ++ E+  +G+L+ +L  ++    + Q + ++  +A+ ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 46/145 (31%), Positives = 76/145 (52%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+        +VAVK   L+ G  + +SF  E ++MK +RH  L+++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L +   +++   VA+ + Y+        IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ D LV  ++DFG+A+L+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 19/159 (11%)

Query: 494 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ-CGRAFKSFAV-ECEMMKSIRHRNL 550
           F   N IG+G FG V+K  R  D    A+K  +L    R  +  A+ E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALE 603
           I+   S  ++    +V+EY  +G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +LH      ++H D+K  N+ LD      + D G+AKLL
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 25/159 (15%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G V+K R  + G  VA+K F   +     K  A+ E  M+K ++H NL+ +I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66

Query: 557 CSNEEFKA-----LVLEYKPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-F 607
              E F+      LV EY  H     LEK        +       I+     A+ + H  
Sbjct: 67  ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKH 119

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            C    IH D+KP+N+L+       L DFG A++L G  
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 8e-11
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 20/162 (12%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV--ECEMMKSIR---H 547
           + E   IG G +G+VYKAR L  G  VA+K   +         +   E  ++K +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 548 RNLIKVISSC----SNEEFK-ALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVA 599
            N+++++  C    ++ E K  LV E+     L  YL  S C    L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKDLMRQLL 117

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
             +++LH      ++H DLKP N+L+  +    ++DFG+A++
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 4/147 (2%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    +V EY  +G L  YL          Q L +  DV   + YL        IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLA 127

Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+DD     +SDFG+++ ++ ++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+        +VA+K   L+ G    ++F  E ++MK +RH  L+ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            EE   +V E+   GSL  +L   +   L + Q +++   +A  + Y+        IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ DNLV  ++DFG+A+L+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 9e-11
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 499 LIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           ++G G FG+VYK   + +G    + VA+K+ N   G +A   F  E  +M S+ H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           ++  C +   + LV +  PHG L  Y++     +     LN  + +A  + YL    L  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL-- 130

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            +H DL   NVL+       ++DFG+A+LL G++
Sbjct: 131 -VHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 41/145 (28%), Positives = 78/145 (53%), Gaps = 7/145 (4%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGCLAPVIHCD 617
            EE   ++ EY   GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  NVL+ ++L+  ++DFG+A+++
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 9/151 (5%)

Query: 497 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLI 551
              IG G FG VY+        + + VAVK        + +  F  E  +M+   H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           K+I   + E    +V+E  P G L  YL  +   LD+   +     +++AL YL      
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H D+   NVL+       L DFG+++ L
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 14/149 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFN-----LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +IGRG FG V+  R  D  +V A+KV        +   A      E +++       ++K
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLA 611
           +  S  +EE   LV+EY P G L   L   +   +   R  I  ++  AL+ +H  G   
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH D+KPDN+L+D +    L+DFG+ K
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 7/144 (4%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNLQ-CGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G+V+KA+  +  E VA+K   L        S A+ E  ++K ++H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
             +++   LV EY     L+KY  S N  +D     + M  +   L + H      V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK-VFNLQCGRAFKSFAV-ECEMMKS 544
           C   + + +   IG+G FG V+KAR       VA+K V        F   A+ E ++++ 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67

Query: 545 IRHRNLIKVISSCSNE-----EFKA---LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
           ++H N++ +I  C  +      +K    LV E+  H  L   L + N    + +   +M 
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            + + L Y+H      ++H D+K  N+L+  + +  L+DFG+A+
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 51/147 (34%), Positives = 72/147 (48%), Gaps = 9/147 (6%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFN----LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +IG+G FG V  A R  DG   AVKV      L+        A    ++K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
             S    E    VL+Y   G L  +L    C L+   R     +VASA+ YLH      +
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNI 117

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           I+ DLKP+N+LLD      L+DFG+ K
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 21/157 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI- 554
           IG G  G V+KA+    G  VA+K   +  L+ G        E + +++ +H  ++K++ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQHPYVVKLLD 66

Query: 555 -----SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
                S         LV+EY P   L + L      L   Q  + M  +   + Y+H   
Sbjct: 67  VFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH--- 116

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              ++H DLKP N+L+  + V  ++DFG+A+L   E+
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 18/153 (11%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH---RN 549
           LIGRG +G+VY+ + +  G  VA+K+ NL          V     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + K   S        +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              VIH D+K  N+L+ +     L DFG+A LL
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 37/178 (20%)

Query: 500 IGRGGFGSVYKAR-LG-----DGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIK 552
           IG+G FG V++AR  G         VAVK+   +     ++ F  E  +M    H N++K
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSN---------------------CILDIFQR 591
           ++  C+  +   L+ EY  +G L ++L   +                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 592 LNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           L I   VA+ + YL    F      +H DL   N L+ +N+V  ++DFG+++ +   D
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 44/157 (28%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 500 IGRGGFGSVYKARLGDGM---EVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVIS 555
           IG G FG V    +  G    +V VK   +    +    F  E +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGC 609
            C+      LV+E+ P G L+ YL S              QR+    ++A  L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               IH DL   N LL  +L   + D+G++     ED
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 39/145 (26%), Positives = 78/145 (53%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+        +VA+K  +L+ G  + ++F  E  +MK ++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ EY  +GSL  +L +   I L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ + L   ++DFG+A+L+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 33/87 (37%), Positives = 51/87 (58%), Gaps = 3/87 (3%)

Query: 39  LHLQNNSLLGCLSSIADV-RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG 97
           L L N  L G + +  D+ +L +L+++ L GN+  G IP  + + + L +L+LS NSF+G
Sbjct: 423 LGLDNQGLRGFIPN--DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 98  FIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            IP + G L +L  LNL  N L+   P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 47/146 (32%), Positives = 69/146 (47%), Gaps = 9/146 (6%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKS----FAVECEMMKSIRHRNLIKVI 554
           IG+G FG V  A+   DG   AVKV   +     K      A    ++K+++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            S    +    VL+Y   G L  +L       +   R     ++ASAL YLH      +I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           + DLKP+N+LLD      L+DFG+ K
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 10/156 (6%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRAFKSFAVECEMMKSIRHRN 549
           F     IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 V+H D+KP NV +    V  L D G+ +  
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 80/266 (30%), Positives = 112/266 (42%), Gaps = 32/266 (12%)

Query: 149 DGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSK 208
              L             D    +   S    E + NL    ++DL  N+L  +I   L +
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLE 114

Query: 209 LQKLQGLGLDDNKLEGSIPDSICRLT-ELYELELGGNKLFGSIPACFSNLASLRILSLSS 267
           L  L  L LD+N +   IP  I  L   L EL+L  NK+  S+P+   NL +L+ L LS 
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSF 172

Query: 268 NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGG 327
           N+L+ +P    NL ++  L+ S N +                         S +P EI  
Sbjct: 173 NDLSDLPKLLSNLSNLNNLDLSGNKI-------------------------SDLPPEIEL 207

Query: 328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
           L  LE L L  N +   +  S  +L +L  L LSNN L   +P S+  LS LE L+LS N
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN 265

Query: 388 KLEGEIPRGGSFGNFAAESFEGNELL 413
           ++   I   GS  N       GN L 
Sbjct: 266 QIS-SISSLGSLTNLRELDLSGNSLS 290

Length = 394

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 44/163 (26%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMM---KSIR----HRNLI 551
           +G G FGSVY AR    G  VA+K       + F S+  EC  +   KS+R    H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 552 K---VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL-------NIMIDVASA 601
           K   V     N+E    V EY     +E  LY    + D   +        +I+  +   
Sbjct: 62  KLKEVFRE--NDELY-FVFEY-----MEGNLY--QLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 602 LEYLH----FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L ++H    F       H DLKP+N+L+    V  ++DFG+A+
Sbjct: 112 LAHIHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 91/325 (28%), Positives = 144/325 (44%), Gaps = 19/325 (5%)

Query: 53  IADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWL 112
             D  L ++    L  N  S T+     + S+L  L+L   S      ++     NL  L
Sbjct: 37  FPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPS----GISSLDGSENLLNL 92

Query: 113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC 172
               +   +     S +S L    +LT + L +N +  I     IG L  +LK+  +S+ 
Sbjct: 93  LPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDI--PPLIGLLKSNLKELDLSD- 149

Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR 232
           N    +P  + NL N   +DL  N L+  +P  LS L  L  L L  NK+   +P  I  
Sbjct: 150 NKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL 207

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNF 292
           L+ L EL+L  N +   + +  SNL +L  L LS+N+L  +P +  NL ++  L+ S+N 
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266

Query: 293 LTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL 352
           ++      +G+L  L  +D S N+ S+ +P     L  LE        L   +       
Sbjct: 267 ISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLE-------LLLNLLLTLKALE 317

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLS 377
           + L  + L+NN LS    +S E LS
Sbjct: 318 LKLNSILLNNNILSNGETSSPEALS 342

Length = 394

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 15/161 (9%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKARLGDGMEVA----VKVFNLQCGRAFKSFAVECEMMK 543
           CR+   F + N IG G +G VY+AR     E+     V++ N + G    S   E  ++ 
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 544 SIRHRNLIK----VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
           ++RH N+++    V+    +  F  LV+EY     L   L +        Q   +M+ + 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             L+YLH      +IH DLK  N+LL D     ++DFG+A+
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 4/144 (2%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+  +    ++VA+K  N +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           ++   +V E+  +G L  YL      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF---IHRDLA 127

Query: 620 PDNVLLDDNLVAYLSDFGIAKLLI 643
             N L+    V  +SDFG+ + ++
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL 151

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 8/149 (5%)

Query: 499 LIGRGGFGSVYKARLGDGME-VAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVI 554
            +G G FG V+  R        A+KV  +      +  +    E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            +  ++ F  +++EY P G L  YL +S    +         ++  ALEYLH      ++
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHS---KEIV 123

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           + DLKP+N+LLD      L+DFG AK L 
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLR 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 47/150 (31%), Positives = 72/150 (48%), Gaps = 12/150 (8%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCGRAFKSF-AVECE--MMKSIRHRNLIK 552
           L+GRG FG VY     D G E+AVK   F+       K   A+ECE  ++K++RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 553 VISSCSNEEFKALVL--EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
                 + E K L +  EY P GS++  L +   + +   R      +   + YLH    
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHSNM- 126

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             ++H D+K  N+L D      L DFG +K
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLIKVI 554
           +G G FG V    YK R    ++VA+KV   +  ++ +     E E+M  + +  ++++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
             C  E    LV+E    G L K+L      + +   + +M  V+  ++YL   +F    
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF---- 116

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 23/157 (14%)

Query: 499 LIGRGGFGSVY---KARLGDGMEVA-VKVFNLQCGR-------AFKSFAVECEMMKSIRH 547
           LIG+G +G VY       G+ M V  V++     GR         K+   E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALE 603
            N+++ +   + EE+ ++ LEY P GS    L  Y      ++  F        V   L 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           YLH      ++H DLK DN+L+D + +  +SDFGI+K
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 22/160 (13%)

Query: 497 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---------------QCGRAFKSFAVECE 540
              +G G +G V KA     G  VA+K   +                CG  F +   E +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72

Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
           +M  I+H N++ ++      +F  LV++      L+K +      L   Q   I++ + +
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILN 130

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            L  LH       +H DL P N+ ++   +  ++DFG+A+
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 49/157 (31%), Positives = 70/157 (44%), Gaps = 15/157 (9%)

Query: 500 IGRGGFGSVYKARLGDGMEVA-VKVFNLQCGRAFK---SFAVECEMMKSIRHRNLIKVIS 555
           IG G FG V       GM  A V V  L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCIL------DIFQRLNIMIDVASALEYLHFGC 609
            C       LVLE+ P G L+ YL S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            A  IH DL   N  L  +L   + D+G+A     ED
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 11/155 (7%)

Query: 499 LIGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
            +G G FG V    +    G  + VAVK   + +       F  E  +M S+ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAP 612
                      +V E  P GSL   L         I    +  + +A+ + YL       
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK-LLIGED 646
            IH DL   N+LL  +    + DFG+ + L   ED
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 28/160 (17%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV--ECEMMKSIR---HRNLIKV 553
           IG G +G+VYKAR    G  VA+K   +Q        +   E  ++K +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 554 ISSC----SNEEFK-ALVLEYKPHGSLEKYL-------YSSNCILDIFQRLNIMIDVASA 601
           +  C    ++ E K  LV E+     L  YL         +  I D+ ++          
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120

Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           L++LH  C   ++H DLKP+N+L+       L+DFG+A++
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 57.9 bits (141), Expect = 4e-09
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)

Query: 500 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAV-----ECEMMKSIRHRNLIKV 553
           +G G FG V   R     +  A+K+ +    +  K   V     E  +++SIRH  L+ +
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
             S  ++    LV+EY P G L  +L  S               V  ALEYLH      +
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLHS---LDI 122

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++ DLKP+N+LLD +    ++DFG AK +
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRV 151

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 500 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V   R    GD  G +VAVK    +  G        E E+++++ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C+ +      L++E+ P GSL++YL  +   +++ Q+L   + +   ++YL      
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---R 128

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             +H DL   NVL++      + DFG+ K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 4/141 (2%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  + G   A KV   +     + + VE E++ +  H  ++K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            +    +++E+ P G+++  +   +  L   Q   I   +  AL+YLH      +IH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDL 136

Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  NVLL  +    L+DFG++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 25/162 (15%)

Query: 500 IGRGGFGSVYK---ARLGDG---MEVAVK-VFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+     +  G     VA+K V      R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYS------SNCILDIFQRLNIM---IDVASALE 603
           ++   S  +   +V+E    G L+ YL S      +N  L        +    ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 604 YL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           YL    F      +H DL   N ++ ++L   + DFG+ + +
Sbjct: 134 YLAAKKF------VHRDLAARNCMVAEDLTVKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 24/154 (15%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNL---QCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           IG G FG+VY AR     E VA+K  +    Q    ++    E   ++ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 556 SCSNEEFKA-LVLEYKPHGSLEKYLYSSNCILDIFQR-------LNIMIDVASALEYLHF 607
            C   E  A LV+EY         L S++ IL++ ++         I       L YLH 
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
                 IH D+K  N+LL +     L+DFG A L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 31/165 (18%)

Query: 498 NLIGRGGFGSVYKA----RLGDG--MEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNL 550
             +G G FG VY+     R GD   ++VAVK     C    +S F +E  +M    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLY---------SSNCILDIFQRLNIMIDVASA 601
           +++I        + ++LE    G L+ +L          SS  + D+   L    DVA  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKG 128

Query: 602 LEYL---HFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAK 640
            +YL   HF      IH D+   N LL       VA ++DFG+A+
Sbjct: 129 CKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N++K++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              E    LV E+  H  L+K++ +S    + +    + +  +   L + H      V+H
Sbjct: 68  IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 12/147 (8%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G+GG+G V+ A+  D  E VA+K      L      +    E +++ + +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI--MIDVASALEYLHFGCLAPV 613
           +  ++E+  L +EY P G     L +   + +   R  +  M +   AL  L +      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           IH DLKP+N L+D +    L+DFG++K
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)

Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y    + D    F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 9/149 (6%)

Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRAFKSFAVECEMMKSIRHRNLIK 552
            +IG+G FG VY   L    G  +  AVK  N +      + F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 553 VISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++  C   E   LV L Y  HG L  ++ S      +   +   + VA  +EYL      
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             +H DL   N +LD++    ++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 20/150 (13%)

Query: 500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G + +VYK +   +G  VA+KV  LQ        A+ E  ++K ++H N++ +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 558 SNEEFKALVLEYKPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
             +E   LV EY  H  L +Y       L+  N  L +FQ L         L Y+H    
Sbjct: 73  HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIH---Q 121

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             ++H DLKP N+L+ D     L+DFG+A+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 14/150 (9%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVK------VFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G GGFG V   ++       A+K      +          S   E E+++   H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  +  ++++  +++EY   G L   L     + D +     +  V  A EYLH      
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRG 113

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +I+ DLKP+N+LLD N    L DFG AK L
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 10/153 (6%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           IGRG F  VY+A  L D   VA+K   +F +   +A +    E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 556 SCSNEEFKALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           S   +    +VLE    G L    KY      ++         + + SA+E++H      
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RR 126

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           V+H D+KP NV +    V  L D G+ +    +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 29/159 (18%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           F+    IG+G FG VYKA        VA+KV +L+          E E+    +    I+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE---IQ 51

Query: 553 VISSCSN-----------EEFK-ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
            +S C +           +  K  +++EY   GS    L      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LEYLH       IH D+K  N+LL +     L+DFG++
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G + +VYK R     E VA+K  +L       S A+ E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 558 SNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E    LV EY     L+KY+  +     LD     +    +   + + H      V+H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 23/69 (33%), Positives = 39/69 (56%)

Query: 162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
             L+   +S  ++ G IP  + ++T+   +DL  N  NGSIP +L +L  L+ L L+ N 
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501

Query: 222 LEGSIPDSI 230
           L G +P ++
Sbjct: 502 LSGRVPAAL 510

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 14/244 (5%)

Query: 159 NLSHSLKDFYMSNCNVSGGIPEEITNLTNSITID------LGGNKLNGSIPITLSKLQKL 212
           +   S     + + N     P+ I        ++      L  N  + ++ +  S L +L
Sbjct: 10  SALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRL 69

Query: 213 QGLGLDDNKLEGS--IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNEL 270
             L L       S    +++  L  L  L+L  N+L  +I      L +L  L L +N +
Sbjct: 70  LSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNI 128

Query: 271 TSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK 329
           T I PL      ++ +L+ S N +   LP  + NL  L  +D S N+  S +P  +  L 
Sbjct: 129 TDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLS 186

Query: 330 NLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
           NL  L L  N++   +P     L +L+ L+LSNN++   + +SL  L  L  L LS NKL
Sbjct: 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244

Query: 390 EGEI 393
           E   
Sbjct: 245 EDLP 248

Length = 394

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS-- 556
           IG+G  G+V+ A  +  G EVA+K  NLQ     +    E  +MK +++ N++  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
             +E F  +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH 
Sbjct: 87  VGDELF--VVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLHAN---QVIHR 139

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           D+K DNVLL  +    L+DFG    +  E
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 30/167 (17%)

Query: 500 IGRGGFGSVYKARLGDGME---------VAVKVFNLQCG-RAFKSFAVECEMMKSI-RHR 548
           +G G FG V  A    G++         VAVK+       +       E EMMK I +H+
Sbjct: 26  LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCI----LDIFQRLN 593
           N+I ++ +C+ +    +++EY   G+L +YL           Y+   +    L     ++
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 29/171 (16%)

Query: 500 IGRGGFGSVYKARLG-DGME----VAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G   FG +YK  L   GM+    VA+K   ++   + +  F  E  +M  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLY----------SSN------CILDIFQRLNIMID 597
           +   + E+   ++ EY   G L ++L           SS+        LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 598 VASALEYL--HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +A+ +EYL  HF      +H DL   N+L+ + L   +SD G+++ +   D
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 27/176 (15%)

Query: 489 RATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSI 545
           R  + F     IG G +G VYKAR  D G  VA+K   L   +  F   A+ E ++++ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 546 RHRNLIK----VISSCSNEEFKA------LVLEYKPH---GSLEKYL--YSSNCILDIFQ 590
            HRN++     V       +FK       LV EY  H   G LE  L  +S + I    +
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +L         L Y H       +H D+K  N+LL++     L+DFG+A+L   E+
Sbjct: 124 QL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142

Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           K DN+LL  +    L+DFG    +  E
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 19/151 (12%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G VYK R    G  VA+K   L+       S A+ E  ++K ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-------FGC 609
              E    L+ E+     L+KYL S              +D      YL+       F  
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              V+H DLKP N+L+D+  V  L+DFG+A+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.0 bits (129), Expect = 8e-08
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA+K  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   AL++LH      VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDI 141

Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           K DN+LL  +    L+DFG    +  E
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +    + VAVK+  +    +       E EMMK I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YS-SNCILD----IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS   C L      F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 9/147 (6%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKV 553
           +IG+G FG V  AR   +    AVKV   +     +  K    E   ++K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
             S    +    VL+Y   G L  +L    C L+   R     ++ASAL YLH      +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNI 117

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++ DLKP+N+LLD      L+DFG+ K
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             +E    LV E+     L+KY+ S     LD     + +  +   + Y H      V+H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DLKP N+L+D      L+DFG+A+
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 12/147 (8%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID----VASALEYLHFGCLAPVIH 615
           E    ++ E+   GSL  +L S        Q L  +ID    +A  + ++        IH
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 125

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DL+  N+L+  +LV  ++DFG+A+++
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 10/150 (6%)

Query: 499 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRHRNLIKVI 554
           L+G+G  G V+  RL G G   A+KV + +             E E++ ++ H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +S   E +  LV++Y P G L + L      C+ +   R     +V  ALEYLH   L  
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLH--LLG- 123

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +++ DLKP+N+LL ++    LSDF ++K  
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 4/141 (2%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  + G+  A KV + +     + + VE +++ S  H N++K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+L   +    L+DFG++
Sbjct: 130 KAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.9 bits (115), Expect = 2e-07
 Identities = 25/60 (41%), Positives = 32/60 (53%)

Query: 330 NLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
           NL+ L L  NRL      +F  L +LK L+LS NNL+   P +   L  L  L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 22/151 (14%)

Query: 500 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +VYK  +R+ +G  VA+KV +++        A+ E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 557 CSNEEFKALVLEYKPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
              +E    V EY  H  L +Y       L+  N  L +FQ L         L Y+H   
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHG-- 121

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              ++H DLKP N+L+       L+DFG+A+
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  ++
Sbjct: 128 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 25/154 (16%)

Query: 500 IGRGGFGSVYKAR---LGDGMEVAV----------KVFNLQCGRAFKSFAVECEMMKSIR 546
           I +G FGSVY A+    GD   + V          +V N++  RA         MM    
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI--------MMIQGE 55

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
              + K+  S  ++++  LV+EY   G     + +   + + + +   + +V   +E LH
Sbjct: 56  SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH 114

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                 +IH D+KP+N+L+D      L+DFG+++
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 27/174 (15%)

Query: 500 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIK 552
           +G G FG V KA             VAVK+       +  +    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI----LDIFQRLNIMIDVASALEYLHFG 608
           +  +CS +    L++EY  +GSL  +L  S  +    L      N           L  G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 609 CL----------------APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            L                  ++H DL   NVL+ +     +SDFG+++ +  ED
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 8/144 (5%)

Query: 500 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +VYK R  L D + VA+K   L+        A+ E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV EY     L++YL      +++      +  +   L Y H      V+H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L+++     L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 10/159 (6%)

Query: 492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRN 549
               E + +G G  GSV K RL   GM  A+K           K    E E+ KS +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 550 LIKVISSCSNEEFK--ALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEY 604
           ++K   +  +E      + +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           LH      +IH D+KP N+LL       L DFG++  L+
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 30/167 (17%)

Query: 500 IGRGGFGSVYKARLGDGME---------VAVKVF-NLQCGRAFKSFAVECEMMKSI-RHR 548
           +G G FG V +A    G++         VAVK+  +    +       E E+MK I +H+
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS-----NCILDI---------FQRL-N 593
           N+I ++  C+ E    +++EY   G+L ++L +      +   DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 139 CAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 494 FSENNL-----IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRAFK-SFAVECEM 541
           F  NNL     +G G FG V +A      +    M+VAVK+       + + +   E ++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 542 MKSI-RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVA 599
           M  +  H N++ ++ +C+      ++ EY  +G L  +L       L +   L+    VA
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 600 SALEYLHF-GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             + +L    C    IH DL   NVLL    +  + DFG+A+
Sbjct: 152 KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 29/162 (17%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNL------ 550
           +IG G +G VYKAR    G  VA+K+ ++      +    E  +++    H N+      
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 551 -IKVISSCSNEEFKALVLEYKPHGS---LEKYLYSSNCILDIFQRLN------IMIDVAS 600
            IK     ++++   LV+E    GS   L K L          +RL       I+ +   
Sbjct: 72  FIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILRETLR 124

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            L YLH      VIH D+K  N+LL  N    L DFG++  L
Sbjct: 125 GLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 12/152 (7%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCGRAFKSF-AVECE--MMKSIRHRNLIK 552
           L+G+G FG VY     D G E+AVK   F+ +     K   A+ECE  ++K++ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 553 VISSCSN--EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
                 +  E   ++ +E+ P GS++  L S   + +   R      +   + YLH    
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSNM- 126

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             ++H D+K  N+L D      L DFG +K L
Sbjct: 127 --IVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 12/152 (7%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCGRAFKSF-AVECE--MMKSIRHRNLIK 552
           L+G+G FG VY     D G E+A K   F+ +     K   A+ECE  ++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 553 VISSCSNEEFKALV--LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
                 +   K L   +EY P GS++  L +   + +   R      +   + YLH    
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSNM- 126

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             ++H D+K  N+L D      L DFG +K L
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 24/166 (14%)

Query: 493 GFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNL----QCGRAFKSFAVECEMM 542
              E   +GRG FG V+ A+       G    V VK             F+    E +M 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMF 62

Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--------LDIFQRLNI 594
           + + H+N+++++  C   E   ++LEY   G L+++L ++           L   Q++ +
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +++L     A  +H DL   N L+       +S   ++K
Sbjct: 123 CTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 493 GFSENNLIGRGGFGSVYKARL---GDGMEVAVKVF--NLQCGRAFKSFAV-ECEMMKSIR 546
            +     IGRG +G VYKA+     DG E A+K F  + +        A  E  +++ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 547 HRNLIKVISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRL---NIMIDVASA 601
           H N++ ++        K+  L+ +Y  H   +   +               +++  + + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 602 LEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKL 641
           + YLH      V+H DLKP N+L+     +  V  + D G+A+L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 30/165 (18%)

Query: 491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---------ECE 540
           TN + +   +G G FG V  AR    G  VA+K       +  K F+          E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61

Query: 541 MMKSIRHRNLIKV----ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
           ++K +RH N+I +    IS   +  F   +L    H  L      S  +   F +   + 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT-----SRPLEKQFIQY-FLY 115

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
            +   L+Y+H    A V+H DLKP N+L+++N    + DFG+A++
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 9/147 (6%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKV 553
           +IG+G FG V  A R  DG   AVKV   +     +  K    E   ++K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
             S    E    VL++   G L  +L       +   R     ++ASAL YLH      +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++ DLKP+N+LLD      L+DFG+ K
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 8/144 (5%)

Query: 500 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +V+K R  L + + VA+K   L+        A+ E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              ++   LV EY     L++Y+     I+ +      +  +   L Y H      V+H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L+++     L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 15/149 (10%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G VYKAR     E +A+K   L Q      S A+ E  ++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI----MIDVASALEYLHFGCLAP 612
             +E+   LV EY     L+K++ SS    D  +   +    +  +   + Y H      
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HR 122

Query: 613 VIHCDLKPDNVLLDDNLVAY-LSDFGIAK 640
           V+H DLKP N+L+D    A  L+DFG+A+
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 49/239 (20%), Positives = 81/239 (33%), Gaps = 43/239 (17%)

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNA----SKLSILELSQNSFSGFIPNT------FGNLR 107
           L  L+ L L GN       + + +A      L  L LS N                    
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 108 NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLD---GILSKTSIGNLSHSL 164
            L+ L+L DN L         L SL    SL  + L++N L      L    + +L  +L
Sbjct: 82  GLQELDLSDNALGPDGCG--VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139

Query: 165 KDFYMSNCNVSGGIPEEITNLTNSI----TIDLGGNKLNGSIPITLSK----LQKLQGLG 216
           +   +    + G   E +     +      ++L  N +  +    L++       L+ L 
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

Query: 217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL 275
           L++N L                 + G + L        ++L SL +L+L  N LT    
Sbjct: 200 LNNNGLT----------------DEGASAL----AETLASLKSLEVLNLGDNNLTDAGA 238

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 23/187 (12%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFNM---SMLKLLHLQNNSL-LGCLSSIADV---RLPN 60
               L+ELDL  N L       + ++   S L+ L L NN L    L  +A       P 
Sbjct: 79  KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138

Query: 61  LEALLLWGNNFSGTIPR-----FIFNASKLSILELSQNSFSGF-IPNTFGNLR---NLEW 111
           LE L+L  N   G            N   L  L L+ N      I      L+   NLE 
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRAN-RDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 112 LNLRDNYLTSSTPELSFLS-SLSNCKSLTFIHLSDNPLD--GILS-KTSIGNLSHSLKDF 167
           L+L +N LT      S L+ +L++ KSL  ++L DN L   G  +  +++ + + SL   
Sbjct: 198 LDLNNNGLTDE--GASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255

Query: 168 YMSNCNV 174
            +S  ++
Sbjct: 256 SLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 6/139 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+  +H N++++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+E+   G+L   +  +   ++  Q   + + V  AL +LH      VIH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 142 KSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 29/158 (18%)

Query: 500 IGRGGFG---SVYKARLGDGMEVAVK----VF-NL-QCGRAFKSFAVECEMMKSIRHRNL 550
           IG G FG   SV   R  DG  VA+K    VF NL  C R F+    E +M+   +H N+
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61

Query: 551 IKVIS-------SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +  +            E +   V+       L K + S   +     ++  +  +   L+
Sbjct: 62  LSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           YLH    A ++H D+KP N+L++ N V  + DFG+A++
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 499 LIGRGGFGSVYKARLGDGME--VAVK---VFNLQCGR-------AFKSFAVECEMMK-SI 545
            +G G FG VYK R  +  +  +A+K   V N   G+       +      E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF--QRL-NIMIDVASAL 602
           RH N+++   +    +   +V++      L ++  S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            YLH      ++H DL P+N++L ++    ++DFG+AK
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 23/164 (14%)

Query: 489 RATNGFSE---NNLIGRGGFGSVYKAR-LGDGMEVAVKV-FNLQCGRAFKSFAVECEMMK 543
            A    SE    N IG G  G+VYK      G   A+KV +        +    E E+++
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 544 SIRHRNLIKVISSC-----SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
            + H N++K    C      N E + L LE+   GSLE        I D     ++   +
Sbjct: 128 DVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLADVARQI 177

Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            S + YLH      ++H D+KP N+L++      ++DFG++++L
Sbjct: 178 LSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218

Length = 353

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 15/193 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LP 59
            +P  + NL NL+ LDL  N L   +P  + N+S L  L L  N     +S +     L 
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK----ISDLPPEIELL 208

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           +    L   NN    +   + N   LS LELS N     +P + GNL NLE L+L +N +
Sbjct: 209 SALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           +S       +SSL +  +L  + LS N L   L   ++  L        +     +  + 
Sbjct: 268 SS-------ISSLGSLTNLRELDLSGNSLSNALPLIALLLLL-LELLLNLLLTLKALELK 319

Query: 180 EEITNLTNSITID 192
                L N+I  +
Sbjct: 320 LNSILLNNNILSN 332

Length = 394

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 35/164 (21%)

Query: 498 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKS--FAV----ECEMMKSIRHRNL 550
           + +G G +G V  A     G +VA+K  +    R F+S   A     E  ++K + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 551 IKVIS----SCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDV 598
           I ++     + S E+F+   LV        L   +          Q+L+      ++  +
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQI 127

Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              L+Y+H    A +IH DLKP N+ ++++    + DFG+A+  
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 6/139 (4%)

Query: 500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             E   +++E+   G+L   +  S   L+  Q   +   V  AL YLH      VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 144 KSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 21/157 (13%)

Query: 500 IGRGGFGSVYKARL---------GDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRN 549
           +G+G F ++YK  L         G G EV+V +  L    R   +F     +M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           L+K+   C  +E   +V EY   G L+ +L+     + +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 610 LAPVIHCDLKPDNVLL---DDN----LVAYLSDFGIA 639
           L   +H ++   N+L+     N        LSD GI 
Sbjct: 122 L---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 17/170 (10%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRAFKSFAVECEMMK 543
           C     +     +G G FG VYKAR +  G  VA+K   + N + G    +   E +++K
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62

Query: 544 SIRHRNLIK----VISSCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++      +      + K     +V  Y  H  L   L + +  L   Q    M
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121

Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           + +   + YLH      ++H D+K  N+L+D+  +  ++DFG+A+   G 
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECE--MMKSIRHRNLIKVISS 556
           IG G FG +Y A+   D     +K  +L      +  A + E  ++  ++H N++   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 557 CSNEEFKALVLEYKPHGSLEK-------YLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
                   +V+EY   G L K        L+S + IL  F      + ++  L+++H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIHD-- 119

Query: 610 LAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLL 642
              ++H D+K  N+ L  N +VA L DFGIA+ L
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 500 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +V+K R  L + + VA+K   L+        A+ E  ++K+++H N++ +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E    LV EY     L++YL +   ++ +      M  +   L Y H      ++H 
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L+++     L+DFG+A+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 44/185 (23%), Positives = 80/185 (43%), Gaps = 31/185 (16%)

Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARL-----GDGME-VAVKVFNLQCGRAFKS-FAVE 538
           E+  +T  F E   +G   FG VYK  L     G+  + VA+K    +     +  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---------------SSN 583
             M   ++H N++ ++   + E+  +++  Y  H  L ++L                +  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 584 CILDIFQRLNIMIDVASALEYL--HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
             L+    ++I+  +A+ +E+L  H      V+H DL   NVL+ D L   +SD G+ + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 642 LIGED 646
           +   D
Sbjct: 174 VYAAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 3e-06
 Identities = 26/63 (41%), Positives = 33/63 (52%), Gaps = 3/63 (4%)

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN 362
           NLK L   D S N  + +      GL NL+ L L  N L    P++F  L SL+ L+LS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 363 NNL 365
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 38/179 (21%), Positives = 72/179 (40%), Gaps = 42/179 (23%)

Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG---RAFKSFAVE 538
           F  + LC A +G  + +        +     L     VAVKV  L+      A + F  E
Sbjct: 18  FGEVHLCEA-DGLQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDFLKE 69

Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY----------------SS 582
            +++  +   N+ +++  C+ +    +++EY  +G L ++L                 S 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 583 NCILDIFQRLNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI 638
           + +      L +   +AS + YL   +F      +H DL   N L+  N    ++DFG+
Sbjct: 130 STL------LYMATQIASGMRYLESLNF------VHRDLATRNCLVGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 38/171 (22%)

Query: 499 LIGRGGFGSVYKARLGDGM----EVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           LIG GGFG VY+ +         +   K+ NL+     ++  +E  +  +I   + I + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74

Query: 555 SSCSNEE------------FKALVLEYKPHGSLEKYLYSSNCILDIFQRL---------N 593
            +  N +            FK   + Y+    LEK + ++    +IF+R+         N
Sbjct: 75  KNIHNIDHLGIPKYYGCGSFKRCRMYYR-FILLEKLVENTK---EIFKRIKCKNKKLIKN 130

Query: 594 IMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           IM D+ + LEY+H  G    + H D+KP+N+++D N   Y+ D+GIA   I
Sbjct: 131 IMKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Length = 294

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 500 IGRGGFGS--VYKARLGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVIS 555
           +G+G FG   +Y+ R  D   V  K  NL +     +  A+ E  ++  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 556 SCSNEEFKALVLEYKPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              ++    + +EY   G+L +K +     + +    L  +  + SA+ Y+H    A ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+K  N+ L    +  L DFGI+K+L
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 28/164 (17%)

Query: 499 LIGRGGFGSVYKARLGDGME----VAVKVF-NLQCGRAFKSFA---VECEMMKSIRHRNL 550
           ++G+GG+G V++ R   G +     A+KV       R  K  A    E  ++++++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS--------AL 602
           + +I +        L+LEY   G L  +L        IF     M D A         AL
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IF-----MEDTACFYLSEISLAL 113

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           E+LH      +I+ DLKP+N+LLD      L+DFG+ K  I E 
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 59/175 (33%), Positives = 87/175 (49%), Gaps = 26/175 (14%)

Query: 486 ELCRATN-GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMK 543
           ++ R+ N  +   N+IG G FG VY+A   D  E VA+K   LQ    +K+   E  +MK
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYKN--RELLIMK 114

Query: 544 SIRHRNLIKVISSCSNEEFKA--------LVLEYKPHGSLEKYL--YS-SNCILDIFQRL 592
           ++ H N+I +      E FK         +V+E+ P  ++ KY+  Y+ +N  L +F   
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173

Query: 593 NIMIDVASALEYLH--FGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIG 644
                +  AL Y+H  F C     H DLKP N+L+D N     L DFG AK L+ 
Sbjct: 174 LYSYQLCRALAYIHSKFIC-----HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223

Length = 440

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 8/146 (5%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRHRNLIKVI 554
           L+G+G FG V   R    G   A+K+   +   A    A    E  ++K+ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            S   ++    V+EY   G L  +L       +   R     ++ SAL+YLH G    ++
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIV 117

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           + DLK +N++LD +    ++DFG+ K
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 20/154 (12%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAV------ECEMMKSIRHRNL-- 550
           IG G +G V  A     G +VA+K    +   AF    +      E ++++  +H N+  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKILRHFKHDNIIA 68

Query: 551 IKVISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           I+ I      +FK   +V++      L   ++S   + +   R   +  +   L+Y+H  
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIHSA 126

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               VIH DLKP N+L++++    + DFG+A+ L
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 11/134 (8%)

Query: 500 IGRGGFGSVYKA---RLGDG-----MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           +G+G F  ++K     +GD       EV +KV +       +SF     MM  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
                C   +   +V EY   GSL+ YL  +  +++I  +L +   +A AL +L    L 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL- 121

Query: 612 PVIHCDLKPDNVLL 625
              H ++   NVLL
Sbjct: 122 --THGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 20/153 (13%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR------HRNLI 551
            +G G F S Y+AR +  G  +AVK        + +   V   + K IR      H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 552 KVISSCSNEEFKALVLEYKPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           +++ +   +    L +E+   GS    L KY      ++     +N    +   L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121

Query: 608 GCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIA 639
                +IH D+K  N+L+D       ++DFG A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 8/148 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G +G V   R   DG +  +K  NL+    R  K+   E +++  ++H N++    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 557 CSNEE-FKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              E+    +V+ +   G L   L      +L   Q +   + +A AL+YLH      ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DLK  NV L    +  + D GIA++L
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 7e-06
 Identities = 24/65 (36%), Positives = 31/65 (47%), Gaps = 5/65 (7%)

Query: 84  KLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHL 143
            L  L+LS N  +      F  L NL+ L+L  N LTS +PE     + S   SL  + L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 144 SDNPL 148
           S N L
Sbjct: 56  SGNNL 60

Length = 60

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 31/160 (19%)

Query: 498 NLIGRGGFGSVYKA-RLGDGMEVAVKV---FNLQ--CGRAFKSFAVECEMMKSIRHRNLI 551
           + IG G +G V  A     G++VA+K    F  Q  C R  +    E ++++  +H N+I
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66

Query: 552 K---VISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASA 601
               +I   S E F    +V E      L K + + +   D     ++Q L         
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR-------G 118

Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           L+Y+H    A V+H DLKP N+LL+ N    + DFG+A++
Sbjct: 119 LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G+GGFG V   ++   G   A K  +   L+  +  +    E ++++ +  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           +   ++   LV+     G L+ ++Y+         + +     +   LE+LH      ++
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIA 639
           + DLKP+NVLLDD+    +SD G+A
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 26/175 (14%)

Query: 474 PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAF 532
           P  ++W+  S  E+            +G G FG V  A+  G G   A+K    +     
Sbjct: 10  PDTSSWK-LSDFEM---------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59

Query: 533 KS---FAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS----NCI 585
           K     A E  ++  + H  ++ ++ S  +E     +LE+   G L  +L  +    N +
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 586 LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +       ++  A EYLH      +I+ DLKP+N+LLD+     ++DFG AK
Sbjct: 120 AKFYH-----AELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 22/160 (13%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRAFKSFAVECEMMKSIRHRN 549
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-------AL 602
            I+       E    LV+EY         L S++ +L++ ++    +++A+        L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            YLH   +   IH D+K  N+LL +  +  L DFG A ++
Sbjct: 129 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM 165

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 27/77 (35%), Positives = 47/77 (61%), Gaps = 5/77 (6%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV--RLP 59
           IP +IS L++L+ ++L  N + G +P ++ +++ L++L L  NS  G   SI +   +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG---SIPESLGQLT 490

Query: 60  NLEALLLWGNNFSGTIP 76
           +L  L L GN+ SG +P
Sbjct: 491 SLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 18/60 (30%), Positives = 27/60 (45%)

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           NL++L L  N  +            L +L+LS N+ +   P  F  L +L  L+L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 22/159 (13%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNL---QCGRAFKSFAVECEMMKSIRHRN 549
           F++   IG G FG+VY AR     EV A+K  +    Q    ++    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-------AL 602
            I+       E    LV+EY         L S++ +L++ ++    +++A+        L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
            YLH   +   IH D+K  N+LL +     L+DFG A +
Sbjct: 139 AYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 47.6 bits (114), Expect = 1e-05
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 44/165 (26%)

Query: 500 IGRGGFGSVYKARLGD---GMEVAVK-VF----NLQ-CGRAFKSFAVECEMM--KSIR-H 547
           +G+G +G V+KA   D      VA+K +F    N     R F+      E+M  + +  H
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR------EIMFLQELGDH 66

Query: 548 RNLIKVISSCSNEEFKA-------LVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMID 597
            N++K+++       KA       LV EY     +E  L++   +N + D+ +R  IM  
Sbjct: 67  PNIVKLLNV-----IKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQ 115

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +  AL+Y+H G    VIH DLKP N+LL+ +    L+DFG+A+ L
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 33/160 (20%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--------- 544
           F    +IGRG FG V   R     + + +V+ ++    F       EM+K          
Sbjct: 45  FDVIKVIGRGAFGEVQLVR----HKSSKQVYAMKLLSKF-------EMIKRSDSAFFWEE 93

Query: 545 ---IRHRN---LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
              + H N   ++++  +  ++++  +V+EY P G L   L S+  I + + R     +V
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EV 151

Query: 599 ASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
             AL+ +H  G     IH D+KPDN+LLD +    L+DFG
Sbjct: 152 VLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 28/106 (26%), Positives = 52/106 (49%), Gaps = 8/106 (7%)

Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--LDIFQRLNI 594
           +E  +++++ H ++I++  +  +     +VL   PH S + Y Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +   L YLH      +IH D+K +N+ ++D     + D G A+
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 47/173 (27%), Positives = 71/173 (41%), Gaps = 37/173 (21%)

Query: 494 FSENNL-----IGRGGFGSVYKARLGD-GMEVAVKVFNLQC-GRAFKSFAVECE-MMKSI 545
           F+  +L     IGRG FG+V K      G  +AVK        +  K   ++ + +M+S 
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 546 RHRNLIKVISSCSNE-------EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
               ++K   +   E       E   + L+        KY+Y    +L       I+  +
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLD-----KFYKYVY---EVLKSVIPEEILGKI 112

Query: 599 A----SALEYL----HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           A     AL YL           +IH D+KP N+LLD N    L DFGI+  L+
Sbjct: 113 AVATVKALNYLKEELK------IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 22/151 (14%)

Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNL---QCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           IG G FG+VY A      E VAVK  +    Q    ++    E + ++ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-------ALEYLHFG 608
               E    LV+EY         L S++ +L++ ++    +++A+        L YLH  
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            +   IH D+K  N+LL +     L+DFG A
Sbjct: 141 NM---IHRDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 22/151 (14%)

Query: 500 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +VYK R  L   + VA+K   L+        A+ E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILD-------IFQRLNIMIDVASALEYLHFGC 609
              ++   LV EY     L++Y+      L        +FQ L         L Y H   
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH--- 120

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              V+H DLKP N+L+ +     L+DFG+A+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 10/150 (6%)

Query: 499 LIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           ++G G FG+VYK   + DG    + VA+KV       +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           ++  C     + LV +  P+G L  Y+  +   +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H DL   NVL+       ++DFG+A+LL
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 31/162 (19%)

Query: 500 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------AFKSFAVECEMMKSIRHRNLI 551
           IG G +G V+KAR     G  VA+K   +Q G         +  AV    +++  H N++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67

Query: 552 KVISSCS----NEEFK-ALVLEYKPHGSLEKYL-------YSSNCILDIFQRLNIMIDVA 599
           ++   C+    + E K  LV E+     L  YL         +  I D+      M  + 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLL 120

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
             L++LH      V+H DLKP N+L+  +    L+DFG+A++
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 15/154 (9%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVI-- 554
           ++G G +G VYK R +  G   A+KV ++      +   +E  M+K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 555 ----SSCSNEEFKALVLEYKPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFG 608
               S   +++   LV+E+   GS+   + ++  N + + +    I  ++   L +LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               VIH D+K  NVLL +N    L DFG++  L
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 35/160 (21%)

Query: 500 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNL 550
           +G G +GSV   Y  RL    +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 551 IKVIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVAS 600
           I ++     + S E F  + L     G+        N I+   Q+L+      ++  +  
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            L+Y+H    A +IH DLKP NV ++++    + DFG+A+
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 11/136 (8%)

Query: 516 GMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYKP 571
           G EVA+K+              F  E  +   + H N++ ++ S          V EY P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDN 628
             +L + L +++  L   +   +M+ V  AL   H      ++H DLKP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 629 LVAYLSDFGIAKLLIG 644
             A + DFGI  LL G
Sbjct: 119 PHAKVLDFGIGTLLPG 134

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 29/78 (37%), Positives = 38/78 (48%), Gaps = 5/78 (6%)

Query: 73  GTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSL 132
           G IP  I     L  + LS NS  G IP + G++ +LE L+L  N    S PE     SL
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-----SL 486

Query: 133 SNCKSLTFIHLSDNPLDG 150
               SL  ++L+ N L G
Sbjct: 487 GQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 35/145 (24%), Positives = 66/145 (45%), Gaps = 10/145 (6%)

Query: 499 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRAFK---SFAVECEMMKSIRHRNLIKV 553
           ++G G FG + +   +L    E+ V +  L+ G + K    F  E   +    H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCLAP 612
               +      +V EY  +G+L+ +L      L   Q + ++  +AS ++YL   G    
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---- 127

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFG 637
            +H  L    VL++ +LV  +S F 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 10/147 (6%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G+GGFG V   ++   G   A K  N   L+  + ++   VE  ++  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +   +    LV+     G L  ++Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +I+ DLKP+NVLLD++    +SD G+A
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 49/166 (29%), Positives = 67/166 (40%), Gaps = 48/166 (28%)

Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNL------ 550
           +IGRG FG V   +  D G   A+K          KS  +E E +  +R  R++      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 551 ---IKVISSCSNEEFKALVLEYKPHGS----LEKY---------LYSSNCILDIFQRLNI 594
              +K+  S  +E +  L++EY P G     L K           Y +  IL        
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-------- 112

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            ID    L Y         IH D+KPDN+LLD      LSDFG+  
Sbjct: 113 AIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 8/146 (5%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRHRNLIKVI 554
           L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            +    +    V+EY   G L  +L       +   R     ++ SALEYLH      V+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLHS---RDVV 117

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           + D+K +N++LD +    ++DFG+ K
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 31/158 (19%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAF------KSFAVECEMMKSIRHRNLIK 552
           IGRG +G V  A+  +   +VA+K    +   AF      K    E ++++ + H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIK----KIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 553 ---VISSCSNEEFKALVLEYKPHGS-LEKYLYSSNCILD------IFQRLNIMIDVASAL 602
              ++     E F  + + Y+   + L + + SS  + D      ++Q L         L
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           +Y+H    A V+H DLKP N+LL+ N    + DFG+A+
Sbjct: 122 KYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 35/140 (25%), Positives = 70/140 (50%), Gaps = 15/140 (10%)

Query: 519 VAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEK 577
           VAVK+      + A   F  E ++M  +++ N+I+++  C +++   ++ EY  +G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 578 YL-----YS----SNCI--LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD 626
           +L      S    +N I  + I   L + + +AS ++YL        +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 627 DNLVAYLSDFGIAKLLIGED 646
           ++    ++DFG+++ L   D
Sbjct: 164 NHYTIKIADFGMSRNLYSGD 183

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMMK------SIRHRNLI 551
           ++G+G FG V  A L    EV A+KV  L+     +   V+C M +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +      ++    V+EY   G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            VI+ DLK DN+LLD      L+DFG+ K
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 9/75 (12%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLP- 59
            IP  + ++ +LE LDL +N   G++P ++  ++ L++L+L  NSL G        R+P 
Sbjct: 457 NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG--------RVPA 508

Query: 60  NLEALLLWGNNFSGT 74
            L   LL   +F+ T
Sbjct: 509 ALGGRLLHRASFNFT 523

Length = 623

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 13/155 (8%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM-KSI-----RHRNLI 551
           ++G+G FG V  A L    E+ AVKV  L+     +   VEC M  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++ S    ++    V+EY   G L  ++  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            +I+ DLK DNVLLD      ++DFG+ K  I   
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 31/146 (21%), Positives = 62/146 (42%), Gaps = 15/146 (10%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI--KVISS 556
           L+  G    VY     D  +  +K+   +   A      E  +++ +  + L   KV++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV-IH 615
             ++ +  L++E+    +L++        +   ++ +I   +A  L  LH      V  H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCH 112

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKL 641
            DL P N+L+DD  +  + D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 6/139 (4%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+E+   G+L   +  +   ++  Q   + + V  AL YLH      VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 145 KSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 138

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 139 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 8e-05
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 28/161 (17%)

Query: 500 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMMKSIR-HRN-------- 549
           I RG FG VY  R  +  ++ AVKV         K+  +   M+  ++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 550 -LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYL 605
            ++ +  S  +     LV+EY   G ++  L+    I   F     +  + +VA AL+YL
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYL 120

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           H      +IH DLKPDN+L+ +     L+DFG++K+ +  +
Sbjct: 121 H---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 26/158 (16%)

Query: 494 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN--- 549
           F    +IGRG FG V   +  D G   A+K+         K+  +E E +  IR      
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDIL 55

Query: 550 -------LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-- 600
                  ++K+  S  ++    L++E+ P G +   L   + + +   +  I   V +  
Sbjct: 56  VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI 638
           A+  L F      IH D+KPDN+LLD      LSDFG+
Sbjct: 116 AIHQLGF------IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 27/156 (17%)

Query: 500 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G FG VY+ R  D   + A+KV +       K    + E+  +I  RN++ V +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNIL-VRTLLD 53

Query: 559 NEEFKA-------------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEY 604
              F               LV +Y   G L  +L       +   R    I ++  ALE+
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           LH      +++ DLKP+N+LLD      L DFG++K
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 23/50 (46%), Positives = 30/50 (60%), Gaps = 2/50 (4%)

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           I + +  ALEYLH      VIH D+KP NVL++ N    L DFGI+  L+
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 17/147 (11%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS--------FAVECEMMKSIRHRNL 550
           +IGRG FG V   R     + + KV+ ++    F+         F  E ++M       +
Sbjct: 50  VIGRGAFGEVQLVR----HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +++  +  ++++  +V+EY P G L   L S+  + + + +     +V  AL+ +H   L
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIHSMGL 163

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFG 637
              IH D+KPDN+LLD +    L+DFG
Sbjct: 164 ---IHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 84/294 (28%), Positives = 123/294 (41%), Gaps = 48/294 (16%)

Query: 1   EIPLEISNL-QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-- 57
           +IP  I  L  NL+ELDL  NK+  ++P+ + N+  LK L L  N     LS +  +   
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFND----LSDLPKLLSN 184

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
           L NL  L L GN  S  +P  I   S L  L+LS N                        
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN------------------------ 219

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
                   +  LSSLSN K+L+ + LS+N L       SIGNLS +L+   +SN  +S  
Sbjct: 220 ------SIIELLSSLSNLKNLSGLELSNNKL--EDLPESIGNLS-NLETLDLSNNQIS-- 268

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
               + +LTN   +DL GN L+ ++P+    L  L  L L+      ++   +  +    
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNN 327

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSN 291
            +   G     S P   S L SL  L    N L    L  + +K+   +    +
Sbjct: 328 NILSNG---ETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLD 378

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 2e-04
 Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 11 NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN 70
          NL+ LDL +N+L      A   +  LK+L L  N+L   +S  A   LP+L +L L GNN
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59

Query: 71 F 71
           
Sbjct: 60 L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 2e-04
 Identities = 21/57 (36%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
           L  L+L  N+L       F  L +L++L LS N LTSI    F  L  +  L+ S N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 13/160 (8%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV----ECEMM 542
           CR+ + + + N I  G +G VY+AR    G  VA+K   L+  +  + F +    E  ++
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 543 KSIRHRNLIKV--ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
             ++H N++ V  +   SN +   +V+EY  H  L+  + +        +   +M+ + S
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            + +LH      ++H DLK  N+LL++  +  + DFG+A+
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)

Query: 500 IGRGGFGSVYKAR-LG---DGMEVAVKVFN----LQCGRAFKSFAVECEMMKSIRHRNLI 551
           +G G +G V+  R +G    G   A+KV      +Q  +  +    E ++++++R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 552 KVISSCSNEEFKA-LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGC 609
             +      + K  L+L+Y   G L  +LY      +   R+ I  ++  AL++LH  G 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQLG- 125

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +I+ D+K +N+LLD      L+DFG++K  + E+
Sbjct: 126 ---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 21/161 (13%)

Query: 499 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL 550
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 551 IKVISSCSNEEFKA-LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEYLH 606
           +  +      E K  L+L+Y   G +  +LY      D F    +     ++  ALE+LH
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122

Query: 607 -FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             G    +++ D+K +N+LLD      L+DFG++K  + E+
Sbjct: 123 KLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 24/157 (15%)

Query: 494 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN--- 549
           F    +IGRG FG V   +  D G   A+K+         K+  +E E +  IR      
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDIL 55

Query: 550 -------LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
                  ++K+  S  ++    L++E+ P G +   L   + + +   +  I  +   A+
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAI 114

Query: 603 EYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI 638
           + +H  G     IH D+KPDN+LLD      LSDFG+
Sbjct: 115 DSIHQLG----FIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 8/53 (15%)

Query: 594 IMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           + + +  AL YL   H      VIH D+KP N+LLD +    L DFGI+  L+
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 19/114 (16%)

Query: 533 KSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY-------SSNCI 585
           K+   E +++K+I HR +I +I +   +    +V+   P    + + Y            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM---PKYKCDLFTYVDRSGPLPLEQA 187

Query: 586 LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           + I +RL        AL YLH      +IH D+K +N+ LD+   A L DFG A
Sbjct: 188 ITIQRRL------LEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 17/155 (10%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNL------ 550
           L+G G +G VYK R +  G   A+KV ++  G   +    E  M+K    HRN+      
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 551 -IKVISSCSNEEFKALVLEYKPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF 607
            IK      +++   LV+E+   GS+   + ++  N + + +    I  ++   L +LH 
Sbjct: 72  FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 128

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                VIH D+K  NVLL +N    L DFG++  L
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 42/164 (25%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKS--FAV----ECEMMKSIRHRNLI 551
            +G G +GSV  A     G +VA+K    +  R F+S  FA     E  ++K ++H N+I
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77

Query: 552 KVI----SSCSNEEFKA--LVLEYK---------PHGSLEKYLYSSNCILDIFQRLNIMI 596
            ++    S+ S +EF+   LV+ Y             S +K  Y       ++Q L    
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML---- 127

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                L+Y+H    A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 128 ---CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 7/151 (4%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLI 551
           F++   IG+G FG V+K       +V A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           K   S        +++EY   GS    L +     D FQ   ++ ++   L+YLH     
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHS---E 120

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             IH D+K  NVLL +     L+DFG+A  L
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 25/155 (16%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS-- 556
           +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55

Query: 557 -----CSNEEFKA-----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
                C    F        +L+    G L  +L       +   R     ++   LE++H
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH 114

Query: 607 --FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             F     V++ DLKP N+LLD++    +SD G+A
Sbjct: 115 NRF-----VVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 39/151 (25%), Positives = 74/151 (49%), Gaps = 8/151 (5%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRAFKSFAV-ECEMMKSIRHRN 549
           F +  ++G+GGFG V   ++   G   A K    +    R  +S A+ E ++++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 608
           ++ +  +   ++   LVL     G L+ ++Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
                ++ DLKP+N+LLDD     +SD G+A
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 30/163 (18%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI---- 554
           +G G  G V+ A   D    VAVK   L   ++ K    E ++++ + H N++KV     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 555 --SSCSNEEFKALV-----------LEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVAS 600
              S   E+  +L            +E      LE+   S     L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLL 642
            L+Y+H    A V+H DLKP NV ++ ++LV  + DFG+A+++
Sbjct: 126 GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 39/183 (21%)

Query: 500 IGRGGFGSV-----------------YKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEM 541
           +G G FG V                 +  R G  + VAVK+      + A   F  E ++
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS----------------SNCI 585
           +  ++  N+I+++  C +E+   ++ EY  +G L ++L S                ++C+
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 586 LDIFQR--LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
             I     L++ + +AS ++YL        +H DL   N L+ +NL   ++DFG+++ L 
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 644 GED 646
             D
Sbjct: 190 AGD 192

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 35/165 (21%)

Query: 500 IGRGGFGSVY-----KARLGDGMEV--AVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG+VY     KA   + ++V   + V  L      ++   E +++  + H  ++K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 553 VISS-------------CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
             +S             C   +    + E K  G       S N + + F +L + +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQVCEWFIQLLLGVH-- 120

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
               Y+H      ++H DLK  N+ L +NL+  + DFG+++LL+G
Sbjct: 121 ----YMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMG 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 17/153 (11%)

Query: 499 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL 550
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 551 IKVISSCSNEEFKA-LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLH-F 607
           +  +      + K  L+L+Y   G L  +L       +  Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLHKL 124

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           G    +I+ D+K +N+LLD N    L+DFG++K
Sbjct: 125 G----IIYRDIKLENILLDSNGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 17/147 (11%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS--------FAVECEMMKSIRHRNL 550
           +IGRG FG V   R     +   KV+ ++    F+         F  E ++M       +
Sbjct: 50  VIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +++  +  ++ +  +V+EY P G L   L S+  + + + R     +V  AL+ +H    
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIHS--- 160

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFG 637
              IH D+KPDN+LLD +    L+DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 7/151 (4%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLI 551
           F++   IG+G FG V+K       +V A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           K   S   +    +++EY   GS    L      LD  Q   I+ ++   L+YLH     
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHS---E 120

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             IH D+K  NVLL ++    L+DFG+A  L
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 7/154 (4%)

Query: 492 NGFSENNLIGRGGFGSVYKARLGDGME-VAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHR 548
           N F    ++G G +G V K R  +  E VA+K F + +     K   + E +M+++++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           N++++  +        LV EY     LE      N +     R + +  +  A+ + H  
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN 119

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               ++H D+KP+N+L+  N V  L DFG A+ L
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 13/149 (8%)

Query: 499 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMK------SIRHRNLI 551
           ++G+G FG V+ A L G     A+K   L+         VEC M++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +  +   +E    V+EY   G L  ++ S +   D+ +      ++   L++LH     
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHS---K 115

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +++ DLK DN+LLD +    ++DFG+ K
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 13/149 (8%)

Query: 499 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMK------SIRHRNLI 551
           ++G+G FG V  ARL   G   AVKV  L+     +   VEC M +      +  H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++       +    V+E+   G L  ++  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD---K 115

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +I+ DLK DNVLLD      L+DFG+ K
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 17/148 (11%)

Query: 499 LIGR----GGFGSVYKARLGDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSIRHRNLIK 552
           LIG+         + K +  + + VAVK  NL        K    E    + ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---NIMIDVASALEYLH-FG 608
            ++S   +    +V     +GS E  L +     +    L    I+ DV +AL+Y+H  G
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG 121

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDF 636
                IH  +K  ++LL  +    LS  
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFK-SFAVECEMMKSIRHRNLIKV 553
           +G G FG+V    YK +  +   VAVK+  N     A K     E  +M+ + +  ++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           I  C  E +  LV+E    G L K+L  +  + +      ++  V+  ++YL        
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H DL   NVLL     A +SDFG++K L G D
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL-GAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 6e-04
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 23/160 (14%)

Query: 500 IGRGGFGSVYKARLGDG---MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI---KV 553
           +GRG +G VYKA+  DG    E A+K   ++      S   E  +++ ++H N+I   KV
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 554 ISSCSNEEFKALVLEYKPHG--SLEKYLYSSNCILDIFQRLNIMI-----DVASALEYLH 606
             S S+ +   L+ +Y  H    + K+  +S       Q    M+      +   + YLH
Sbjct: 67  FLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 607 FGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLL 642
                 V+H DLKP N+L+     +     ++D G A+L 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 8/151 (5%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRHRN 549
           F +  ++G+GGFG V   ++   G   A K    +  +  K  ++   E ++++ +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 608
           ++ +  +   ++   LVL     G L+ ++Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               +++ DLKP+N+LLDD+    +SD G+A
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 19/157 (12%)

Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYS-----SNCILDIFQRLNIMI----DVASALE 603
           ++   S  +   +V+E   HG L+ YL S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           YL+       +H DL   N ++  +    + DFG+ +
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 20/157 (12%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVIS--- 555
           IG+G FG V + R  D      +++ L+  R  K+  V   E+  ++  R ++  ++   
Sbjct: 1   IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 556 ------SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
                 S  + E   LVL +   G L  +L       D+ +      ++  ALE LH   
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              VI+ DLKP+N+LLD      L DFG+ KL + +D
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS-- 556
           +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55

Query: 557 -----CSNEEFK-----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
                C +  F      + +L+    G L  +L S + +    +      ++   LE++H
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
                 V++ DLKP N+LLD++    +SD G+A
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 6/139 (4%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+E+   G+L   +  +   ++  Q   + + V  AL  LH      VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 143 KSDSILLTHDGRVKLSDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 25/161 (15%)

Query: 499 LIGRGGFGSV-YKARLGDGMEVAVKVFNLQ------CGRAFKSFAVECEM---MKSIR-- 546
           ++G G  G+V    R+ DG   AVKV +++        RA     V C +     SI   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA--QAEVCCLLNCDFFSIVKC 96

Query: 547 HRNLIKVISSCSNEE---FKALVLEYKPHGSLEKYLYSSNCILDIFQRLN---IMIDVAS 600
           H +  K      N E     ALVL+Y   G L + + S       F+      + I V  
Sbjct: 97  HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           A+ ++H      +IH D+K  N+LL  N +  L DFG +K+
Sbjct: 155 AVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192

Length = 496

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 29/154 (18%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFN---------LQCGRAFKSFAV--ECEMMKSIR 546
           +IGRG FG V   ++     + A+K+ N           C R  ++  V  +C+ + ++ 
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNI--MIDVASALE 603
           +        +  +E +  LV++Y   G L   L    + + +   R  I  M+    ++ 
Sbjct: 68  Y--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
            LH+      +H D+KPDNVLLD N    L+DFG
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.6 bits (96), Expect = 0.002
 Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 19/107 (17%)

Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQRLNI 594
           +MK   + N IK+  S +  +   L+++Y   G L      E  L  +     I Q    
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ---- 117

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV-AYLSDFGIAK 640
              +  AL  LH      +IH D+K +NVL D      YL D+G+ K
Sbjct: 118 ---LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 7/146 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRHRNLIKVI 554
           L+G+G FG V   +    G   A+K+   +   A    A    E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            S    +    V+EY   G L  +L       +   R     ++ SAL+YLH      V+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           + DLK +N++LD +    ++DFG+ K
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 9/156 (5%)

Query: 492 NGFSENNLIGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIR 546
             F   +L+GRG FG V   R    GD   M+V +K   L        F  E +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
              + ++  +  +++   LV+EY+P G L   L   N   D F        +A  +  +H
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIH 116

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                  +H D+KP+NVL+D      L+DFG A  L
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 39/179 (21%)

Query: 500 IGRGGFGSVYKARLGDGME------------------VAVKVFNLQCGR-AFKSFAVECE 540
           +G G FG V+     +GME                  VAVK+      + A   F  E +
Sbjct: 13  LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQR 591
           +M  ++  N+I++++ C   +   ++ EY  +G L ++L           ++ +   +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 592 LNIM-IDVASALEY---LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           L  M   +AS ++Y   L+F      +H DL   N L+  N    ++DFG+++ L   D
Sbjct: 132 LIFMATQIASGMKYLSSLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 28/153 (18%)

Query: 500 IGRGGFGSVYKARLGDGMEV-AVK------VFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           IG G FG V   R  D   + A+K      V         K+   E +++    +  ++K
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQ----RLNIMIDVASALEYLH-- 606
           +  S  +++    V++Y P G +   L      L IF+    R  I  ++  A+E +H  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESVHKM 120

Query: 607 -FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI 638
            F      IH D+KPDN+L+D +    L+DFG+
Sbjct: 121 GF------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 15/151 (9%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRHRNLIKVI 554
           +G G FG V  A   +     V +   +  +  K   V     E +++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHFGCLA 611
            S  +E +  LVLE+   G    +L  +      +  F    I++      EYL      
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQS---L 150

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +++ DLKP+N+LLD +    ++DFG AK++
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181

Length = 340

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 35/147 (23%), Positives = 72/147 (48%), Gaps = 12/147 (8%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQ-----CGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G+GGFG V   ++ + G   A K  + +      G   K   +E E+++ +    ++ +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAP 612
             +  ++    LV+     G L+ ++Y+     L++ + ++    +   + +LH      
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +++ D+KP+NVLLDD     LSD G+A
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 10/147 (6%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFA---VECEMMKSIRHRNLIKVI 554
           L+G+G FG V   R     +  A+K+   +   A    A    E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIM-IDVASALEYLHFGCLAPV 613
            S    +    V+EY   G L  + + S   +    R      ++ SAL YLH      V
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DV 116

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++ DLK +N++LD +    ++DFG+ K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 21/166 (12%)

Query: 484 YLELCRATNGFSENNLIGRGGFGSVYKARLGDGM-----EVAVK-VFNLQCGRAFKSFAV 537
            +   R T      +L+  G FG ++   L D       EV VK V +            
Sbjct: 2   AISRDRVTLS----DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ 57

Query: 538 ECEMMKSIRHRNLIKVISSCSNEEFKALVLE-YKPHGSLEKYLYSSNCI-------LDIF 589
           E  ++  + H+N++ ++  C  +     VL  Y   G+L+ +L             L   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 590 QRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD 635
           Q +++ I +A  + YLH      VIH D+   N ++D+ L   ++D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 41/164 (25%)

Query: 500 IGRGGFGSVYKAR---LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIR-HRN 549
           +G+G +G V  AR     +   VA+K    VF+  +   RA +    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSL-EKYLYSS------NCILDIFQRLN------IMI 596
           +  +             ++    G+  E YLY        + I+   Q L        + 
Sbjct: 64  ITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY 112

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +   L+Y+H    A V+H DLKP N+L++ +    + DFG+A+
Sbjct: 113 QILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 20/42 (47%), Positives = 29/42 (69%), Gaps = 5/42 (11%)

Query: 601 ALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           ALEYLH +G    ++H DLKPDN+L+       L+DFG++K+
Sbjct: 113 ALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 12/153 (7%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFK----SFAV-ECEMMKSIRH 547
           F    ++G+GGFG V   ++   G   A K   L+  R  K    + A+ E  +++ +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 606
           R ++ +  +   ++   LVL     G L+ ++Y+  N   D  + +    ++   LE L 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
                 +++ DLKP+N+LLDD     +SD G+A
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 17/67 (25%)

Query: 587 DIFQRLN--IMI----------DVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYL 633
           D+F RL+  +M           ++A AL++LH  G    +I+ DLKP+N+LLD+     L
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKL 139

Query: 634 SDFGIAK 640
           +DFG++K
Sbjct: 140 TDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 32/164 (19%)

Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMK--SIRH-- 547
             F    +IG+G FG V   RL    +   K++      A K+  ++ EM K   + H  
Sbjct: 1   EDFHTVKVIGKGAFGEV---RLVQKKDTG-KIY------AMKTL-LKSEMFKKDQLAHVK 49

Query: 548 --RNL---------IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
             R++         + +  S  + ++  L++E+ P G L   L   +   +   R   M 
Sbjct: 50  AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMA 108

Query: 597 DVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +   A+E +H  G     IH D+KPDN+L+D      LSDFG++
Sbjct: 109 ECVLAIEAVHKLG----FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 41/129 (31%)

Query: 530 RAFKSFAVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYKP------------ 571
           RA++       +MK + H+N+I +++      S EEF+   LV+E               
Sbjct: 61  RAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD 116

Query: 572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA 631
           H  +   LY   C                 +++LH    A +IH DLKP N+++  +   
Sbjct: 117 HERMSYLLYQMLC----------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTL 157

Query: 632 YLSDFGIAK 640
            + DFG+A+
Sbjct: 158 KILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 43/177 (24%)

Query: 500 IGRGGFGSVYKARLGDGMEV----AVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           IG G FG V+  +     E     A+    L+  R      +E  +M+ ++H+N+++ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 556 SCSNEEFKAL--VLEYKPHGSLEKYL---------YSSNCILDIFQRLNIMIDVASALEY 604
              N+  + L  ++E+   G L + +            + I+DI ++L        AL Y
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133

Query: 605 LHFGCLAP----VIHCDLKPDNVLLD-------------DNL----VAYLSDFGIAK 640
            H     P    V+H DLKP N+ L              +NL    +A + DFG++K
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Length = 1021

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 7/151 (4%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLI 551
           F++   IG+G FG VYK       EV A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +   S        +++EY   GS    L      L+      I+ ++   L+YLH     
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHS---E 120

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             IH D+K  NVLL +     L+DFG+A  L
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	646
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.95
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.95
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
KOG0198	313	consensus MEKK and related serine/threonine protei	99.94
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.92
KOG0578	550	consensus p21-activated serine/threonine protein k	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.92
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.92
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.92
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.91
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.91
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.91
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.91
KOG0589	426	consensus Serine/threonine protein kinase [General	99.91
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.9
KOG0586	596	consensus Serine/threonine protein kinase [General	99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
KOG0610	459	consensus Putative serine/threonine protein kinase	99.9
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.89
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.89
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.89
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.89
PHA02988	283	hypothetical protein; Provisional	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
PHA03212	391	serine/threonine kinase US3; Provisional	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.89
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.89
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.88
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.88
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.88
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.88
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.88
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.88
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.88
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.88
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.88
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.88
PHA03211	461	serine/threonine kinase US3; Provisional	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.88
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.88
PTZ00283	496	serine/threonine protein kinase; Provisional	99.88
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.88
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.87
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.87
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.87
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.87
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.87
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.87
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.87
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.87
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.87
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.87
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.87
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.87
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.87
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.87
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.87
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.87
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
PTZ00036	440	glycogen synthase kinase; Provisional	99.87
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.87
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.87
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.87
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.87
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.87
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.87
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.87
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.87
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.87
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.87
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.87
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.87
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.87
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.87
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.87
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.87
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.87
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.87
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.87
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.87
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.87
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.87
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.87
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.87
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.86
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.86
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.86
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.86
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.86
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.86
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.86
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.86
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.86
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.86
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.86
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.86
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.86
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.86
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.86
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.86
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
PHA03207	392	serine/threonine kinase US3; Provisional	99.86
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.86
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.86
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.86
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.86
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.86
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.86
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.86
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.86
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.85
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.85
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.85
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.85
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.85
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.85
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.85
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.85
KOG0584	632	consensus Serine/threonine protein kinase [General	99.85
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.85
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.85
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.85
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.85
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.85
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.85
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.85
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.85
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.85
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.85
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.85
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.85
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.84
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.84
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
KOG1152	772	consensus Signal transduction serine/threonine kin	99.84
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.84
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.84
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.84
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.84
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.84
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.84
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.84
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.84
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.84
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.84
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.84
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.84
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.84
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.83
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.83
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.83
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.83
PHA03210	501	serine/threonine kinase US3; Provisional	99.83
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.83
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.83
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.83
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.83
PLN00009	294	cyclin-dependent kinase A; Provisional	99.83
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.83
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.83
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.83
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.83
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.83
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.83
PTZ00284	467	protein kinase; Provisional	99.82
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.82
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.82
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.82
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.82
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.82
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.82
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.82
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.82
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.82
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.82
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.82
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.81
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.81
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.81
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.81
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.81
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.81
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.81
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.8
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.8
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.8
PHA02882	294	putative serine/threonine kinase; Provisional	99.8
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.79
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.79
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.79
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.79
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.79
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.79
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.78
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.78
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.78
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
smart00090	237	RIO RIO-like kinase.	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.76
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.74
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.72
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.71
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.69
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.67
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.66
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.61
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.6
PLN03150	623	hypothetical protein; Provisional	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.55
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.48
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.47
PLN03150	623	hypothetical protein; Provisional	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.32
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.32
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.3
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.29
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.24
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.23
PLN00181	793	protein SPA1-RELATED; Provisional	99.21
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.16
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.14
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.1
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.1
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.1
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.05
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.99
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.9
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.84
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
KOG1243	690	consensus Protein kinase [General function predict	98.77
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.64
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.62
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.56
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.5
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.48
PRK09902	216	hypothetical protein; Provisional	98.45
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.42
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.34
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.33

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-76  Score=696.31  Aligned_cols=616  Identities=30%  Similarity=0.442  Sum_probs=443.8

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCc-cCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSS-IADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +|..|+++++|++|+|++|++++..|..+.++++|++|+|++|++++.++. +.  .+++|++|+|++|++++..|..|.
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~  257 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG--GLTSLNHLDLVYNNLTGPIPSSLG  257 (968)
T ss_pred             CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHh--cCCCCCEEECcCceeccccChhHh
Confidence            677788888888888888888888888888888888888888888765554 33  477888888888888877888888


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNL  160 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  160 (646)
                      ++++|++|+|++|.+.+..|..+.++++|++|+|++|.++...     +..+.++++|++|++++|.+.+..+.. +.. 
T Consensus       258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-----p~~~~~l~~L~~L~l~~n~~~~~~~~~-~~~-  330 (968)
T PLN00113        258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI-----PELVIQLQNLEILHLFSNNFTGKIPVA-LTS-  330 (968)
T ss_pred             CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC-----ChhHcCCCCCcEEECCCCccCCcCChh-Hhc-
Confidence            8888888888888887777777778888888888888776542     233556666666666666665443321 111 


Q ss_pred             cccCcEEEeecccccccCCcccccCCCCCEEEccCCccc------------------------cccCccccCCCCCCeEE
Q 046544          161 SHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLN------------------------GSIPITLSKLQKLQGLG  216 (646)
Q Consensus       161 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~~L~~L~  216 (646)
                      .++|+.|++++|.+.+..|..+..+++|+.|++++|++.                        +..|..+..+++|+.|+
T Consensus       331 l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~  410 (968)
T PLN00113        331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR  410 (968)
T ss_pred             CCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence            134555555555555555555555555555555555554                        44455555555555555


Q ss_pred             eecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCC
Q 046544          217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP  296 (646)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  296 (646)
                      +++|++++..|..|..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+..........++|+.|++++|.+++.
T Consensus       411 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~  490 (968)
T PLN00113        411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGA  490 (968)
T ss_pred             CcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCc
Confidence            55555555555556666666666666666665555555666666666666666653322333457788888999999888


Q ss_pred             CCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCC
Q 046544          297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKL  376 (646)
Q Consensus       297 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  376 (646)
                      .|..+..+++|+.|++++|.+++..|..++.+++|++|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+
T Consensus       491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  570 (968)
T PLN00113        491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV  570 (968)
T ss_pred             cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC-cccCCCcccccccccccccchhhhhhHHHHHHHHHHh
Q 046544          377 SYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT-LQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIW  455 (646)
Q Consensus       377 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  455 (646)
                      ++|+.|++++|++++.+|..+.+..+....+.||+..|+.+. ...++|.....  +....+++++++++++++++++++
T Consensus       571 ~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  648 (968)
T PLN00113        571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFG  648 (968)
T ss_pred             cccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHH
Confidence            999999999999999999988888888888999999997653 33456643211  111122222233222222222222


Q ss_pred             hhheeccCCC-CCCCCCCCcccc-------ccccccHHHHHHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEec
Q 046544          456 LILRYRKRGK-QPSNDANMPLVA-------TWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNL  526 (646)
Q Consensus       456 l~~~~r~r~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~  526 (646)
                      +++++++++. .+......+.+.       ....+++.++   ...|...+.||+|+||.||+|+. .+|+.||||.+..
T Consensus       649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~  725 (968)
T PLN00113        649 FVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND  725 (968)
T ss_pred             HHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccC
Confidence            2222222211 111111100000       0112233333   34577888999999999999986 4789999998864


Q ss_pred             cCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046544          527 QCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  606 (646)
Q Consensus       527 ~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH  606 (646)
                      ....    ...|++++++++|||||+++++|..++..++||||+++|+|.++++.    ++|..+.+++.|+++|++|+|
T Consensus       726 ~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH  797 (968)
T PLN00113        726 VNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLH  797 (968)
T ss_pred             Cccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhc
Confidence            3322    13468899999999999999999999999999999999999999953    788999999999999999999


Q ss_pred             cCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       607 ~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      +.+.++|+|||+||+||+++.++.+++. ||.+.
T Consensus       798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             cCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            7777899999999999999998888875 66554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-50  Score=478.22  Aligned_cols=407  Identities=35%  Similarity=0.545  Sum_probs=342.6

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCc-cCcCCCCCCCEEEccCCcccccCCccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSS-IADVRLPNLEALLLWGNNFSGTIPRFI   79 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~   79 (646)
                      ++|..++.+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++.++. +.  .+++|++|+|++|++++..|..+
T Consensus       155 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l  232 (968)
T PLN00113        155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG--QMKSLKWIYLGYNNLSGEIPYEI  232 (968)
T ss_pred             cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHc--CcCCccEEECcCCccCCcCChhH
Confidence            3688999999999999999999999999999999999999999999876554 33  48999999999999999999999


Q ss_pred             cCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcc
Q 046544           80 FNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN  159 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~  159 (646)
                      .++++|++|++++|.+.+..|..|+++++|++|+|++|+++..     .+..+.++++|++|++++|.+.+..+.. +..
T Consensus       233 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~  306 (968)
T PLN00113        233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP-----IPPSIFSLQKLISLDLSDNSLSGEIPEL-VIQ  306 (968)
T ss_pred             hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeecc-----CchhHhhccCcCEEECcCCeeccCCChh-HcC
Confidence            9999999999999999999999999999999999999999865     3456889999999999999998765542 233


Q ss_pred             ccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEE
Q 046544          160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL  239 (646)
Q Consensus       160 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  239 (646)
                       .++|+.|++++|.+.+..|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++.+..|..++.+++|+.|
T Consensus       307 -l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L  385 (968)
T PLN00113        307 -LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL  385 (968)
T ss_pred             -CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence             3589999999999999999999999999999999999999999999999999999999999887777777766666666


Q ss_pred             EecCCcccccCCccccCCCCCceeecCCCccc-cccccccc------------------------ccccccccCCCCccc
Q 046544          240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWN------------------------LKDILQLNFSSNFLT  294 (646)
Q Consensus       240 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~------------------------l~~L~~L~l~~N~l~  294 (646)
                      ++++|++.+..|..+..+++|+.|++++|.++ .+|..+..                        +++|+.|++++|.+.
T Consensus       386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~  465 (968)
T PLN00113        386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF  465 (968)
T ss_pred             ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence            66666666555555555555555555555555 33444444                        445555555555555


Q ss_pred             CCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       295 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                      +..|..+ ..++|+.|++++|++++..|..|..+++|++|+|++|++.+.+|+.+..+++|++|+|++|.+++.+|..|.
T Consensus       466 ~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  544 (968)
T PLN00113        466 GGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS  544 (968)
T ss_pred             eecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence            4444433 346677888888888888888899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCC
Q 046544          375 KLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      .+++|+.|+|++|++++.+|.. ..+..++.+++++|++.+..|
T Consensus       545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            9999999999999999988876 457889999999999987555

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-46  Score=374.30  Aligned_cols=396  Identities=24%  Similarity=0.267  Sum_probs=231.3

Q ss_pred             CEEECCCCcccccCCcCccCC--CCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEc
Q 046544           13 EELDLRHNKLVGTVPAAIFNM--SMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILEL   90 (646)
Q Consensus        13 ~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (646)
                      ..||.+++.|..+.-..+.+.  +.-++||+++|.|+. +....+..+++|++++|.+|.++ .+|.+.....+|+.|+|
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~-id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L  132 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSH-IDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL  132 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeecccccccc-CcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence            345556665554333333322  223346666666643 22233344666666666666665 55555555555666666


Q ss_pred             ccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEee
Q 046544           91 SQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS  170 (646)
Q Consensus        91 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~  170 (646)
                      .+|.|+.+..+.+..++.|+.|||+.|.|+.++.     .+|..-.++++|+|++|+|+.+.... |.++. +|..|.|+
T Consensus       133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~-----~sfp~~~ni~~L~La~N~It~l~~~~-F~~ln-sL~tlkLs  205 (873)
T KOG4194|consen  133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPK-----PSFPAKVNIKKLNLASNRITTLETGH-FDSLN-SLLTLKLS  205 (873)
T ss_pred             eccccccccHHHHHhHhhhhhhhhhhchhhcccC-----CCCCCCCCceEEeecccccccccccc-ccccc-hheeeecc
Confidence            6666665555566666666666666666665543     23444455666666666665554332 22332 56666666


Q ss_pred             cccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccC
Q 046544          171 NCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI  250 (646)
Q Consensus       171 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  250 (646)
                      +|+|+...+..|.+|+.|+.|||..|+|...--.+|.++++|+.|.|..|.|+.....+|..+.++++|+|+.|+++...
T Consensus       206 rNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn  285 (873)
T KOG4194|consen  206 RNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN  285 (873)
T ss_pred             cCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh
Confidence            66666555566666666666666666666444555666666666666666666666666666666666666666666666


Q ss_pred             CccccCCCCCceeecCCCccccc-ccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCC
Q 046544          251 PACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK  329 (646)
Q Consensus       251 ~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  329 (646)
                      .+++.++++|+.|+||+|.|..+ +.++...++|++|+|++|+|+...++.|..+..|+.|.|++|.++.+-..+|.+++
T Consensus       286 ~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls  365 (873)
T KOG4194|consen  286 EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS  365 (873)
T ss_pred             cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence            66666666666666666666655 23444455666666666666666666666666666666666666666666666666


Q ss_pred             CCCEEEccCccCCCccc---ccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCcccc
Q 046544          330 NLEYLFLGYNRLEGSIP---DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAES  406 (646)
Q Consensus       330 ~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~  406 (646)
                      +|+.|||++|.|+..+.   ..|.++++|+.|+|.+|+|..+.-.+|.+++.|++|||.+|.+...-|....-..+..+-
T Consensus       366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv  445 (873)
T KOG4194|consen  366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELV  445 (873)
T ss_pred             hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhh
Confidence            66666666666654432   245566666666666666665445566666666666666666665444443322455555


Q ss_pred             ccCCccccCCC
Q 046544          407 FEGNELLCGSP  417 (646)
Q Consensus       407 ~~~N~~~c~~~  417 (646)
                      +..-.++|||.
T Consensus       446 ~nSssflCDCq  456 (873)
T KOG4194|consen  446 MNSSSFLCDCQ  456 (873)
T ss_pred             hcccceEEecc
Confidence            55555666664

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=369.81  Aligned_cols=374  Identities=24%  Similarity=0.269  Sum_probs=342.5

Q ss_pred             CCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcc
Q 046544           12 LEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELS   91 (646)
Q Consensus        12 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls   91 (646)
                      -+.||+++|+|..+.+..|.++++|+.++|.+|.++. +|.... ...+|+.|+|.+|.|+.+-.+.+..++.|+.||||
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4579999999999999999999999999999999987 444332 26689999999999999889999999999999999


Q ss_pred             cCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeec
Q 046544           92 QNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSN  171 (646)
Q Consensus        92 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~  171 (646)
                      .|.|+.+.-.+|..-.++++|+|++|+|+.+..+     .|.++.+|..|.|++|+++.++... |.++ +.|+.|+|..
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~-----~F~~lnsL~tlkLsrNrittLp~r~-Fk~L-~~L~~LdLnr  230 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETG-----HFDSLNSLLTLKLSRNRITTLPQRS-FKRL-PKLESLDLNR  230 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccc-----cccccchheeeecccCcccccCHHH-hhhc-chhhhhhccc
Confidence            9999999888999989999999999999998654     6899999999999999999986543 3333 5799999999


Q ss_pred             ccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCC
Q 046544          172 CNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP  251 (646)
Q Consensus       172 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  251 (646)
                      |+|....--.|.+|++|+.|.|..|.|.....++|..+.++++|+|+.|+++.+-..++.+++.|+.|+||+|.|..+.+
T Consensus       231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~  310 (873)
T KOG4194|consen  231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI  310 (873)
T ss_pred             cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence            99997767889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCc---cccCC
Q 046544          252 ACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIP---TEIGG  327 (646)
Q Consensus       252 ~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~---~~~~~  327 (646)
                      +.++-.++|+.|+|++|+|+++++ +|..+..|+.|+|++|+++......|..+++|+.|||++|.++..+.   ..|.+
T Consensus       311 d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~g  390 (873)
T KOG4194|consen  311 DSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNG  390 (873)
T ss_pred             chhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhcc
Confidence            999999999999999999999976 68889999999999999998888999999999999999999987655   46889


Q ss_pred             CCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC
Q 046544          328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       328 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      |+.|+.|.+.+|+|..+...+|.++.+|+.|||.+|.|..+.|.+|..+ .|++|-+..-.+-|++.-
T Consensus       391 l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  391 LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL  457 (873)
T ss_pred             chhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccH
Confidence            9999999999999997777899999999999999999999999999999 999999988777776653

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.7e-42  Score=332.35  Aligned_cols=391  Identities=29%  Similarity=0.425  Sum_probs=251.6

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      +|++++.+..++.|+.++|++. ..|.++..+..|+.|+.++|.+..++++++.  +-.|+.|+..+|+++ ..|+.++.
T Consensus        83 lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~--~~~l~dl~~~~N~i~-slp~~~~~  158 (565)
T KOG0472|consen   83 LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGR--LLDLEDLDATNNQIS-SLPEDMVN  158 (565)
T ss_pred             CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHH--Hhhhhhhhccccccc-cCchHHHH
Confidence            4555666666666666666655 4555555666666666666666555555443  455666666666665 45555555


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcccc
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS  161 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  161 (646)
                      +.+|..|++.+|++...+|..+. ++.|++||+..|-+.++|++      ++++.+|+.|+|.+|+|..++....    .
T Consensus       159 ~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~------lg~l~~L~~LyL~~Nki~~lPef~g----c  227 (565)
T KOG0472|consen  159 LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPE------LGGLESLELLYLRRNKIRFLPEFPG----C  227 (565)
T ss_pred             HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChh------hcchhhhHHHHhhhcccccCCCCCc----c
Confidence            55555555555555544443333 55566666666655555443      4555666666666666655542211    1


Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      ..|++|+++.|+|.-...+...+++++.+|||.+|+++ ..|+....+.+|.+||+|+|.|+ ..|..++++ .|+.|-+
T Consensus       228 s~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~l  304 (565)
T KOG0472|consen  228 SLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLAL  304 (565)
T ss_pred             HHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhh
Confidence            24555666666655332223335566666666666665 44555555555666666666665 345555555 5556666


Q ss_pred             cCCcc-----------------------------------------------------------------cccCCccccC
Q 046544          242 GGNKL-----------------------------------------------------------------FGSIPACFSN  256 (646)
Q Consensus       242 ~~N~i-----------------------------------------------------------------~~~~~~~~~~  256 (646)
                      .+|.+                                                                 +.++.+.|..
T Consensus       305 eGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea  384 (565)
T KOG0472|consen  305 EGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEA  384 (565)
T ss_pred             cCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHH
Confidence            65554                                                                 3221122211


Q ss_pred             C--CCCceeecCCCccccccccccccccccc-ccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCE
Q 046544          257 L--ASLRILSLSSNELTSIPLTFWNLKDILQ-LNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEY  333 (646)
Q Consensus       257 l--~~L~~L~L~~N~l~~lp~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  333 (646)
                      -  .-....+++.|++.++|..+..++.+.. +.+++|.+ +.+|..++.+++|..|+|++|-+. ..|..++.+..||.
T Consensus       385 ~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~  462 (565)
T KOG0472|consen  385 AKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQT  462 (565)
T ss_pred             hhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhhe
Confidence            1  0144556666666666666555555544 44455544 467888889999999999999887 46888888989999


Q ss_pred             EEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccc
Q 046544          334 LFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELL  413 (646)
Q Consensus       334 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~  413 (646)
                      |++|.|++. ..|.....+..++.+-.++|++....|+.+.+|++|..|||.+|.+...+|..+.+.+++++.+.|||+.
T Consensus       463 LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  463 LNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            999999998 7888888888888888888999877777799999999999999999987777799999999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.2e-41  Score=325.72  Aligned_cols=389  Identities=27%  Similarity=0.412  Sum_probs=319.1

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      ++|++++.+.+|..|+.++|.+. ..|+.++.+..|..|+..+|+++..++++.+  +.+|..|++.+|+++...|..+.
T Consensus       105 ~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~--~~~l~~l~~~~n~l~~l~~~~i~  181 (565)
T KOG0472|consen  105 ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVN--LSKLSKLDLEGNKLKALPENHIA  181 (565)
T ss_pred             hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHH--HHHHHHhhccccchhhCCHHHHH
Confidence            58999999999999999999998 6788888999999999999999988888776  88999999999999966666655


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNL  160 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  160 (646)
                       ++.|++||..+|.++ ..|..+++|.+|+.|||.+|+|..+|       .|.+|..|.+|+++.|+|+-++.  ....-
T Consensus       182 -m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-------ef~gcs~L~Elh~g~N~i~~lpa--e~~~~  250 (565)
T KOG0472|consen  182 -MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-------EFPGCSLLKELHVGENQIEMLPA--EHLKH  250 (565)
T ss_pred             -HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-------CCCccHHHHHHHhcccHHHhhHH--HHhcc
Confidence             999999999999999 56778999999999999999999875       47788888888888888876633  22222


Q ss_pred             cccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccC----------------
Q 046544          161 SHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEG----------------  224 (646)
Q Consensus       161 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------------  224 (646)
                      ..++..|||.+|++.+ .|+.++-+.+|..||+|+|.|+ ..|.+++++ +|+.|-+.+|.+..                
T Consensus       251 L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  251 LNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY  327 (565)
T ss_pred             cccceeeecccccccc-CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence            3578888888888884 6888888888888888888888 456677887 78888888887651                


Q ss_pred             ------------------------------------------------cCchhhcCCCC---CcEEEecCCcccccCCcc
Q 046544          225 ------------------------------------------------SIPDSICRLTE---LYELELGGNKLFGSIPAC  253 (646)
Q Consensus       225 ------------------------------------------------~~~~~~~~l~~---L~~L~L~~N~i~~~~~~~  253 (646)
                                                                      .+|+.......   ....+++.|++. ..|..
T Consensus       328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~  406 (565)
T KOG0472|consen  328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKR  406 (565)
T ss_pred             HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhh
Confidence                                                            11221111111   467899999997 67776


Q ss_pred             ccCCCCC-ceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCC
Q 046544          254 FSNLASL-RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE  332 (646)
Q Consensus       254 ~~~l~~L-~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  332 (646)
                      +..++.+ ..+.+++|.++-+|..++.+++|..|++++|.+. .+|..++.+..|+.||+|+|+|. ..|..+-.+..|+
T Consensus       407 L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE  484 (565)
T KOG0472|consen  407 LVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE  484 (565)
T ss_pred             hHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH
Confidence            7666554 4567888888888888999999999999999998 68999999999999999999998 6788877777888


Q ss_pred             EEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCc
Q 046544          333 YLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNE  411 (646)
Q Consensus       333 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~  411 (646)
                      .+-.++|++..+.|+.+.++.+|.+|||.+|.+. .+|..++++++|++|++.+|++.- ++.. ..-++...+.+-+++
T Consensus       485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~-Pr~~iLmkgT~aiL~ylrdr  562 (565)
T KOG0472|consen  485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ-PRHQILMKGTAAILSYLRDR  562 (565)
T ss_pred             HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC-CHHHHhccChHHHHHHhccc
Confidence            8888889999888888999999999999999998 899999999999999999999993 3332 334555556666665

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.1e-38  Score=321.63  Aligned_cols=374  Identities=26%  Similarity=0.354  Sum_probs=295.6

Q ss_pred             cCCCCCCEEECCCCccc-ccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCC
Q 046544            7 SNLQNLEELDLRHNKLV-GTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKL   85 (646)
Q Consensus         7 ~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (646)
                      +-|+-.+-.|+++|.++ +..|.....+++++-|-|.+.++...+...+.  +.+|++|.+++|++. .+.+.+..++.|
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~--lqkLEHLs~~HN~L~-~vhGELs~Lp~L   80 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSR--LQKLEHLSMAHNQLI-SVHGELSDLPRL   80 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHH--HhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence            34555667788888887 56788888888888888888888765555554  778888888888887 566777788888


Q ss_pred             cEEEcccCccccc-cCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccC
Q 046544           86 SILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSL  164 (646)
Q Consensus        86 ~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L  164 (646)
                      +.+++.+|++... +|..+..|..|+.||||+|+++..|.+      +..-+++-.|+||+|+|+.++...++. + ..|
T Consensus        81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~------LE~AKn~iVLNLS~N~IetIPn~lfin-L-tDL  152 (1255)
T KOG0444|consen   81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN------LEYAKNSIVLNLSYNNIETIPNSLFIN-L-TDL  152 (1255)
T ss_pred             HHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh------hhhhcCcEEEEcccCccccCCchHHHh-h-HhH
Confidence            8888888887621 355566788888888888888886554      566678888888888888876554432 2 356


Q ss_pred             cEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeeccccc-CcCchhhcCCCCCcEEEecC
Q 046544          165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLE-GSIPDSICRLTELYELELGG  243 (646)
Q Consensus       165 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~  243 (646)
                      -.||||+|++.. +|+.+..+.+|++|+|++|.+...--..+..+++|+.|.+++.+=+ .-+|.++..+.+|..+|+|.
T Consensus       153 LfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~  231 (1255)
T KOG0444|consen  153 LFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSE  231 (1255)
T ss_pred             hhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccc
Confidence            778888888874 5667888888888888888887555556667778888888886532 35778888888888888888


Q ss_pred             CcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEccccccc-ccCc
Q 046544          244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS-SVIP  322 (646)
Q Consensus       244 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~  322 (646)
                      |.+. ..|+++.++++|+.|+||+|+|+++........+|+.|++|.|+++ .+|.+++.++.|+.|++.+|+++ .-+|
T Consensus       232 N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiP  309 (1255)
T KOG0444|consen  232 NNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIP  309 (1255)
T ss_pred             cCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCc
Confidence            8887 7888888888888888998888888777777788888888888888 68888888888888888888765 2368


Q ss_pred             cccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          323 TEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       323 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      +.++.+.+|+.+..++|.+. ..|+.++.+..|+.|.|+.|++- .+|.++.-|+.|+.||++.|+=--.+|..
T Consensus       310 SGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  310 SGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             cchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence            88999999999999999998 88999999999999999999987 78999999999999999999865555543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.4e-37  Score=314.04  Aligned_cols=372  Identities=24%  Similarity=0.355  Sum_probs=321.6

Q ss_pred             CCCCCEEECcCCcCccc-CCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCE
Q 046544           33 MSMLKLLHLQNNSLLGC-LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEW  111 (646)
Q Consensus        33 l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  111 (646)
                      ++-.+-.|+++|.++|. .|.. -..+++++.|.|...++. .+|+.++.+.+|++|.+++|++.. ..+.+..|+.|+.
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~-v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRs   82 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHD-VEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRS   82 (1255)
T ss_pred             cceeecccccCCcCCCCcCchh-HHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHH
Confidence            55677889999999853 2221 124889999999999999 899999999999999999999994 4677899999999


Q ss_pred             EEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEE
Q 046544          112 LNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITI  191 (646)
Q Consensus       112 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  191 (646)
                      +.++.|++....    +|..+-.+..|+.||||+|++..++....   ..+++-.|+||+|+|..++-..|.+++.|-.|
T Consensus        83 v~~R~N~LKnsG----iP~diF~l~dLt~lDLShNqL~EvP~~LE---~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL  155 (1255)
T KOG0444|consen   83 VIVRDNNLKNSG----IPTDIFRLKDLTILDLSHNQLREVPTNLE---YAKNSIVLNLSYNNIETIPNSLFINLTDLLFL  155 (1255)
T ss_pred             HhhhccccccCC----CCchhcccccceeeecchhhhhhcchhhh---hhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence            999999997642    45567789999999999999998865432   23578899999999998877888999999999


Q ss_pred             EccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccc-ccCCccccCCCCCceeecCCCcc
Q 046544          192 DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLF-GSIPACFSNLASLRILSLSSNEL  270 (646)
Q Consensus       192 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l  270 (646)
                      |||+|++. ..|+....+..|++|+|++|.+....-..+..+++|++|.+++.+-+ .-+|.++..+.+|..+|+|.|.+
T Consensus       156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L  234 (1255)
T KOG0444|consen  156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL  234 (1255)
T ss_pred             ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence            99999998 56667888999999999999987555555667889999999997743 35788899999999999999999


Q ss_pred             cccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCC-cccccc
Q 046544          271 TSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG-SIPDSF  349 (646)
Q Consensus       271 ~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~  349 (646)
                      ..+|..+.++.+|+.|+||+|.|+ .+....+...+|+.|++|.|+++ ..|++++.++.|+.|++.+|++.. -+|..+
T Consensus       235 p~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI  312 (1255)
T KOG0444|consen  235 PIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI  312 (1255)
T ss_pred             CcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence            999999999999999999999998 45666778889999999999999 689999999999999999999863 378999


Q ss_pred             cCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC
Q 046544          350 GDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       350 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      +.+.+|+.+..++|.+. .+|..+..+..|+.|.|+.|++-..+.....++.+..+++..||-+--+|.
T Consensus       313 GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence            99999999999999997 999999999999999999999997554456689999999999997665543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=283.78  Aligned_cols=166  Identities=48%  Similarity=0.751  Sum_probs=152.9

Q ss_pred             ccccccHHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEE
Q 046544          478 TWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC  557 (646)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~  557 (646)
                      ..+.|+|.++..+|++|...+.||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999987755433145699999999999999999999999


Q ss_pred             ecCCe-eEEEEEecCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          558 SNEEF-KALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       558 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                      .+.+. .++|+|||++|+|.+++..... .++|..+++||.++|+||+|||..+.++||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            99984 9999999999999999988766 899999999999999999999988888999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+|+...
T Consensus       221 FGLa~~~~  228 (361)
T KOG1187|consen  221 FGLAKLGP  228 (361)
T ss_pred             ccCcccCC
Confidence            99997653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=269.68  Aligned_cols=150  Identities=32%  Similarity=0.554  Sum_probs=136.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ..+|...+.||+|+||+||+|+++ ++.+||||.+.++  ..+..+....|++++++++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888888999999999999965 6899999999877  3455667789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC------CcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN------LVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~------~~~ki~DfGla~~  641 (646)
                      |||.||||.+|++.++ .+++..+..++.|+|.|+++||   +++||||||||.|||++..      -.+||+|||+||.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999998876 6899999999999999999999   9999999999999999754      5699999999998


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      +..
T Consensus       165 L~~  167 (429)
T KOG0595|consen  165 LQP  167 (429)
T ss_pred             CCc
Confidence            754

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-35  Score=313.17  Aligned_cols=383  Identities=30%  Similarity=0.370  Sum_probs=247.1

Q ss_pred             CCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcc
Q 046544           12 LEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELS   91 (646)
Q Consensus        12 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls   91 (646)
                      |+.|||++|++. ..|..+..+.+|+.|+++.|-|...+.+...  +.+|++|.|.+|.+. ..|..+..+.+|+.||+|
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~--~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSN--MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhh--hhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            666666666664 5666666666666666666666554433332  556666666666665 566666666666666666


Q ss_pred             cCccccccCccccCcCCCCE-----------------------------------------EEccCCCCCCCCCcccccc
Q 046544           92 QNSFSGFIPNTFGNLRNLEW-----------------------------------------LNLRDNYLTSSTPELSFLS  130 (646)
Q Consensus        92 ~N~l~~~~~~~~~~l~~L~~-----------------------------------------L~L~~N~l~~~~~~~~~~~  130 (646)
                      .|++.. .|..+..+..++.                                         |+|++|.+...        
T Consensus       123 ~N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~--------  193 (1081)
T KOG0618|consen  123 FNHFGP-IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVL--------  193 (1081)
T ss_pred             hhccCC-CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhh--------
Confidence            666652 2333333333333                                         44444444411        


Q ss_pred             cCCCCCCCCEEECCCCCCCCcCCcc----------------hhccccccCcEEEeecccccccCCcccccCCCCCEEEcc
Q 046544          131 SLSNCKSLTFIHLSDNPLDGILSKT----------------SIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLG  194 (646)
Q Consensus       131 ~l~~l~~L~~L~Ls~N~l~~~~~~~----------------~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  194 (646)
                      .+.++.+|+.|+...|++..+....                ...-.+..|+.++++.|++++. |+|++.+.+|+.++..
T Consensus       194 dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n  272 (1081)
T KOG0618|consen  194 DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNAN  272 (1081)
T ss_pred             hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcc-hHHHHhcccceEeccc
Confidence            1333444444444444443221100                0011123455555555555543 3555556666666666


Q ss_pred             CCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCC-CceeecCCCccccc
Q 046544          195 GNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLAS-LRILSLSSNELTSI  273 (646)
Q Consensus       195 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~l  273 (646)
                      +|++. ..|......++|+.|....|.++ .+|+...+++.|++|+|..|.|...++..|..+.. |+.|..+.|.+...
T Consensus       273 ~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l  350 (1081)
T KOG0618|consen  273 HNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL  350 (1081)
T ss_pred             chhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc
Confidence            66553 34444455555555566666555 44555555566666666666665333333333332 55555555665555


Q ss_pred             ccc-cccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCC
Q 046544          274 PLT-FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL  352 (646)
Q Consensus       274 p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  352 (646)
                      |.. -...+.|+.|++.+|.+++..-..+.+...|+.|+|++|++...+...+.++..|++|+||+|+++ .+|+++..+
T Consensus       351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~  429 (1081)
T KOG0618|consen  351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANL  429 (1081)
T ss_pred             ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhh
Confidence            521 123567889999999999887788999999999999999999887788999999999999999999 788999999


Q ss_pred             CCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee-ccCCCCCCCCccccccCCccc
Q 046544          353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE-IPRGGSFGNFAAESFEGNELL  413 (646)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~~~~~~~~~~~N~~~  413 (646)
                      ..|++|...+|++. ..| .+..++.|+.+|++.|.|+.. +|....+++++.++++||.|.
T Consensus       430 ~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  430 GRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99999999999998 777 899999999999999999864 455555689999999999963

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-33  Score=299.05  Aligned_cols=393  Identities=25%  Similarity=0.290  Sum_probs=260.3

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      ||..+..-..++.|++++|-+-..+-+...+.-+|+.|||++|.+...+..+..  +++|+.|+++.|-|. ..|....+
T Consensus        13 ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~--l~~L~~ln~s~n~i~-~vp~s~~~   89 (1081)
T KOG0618|consen   13 IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITL--LSHLRQLNLSRNYIR-SVPSSCSN   89 (1081)
T ss_pred             cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhh--HHHHhhcccchhhHh-hCchhhhh
Confidence            566666666688899999987644444555556699999999999765555654  789999999999998 67788888


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCC-CCCCcCCcc-----
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN-PLDGILSKT-----  155 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~-----  155 (646)
                      +.+|++|+|.+|.+. ..|..+..+.+|++|+++.|++...|.      .+..++.++.+..++| +++.+....     
T Consensus        90 ~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl------~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~  162 (1081)
T KOG0618|consen   90 MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPL------VIEVLTAEEELAASNNEKIQRLGQTSIKKLD  162 (1081)
T ss_pred             hhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCch------hHHhhhHHHHHhhhcchhhhhhccccchhhh
Confidence            999999999999998 678899999999999999999987654      3556666666666666 221111000     


Q ss_pred             ---------hhccccccCcE-EEeecccccccCCcccccCCCCCE--------------------EEccCCccccccCcc
Q 046544          156 ---------SIGNLSHSLKD-FYMSNCNVSGGIPEEITNLTNSIT--------------------IDLGGNKLNGSIPIT  205 (646)
Q Consensus       156 ---------~~~~~~~~L~~-L~L~~n~l~~~~p~~~~~l~~L~~--------------------L~L~~N~l~~~~~~~  205 (646)
                               +... ...++. |+|..|.+...   .+.++.+|+.                    |+.+.|.+....+. 
T Consensus       163 l~~n~l~~~~~~~-i~~l~~~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~-  237 (1081)
T KOG0618|consen  163 LRLNVLGGSFLID-IYNLTHQLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH-  237 (1081)
T ss_pred             hhhhhcccchhcc-hhhhheeeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc-
Confidence                     0000 012232 66666665521   1222222332                    33333333211110 


Q ss_pred             ccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccccccccccccccc
Q 046544          206 LSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQ  285 (646)
Q Consensus       206 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~  285 (646)
                       ..-.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ ..|..+....+|+.|++.+|.++.+|....+++.|+.
T Consensus       238 -p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~t  314 (1081)
T KOG0618|consen  238 -PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRT  314 (1081)
T ss_pred             -cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeee
Confidence             11135667777777777 34577777777777777777764 3333333344444444444444444444444444444


Q ss_pred             ccCCCCccc-------------------------CCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          286 LNFSSNFLT-------------------------GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       286 L~l~~N~l~-------------------------~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      |+|..|.+.                         ......=..+..|+.|++.+|.++...-..+.++++|+.|+|++|+
T Consensus       315 LdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr  394 (1081)
T KOG0618|consen  315 LDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR  394 (1081)
T ss_pred             eeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence            444444443                         2221112234567788888888887777778888899999999999


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCcccc
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLC  414 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c  414 (646)
                      +...+...+.++..|++|+||+|+++ .+|..+..+..|++|...+|++.. .|.....+.++.+|++.|.+.-
T Consensus       395 L~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fPe~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  395 LNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FPELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             cccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-chhhhhcCcceEEecccchhhh
Confidence            98666667888889999999999998 788888899999999999999986 5677778888889998887543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=248.10  Aligned_cols=149  Identities=27%  Similarity=0.418  Sum_probs=131.1

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCC------c-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG------R-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      .+.|.+.+.+|+|+||.|-+|. .++|+.||||++.++..      . ......+|+++|++++|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567888999999999999997 45899999999975531      1 12234689999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC---CcEEEEeecCc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA  639 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~---~~~ki~DfGla  639 (646)
                      .|+||||++||+|.+++-..+ .+.+.....+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999997765 6778888899999999999999   9999999999999999654   88999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      |...
T Consensus       327 K~~g  330 (475)
T KOG0615|consen  327 KVSG  330 (475)
T ss_pred             hccc
Confidence            9864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=9.5e-30  Score=254.66  Aligned_cols=150  Identities=31%  Similarity=0.423  Sum_probs=135.3

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv  566 (646)
                      +.|+..++||+|+||.||+|+. .+|+.||+|.+..+.  +.......+||.++++++||||+++.+....+  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4566778999999999999984 589999999998665  34455678999999999999999999998877  689999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      +|||++ ||.-++...+-.+++.++..+++|++.||.|+|   .++|+|||||.+|||||.+|.+||+|||+|+++..+
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999988 999999888778999999999999999999999   999999999999999999999999999999987543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.5e-29  Score=256.95  Aligned_cols=150  Identities=29%  Similarity=0.428  Sum_probs=139.6

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+|...+.||+|+|+.||.++. .+|+.||+|++++.   .....+...+||++.+.++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 78999999999864   3456678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      |+|+.|+|.++++ .+..+++.++..+++||+.|+.|||   +.+|+|||||..|++++++++|||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998 4558999999999999999999999   899999999999999999999999999999998754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=243.28  Aligned_cols=148  Identities=26%  Similarity=0.372  Sum_probs=132.8

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe-eEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-KALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-~~lv~e~~  570 (646)
                      .+..+.||+|..|+||+++++ +++.+|+|++....+ ...+++.+|++++++.+||+||.+||+|...+. .+++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            455678999999999999976 789999999965543 445789999999999999999999999999984 99999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .+|+|.++++..+ .+++...-+|+.+|++||.|||.  .++||||||||+|||++..|.|||||||.++.+.+
T Consensus       161 DgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  161 DGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             CCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999998764 68899999999999999999993  37899999999999999999999999999987653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=1e-29  Score=238.56  Aligned_cols=148  Identities=28%  Similarity=0.383  Sum_probs=131.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      +.|+...++|+|+||.||+|+.+ +|+.||||.+....+  ...+-.++|++++++++|||+|.+.++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999965 699999999875432  234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+. ++.+-+......++.....+++.|++.|+.|+|   .+++|||||||+||||...|.+|+||||+||.+.
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            9988 555556666667888899999999999999999   8999999999999999999999999999999886

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=4.4e-29  Score=230.63  Aligned_cols=150  Identities=28%  Similarity=0.474  Sum_probs=137.1

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCc--hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR--AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .+|...+++|+|.||.||+|++ .+|+.||||.++....+  ......+||+.++.++|+||+.+.++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4678889999999999999984 57999999999865432  23467899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      ||+. +|+..+++....++..+...++.++.+|++|+|   .+.|+|||+||.|+||+++|.+||+|||+|+.+..+
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 999999999989999999999999999999999   899999999999999999999999999999998654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-29  Score=254.37  Aligned_cols=149  Identities=33%  Similarity=0.563  Sum_probs=135.0

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      .++..+.||+|.||+||.|+++....||+|.++... ...++|.+|+++|++++|++||+++++|..++.+|||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            345568899999999999999888899999987652 3447899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          573 GSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       573 g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      |+|.+|++. .+..+...+.+.++.|||+||+||+   ++++|||||.++||||+++..|||+|||+||.+.++
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999987 4567888899999999999999999   899999999999999999999999999999965443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=3e-28  Score=248.94  Aligned_cols=146  Identities=33%  Similarity=0.541  Sum_probs=130.5

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCC-eeEEEEEecC
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYKP  571 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~  571 (646)
                      ...+.+|+|+||+||+|.++....||||++.....  ...++|.+|+.+|++++|||||+++|+|.... ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            44556999999999999997655699999986542  22568999999999999999999999999887 7999999999


Q ss_pred             CCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          572 HGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAP-VIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      +|+|.+++.. .+..+++..+++++.|||+||.|||   ..+ ||||||||+|||++.++ ++||+|||+++...
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            9999999988 3678999999999999999999999   677 99999999999999997 99999999998764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=238.72  Aligned_cols=150  Identities=31%  Similarity=0.440  Sum_probs=136.0

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..++|+..++||+|+||+||.++.+ +++.+|+|+++++.   ....+...+|..++.+++||.||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3468999999999999999999854 68999999998653   3345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||+.||+|..++++.+ .+++..+.-++.+|+.||.|||   +++|||||+||+|||+|.+|+++++|||+||...
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999997665 6888888889999999999999   9999999999999999999999999999999643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.95  E-value=1.9e-28  Score=233.20  Aligned_cols=154  Identities=25%  Similarity=0.351  Sum_probs=137.1

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCch--HHHHHHHHHHHHhCCCCCceeEEEEEecC--C
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRA--FKSFAVECEMMKSIRHRNLIKVISSCSNE--E  561 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~  561 (646)
                      -|+..+.|+..+.|++|+||.||+|+++ +++.||+|+++...++.  .-...+||.++.+++|||||.+.++....  +
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            3566678889999999999999999954 78999999998765322  23568999999999999999999988765  5


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .+|+|||||+. ||..++...+..+...++..++.|+++|++|||   .+.|+|||+|++|+|+.+.|.+||+|||+||.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence            79999999988 999999888888999999999999999999999   89999999999999999999999999999998


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      +..
T Consensus       227 ygs  229 (419)
T KOG0663|consen  227 YGS  229 (419)
T ss_pred             hcC
Confidence            764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.1e-28  Score=239.64  Aligned_cols=150  Identities=28%  Similarity=0.456  Sum_probs=137.1

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+|++.+.+|+|.||+|-+|.. ..|+.||||.+++..   +++.-.+.+||+||+.++||||+++|++|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4678889999999999999984 679999999987653   445567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      ||..+|.|++|+.+.+ .+++.++..+++||..|+.|+|   .++++|||+|.+|||+|.++++||+|||++-++.++
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999998876 7899999999999999999999   899999999999999999999999999999877543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=245.42  Aligned_cols=153  Identities=32%  Similarity=0.478  Sum_probs=137.4

Q ss_pred             HHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEecc---CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      ....++|..++.||+|+|++|++|+. .++++||||++.+.   .+...+...+|-.+|..+ .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34457889999999999999999985 47999999998754   233445667899999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+|+||+++|+|.++++..+ .+++..++.++.+|+.|++|||   .+|||||||||+|||+|++|++||+|||-||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998875 7899999999999999999999   999999999999999999999999999999988


Q ss_pred             cC
Q 046544          643 IG  644 (646)
Q Consensus       643 ~~  644 (646)
                      .+
T Consensus       225 ~~  226 (604)
T KOG0592|consen  225 SP  226 (604)
T ss_pred             Ch
Confidence            54

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-29  Score=247.76  Aligned_cols=150  Identities=26%  Similarity=0.387  Sum_probs=135.4

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHH-HHHHHHHHHHhCC-CCCceeEEEEEecCC-eeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIR-HRNLIKVISSCSNEE-FKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-H~niv~~~~~~~~~~-~~~lv  566 (646)
                      .++|...+++|.|+||.||+|+ ..+|+.||||.++.+...+.+ --.||++.++++. |||||++.+++.+.+ .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4678899999999999999998 557999999988766544333 3468999999998 999999999999887 89999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||||+. +|++++++++..+++..+..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+||.+..
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            999976 999999999999999999999999999999999   99999999999999999888999999999998754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-30  Score=251.13  Aligned_cols=263  Identities=25%  Similarity=0.269  Sum_probs=208.2

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccC-CcccccCCccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWG-NNFSGTIPRFI   79 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~   79 (646)
                      |||..+.  ..-++++|..|+|+.++|.+|..+++|++||||+|.|+. |.+.+|.++++|..|-+-+ |+|+.+..+.|
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~-I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F  136 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISF-IAPDAFKGLASLLSLVLYGNNKITDLPKGAF  136 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhh-cChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence            4666655  567899999999999999999999999999999999976 6666777899987777666 99998888999


Q ss_pred             cCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcch---
Q 046544           80 FNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS---  156 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~---  156 (646)
                      .++..|+.|.+.-|++.-+..++|..|++|..|.+..|.+..+..+     +|..+.+++.+++..|++-..-.-.+   
T Consensus       137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~-----tf~~l~~i~tlhlA~np~icdCnL~wla~  211 (498)
T KOG4237|consen  137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKG-----TFQGLAAIKTLHLAQNPFICDCNLPWLAD  211 (498)
T ss_pred             hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccc-----cccchhccchHhhhcCccccccccchhhh
Confidence            9999999999999999999999999999999999999999987653     58899999999999998422110000   


Q ss_pred             --------hccc---------------------cccCcEE---EeecccccccCC-cccccCCCCCEEEccCCccccccC
Q 046544          157 --------IGNL---------------------SHSLKDF---YMSNCNVSGGIP-EEITNLTNSITIDLGGNKLNGSIP  203 (646)
Q Consensus       157 --------~~~~---------------------~~~L~~L---~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~  203 (646)
                              ++..                     ...++.+   ..+.+..-++.| ..|..+++|++|+|++|+|+++-+
T Consensus       212 ~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~  291 (498)
T KOG4237|consen  212 DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIED  291 (498)
T ss_pred             HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhh
Confidence                    0000                     0011111   222333333434 557788888888888888888888


Q ss_pred             ccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccc
Q 046544          204 ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT  271 (646)
Q Consensus       204 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  271 (646)
                      .+|.++..+++|.|..|+|..+....|.++..|++|+|.+|+|+...|.+|..+.+|..|.|-.|.+-
T Consensus       292 ~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  292 GAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            88888888888888888888777788888888888888888888888888888888888888777654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=222.23  Aligned_cols=149  Identities=32%  Similarity=0.443  Sum_probs=135.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.+|.|+||+|..++.+ +|..+|+|+++++.-   +..+....|..+++.+.||.++++++.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46788899999999999999965 688999999986642   33456678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||++||.|..+++..+ .+++..+.-+++||+.|++|||   ..+|++||+||+|||+|..|.+||+|||+||.+.+
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998876 6888899999999999999999   89999999999999999999999999999998765

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=8.9e-28  Score=251.04  Aligned_cols=164  Identities=27%  Similarity=0.485  Sum_probs=147.1

Q ss_pred             cccccHHHHHHHhCCC---------CcceeecccccceEEEEEeCC----CcEEEEEEEeccC-CchHHHHHHHHHHHHh
Q 046544          479 WRTFSYLELCRATNGF---------SENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRAFKSFAVECEMMKS  544 (646)
Q Consensus       479 ~~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~  544 (646)
                      ...++|+|...+...|         .+.++||.|.||+||+|+++.    ...||||.++... ++...+|+.|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3567888887777654         356999999999999998652    3469999998654 4566789999999999


Q ss_pred             CCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 046544          545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVL  624 (646)
Q Consensus       545 l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil  624 (646)
                      ++||||+++.|+........||+|||++|+|..+++..++.+.+.+.+.|.++||.||.||-   ++++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence            99999999999999999999999999999999999999989999999999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCcccccCC
Q 046544          625 LDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       625 ~~~~~~~ki~DfGla~~~~~~  645 (646)
                      ++.+-.+||+|||++|.+.++
T Consensus       764 VNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eccceEEEeccccceeecccC
Confidence            999999999999999988654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.7e-29  Score=230.45  Aligned_cols=152  Identities=28%  Similarity=0.428  Sum_probs=131.1

Q ss_pred             CCCCcceeecccccceEEEEE-eCCCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEE-EEecCCe-eEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVIS-SCSNEEF-KALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~-~~~~~~~-~~lv  566 (646)
                      .+|++.++||+|.||+||+++ ..+|+.||.|.+.-.  +.+..++...|+.+++.++|||||++++ .+..+.. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357788999999999999998 568999999987633  3455678899999999999999999998 4555544 8999


Q ss_pred             EEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          567 LEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||||++|+|.++++.   .++.+++..+++++.|++.|+.++|... ++  |+||||||.||+++..|.||++|||++|.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999864   3457899999999999999999999421 44  89999999999999999999999999998


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      +..
T Consensus       178 l~s  180 (375)
T KOG0591|consen  178 LSS  180 (375)
T ss_pred             hcc
Confidence            754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-27  Score=234.28  Aligned_cols=146  Identities=36%  Similarity=0.505  Sum_probs=127.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHh--CCCCCceeEEEEEecCC----eeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--IRHRNLIKVISSCSNEE----FKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~~----~~~l  565 (646)
                      ...+..+.+|+|+||.||+|++ +++.||||++..+   ..+.|..|-+|.+.  ++|+||++++++-....    ..++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3455678899999999999998 4589999999854   45678888888765  58999999998876554    7899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~------~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      |+||.+.|+|.+|++.+  ..+|.+..+|+..+++||+|||+      ++.++|+|||||++||||..|+++.|+|||+|
T Consensus       286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999999876  58999999999999999999994      45678999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      ..+.
T Consensus       364 l~~~  367 (534)
T KOG3653|consen  364 LRLE  367 (534)
T ss_pred             EEec
Confidence            8874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=8.4e-27  Score=235.75  Aligned_cols=148  Identities=28%  Similarity=0.409  Sum_probs=135.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+....||+|+||+||.|+.+ +|..+|+|++++..   ....+....|-.+|...++|+||+++..|++.+++|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            368999999999999999999855 69999999998653   34456778899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||++|||+..++...+ .+++..+..++.+++-|++.+|   ..|+|||||||+|+|||..|++|++|||+++-+
T Consensus       220 MEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999998776 7899999999999999999999   899999999999999999999999999999654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=243.32  Aligned_cols=151  Identities=29%  Similarity=0.520  Sum_probs=135.6

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      +++....+.+.....||+|+||+||+|+|-  ..||||++....  +...+.|..|+..+++-+|.||+-+.|+|..++.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444445556678899999999999999974  359999998764  4467899999999999999999999999998877


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                       .||+-+|+|.+|+.+++..+..++..+...|++|||+||.|||   +++|||||||+.||++.+++.|||+|||+|..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceee
Confidence             8999999999999999988878999999999999999999999   99999999999999999999999999999853

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=238.11  Aligned_cols=148  Identities=24%  Similarity=0.482  Sum_probs=132.9

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .....++||+|.||+|..+....+..||||.++....+ ...+|.+|+++|.+++|||||+++|+|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            34566899999999999999878899999999876543 45799999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l-~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+|+..+..+. +....++|+.||+.||+||.   +.++||||+.++|+|+|.++++||+|||++|-+.
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccc
Confidence            999999998875433 55567889999999999999   8899999999999999999999999999999553

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=238.31  Aligned_cols=149  Identities=28%  Similarity=0.439  Sum_probs=134.3

Q ss_pred             HhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC----C-chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC----G-RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEF  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~  562 (646)
                      ....|...+.||+|+||+|+.|+. .+|+.||+|++..+.    . ...+...+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346899999999999999999975 478999999876541    1 22346668999999998 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKL  641 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~~  641 (646)
                      .|+||||+.||+|.+++.. .+.+.+.++..+++|++.|++|+|   .++|+||||||+||+++.+ +++||+|||+++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 557889999999999999999999   8999999999999999998 9999999999998


Q ss_pred             c
Q 046544          642 L  642 (646)
Q Consensus       642 ~  642 (646)
                      .
T Consensus       171 ~  171 (370)
T KOG0583|consen  171 S  171 (370)
T ss_pred             c
Confidence            7

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-26  Score=239.57  Aligned_cols=147  Identities=32%  Similarity=0.499  Sum_probs=131.8

Q ss_pred             CCCcceeecccccceEEEEEeC--CC---cEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG--DG---MEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      +....++||+|+||+||+|+++  ++   ..||||..+...   ....++|.+|+++|+.++|||||+++|++..+..++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            3445589999999999999854  22   238999887532   455678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|||+|.||+|.++++..+..++..+...++.+.|+||+|||   .+++|||||.++|+|+..++.+||+|||+++.-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999999999988777999999999999999999999   999999999999999999999999999998864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=8.6e-27  Score=248.67  Aligned_cols=150  Identities=30%  Similarity=0.515  Sum_probs=132.7

Q ss_pred             CCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +.+..+.||+|+||+||+|+..      +.+.||||.++..... ..++|.+|++.++.++|||||+++|+|..++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3455678999999999999742      3467999999877655 67899999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          566 VLEYKPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                      |+|||..|||.+++....             .+++..+.+.||.|||.||+||-   ++.+|||||..+|+||.+...||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999997432             23778899999999999999999   88899999999999999999999


Q ss_pred             EEeecCcccccCC
Q 046544          633 LSDFGIAKLLIGE  645 (646)
Q Consensus       633 i~DfGla~~~~~~  645 (646)
                      |+|||++|.+...
T Consensus       644 IsDfGLsRdiYss  656 (774)
T KOG1026|consen  644 ISDFGLSRDIYSS  656 (774)
T ss_pred             ecccccchhhhhh
Confidence            9999999976543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-26  Score=225.95  Aligned_cols=150  Identities=34%  Similarity=0.507  Sum_probs=134.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC--eeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--FKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv~  567 (646)
                      ..+|...+.||+|+||.||.+... +|...|||.+........+.+.+|+.++++++|||||+++|......  ..++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            356788899999999999999854 58999999988764333677899999999999999999999855554  689999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++...+..+++..+..+.+||++|+.|||   +++||||||||+|||++. ++.+||+|||+|+...
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999999987767899999999999999999999   999999999999999999 7999999999998765

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.94  E-value=2.9e-26  Score=222.80  Aligned_cols=148  Identities=28%  Similarity=0.412  Sum_probs=130.5

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCC-ceeEEEEEecCC------
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRN-LIKVISSCSNEE------  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~------  561 (646)
                      ..|+..+++|+|+||+||+|+. .+|+.||+|.+....+  .......+|+.+++.++|+| ||.+++++.+..      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4466678899999999999984 5799999999987644  24456789999999999999 999999999877      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                      ..++|+||++. +|.+++....   ..++...+..+++|+++|++|||   +++|+||||||.||+|+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            88999999965 9999998765   35777889999999999999999   89999999999999999999999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      |+...
T Consensus       167 Ara~~  171 (323)
T KOG0594|consen  167 ARAFS  171 (323)
T ss_pred             HHHhc
Confidence            98653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.94  E-value=8e-27  Score=235.70  Aligned_cols=148  Identities=30%  Similarity=0.467  Sum_probs=134.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|-..+.||+|+||+||||+.+ +.+.||+|.+.+..  +++.+...+|++++++++|||||.++++|++...+|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777788999999999999854 78899999997653  4556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||.| +|..++...+ .+++..+..|+.+++.|+.|||   +.+|+|||+||.|||++..|.+|+||||+||.+..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9977 9999987654 7899999999999999999999   89999999999999999999999999999998753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=227.88  Aligned_cols=150  Identities=30%  Similarity=0.416  Sum_probs=129.0

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---------c-----hHHHHHHHHHHHHhCCCCCcee
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---------R-----AFKSFAVECEMMKSIRHRNLIK  552 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~-----~~~~~~~e~~~l~~l~H~niv~  552 (646)
                      +...++|++.+.||+|.||+|-+|+.. +++.||||++.+...         .     ..+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            445588999999999999999999854 799999999875321         1     1247788999999999999999


Q ss_pred             EEEEEecC--CeeEEEEEecCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC
Q 046544          553 VISSCSNE--EFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       553 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      ++++..+.  +.+|+|+|||..|.+...-.  ... +++.++.+++++++.||+|||   .++||||||||+|+|++++|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            99998765  67999999999988765432  233 889999999999999999999   89999999999999999999


Q ss_pred             cEEEEeecCcccc
Q 046544          630 VAYLSDFGIAKLL  642 (646)
Q Consensus       630 ~~ki~DfGla~~~  642 (646)
                      +|||+|||.+-..
T Consensus       248 ~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  248 TVKISDFGVSNEF  260 (576)
T ss_pred             cEEeeccceeeec
Confidence            9999999998765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-25  Score=220.71  Aligned_cols=146  Identities=31%  Similarity=0.497  Sum_probs=126.3

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHh--CCCCCceeEEEEEecC----CeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--IRHRNLIKVISSCSNE----EFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~----~~~~l  565 (646)
                      .+.+..+.||+|+||+||+|+|+ |+.||||++...   +.+.+.+|.+++..  ++|+||..+.+.-..+    .++|+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            34667799999999999999994 889999999744   34667788888876  5999999998876554    36899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      |+||.+.|+|+||+...  .++....++++..+|.||+|||     .+..+.|.|||||+.||||.+++.+.|+|+|+|-
T Consensus       287 vTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             eeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999999774  5888999999999999999999     3456889999999999999999999999999997


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       365 ~h~  367 (513)
T KOG2052|consen  365 RHD  367 (513)
T ss_pred             Eec
Confidence            654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=2.7e-25  Score=244.81  Aligned_cols=265  Identities=23%  Similarity=0.300  Sum_probs=168.6

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      .+-..|+|++|+|+. +|..+.  ++|+.|++++|+|+..+ .    .+++|++|+|++|+|+. +|..   .++|+.|+
T Consensus       201 ~~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~LP-~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~  268 (788)
T PRK15387        201 NGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLP-A----LPPELRTLEVSGNQLTS-LPVL---PPGLLELS  268 (788)
T ss_pred             CCCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCCCC-C----CCCCCcEEEecCCccCc-ccCc---ccccceee
Confidence            456789999999984 566664  47999999999998643 2    25789999999999984 4543   46788999


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEe
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      +++|.|+.+ |..   ..+|+.|+|++|+|+.+|..         .++|++|++++|++++++.      ++.+|+.|++
T Consensus       269 Ls~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~LP~~---------p~~L~~LdLS~N~L~~Lp~------lp~~L~~L~L  329 (788)
T PRK15387        269 IFSNPLTHL-PAL---PSGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASLPA------LPSELCKLWA  329 (788)
T ss_pred             ccCCchhhh-hhc---hhhcCEEECcCCcccccccc---------ccccceeECCCCccccCCC------Cccccccccc
Confidence            999998854 333   25688899999998876531         3678888999998887643      1345677777


Q ss_pred             ecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       170 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                      ++|++++ +|..   ..+|+.|+|++|+|+++ |..   ..+|+.|++++|+|+. +|..   ..+|+.|++++|+|++ 
T Consensus       330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-  396 (788)
T PRK15387        330 YNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-  396 (788)
T ss_pred             ccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-
Confidence            7777764 3321   13566677777776643 222   2345566666666663 3432   2345666666666553 


Q ss_pred             CCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCC
Q 046544          250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK  329 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  329 (646)
                      +|..   .++|+.|++++|+|+++|...                           ..|+.|++++|+++ .+|..+..++
T Consensus       397 LP~l---~s~L~~LdLS~N~LssIP~l~---------------------------~~L~~L~Ls~NqLt-~LP~sl~~L~  445 (788)
T PRK15387        397 LPVL---PSELKELMVSGNRLTSLPMLP---------------------------SGLLSLSVYRNQLT-RLPESLIHLS  445 (788)
T ss_pred             CCCc---ccCCCEEEccCCcCCCCCcch---------------------------hhhhhhhhccCccc-ccChHHhhcc
Confidence            2322   234555555555555555321                           23444555555555 3455566666


Q ss_pred             CCCEEEccCccCCCcccccc
Q 046544          330 NLEYLFLGYNRLEGSIPDSF  349 (646)
Q Consensus       330 ~L~~L~Ls~N~l~~~~p~~~  349 (646)
                      +|+.|+|++|++++..+..+
T Consensus       446 ~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        446 SETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCCeEECCCCCCCchHHHHH
Confidence            66666666666666655555

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.93  E-value=3.4e-26  Score=221.80  Aligned_cols=145  Identities=31%  Similarity=0.489  Sum_probs=122.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-----eeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-----FKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~lv  566 (646)
                      .|...+++|.|+||.||+|... +++.||||.+..+.+.    -.+|.++|+.++|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667899999999999999965 5799999988654332    246999999999999999998886542     34589


Q ss_pred             EEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~~~  642 (646)
                      ||||+. +|.++++..   +..++...+.-++.|+.+|++|||   ..+|+||||||.|+|+|.+ |.+||||||.||.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 999998853   446777788889999999999999   8999999999999999965 99999999999988


Q ss_pred             cCC
Q 046544          643 IGE  645 (646)
Q Consensus       643 ~~~  645 (646)
                      ...
T Consensus       177 ~~~  179 (364)
T KOG0658|consen  177 VKG  179 (364)
T ss_pred             ccC
Confidence            643

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=1.9e-25  Score=245.91  Aligned_cols=264  Identities=25%  Similarity=0.279  Sum_probs=132.9

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCC
Q 046544           60 NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLT  139 (646)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  139 (646)
                      .-..|+|++|.++ .+|..+.  ++|+.|++++|+|+.+ |.   .+++|++|+|++|+|+.+|..         .++|+
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~LtsLP~l---------p~sL~  265 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSLPVL---------PPGLL  265 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccCcccCc---------ccccc
Confidence            3456666666666 4454443  3566666666666643 32   245666666666666665421         24566


Q ss_pred             EEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeec
Q 046544          140 FIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD  219 (646)
Q Consensus       140 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  219 (646)
                      .|++++|.++.++.      ++..|+.|++++|+++.. |.   ..++|+.|++++|+++++ |...   .+|+.|++++
T Consensus       266 ~L~Ls~N~L~~Lp~------lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~  331 (788)
T PRK15387        266 ELSIFSNPLTHLPA------LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYN  331 (788)
T ss_pred             eeeccCCchhhhhh------chhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCCc---cccccccccc
Confidence            66666666654432      123455566666655532 22   124566666666666543 2211   2355556666


Q ss_pred             ccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCC
Q 046544          220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPL  299 (646)
Q Consensus       220 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~  299 (646)
                      |+|++ +|..   ..+|+.|+|++|+|++ +|..   .++|+.|++++|+|+.+|..   ..+|+.|++++|.+++ +|.
T Consensus       332 N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~-LP~  399 (788)
T PRK15387        332 NQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPV  399 (788)
T ss_pred             Ccccc-cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCccc---ccccceEEecCCcccC-CCC
Confidence            66653 3321   1345566666666653 2322   23455556666666555532   1345555555555553 222


Q ss_pred             ccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccc
Q 046544          300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL  373 (646)
Q Consensus       300 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  373 (646)
                      .   .++|+.|++++|.+++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..|..+
T Consensus       400 l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        400 L---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             c---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            1   1344555555555553 2322   123445555555554 344555555555555555555554444443

>PLN03210 Resistant to P

Probab=99.93  E-value=1.7e-24  Score=256.49  Aligned_cols=339  Identities=24%  Similarity=0.266  Sum_probs=138.3

Q ss_pred             ccCCCCCCEEECCCCc------ccccCCcCccCCC-CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcc
Q 046544            6 ISNLQNLEELDLRHNK------LVGTVPAAIFNMS-MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRF   78 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~------l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~   78 (646)
                      |..+++|+.|.+.++.      +....|..|..++ +|+.|++.+|.+...++.+   ...+|++|+|++|+++ .++..
T Consensus       554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f---~~~~L~~L~L~~s~l~-~L~~~  629 (1153)
T PLN03210        554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF---RPENLVKLQMQGSKLE-KLWDG  629 (1153)
T ss_pred             HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC---CccCCcEEECcCcccc-ccccc
Confidence            4445555555554332      1122344444432 3555555555554332222   1345555555555554 34444


Q ss_pred             ccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCC-CCCCCcccccccCCCCCCCCEEECCCC-CCCCcCCcch
Q 046544           79 IFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL-TSSTPELSFLSSLSNCKSLTFIHLSDN-PLDGILSKTS  156 (646)
Q Consensus        79 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~~  156 (646)
                      +..+++|+.|+|++|......| .+..+++|++|+|++|.. ..      +|..+.++++|+.|++++| .++.++... 
T Consensus       630 ~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~------lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-  701 (1153)
T PLN03210        630 VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVE------LPSSIQYLNKLEDLDMSRCENLEILPTGI-  701 (1153)
T ss_pred             cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccc------cchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence            4455555555555443222223 244455555555555432 22      2233445555555555543 232222111 


Q ss_pred             hccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCC
Q 046544          157 IGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL  236 (646)
Q Consensus       157 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  236 (646)
                         -.++|+.|++++|......|..   .++|+.|++++|.+.. +|..+ .+++|++|++.++.... +.         
T Consensus       702 ---~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~-l~---------  763 (1153)
T PLN03210        702 ---NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEK-LW---------  763 (1153)
T ss_pred             ---CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhh-cc---------
Confidence               1124444444444333333321   2334444444444432 22222 23444444443321110 00         


Q ss_pred             cEEEecCCcccccCCccccCCCCCceeecCCCc-ccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccc
Q 046544          237 YELELGGNKLFGSIPACFSNLASLRILSLSSNE-LTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN  315 (646)
Q Consensus       237 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N  315 (646)
                             +.+....+..+...++|+.|++++|. +.++|..+.++++|+.|++++|...+.+|..+ ++++|+.|++++|
T Consensus       764 -------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c  835 (1153)
T PLN03210        764 -------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC  835 (1153)
T ss_pred             -------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence                   00000111111222344444444442 22444444444444444444443222333333 3444455555444


Q ss_pred             cccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCC-cCcccCCccccCCCCCCceeCcCC
Q 046544          316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN-NLSGAIPTSLEKLSYLEDLNLSFN  387 (646)
Q Consensus       316 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N  387 (646)
                      ......|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+|++| +++ .+|..+..+++|+.++++++
T Consensus       836 ~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        836 SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            322222221   234555555555554 34445555555555555542 333 34444444555555555444

syringae 6; Provisional

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=198.39  Aligned_cols=147  Identities=30%  Similarity=0.426  Sum_probs=132.9

Q ss_pred             CCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .|...++||+|.||+||+|+ +.+++.||+|.++.+..  .......+|+.+++.++|.|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46677899999999999998 45789999999987643  3345778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |. .+|.+|.....+.++...+..++.|+++|+.|+|   ++.+.|||+||.|.+|+.+|+.|++|||+|+.+.
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            95 4999999888888999999999999999999999   8899999999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-25  Score=218.16  Aligned_cols=150  Identities=28%  Similarity=0.397  Sum_probs=136.7

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .+.|+..+.||.|..+.||+|+ ...++.||||++..+. ..+.+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3678999999999999999998 4578999999998664 4457889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||.+|++.+.++.. ...+++..+..|.+++++||.|||   .+|.||||+|+.||||+++|.|||+|||.+..+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999865 345889999999999999999999   8999999999999999999999999999877654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.5e-26  Score=208.52  Aligned_cols=148  Identities=31%  Similarity=0.435  Sum_probs=132.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|++++.+|+|.||.||.|+.+ ++-.||+|++.+..   .....++.+|+++-+.++||||.++|++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999954 67789999986542   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          567 LEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      +||...|++...+++.. ..+++..+..+++|+|.|+.|+|   .++||||||||+|+|++..+..||+|||.+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999998543 35888889999999999999999   99999999999999999999999999998754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=228.69  Aligned_cols=148  Identities=28%  Similarity=0.407  Sum_probs=136.3

Q ss_pred             CCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ..|....+||+|+.|.||.|+ ..+++.||||++........+-..+|+.+|+..+|+|||.+++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457778899999999999997 4578999999999887766677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+.+...  .+++.+...|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+..
T Consensus       353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999765  4899999999999999999999   99999999999999999999999999999988754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=7e-28  Score=233.98  Aligned_cols=291  Identities=24%  Similarity=0.270  Sum_probs=185.3

Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccC-CCCCCCCCcccccccCCCCCC
Q 046544           59 PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD-NYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      ++-..++|..|+|+.++|++|+.+.+|+.||||+|.|+.|.|++|.++++|..|-+.+ |+|+.++.+     .|+++.+
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~-----~F~gL~s  141 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKG-----AFGGLSS  141 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhh-----HhhhHHH
Confidence            3567888888888888888888888888888888888888888888888887776666 888887665     3777777


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |+.|.+.-|++..+                          ..++|..++++..|.+.+|.+..+.-.+|..+..++++.+
T Consensus       142 lqrLllNan~i~Ci--------------------------r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhl  195 (498)
T KOG4237|consen  142 LQRLLLNANHINCI--------------------------RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHL  195 (498)
T ss_pred             HHHHhcChhhhcch--------------------------hHHHHHHhhhcchhcccchhhhhhccccccchhccchHhh
Confidence            77777666666543                          4567788888888888888888666668888888888888


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccc-cc-cccccccccCCCCcccC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FW-NLKDILQLNFSSNFLTG  295 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~-~l~~L~~L~l~~N~l~~  295 (646)
                      ..|.+..     .++++.+.. ++.      ..|-.+++..-..-..+.++++..++.. |. .+.++..=..+.....+
T Consensus       196 A~np~ic-----dCnL~wla~-~~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~  263 (498)
T KOG4237|consen  196 AQNPFIC-----DCNLPWLAD-DLA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS  263 (498)
T ss_pred             hcCcccc-----ccccchhhh-HHh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC
Confidence            8887431     233333221 122      2233455555555666666666666542 21 12222221122222222


Q ss_pred             CCC-CccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          296 PLP-LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       296 ~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                      +.| ..|..+++|+.|+|++|.++++-+.+|.++..+++|+|..|+|..+-...|.++..|++|+|.+|+|+...|.+|.
T Consensus       264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~  343 (498)
T KOG4237|consen  264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ  343 (498)
T ss_pred             cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence            333 3456666666666666666666666666666666666666666655555666666666666666666666666666


Q ss_pred             CCCCCCceeCcCCcceee
Q 046544          375 KLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~  392 (646)
                      .+.+|.+|+|-.|++.+.
T Consensus       344 ~~~~l~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  344 TLFSLSTLNLLSNPFNCN  361 (498)
T ss_pred             ccceeeeeehccCcccCc
Confidence            555555555555555443

>PLN03210 Resistant to P

Probab=99.92  E-value=4.4e-24  Score=253.08  Aligned_cols=305  Identities=22%  Similarity=0.245  Sum_probs=212.2

Q ss_pred             CCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCC-CCCcCCcchhccccc
Q 046544           84 KLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP-LDGILSKTSIGNLSH  162 (646)
Q Consensus        84 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~~~  162 (646)
                      +|+.|++.+|.+.. .|..| ...+|+.|+|++|++..++.      .+..+++|+.|+|++|. +..++.   +.. .+
T Consensus       590 ~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~~L~~------~~~~l~~Lk~L~Ls~~~~l~~ip~---ls~-l~  657 (1153)
T PLN03210        590 KLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLEKLWD------GVHSLTGLRNIDLRGSKNLKEIPD---LSM-AT  657 (1153)
T ss_pred             ccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccccccc------ccccCCCCCEEECCCCCCcCcCCc---ccc-CC
Confidence            35555555555542 23334 23555555555555554322      23445555555555443 222221   111 24


Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +|+.|+|++|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|++++|......|..   .++|++|+++
T Consensus       658 ~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~  733 (1153)
T PLN03210        658 NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLD  733 (1153)
T ss_pred             cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecC
Confidence            56666666665555678888899999999999865434555544 6889999999998765555543   4678999999


Q ss_pred             CCcccccCCccccCCCCCceeecCCCccccccc--------ccccccccccccCCCCcccCCCCCccCccccceEEEccc
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPL--------TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM  314 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~  314 (646)
                      +|.+. ..|..+ .+++|+.|++.++....++.        .+...++|+.|++++|...+.+|..++++++|+.|++++
T Consensus       734 ~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~  811 (1153)
T PLN03210        734 ETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIEN  811 (1153)
T ss_pred             CCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCC
Confidence            99987 455544 57888888888754332221        223457899999999988888999999999999999999


Q ss_pred             ccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcC-Ccceeec
Q 046544          315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF-NKLEGEI  393 (646)
Q Consensus       315 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~  393 (646)
                      |...+.+|..+ .+++|+.|++++|.....+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++++.+
T Consensus       812 C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~  886 (1153)
T PLN03210        812 CINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVS  886 (1153)
T ss_pred             CCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccC
Confidence            86545667665 7899999999998655455543   368999999999998 7899999999999999998 7787755


Q ss_pred             cCCCCCCCCccccccCCc
Q 046544          394 PRGGSFGNFAAESFEGNE  411 (646)
Q Consensus       394 p~~~~~~~~~~~~~~~N~  411 (646)
                      +....+..++.+++.+++
T Consensus       887 ~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        887 LNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccccccCCCeeecCCCc
Confidence            555667778887777654

syringae 6; Provisional

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=1.5e-24  Score=227.82  Aligned_cols=147  Identities=26%  Similarity=0.379  Sum_probs=132.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|+.++.+++|++|+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999864 68999999997542   223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999997654 6889999999999999999999   899999999999999999999999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=4.3e-25  Score=227.81  Aligned_cols=148  Identities=28%  Similarity=0.427  Sum_probs=133.9

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .-|+.++.+|+|+.|.|..|++ .+|+.+|||++.+..   ......+.+|+.+|+-+.||||++++++++...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577889999999999999985 489999999998663   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||.|.+++..++ .+++.++.++++||+.|+.|+|   +.+|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            9999999999998776 6888999999999999999999   8899999999999999999999999999998643

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-24  Score=227.03  Aligned_cols=147  Identities=24%  Similarity=0.357  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999854 78999999986532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+|++|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999987654 6788889999999999999999   899999999999999999999999999999743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=227.25  Aligned_cols=147  Identities=27%  Similarity=0.399  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999865 68999999997542   233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654 6889999999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.92  E-value=3e-24  Score=222.27  Aligned_cols=148  Identities=26%  Similarity=0.360  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 68999999987542   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            9999999999987654 6788888899999999999999   8999999999999999999999999999998653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-24  Score=219.90  Aligned_cols=148  Identities=30%  Similarity=0.423  Sum_probs=132.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   .+..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999865 68999999987542   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+++.+.
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            9999999999997654 6788899999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=3.1e-24  Score=226.75  Aligned_cols=146  Identities=23%  Similarity=0.323  Sum_probs=131.0

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999854 68899999997542   2334578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |++||+|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999987654 5788888999999999999999   889999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=3.3e-24  Score=225.12  Aligned_cols=149  Identities=25%  Similarity=0.330  Sum_probs=132.4

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999865 68899999987432   2234567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++...  .+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+|+.+.
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999754  4788889999999999999999   8999999999999999999999999999998653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=4.3e-24  Score=225.50  Aligned_cols=146  Identities=24%  Similarity=0.338  Sum_probs=130.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999854 68999999986432   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999997654 6788888899999999999999   89999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.2e-24  Score=220.08  Aligned_cols=149  Identities=28%  Similarity=0.342  Sum_probs=133.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++..++|+||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999864 68999999987421   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            999999999999776567889999999999999999999   8999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=7e-24  Score=219.70  Aligned_cols=149  Identities=26%  Similarity=0.299  Sum_probs=132.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++..++|++|+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 68899999987431   223345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++......+++..+..++.|++.||+|+|   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999875557889999999999999999999   8999999999999999999999999999997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=6.3e-24  Score=219.32  Aligned_cols=141  Identities=27%  Similarity=0.357  Sum_probs=126.3

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999864 78999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|.+++...+ .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            9999987654 6789999999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=4.3e-24  Score=225.96  Aligned_cols=145  Identities=23%  Similarity=0.337  Sum_probs=130.2

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999864 68899999987542   2334577889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||++|+|.+++...+ .+++..+..++.|++.|++|+|   .++|+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987654 5788888999999999999999   88999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.8e-24  Score=220.73  Aligned_cols=147  Identities=27%  Similarity=0.442  Sum_probs=132.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 58999999997542   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            9999999999997654 6788899999999999999999   889999999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.91  E-value=4e-24  Score=222.51  Aligned_cols=149  Identities=26%  Similarity=0.448  Sum_probs=127.5

Q ss_pred             hCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecC-C
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNE-E  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-~  561 (646)
                      .++|+..+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35788999999999999999973      2356799999875432 3346788999999999 899999999988765 4


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC----------------------------------------------------------
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN----------------------------------------------------------  583 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  583 (646)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5899999999999999986532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          584 ---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       584 ---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                         ..+++.++..++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~  224 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  224 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence               23667788899999999999999   889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=5.5e-24  Score=220.86  Aligned_cols=148  Identities=26%  Similarity=0.356  Sum_probs=131.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-C-CcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+.+ + +..||+|++....   ....+.+.+|+++++.++||||+++++++..++..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            56888999999999999999854 3 4689999987432   23446788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|+|.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999997654 6888999999999999999999   8999999999999999999999999999998653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.91  E-value=6.9e-24  Score=217.29  Aligned_cols=148  Identities=26%  Similarity=0.484  Sum_probs=128.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-----------------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-----------------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV  553 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~  553 (646)
                      .+|...+.||+|+||.||+|+++                 ++..||+|++..... ...+++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            57888899999999999999753                 234699999876533 334578999999999999999999


Q ss_pred             EEEEecCCeeEEEEEecCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 046544          554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIH  615 (646)
Q Consensus       554 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH  615 (646)
                      ++++...+..++||||+++|+|.+++....                  ..+++....+++.|++.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986432                  23567788999999999999999   889999


Q ss_pred             cCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          616 CDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       616 rdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||||+||++++++.+||+|||+++.+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~  188 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNL  188 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceec
Confidence            999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-24  Score=209.95  Aligned_cols=149  Identities=28%  Similarity=0.379  Sum_probs=130.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEe--ccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec-----CC
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-----EE  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-----~~  561 (646)
                      ....|...+.||+|+||.|+.|..+ +|+.||||.+.  -+.....++..+|+++++.++|+||+.+.+++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666789999999999999854 79999999887  3344556788999999999999999999999876     25


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .+|+|+|+| +.+|.+.++..+ .++...+.-++.|+++|+.|+|   +.+|+|||+||+|++++.+..+||+|||+||.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            689999999 559999997654 5888899999999999999999   89999999999999999999999999999998


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       175 ~~  176 (359)
T KOG0660|consen  175 LD  176 (359)
T ss_pred             cc
Confidence            74

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.91  E-value=7.4e-24  Score=215.22  Aligned_cols=147  Identities=26%  Similarity=0.443  Sum_probs=131.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57889999999999999999865 689999999875432 2335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++ +|.+++...+..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||+++..
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            975 999998776666788999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.91  E-value=7.3e-24  Score=219.70  Aligned_cols=149  Identities=27%  Similarity=0.359  Sum_probs=134.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999864 68999999998542   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++......+++..+..++.|++.||.|+|   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            999999999999887667899999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=1.2e-24  Score=220.96  Aligned_cols=151  Identities=27%  Similarity=0.420  Sum_probs=136.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe-eEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-KALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-~~lv~  567 (646)
                      ++|...+.+|+|+||.++.++++ +++.|++|.+....  ....+...+|+.++++++|||||.+.+.|+.++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999998854 67899999987654  3444577889999999999999999999999988 99999


Q ss_pred             EecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          568 EYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      +||+||++.+.+...+ ..+++.....++.|++.|++|||   +.+|+|||+|+.||++..++.||++|||+||.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998766 67899999999999999999999   899999999999999999999999999999998765

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=238.56  Aligned_cols=149  Identities=30%  Similarity=0.522  Sum_probs=133.1

Q ss_pred             CCCcceeecccccceEEEEEeCC--Cc----EEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLGD--GM----EVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..+..+.||+|+||.||+|...+  |.    .||||.++... .....+|.+|+.+|++++|||||++.|+|.+.+..+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34566889999999999998542  43    48999887654 4556789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          566 VLEYKPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      ++|||+||+|..|+++.      ...+...+.+.++.|||+|+.||+   ++++|||||.++|+|++....|||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999987      567888999999999999999999   899999999999999999999999999999


Q ss_pred             ccccC
Q 046544          640 KLLIG  644 (646)
Q Consensus       640 ~~~~~  644 (646)
                      |.+.+
T Consensus       850 rDiy~  854 (1025)
T KOG1095|consen  850 RDIYD  854 (1025)
T ss_pred             Hhhhh
Confidence            96543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=1.4e-23  Score=212.85  Aligned_cols=147  Identities=24%  Similarity=0.362  Sum_probs=129.8

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+.+++.++|++|+++.+++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999985 479999999987543   1223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+|+.+
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999998876543 36889999999999999999999   899999999999999999999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=8.2e-24  Score=218.42  Aligned_cols=141  Identities=26%  Similarity=0.360  Sum_probs=126.1

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999864 68999999997542   234456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|..++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            9998886654 6789999999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=225.55  Aligned_cols=150  Identities=34%  Similarity=0.511  Sum_probs=128.7

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------eeE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------FKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------~~~  564 (646)
                      .|...+.+|+|+||.||+|+. .+|+.||||.+.... .+..+...+|++++++++|||||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355668899999999999994 579999999987643 345677889999999999999999998866543      457


Q ss_pred             EEEEecCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--CCC--cEEEEeecC
Q 046544          565 LVLEYKPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--DNL--VAYLSDFGI  638 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~~~--~~ki~DfGl  638 (646)
                      +|||||.||+|...+....  ..+++.+.+.+..+++.||.|||   +++|+||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999997653  46999999999999999999999   99999999999999983  333  579999999


Q ss_pred             cccccCC
Q 046544          639 AKLLIGE  645 (646)
Q Consensus       639 a~~~~~~  645 (646)
                      ||.+.++
T Consensus       171 Arel~d~  177 (732)
T KOG4250|consen  171 ARELDDN  177 (732)
T ss_pred             cccCCCC
Confidence            9988664

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=1.3e-23  Score=217.22  Aligned_cols=141  Identities=27%  Similarity=0.370  Sum_probs=126.4

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999864 68999999997542   234467788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|..++.... .+++.++..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            9998886654 6889999999999999999999   889999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=1.2e-23  Score=221.09  Aligned_cols=154  Identities=25%  Similarity=0.311  Sum_probs=134.9

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecC
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE  560 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  560 (646)
                      .+.....++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455578999999999999999999865 68899999986432   22345577899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      +..|+||||++||+|.+++...  .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999998764  4788888899999999999999   8999999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       191 ~~~  193 (371)
T cd05622         191 KMN  193 (371)
T ss_pred             EcC
Confidence            653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=1.6e-23  Score=214.52  Aligned_cols=148  Identities=27%  Similarity=0.422  Sum_probs=131.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999965 689999999875432 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |++ +++.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+|+..
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            995 5888888776667888999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=2.5e-23  Score=215.07  Aligned_cols=141  Identities=26%  Similarity=0.350  Sum_probs=125.2

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999854 78999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|.+++...+ .+++..+..++.|++.|++|||   . .+|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            9998886554 6889999999999999999999   6 69999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=1.5e-23  Score=220.01  Aligned_cols=147  Identities=26%  Similarity=0.384  Sum_probs=131.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++..++||+|+++++.+..++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 68999999997432   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999987654 6888899999999999999999   899999999999999999999999999998765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-23  Score=215.22  Aligned_cols=139  Identities=29%  Similarity=0.328  Sum_probs=125.0

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 68899999987532   33446678899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            99987654 6889999999999999999999   899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.2e-24  Score=220.56  Aligned_cols=148  Identities=28%  Similarity=0.372  Sum_probs=131.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|...+++|+|.||+|+.+..+ +++.+|||++++..   .++.+..+.|.+++... +||.+++++..|++++++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            367899999999999999999865 68899999998764   45667888899888777 69999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+.||++..+.  +...+++..+.-+++.|+.||+|||   .++||+||||.+|||+|.+|++||+|||++|.-.
T Consensus       447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999954433  3346899999999999999999999   9999999999999999999999999999999754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=8.6e-24  Score=217.64  Aligned_cols=150  Identities=31%  Similarity=0.465  Sum_probs=134.7

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .+..|.+.+.||+|.|++|..|+.. +|..||||.+++..  ....+.+.+|+++|+.+.|||||+++.+.+++..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467889999999999999999864 79999999998664  23345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+.+|.+++|+...+.. .+..+..++.|+.+|++|+|   .+.|||||||++||+++.++++||+|||++.++.
T Consensus       134 ~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999887744 44888899999999999999   8999999999999999999999999999988764

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=1.7e-23  Score=219.95  Aligned_cols=148  Identities=26%  Similarity=0.334  Sum_probs=131.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            357889999999999999999865 68899999987432   22334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||++||+|.+++...  .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+++.+.
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998764  4778888899999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=7.9e-24  Score=207.64  Aligned_cols=148  Identities=27%  Similarity=0.394  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+.||+|.-|+||.++.+ +++.+|+|++.+..   .+...+...|.+|++.++||.++.+|+.++++++.|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45677889999999999999976 46899999998653   334567778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+||+|....+.+ +..+++..+.-++.+|+-||+|||   -.|||.|||||+||||.++|++-++||-++...
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999988655 457899999999999999999999   899999999999999999999999999998754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.90  E-value=2.2e-25  Score=208.90  Aligned_cols=147  Identities=27%  Similarity=0.380  Sum_probs=135.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      -|.+..++|+|+||.||+|.++ +|..||||.+...  .+.+++..|+.+|.+++.|++|++||.+.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3567789999999999999755 6999999988765  467889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .|+..+.++.++..+.+.+...+.+..++|++|||   ...-||||||+.|||++.+|.+|++|||+|-.+.+
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            99999999999889999999999999999999999   77789999999999999999999999999987653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=3e-23  Score=215.36  Aligned_cols=146  Identities=24%  Similarity=0.360  Sum_probs=129.2

Q ss_pred             CCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          493 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      +|+..+.||+|+||.||+++.    .+++.||+|++....    ....+.+.+|+.+++.+ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999975    358899999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999987654 5888999999999999999999   889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=2.9e-23  Score=215.23  Aligned_cols=148  Identities=26%  Similarity=0.308  Sum_probs=131.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....   ....+.+..|+.++..++|++|+++++++...+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 57889999986432   222345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++......+++..+..++.|++.|++|+|   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            999999999999876557889999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=215.40  Aligned_cols=150  Identities=28%  Similarity=0.404  Sum_probs=134.3

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~  564 (646)
                      ....|+..+.+|+|.||.||+++.+ +|+.+|+|++.+...   .+.+...+|+++|+++. |||||.+++++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457888899999999999999965 599999999986643   34468899999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC----CCcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD----NLVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~----~~~~ki~DfGla~  640 (646)
                      +|||+|.||.|.+.+...  .+++..+..+++|++.|+.|+|   ..+|+|||+||+|+|+..    ++.+|++|||+|+
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  3899999999999999999999   899999999999999953    3589999999999


Q ss_pred             cccC
Q 046544          641 LLIG  644 (646)
Q Consensus       641 ~~~~  644 (646)
                      ....
T Consensus       188 ~~~~  191 (382)
T KOG0032|consen  188 FIKP  191 (382)
T ss_pred             EccC
Confidence            8754

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.6e-23  Score=219.06  Aligned_cols=148  Identities=29%  Similarity=0.425  Sum_probs=133.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999965 68999999997542   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999776 46889999999999999999999   8999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.90  E-value=1.5e-23  Score=220.69  Aligned_cols=150  Identities=26%  Similarity=0.412  Sum_probs=130.0

Q ss_pred             hCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      .++|+..+.||+|+||.||+|++      .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35688899999999999999963      246689999987443 23446788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------------------------------------------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------------------------------------------------  583 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  583 (646)
                      .++|||||++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          584 ---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       584 ---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                                     ..+++..+..++.||+.|++|||   .++|+||||||+||++++++.+||+|||+|+.+.
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                           14677888999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=2.8e-23  Score=208.46  Aligned_cols=147  Identities=22%  Similarity=0.399  Sum_probs=131.5

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+..+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999753    366899999876533 3345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |||+++|+|.+++......+++.++..++.|++.|++|||   .++++||||||+||+++.++.+|++|||.+..
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999876667899999999999999999999   88999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=3.1e-23  Score=214.23  Aligned_cols=141  Identities=28%  Similarity=0.422  Sum_probs=124.7

Q ss_pred             eeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +.||+|+||.||+++.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    357899999987532    23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999987654 5778888889999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=3.4e-23  Score=206.56  Aligned_cols=147  Identities=27%  Similarity=0.420  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|+++++..+|+|.+.... ...+++.+|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577889999999999999998888889999876432 334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+|.+++......+++..+..++.|++.|++|+|   .++|+|||+||+||++++++.+|++|||.++..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            99999999765556889999999999999999999   889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=1e-23  Score=226.47  Aligned_cols=150  Identities=31%  Similarity=0.431  Sum_probs=129.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCC-cEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEE-EecC------Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISS-CSNE------EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~-~~~~------~~  562 (646)
                      .++++.+.|.+|||+.||.|+...+ .+||+|++-..++.+.+...+||++|+.++ |+|||.+++. ...+      -+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4567789999999999999997654 999999987777778889999999999996 9999999993 3221      24


Q ss_pred             eEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          563 KALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..+.||||+||.|-+++..+ ...+.+.++++|+.++++|+++||.. ..+|||||||.||||+..++..|+||||.|..
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            67999999999999999743 23489999999999999999999944 67899999999999999999999999998864


Q ss_pred             c
Q 046544          642 L  642 (646)
Q Consensus       642 ~  642 (646)
                      .
T Consensus       196 ~  196 (738)
T KOG1989|consen  196 K  196 (738)
T ss_pred             c
Confidence            3

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=4.5e-23  Score=212.61  Aligned_cols=142  Identities=28%  Similarity=0.392  Sum_probs=125.9

Q ss_pred             eeecccccceEEEEEe----CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      +.||+|+||.||+++.    .+|+.||+|++....  ......+.+|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    358899999997543  2233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            999999986543 6889999999999999999999   8899999999999999999999999999988653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3e-24  Score=218.79  Aligned_cols=156  Identities=28%  Similarity=0.484  Sum_probs=137.6

Q ss_pred             HHHHHhCCCCcceeecccccceEEEEEeCC-CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          486 ELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       486 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      +++-...+....+++|-|.||.||.|.|+. ...||||.++.+ ....++|+.|+.+|+.++|||+|+++|+|..+...|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333334556778999999999999999864 677999998754 345689999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+|||.+|+|.+|+++.++ .++.-..+.|+.||..||+||.   .+.+||||+.++|+|+.++..|||+|||++|++.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999998753 4555667889999999999999   8999999999999999999999999999999998


Q ss_pred             CC
Q 046544          644 GE  645 (646)
Q Consensus       644 ~~  645 (646)
                      +|
T Consensus       417 gD  418 (1157)
T KOG4278|consen  417 GD  418 (1157)
T ss_pred             CC
Confidence            76

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=5.4e-23  Score=205.14  Aligned_cols=148  Identities=26%  Similarity=0.432  Sum_probs=132.9

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||.|++.++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577889999999999999998777789999887433 334678899999999999999999999998889999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++......+++.++..++.|++.|++|||   ..+++|+||||+||++++++.+||+|||.++...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999775557899999999999999999999   8899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=5.5e-23  Score=212.84  Aligned_cols=140  Identities=26%  Similarity=0.315  Sum_probs=125.1

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..+++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999865 68999999998542   23345678899999988 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            99998886553 6899999999999999999999   89999999999999999999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=6.3e-23  Score=212.04  Aligned_cols=145  Identities=24%  Similarity=0.282  Sum_probs=127.4

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCC-CceeEEEEEecCCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHR-NLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~-niv~~~~~~~~~~~~~lv~  567 (646)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+++++.++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999865 57899999987542   23456778899999999765 6888999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+++.
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999987654 5788999999999999999999   88999999999999999999999999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=6.6e-23  Score=212.55  Aligned_cols=148  Identities=22%  Similarity=0.325  Sum_probs=132.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367899999999999999999865 688899998876532 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++|+|.+++...+ .+++..+..++.|++.|+.|||   . .+|+||||||+||++++++.+||+|||+++.+
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999997654 5788888999999999999999   5 47999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=7.9e-23  Score=211.89  Aligned_cols=148  Identities=22%  Similarity=0.319  Sum_probs=132.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67899999999999999999865 688999999876533 3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++.... .+++..+..++.|++.|+.|+|   +. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999997654 5788899999999999999999   54 69999999999999999999999999987653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=6.8e-23  Score=212.04  Aligned_cols=141  Identities=28%  Similarity=0.319  Sum_probs=124.6

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 68899999998542   23345677888888776 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|..++.... .+++..+..++.|++.|++|+|   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99998886654 6889999999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=5.4e-23  Score=211.82  Aligned_cols=148  Identities=28%  Similarity=0.437  Sum_probs=130.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|++. +|+    .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56889999999999999999853 333    48999987543 33456788999999999999999999998765 5779


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||+++|+|.+++......+++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|+.+.
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999999877667888899999999999999999   8899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=8.5e-23  Score=207.05  Aligned_cols=149  Identities=32%  Similarity=0.482  Sum_probs=132.4

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  564 (646)
                      .+|+..+.||+|+||.||+|..     .+++.||+|.+........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788889999999999999974     25789999998766555567889999999999999999999987543  4689


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+++.+.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999999776667899999999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=6.1e-23  Score=211.86  Aligned_cols=141  Identities=28%  Similarity=0.336  Sum_probs=124.2

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999865 58899999987542   23345677888888866 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|..++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999887654 6788899999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=6.3e-23  Score=211.11  Aligned_cols=141  Identities=28%  Similarity=0.366  Sum_probs=122.7

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHh-CCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.. .+||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999864 68899999997542   2334455667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999987654 6888899999999999999999   889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.89  E-value=7.9e-23  Score=215.99  Aligned_cols=151  Identities=26%  Similarity=0.442  Sum_probs=129.8

Q ss_pred             HhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCC-CCCceeEEEEEecCC
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEE  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~  561 (646)
                      ..++|++.+.||+|+||.||+|+..      .+..||||++..... ...+.+.+|+++++.+. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3468899999999999999999752      235799999875432 33467899999999996 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC----------------------------------------------------------
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN----------------------------------------------------------  583 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  583 (646)
                      ..|+|||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          584 -------------------------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       584 -------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                                                           ..+++..+..++.|+++|++|||   ..+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13667778899999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      +++.+|++|||+++.+.
T Consensus       272 ~~~~~kL~DfGla~~~~  288 (400)
T cd05105         272 QGKIVKICDFGLARDIM  288 (400)
T ss_pred             CCCEEEEEeCCcceecc
Confidence            99999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.89  E-value=4e-23  Score=217.33  Aligned_cols=149  Identities=26%  Similarity=0.445  Sum_probs=129.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      .++|+..+.||+|+||.||+|++.      +++.||+|+++... ....+.+.+|+++++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357889999999999999998742      34579999987543 23345788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------------------------------------------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------------------------------------------------  583 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  583 (646)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          584 ----------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       584 ----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                                ..+++..+.+++.|++.|++|||   +++|+||||||+||++++++.+||+|||+|+.+
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~  262 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDI  262 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence                      13677888999999999999999   889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=214.95  Aligned_cols=150  Identities=29%  Similarity=0.510  Sum_probs=133.2

Q ss_pred             CCCCcceeecccccceEEEEEeC---CC--cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG---DG--MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +..+..+.||+|-||.||+|...   .|  -.||||..+.++ ....+.|..|+.+|+.++|||||++.|+|.+. ..|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            34455688999999999999743   23  358999887754 34567899999999999999999999999765 6899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      |||.++-|.|..|++.....++......++.||+.|++|||   +.++|||||.++|||+.+...||++|||++|.+.++
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999999988888999999999999999999999   899999999999999999999999999999998765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=7.7e-23  Score=221.96  Aligned_cols=148  Identities=22%  Similarity=0.312  Sum_probs=131.0

Q ss_pred             CCCcceeecccccceEEEEEeC-C-CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .|...+.+|+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||++++++...+..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999754 4 6789999876555555566788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++...   ...+++.++..++.|++.||.|+|   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999887642   346788899999999999999999   8899999999999999999999999999998754

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.89  E-value=6.5e-23  Score=211.93  Aligned_cols=144  Identities=28%  Similarity=0.383  Sum_probs=125.1

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHH---HhCCCCCceeEEEEEecCCeeEEE
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMM---KSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      |+..+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999864 68999999997542   22345566676655   567899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++|+|..++..  ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999988754  35899999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=9.1e-23  Score=210.73  Aligned_cols=141  Identities=33%  Similarity=0.427  Sum_probs=122.0

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHH-HHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||+||+|+.. +|+.||+|++....   ....+.+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999965 68999999987542   222344555554 46789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|..++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999887654 6788899999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.89  E-value=1.1e-23  Score=195.28  Aligned_cols=150  Identities=30%  Similarity=0.467  Sum_probs=131.9

Q ss_pred             HhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC--------chHHHHHHHHHHHHhC-CCCCceeEEEEEec
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--------RAFKSFAVECEMMKSI-RHRNLIKVISSCSN  559 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  559 (646)
                      .-+.|...+.+|.|..+.|.++.. .+|+++|+|++.....        .-.++..+|+.+++++ .||+|+++.+++++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345678889999999999988864 5788999998864321        1234667899999997 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      +...++|+|.|+.|.|.+++...- .+++.+..+|++|+.+|+.|+|   +..|||||+||+|||+|+++++||+|||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence            999999999999999999997654 6899999999999999999999   999999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      ..+.
T Consensus       171 ~~l~  174 (411)
T KOG0599|consen  171 CQLE  174 (411)
T ss_pred             eccC
Confidence            8774

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.89  E-value=7e-23  Score=208.00  Aligned_cols=148  Identities=25%  Similarity=0.361  Sum_probs=129.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999975 68899999987543  2334677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++.+..+. .....+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99987666544 33446888999999999999999999   8899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=1e-22  Score=210.50  Aligned_cols=141  Identities=32%  Similarity=0.419  Sum_probs=122.0

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHH-HHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||+||+|+.. +|+.||+|++....   ....+.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999864 68999999987542   223345555655 46779999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|..++.... .+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+++..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99998886543 6889999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.89  E-value=1e-22  Score=209.10  Aligned_cols=147  Identities=25%  Similarity=0.430  Sum_probs=130.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999865 688899999875432 2334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++ ++.+++...+..+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence            975 898888776667888999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=9.1e-23  Score=203.50  Aligned_cols=147  Identities=29%  Similarity=0.448  Sum_probs=132.2

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +|+..+.||+|+||.||+|+++++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4778899999999999999987778899998864332 335688899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|.+++......+++..+..++.|++.|++|+|   ..+++|||+||+||++++++.+||+|||+++...
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999999876557889999999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=9.8e-23  Score=210.37  Aligned_cols=141  Identities=33%  Similarity=0.412  Sum_probs=121.4

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHH-HHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 68899999987542   222344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|..++.... .+++..+..++.||+.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99998886543 5788888999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=1.1e-22  Score=210.12  Aligned_cols=146  Identities=24%  Similarity=0.278  Sum_probs=127.4

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +|+..+.||+|+||+||+|+.. +|+.||+|++....   ....+.+..|..+++.+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667899999999999999864 68999999987542   233456778888888885 577888999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            9999999999987654 6889999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.89  E-value=1.3e-22  Score=203.54  Aligned_cols=149  Identities=28%  Similarity=0.495  Sum_probs=133.5

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|++.    +...||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999864    245799998875433 3446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++......+++..+.+++.|++.|++|||   .++|+||||||+||++++++.+|++|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999876667899999999999999999999   8899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.2e-22  Score=205.97  Aligned_cols=147  Identities=25%  Similarity=0.373  Sum_probs=129.7

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999864 68999999987542   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++|+|.+++... ...+++..+..++.|++.|++|+|   ..+|+||||||+||++++++.++|+|||+++.+
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999888654 346889999999999999999999   889999999999999999999999999998865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=9.8e-23  Score=210.09  Aligned_cols=141  Identities=30%  Similarity=0.365  Sum_probs=124.5

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 68899999987532   23445677888888876 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999887654 6889999999999999999999   899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=5.8e-23  Score=205.96  Aligned_cols=144  Identities=27%  Similarity=0.445  Sum_probs=124.4

Q ss_pred             ceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          497 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      .+++|+|.||.||-|+++ +|+.||||++++-.  .+...+..+|++|+..++||.||.+.-.|++.++.++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            478999999999999865 79999999997543  33446788999999999999999999999999999999999955 


Q ss_pred             CHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcccccC
Q 046544          574 SLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       574 ~L~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~~~~~  644 (646)
                      +..+++ ....+.+++....-+..||+.||.|||   .++|+|+|+||+|||+.+   .-.+|+||||+||++..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            666555 444567888888889999999999999   899999999999999953   45899999999998753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=197.80  Aligned_cols=150  Identities=26%  Similarity=0.406  Sum_probs=133.8

Q ss_pred             cHHHHHHHhCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecC
Q 046544          483 SYLELCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE  560 (646)
Q Consensus       483 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  560 (646)
                      +++|...-+.     +.+|+|+|+.|-.+. ..+|.+||||++.++......+..+|++++..+ .|+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            4566666553     679999999999987 678999999999988877888999999999999 599999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC---CcEEEEeec
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFG  637 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~---~~~ki~DfG  637 (646)
                      ...|+|||-|.||.|...+.++. .+.+.++.++.++|+.||.|||   .+||.|||+||+|||-.+.   .-+|||||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999998765 7889999999999999999999   9999999999999998643   358999998


Q ss_pred             Cccc
Q 046544          638 IAKL  641 (646)
Q Consensus       638 la~~  641 (646)
                      ++.-
T Consensus       225 LgSg  228 (463)
T KOG0607|consen  225 LGSG  228 (463)
T ss_pred             cccc
Confidence            7653

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=1.4e-22  Score=209.27  Aligned_cols=146  Identities=24%  Similarity=0.281  Sum_probs=127.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +|...+.||+|+||+||+|+.. +++.||+|++....   ....+.+..|..++... +|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 67899999987542   22334566788888777 6899999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+|+..
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            9999999999987654 5788999999999999999999   889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=6.6e-25  Score=200.28  Aligned_cols=149  Identities=26%  Similarity=0.466  Sum_probs=130.7

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+.|+..+.||+|.|+.||++.. .+|+.+|+|++..+  +..+.+.+.+|++|-+.++|||||++.+.+...+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35788889999999999999864 47999999988644  3456788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~  643 (646)
                      |+|.|++|..-+-.. ...++..+..+++||++|+.|+|   .++|||||+||+|+++.   ....+|++|||+|..+.
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999997666443 36788889999999999999999   99999999999999995   34579999999999875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.89  E-value=1.3e-22  Score=205.28  Aligned_cols=140  Identities=28%  Similarity=0.396  Sum_probs=123.5

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||+||+|+.. +|+.||+|.+....   ....+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 68999999987542   12335677899999999999999999999999999999999999999


Q ss_pred             HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++..   ....+++..+..++.|++.|++|+|   +++|+||||||+||++++++.+||+|||+++.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  147 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL  147 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence            988753   2346889999999999999999999   889999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.89  E-value=5.2e-23  Score=215.30  Aligned_cols=143  Identities=27%  Similarity=0.420  Sum_probs=125.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4566788999999999999865 689999999875433 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|....     ..++.....++.|++.||+|||   ..+|+||||||+||++++++.+||+|||+++.+.
T Consensus       155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999986532     3456778889999999999999   8899999999999999999999999999998653

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=1.4e-22  Score=226.10  Aligned_cols=148  Identities=28%  Similarity=0.358  Sum_probs=130.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..++||+|+||.||+|+.. +|+.||+|++....   ....+++.+|++++++++||||+++++++...+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999865 68999999987542   223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          568 EYKPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       568 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      ||++||+|.+++...          ....++..+.+++.|+++|++|+|   .++|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123456678899999999999999   8899999999999999999999999999


Q ss_pred             Ccccc
Q 046544          638 IAKLL  642 (646)
Q Consensus       638 la~~~  642 (646)
                      +|+..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99876

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=1.7e-22  Score=207.91  Aligned_cols=140  Identities=26%  Similarity=0.386  Sum_probs=123.0

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHh-CCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999965 58899999997542   2334556678888876 4999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|.+++.... .+++.++..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            99999987643 5788899999999999999999   88999999999999999999999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=1.1e-22  Score=211.57  Aligned_cols=145  Identities=24%  Similarity=0.376  Sum_probs=126.0

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----CeeE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~~  564 (646)
                      +|+..+.||+|+||.||+|+.. +|+.||||++....  .....++.+|+++++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999864 68999999987432  23345688999999999999999999988643     2479


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68999887654 5889999999999999999999   889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA02988 hypothetical protein; Provisional

Probab=99.89  E-value=2.3e-22  Score=203.50  Aligned_cols=142  Identities=22%  Similarity=0.263  Sum_probs=124.7

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCch---HHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeEEEEEe
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEY  569 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~  569 (646)
                      ...||+|++|.||+|.+ +|+.||||+++......   .+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 68899999987543222   4678899999999999999999999876    3568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++...+ .+++....+++.|++.|+.|+|   . .+++||||||+||++++++.+||+|||+++.+.
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999997654 6788899999999999999999   5 478899999999999999999999999998643

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=2.1e-22  Score=202.25  Aligned_cols=147  Identities=31%  Similarity=0.433  Sum_probs=133.3

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4688999999999999999986 478899999997665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++.... .+++..+..++.|++.|++|+|   ..+|+|||+||+||++++++.+||+|||+++.+
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            9999999886543 6789999999999999999999   889999999999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=1.2e-22  Score=208.92  Aligned_cols=140  Identities=26%  Similarity=0.395  Sum_probs=123.0

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ....+....|..++... +||+|+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 68999999997542   23345567788887754 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++.
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            99999987653 6788899999999999999999   88999999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=2e-22  Score=201.67  Aligned_cols=149  Identities=32%  Similarity=0.478  Sum_probs=133.8

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688889999999999999998778889999987543 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++.... ..+++.....++.|++.|+.|+|   .++|+||||||+||++++++.+||+|||+++.+.
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            9999999997643 46889999999999999999999   8899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.5e-22  Score=213.81  Aligned_cols=140  Identities=26%  Similarity=0.359  Sum_probs=125.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|+.. +++.||+|...      .+.+.+|++++++++||||+++++++......++|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999864 68999999643      235678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      . ++|.+++.... .+++.++..++.|++.||+|+|   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            5 68988886654 5789999999999999999999   889999999999999999999999999999753

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=1.9e-22  Score=208.56  Aligned_cols=141  Identities=31%  Similarity=0.397  Sum_probs=120.4

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHH-HHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999865 67889999987532   122234444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|.+++.... .+++..+..++.|+++||+|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999987654 5778888889999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.89  E-value=1.9e-22  Score=202.55  Aligned_cols=149  Identities=28%  Similarity=0.494  Sum_probs=131.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-C---CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .+|+..+.||+|+||.||+|+.. +   +..||+|.++... ....+.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853 2   3479999886543 23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++......+++.+...++.|++.|++|+|   +.+++|||+||+||+++.++.+|++|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.3e-22  Score=205.22  Aligned_cols=148  Identities=26%  Similarity=0.397  Sum_probs=136.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            56888999999999999999864 68999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++...+..+++..+..++.|++.|++|+|   ..+|+|||+||+||+++.++.++|+|||++...
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999876667899999999999999999999   889999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=2e-22  Score=208.48  Aligned_cols=140  Identities=27%  Similarity=0.320  Sum_probs=124.7

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 68899999998542   23345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            99998886554 6899999999999999999999   88999999999999999999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.89  E-value=1.9e-22  Score=226.53  Aligned_cols=148  Identities=29%  Similarity=0.398  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67889999999999999999975 68999999987543   223467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++|++|.+++...+ .+++..+..++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            9999999999987654 5788889999999999999999   8899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.89  E-value=1.6e-22  Score=201.96  Aligned_cols=144  Identities=40%  Similarity=0.623  Sum_probs=126.1

Q ss_pred             cceeecccccceEEEEEeC-----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          496 ENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..+.||+|+||.||+|.+.     .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999865     357899999965433 3467899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++... ...+++..+..|+.|+++||+|||   +.+++|++|+++||++++++.+||+|||+++..
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999999887 567899999999999999999999   789999999999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=8.2e-23  Score=204.39  Aligned_cols=149  Identities=29%  Similarity=0.501  Sum_probs=135.6

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ..+|+..+.||+|+||.||+|...+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            35688889999999999999998889999999988765555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|+|.+++... +..+++.....++.|++.|++|||   ..+|+||||||+||++++++.+||+|||.++.+
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999764 345789999999999999999999   889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=3.5e-23  Score=217.59  Aligned_cols=149  Identities=30%  Similarity=0.472  Sum_probs=133.3

Q ss_pred             CCcceeecccccceEEEEEe-CCC----cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          494 FSENNLIGRGGFGSVYKARL-GDG----MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ....++||+|+||.||+|.| ..|    .+||+|++.... .+..+++..|+-+|.+++|||+++++++|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            45568899999999999975 333    468999887553 455678999999999999999999999998876 77999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCCC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED  646 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~~  646 (646)
                      +|+++|+|.+|++.++..+.....+.+..|||+||.|||   .+++|||||.++||||.....+||+|||+|+.+..|+
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999999888888999999999999999999   8999999999999999999999999999999987653

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=2.8e-22  Score=199.43  Aligned_cols=142  Identities=29%  Similarity=0.478  Sum_probs=127.3

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      +.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999864 789999998764432 3346788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+|++|||+++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccc
Confidence            9999776656889999999999999999999   889999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.89  E-value=1.2e-23  Score=198.47  Aligned_cols=149  Identities=27%  Similarity=0.379  Sum_probs=127.4

Q ss_pred             CCCCcceeecccccceEEEEEeC---C--CcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEec-CCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG---D--GMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~  563 (646)
                      ..|+....||+|.||.||+|...   +  .+.+|+|.++...+  .......+|+..++.++|||++.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            56888899999999999999532   2  34789998875532  223567899999999999999999999887 7889


Q ss_pred             EEEEEecCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC----CcEEEEe
Q 046544          564 ALVLEYKPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN----LVAYLSD  635 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~----~~~ki~D  635 (646)
                      ++++||.+. +|.+.++-++    ..++...+..|+.||+.|+.|||   ++=|+|||+||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999988 9999987543    46888889999999999999999   8889999999999999766    9999999


Q ss_pred             ecCcccccC
Q 046544          636 FGIAKLLIG  644 (646)
Q Consensus       636 fGla~~~~~  644 (646)
                      ||+||.+.+
T Consensus       180 lGlaR~~~~  188 (438)
T KOG0666|consen  180 LGLARLFNN  188 (438)
T ss_pred             ccHHHHhhc
Confidence            999998754

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=4.6e-23  Score=228.81  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=135.3

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      .+.+.|++++++++. +|..+.  +.|+.|+|++|+|+..+..+    .++|++|++++|+|+ .+|..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~LtsLP~~l----~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKSLPENL----QGNIKTLYANSNQLT-SIPATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCcCChhh----ccCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence            456778888888874 444442  46788888888887644332    247788888888877 4454443  3677788


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEe
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      |++|.+..+ |..+.  .+|+.|+|++|+|+.+|..+        .++|+.|++++|+++.++..     ++.+|+.|++
T Consensus       248 Ls~N~L~~L-P~~l~--s~L~~L~Ls~N~L~~LP~~l--------~~sL~~L~Ls~N~Lt~LP~~-----lp~sL~~L~L  311 (754)
T PRK15370        248 LSINRITEL-PERLP--SALQSLDLFHNKISCLPENL--------PEELRYLSVYDNSIRTLPAH-----LPSGITHLNV  311 (754)
T ss_pred             CcCCccCcC-ChhHh--CCCCEEECcCCccCcccccc--------CCCCcEEECCCCccccCccc-----chhhHHHHHh
Confidence            888877743 44443  46777788777777655432        14677777777777665321     1234555555


Q ss_pred             ecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       170 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                      ++|.++.. |..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+.                  
T Consensus       312 s~N~Lt~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp------------------  366 (754)
T PRK15370        312 QSNSLTAL-PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP------------------  366 (754)
T ss_pred             cCCccccC-Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc------------------
Confidence            55555532 22221  345555555555543 222221  34444445444444 2333321                  


Q ss_pred             CCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCc----cCccccceEEEccccccc
Q 046544          250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE----IGNLKVLIGIDFSMNNFS  318 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~ls~N~l~  318 (646)
                              ++|+.|++++|.|+.+|..+.  ..|+.|++++|++.+ +|..    +..++.+..+++.+|.++
T Consensus       367 --------~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        367 --------PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             --------CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence                    345555555555555544332  234555555555542 2222    223355566666666655

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.88  E-value=2e-22  Score=212.90  Aligned_cols=149  Identities=25%  Similarity=0.435  Sum_probs=128.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~  562 (646)
                      .++|...+.||+|+||.||+|+++      .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++..++.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            346788899999999999999853      346899999975432 33457889999999997 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------------------------------------------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------------------------------------------------  583 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  583 (646)
                      .++||||+++|+|.+++...+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999986431                                                           


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          584 --------------------------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       584 --------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                                                            ..+++.....++.|++.|++|||   .++|+||||||+||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence                                                  13566677889999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccc
Q 046544          626 DDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~  642 (646)
                      ++++.+|++|||+++.+
T Consensus       273 ~~~~~~kL~DfGla~~~  289 (401)
T cd05107         273 CEGKLVKICDFGLARDI  289 (401)
T ss_pred             eCCCEEEEEecCcceec
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=3.4e-22  Score=202.68  Aligned_cols=149  Identities=27%  Similarity=0.500  Sum_probs=130.7

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  563 (646)
                      ..|+..+.||+|+||.||+|+.     .+++.||+|.++... ....+.+.+|+++++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3468889999999999999974     357889999987553 33446788999999999999999999998875  568


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||++|++|.+++......+++.++..++.|++.|++|+|   +++++||||||+||+++.++.+|++|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999999766556899999999999999999999   8999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.88  E-value=3.8e-22  Score=202.20  Aligned_cols=148  Identities=26%  Similarity=0.461  Sum_probs=128.8

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|+.     .+++.||+|.+..... ...+.+.+|++++++++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999974     2467899999875432 334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC
Q 046544          566 VLEYKPHGSLEKYLYSSN----------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      ||||+++|+|.+++....                ..+++.+...++.|++.|++|+|   .++++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678888999999999999999   88999999999999999999


Q ss_pred             cEEEEeecCcccc
Q 046544          630 VAYLSDFGIAKLL  642 (646)
Q Consensus       630 ~~ki~DfGla~~~  642 (646)
                      .+|++|||+++.+
T Consensus       162 ~~kl~dfg~~~~~  174 (283)
T cd05090         162 HVKISDLGLSREI  174 (283)
T ss_pred             cEEeccccccccc
Confidence            9999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=3.3e-22  Score=206.01  Aligned_cols=140  Identities=28%  Similarity=0.352  Sum_probs=124.5

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 58899999997542   23345677888998887 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|..++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            99999887654 6889999999999999999999   89999999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.88  E-value=5.2e-22  Score=203.69  Aligned_cols=147  Identities=22%  Similarity=0.304  Sum_probs=131.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.. ++..||+|.+..... ....++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 688899998875533 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++...+ .+++..+..++.|+++|+.|||   + .+++||||||+||++++++.+|++|||+++.+
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            99999999997653 6788899999999999999999   5 58999999999999999999999999998765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.88  E-value=5.3e-22  Score=202.10  Aligned_cols=148  Identities=28%  Similarity=0.397  Sum_probs=135.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999865 58999999998766666678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++..++.+....+++..+..++.|++.|++|+|   ..+++|||+||+||+++.++.+||+|||+++..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999888766667899999999999999999999   889999999999999999999999999988653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=2.7e-22  Score=202.18  Aligned_cols=141  Identities=24%  Similarity=0.339  Sum_probs=121.1

Q ss_pred             eecccccceEEEEEeCC-------------------------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeE
Q 046544          499 LIGRGGFGSVYKARLGD-------------------------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV  553 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~  553 (646)
                      .||+|+||.||+|....                         ...||+|++.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13488888865544445678889999999999999999


Q ss_pred             EEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----
Q 046544          554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----  629 (646)
Q Consensus       554 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----  629 (646)
                      ++++......++||||+++|+|..++......+++..+..++.|+++|++|+|   .++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998776667899999999999999999999   88999999999999997543    


Q ss_pred             ---cEEEEeecCcccc
Q 046544          630 ---VAYLSDFGIAKLL  642 (646)
Q Consensus       630 ---~~ki~DfGla~~~  642 (646)
                         .+|++|||+++..
T Consensus       159 ~~~~~kl~d~g~~~~~  174 (274)
T cd05076         159 TSPFIKLSDPGVSFTA  174 (274)
T ss_pred             ccceeeecCCcccccc
Confidence               4899999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.88  E-value=4e-22  Score=199.45  Aligned_cols=148  Identities=26%  Similarity=0.475  Sum_probs=132.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5688899999999999999998888899999876433 235678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++... ....++..+..++.|++.|++|||   ..+++||||||+||++++++.+|++|||+++...
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence            99999998654 346788888999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-23  Score=209.33  Aligned_cols=137  Identities=28%  Similarity=0.456  Sum_probs=121.0

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      ...+-+|+|+.|.||.|++ .++.||||.++.-       -..+|+-+++++||||+.+.|+|....-+|||||||+.|-
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3456699999999999998 4678999976522       1357889999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          575 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       575 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+..++..+ .+.....+.+.++||.||.|||   .+.|||||||+-||||..+..|||+|||-++.+.
T Consensus       199 L~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  199 LYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             HHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            999998765 5666778899999999999999   8899999999999999999999999999887653

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.88  E-value=4.3e-22  Score=200.17  Aligned_cols=148  Identities=26%  Similarity=0.510  Sum_probs=131.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CC---cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ..|+..+.||+|+||.||+|+.. ++   ..||+|++.... ....++|..|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34778899999999999999864 33   369999987542 33456899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++|+|.+++......+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||+++.+
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999876667899999999999999999999   889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=6.9e-22  Score=200.45  Aligned_cols=146  Identities=24%  Similarity=0.357  Sum_probs=128.7

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      |+..+.||+|+||+||+|+.. +++.||+|.+....   ....+.+.+|+++++.++|++|+.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999864 68999999987542   22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++.... ..+++..+..++.|++.|+.|+|   .++|+||||||+||++++++.+||+|||+++..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            99999998886543 36899999999999999999999   889999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.88  E-value=5.6e-22  Score=200.80  Aligned_cols=146  Identities=27%  Similarity=0.405  Sum_probs=132.2

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      |+..+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999865 5788999998766555667888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++..++......+++..+..++.|+++|+.|||   ..+++||||||+||+++.++.+|++|||+++..
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            9999988765567899999999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=7.9e-22  Score=199.13  Aligned_cols=141  Identities=25%  Similarity=0.380  Sum_probs=122.9

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||.||+++.+ +|+.||+|++....   ....+.+..|++++++++||||+++++++..+...++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 68999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          576 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       576 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      .+++.... ..+++..+..++.|++.|++|+|   ..+|+||||||+||++++++.++|+|||++..+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            98886543 35788888999999999999999   8999999999999999999999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=4.7e-22  Score=202.02  Aligned_cols=148  Identities=30%  Similarity=0.510  Sum_probs=131.5

Q ss_pred             CCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|...+.+|+|+||.||++..      .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4678889999999999999974      2345689998876655556788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          566 VLEYKPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                      ||||+++++|.+++....            ..+++..+..++.|++.|++|+|   .++++||||||+||++++++.+|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999987543            24889999999999999999999   889999999999999999999999


Q ss_pred             EeecCcccc
Q 046544          634 SDFGIAKLL  642 (646)
Q Consensus       634 ~DfGla~~~  642 (646)
                      +|||+++.+
T Consensus       162 ~dfg~~~~~  170 (288)
T cd05093         162 GDFGMSRDV  170 (288)
T ss_pred             ccCCccccc
Confidence            999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-23  Score=212.10  Aligned_cols=146  Identities=30%  Similarity=0.394  Sum_probs=130.9

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||.|+||.||-|+. ++.+.||||.+....+   ....++..|+..+.+++|||++.+.|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            477788999999999999985 5788899998865432   334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||-| +-.+++.-++.++.+.++..|+.+.+.||+|||   +.+.||||||+.|||+.+.|.||++|||.|...
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            9955 889998878788999999999999999999999   889999999999999999999999999998765

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=7e-22  Score=196.28  Aligned_cols=142  Identities=31%  Similarity=0.499  Sum_probs=127.9

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHH
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLE  576 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~  576 (646)
                      +.||+|+||.||+|...++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999998875543 23346889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          577 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       577 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++......+++.....++.|++.|+.|+|   .++++|||+||+||++++++.+|++|||+++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  143 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQE  143 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceec
Confidence            998776666889999999999999999999   889999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.88  E-value=5.1e-22  Score=199.63  Aligned_cols=142  Identities=29%  Similarity=0.394  Sum_probs=121.2

Q ss_pred             eeecccccceEEEEEeCC---CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLGD---GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||+||+|+..+   ...+|+|.+..... .....+.+|+++++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997433   45688887764432 33456888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNC----ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|.+++.....    ..++.....++.|++.|++|+|   +.+|+||||||+||++++++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccccc
Confidence            99999976532    2456778899999999999999   889999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=6.2e-22  Score=198.92  Aligned_cols=151  Identities=29%  Similarity=0.414  Sum_probs=132.6

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666688999999999999854 67889999988766556678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~  642 (646)
                      ||+++++|.+++......+  ++..+..++.|++.|++|||   .++|+|||+||+||+++. ++.+||+|||++..+
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999997654444  77888889999999999999   889999999999999976 679999999998764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.2e-22  Score=206.47  Aligned_cols=139  Identities=27%  Similarity=0.307  Sum_probs=120.2

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC---CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI---RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      ||+|+||.||+|+.. +|+.||+|++....   .........|..++...   +||+|+++++++...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 68999999987532   12233455677776655   799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|.+++...+ .+++..+..++.|+++|++|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999887654 6889999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=5.4e-22  Score=198.59  Aligned_cols=142  Identities=23%  Similarity=0.383  Sum_probs=123.4

Q ss_pred             eeecccccceEEEEEeCC-------------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          498 NLIGRGGFGSVYKARLGD-------------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      +.||+|+||.||+|+..+             ...||+|++........+.+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999997432             2358889877655455567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc-------EEEEeec
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV-------AYLSDFG  637 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~-------~ki~DfG  637 (646)
                      +||||+++|++..++......+++..+..++.|+++|++|+|   +++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998776667899999999999999999999   899999999999999986654       8999999


Q ss_pred             Ccccc
Q 046544          638 IAKLL  642 (646)
Q Consensus       638 la~~~  642 (646)
                      ++...
T Consensus       158 ~~~~~  162 (262)
T cd05077         158 IPITV  162 (262)
T ss_pred             CCccc
Confidence            98754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.88  E-value=7.7e-22  Score=196.91  Aligned_cols=140  Identities=29%  Similarity=0.477  Sum_probs=123.2

Q ss_pred             eecccccceEEEEEeC---CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          499 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .||+|+||.||+|.++   ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999754   356799999875543 334578899999999999999999998864 56899999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          575 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       575 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |.+++......+++..+.+++.|++.|++|+|   .++++||||||+||+++.++.+|++|||+++.+
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            99999766667899999999999999999999   889999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.88  E-value=6.6e-22  Score=202.32  Aligned_cols=147  Identities=27%  Similarity=0.433  Sum_probs=131.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999865 68899999987543 23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++ +++.+++......+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||+++..
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            97 5899998776667889999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.88  E-value=4.5e-22  Score=200.95  Aligned_cols=150  Identities=22%  Similarity=0.409  Sum_probs=129.4

Q ss_pred             HhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      ..++|+..+.||+|+||.||+|.+.      ++..||+|.+.... .....++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998743      35679999886432 2334568899999999999999999999999899


Q ss_pred             eEEEEEecCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          563 KALVLEYKPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|++|+|   ..+++||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         23567788899999999999999   889999999999999999999999


Q ss_pred             EeecCcccc
Q 046544          634 SDFGIAKLL  642 (646)
Q Consensus       634 ~DfGla~~~  642 (646)
                      +|||+|+.+
T Consensus       161 ~dfg~~~~~  169 (277)
T cd05062         161 GDFGMTRDI  169 (277)
T ss_pred             CCCCCcccc
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.88  E-value=7e-22  Score=201.61  Aligned_cols=146  Identities=30%  Similarity=0.405  Sum_probs=133.3

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6788999999999999999985 479999999998665555577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++...  .+++.++..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++..
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            999999998653  4788899999999999999999   889999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=4.6e-22  Score=212.66  Aligned_cols=143  Identities=24%  Similarity=0.316  Sum_probs=127.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..+|.+.+.||+|+||.||+|+.. +++.||||...      ...+.+|++++++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347899999999999999999865 58899999532      23456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +. ++|.+++......+++.++..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            95 6899988766567899999999999999999999   8899999999999999999999999999998653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=6.5e-22  Score=198.05  Aligned_cols=147  Identities=29%  Similarity=0.491  Sum_probs=129.0

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|...++||+|+||.||+|++.++..||+|.++.... ..+.+.+|++++++++||||+++++++. ++..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56889999999999999999987767799999875332 3467889999999999999999999874 456899999999


Q ss_pred             CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++... ...+++..+..++.|++.|++|+|   ..+++||||||+||++++++.+||+|||.++.+.
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            99999999764 345788999999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.88  E-value=3.9e-22  Score=200.26  Aligned_cols=147  Identities=31%  Similarity=0.422  Sum_probs=132.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999854 68899999988665555567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++...+ .+++.+...++.|++.|++|+|   ..+++|+||||+||+++.++.+||+|||++..+
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999987654 6889999999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=1.2e-22  Score=225.63  Aligned_cols=288  Identities=24%  Similarity=0.348  Sum_probs=181.5

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCC
Q 046544           60 NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLT  139 (646)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  139 (646)
                      +...|+++++.++ .+|..+  .++|+.|+|++|.|+.+ |..+.  .+|++|+|++|+|+.+|..+        .++|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~I--p~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~LtsLP~~l--------~~~L~  244 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACI--PEQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLTSIPATL--------PDTIQ  244 (754)
T ss_pred             CceEEEeCCCCcC-cCCccc--ccCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCccccCChhh--------hcccc
Confidence            3455555555555 233333  23455555555555533 22222  35566666666655544321        12455


Q ss_pred             EEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeec
Q 046544          140 FIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD  219 (646)
Q Consensus       140 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  219 (646)
                      .|+|++|.+..++..     +..+|+.|++++|+++. +|..+.  ++|+.|++++|++++. |..+.  ++|+.|++++
T Consensus       245 ~L~Ls~N~L~~LP~~-----l~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~  313 (754)
T PRK15370        245 EMELSINRITELPER-----LPSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQS  313 (754)
T ss_pred             EEECcCCccCcCChh-----HhCCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcC
Confidence            666666666544321     12356666666666663 344443  4788888888888754 33332  4688899999


Q ss_pred             ccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCC
Q 046544          220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPL  299 (646)
Q Consensus       220 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~  299 (646)
                      |+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+.+|..+.  ++|+.|++++|.++. +|.
T Consensus       314 N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~-LP~  384 (754)
T PRK15370        314 NSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTN-LPE  384 (754)
T ss_pred             Ccccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCC-CCH
Confidence            99984 454443  689999999999985 555543  799999999999999997663  689999999999985 555


Q ss_pred             ccCccccceEEEcccccccccCcc----ccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcc-cCCcccc
Q 046544          300 EIGNLKVLIGIDFSMNNFSSVIPT----EIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG-AIPTSLE  374 (646)
Q Consensus       300 ~~~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~  374 (646)
                      .+.  ..|+.|++++|++++. |.    .++.++++..|++.+|+++.      ..+.+|+.| ++.+.+.| .++..+.
T Consensus       385 ~l~--~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~  454 (754)
T PRK15370        385 NLP--AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMG  454 (754)
T ss_pred             hHH--HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccc
Confidence            443  3699999999999854 43    44556889999999999972      334455555 34444433 3444444


Q ss_pred             CCCCCCceeCcCCccee
Q 046544          375 KLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~  391 (646)
                      ..++++....-.+...+
T Consensus       455 ~~~~l~~~~~l~~a~~~  471 (754)
T PRK15370        455 DFSIVRVTRPLHQAVQG  471 (754)
T ss_pred             ccccccccchHHHHHhc
Confidence            55555544433444443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.88  E-value=4.1e-22  Score=210.08  Aligned_cols=145  Identities=27%  Similarity=0.367  Sum_probs=126.9

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-----eeE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-----FKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~  564 (646)
                      +|+..+.||+|+||.||+|+. .+|+.||+|.+....  ....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986 478999999886432  233467889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||+. +++.+++... ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 5888877554 36889999999999999999999   889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.6e-22  Score=202.82  Aligned_cols=140  Identities=23%  Similarity=0.235  Sum_probs=113.8

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC--CCcEEEEEEEecc-----CCchHHHHHHHHHHHHhCCCCCcee-EEEEEecC
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ-----CGRAFKSFAVECEMMKSIRHRNLIK-VISSCSNE  560 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~-~~~~~~~~  560 (646)
                      ....+|+..+.||+|+||+||+|++.  +++.||||+....     .....+.+.+|++++++++|+||+. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34468999999999999999999864  5777899986533     1223456889999999999999985 4432    


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEEcCCCcEEEEeecCc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL-KPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-k~~Nil~~~~~~~ki~DfGla  639 (646)
                      +..|+||||++|++|... ..    ..   ...++.++++|++|+|   +++|+|||| ||+||+++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999732 11    11   1467889999999999   899999999 999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       160 ~~~~  163 (365)
T PRK09188        160 SVFR  163 (365)
T ss_pred             eecc
Confidence            9764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.88  E-value=5e-22  Score=201.84  Aligned_cols=150  Identities=23%  Similarity=0.421  Sum_probs=128.4

Q ss_pred             HhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3467899999999999999999643      245799998764432 233467889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          563 KALVLEYKPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                      .++||||+++|+|.+++....         ...++.....++.|++.|+.|+|   +++|+||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532         23456678889999999999999   899999999999999999999999


Q ss_pred             EeecCcccc
Q 046544          634 SDFGIAKLL  642 (646)
Q Consensus       634 ~DfGla~~~  642 (646)
                      +|||+++.+
T Consensus       161 ~Dfg~~~~~  169 (288)
T cd05061         161 GDFGMTRDI  169 (288)
T ss_pred             CcCCccccc
Confidence            999998854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=1e-21  Score=199.82  Aligned_cols=148  Identities=28%  Similarity=0.415  Sum_probs=123.4

Q ss_pred             CCCCcceeecccccceEEEEEeC--CCcEEEEEEEeccC--CchHHHHHHHHHHHHhC---CCCCceeEEEEEec-----
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSI---RHRNLIKVISSCSN-----  559 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~-----  559 (646)
                      ++|+..+.||+|+||.||+|+..  +|+.||+|.++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  47889999987543  22234566787777665   69999999998852     


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                      ....++||||+. ++|.+++.... ..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            356899999996 58999886543 45788999999999999999999   88999999999999999999999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      |+...
T Consensus       157 ~~~~~  161 (290)
T cd07862         157 ARIYS  161 (290)
T ss_pred             eEecc
Confidence            97653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=1e-21  Score=195.83  Aligned_cols=146  Identities=34%  Similarity=0.548  Sum_probs=132.5

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            56888899999999999999874 78899999875543 45788999999999999999999999998899999999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|.+++.... ..+++.....++.|++.|+.|+|   ..+++||||||+||+++.++.+||+|||.++..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999997654 36889999999999999999999   899999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.88  E-value=5.9e-22  Score=200.39  Aligned_cols=148  Identities=31%  Similarity=0.512  Sum_probs=130.9

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      .+|...+.||+|+||.||+|+..      +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45778899999999999999753      3578999998765443 4568899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          565 LVLEYKPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      +||||+++|+|.+++...+             ..+++..+..++.|++.|++|+|   .++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997542             34678888999999999999999   8899999999999999999999


Q ss_pred             EEEeecCcccc
Q 046544          632 YLSDFGIAKLL  642 (646)
Q Consensus       632 ki~DfGla~~~  642 (646)
                      |++|||+++.+
T Consensus       162 kl~d~g~~~~~  172 (280)
T cd05049         162 KIGDFGMSRDV  172 (280)
T ss_pred             EECCcccceec
Confidence            99999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.6e-22  Score=202.20  Aligned_cols=148  Identities=24%  Similarity=0.460  Sum_probs=128.2

Q ss_pred             CCCCcceeecccccceEEEEEeCC---------------CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD---------------GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVIS  555 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~  555 (646)
                      ++|+..+.||+|+||.||+|+...               ...||+|.+..... .....+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987532               23589999875432 33457889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 046544          556 SCSNEEFKALVLEYKPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVL  624 (646)
Q Consensus       556 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil  624 (646)
                      ++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   ..+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986532           13678888999999999999999   889999999999999


Q ss_pred             EcCCCcEEEEeecCcccc
Q 046544          625 LDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       625 ~~~~~~~ki~DfGla~~~  642 (646)
                      +++++.+|++|||+++.+
T Consensus       162 l~~~~~~kl~dfg~~~~~  179 (295)
T cd05097         162 VGNHYTIKIADFGMSRNL  179 (295)
T ss_pred             EcCCCcEEeccccccccc
Confidence            999999999999998754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.6e-22  Score=216.01  Aligned_cols=152  Identities=26%  Similarity=0.361  Sum_probs=130.7

Q ss_pred             HHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC----
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----  561 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----  561 (646)
                      ...++|.+.+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.++..++|+||+++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3446899999999999999999985 479999999987543  334456788999999999999999988765432    


Q ss_pred             ----eeEEEEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          562 ----FKALVLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       562 ----~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                          ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|+|   .++|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                368999999999999998653   246888999999999999999999   8899999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+++.+.
T Consensus       186 DFGls~~~~  194 (496)
T PTZ00283        186 DFGFSKMYA  194 (496)
T ss_pred             ecccCeecc
Confidence            999998653

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.88  E-value=8.4e-22  Score=199.21  Aligned_cols=148  Identities=28%  Similarity=0.434  Sum_probs=129.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|++. +|+    .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            56888899999999999999853 444    48999887543 23356788899999999999999999998754 5789


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|||+++|++.+++......+++..+..++.|++.|++|+|   +++|+||||||+||++++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999999876667899999999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.88  E-value=8.2e-22  Score=199.24  Aligned_cols=148  Identities=28%  Similarity=0.451  Sum_probs=126.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|.+. +++    .|++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999864 444    477777754332 234567788889999999999999998754 45789


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||+++|+|.+++......+++..+..++.|++.|++|+|   .++++||||||+||++++++.+|++|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999877667899999999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=1e-21  Score=196.42  Aligned_cols=149  Identities=32%  Similarity=0.523  Sum_probs=134.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|.+.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            36788899999999999999998778889999987543 33467889999999999999999999999888999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++.... ..+++.++..++.|++.|++|+|   ..+++|+||||+||++++++.+|++|||+++.+.
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999997643 46889999999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=1.4e-21  Score=194.95  Aligned_cols=148  Identities=24%  Similarity=0.360  Sum_probs=132.5

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||.++. .+++.|++|.+....  ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578899999999999999985 468899999987543  34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++... ...+++..+..++.|++.|+.|+|   +.+++||||+|+||++++++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            9999999999765 346889999999999999999999   8899999999999999999999999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.87  E-value=1e-21  Score=199.82  Aligned_cols=148  Identities=31%  Similarity=0.403  Sum_probs=132.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999865 68999999987532   233467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++.... .+++..+..++.|++.|+.|+|   ..+++||||+|+||++++++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            9999999999987654 6888999999999999999999   8999999999999999999999999999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.87  E-value=1.3e-21  Score=198.49  Aligned_cols=146  Identities=24%  Similarity=0.372  Sum_probs=128.5

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      |+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+.+++.++|++|+.+++.+..++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999865 689999998875421   2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++.... ..+++..+..++.|++.|+.|+|   .++|+||||||+||++++++.++++|||++...
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            99999999886543 35888999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.87  E-value=1.3e-21  Score=195.08  Aligned_cols=148  Identities=28%  Similarity=0.365  Sum_probs=132.6

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|++|.||+|+.. +++.|++|.+...  .....+++.+|+++++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677899999999999999865 6899999998754  234556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++... ...+++..+..++.|++.|+.|+|   ..+++|||+||+||+++.++.+|++|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            9999999999765 456888899999999999999999   8899999999999999999999999999988653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=9.4e-22  Score=197.01  Aligned_cols=148  Identities=28%  Similarity=0.500  Sum_probs=131.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|.++ .++.||+|++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777899999999999999865 5889999988744 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++.... ..+++..+..++.|+++|++|+|   ..+++||||||+||++++++.+||+|||+++...
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999987543 45788899999999999999999   8899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.2e-22  Score=201.35  Aligned_cols=148  Identities=27%  Similarity=0.348  Sum_probs=132.7

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      -|...+.||+|-|+.|-.|++ -+|+.||||++++..  ......+.+|++.|+-++|||||++|++..+...+|+|.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            467778899999999999974 489999999998654  23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~  643 (646)
                      =.+|+|++|+-.+...+.+..+.+++.||+.|+.|+|   ...+||||+||+|+.+- .-|-||++|||++-.+.
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999988888999999999999999999999   77899999999999875 66899999999987653

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.87  E-value=1e-21  Score=200.64  Aligned_cols=147  Identities=29%  Similarity=0.440  Sum_probs=130.9

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc-----hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR-----AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      +|+..+.||+|+||.||+|... +|+.||+|.+......     ....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999865 6899999998755322     234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+ +|+|.+++......+++..+..++.|+++||+|||   .++|+|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 88999999765546899999999999999999999   8899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.87  E-value=9.8e-22  Score=197.44  Aligned_cols=149  Identities=27%  Similarity=0.518  Sum_probs=132.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CC---cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+.. ++   ..||+|.++... ....+.+..|++++++++||||+++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999864 33   379999886543 33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++......+++.++..++.|++.|++|+|   ..+++|||+||+||++++++.+|++|||+++...
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999876667899999999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.4e-21  Score=195.59  Aligned_cols=147  Identities=27%  Similarity=0.453  Sum_probs=131.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-----chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....     ...+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999854 689999999874421     223567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.++|+|||+++.+
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999987654 5788889999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.87  E-value=1.1e-21  Score=200.02  Aligned_cols=146  Identities=30%  Similarity=0.408  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.+|+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788889999999999999985 468899999998765555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++...  .+++.+...++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            999999998653  4788899999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=7e-22  Score=197.32  Aligned_cols=141  Identities=26%  Similarity=0.425  Sum_probs=122.7

Q ss_pred             eeecccccceEEEEEeCC-C----------cEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          498 NLIGRGGFGSVYKARLGD-G----------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      +.||+|+||.||+|.... +          ..|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998653 3          24778876544332 5788899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-------cEEEEeecCc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-------VAYLSDFGIA  639 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-------~~ki~DfGla  639 (646)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   .++|+||||||+||+++.++       .+|++|||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876557889999999999999999999   89999999999999999877       7999999998


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +...
T Consensus       156 ~~~~  159 (259)
T cd05037         156 ITVL  159 (259)
T ss_pred             cccc
Confidence            8743

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.87  E-value=9.7e-22  Score=200.57  Aligned_cols=148  Identities=24%  Similarity=0.440  Sum_probs=128.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-----------------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKV  553 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~  553 (646)
                      ++|+..+.||+|+||.||+++..                 ++..||+|++.... ....+++.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998532                 23468999987543 3345678899999999999999999


Q ss_pred             EEEEecCCeeEEEEEecCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 046544          554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNV  623 (646)
Q Consensus       554 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni  623 (646)
                      ++++...+..++||||+++|+|.+++....          ..+++.+...++.|++.|++|+|   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987542          23667789999999999999999   88999999999999


Q ss_pred             EEcCCCcEEEEeecCcccc
Q 046544          624 LLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       624 l~~~~~~~ki~DfGla~~~  642 (646)
                      ++++++.++++|||+++.+
T Consensus       162 li~~~~~~~l~dfg~~~~~  180 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             EEcCCCCEEeccCcccccc
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.87  E-value=6.3e-22  Score=206.18  Aligned_cols=148  Identities=27%  Similarity=0.473  Sum_probs=126.5

Q ss_pred             CCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecC-Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE-EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-~~  562 (646)
                      ++|+..+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999973      347889999997543 23345788899999999 789999999988655 46


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------------------------------------------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------------------------------------------------  583 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  583 (646)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986431                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          584 -------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       584 -------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                             ..+++..+..++.|+++|++|+|   +++|+||||||+||+++.++.+|++|||+++.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence                   13567778899999999999999   899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.87  E-value=1.2e-21  Score=196.58  Aligned_cols=149  Identities=28%  Similarity=0.429  Sum_probs=131.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+++++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999854 78999999876432   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++..   ....+++..+..++.|++.|++|||   ..+++||||||+||+++.++.++++|||+++.+.
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999988753   2345788889999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.4e-21  Score=195.47  Aligned_cols=148  Identities=32%  Similarity=0.449  Sum_probs=135.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.+|+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++...+..|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999864 67889999998765556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++......+++.++..++.|++.|++|||   ..+++|+|++|+||++++++.+||+|||++..+
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhh
Confidence            999999998776557899999999999999999999   889999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=2.1e-21  Score=193.43  Aligned_cols=148  Identities=22%  Similarity=0.344  Sum_probs=131.6

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +|+..+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999865 68999999987543 344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|++.+++... ...+++.....++.|++.|+.|+|   .++|+|+||||+||++++++.++++|||.++...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            999999988653 345788899999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=1.3e-21  Score=196.23  Aligned_cols=146  Identities=27%  Similarity=0.503  Sum_probs=130.7

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      +|+..+.||+|+||+||+|...+|+.||+|.+.....      ...+.+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999988899999998875421      2235678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++++|.+++.... .+++..+..++.|++.|++|+|   ..+|+|+||+|+||++++++.+|++|||+++..
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            99999999999997654 5788889999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=1.3e-21  Score=195.61  Aligned_cols=147  Identities=31%  Similarity=0.500  Sum_probs=130.0

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|...++..||+|.+..... ..+++.+|+.++++++|++|+++++++. +...++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888899999999999999988888899999875433 3467889999999999999999999875 456899999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++|.+++.... ..+++.++..++.|++.|++|||   ..+|+||||||+||++++++.++++|||+++.+.
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            999999987643 45789999999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.87  E-value=8.2e-22  Score=200.77  Aligned_cols=150  Identities=31%  Similarity=0.513  Sum_probs=130.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      .++|+..+.||+|+||.||+|...      ....||+|.+.... .+....+.+|+++++++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356888899999999999999853      23679999887543 23445788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC
Q 046544          563 KALVLEYKPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD  627 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~  627 (646)
                      .+++|||+++|+|.+++...               ...+++..+..++.|++.|++|||   .++|+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998642               246788899999999999999999   899999999999999999


Q ss_pred             CCcEEEEeecCccccc
Q 046544          628 NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ~~~~ki~DfGla~~~~  643 (646)
                      ++.+|++|||+++.+.
T Consensus       168 ~~~~kL~Dfg~~~~~~  183 (293)
T cd05053         168 DHVMKIADFGLARDIH  183 (293)
T ss_pred             CCeEEeCccccccccc
Confidence            9999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.87  E-value=1.3e-21  Score=197.09  Aligned_cols=147  Identities=30%  Similarity=0.533  Sum_probs=123.5

Q ss_pred             CCcceeecccccceEEEEEeCC-Cc--EEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------Ce
Q 046544          494 FSENNLIGRGGFGSVYKARLGD-GM--EVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------EF  562 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~  562 (646)
                      |.+.+.||+|+||.||+|++.. +.  .||+|.++...  ....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999998654 33  68999887542  33456788999999999999999999987532      24


Q ss_pred             eEEEEEecCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          563 KALVLEYKPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      .+++|||+++|+|.+++...     ...+++.....++.|++.|++|+|   .++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432     235788899999999999999999   8899999999999999999999999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +|+.+.
T Consensus       158 ~~~~~~  163 (272)
T cd05075         158 LSKKIY  163 (272)
T ss_pred             cccccC
Confidence            998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.87  E-value=1e-21  Score=201.04  Aligned_cols=147  Identities=35%  Similarity=0.622  Sum_probs=127.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc--EEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+++ ++.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++..++..|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888899999999999999864 454  45777665432 23445788899999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          567 LEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      |||+++|+|.+++...+               ..+++.++..++.|++.|++|||   .++++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999997542               24788899999999999999999   8999999999999999999999


Q ss_pred             EEEeecCccc
Q 046544          632 YLSDFGIAKL  641 (646)
Q Consensus       632 ki~DfGla~~  641 (646)
                      ||+|||+++.
T Consensus       164 kl~dfg~~~~  173 (303)
T cd05088         164 KIADFGLSRG  173 (303)
T ss_pred             EeCccccCcc
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.87  E-value=5.1e-22  Score=206.83  Aligned_cols=146  Identities=25%  Similarity=0.399  Sum_probs=127.9

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-C-----CCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-H-----RNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~~~~~~~~~~~~~l  565 (646)
                      +|.+.+.||+|+||+|.+|.+ .+++.||||+++.+.. ...+...|+.++..++ |     -|+|+++++|..++..||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788999999999999999985 4799999999986543 3455677999999996 4     499999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC--CCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~~  642 (646)
                      |+|.++. +|+++++..+ ..++...+..|+.||+.||.+||   ..+|||+||||+|||+.+  ...+||+|||.|...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999954 9999998764 46889999999999999999999   999999999999999964  458999999999865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       342 ~  342 (586)
T KOG0667|consen  342 S  342 (586)
T ss_pred             C
Confidence            4

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.7e-21  Score=196.88  Aligned_cols=148  Identities=28%  Similarity=0.466  Sum_probs=130.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|... +|+    .||+|....... .....+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999854 333    589998765543 344678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   .++++||||||+||++++++.+|++|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999876667899999999999999999999   8899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=2.1e-21  Score=196.33  Aligned_cols=143  Identities=27%  Similarity=0.348  Sum_probs=126.9

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +|+..+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 478899999987553 233457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++..+.     .+++..+..++.|++.|++|+|   +.+|+|+||||+||+++.++.+||+|||++..+.
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999997652     4678888899999999999999   8999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.87  E-value=5e-22  Score=198.44  Aligned_cols=144  Identities=33%  Similarity=0.569  Sum_probs=127.9

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchH--HHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAF--KSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      |+..+.||+|+||.||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999965 577899999987653322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ++++|.+++... ..+++..+..++.|+++|+.|||   ..+|+|+||||+||+++.++.++|+|||.+..
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            999999999733 36799999999999999999999   88999999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=1.5e-21  Score=196.98  Aligned_cols=148  Identities=24%  Similarity=0.417  Sum_probs=131.0

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999853      3467999988765443 4567899999999999999999999999888999


Q ss_pred             EEEEecCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          565 LVLEYKPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997543        15789999999999999999999   889999999999999999999999999


Q ss_pred             cCcccc
Q 046544          637 GIAKLL  642 (646)
Q Consensus       637 Gla~~~  642 (646)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=210.52  Aligned_cols=145  Identities=33%  Similarity=0.472  Sum_probs=120.9

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC--------C
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--------E  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--------~  561 (646)
                      ..+|+..+.||+|+||.||+|... +++.||||.+....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999864 68999999886432    2335799999999999999998876432        2


Q ss_pred             eeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeec
Q 046544          562 FKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFG  637 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfG  637 (646)
                      ..++||||+++ ++.+++..   ....+++..+..++.|++.||+|||   .++|+||||||+||+++.+ +.+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 77776643   3456889999999999999999999   8899999999999999865 479999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +|+.+.
T Consensus       217 la~~~~  222 (440)
T PTZ00036        217 SAKNLL  222 (440)
T ss_pred             cchhcc
Confidence            998653

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.87  E-value=1.8e-21  Score=194.53  Aligned_cols=147  Identities=24%  Similarity=0.464  Sum_probs=130.4

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..++||+|+||.||+|...+++.||+|.+..... ..+++.+|+.++++++|+||+++++++ .++..++||||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence            56888999999999999999988899999999875433 346788999999999999999999986 4567899999999


Q ss_pred             CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++... +..+++.++..++.|++.|++|||   ..+++||||||+||++++++.++++|||+++...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            99999998654 346788899999999999999999   8899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.87  E-value=1.3e-21  Score=198.11  Aligned_cols=148  Identities=30%  Similarity=0.566  Sum_probs=129.2

Q ss_pred             CCCCcceeecccccceEEEEEeCC------CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|....      .+.||+|.+..... ...+++.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998532      25799998875432 33457889999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC
Q 046544          565 LVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      ++|||+++|+|.+++....               ..+++.+...++.|++.|+.|||   ..+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999987542               34778888999999999999999   88999999999999999999


Q ss_pred             cEEEEeecCcccc
Q 046544          630 VAYLSDFGIAKLL  642 (646)
Q Consensus       630 ~~ki~DfGla~~~  642 (646)
                      .+||+|||+++..
T Consensus       162 ~~~L~dfg~~~~~  174 (283)
T cd05048         162 TVKISDFGLSRDI  174 (283)
T ss_pred             cEEECCCcceeec
Confidence            9999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=7e-22  Score=206.87  Aligned_cols=143  Identities=24%  Similarity=0.353  Sum_probs=126.9

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ...+|...+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999865 5788999974322      23469999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+. +++.+++......+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            995 5899998776667899999999999999999999   889999999999999999999999999999753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.87  E-value=1.6e-21  Score=198.38  Aligned_cols=149  Identities=26%  Similarity=0.410  Sum_probs=129.7

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3478999999999999999999864 688999999875432 22346678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+. +++.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9995 6887777665556778888899999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.87  E-value=1.4e-21  Score=198.85  Aligned_cols=147  Identities=27%  Similarity=0.440  Sum_probs=130.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67889999999999999999865 688999999875432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++ +|.+++......+++..+..++.|+++|+.|+|   ..+|+||||||+||++++++.+|++|||+++..
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence            975 999998776667889999999999999999999   889999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.4e-22  Score=205.64  Aligned_cols=144  Identities=24%  Similarity=0.357  Sum_probs=128.2

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      -|...+.||-|+||+|+.++. ++...||+|.+++++.   ........|-.|++..+.+-||++|..|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            477889999999999999974 4567799999876642   233456679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      |++||++..++-..+ .+++..+.-+++++..|+++.|   ..|+|||||||+|||||.+|++|++|||++.
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence            999999999987765 6788888889999999999999   9999999999999999999999999999975

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.8e-21  Score=196.05  Aligned_cols=147  Identities=31%  Similarity=0.547  Sum_probs=126.1

Q ss_pred             CCcceeecccccceEEEEEeC----CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe-----
Q 046544          494 FSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-----  562 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-----  562 (646)
                      |+..+.||+|+||.||+|...    .+..||+|.++...  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567789999999999999853    24779999987543  2334678899999999999999999998866544     


Q ss_pred             -eEEEEEecCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          563 -KALVLEYKPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       563 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                       .++||||+++|+|..++...     ...+++..+..++.|++.|++|+|   ..+++|||+||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999988543     235788899999999999999999   889999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+|+.+.
T Consensus       158 g~~~~~~  164 (273)
T cd05035         158 GLSKKIY  164 (273)
T ss_pred             cceeecc
Confidence            9998653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.87  E-value=1.6e-21  Score=198.51  Aligned_cols=148  Identities=31%  Similarity=0.500  Sum_probs=130.5

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|...+.||+|+||.||+|+..      ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777899999999999999742      355689998876555555778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc
Q 046544          566 VLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV  630 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~  630 (646)
                      ||||+++++|.+++....               ..+++..+..++.|++.|++|+|   .++|+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996532               24788899999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccc
Q 046544          631 AYLSDFGIAKLL  642 (646)
Q Consensus       631 ~ki~DfGla~~~  642 (646)
                      +|++|||+|+..
T Consensus       162 ~~l~dfg~a~~~  173 (291)
T cd05094         162 VKIGDFGMSRDV  173 (291)
T ss_pred             EEECCCCccccc
Confidence            999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.87  E-value=2e-21  Score=196.95  Aligned_cols=145  Identities=34%  Similarity=0.574  Sum_probs=126.5

Q ss_pred             CCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEE
Q 046544          494 FSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKAL  565 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  565 (646)
                      |+..+.||+|+||+||.+..     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988652     3578899999876532 3456788999999999999999999988654  45889


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++...  .+++.++..++.|++.|++|||   .++|+||||||+||++++++.+|++|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999998764  4899999999999999999999   8899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.87  E-value=1.2e-21  Score=200.62  Aligned_cols=149  Identities=30%  Similarity=0.512  Sum_probs=129.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecC
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  560 (646)
                      ..+|.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356788899999999999999741        24579999886443 33456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   .++|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997532               24677888999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccc
Q 046544          626 DDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~  642 (646)
                      ++++.+||+|||+|+.+
T Consensus       171 ~~~~~~kl~D~g~~~~~  187 (304)
T cd05101         171 TENNVMKIADFGLARDV  187 (304)
T ss_pred             cCCCcEEECCCccceec
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=9.6e-22  Score=199.54  Aligned_cols=149  Identities=26%  Similarity=0.368  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788899999999999999975 78999999887543 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||+  ..+|+||||||+||+++.++.+|++|||+++.+
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999988764  2368999999999999999999993  258999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.87  E-value=2.8e-21  Score=193.91  Aligned_cols=148  Identities=28%  Similarity=0.436  Sum_probs=132.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999876 79999999886432   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|..++...   +..+++.++..++.+++.|+.|||   ..+|+||||+|+||+++.++.++++|||+++.+
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            999999999988642   345788999999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=1.2e-21  Score=200.90  Aligned_cols=148  Identities=30%  Similarity=0.497  Sum_probs=129.5

Q ss_pred             CCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56889999999999999999742        23569999987542 33456788899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..|+||||+++|+|.+++....               ..+++.++..++.|++.|++|+|   .++++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997542               24788899999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCcccc
Q 046544          627 DNLVAYLSDFGIAKLL  642 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~  642 (646)
                      .++.+|++|||.|+.+
T Consensus       175 ~~~~~kL~dfg~a~~~  190 (307)
T cd05098         175 EDNVMKIADFGLARDI  190 (307)
T ss_pred             CCCcEEECCCcccccc
Confidence            9999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.87  E-value=2.1e-21  Score=195.23  Aligned_cols=142  Identities=28%  Similarity=0.432  Sum_probs=122.0

Q ss_pred             eeecccccceEEEEEeC---CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          498 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.||+|+||.||+|.+.   ++..+|+|.++.... .....+.+|+.++++++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999854   346799998865542 33357888999999999999999999999988999999999999


Q ss_pred             CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|.+++....    ...++..+..++.|++.|++|+|   ..+++|||+||+||+++.++.+|++|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            9999987532    24566777889999999999999   889999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.87  E-value=2.4e-21  Score=193.65  Aligned_cols=146  Identities=29%  Similarity=0.503  Sum_probs=128.1

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|...+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999998777789999876443 23467889999999999999999998875 456899999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+|.+++.... ..+++..+..++.|++.|++|+|   ..+++||||||+||++++++.++|+|||+++.+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            999999997643 35788899999999999999999   889999999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.87  E-value=1.6e-21  Score=194.58  Aligned_cols=143  Identities=28%  Similarity=0.408  Sum_probs=126.9

Q ss_pred             eeecccccceEEEEEeCC--C--cEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLGD--G--MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3699999876654 556788999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          573 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       573 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |+|.+++.... ..+++.....++.|++.|++|+|   .++++||||||+||+++.++.+|++|||+++.+..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            99999997755 46889999999999999999999   88999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.5e-23  Score=223.05  Aligned_cols=155  Identities=28%  Similarity=0.333  Sum_probs=137.9

Q ss_pred             HHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC
Q 046544          486 ELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE  561 (646)
Q Consensus       486 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  561 (646)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||+|++.+.   ...+..-|..|-.+|..-..+-|+.++.+|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44444578999999999999999999865 6889999998752   2334467888999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ++|+|||||+||+|..++...+ .+++.-+.-++..|+-||.-+|   ..|+|||||||+|||+|..|++|++|||-+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999999887 7899989999999999999999   99999999999999999999999999998877


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      +..
T Consensus       225 m~~  227 (1317)
T KOG0612|consen  225 MDA  227 (1317)
T ss_pred             cCC
Confidence            653

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.87  E-value=2.6e-21  Score=193.05  Aligned_cols=147  Identities=32%  Similarity=0.440  Sum_probs=131.3

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-----CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      +|+..+.||+|+||+||+|... +++.||+|.+....     ++..+.+.+|+++++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 78999999986543     22446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++.... .+++..+..++.|++.|++|+|   ..+++|+||+|+||+++.++.+||+|||+++...
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999987654 5788899999999999999999   8899999999999999999999999999987653

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.87  E-value=2.4e-21  Score=196.51  Aligned_cols=147  Identities=27%  Similarity=0.387  Sum_probs=133.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999864 68999999987654  33356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      + +++|.+++......+++.++..++.|+++|++|+|   ..+++|+||||+||++++++.++++|||+++...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9 99999999776667899999999999999999999   8899999999999999999999999999988654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=1.6e-21  Score=197.25  Aligned_cols=148  Identities=30%  Similarity=0.489  Sum_probs=131.1

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..++||+|+||.||+|+..      ++..||+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677899999999999999632      356799998876665666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          566 VLEYKPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      ||||+++|+|.+++....              ..+++..+..++.|++.|++|||   .++++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987643              24788899999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccc
Q 046544          632 YLSDFGIAKLL  642 (646)
Q Consensus       632 ki~DfGla~~~  642 (646)
                      ||+|||+++.+
T Consensus       162 kL~dfg~~~~~  172 (280)
T cd05092         162 KIGDFGMSRDI  172 (280)
T ss_pred             EECCCCceeEc
Confidence            99999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.87  E-value=2.5e-21  Score=198.42  Aligned_cols=146  Identities=27%  Similarity=0.411  Sum_probs=130.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.+|+|+||.||+++.. +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999865 58899999987553   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||++|++|.+++...+ .+++..+..++.|++.|++|+|   ..+++|||+||+||+++.++.+|++|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997654 6788889999999999999999   88999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.87  E-value=1.9e-21  Score=197.77  Aligned_cols=147  Identities=27%  Similarity=0.451  Sum_probs=127.4

Q ss_pred             CCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +|+..+.||+|+||.||+|+..      ....||+|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999742      235788998865432 334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 046544          566 VLEYKPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDN  622 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~N  622 (646)
                      ||||+.+|+|.+++....                       ..+++..+..++.|++.|++|||   ..+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                       24678888999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeecCcccc
Q 046544          623 VLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       623 il~~~~~~~ki~DfGla~~~  642 (646)
                      |++++++.+||+|||+++.+
T Consensus       158 ill~~~~~~kl~dfg~~~~~  177 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDV  177 (290)
T ss_pred             EEEcCCCcEEeccccccccc
Confidence            99999999999999999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.9e-21  Score=192.01  Aligned_cols=142  Identities=35%  Similarity=0.531  Sum_probs=128.6

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHH
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLE  576 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~  576 (646)
                      ++||+|+||.||+|...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999766999999988765433 4567889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          577 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       577 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++......+++.....++.+++.|++|+|   .++++|||+||+||+++.++.+|++|||+++..
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            999776556788899999999999999999   889999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.6e-23  Score=203.25  Aligned_cols=149  Identities=32%  Similarity=0.448  Sum_probs=133.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++.... +...++..+|+.++..++++||.++|+.+..+..+|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999854 78999999998764 34567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |.||++.+.++... .+++.+..-|++++..|+.|+|   ..+.+|||||+.||++..+|.||++|||+|..+..
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999987654 4478888889999999999999   88999999999999999999999999999887643

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.87  E-value=2.4e-21  Score=193.20  Aligned_cols=147  Identities=28%  Similarity=0.466  Sum_probs=132.2

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .+|+..+.||+|+||.||+|.+..+..+|+|.+..... ...++.+|++++++++||+|+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46778899999999999999887788899998864432 34578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|.+++......+++..+..++.|++.|++|+|   ..+++|||+||+||+++.++.+||+|||+++..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            99999999876667889999999999999999999   889999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.87  E-value=1.7e-21  Score=195.95  Aligned_cols=148  Identities=27%  Similarity=0.422  Sum_probs=129.4

Q ss_pred             CCCCcceeecccccceEEEEEeCC----CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998532    3468999887554 3345678899999999999999999998875 457899


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|+|.+++......+++..+..++.|++.|++|+|   ..+++||||||+||+++.++.+|++|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999876656899999999999999999999   8899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=2.4e-21  Score=196.26  Aligned_cols=149  Identities=30%  Similarity=0.483  Sum_probs=132.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-----CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEec--CCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~  563 (646)
                      ..|+..+.||+|+||.||+|++.     +++.||+|++...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677899999999999999853     3788999998765443 45688999999999999999999999877  4578


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||+++++|.+++......+++..+..++.|++.|++|||   ..+++||||||+||+++.++.++++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   8899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=2.7e-21  Score=196.21  Aligned_cols=148  Identities=28%  Similarity=0.393  Sum_probs=130.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++....  ....+.+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999875 68999999886442  2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++.+..+.... ..+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||++..+.
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence            99998888776543 36899999999999999999999   8899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=2.6e-21  Score=194.04  Aligned_cols=147  Identities=25%  Similarity=0.404  Sum_probs=128.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-----CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  563 (646)
                      .+|+..+.||+|+||.||+|+.. +|+.||+|.+....     ....+.+.+|++++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999864 68999999886432     12345778899999999999999999988764  467


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||+++++|.+++.... .+++.....++.|++.|++|+|   +.+++|+||||+||+++.++.+||+|||+++.+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999987654 5788888999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=2.3e-21  Score=194.60  Aligned_cols=147  Identities=31%  Similarity=0.487  Sum_probs=129.9

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc---------hHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR---------AFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      +|...+.||+|+||.||+|... +++.||+|.+......         ..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 6889999988654321         12467889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++||||+++++|.+++...+ .+++..+..++.|++.|++|+|   ..+++||||+|+||++++++.+||+|||.++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 6788889999999999999999   889999999999999999999999999998876


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       157 ~  157 (267)
T cd06628         157 E  157 (267)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.87  E-value=1.1e-21  Score=203.46  Aligned_cols=148  Identities=28%  Similarity=0.476  Sum_probs=126.7

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecC-Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNE-EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-~~  562 (646)
                      ++|++.+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            47889999999999999999632      357899999875432 3345678899999999 899999999988754 56


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------------------------------------------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------------------------------------------------  583 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  583 (646)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999985421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          584 -CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       584 -~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                       ..+++..+..++.||+.|++|+|   ..+|+||||||+||++++++.+||+|||+|+.+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~  223 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI  223 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence             25788889999999999999999   889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.87  E-value=1.7e-21  Score=199.18  Aligned_cols=148  Identities=27%  Similarity=0.444  Sum_probs=130.3

Q ss_pred             CCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      ++|...+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4688899999999999999973      135679999887543 23346788999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||+++|+|.+++.... ..+++.+...++.|++.|++|+|   .++|+|+||||+||+++.++.+|++|||+++.+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999997543 34799999999999999999999   889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=3e-21  Score=192.83  Aligned_cols=144  Identities=35%  Similarity=0.594  Sum_probs=129.7

Q ss_pred             eeecccccceEEEEEeCC----CcEEEEEEEeccCCch-HHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|....    +..||+|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    7889999987654333 57888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          573 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       573 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ++|.+++...        ...+++.++..++.|++.|++|||   .++++||||||+||+++.++.+|++|||.++.+..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        467899999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.87  E-value=1.9e-21  Score=203.94  Aligned_cols=146  Identities=25%  Similarity=0.336  Sum_probs=125.0

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-----
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-----  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----  561 (646)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999864 68999999986442  233467788999999999999999999886543     


Q ss_pred             -eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          562 -FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       562 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                       ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999975 67666543   4678888899999999999999   8899999999999999999999999999997


Q ss_pred             cc
Q 046544          641 LL  642 (646)
Q Consensus       641 ~~  642 (646)
                      ..
T Consensus       172 ~~  173 (359)
T cd07876         172 TA  173 (359)
T ss_pred             cc
Confidence            64

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.87  E-value=1.9e-21  Score=200.15  Aligned_cols=149  Identities=29%  Similarity=0.489  Sum_probs=129.3

Q ss_pred             CCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      .+|...+.||+|+||.||+|+..        .+..||+|.+.... ......+..|+++++.+ +||||+++++++..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56788999999999999999742        24579999887543 23456788899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..++||||+++|+|.+++....               ..+++.+...++.|++.|++|+|   +++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999996532               34788889999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      +++.+|++|||+++.+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         169 EDNVMKIADFGLARGVH  185 (314)
T ss_pred             CCCcEEEcccccccccc
Confidence            99999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.5e-21  Score=195.51  Aligned_cols=149  Identities=23%  Similarity=0.402  Sum_probs=129.7

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            57888999999999999999753      24689999986443 233457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          565 LVLEYKPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                      +||||+++|+|.+++....         ..+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999986532         23677888999999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++.+.
T Consensus       163 fg~~~~~~  170 (277)
T cd05032         163 FGMTRDIY  170 (277)
T ss_pred             cccchhhc
Confidence            99987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.86  E-value=2.1e-21  Score=198.22  Aligned_cols=147  Identities=32%  Similarity=0.582  Sum_probs=127.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc--EEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888899999999999999864 343  47888876432 33456788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          567 LEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      |||+++|+|.+++....               ..+++..+..++.|++.|++|||   .++|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24778899999999999999999   8899999999999999999999


Q ss_pred             EEEeecCccc
Q 046544          632 YLSDFGIAKL  641 (646)
Q Consensus       632 ki~DfGla~~  641 (646)
                      ||+|||++..
T Consensus       159 kl~dfg~~~~  168 (297)
T cd05089         159 KIADFGLSRG  168 (297)
T ss_pred             EECCcCCCcc
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.86  E-value=2.9e-21  Score=195.86  Aligned_cols=146  Identities=29%  Similarity=0.440  Sum_probs=128.3

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999865 68999999986543  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++ +++.+++....  ..+++..+..++.|++.||+|+|   ..+|+||||||+||++++++.+||+|||+++..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            97 58888876532  46889999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.86  E-value=2.7e-21  Score=195.25  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=129.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      .++|+..+.||+|+||.||+|.+.      .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            356888999999999999999864      356789998764432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 046544          564 ALVLEYKPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLS  634 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki~  634 (646)
                      ++||||+++|+|.+++...+      ..+++..+.+++.||+.|++|||   .++++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987653      25788999999999999999999   88999999999999998654   69999


Q ss_pred             eecCcccc
Q 046544          635 DFGIAKLL  642 (646)
Q Consensus       635 DfGla~~~  642 (646)
                      |||+++.+
T Consensus       162 dfg~~~~~  169 (277)
T cd05036         162 DFGMARDI  169 (277)
T ss_pred             cCcccccc
Confidence            99999865

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.86  E-value=3.2e-21  Score=196.73  Aligned_cols=149  Identities=24%  Similarity=0.423  Sum_probs=130.6

Q ss_pred             hCCCCcceeecccccceEEEEEeCC-----------------CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCcee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGD-----------------GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK  552 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~  552 (646)
                      ..+|+..+.||+|+||.||+|+...                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987432                 24589998875532 34567889999999999999999


Q ss_pred             EEEEEecCCeeEEEEEecCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 046544          553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDN  622 (646)
Q Consensus       553 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~N  622 (646)
                      +++++..++..++||||+++++|.+++....          ..+++.....++.|++.|++|||   ..+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987643          25788999999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeecCcccc
Q 046544          623 VLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       623 il~~~~~~~ki~DfGla~~~  642 (646)
                      |++++++.++++|||+++.+
T Consensus       161 ili~~~~~~~l~dfg~~~~~  180 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             eeecCCCceEEccccceeec
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.86  E-value=3.1e-21  Score=192.26  Aligned_cols=147  Identities=30%  Similarity=0.411  Sum_probs=134.6

Q ss_pred             CCCCcceeecccccceEEEEEeCC-CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||.||+|+... ++.||+|.+.....  .+++.+|++++++++||||+++++++..+...|+++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999764 88999999875532  578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++...+..+++..+..++.|++.|+.|+|   ..+++|||++|+||++++++.+|++|||++..+.
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            999999999876667899999999999999999999   8899999999999999999999999999988654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5e-23  Score=210.35  Aligned_cols=147  Identities=27%  Similarity=0.386  Sum_probs=135.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|.+...+|.|+||+||+|..+ ++-..|.|++..+.....++|.-||+|++.++||+||++++.|..++.+||..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34666778999999999999865 45556889998888888999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .||-....+.+-+..+.+.++..+++|++.||.|||   +++|||||+|+.|||+.-+|.++++|||++..
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccccccc
Confidence            999999998888889999999999999999999999   89999999999999999999999999998654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.86  E-value=3e-21  Score=196.83  Aligned_cols=147  Identities=31%  Similarity=0.427  Sum_probs=133.4

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999985 478999999998665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++...  .+++.++..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||+++.+.
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            999999988654  4789999999999999999999   8899999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.1e-21  Score=184.66  Aligned_cols=140  Identities=18%  Similarity=0.164  Sum_probs=108.4

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCc--h-------H-----------------HHHHHHHHHHHhCCCCCc
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--A-------F-----------------KSFAVECEMMKSIRHRNL  550 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~H~ni  550 (646)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999878999999998754211  0       0                 122349999999988776


Q ss_pred             eeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCEEEcCCC
Q 046544          551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       551 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      .....+..  ...++||||++|+++...... ...+++.+...++.|++.++.|+ |   ..+|+|||+||+||+++ ++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            44333222  224899999998877654332 23678888999999999999999 6   77999999999999998 47


Q ss_pred             cEEEEeecCccccc
Q 046544          630 VAYLSDFGIAKLLI  643 (646)
Q Consensus       630 ~~ki~DfGla~~~~  643 (646)
                      .++++|||+|....
T Consensus       155 ~v~LiDFG~a~~~~  168 (190)
T cd05147         155 KLYIIDVSQSVEHD  168 (190)
T ss_pred             cEEEEEccccccCC
Confidence            89999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.86  E-value=2.4e-21  Score=194.64  Aligned_cols=140  Identities=23%  Similarity=0.396  Sum_probs=119.2

Q ss_pred             eecccccceEEEEEeCCC---cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          499 LIGRGGFGSVYKARLGDG---MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   345667665443 2345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          575 LEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       575 L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |.+++....   ...++.....++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence            999987542   24566677889999999999999   88999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.86  E-value=2.1e-21  Score=197.03  Aligned_cols=158  Identities=24%  Similarity=0.334  Sum_probs=133.5

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEe-
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCS-  558 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~-  558 (646)
                      ..++.+..+.++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344555667789999999999999999999864 68899999876432 2335677899999999 7999999999874 


Q ss_pred             ----cCCeeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          559 ----NEEFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       559 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                          .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.|||   ..+|+|||+||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34568999999999999998753   2346788889999999999999999   8899999999999999999999


Q ss_pred             EEEeecCccccc
Q 046544          632 YLSDFGIAKLLI  643 (646)
Q Consensus       632 ki~DfGla~~~~  643 (646)
                      |++|||+++.+.
T Consensus       164 kl~dfg~~~~~~  175 (286)
T cd06638         164 KLVDFGVSAQLT  175 (286)
T ss_pred             EEccCCceeecc
Confidence            999999987653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.4e-21  Score=203.65  Aligned_cols=150  Identities=23%  Similarity=0.311  Sum_probs=128.0

Q ss_pred             HHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC----
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE----  560 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~----  560 (646)
                      ....++|+..+.||+|+||.||+|.. .+++.||||.+.....  ...+.+.+|+++++.++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34557899999999999999999985 4688999999875422  2345677899999999999999999887543    


Q ss_pred             --CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          561 --EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       561 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                        ...|++||++ +++|.+++...  .+++..+..++.|++.||+|||   .++|+||||||+||++++++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3468999988 77998887543  5889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      |+...
T Consensus       165 ~~~~~  169 (343)
T cd07878         165 ARQAD  169 (343)
T ss_pred             ceecC
Confidence            98653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.86  E-value=4.5e-21  Score=191.26  Aligned_cols=145  Identities=33%  Similarity=0.481  Sum_probs=127.4

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEe-cCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|..+ |..||+|.+....  ..+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999864 7789999886432  3467889999999999999999999764 456789999999


Q ss_pred             CCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++..... .+++..+..++.|++.|++|+|   .++++||||||+||++++++.+|++|||+++..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceec
Confidence            99999999976543 4788899999999999999999   889999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.86  E-value=4.4e-21  Score=191.31  Aligned_cols=147  Identities=33%  Similarity=0.586  Sum_probs=131.0

Q ss_pred             CCcceeecccccceEEEEEeCC-----CcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          494 FSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++..+.||+|+||.||+|+...     +..||+|++...... ..+.+..|++.++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999998653     488999998755433 5678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++...... +++..+..++.|++.|++|+|   ..+++||||||+||++++++.++++|||+++...
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            999999999999765544 899999999999999999999   8899999999999999999999999999997654

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-22  Score=207.82  Aligned_cols=147  Identities=27%  Similarity=0.418  Sum_probs=129.9

Q ss_pred             CcceeecccccceEEEEEeC--CCc--EEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          495 SENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +..+.||+|.||.|++|.|.  .|+  .||||+++..... ...+|.+|+.+|.+++|||++++||+..+ ....+|||+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            44578999999999999875  344  5899999866543 67899999999999999999999999887 678899999


Q ss_pred             cCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          570 KPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       570 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      ++.|+|.+.++. .+..+.......++.|||.||+||.   .++.||||+.++|+++.....|||+|||+.|-+.+.
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999987 4556777888999999999999999   899999999999999999999999999999987643

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.86  E-value=4.3e-21  Score=191.51  Aligned_cols=140  Identities=28%  Similarity=0.415  Sum_probs=122.3

Q ss_pred             eecccccceEEEEEe---CCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          499 LIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      .||+|+||.||+|.+   .+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999974   3578899999865432  234678899999999999999999998764 4678999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|.+++.... .+++..+..++.|++.|++|+|   .++|+||||||+||++++++.+|++|||+++.+.
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            9999987554 6889999999999999999999   8899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.86  E-value=2.1e-21  Score=195.42  Aligned_cols=149  Identities=30%  Similarity=0.406  Sum_probs=129.9

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecC------C
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE------E  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~------~  561 (646)
                      +.+.|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++++ +||||+++.+++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999864 688999999875543 345778899999998 799999999998753      4


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ..|+||||+++|+|.+++.... ..+++..+..++.|++.|++|||   +++|+|||+||+||++++++.+||+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            5899999999999999987643 46889999999999999999999   8899999999999999999999999999987


Q ss_pred             cc
Q 046544          641 LL  642 (646)
Q Consensus       641 ~~  642 (646)
                      ..
T Consensus       160 ~~  161 (272)
T cd06637         160 QL  161 (272)
T ss_pred             ec
Confidence            64

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.86  E-value=1.9e-21  Score=196.96  Aligned_cols=147  Identities=25%  Similarity=0.406  Sum_probs=127.3

Q ss_pred             CCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +|...+.||+|+||.||+|+..      +++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999853      2578999998755432 24568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc
Q 046544          566 VLEYKPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV  630 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~  630 (646)
                      ++||+++++|.+++...               ...+++..+..++.|++.|++|+|   +++|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               124778888999999999999999   889999999999999999999


Q ss_pred             EEEEeecCcccc
Q 046544          631 AYLSDFGIAKLL  642 (646)
Q Consensus       631 ~ki~DfGla~~~  642 (646)
                      +|++|||+++.+
T Consensus       163 ~kl~Dfg~~~~~  174 (283)
T cd05091         163 VKISDLGLFREV  174 (283)
T ss_pred             eEeccccccccc
Confidence            999999998765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=5.5e-24  Score=195.05  Aligned_cols=152  Identities=25%  Similarity=0.434  Sum_probs=129.0

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----  560 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----  560 (646)
                      .....|....+||+|.||+||+|+.+ +|+.||+|.+-.+.  ........+|++++..++|+|++.+.+.|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            33455667789999999999999854 68889988654432  22335668899999999999999998887542     


Q ss_pred             ---CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          561 ---EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       561 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                         ...|+||++|+. +|.-++.+....++..++.++++++..|+.|+|   ...|+|||+||+|+||+.+|.+||+|||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence               348999999987 999999887778899999999999999999999   9999999999999999999999999999


Q ss_pred             CcccccC
Q 046544          638 IAKLLIG  644 (646)
Q Consensus       638 la~~~~~  644 (646)
                      +|+.+..
T Consensus       170 lar~fs~  176 (376)
T KOG0669|consen  170 LARAFST  176 (376)
T ss_pred             cccceec
Confidence            9987754

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.86  E-value=2.8e-21  Score=194.08  Aligned_cols=147  Identities=25%  Similarity=0.399  Sum_probs=129.6

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +|+..+.||+|+||.||+|+. .+++.||+|++.....      ...+.+.+|++++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 5789999999874331      134678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      ||||+++++|.+++...+ .+++..+..++.|++.|+.|||   .++++||||+|+||+++.++ .+||+|||.++.+.
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999987654 6788899999999999999999   88999999999999998765 69999999987653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.86  E-value=4.2e-21  Score=191.92  Aligned_cols=148  Identities=25%  Similarity=0.465  Sum_probs=130.5

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            36788899999999999999998778889999876432 234678899999999999999999999877 7789999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++... ....++..+..++.|++.|++|+|   ..+++||||||+||+++.++.+|++|||.++.+.
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            999999999764 345788889999999999999999   8899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=3.8e-21  Score=192.45  Aligned_cols=143  Identities=29%  Similarity=0.498  Sum_probs=122.4

Q ss_pred             eeecccccceEEEEEeC----CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCeeEEEEEecC
Q 046544          498 NLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYKP  571 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~  571 (646)
                      +.||+|+||.||+|...    .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999853    24579999875432 3345678899999999999999999998764 556899999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++.......++.....++.|++.|++|+|   ..+++||||||+||++++++.+|++|||+++.+.
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999776556678888899999999999999   8899999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.86  E-value=2.3e-21  Score=194.58  Aligned_cols=148  Identities=29%  Similarity=0.457  Sum_probs=130.8

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+....   ....+++.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999985 478999999876432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++++|.+++..   ....+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.++++|||+++.+
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            99999999998864   2346789999999999999999999   899999999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.86  E-value=5e-22  Score=182.25  Aligned_cols=152  Identities=26%  Similarity=0.334  Sum_probs=134.2

Q ss_pred             HHhCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Ce
Q 046544          489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EF  562 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  562 (646)
                      ...++|.+.+.+|+|+|+.||.++ ..++..||+|.+.....++.+..++|++..++++|||++++++++..+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345789999999999999999998 567899999999888777788899999999999999999998876544     34


Q ss_pred             eEEEEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          563 KALVLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      .|++++|...|+|.+.+...   +..+++.+.+.|+.+|++|++++|.. .++++||||||.||++.+.+.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            89999999999999998653   34789999999999999999999943 345999999999999999999999999987


Q ss_pred             cc
Q 046544          640 KL  641 (646)
Q Consensus       640 ~~  641 (646)
                      ..
T Consensus       177 ~~  178 (302)
T KOG2345|consen  177 TQ  178 (302)
T ss_pred             cc
Confidence            65

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.86  E-value=4.2e-21  Score=197.90  Aligned_cols=141  Identities=25%  Similarity=0.365  Sum_probs=117.9

Q ss_pred             ceeecccccceEEEEEeC---CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEEEEEecC
Q 046544          497 NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYKP  571 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~  571 (646)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999886442  23456789999999999999999998854  456899999985


Q ss_pred             CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecCc
Q 046544          572 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIA  639 (646)
Q Consensus       572 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~----~~~~~~ki~DfGla  639 (646)
                       +++.+++...        ...+++..+..++.|++.|++|||   +.+|+||||||+||++    +..+.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4888887532        124788889999999999999999   8899999999999999    45678999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       160 ~~~~  163 (317)
T cd07868         160 RLFN  163 (317)
T ss_pred             eccC
Confidence            8653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=5.9e-21  Score=191.21  Aligned_cols=147  Identities=34%  Similarity=0.464  Sum_probs=132.8

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc--hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR--AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|+++++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 6889999998866543  567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++.... .+++..+..++.|++.|++|||   ..+++|+||+|+||++++++.+||+|||++....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            99999999987653 5788889999999999999999   8899999999999999999999999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=6.2e-21  Score=196.57  Aligned_cols=148  Identities=32%  Similarity=0.450  Sum_probs=132.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+..|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999865 589999999876532   24457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++++|.+++... ...+++.....++.|++.|++|||   ..+++||||||+||+++.++.++++|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999999998754 346889999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=5.5e-21  Score=194.41  Aligned_cols=147  Identities=25%  Similarity=0.340  Sum_probs=129.2

Q ss_pred             CCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          493 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      +|+..+.||+|+||.||+|+.    .+|+.||+|++....    ....+.+.+|+++++++ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    368899999987532    22345678899999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||+++++|.+++.... .+++..+..++.|++.|+.|+|   ..+++||||+|+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 5788888899999999999999   8999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=2.2e-21  Score=205.64  Aligned_cols=142  Identities=27%  Similarity=0.334  Sum_probs=125.0

Q ss_pred             CCCCcceeecccccceEEEEEeC---CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .+|...+.||+|+||.||+|...   .++.||+|.+...     +...+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            57899999999999999999743   4678999987543     234579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+. +++.+++.. ...+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       167 ~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        167 KYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             hcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            995 589888843 347899999999999999999999   8899999999999999999999999999987653

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.86  E-value=2.2e-21  Score=196.66  Aligned_cols=146  Identities=29%  Similarity=0.442  Sum_probs=129.2

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.++....  .....+.+|+++++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999865 689999999875432  2234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++ +++.+++......+++..+..++.||++|+.|||   .++|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            96 5888888765567899999999999999999999   889999999999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.86  E-value=4.9e-21  Score=198.23  Aligned_cols=143  Identities=22%  Similarity=0.261  Sum_probs=124.4

Q ss_pred             cceeeccc--ccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          496 ENNLIGRG--GFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       496 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ..++||+|  +|++||+++. .+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  6789999986 478999999987543  223456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ++|++.+++... ...+++..+..++.|++.||+|||   .++|+||||||+||+++.++.++++|||.+..
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence            999999998654 335889999999999999999999   88999999999999999999999999986443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.86  E-value=3.6e-21  Score=196.10  Aligned_cols=150  Identities=24%  Similarity=0.339  Sum_probs=131.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  565 (646)
                      .++|+..+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357888899999999999999975 688999999875432  2234567899999999999999999998877  88999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||||+++ +|.+++......+++.++..++.|++.||+|||   ..+++||||||+||++++++.+|++|||+++.+..
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9999974 999988776657899999999999999999999   88999999999999999999999999999886543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.86  E-value=4.2e-21  Score=195.07  Aligned_cols=149  Identities=29%  Similarity=0.484  Sum_probs=130.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      .++|+..+.||+|+||.||+|+..      +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356888899999999999999853      467899999875433 3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 046544          564 ALVLEYKPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDN  622 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~N  622 (646)
                      ++||||+++|+|.+++....                     ..+++..+..++.|++.|++|+|   .++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996432                     24677888999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeecCcccc
Q 046544          623 VLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       623 il~~~~~~~ki~DfGla~~~  642 (646)
                      |++++++.+|++|||+++.+
T Consensus       161 il~~~~~~~~l~dfg~~~~~  180 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNI  180 (288)
T ss_pred             eEecCCCceEECccccceec
Confidence            99999999999999998754

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.86  E-value=2.4e-21  Score=193.37  Aligned_cols=147  Identities=29%  Similarity=0.379  Sum_probs=132.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++......++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999865 68999999987543   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++|++|.+++... ..+++..+..++.|+++|+.|||   .++++|+||+|+||++++++.++++|||++....
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            99999999998765 46889999999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=1.2e-21  Score=195.73  Aligned_cols=143  Identities=27%  Similarity=0.396  Sum_probs=123.7

Q ss_pred             eeecccccceEEEEEeCC--------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          498 NLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +.||+|+||.||+|..+.        ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999997532        234888887655444556788899999999999999999999998899999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc--------EEEEeecCccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV--------AYLSDFGIAKL  641 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~--------~ki~DfGla~~  641 (646)
                      +++|+|.+++...+..+++..+..++.|++.|++|+|   .++|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   899999999999999986654        69999999875


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       158 ~~  159 (258)
T cd05078         158 VL  159 (258)
T ss_pred             cC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.86  E-value=5.4e-21  Score=193.41  Aligned_cols=150  Identities=23%  Similarity=0.398  Sum_probs=130.4

Q ss_pred             hCCCCcceeecccccceEEEEEeCC-----CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~  563 (646)
                      .++|+..+.||+|+||.||+|.+..     +..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999998654     6889999886443 2335678889999999999999999998776 4678


Q ss_pred             EEEEEecCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          564 ALVLEYKPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      ++++||+++|+|.+++....       ..+++..+..++.|++.|++|||   ..+++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986542       35789999999999999999999   889999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+++.+.
T Consensus       162 g~~~~~~  168 (280)
T cd05043         162 ALSRDLF  168 (280)
T ss_pred             CCccccc
Confidence            9998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.86  E-value=3.5e-21  Score=199.95  Aligned_cols=148  Identities=30%  Similarity=0.500  Sum_probs=128.4

Q ss_pred             CCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887543 33456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..+++|||+++|+|.+++....               ..+++.++..++.|++.|++|||   .++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532               24678888999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccc
Q 046544          627 DNLVAYLSDFGIAKLL  642 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~  642 (646)
                      .++.+||+|||+++.+
T Consensus       169 ~~~~~kL~Dfg~~~~~  184 (334)
T cd05100         169 EDNVMKIADFGLARDV  184 (334)
T ss_pred             CCCcEEECCcccceec
Confidence            9999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=4.3e-22  Score=218.45  Aligned_cols=150  Identities=29%  Similarity=0.480  Sum_probs=125.3

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEec-------
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-------  559 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-------  559 (646)
                      +-.++|+..+.+|+|+||.||+++.+ ||+.||||.+.... ........+|+..+++++|||||+++..|.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34467888999999999999999966 89999999998663 3445678899999999999999999855400       


Q ss_pred             --------------------------------------------------------------------------------
Q 046544          560 --------------------------------------------------------------------------------  559 (646)
Q Consensus       560 --------------------------------------------------------------------------------  559 (646)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 046544          560 ------------------------E--------EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  607 (646)
Q Consensus       560 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~  607 (646)
                                              +        -.+||-||||+...+.+++......-......+++++|++|+.|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                    0        1357899999997777777665422246678899999999999999 


Q ss_pred             CCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       608 ~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                        .+|||||||||.||+++++..|||+|||+|+.
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence              89999999999999999999999999999987

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.86  E-value=6.9e-21  Score=192.28  Aligned_cols=147  Identities=28%  Similarity=0.399  Sum_probs=131.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999865 68899999987553 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++...  .+++.+...++.|++.|++|+|   ..+++|+||+|+||+++.++.++++|||+++.+.
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            9999999998653  5788899999999999999999   8899999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=6.3e-21  Score=192.00  Aligned_cols=146  Identities=32%  Similarity=0.485  Sum_probs=128.7

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC----------chHHHHHHHHHHHHhCCCCCceeEEEEEecCC
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG----------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE  561 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  561 (646)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999854 689999998864211          11246778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.|++|+|   +.+++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987664 6888889999999999999999   88999999999999999999999999999875


Q ss_pred             c
Q 046544          642 L  642 (646)
Q Consensus       642 ~  642 (646)
                      .
T Consensus       158 ~  158 (272)
T cd06629         158 S  158 (272)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.86  E-value=6.8e-21  Score=191.57  Aligned_cols=140  Identities=36%  Similarity=0.659  Sum_probs=121.7

Q ss_pred             eeecccccceEEEEEeC-CCc--EEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|+.. ++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            35899999999999864 344  46888876432 33456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          573 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       573 g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      |+|.+++....               ..+++.+...++.|++.|++|+|   .++++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               24678899999999999999999   8899999999999999999999999999


Q ss_pred             Ccc
Q 046544          638 IAK  640 (646)
Q Consensus       638 la~  640 (646)
                      +++
T Consensus       158 l~~  160 (270)
T cd05047         158 LSR  160 (270)
T ss_pred             Ccc
Confidence            985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=3.4e-21  Score=215.93  Aligned_cols=156  Identities=23%  Similarity=0.369  Sum_probs=129.9

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--C
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--E  561 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~  561 (646)
                      .....++|.+.+.||+|+||.||+|+.. +++.||+|++....  ......+..|+.+++.++|||||+++++|...  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3445578999999999999999999865 57889999987542  23456788999999999999999999988543  5


Q ss_pred             eeEEEEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCEEEcC-------
Q 046544          562 FKALVLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGC----LAPVIHCDLKPDNVLLDD-------  627 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~----~~~iiHrdlk~~Nil~~~-------  627 (646)
                      ..|+||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999998653   246899999999999999999999421    146999999999999964       


Q ss_pred             ----------CCcEEEEeecCcccc
Q 046544          628 ----------NLVAYLSDFGIAKLL  642 (646)
Q Consensus       628 ----------~~~~ki~DfGla~~~  642 (646)
                                .+.+||+|||+++.+
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l  192 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNI  192 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccc
Confidence                      235899999999865

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.86  E-value=3.5e-21  Score=201.73  Aligned_cols=147  Identities=24%  Similarity=0.310  Sum_probs=125.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------  560 (646)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 68899999987542  23346778899999999999999999988643      


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ...++||||+++ ++.+.+..   .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            347999999965 67776643   4788888999999999999999   8999999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       168 ~~~  170 (355)
T cd07874         168 TAG  170 (355)
T ss_pred             cCC
Confidence            653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=4.3e-21  Score=196.43  Aligned_cols=148  Identities=30%  Similarity=0.503  Sum_probs=127.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|++. +|+    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778899999999999999853 444    578888765432 2234688899999999999999999998754 4679


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||+++|++.+++......+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999999876667889999999999999999999   8899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=9e-21  Score=190.24  Aligned_cols=147  Identities=24%  Similarity=0.422  Sum_probs=128.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-----CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  563 (646)
                      .+|+..+.||+|+||.||+|... ++..||+|.+....     .+..+.+.+|+.+++.++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999864 68999999886432     12345678899999999999999999988753  578


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|||+++++|.+++.... .+++.....++.|++.|++|||   ..+|+|||+||+||+++.++.+||+|||+++.+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999987654 5788889999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.86  E-value=5.2e-21  Score=194.66  Aligned_cols=157  Identities=27%  Similarity=0.349  Sum_probs=134.2

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN  559 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  559 (646)
                      +++.++..++++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455566778999999999999999999986 468899999886442 2345677899999998 89999999999875


Q ss_pred             C-----CeeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          560 E-----EFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       560 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      .     +..++||||+++|+|.+++..   ....+++..+..++.|++.|++|+|   ..+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     358999999999999998863   3346889999999999999999999   8899999999999999999999


Q ss_pred             EEEeecCcccc
Q 046544          632 YLSDFGIAKLL  642 (646)
Q Consensus       632 ki~DfGla~~~  642 (646)
                      |++|||+++.+
T Consensus       168 kl~dfg~~~~~  178 (291)
T cd06639         168 KLVDFGVSAQL  178 (291)
T ss_pred             EEeecccchhc
Confidence            99999998764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.85  E-value=8.1e-21  Score=192.39  Aligned_cols=148  Identities=28%  Similarity=0.388  Sum_probs=125.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHH-HHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEM-MKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|..+ ++..+||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999865 699999999876532 233455566665 566799999999999999999999999


Q ss_pred             ecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++ |+|.+++..   ....+++..+..++.|++.|++|+|   ++ +++||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            996 588877754   2346889999999999999999999   65 89999999999999999999999999988653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=1.1e-20  Score=188.38  Aligned_cols=147  Identities=24%  Similarity=0.405  Sum_probs=131.1

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+++. .+|+.||+|.+....  ....+++.+|+.++++++||||+++.+++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999985 468999999987542  33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++.... ..+++.++..++.|++.|+.|+|   ..+++|+|++|+||+++.++.++++|||++...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            99999999987643 35788899999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=7.3e-21  Score=193.24  Aligned_cols=147  Identities=30%  Similarity=0.456  Sum_probs=122.7

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhC---CCCCceeEEEEEec-----CC
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSI---RHRNLIKVISSCSN-----EE  561 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~-----~~  561 (646)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 689999999875432  2223556677777665   79999999998764     24


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ..++||||+.+ ++.+++.... ..+++..+..++.|++.|++|+|   ..+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999975 8988886543 35889999999999999999999   8899999999999999999999999999988


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       157 ~~~  159 (288)
T cd07863         157 IYS  159 (288)
T ss_pred             ccc
Confidence            653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.85  E-value=6.2e-21  Score=200.51  Aligned_cols=147  Identities=24%  Similarity=0.302  Sum_probs=125.7

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------  560 (646)
                      ..++|+..+.||+|+||.||+|+.. .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3478999999999999999999864 68899999987542  23446778899999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ...|+||||+++ ++.+++..   .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77777643   3678888999999999999999   8899999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       175 ~~~  177 (364)
T cd07875         175 TAG  177 (364)
T ss_pred             ccC
Confidence            653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7.7e-21  Score=191.63  Aligned_cols=147  Identities=31%  Similarity=0.376  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999865 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|   .++++|||++|+||++++++.++++|||+++.+.
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999998764  6889999999999999999999   8899999999999999999999999999987764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.85  E-value=5.2e-21  Score=190.53  Aligned_cols=144  Identities=29%  Similarity=0.534  Sum_probs=126.9

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|.. +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578899999999999999875 67889999886432  346788999999999999999999998655 4799999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+|.+++.... ..+++..+..++.|++.|+.|+|   ..+++|||+||+||+++.++.+||+|||+++..
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence            999999997653 35788899999999999999999   899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.85  E-value=6.5e-21  Score=194.09  Aligned_cols=146  Identities=32%  Similarity=0.418  Sum_probs=131.8

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999985 468899999987655555577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++...  .+++.++..++.|++.|+.|||   ..+++|||+||+||+++.++.+||+|||++...
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            999999998654  4788889999999999999999   889999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.85  E-value=1.3e-20  Score=187.89  Aligned_cols=148  Identities=27%  Similarity=0.450  Sum_probs=129.3

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e  568 (646)
                      +|+..+.+|+|++|.||+++.. +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5788999999999999999854 57899999987543  2344578889999999999999999988764 446899999


Q ss_pred             ecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++++.+++... ...+++.++..++.|++.|++|+|   ..+++||||||+||+++.++.++|+|||+++.+.
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            99999999998764 345889999999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.85  E-value=3.4e-21  Score=194.54  Aligned_cols=146  Identities=27%  Similarity=0.373  Sum_probs=129.2

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999854 68899999987543 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++...  .+++..+..++.|+++|+.|+|   .++++|+||+|+||++++++.++++|||+++.+.
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999988643  5788899999999999999999   8899999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.85  E-value=1.3e-20  Score=190.40  Aligned_cols=146  Identities=29%  Similarity=0.393  Sum_probs=129.7

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      -|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999864 68899999886543 233467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++.+++...  .+++..+..++.|++.|+.|+|   ..+++|+|++|+||+++.++.++++|||+++.+.
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999998643  5788999999999999999999   8999999999999999999999999999987653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=8.9e-21  Score=179.33  Aligned_cols=140  Identities=24%  Similarity=0.247  Sum_probs=111.3

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCch--------------------------HHHHHHHHHHHHhCCCCCc
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA--------------------------FKSFAVECEMMKSIRHRNL  550 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~H~ni  550 (646)
                      .+.||+|+||+||+|+..+|+.||||+++......                          ...+.+|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999997789999999987542110                          1123578999999999988


Q ss_pred             eeEEEEEecCCeeEEEEEecCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCC
Q 046544          551 IKVISSCSNEEFKALVLEYKPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDN  628 (646)
Q Consensus       551 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~  628 (646)
                      .....+....  .++||||++|+++... +..  ..++..+...++.|++.++.++|   . .+|+|||+||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5544443332  4899999998855433 332  35677888999999999999999   7 8999999999999999 7


Q ss_pred             CcEEEEeecCcccccC
Q 046544          629 LVAYLSDFGIAKLLIG  644 (646)
Q Consensus       629 ~~~ki~DfGla~~~~~  644 (646)
                      +.++++|||+|+.+..
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.85  E-value=1.3e-20  Score=188.57  Aligned_cols=148  Identities=28%  Similarity=0.394  Sum_probs=134.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999866 599999999876643 3457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++... ..+++.....++.|+++|++|+|   . .+++|||++|+||+++.++.++++|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999765 46889999999999999999999   8 999999999999999999999999999988654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.7e-22  Score=189.31  Aligned_cols=148  Identities=26%  Similarity=0.357  Sum_probs=131.7

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+++|+|.||+|-.++. .+|+.||+|++++..   +........|-++++..+||.+..+.-.|++.+++|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            5788889999999999999984 579999999988653   334456678999999999999999998999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+.||.|.-++...+ .+++..+.-+...|+.|+.|||   +++||.||+|.+|.++|.+|++||+|||++|.-+
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999998887654 6788888889999999999999   8899999999999999999999999999998643

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.85  E-value=1e-20  Score=191.70  Aligned_cols=146  Identities=28%  Similarity=0.458  Sum_probs=129.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +|+..+.||+|++|.||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 689999999876542 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++ ++.+++....  ..+++..+..++.|++.|++|+|   ..+++|||+||+||++++++.+|++|||+++..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            75 8988886543  45899999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1e-21  Score=202.68  Aligned_cols=145  Identities=29%  Similarity=0.450  Sum_probs=125.4

Q ss_pred             ceeecccccceEEEEEeC-CCcEEEEEEEe----ccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe--eEEEEEe
Q 046544          497 NNLIGRGGFGSVYKARLG-DGMEVAVKVFN----LQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF--KALVLEY  569 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~--~~lv~e~  569 (646)
                      ..+||+|+|-+||+|.+. +|.+||--.++    .+.....++|..|+++++.++||||+++|.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999864 68888743332    1234556899999999999999999999999988765  7789999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~  643 (646)
                      +..|+|..|.++.+ .........+++||++||.|||++ .++|||||||-+||+|+ ..|.|||+|.|+|+.+.
T Consensus       125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999998876 578889999999999999999976 78999999999999997 56999999999998753

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.85  E-value=3.1e-21  Score=196.34  Aligned_cols=143  Identities=29%  Similarity=0.362  Sum_probs=127.8

Q ss_pred             CcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          495 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      .....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33466999999999999854 68899999987665555667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|.+++...  .+++.++..++.|++.|++|+|   +++|+||||||+||++++++.+||+|||++..+
T Consensus       105 ~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658         105 ALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            999988543  4788899999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.85  E-value=3.8e-21  Score=195.14  Aligned_cols=148  Identities=29%  Similarity=0.431  Sum_probs=130.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999975 589999998764432  234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++++..+.... ..+++.++..++.|++.|++|||   +.+++|||++|+||++++++.++++|||+++.+.
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            99998888776543 35889999999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.4e-20  Score=188.71  Aligned_cols=147  Identities=26%  Similarity=0.434  Sum_probs=128.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-----CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  563 (646)
                      .+|...+.||+|+||.||+|+.. +++.||+|.+....     ....+.+.+|++++++++|+||+++++++...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57888999999999999999864 68999999876431     23345788899999999999999999988764  468


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||+++++|.+++.... .+++.....++.|++.|+.|||   ..+++|+|+||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999987654 5788889999999999999999   889999999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.3e-20  Score=187.93  Aligned_cols=140  Identities=33%  Similarity=0.480  Sum_probs=122.6

Q ss_pred             eeecccccceEEEEEeC--C--CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG--D--GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      ++||+|+||.||+|.+.  +  +..||+|.+..... ...+++.+|+++++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46899999999999743  2  36899999875543 244678899999999999999999998764 467999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||++++++.+|++|||+++.+
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccccee
Confidence            99999997655 6889999999999999999999   889999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1e-21  Score=193.21  Aligned_cols=152  Identities=31%  Similarity=0.458  Sum_probs=129.0

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-------CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-------GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-~~  562 (646)
                      ++|-....+|+|+|++||+|.+ ...+.||||+-....       ....+...+|..|.+.++||.||++|+++.-+ +.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3566778899999999999984 457889999754321       11235567899999999999999999999765 56


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIA  639 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla  639 (646)
                      .|-|.|||+|.+|.-|++.++ .+++.++..|+.||+.||.||... ..+|||-|+||.|||+.   ..|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            889999999999999998775 688999999999999999999855 68999999999999995   4588999999999


Q ss_pred             ccccCC
Q 046544          640 KLLIGE  645 (646)
Q Consensus       640 ~~~~~~  645 (646)
                      |++.++
T Consensus       621 KIMddd  626 (775)
T KOG1151|consen  621 KIMDDD  626 (775)
T ss_pred             hhccCC
Confidence            999765

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.85  E-value=8.2e-21  Score=194.97  Aligned_cols=150  Identities=29%  Similarity=0.395  Sum_probs=130.3

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKA  564 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  564 (646)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            4578999999999999999999864 689999999875432  2233566899999999999999999998765  5689


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++ +|.+++......+++.++..++.|++.|++|+|   ..+++||||||+||++++++.+||+|||+++.+.
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            99999965 898888766567899999999999999999999   8899999999999999999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.3e-20  Score=190.31  Aligned_cols=146  Identities=29%  Similarity=0.450  Sum_probs=130.2

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCC---CCCceeEEEEEecCCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIR---HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... ....+++.+|+++++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999986 478999999987543 334567888999999986   999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|+|   ..+|+|+||+|+||++++++.++++|||+++.+.
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            999999999998654  6889999999999999999999   8899999999999999999999999999987654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=200.26  Aligned_cols=144  Identities=31%  Similarity=0.464  Sum_probs=129.2

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHH
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLE  576 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~  576 (646)
                      -++|+|.||+||.|++. +...+|||.+..+..+..+....||...++++|.|||++.|.+...++.-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            46999999999999965 46679999998887777788899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCcccccC
Q 046544          577 KYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       577 ~~l~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~~  644 (646)
                      .+++..=+++  .+.+.--+.+||++|+.|||   +..|||||||-+|+||+ -.|.+||+|||-+|.+.+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9998765555  56667778999999999999   89999999999999996 579999999999987754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.85  E-value=5.7e-21  Score=194.86  Aligned_cols=143  Identities=30%  Similarity=0.370  Sum_probs=127.6

Q ss_pred             CcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          495 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      .....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33457999999999999864 68999999987655455567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|..++...  .+++..+..++.|++.|++|+|   ..+++||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659         104 ALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999987553  4788999999999999999999   889999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=1.6e-20  Score=192.72  Aligned_cols=147  Identities=31%  Similarity=0.392  Sum_probs=129.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|.+.....   ...+.+.+|+++++.++||||+++.+++...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999864 689999999864432   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+. |++.+++......+++..+..++.|++.|+.|+|   ..+|+||||+|+||++++++.+||+|||+++..
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            9996 5787777665557899999999999999999999   889999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.85  E-value=1.6e-20  Score=193.51  Aligned_cols=141  Identities=26%  Similarity=0.386  Sum_probs=117.5

Q ss_pred             ceeecccccceEEEEEeC---CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEEEEEecC
Q 046544          497 NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYKP  571 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~  571 (646)
                      ..+||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999864   45789999886442  23457789999999999999999998854  457899999986


Q ss_pred             CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecCc
Q 046544          572 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIA  639 (646)
Q Consensus       572 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~----~~~~~~ki~DfGla  639 (646)
                      + ++.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787777532        124788889999999999999999   8899999999999999    46679999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       160 ~~~~  163 (317)
T cd07867         160 RLFN  163 (317)
T ss_pred             eccC
Confidence            8653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.85  E-value=1.1e-20  Score=193.23  Aligned_cols=151  Identities=29%  Similarity=0.401  Sum_probs=130.8

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC----
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----  561 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----  561 (646)
                      ...++|+..+.+|+|+||.||+|... +|+.||+|+++...  ......+.+|+++++.++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999975 68899999987543  223356778999999999999999999887654    


Q ss_pred             ------eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          562 ------FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       562 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                            ..++||||+++ ++.+++......+++..+..++.|++.|++|||   ..+|+|||+||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 787777665557899999999999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++.+.
T Consensus       160 fg~~~~~~  167 (302)
T cd07864         160 FGLARLYN  167 (302)
T ss_pred             cccccccc
Confidence            99988653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=8.2e-21  Score=192.48  Aligned_cols=148  Identities=24%  Similarity=0.347  Sum_probs=130.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999864 68899999887543 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++...+ .+++.....++.+++.|+.|||+  ..+++|||+||+||++++++.++|+|||+++..
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            99999999887643 67899999999999999999993  258999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.85  E-value=8.3e-21  Score=190.29  Aligned_cols=147  Identities=26%  Similarity=0.331  Sum_probs=132.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +|+..+.||+|+||.||+|... +++.||+|.+..... ...+++.+|+++++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999875 689999999876543 34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++++|.+++......+++.....++.|++.|++|+|   . .+++|+||||+||++++++.+||+|||.+..+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            999999999876567889999999999999999999   7 89999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.85  E-value=2.5e-20  Score=186.93  Aligned_cols=149  Identities=29%  Similarity=0.369  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 68899999987543 33556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   ..+++|||++|+||++++++.+|++|||++..+.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999997642  36788999999999999999999   8899999999999999999999999999987654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.85  E-value=2.1e-20  Score=189.66  Aligned_cols=149  Identities=32%  Similarity=0.402  Sum_probs=134.8

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ..+.|+..+.+|+|+||.||+|... +++.||+|++..... ..+.+.+|++.++.++|+||+++++++...+..|+|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456888899999999999999876 688999999986544 45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++++|.+++......+++..+..++.|++.|++|+|   ..+++|+|++|+||+++.++.++|+|||++...
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            99999999999876546899999999999999999999   899999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=3.3e-20  Score=184.50  Aligned_cols=147  Identities=34%  Similarity=0.470  Sum_probs=132.8

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 688999999876543  4556889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++... ..+++..+..++.|++.|+.|+|   ..+|+|||++|+||+++.++.++|+|||.++...
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999998765 46899999999999999999999   8899999999999999999999999999988654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.84  E-value=4.1e-20  Score=183.43  Aligned_cols=149  Identities=35%  Similarity=0.491  Sum_probs=135.3

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .|+..+.||+|++|.||+|... +++.|++|++........+.+.+|++.++.++|++|+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999975 689999999986655556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +++|.+++......+++..+..++.|++.|++|+|   ..+++|||++|+||++++++.++|+|||.+.....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            99999998776557899999999999999999999   89999999999999999999999999999877643

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.84  E-value=1.8e-20  Score=192.55  Aligned_cols=150  Identities=25%  Similarity=0.401  Sum_probs=128.7

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCC-----
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-----  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----  561 (646)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+.....  .....+.+|++++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457899999999999999999865 689999998865432  22345678999999999999999999987654     


Q ss_pred             ---eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          562 ---FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       562 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                         ..++||||+. +++.+++......+++.++..++.|++.|++|||   ..+++|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               3599999996 4888888776557899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      ++.+.
T Consensus       166 ~~~~~  170 (310)
T cd07865         166 ARAFS  170 (310)
T ss_pred             ccccc
Confidence            87653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.84  E-value=2.2e-20  Score=190.46  Aligned_cols=147  Identities=26%  Similarity=0.377  Sum_probs=126.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCe-----
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEF-----  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~-----  562 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++....  ...+.+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999865 689999998765432  23456788999999994 6999999999887665     


Q ss_pred             eEEEEEecCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeec
Q 046544          563 KALVLEYKPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFG  637 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfG  637 (646)
                      .|+||||+++ ++.+++....    ..+++..+..++.||+.|++|||   .++|+||||||+||+++. ++.+|++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8988876432    35789999999999999999999   889999999999999998 8999999999


Q ss_pred             Ccccc
Q 046544          638 IAKLL  642 (646)
Q Consensus       638 la~~~  642 (646)
                      +++.+
T Consensus       157 ~~~~~  161 (295)
T cd07837         157 LGRAF  161 (295)
T ss_pred             cceec
Confidence            98754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=2.1e-20  Score=188.73  Aligned_cols=140  Identities=25%  Similarity=0.368  Sum_probs=124.0

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||+||+|... +|+.||+|.+....   ....+.+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 68999999987542   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++.... ..+++..+..++.|++.|+.|+|   ..+++||||+|+||++++++.+|++|||.++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence            99987654 35889999999999999999999   889999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.84  E-value=3.8e-21  Score=195.41  Aligned_cols=150  Identities=22%  Similarity=0.340  Sum_probs=128.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--------CchHHHHHHHHHHHHhCC---CCCceeEEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRAFKSFAVECEMMKSIR---HRNLIKVISSC  557 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---H~niv~~~~~~  557 (646)
                      ...+|+..+.+|+|+||.|+.|.++ ...+|+||.+.+.+        ++..-..-.||+||+.++   |+||+++.++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3357899999999999999999865 46789999886543        111223445999999997   99999999999


Q ss_pred             ecCCeeEEEEEec-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          558 SNEEFKALVLEYK-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       558 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      +++++.|++||-. +|-+|.+++..+. .+++.++..|++||+.|+++||   +.+|||||||-+|+.++.+|-+|++||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence            9999999999965 4559999997664 6889999999999999999999   899999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |.|....
T Consensus       715 gsaa~~k  721 (772)
T KOG1152|consen  715 GSAAYTK  721 (772)
T ss_pred             cchhhhc
Confidence            9987653

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.84  E-value=2.7e-20  Score=187.42  Aligned_cols=146  Identities=33%  Similarity=0.566  Sum_probs=123.5

Q ss_pred             CCcceeecccccceEEEEEeC----CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------
Q 046544          494 FSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------  561 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  561 (646)
                      |...+.||+|+||.||+|.++    +++.||+|++..+.  ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566788999999999999753    46889999987543  234567889999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      ..++++||+++|++.+++....     ..+++.....++.|++.|++|+|   +.+|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875321     24688889999999999999999   889999999999999999999999999


Q ss_pred             cCcccc
Q 046544          637 GIAKLL  642 (646)
Q Consensus       637 Gla~~~  642 (646)
                      |+++.+
T Consensus       158 g~~~~~  163 (273)
T cd05074         158 GLSKKI  163 (273)
T ss_pred             cccccc
Confidence            998865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.84  E-value=2.3e-20  Score=192.29  Aligned_cols=146  Identities=27%  Similarity=0.444  Sum_probs=126.2

Q ss_pred             CCCcceeecccccceEEEEEeC---CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  564 (646)
                      +|+..+.||+|+||.||+|+..   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999988633   33346778899999999999999999999988  7899


Q ss_pred             EEEEecCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC----CCcEEEEee
Q 046544          565 LVLEYKPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD----NLVAYLSDF  636 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~----~~~~ki~Df  636 (646)
                      +||||+++ ++.+++....    ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6777664322    35788899999999999999999   889999999999999998    899999999


Q ss_pred             cCcccc
Q 046544          637 GIAKLL  642 (646)
Q Consensus       637 Gla~~~  642 (646)
                      |+++.+
T Consensus       157 g~~~~~  162 (316)
T cd07842         157 GLARLF  162 (316)
T ss_pred             cccccc
Confidence            998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.84  E-value=3e-20  Score=185.13  Aligned_cols=148  Identities=30%  Similarity=0.509  Sum_probs=130.0

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999864 68899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++.... ..+++..+..++.|++.|++|+|   .++++|+|++|+||++++ ++.+|++|||+++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            99999999997653 45789999999999999999999   889999999999999985 4568999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.84  E-value=3.2e-20  Score=185.78  Aligned_cols=151  Identities=26%  Similarity=0.402  Sum_probs=129.8

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~  567 (646)
                      +|+..+.+|+|+||.||+|.. .+++.||+|++....  ....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999985 468899999987542  3344678889999999999999999998764  35679999


Q ss_pred             EecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGC--LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++++|.+++...   ...+++..+..++.|++.|+.|+|..+  ..+++|+||+|+||++++++.+|++|||+++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   457889999999999999999999543  678999999999999999999999999998875


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       161 ~  161 (265)
T cd08217         161 G  161 (265)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=1.7e-20  Score=190.42  Aligned_cols=148  Identities=28%  Similarity=0.390  Sum_probs=129.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...  ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 68899999886542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++.+..+... ...+++..+..++.|++.|++|||   ..+++|||++|+||++++++.+||+|||+++.+.
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            9998766655543 345889999999999999999999   8899999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=4.3e-20  Score=187.54  Aligned_cols=148  Identities=30%  Similarity=0.359  Sum_probs=128.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~  567 (646)
                      ++|...+.||.|++|.||+|... +++.||+|.+..... ....++.+|+++++.++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999964 688999999875433 3456788999999999999999999988654  4689999


Q ss_pred             EecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++++|.+++..   ....+++.....++.|++.|+.|+|   ..+++|+|++|+||++++++.++++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            99999999988653   3345788889999999999999999   889999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.84  E-value=1.4e-20  Score=188.41  Aligned_cols=139  Identities=32%  Similarity=0.449  Sum_probs=125.4

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999976 599999999875432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++...+ .+++..+..++.|+++|++|+|   ..+++||||+|+||++++++.++++|||++...
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            99997755 6889999999999999999999   889999999999999999999999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=3e-20  Score=187.79  Aligned_cols=140  Identities=25%  Similarity=0.307  Sum_probs=117.6

Q ss_pred             eecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHH---HhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          499 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMM---KSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|..++   ...+||+|+.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4799999999999864 689999998875421   1122334444333   33479999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+|.+++...+ .+++..+..++.|++.|++|+|   ..+|+||||||+||++++++.++++|||++...
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            999999987654 6899999999999999999999   889999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.84  E-value=4e-20  Score=185.82  Aligned_cols=149  Identities=25%  Similarity=0.424  Sum_probs=126.6

Q ss_pred             CCCcceeecccccceEEEEEeCC--CcEEEEEEEeccC----------CchHHHHHHHHHHHHh-CCCCCceeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQC----------GRAFKSFAVECEMMKS-IRHRNLIKVISSCSN  559 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~  559 (646)
                      +|+..+.||+|+||.||+|+...  ++.||+|.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999654  7889999875321          2234567778888865 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          560 EEFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      ++..++||||+++++|.+++..   ....+++..+..++.|++.|+.|+|+  ..+++|+||+|+||++++++.+|++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743   34468888999999999999999992  257999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |.+....
T Consensus       159 g~~~~~~  165 (269)
T cd08528         159 GLAKQKQ  165 (269)
T ss_pred             cceeecc
Confidence            9987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.84  E-value=4.4e-20  Score=187.23  Aligned_cols=145  Identities=28%  Similarity=0.356  Sum_probs=129.5

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .|...+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567899999999999985 4688999999876554555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|.+++..  ..+++.++..++.|++.|++|+|   .++++||||+|+||+++.++.++++|||.++..
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            9999999876  35788899999999999999999   889999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.84  E-value=4.8e-20  Score=189.92  Aligned_cols=146  Identities=29%  Similarity=0.372  Sum_probs=128.4

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+++++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677889999999999999864 68899999987442   2334578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+.| ++.+++......+++.++..++.|++.|+.|+|   ..+|+||||+|+||+++.++.+|++|||++...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            9965 888887666667899999999999999999999   889999999999999999999999999988754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.84  E-value=2.6e-20  Score=188.62  Aligned_cols=156  Identities=28%  Similarity=0.392  Sum_probs=132.9

Q ss_pred             cHHHHHHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec-
Q 046544          483 SYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN-  559 (646)
Q Consensus       483 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~-  559 (646)
                      ++.++..+...|+..+.+|+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455555667899999999999999999986 468899999987543 2335678899999998 79999999998853 


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          560 -----EEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       560 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                           ....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+|||+||+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999987643 35788888899999999999999   889999999999999999999999


Q ss_pred             EeecCcccc
Q 046544          634 SDFGIAKLL  642 (646)
Q Consensus       634 ~DfGla~~~  642 (646)
                      +|||+++..
T Consensus       163 ~dfg~~~~~  171 (282)
T cd06636         163 VDFGVSAQL  171 (282)
T ss_pred             eeCcchhhh
Confidence            999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.84  E-value=2.2e-20  Score=189.30  Aligned_cols=146  Identities=29%  Similarity=0.451  Sum_probs=128.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|++|.||+|+.. +|+.||||.+....  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999865 68999999887543  22335788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +. +++..++... ...+++..+..++.|++.|++|||   ..+++|||++|+||++++++.+|++|||+++.+
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            96 5898888653 346789999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=3.4e-20  Score=188.09  Aligned_cols=146  Identities=28%  Similarity=0.430  Sum_probs=129.8

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEEEEE
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKALVLE  568 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e  568 (646)
                      |+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+++++.++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999876 58899999998653  33345788899999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++ ++.+++......+++..+..++.|++.|++|||   ..+++|+||+|+||++++++.+|++|||+++...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            9975 899888766557899999999999999999999   8899999999999999999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=1e-21  Score=216.56  Aligned_cols=150  Identities=33%  Similarity=0.445  Sum_probs=133.3

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +-+|+...+||.|.||.||.|. ..+|+-.|+|.++.+.  .+..+...+|..++..++|||+|+++|+-.+++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3578889999999999999998 5679999999887553  344567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |||++|+|.+.+... +..++.....+..|++.|++|||   ..|||||||||+||+++.+|.+|.+|||.|+.+.+
T Consensus      1314 EyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999988654 35677777788999999999999   89999999999999999999999999999988753

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.5e-20  Score=187.72  Aligned_cols=149  Identities=29%  Similarity=0.385  Sum_probs=130.7

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC------
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE------  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~------  561 (646)
                      .+++|+..+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999975 678999999875543 346788999999999 7999999999997644      


Q ss_pred             eeEEEEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          562 FKALVLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.|++|||   ..+++|+||+|+||++++++.+|++|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988653   356889999999999999999999   88999999999999999999999999999


Q ss_pred             cccc
Q 046544          639 AKLL  642 (646)
Q Consensus       639 a~~~  642 (646)
                      +...
T Consensus       160 ~~~~  163 (275)
T cd06608         160 SAQL  163 (275)
T ss_pred             ceec
Confidence            8654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.84  E-value=3e-20  Score=193.51  Aligned_cols=149  Identities=23%  Similarity=0.354  Sum_probs=128.2

Q ss_pred             HHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC---
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE---  561 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~---  561 (646)
                      ....++|+..+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|++++++++||||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567899999999999999999985 478999999986432  223456788999999999999999999887653   


Q ss_pred             ---eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          562 ---FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       562 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                         ..++||||+ ++++.+++...  .+++..+..++.|++.|++|+|   ..+|+||||||+||+++.++.+|++|||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence               358999999 77999887643  5889999999999999999999   88999999999999999999999999999


Q ss_pred             cccc
Q 046544          639 AKLL  642 (646)
Q Consensus       639 a~~~  642 (646)
                      ++..
T Consensus       165 ~~~~  168 (343)
T cd07880         165 ARQT  168 (343)
T ss_pred             cccc
Confidence            8765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.3e-21  Score=190.77  Aligned_cols=149  Identities=24%  Similarity=0.344  Sum_probs=132.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +.|..-++||+|+||+||-++.+ +|+.||+|.+.++.-   ....-...|..++.++..+.||.+--+|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45778899999999999999855 799999998765431   22234567999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ..|.||+|.-++.+.+ ..+++..++-++++|+.||++||   ..+||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999988765 46899999999999999999999   8999999999999999999999999999998764

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.84  E-value=5.5e-20  Score=185.79  Aligned_cols=140  Identities=24%  Similarity=0.305  Sum_probs=117.9

Q ss_pred             eecccccceEEEEEeC-CCcEEEEEEEeccCCc---hHHHHHHHH---HHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          499 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR---AFKSFAVEC---EMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .||+|+||.||+|+.. +|+.||+|.+......   ....+..|.   +.++...||+|+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3799999999999854 6899999998754311   112233343   34455689999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+|.+++... ..+++..+..++.|++.|+.|+|   +.+|+|||+||+||+++.++.+||+|||+++.+
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            99999988654 36899999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.83  E-value=2e-20  Score=187.93  Aligned_cols=142  Identities=32%  Similarity=0.533  Sum_probs=122.8

Q ss_pred             eeecccccceEEEEEeCC-------CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          498 NLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998532       3579999876543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-----cEEEEeecC
Q 046544          570 KPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-----VAYLSDFGI  638 (646)
Q Consensus       570 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-----~~ki~DfGl  638 (646)
                      +++|+|.+++...      ...+++.++..++.|++.|++|+|   ..+++|+|+||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753      234678889999999999999999   88999999999999999877     899999999


Q ss_pred             cccc
Q 046544          639 AKLL  642 (646)
Q Consensus       639 a~~~  642 (646)
                      ++.+
T Consensus       158 ~~~~  161 (269)
T cd05044         158 ARDI  161 (269)
T ss_pred             cccc
Confidence            8754

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.83  E-value=6.6e-20  Score=182.69  Aligned_cols=148  Identities=30%  Similarity=0.473  Sum_probs=133.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||++... +++.||+|++.....  ...+.+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999865 689999999876533  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++...   ...+++.....++.+++.|+.|||   ..+++|+|++|+||++++++.++++|||++....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            9999999999775   367899999999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.83  E-value=7e-20  Score=182.52  Aligned_cols=147  Identities=32%  Similarity=0.452  Sum_probs=133.0

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~  567 (646)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  ...++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999976 689999999876542  4467888999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   ..+++|+|++|+||+++.++.++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            9999999999997765 7899999999999999999999   8899999999999999999999999999988664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.83  E-value=5.4e-20  Score=184.11  Aligned_cols=141  Identities=29%  Similarity=0.424  Sum_probs=126.1

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++..+...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 58999999987543   23346788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .+++.... .+++..+..++.|++.|++|+|   .++++|+||+|+||+++.++.+|++|||+++....
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            99997654 5788899999999999999999   89999999999999999999999999999887643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=1.5e-20  Score=204.90  Aligned_cols=150  Identities=22%  Similarity=0.255  Sum_probs=118.9

Q ss_pred             HhCCCCcceeecccccceEEEEEeC--CCcEEEEEEE--------------ec---cCCchHHHHHHHHHHHHhCCCCCc
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVF--------------NL---QCGRAFKSFAVECEMMKSIRHRNL  550 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~H~ni  550 (646)
                      ..++|++.+.||+|+||+||+|..+  ++..++.|.+              .+   ........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3468999999999999999998753  2222222211              00   111233567889999999999999


Q ss_pred             eeEEEEEecCCeeEEEEEecCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       551 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      +++++++...+..|+|+|++. +++.+++....    .......+..++.|++.||+|||   +++||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999985 57887775432    12335567789999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      .++.+||+|||+|+.+.
T Consensus       302 ~~~~vkL~DFGla~~~~  318 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFE  318 (501)
T ss_pred             CCCCEEEEeCCCceecC
Confidence            99999999999998764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.83  E-value=1.7e-20  Score=189.51  Aligned_cols=148  Identities=34%  Similarity=0.526  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999865 79999999987532   233456788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++...+ .+++..+..++.|++.|+.|||   ..+++|+|++|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999997664 6899999999999999999999   8899999999999999999999999999988654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.83  E-value=9.8e-20  Score=182.75  Aligned_cols=151  Identities=25%  Similarity=0.296  Sum_probs=124.4

Q ss_pred             HHHHHHHhCCCCcceee--cccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec
Q 046544          484 YLELCRATNGFSENNLI--GRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN  559 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  559 (646)
                      ..+.....+.|+..+.+  |+|+||.||+++.+ +++.+|+|.+........     |+.....+ +||||+++++.+..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34445555677776666  99999999999854 688899999875422111     22222222 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecC
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGI  638 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGl  638 (646)
                      .+..++||||+++|+|.+++.... .+++.++..++.|+++|++|+|   ..+++||||||+||+++.++ .++++|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999997764 7899999999999999999999   88999999999999999888 999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      ++...
T Consensus       157 ~~~~~  161 (267)
T PHA03390        157 CKIIG  161 (267)
T ss_pred             ceecC
Confidence            87654

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.83  E-value=5.9e-20  Score=185.90  Aligned_cols=145  Identities=23%  Similarity=0.326  Sum_probs=124.7

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCC-CCCceeEEEEEecC--CeeEEEEE
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLE  568 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e  568 (646)
                      |+..+.+|+|+||.||+|+.. +++.||+|+++... ........+|+.+++++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999854 68999999887542 222234457888899885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++ |++.+++......+++.++..++.|++.|++|||   ..+++||||+|+||+++. +.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            997 5888888766567899999999999999999999   889999999999999999 999999999998653

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.83  E-value=2.4e-21  Score=182.17  Aligned_cols=146  Identities=26%  Similarity=0.315  Sum_probs=121.2

Q ss_pred             HhCCCCcc-eeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec----CCe
Q 046544          490 ATNGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN----EEF  562 (646)
Q Consensus       490 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~----~~~  562 (646)
                      .+++|++. ++||-|--|+|..+.. ++|+.+|+|++..     .+...+|++..-.. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556543 7899999999999975 4799999998752     24456788764443 79999999998764    355


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecC
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGI  638 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGl  638 (646)
                      +.+|||.|+||.|...+++++ ..+.+.++..|++||+.|++|||   +.+|.|||+||+|+|..   .+..+|++|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            779999999999999998775 46899999999999999999999   89999999999999995   456899999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      ||.-.
T Consensus       211 AK~t~  215 (400)
T KOG0604|consen  211 AKETQ  215 (400)
T ss_pred             ccccC
Confidence            99754

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.83  E-value=7.2e-20  Score=186.58  Aligned_cols=147  Identities=28%  Similarity=0.413  Sum_probs=125.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|.+.....  ...+.+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999865 689999998865432  234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~  642 (646)
                      |++ +++.+++.... ...++..+..++.|++.|++|||   .++++||||+|+||+++. ++.+|++|||+++..
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            996 58888775543 23577788899999999999999   889999999999999984 567999999998754

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.83  E-value=4.2e-20  Score=187.71  Aligned_cols=147  Identities=24%  Similarity=0.385  Sum_probs=128.2

Q ss_pred             CCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          493 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      +|+..+.||+|+||.||+|+.    .+++.||+|+++...    ....+.+.+|++++.++ +||+|+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477789999999999999974    257889999987432    22345678899999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||+++|+|.+++.... .+++..+..++.|+++|++|||   ..+++|||++|+||+++.++.++++|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999986543 5788889999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.83  E-value=3.7e-20  Score=188.37  Aligned_cols=141  Identities=28%  Similarity=0.356  Sum_probs=126.4

Q ss_pred             ceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          497 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ..+||+|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999986 47899999988755544556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++...  .+++.....++.|++.|++|+|   ..+++|||++|+||+++.++.++++|||++..+
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            9987543  4788899999999999999999   889999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.83  E-value=5.4e-20  Score=191.77  Aligned_cols=155  Identities=23%  Similarity=0.311  Sum_probs=131.5

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEe
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCS  558 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  558 (646)
                      ....++...+++|+..+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            33456677889999999999999999999985 478999999987532  223456778999999999999999999876


Q ss_pred             cC------CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          559 NE------EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       559 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                      ..      ...+++++++ +++|.+++...  .+++..+..++.|++.|++|+|   +.+|+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 78998887643  4889999999999999999999   88999999999999999999999


Q ss_pred             EEeecCcccc
Q 046544          633 LSDFGIAKLL  642 (646)
Q Consensus       633 i~DfGla~~~  642 (646)
                      |+|||+++..
T Consensus       161 l~dfg~~~~~  170 (345)
T cd07877         161 ILDFGLARHT  170 (345)
T ss_pred             Eecccccccc
Confidence            9999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.83  E-value=5.8e-20  Score=183.21  Aligned_cols=148  Identities=26%  Similarity=0.416  Sum_probs=129.4

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999865 68899999987542  23445778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      +++++|.+++.... ..+++..+..++.|+++|++|+|   ..+++|+|+||+||++++++ .+|++|||.+....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            99999999986543 35789999999999999999999   88999999999999998775 57999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.83  E-value=7.5e-20  Score=185.30  Aligned_cols=145  Identities=31%  Similarity=0.460  Sum_probs=128.2

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      |+..+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+++++.++|||++++++++...+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999864 79999999987553  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      + +++.+++.... ..+++..+..++.|+++|++|+|   .++++|||++|+||++++++.++++|||+++.+
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            5 68999886544 35889999999999999999999   889999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=4e-20  Score=192.19  Aligned_cols=146  Identities=25%  Similarity=0.382  Sum_probs=126.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Cee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~  563 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999854 78999999986432 33446678899999999999999999887654     357


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|+||+++ ++.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999964 888887543  5889999999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=6.9e-20  Score=191.72  Aligned_cols=147  Identities=25%  Similarity=0.326  Sum_probs=126.1

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------  560 (646)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3478999999999999999999864 78999999986432  23345677899999999999999999988644      


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ...|+||||+.+ ++.+.+...   +++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+|++|||+++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            346999999964 888887543   788889999999999999999   8899999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       167 ~~~  169 (353)
T cd07850         167 TAG  169 (353)
T ss_pred             eCC
Confidence            653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.8e-20  Score=182.33  Aligned_cols=141  Identities=27%  Similarity=0.348  Sum_probs=119.8

Q ss_pred             eeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHH-HhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMM-KSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|... +|+.||+|++.....   .....+..|..++ ...+|+||+++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 689999999865431   1223344555444 455899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|.+++...+ .+++..+..++.|++.|+.|+|   ..+++||||+|+||++++++.+|++|||+++..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999987654 6788999999999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00284 protein kinase; Provisional

Probab=99.82  E-value=4.4e-20  Score=200.35  Aligned_cols=149  Identities=23%  Similarity=0.327  Sum_probs=121.1

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC------CCceeEEEEEec
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH------RNLIKVISSCSN  559 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~~~~~~~~  559 (646)
                      +.....+|++.+.||+|+||+||+|... +++.||||+++... ...+....|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999864 68899999986432 223445667777777654      458888888876


Q ss_pred             C-CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCC--------
Q 046544          560 E-EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNL--------  629 (646)
Q Consensus       560 ~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~--------  629 (646)
                      . +..++|||++ |++|.+++...+ .+++..+..|+.||+.||+|||   . .+||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            5 5788999988 778999887654 6889999999999999999999   6 5999999999999998655        


Q ss_pred             --------cEEEEeecCccc
Q 046544          630 --------VAYLSDFGIAKL  641 (646)
Q Consensus       630 --------~~ki~DfGla~~  641 (646)
                              .+||+|||.+..
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~  297 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCD  297 (467)
T ss_pred             cccCCCCceEEECCCCcccc
Confidence                    499999998764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.82  E-value=3.6e-20  Score=192.38  Aligned_cols=146  Identities=25%  Similarity=0.355  Sum_probs=126.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~  564 (646)
                      .+|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999854 69999999987543  2334667789999999999999999988753    34689


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||+. |++.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||++++++.+||+|||+++..
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 58988886544 5899999999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.82  E-value=2.2e-19  Score=184.64  Aligned_cols=145  Identities=30%  Similarity=0.376  Sum_probs=127.4

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      |...+.||+|+||.||+|+.. +|+.||+|.+.....   ...+.+.+|+++++.++|||++++++++......|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566788999999999999864 688999999875432   3345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +. |++.+++......+++.++..++.|++.|++|||   ..+++|||++|+||++++++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 5888888766667899999999999999999999   889999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.82  E-value=6.8e-20  Score=190.56  Aligned_cols=147  Identities=29%  Similarity=0.421  Sum_probs=126.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc--CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecC--CeeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE--EFKA  564 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~--~~~~  564 (646)
                      .++|+..+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888899999999999999865 6889999988543  223345677899999999 999999999988654  3579


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||++ ++|..++...  .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++.+.
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999997 5999988654  5788888999999999999999   8899999999999999999999999999988653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.82  E-value=1e-19  Score=181.25  Aligned_cols=148  Identities=28%  Similarity=0.433  Sum_probs=130.5

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+++.. +++.||+|.+....  ......+.+|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999754 68899999987543  23345778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++...   +..+++..+..++.|++.|++|+|   ..+++|+||+|+||++++++.+|++|||+++...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            9999999998662   245788889999999999999999   8899999999999999999999999999987653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.82  E-value=1.2e-19  Score=188.62  Aligned_cols=147  Identities=24%  Similarity=0.356  Sum_probs=126.4

Q ss_pred             CCCC-cceeecccccceEEEEEeC-CCcEEEEEEEeccCCch--------------HHHHHHHHHHHHhCCCCCceeEEE
Q 046544          492 NGFS-ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRA--------------FKSFAVECEMMKSIRHRNLIKVIS  555 (646)
Q Consensus       492 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~~~~  555 (646)
                      ++|. ..+.||+|+||.||+|+.. +++.||+|.+.......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999864 68999999986442211              124678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       556 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                      ++...+..++||||+. |++.+++.... .+++.....++.|++.|++|||   ..+|+||||+|+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 58999886543 5788999999999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++...
T Consensus       163 fg~~~~~~  170 (335)
T PTZ00024        163 FGLARRYG  170 (335)
T ss_pred             ccceeecc
Confidence            99987654

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.82  E-value=1.3e-19  Score=185.79  Aligned_cols=147  Identities=30%  Similarity=0.415  Sum_probs=128.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+...   .....+++.+|+++++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667788999999999999864 6888999988643   2233457788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+. |++.+++......+++.++..++.|++.|+.|+|   ..+++||||+|+||+++.++.+|++|||++...
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            9996 5888887665566889999999999999999999   889999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.82  E-value=1.2e-19  Score=183.66  Aligned_cols=146  Identities=29%  Similarity=0.408  Sum_probs=129.5

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      |+..+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999864 689999999875432  23467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++ ++.+++......+++..+..++.|++.|+.|||   ..+|+|+||||+||++++++.+||+|||.+....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            75 898888776567899999999999999999999   8899999999999999999999999999987654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.82  E-value=1.2e-19  Score=186.92  Aligned_cols=142  Identities=23%  Similarity=0.213  Sum_probs=120.6

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .+.+|.|+++.||+++. +++.||+|++...  .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555444 6899999998755  33455688999999999999999999999999999999999999999


Q ss_pred             HHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          575 LEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       575 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +.+++... ...+++.....++.|++.|++|||   ..+|+||||||+||+++.++.+|++|||.+..+
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            99999764 345788889999999999999999   889999999999999999999999999988654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.82  E-value=8.9e-20  Score=189.63  Aligned_cols=148  Identities=26%  Similarity=0.354  Sum_probs=127.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Ce
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  562 (646)
                      .++|...+.||+|+||.||+|+.. +++.||||.+...  .....+.+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357889999999999999999854 6899999988753  233345677899999999999999999987654     34


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+||||+. ++|.+++...+ .+++..+..++.|++.|+.|||   .++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68988886553 6889999999999999999999   889999999999999999999999999998865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       159 ~  159 (337)
T cd07858         159 S  159 (337)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.82  E-value=7.9e-20  Score=187.77  Aligned_cols=148  Identities=26%  Similarity=0.397  Sum_probs=127.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC-------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE-------  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  560 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.....  .....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999865 689999998865432  2234667899999999999999999887543       


Q ss_pred             -CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          561 -EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       561 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                       ...++||||+++ ++...+......+++..+..++.|+++|++|+|   ..+|+|||+||+||++++++.+|++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999965 787777665567899999999999999999999   889999999999999999999999999998


Q ss_pred             ccc
Q 046544          640 KLL  642 (646)
Q Consensus       640 ~~~  642 (646)
                      +..
T Consensus       163 ~~~  165 (311)
T cd07866         163 RPY  165 (311)
T ss_pred             hhc
Confidence            765

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.2e-19  Score=193.80  Aligned_cols=150  Identities=22%  Similarity=0.299  Sum_probs=117.4

Q ss_pred             HhCCCCcceeecccccceEEEEEe-----------------CCCcEEEEEEEeccCCchHHH--------------HHHH
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL-----------------GDGMEVAVKVFNLQCGRAFKS--------------FAVE  538 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  538 (646)
                      ..++|++.++||+|+||.||+|..                 ..++.||||.+........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 235679999987543322222              3346


Q ss_pred             HHHHHhCCCCCc-----eeEEEEEec--------CCeeEEEEEecCCCCHHHHHhhCC----------------------
Q 046544          539 CEMMKSIRHRNL-----IKVISSCSN--------EEFKALVLEYKPHGSLEKYLYSSN----------------------  583 (646)
Q Consensus       539 ~~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  583 (646)
                      +.++.+++|.++     +++.++|..        ++..++||||+++|+|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766654     566666643        356899999999999999886431                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          584 -CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       584 -~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                       ...++..+..++.|++.|+.|+|   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  359 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM  359 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence             12356678889999999999999   889999999999999999999999999998754

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.82  E-value=1.6e-19  Score=184.10  Aligned_cols=148  Identities=26%  Similarity=0.331  Sum_probs=126.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|.+. +++.||||.++... ....+.+.+|+.++.+. .||||+++++++......|+|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56888999999999999999976 48999999987543 23345567788777666 49999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+. +++..+.......+++..+..++.|++.|++|+|   . ++|+||||+|+||++++++.+||+|||+++.+.
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            985 4788777665557899999999999999999999   5 589999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.81  E-value=1.6e-19  Score=186.74  Aligned_cols=149  Identities=30%  Similarity=0.388  Sum_probs=128.4

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCee
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFK  563 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~  563 (646)
                      ...+++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346688999999999999999999854 79999999876432  2334677889999999999999999998876 4578


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||+ ++++.+++...  .+++.....++.|+++|++|||   ..+|+|||++|+||++++++.+|++|||.++..
T Consensus        86 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            9999998 56898888643  4677888889999999999999   889999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.81  E-value=8.7e-20  Score=189.24  Aligned_cols=146  Identities=28%  Similarity=0.354  Sum_probs=129.3

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-----eeE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-----FKA  564 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~  564 (646)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+++++.++|+||+++.+++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999965 58999999987543  334567889999999999999999999988775     789


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||++ +++.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.++++|||+++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 48998886654 7889999999999999999999   8899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-19  Score=192.44  Aligned_cols=155  Identities=28%  Similarity=0.381  Sum_probs=132.9

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec---
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN---  559 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~---  559 (646)
                      +.+...+.-|.+.+.||+|.+|+||+++ .++|+.+|+|+.....+.+ ++...|.++++.. +|||++.+++++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3334455678899999999999999998 4578889999987665433 5667788888887 79999999999864   


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          560 --EEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       560 --~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                        ++.+|+|||||.||+..++++.- +..+.|.....|++.++.|+++||   ...++|||+|-.|||++..+.||++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence              36899999999999999999764 456888889999999999999999   889999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |++..+.
T Consensus       168 GvSaQld  174 (953)
T KOG0587|consen  168 GVSAQLD  174 (953)
T ss_pred             eeeeeee
Confidence            9988663

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=7.4e-22  Score=203.72  Aligned_cols=208  Identities=24%  Similarity=0.268  Sum_probs=94.0

Q ss_pred             cccCCCCCEEEccCCccccccCccccCCCC---CCeEEeecccccC----cCchhhcCC-CCCcEEEecCCccccc----
Q 046544          182 ITNLTNSITIDLGGNKLNGSIPITLSKLQK---LQGLGLDDNKLEG----SIPDSICRL-TELYELELGGNKLFGS----  249 (646)
Q Consensus       182 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~i~~~----  249 (646)
                      +..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++.+    .+...+..+ ++|+.|++++|.+++.    
T Consensus        77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  156 (319)
T cd00116          77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA  156 (319)
T ss_pred             HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence            333444444444444444333333333322   5555555555442    122233344 5555555555555421    


Q ss_pred             CCccccCCCCCceeecCCCcccc-----cccccccccccccccCCCCcccCC----CCCccCccccceEEEccccccccc
Q 046544          250 IPACFSNLASLRILSLSSNELTS-----IPLTFWNLKDILQLNFSSNFLTGP----LPLEIGNLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~  320 (646)
                      .+..+..+++|+.|++++|.++.     ++..+...++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++.
T Consensus       157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence            22234444555555555555541     122223334455555555544322    112233444555555555555432


Q ss_pred             CccccC-----CCCCCCEEEccCccCCC----cccccccCCCCCCEEEccCCcCccc----CCccccCC-CCCCceeCcC
Q 046544          321 IPTEIG-----GLKNLEYLFLGYNRLEG----SIPDSFGDLISLKFLNLSNNNLSGA----IPTSLEKL-SYLEDLNLSF  386 (646)
Q Consensus       321 ~~~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~  386 (646)
                      ....+.     ..+.|++|++++|.+++    .....+..+++|+.+++++|.++..    ....+... +.|+++++.+
T Consensus       237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (319)
T cd00116         237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD  316 (319)
T ss_pred             HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence            221111     12456666666666541    1223444445666666666666533    22233333 4556666655


Q ss_pred             Ccc
Q 046544          387 NKL  389 (646)
Q Consensus       387 N~l  389 (646)
                      |++
T Consensus       317 ~~~  319 (319)
T cd00116         317 DSF  319 (319)
T ss_pred             CCC
Confidence            543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=1.1e-19  Score=183.80  Aligned_cols=145  Identities=32%  Similarity=0.465  Sum_probs=129.3

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      |+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+..|+++++.++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999865 58999999988653  333467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      + ++|.+++......+++..+..++.|++.|++|||   ..+|+||||+|+||++++++.+||+|||.++..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            7 5999999876456899999999999999999999   889999999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.81  E-value=2.4e-20  Score=173.28  Aligned_cols=148  Identities=24%  Similarity=0.289  Sum_probs=126.4

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+....+|.|+.|.|++++.+ +|...|||.+.... ....+++.+.+.++..- +.|+||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344567999999999999976 58899999987654 44567788888877666 4899999999999999999999998


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      . .....+++.-..++++.-+=++...+++||.||..  .++|+|||+||+|||+|+.|++|+||||++-.+.+
T Consensus       174 s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence            4 46777777767788888888899999999999985  45899999999999999999999999999887754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.81  E-value=3.7e-20  Score=165.34  Aligned_cols=150  Identities=25%  Similarity=0.340  Sum_probs=124.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHH-hCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMK-SIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~-~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      +.......||+|+||.|-+-++. +|+..|+|.++..- .+..++..+|..+.. ....|.+|+++|....++..|+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            33445577999999999888754 79999999987553 344567778887754 4589999999999999999999999


Q ss_pred             ecCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .|. .+|..+.+   ..+...++.-.=+|+..|+.|+.|||+  ...+||||+||+||||+.+|+||+||||++-.+.+
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            995 47766654   345678898889999999999999996  45899999999999999999999999999877653

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.81  E-value=1.9e-19  Score=186.50  Aligned_cols=139  Identities=24%  Similarity=0.313  Sum_probs=121.5

Q ss_pred             eeeccc--ccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      ..||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  89999999864 79999999987543  22346788899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          573 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       573 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      +++.+++.... ..+++..+..++.|++.||+|+|   .++|+||||||+||+++.++.+|++|||.+
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            99999987643 35788888999999999999999   889999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=1.4e-19  Score=183.81  Aligned_cols=148  Identities=28%  Similarity=0.366  Sum_probs=123.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999865 68999999987543 234457888999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYL---YS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +.. ++.++.   .. ....+++..+..++.|++.|++|+|+  ..+++||||||+||+++.++.+||+|||+|+.+.
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            864 554433   22 23568899999999999999999993  2489999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=3.4e-19  Score=169.06  Aligned_cols=138  Identities=15%  Similarity=0.254  Sum_probs=107.6

Q ss_pred             CCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-----CCCCceeEEEEEecCC---eeE-
Q 046544          494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-----RHRNLIKVISSCSNEE---FKA-  564 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~~~~~~~~~~---~~~-  564 (646)
                      ....+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     .||||++++++++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996 2223444 69988765444557889999999999     5799999999999873   434 


Q ss_pred             EEEEe--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCEEEcC----CCcEEEEeec
Q 046544          565 LVLEY--KPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGCLAPVIHCDLKPDNVLLDD----NLVAYLSDFG  637 (646)
Q Consensus       565 lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~iiHrdlk~~Nil~~~----~~~~ki~DfG  637 (646)
                      +||||  +.+|+|.+++.+.  .+++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5579999999764  35544  35677888777 9999   899999999999999973    3489999944


Q ss_pred             Ccc
Q 046544          638 IAK  640 (646)
Q Consensus       638 la~  640 (646)
                      -++
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=1.7e-19  Score=182.76  Aligned_cols=146  Identities=25%  Similarity=0.357  Sum_probs=127.3

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      |+..+.||+|++|.||+|+.. +++.||+|.+..... .......+|+..+++++ |+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 588899998865432 22234557899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                       +|++.+++.... ..+++..+..++.|++.|+.|||   .++++|+||+|+||++++++.++++|||+++...
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence             789999887654 46789999999999999999999   8899999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.81  E-value=2.8e-19  Score=185.50  Aligned_cols=146  Identities=23%  Similarity=0.285  Sum_probs=123.0

Q ss_pred             CCCcceeecccccceEEEEEeC-C--CcEEEEEEEeccC--CchHHHHHHHHHHHHhC-CCCCceeEEEEEecC----Ce
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-D--GMEVAVKVFNLQC--GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE----EF  562 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~----~~  562 (646)
                      +|+..+.||+|+||.||+|+.. +  ++.||+|++....  ....+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999864 4  7889999886432  22345678899999999 599999999875432    45


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++++||+. ++|.+++... ..+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+|+.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 5899888654 36889999999999999999999   889999999999999999999999999999865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       156 ~  156 (332)
T cd07857         156 S  156 (332)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=5.4e-19  Score=179.30  Aligned_cols=145  Identities=28%  Similarity=0.449  Sum_probs=123.6

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhC---CCCCceeEEEEEecCCe-----
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSI---RHRNLIKVISSCSNEEF-----  562 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~-----  562 (646)
                      |+..+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 489999999975432  2234566787777665   69999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .+++|||+.+ ++.+++.... ..+++..+..++.|+++|++|||   ..+++|+|++|+||++++++.+|++|||.++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999964 8988886643 35889999999999999999999   88999999999999999999999999999876


Q ss_pred             c
Q 046544          642 L  642 (646)
Q Consensus       642 ~  642 (646)
                      +
T Consensus       157 ~  157 (287)
T cd07838         157 Y  157 (287)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.81  E-value=6e-21  Score=197.13  Aligned_cols=148  Identities=30%  Similarity=0.440  Sum_probs=135.6

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|...+.+|+|+||.||||+. ++++.+|+|+++.....+.+-..+|+-+++..+|||||.+++.+..++..|++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            5788899999999999999995 579999999999888778888889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      .||+|++..+-. +++++.+...+++...+|+.|+|   .++=+|||||-.||++.+.|.+|++|||.+..+.
T Consensus        95 gggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   95 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             CCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh
Confidence            999999876544 47889999999999999999999   8888999999999999999999999999987653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-19  Score=199.92  Aligned_cols=150  Identities=29%  Similarity=0.495  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEeC----C----CcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----D----GMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ++.+..+.+|+|+||.|++|...    .    ...||||..+... ..+.+.+..|+++|+.+ +|+||+.+.|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44455669999999999999732    1    4569999987543 34567899999999998 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..++|+||++.|+|.++++..+               ..++..+.+.++.|||.|++||+   +.++||||+.++|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999998876               34888899999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCcccccC
Q 046544          627 DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~~  644 (646)
                      ++..+||+|||+||....
T Consensus       453 ~~~~~kIaDFGlar~~~~  470 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYN  470 (609)
T ss_pred             CCCEEEEccccceeccCC
Confidence            999999999999996544

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=4.2e-22  Score=172.47  Aligned_cols=162  Identities=31%  Similarity=0.520  Sum_probs=105.8

Q ss_pred             cCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccc
Q 046544          207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQL  286 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  286 (646)
                      .++.+++.|.||+|+++ .+|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++..+|..|+.++.|+.|
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levl  107 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVL  107 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhh
Confidence            34566777778888887 56666777777888888877776 56667777777777777777777777777777777777


Q ss_pred             cCCCCcccC-CCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcC
Q 046544          287 NFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNL  365 (646)
Q Consensus       287 ~l~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  365 (646)
                      |+..|++.. .+|+.|..++.|+.|+|+.|.+. +.|..++.+++||.|.+.+|.+- ..|..++.++.|++|.+.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            777776643 44566666666666666666655 45555555555555555555554 4555555555555555555555


Q ss_pred             cccCCccc
Q 046544          366 SGAIPTSL  373 (646)
Q Consensus       366 ~~~~p~~~  373 (646)
                      + .+|..+
T Consensus       186 ~-vlppel  192 (264)
T KOG0617|consen  186 T-VLPPEL  192 (264)
T ss_pred             e-ecChhh
Confidence            5 344333

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=3.8e-19  Score=185.27  Aligned_cols=145  Identities=26%  Similarity=0.367  Sum_probs=123.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  561 (646)
                      ..+|...+.||+|+||.||+|+.. +|+.||+|.+....  ......+.+|+++++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999854 68999999886532  223456788999999999999999999887542      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..++||||+.. ++..+..   ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776652   25788899999999999999999   88999999999999999999999999999876


Q ss_pred             c
Q 046544          642 L  642 (646)
Q Consensus       642 ~  642 (646)
                      .
T Consensus       167 ~  167 (342)
T cd07879         167 A  167 (342)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.80  E-value=4.2e-19  Score=176.25  Aligned_cols=140  Identities=34%  Similarity=0.436  Sum_probs=125.5

Q ss_pred             ecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          500 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       500 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      ||+|+||.||++... +++.||+|++.....   .....+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 589999999875532   2345788899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      .+++.... .+++.....++.|++.|+.|+|   ..+++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            99997654 5789999999999999999999   8999999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.80  E-value=2.4e-19  Score=186.75  Aligned_cols=145  Identities=28%  Similarity=0.409  Sum_probs=125.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC----------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE----------  560 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~----------  560 (646)
                      .+|+..+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67899999999999999999864 6899999998776655667788999999999999999999776544          


Q ss_pred             ----CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEe
Q 046544          561 ----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSD  635 (646)
Q Consensus       561 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~D  635 (646)
                          ...++||||++ ++|.+++...  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 5898887543  5788999999999999999999   88999999999999997 556799999


Q ss_pred             ecCcccc
Q 046544          636 FGIAKLL  642 (646)
Q Consensus       636 fGla~~~  642 (646)
                      ||.++.+
T Consensus       159 fg~~~~~  165 (342)
T cd07854         159 FGLARIV  165 (342)
T ss_pred             cccceec
Confidence            9998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.80  E-value=7.4e-19  Score=179.02  Aligned_cols=146  Identities=26%  Similarity=0.407  Sum_probs=111.7

Q ss_pred             CCCCcceeecccccceEEEEEeCC----CcEEEEEEEeccCCchH-----------HHHHHHHHHHHhCCCCCceeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCGRAF-----------KSFAVECEMMKSIRHRNLIKVISS  556 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~~~~~  556 (646)
                      ++|++.+.||+|+||.||+|+..+    +..+|+|+.........           .....+...+..++|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998653    45677776443322110           112223345566789999999987


Q ss_pred             EecCC----eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          557 CSNEE----FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       557 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                      +....    ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|+|   +++|+||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            66543    45788888743 6666665432 3567788899999999999999   88999999999999999999999


Q ss_pred             EEeecCcccc
Q 046544          633 LSDFGIAKLL  642 (646)
Q Consensus       633 i~DfGla~~~  642 (646)
                      |+|||+|+.+
T Consensus       167 l~DFGla~~~  176 (294)
T PHA02882        167 IIDYGIASHF  176 (294)
T ss_pred             EEEcCCceee
Confidence            9999999865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.79  E-value=2.6e-19  Score=186.54  Aligned_cols=148  Identities=23%  Similarity=0.330  Sum_probs=128.0

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCe----
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF----  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----  562 (646)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999865 68899999886432  2234567789999999999999999988766554    


Q ss_pred             --eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          563 --KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       563 --~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                        .++|+||+ +++|.+++...  .+++..+..++.|++.|++|+|   ..+|+||||||+||++++++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999998 67999988653  5889999999999999999999   8899999999999999999999999999988


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       167 ~~~  169 (343)
T cd07851         167 HTD  169 (343)
T ss_pred             ccc
Confidence            653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=7.5e-21  Score=176.36  Aligned_cols=146  Identities=26%  Similarity=0.381  Sum_probs=122.7

Q ss_pred             CcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----CeeEEE
Q 046544          495 SENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFKALV  566 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~~lv  566 (646)
                      +..+.||-|+||.||.+++ ++|+.||.|.+..-.  -...+++.+|++++..++|.|+....++....     .++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4457899999999999985 479999999775332  23457888999999999999999988876654     356889


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      +|.|. .+|.+.+-... .++.+.+.-+..||++|+.|||   +.+|.||||||.|.|++++...||||||+||....+
T Consensus       136 TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            99985 48888775543 6777888889999999999999   899999999999999999999999999999987654

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=3e-19  Score=181.13  Aligned_cols=149  Identities=23%  Similarity=0.289  Sum_probs=128.9

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEec--cCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ...|++.+.||+||.++||++...+.+.||+|.+..  .+......|..|++.+.++ .|.+||++++|-..++++|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356889999999999999999987778888876543  2345567899999999999 5999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||= .-+|.+++..+....+...+..++.|++.|+.++|   ..||||.||||.|+|+-+ |.+||+|||+|+.+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            975 45999999887766664577889999999999999   899999999999999874 5899999999998744

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.79  E-value=8.9e-20  Score=169.40  Aligned_cols=146  Identities=21%  Similarity=0.385  Sum_probs=123.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEE-EEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVIS-SCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~-~~~~~~~~~lv~  567 (646)
                      .+.|.+.+.+|+|.||.+-.++++ +.+.+++|.++..- ...++|.+|...--.+ .|.||+.-|+ .|++.+...++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888899999999999999976 57789999887543 3457889998765555 6899998776 467778888999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--CCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~~~~~ki~DfGla~~~  642 (646)
                      ||++.|+|..-+...+  +.+....+++.|+++|+.|+|   ++++||||||.+||||-  +..++|+||||..+..
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999999886654  778888999999999999999   99999999999999993  4568999999998754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.79  E-value=5.2e-20  Score=166.78  Aligned_cols=143  Identities=22%  Similarity=0.424  Sum_probs=122.3

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCC--eeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEE--FKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~--~~~lv  566 (646)
                      .++|++.+++|+|.|++||.|. ..+.+.++||+++.-   ..+.+.+|+.++..+. ||||++++++..++.  ...+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678889999999999999997 457888999998744   3467889999999996 999999999987763  45799


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~~  643 (646)
                      +||+.+.+...+..    .++......++.++++|+.|+|   ++||+|||+||.|++||. .-..+++|+|+|.++.
T Consensus       114 FE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999888776653    3566678889999999999999   999999999999999985 4579999999998764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.79  E-value=4.4e-19  Score=177.29  Aligned_cols=147  Identities=22%  Similarity=0.365  Sum_probs=123.0

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEecc-----CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-----CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      +|...+.||+|+||.||+++.. .+..+++|+.+..     ......++.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999864 3455666655421     122334567799999999999999999999988899999


Q ss_pred             EEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++..   ....+++..+..++.|++.|+.|+|   ..+++|+|+||+||++++ +.+|++|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   2346889999999999999999999   899999999999999975 569999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=4.9e-19  Score=161.81  Aligned_cols=148  Identities=26%  Similarity=0.402  Sum_probs=128.0

Q ss_pred             hCCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC-CCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH-RNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ...|...++||+|+||.+|.|. ..+|++||||+-.....  ..+...|..+.+.++| ..|..+..+..++.+..+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3578899999999999999997 66899999998764432  3567789999999864 678888888888889999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~~  644 (646)
                      .. |.+|+++..-+...++..+++..+-|++.-++|+|   .+++|||||||+|+|..   ....+.++|||+||.+.+
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            88 88999999877778899999999999999999999   88999999999999995   345789999999998754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.79  E-value=8.2e-19  Score=172.74  Aligned_cols=131  Identities=19%  Similarity=0.119  Sum_probs=114.3

Q ss_pred             cccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhh
Q 046544          503 GGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS  581 (646)
Q Consensus       503 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  581 (646)
                      |.||.||+++.. +++.||+|.+....     .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999864 68999999987543     233455555666799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          582 SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       582 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .. .+++..+..++.|+++|++|+|   .++|+||||||+||+++.++.++++|||.+..+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~  135 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV  135 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence            54 5889999999999999999999   899999999999999999999999999987654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=2.3e-21  Score=167.90  Aligned_cols=179  Identities=28%  Similarity=0.468  Sum_probs=142.5

Q ss_pred             cCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEE
Q 046544          231 CRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGI  310 (646)
Q Consensus       231 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  310 (646)
                      ..+.+.+.|-||+|+++ ..|..+..+.+|++|++++|+|+++|..+..++.|+.|+++-|++. ..|..|+.++.|+.|
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            34566777888888887 4555678888888888888888888888888888888888888887 678888888888888


Q ss_pred             Ecccccccc-cCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcc
Q 046544          311 DFSMNNFSS-VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL  389 (646)
Q Consensus       311 ~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  389 (646)
                      ||++|++.. ..|..|..|..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|..++.++.|++|.+++|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            888888764 46777888888888888888887 77888888888888888888887 6888888888888888888888


Q ss_pred             eeeccCCCC---CCCCccccccCCccc
Q 046544          390 EGEIPRGGS---FGNFAAESFEGNELL  413 (646)
Q Consensus       390 ~~~~p~~~~---~~~~~~~~~~~N~~~  413 (646)
                      +-.+|..+.   ..+-+.+..+.|||.
T Consensus       186 ~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  186 TVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            877776543   233345566777775

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=1e-20  Score=195.22  Aligned_cols=235  Identities=24%  Similarity=0.232  Sum_probs=177.2

Q ss_pred             CCcccccCCCCCEEEccCCcccc------ccCccccCCCCCCeEEeecccccCcCchhhcCCCC---CcEEEecCCcccc
Q 046544          178 IPEEITNLTNSITIDLGGNKLNG------SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTE---LYELELGGNKLFG  248 (646)
Q Consensus       178 ~p~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~i~~  248 (646)
                      ++..+...++++.++++++.+.+      ..+..+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++.+
T Consensus        43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~  122 (319)
T cd00116          43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD  122 (319)
T ss_pred             HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence            34556677788888888888762      23456778899999999999998777777776666   9999999999873


Q ss_pred             ----cCCccccCC-CCCceeecCCCccc-----ccccccccccccccccCCCCcccCC----CCCccCccccceEEEccc
Q 046544          249 ----SIPACFSNL-ASLRILSLSSNELT-----SIPLTFWNLKDILQLNFSSNFLTGP----LPLEIGNLKVLIGIDFSM  314 (646)
Q Consensus       249 ----~~~~~~~~l-~~L~~L~L~~N~l~-----~lp~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~ls~  314 (646)
                          .....+..+ ++|+.|++++|.++     .++..+..++.|+.|++++|.+++.    ++..+..+++|+.|++++
T Consensus       123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~  202 (319)
T cd00116         123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN  202 (319)
T ss_pred             HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence                233445666 89999999999998     3344566778899999999998853    233445567999999999


Q ss_pred             ccccccC----ccccCCCCCCCEEEccCccCCCccccccc-----CCCCCCEEEccCCcCcc----cCCccccCCCCCCc
Q 046544          315 NNFSSVI----PTEIGGLKNLEYLFLGYNRLEGSIPDSFG-----DLISLKFLNLSNNNLSG----AIPTSLEKLSYLED  381 (646)
Q Consensus       315 N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~  381 (646)
                      |.+++..    +..+..+++|++|++++|++++.....+.     ..+.|+.|++++|.++.    .+...+..+++|++
T Consensus       203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~  282 (319)
T cd00116         203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE  282 (319)
T ss_pred             CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence            9987543    34567789999999999999864443333     24799999999999972    34455667789999


Q ss_pred             eeCcCCcceeec----cCC-CCC-CCCccccccCCcc
Q 046544          382 LNLSFNKLEGEI----PRG-GSF-GNFAAESFEGNEL  412 (646)
Q Consensus       382 L~L~~N~l~~~~----p~~-~~~-~~~~~~~~~~N~~  412 (646)
                      +++++|.++...    ... -.+ ..++.+++.+|||
T Consensus       283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            999999998642    211 123 5677788888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.78  E-value=2.9e-20  Score=172.22  Aligned_cols=147  Identities=29%  Similarity=0.327  Sum_probs=119.9

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHH-HhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMM-KSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+....||.|+||+|++-.++ .|+..|||+++.... ++.+++..|.+.. +.-+.||||+++|++..++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            345567999999999998754 799999999986643 5667888888764 5558999999999999999999999999


Q ss_pred             CCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      . .++..+.+.    .+..+++.-.-.|....+.||.||-.  ...|||||+||+|||++..|.+|+||||++-.+.
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            4 366554431    22357777777788888999999985  4689999999999999999999999999987653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.78  E-value=1.4e-18  Score=190.53  Aligned_cols=146  Identities=23%  Similarity=0.287  Sum_probs=104.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-C----CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEE------Ee
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-D----GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS------CS  558 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~------~~  558 (646)
                      ..++|+..+.||+|+||.||+|+.. +    +..||+|.+.....  .+....|  .++...+.+++.+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999864 4    68999998754321  1111111  1111122222221111      24


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 046544          559 NEEFKALVLEYKPHGSLEKYLYSSNCIL-------------------DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK  619 (646)
Q Consensus       559 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk  619 (646)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+|+|   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5567899999999999999987543111                   12235578999999999999   8899999999


Q ss_pred             CCCEEEcC-CCcEEEEeecCcccc
Q 046544          620 PDNVLLDD-NLVAYLSDFGIAKLL  642 (646)
Q Consensus       620 ~~Nil~~~-~~~~ki~DfGla~~~  642 (646)
                      |+|||+++ ++.+||+|||+|+.+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l  306 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADL  306 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccc
Confidence            99999985 689999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=3.9e-18  Score=166.06  Aligned_cols=148  Identities=33%  Similarity=0.494  Sum_probs=132.6

Q ss_pred             CCcceeecccccceEEEEEeCC-CcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          494 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      |...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999764 889999999876554 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +++|.+++......+++.....++.+++.++.|+|   ..+++|+|++|+||+++.++.++++|||.+.....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            99999999776533788899999999999999999   78999999999999999999999999999887643

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.3e-19  Score=177.07  Aligned_cols=148  Identities=24%  Similarity=0.281  Sum_probs=127.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..+|....+||+|+||+|..|..+ +.+.+|||+++++.   ..+.+-.+.|-++++-- +-|.+++++..|++-+++|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346888899999999999999754 56779999987653   23344456677777665 67899999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||||+.||+|.-.+++.+ .+.+..++-+|++||-||-|||   .++||.||+|.+||++|.+|++||+|||++|.-
T Consensus       428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999999988776 5677788889999999999999   999999999999999999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.7e-18  Score=165.37  Aligned_cols=149  Identities=23%  Similarity=0.303  Sum_probs=130.3

Q ss_pred             CCCCcceeecccccceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      -+|.++++||+|.||+++.|+ .-++++||||.-..+++  ..++..|.+..+-+ .-++|..++-+..+..+-.+|||.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999998 55799999998765543  35677788888887 578999999888888888999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecCcccccC
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-----~~~~ki~DfGla~~~~~  644 (646)
                      + |.+|+++..-+++.++..++..+|.|++.-++|+|   ++..|.|||||+|+||..     ...+.++|||+||.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 88999999888889999999999999999999999   889999999999999963     34689999999999887


Q ss_pred             CC
Q 046544          645 ED  646 (646)
Q Consensus       645 ~~  646 (646)
                      .+
T Consensus       182 p~  183 (449)
T KOG1165|consen  182 PK  183 (449)
T ss_pred             cc
Confidence            53

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3.5e-18  Score=166.47  Aligned_cols=143  Identities=19%  Similarity=0.140  Sum_probs=111.9

Q ss_pred             CCCCcceeecccccceEEEEE--eCCCcEEEEEEEeccCCc------------------------hHHHHHHHHHHHHhC
Q 046544          492 NGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------------------------AFKSFAVECEMMKSI  545 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  545 (646)
                      ..|++.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+.+|++.++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  568999999998753210                        012356799999999


Q ss_pred             CCCC--ceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCC
Q 046544          546 RHRN--LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP-VIHCDLKPDN  622 (646)
Q Consensus       546 ~H~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlk~~N  622 (646)
                      .+..  +++++++    ...++||||++|+++....... ...+..+...++.|++.+++|+|   ..+ |+|||+||+|
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            7533  4444443    2358999999998887654332 23555567789999999999999   888 9999999999


Q ss_pred             EEEcCCCcEEEEeecCccccc
Q 046544          623 VLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       623 il~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++ ++.++++|||.|+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999998654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.76  E-value=3.2e-18  Score=162.69  Aligned_cols=139  Identities=14%  Similarity=0.107  Sum_probs=114.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchH---HH------HHHHHHHHHhCCCCCceeEEEEEecC-
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAF---KS------FAVECEMMKSIRHRNLIKVISSCSNE-  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~H~niv~~~~~~~~~-  560 (646)
                      .++|...+.+|+|+||.||.+.. ++..+|+|++........   +.      +.+|+..+.++.||+|..+..++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            37899999999999999999766 577899999975432221   22      67899999999999999998886543 


Q ss_pred             -------CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          561 -------EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       561 -------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                             +..++||||++|.+|.++..     .++    ....+++.++..+|   ..+++|||++|+||+++.++ +++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEE
Confidence                   35789999999999988731     222    24569999999999   89999999999999999888 999


Q ss_pred             EeecCccccc
Q 046544          634 SDFGIAKLLI  643 (646)
Q Consensus       634 ~DfGla~~~~  643 (646)
                      +|||..+...
T Consensus       176 iDfg~~~~~~  185 (232)
T PRK10359        176 IDLSGKRCTA  185 (232)
T ss_pred             EECCCccccc
Confidence            9999887653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.76  E-value=1.9e-17  Score=158.97  Aligned_cols=141  Identities=38%  Similarity=0.620  Sum_probs=126.4

Q ss_pred             ecccccceEEEEEeCC-CcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHH
Q 046544          500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEK  577 (646)
Q Consensus       500 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  577 (646)
                      ||+|.+|.||+++... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998865432 34678899999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCccccc
Q 046544          578 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       578 ~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~~  643 (646)
                      ++.......++..+..++.+++++++|+|   ..+++|+|++|.||+++. ++.++++|||.+....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            99776446788999999999999999999   889999999999999998 8999999999988654

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1e-17  Score=159.76  Aligned_cols=142  Identities=23%  Similarity=0.169  Sum_probs=111.4

Q ss_pred             HHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCc----------------------hHHHHHHHHHHHHhCC
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR----------------------AFKSFAVECEMMKSIR  546 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~  546 (646)
                      .....|...+.||+|+||.||+|...+|+.||||+++.....                      ......+|+.++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333447788999999999999999888999999987643210                      0123567888899888


Q ss_pred             CCC--ceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 046544          547 HRN--LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVL  624 (646)
Q Consensus       547 H~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil  624 (646)
                      |++  ++..++    ....++||||++|+++.+....       .....++.+++.++.++|   ..+|+|||+||+||+
T Consensus        92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil  157 (198)
T cd05144          92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL  157 (198)
T ss_pred             HcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence            874  444443    2456899999999998775421       234578899999999999   889999999999999


Q ss_pred             EcCCCcEEEEeecCcccccC
Q 046544          625 LDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       625 ~~~~~~~ki~DfGla~~~~~  644 (646)
                      +++++.++|+|||+|.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.2e-17  Score=161.22  Aligned_cols=135  Identities=24%  Similarity=0.332  Sum_probs=113.5

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCCc--------hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--------AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +.||+|++|.||+|++ .|..|++|+.......        ....+.+|++++..++|++|+....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 6778999976533211        123577899999999999988777777777788999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|++|.+++....    . ....++.+++.++.++|   ..+++|||++|+||+++ ++.++++|||.++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999986532    2 67889999999999999   88999999999999999 788999999998753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2e-18  Score=164.63  Aligned_cols=147  Identities=27%  Similarity=0.292  Sum_probs=129.1

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEecc---CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|...++||+|+|++|..+++ ++.+.||+|++++.   .+.+......|-.+..+. +||.+|.++.+|.++.++++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5788999999999999999985 46888999998754   233445566677777665 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .||+.||+|.-+++..+ .+++..+.-+...|+-|+.|||   ++|||.||+|.+|+|+|..|++|++|+|++|.-
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999988876654 6888899999999999999999   999999999999999999999999999999864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.8e-17  Score=182.03  Aligned_cols=138  Identities=21%  Similarity=0.254  Sum_probs=112.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEecc--CC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  562 (646)
                      ...|...+.||+|+||.||+|.+.+.. +++|+....  ..      ...+++.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345567899999999999999875443 444432211  11      123467889999999999999988887777778


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++||||++|++|.+++.         ....++.++++++.|+|   ..+++|||+||+||++ +++.++++|||+|+..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999999874         35678999999999999   8999999999999999 5778999999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.8e-19  Score=180.56  Aligned_cols=149  Identities=25%  Similarity=0.359  Sum_probs=129.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCC-cEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+++....+|-|+||.|-.++.... ..+|+|++++..   .+..+....|-.+|...+.|.||++|..|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4556677899999999998886543 348888876542   344456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |-|-||.+-..+++.+ .++...+.-++..+.+|++|||   +++||.||+||+|.++|.+|.+|+.|||+||.+..
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999998765 6788888889999999999999   99999999999999999999999999999998753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.74  E-value=3.1e-18  Score=181.87  Aligned_cols=143  Identities=32%  Similarity=0.497  Sum_probs=116.4

Q ss_pred             CCcceeecccccc-eEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecC
Q 046544          494 FSENNLIGRGGFG-SVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       494 ~~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      |...+++|.|+-| .||+|.. +|++||||++-..+   ..-..+|+..++.- +|||||++++.-.++...||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4455778999888 5799988 67899999876432   33456899999888 79999999999999999999999996


Q ss_pred             CCCHHHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCIL---DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l---~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-----~~~~ki~DfGla~~~~  643 (646)
                      . +|.++++......   .......+..|+++|+++||   +.+||||||||.||||+.     ..+++|+|||++|.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 9999998741111   11234678899999999999   889999999999999964     2579999999999875


Q ss_pred             C
Q 046544          644 G  644 (646)
Q Consensus       644 ~  644 (646)
                      .
T Consensus       663 ~  663 (903)
T KOG1027|consen  663 G  663 (903)
T ss_pred             C
Confidence            4

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=4.4e-17  Score=151.38  Aligned_cols=132  Identities=17%  Similarity=0.121  Sum_probs=104.5

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCC----chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEe
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG----RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .....+++|+||+||.+.. .+.+++.+.+.....    .....+.+|++++++++ |++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997765 677777776654422    11125788999999995 5889999886    347999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL-KPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-k~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|.+|.+....        ....++.|++++++++|   ..||+|||| ||+||+++.++.++|+|||+|+..
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999998764321        12357789999999999   899999999 799999999999999999999853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=8.7e-18  Score=174.57  Aligned_cols=145  Identities=26%  Similarity=0.288  Sum_probs=121.8

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|++....    .+..+|+.++... +||||+++.+.+.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677777899999999998875 468899999997652    2234577665555 89999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE-cCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL-DDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~-~~~~~~ki~DfGla~~~~~  644 (646)
                      ++.||-+.+.+.....  ...++..|+++++.|+.|||   ++||||||+||+|||+ ++.++++|+|||.++....
T Consensus       397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999988888765542  22677789999999999999   8999999999999999 5899999999999987653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.4e-17  Score=156.54  Aligned_cols=131  Identities=21%  Similarity=0.319  Sum_probs=107.0

Q ss_pred             eecccccceEEEEEeCCCcEEEEEEEeccCC--------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .||+|+||.||+|.+ +|..|++|+......        ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 577899998653221        11245678999999999887665555556666779999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+++.+++.....        .++.+++.++.++|   ..+++|||++|+||+++ ++.++++|||.|+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988754321        78999999999999   89999999999999999 789999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.72  E-value=5.1e-17  Score=159.99  Aligned_cols=137  Identities=34%  Similarity=0.464  Sum_probs=123.0

Q ss_pred             ccceEEEEEeC-CCcEEEEEEEeccCCch-HHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhh
Q 046544          504 GFGSVYKARLG-DGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYS  581 (646)
Q Consensus       504 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  581 (646)
                      +||.||+|+.. +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999998665444 67889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          582 SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       582 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ... +++..+..++.+++.|+.|+|   ..+++|+|++|+||++++++.++++|||.+.....
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            543 788899999999999999999   88999999999999999999999999999886643

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=8.2e-17  Score=165.53  Aligned_cols=144  Identities=29%  Similarity=0.424  Sum_probs=122.4

Q ss_pred             CCCcceeecccccceEEEEEeCC--CcEEEEEEEeccCCchHHHHHHHHHHHHhCCC----CCceeEEEEE-ecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH----RNLIKVISSC-SNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~~~~~~-~~~~~~~l  565 (646)
                      +|.+.+.||+|+||.||.|....  ...+|+|+...........+..|+.++..+..    +++..+++.+ ....+.|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999998654  35899998775533322367778998888863    6899999988 47788999


Q ss_pred             EEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-----CcEEEEeecCc
Q 046544          566 VLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-----LVAYLSDFGIA  639 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-----~~~ki~DfGla  639 (646)
                      ||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++|   +.|++||||||.|+.+...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999886554 67899999999999999999999   9999999999999999754     46999999999


Q ss_pred             c
Q 046544          640 K  640 (646)
Q Consensus       640 ~  640 (646)
                      +
T Consensus       175 r  175 (322)
T KOG1164|consen  175 R  175 (322)
T ss_pred             c
Confidence            9

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.69  E-value=7e-17  Score=157.62  Aligned_cols=149  Identities=22%  Similarity=0.288  Sum_probs=124.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC--C----CceeEEEEEecCCe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH--R----NLIKVISSCSNEEF  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~~~~~~~~~~~  562 (646)
                      .+++|.+...+|+|.||+|..+.++ .+..||+|+++.- .+..++...|++++.++.+  |    -+|++.++|.-.+.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3688999999999999999999754 4789999988643 2344666779999999832  2    46788888999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC--------------
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD--------------  627 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~--------------  627 (646)
                      .++|+|.+ |.++.+++...+ .+++...+..|++|+++++.|||   +.+++|-|+||+||++.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999988 669999998744 57889999999999999999999   999999999999999831              


Q ss_pred             ------CCcEEEEeecCccccc
Q 046544          628 ------NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ------~~~~ki~DfGla~~~~  643 (646)
                            ...+|++|||.|.+-.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~  263 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDH  263 (415)
T ss_pred             eeccCCCcceEEEecCCcceec
Confidence                  2358999999998753

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.67  E-value=4.3e-17  Score=155.42  Aligned_cols=143  Identities=26%  Similarity=0.328  Sum_probs=119.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~  562 (646)
                      .+|...+.+|.|+- .|..|.+. .+++||+|......  ....++..+|...+..+.|+||++++.++...      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            57788888999988 56666543 58899999765432  23345678899999999999999999998755      35


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+|||||.+ ++.+.+..   .++......+..|++.|++|+|   +.+|+||||||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            7999999954 89988873   3677788899999999999999   999999999999999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.66  E-value=1.6e-16  Score=157.21  Aligned_cols=146  Identities=29%  Similarity=0.373  Sum_probs=125.5

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      +....+.|...++||+|.|+.||+|...    .++.||+|.+....  .......|++++..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3444567889999999999999999743    46789999886553  335688999999998 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCcc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAK  640 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~  640 (646)
                      ...+|+||+++-+..++...    ++..+...+++.+..||+++|   .+||||||+||.|++.+ ..+.-.++|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888888754    557788899999999999999   99999999999999997 45778899999997


Q ss_pred             c
Q 046544          641 L  641 (646)
Q Consensus       641 ~  641 (646)
                      .
T Consensus       182 ~  182 (418)
T KOG1167|consen  182 R  182 (418)
T ss_pred             H
Confidence            4

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.66  E-value=1.9e-16  Score=154.43  Aligned_cols=157  Identities=23%  Similarity=0.305  Sum_probs=128.1

Q ss_pred             HHHHHhCCCCcceeecccccceEEEEEeCC------CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEe
Q 046544          486 ELCRATNGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCS  558 (646)
Q Consensus       486 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  558 (646)
                      ++.....+++....+.+|.||+||+|.|++      .+.|-+|.++.+. +-....+..|...+..+.|||+.++.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            444444567777889999999999996543      4456677766442 344567888999999999999999999987


Q ss_pred             cC-CeeEEEEEecCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc
Q 046544          559 NE-EFKALVLEYKPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV  630 (646)
Q Consensus       559 ~~-~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~  630 (646)
                      ++ ...++++.++.-|+|..++...+       +.+...+.+.++.|++.|++|||   ..+|||.||.++|++||+.-.
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence            66 45778889999999999998332       34566778899999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccccCC
Q 046544          631 AYLSDFGIAKLLIGE  645 (646)
Q Consensus       631 ~ki~DfGla~~~~~~  645 (646)
                      ||++|=.++|.+...
T Consensus       435 VkltDsaLSRDLFP~  449 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPG  449 (563)
T ss_pred             EEeccchhccccCcc
Confidence            999999999987643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=5.9e-16  Score=146.40  Aligned_cols=137  Identities=25%  Similarity=0.237  Sum_probs=98.8

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCc--hHHH----------------------HHHHHHHHHhCCCCC--c
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--AFKS----------------------FAVECEMMKSIRHRN--L  550 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~H~n--i  550 (646)
                      .+.||+|+||+||+|...+|+.||||++......  ....                      ...|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999998753211  1111                      124556666664433  4


Q ss_pred             eeEEEEEecCCeeEEEEEecCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCC
Q 046544          551 IKVISSCSNEEFKALVLEYKPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDN  628 (646)
Q Consensus       551 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~  628 (646)
                      .+.++.    ...++||||++++.+... +....  .. .+...++.+++.++.++|   . ++|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444433    245899999998543211 11111  11 457789999999999999   7 8999999999999999 8


Q ss_pred             CcEEEEeecCcccccC
Q 046544          629 LVAYLSDFGIAKLLIG  644 (646)
Q Consensus       629 ~~~ki~DfGla~~~~~  644 (646)
                      +.++++|||.|.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.6e-15  Score=137.90  Aligned_cols=136  Identities=21%  Similarity=0.230  Sum_probs=113.8

Q ss_pred             cceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC--CCceeEEEEEecCCeeEEEEEecCCC
Q 046544          496 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      +.+.+|+|.++.||+++..+ ..+++|.......  ...+.+|+.+++.++|  ..+++++++....+..+++|||++|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35779999999999999754 7899998765433  4578889999999976  58999999888888899999999987


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77654        44566778999999999999544468999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=7.9e-15  Score=143.22  Aligned_cols=137  Identities=19%  Similarity=0.232  Sum_probs=105.8

Q ss_pred             ceeec-ccccceEEEEEeCCCcEEEEEEEeccC-------------CchHHHHHHHHHHHHhCCCCCc--eeEEEEEecC
Q 046544          497 NNLIG-RGGFGSVYKARLGDGMEVAVKVFNLQC-------------GRAFKSFAVECEMMKSIRHRNL--IKVISSCSNE  560 (646)
Q Consensus       497 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~~~~~~~~~  560 (646)
                      ...+| .|+.|+||.++.. +..+++|.+....             ......+.+|++++..++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35677 8899999998874 6788999885321             1123467889999999998875  6667664433


Q ss_pred             -C---eeEEEEEecCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          561 -E---FKALVLEYKPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       561 -~---~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                       +   ..++||||++| .+|.+++...  .++..    .+.+++.++.++|   ..||+|||+||+|||++.++.++++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 6999887543  34433    3678999999999   99999999999999999888999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||.++...
T Consensus       186 fg~~~~~~  193 (239)
T PRK01723        186 FDRGELRT  193 (239)
T ss_pred             CCCcccCC
Confidence            99988653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2.8e-15  Score=150.52  Aligned_cols=132  Identities=26%  Similarity=0.342  Sum_probs=110.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-----C---CCceeEEEEEecC--
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-----H---RNLIKVISSCSNE--  560 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~~~~~~~~~--  560 (646)
                      .+|...+++|.|-|++||.|.+. +.+.||+|+++... ...+....||+++++++     |   .+||++++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57889999999999999999864 57789999987543 34466778999999873     2   4799999998765  


Q ss_pred             --CeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC
Q 046544          561 --EFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD  627 (646)
Q Consensus       561 --~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~  627 (646)
                        ..+++|+|++ |-+|..+|.... +.++...+.+|++||+.||.|||.  ..+|||-||||+|||+..
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCS  223 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeec
Confidence              4689999999 668988887654 468889999999999999999996  459999999999999953

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.60  E-value=1.3e-15  Score=153.68  Aligned_cols=159  Identities=24%  Similarity=0.294  Sum_probs=130.3

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC------CCCceeEE
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR------HRNLIKVI  554 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~~~  554 (646)
                      +.+.-.+.-..+|.+....|+|-|+.|.+|... .|..||||++.... ...+.=++|+++++++.      --|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            333333445578888888999999999999865 48899999997543 22344567999999984      34789999


Q ss_pred             EEEecCCeeEEEEEecCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcE
Q 046544          555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVA  631 (646)
Q Consensus       555 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~  631 (646)
                      ..|...+.+|+|+|-+. -+|.+.++..+.  .+....+..++.|+.-||..|-   .++|+|.||||+||||++ ...+
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence            99999999999999884 489999987653  5677888999999999999999   889999999999999985 4679


Q ss_pred             EEEeecCcccccCC
Q 046544          632 YLSDFGIAKLLIGE  645 (646)
Q Consensus       632 ki~DfGla~~~~~~  645 (646)
                      ||||||.|....+.
T Consensus       577 KLCDfGSA~~~~en  590 (752)
T KOG0670|consen  577 KLCDFGSASFASEN  590 (752)
T ss_pred             eeccCccccccccc
Confidence            99999999876543

>PLN03150 hypothetical protein; Provisional

Probab=99.58  E-value=3.4e-15  Score=165.73  Aligned_cols=118  Identities=36%  Similarity=0.587  Sum_probs=106.6

Q ss_pred             cceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCc
Q 046544          306 VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS  385 (646)
Q Consensus       306 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  385 (646)
                      .++.|+|++|.+++..|..++.+++|+.|+|++|.+++.+|..++.+++|+.|||++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcceeeccCCC--CCCCCccccccCCccccCCCCcccCCCc
Q 046544          386 FNKLEGEIPRGG--SFGNFAAESFEGNELLCGSPTLQVLPCK  425 (646)
Q Consensus       386 ~N~l~~~~p~~~--~~~~~~~~~~~~N~~~c~~~~~~~~~~~  425 (646)
                      +|+++|.+|...  .......+++.+|+..|+.|..  .+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence            999999999762  2345567889999999987753  3664

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.55  E-value=8.5e-14  Score=143.77  Aligned_cols=145  Identities=39%  Similarity=0.535  Sum_probs=126.3

Q ss_pred             CCcceeecccccceEEEEEeCCCcEEEEEEEeccCCc---hHHHHHHHHHHHHhCCCC-CceeEEEEEecCCeeEEEEEe
Q 046544          494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR---AFKSFAVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~  569 (646)
                      |...+.+|.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999876  78899988765432   367889999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      +.++++.+++....  ...+......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++.+.
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999997776554  25788899999999999999999   88899999999999999888 79999999988543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.54  E-value=1.1e-16  Score=163.28  Aligned_cols=173  Identities=31%  Similarity=0.508  Sum_probs=92.1

Q ss_pred             CCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeec
Q 046544          186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSL  265 (646)
Q Consensus       186 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  265 (646)
                      +--...||+.|++. ..|..+..+..|+.+.|..|.+. .+|.+++++..|..|||+.|+++ ..|..++.|+ |+.|-+
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~  150 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV  150 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence            33344555555555 44444555555555555555555 45555555555555555555554 3444444443 555555


Q ss_pred             CCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcc
Q 046544          266 SSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSI  345 (646)
Q Consensus       266 ~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  345 (646)
                      ++|+++.+|..++....|..||.+.|.+. .+|..++++.+|+.|.+..|++.. .|..+..| .|..||+|.|+++ .+
T Consensus       151 sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  151 SNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS-YL  226 (722)
T ss_pred             ecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee-ec
Confidence            55555555555555555555555555554 344455555555555555555553 33334433 2555555555555 45


Q ss_pred             cccccCCCCCCEEEccCCcCc
Q 046544          346 PDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       346 p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      |-.|..|+.|++|-|.+|.++
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             chhhhhhhhheeeeeccCCCC
Confidence            555555555555555555554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=2.9e-14  Score=151.36  Aligned_cols=142  Identities=23%  Similarity=0.252  Sum_probs=100.2

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCchH----------------------------------------HHHH
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAF----------------------------------------KSFA  536 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  536 (646)
                      .+.+|+|++|+||+|+..+|+.||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            478999999999999999999999999764321000                                        0234


Q ss_pred             HHHHHHHhC----CCCCceeEEEEE-ecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 046544          537 VECEMMKSI----RHRNLIKVISSC-SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFGCL  610 (646)
Q Consensus       537 ~e~~~l~~l----~H~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~lH~~~~  610 (646)
                      +|++.+.++    +|..-+.+-.++ ...+..++||||++|+++.++........+   ...++.+++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            455555554    233223322222 223457899999999999887653321222   3456666665 467788   8


Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       611 ~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .|++|+|++|.||++++++.++++|||+++.+.+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=4.1e-16  Score=159.14  Aligned_cols=189  Identities=32%  Similarity=0.453  Sum_probs=159.4

Q ss_pred             EEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcc
Q 046544          167 FYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKL  246 (646)
Q Consensus       167 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  246 (646)
                      .||+.|++. .+|..++.+..|+.+.|..|.+. .+|....++..|++|||+.|+++ ..|..++.++ |+.|.+++|++
T Consensus        80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl  155 (722)
T KOG0532|consen   80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL  155 (722)
T ss_pred             hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence            455666665 46778888888888999999998 77888999999999999999999 7888899887 99999999999


Q ss_pred             cccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccC
Q 046544          247 FGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG  326 (646)
Q Consensus       247 ~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  326 (646)
                      + ..|+.++.+..|..||.+.|.+.++|..++++.+|+.|++..|++. .+|..+..| .|..||+|.|+++ .+|-.|.
T Consensus       156 ~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr  231 (722)
T KOG0532|consen  156 T-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFR  231 (722)
T ss_pred             c-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhh
Confidence            7 6777788899999999999999999999999999999999999998 467677755 4899999999999 5799999


Q ss_pred             CCCCCCEEEccCccCCCcccccccCCC---CCCEEEccCCc
Q 046544          327 GLKNLEYLFLGYNRLEGSIPDSFGDLI---SLKFLNLSNNN  364 (646)
Q Consensus       327 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~---~L~~L~Ls~N~  364 (646)
                      .|+.|++|-|.+|.+. .+|..+...-   =-++|+..-++
T Consensus       232 ~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  232 KMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             hhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            9999999999999998 6776664322   24566666663

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=3.4e-14  Score=158.45  Aligned_cols=146  Identities=30%  Similarity=0.448  Sum_probs=113.9

Q ss_pred             HhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC---CCCceeEEEEEecCCeeEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR---HRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv  566 (646)
                      ....|.+.+.+|+|+||+||+|...+|+.||+|+-+....-+   |..=.+++.+++   -+.|..+..++...+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            335688889999999999999998889999999877554321   111112233333   23455555556666778899


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-------CCCcEEEEeecCc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-------DNLVAYLSDFGIA  639 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-------~~~~~ki~DfGla  639 (646)
                      +||.+.|+|.+++. ..+..++.-++.++.|++.-+++||   +.+|||+||||+|+++.       +...++|+|||-|
T Consensus       773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            99999999999997 4457899999999999999999999   99999999999999994       2346999999987


Q ss_pred             ccc
Q 046544          640 KLL  642 (646)
Q Consensus       640 ~~~  642 (646)
                      -.+
T Consensus       849 iDm  851 (974)
T KOG1166|consen  849 IDM  851 (974)
T ss_pred             eee
Confidence            654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.48  E-value=6.5e-14  Score=148.82  Aligned_cols=195  Identities=32%  Similarity=0.437  Sum_probs=98.7

Q ss_pred             EEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcC-CCCEEEccCCCCCCCCCcccccccCCCCCCCCEE
Q 046544           63 ALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLR-NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFI  141 (646)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L  141 (646)
                      .|+++.|.+. .....+..++.++.|++.+|.++.+ |.....+. +|+.|++++|.+..++      ..+..+++|+.|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~~l~------~~~~~l~~L~~L  168 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIESLP------SPLRNLPNLKNL  168 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccC-ccccccchhhcccccccccchhhhh------hhhhcccccccc
Confidence            5666666664 2333344456677777777777744 33444453 7777777777777653      235667777777


Q ss_pred             ECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeeccc
Q 046544          142 HLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK  221 (646)
Q Consensus       142 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  221 (646)
                      ++++|++..+++...   ....|+.|++++|+++. +|........|++|++++|.+. ..+..+.++.++..+.+++|+
T Consensus       169 ~l~~N~l~~l~~~~~---~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         169 DLSFNDLSDLPKLLS---NLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             ccCCchhhhhhhhhh---hhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence            777777765532210   12234444444444442 2222233333555555555322 233344444455555555555


Q ss_pred             ccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccc
Q 046544          222 LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI  273 (646)
Q Consensus       222 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l  273 (646)
                      +. ..+..++.++++++|++++|+++...+  +..+.+++.|++++|.+..+
T Consensus       244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~  292 (394)
T COG4886         244 LE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA  292 (394)
T ss_pred             ee-eccchhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence            44 224444444445555555555542222  44445555555555554443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.47  E-value=7.3e-14  Score=148.44  Aligned_cols=262  Identities=31%  Similarity=0.367  Sum_probs=159.6

Q ss_pred             cEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCC-CCCEEECCCCCCCCcCCcchhccccccC
Q 046544           86 SILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCK-SLTFIHLSDNPLDGILSKTSIGNLSHSL  164 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~~L  164 (646)
                      ..|+++.|.+.. .......++.++.|++.+|.++.+++.      ...++ +|++|++++|.+..+             
T Consensus        96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~i~~~------~~~~~~nL~~L~l~~N~i~~l-------------  155 (394)
T COG4886          96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNITDIPPL------IGLLKSNLKELDLSDNKIESL-------------  155 (394)
T ss_pred             ceeecccccccc-CchhhhcccceeEEecCCcccccCccc------cccchhhcccccccccchhhh-------------
Confidence            479999999852 344566778999999999999998764      33343 888999998888754             


Q ss_pred             cEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCC
Q 046544          165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       165 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                                    |..+..+++|+.|++++|++... |.....++.|+.|++++|+++ .+|........|++|.+++|
T Consensus       156 --------------~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N  219 (394)
T COG4886         156 --------------PSPLRNLPNLKNLDLSFNDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN  219 (394)
T ss_pred             --------------hhhhhccccccccccCCchhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence                          23455666666666666666633 333335566677777777776 44444444455777777777


Q ss_pred             cccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccc
Q 046544          245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE  324 (646)
Q Consensus       245 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  324 (646)
                      ++. ..+..+.++.++..+.+++|++..++..+..+++++.|++++|.++...+  ++.+.+++.|++++|.++...|..
T Consensus       220 ~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         220 SII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             cce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence            533 34555666677777777777777666666667777777777777764333  667777777777777777665554


Q ss_pred             cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcce
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  390 (646)
                      .......+.+.-  +.+. ..+..+.....+...++..+... ..+..+.....+..++...+...
T Consensus       297 ~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         297 ALLLLLLELLLN--LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             hccchhHHhhhh--hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence            433222221111  2222 22222233333444444455544 44555555555555555555544

>PLN03150 hypothetical protein; Provisional

Probab=99.38  E-value=1.1e-12  Score=145.68  Aligned_cols=113  Identities=37%  Similarity=0.537  Sum_probs=104.7

Q ss_pred             ccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEcc
Q 046544          282 DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLS  361 (646)
Q Consensus       282 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  361 (646)
                      .+..|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|+.++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcccCCccccCC-CCCCceeCcCCcceeecc
Q 046544          362 NNNLSGAIPTSLEKL-SYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       362 ~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p  394 (646)
                      +|++++.+|..+..+ .++..+++++|+..|..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999988764 467889999998776444

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=3.1e-12  Score=137.31  Aligned_cols=146  Identities=18%  Similarity=0.155  Sum_probs=93.7

Q ss_pred             CCCCcceeecccccceEEEEEeCC-CcEEEEEEEeccCCc---------------------------------h-HH---
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR---------------------------------A-FK---  533 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------------------------------~-~~---  533 (646)
                      ..|+. +.+|+|++|+||+|+.++ |+.||||+.+.....                                 + .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999876 999999998743110                                 0 01   


Q ss_pred             ---HHHHHHHHHHhC----CCCCceeEEEEEe-cCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHH
Q 046544          534 ---SFAVECEMMKSI----RHRNLIKVISSCS-NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA-LEY  604 (646)
Q Consensus       534 ---~~~~e~~~l~~l----~H~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~  604 (646)
                         ++.+|+..+.++    .+...+.+-.++. -....++||||++|+.+.++-.-.....+..   .++...+.. +.-
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Q  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQ  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHH
Confidence               233455444444    2443343333332 2456789999999999987532111112221   122222211 222


Q ss_pred             HhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCcccccC
Q 046544          605 LHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIG  644 (646)
Q Consensus       605 lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla~~~~~  644 (646)
                      +.   ..|++|+|++|.||+++.++    .+++.|||++..+..
T Consensus       276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33   56899999999999999887    999999999987753

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.36  E-value=7.2e-14  Score=138.90  Aligned_cols=211  Identities=22%  Similarity=0.228  Sum_probs=141.6

Q ss_pred             CCCCCcEEEcccCccccccC-ccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcc
Q 046544           81 NASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN  159 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~  159 (646)
                      ++.+|+...|.+.......- .....+++++.|||++|-+....+   ...-...+++|+.|+|+.|++.......... 
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~---v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~-  194 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFP---VLKIAEQLPSLENLNLSSNRLSNFISSNTTL-  194 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHH---HHHHHHhcccchhcccccccccCCccccchh-
Confidence            45566666776666663221 245566777777777776655322   1222456677777777777765443322222 


Q ss_pred             ccccCcEEEeecccccccC-CcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcC-chhhcCCCCCc
Q 046544          160 LSHSLKDFYMSNCNVSGGI-PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI-PDSICRLTELY  237 (646)
Q Consensus       160 ~~~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~  237 (646)
                      ....++.|.|+.|.++... -..+..+|+|+.|+|.+|............++.|+.|||++|++.... -...+.++.|+
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence            3357888999999888532 233456789999999999654455556677889999999999987432 14567788999


Q ss_pred             EEEecCCcccccC-Ccc-----ccCCCCCceeecCCCccccccc--ccccccccccccCCCCcccC
Q 046544          238 ELELGGNKLFGSI-PAC-----FSNLASLRILSLSSNELTSIPL--TFWNLKDILQLNFSSNFLTG  295 (646)
Q Consensus       238 ~L~L~~N~i~~~~-~~~-----~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~  295 (646)
                      .|+++.+.|..+- |+.     ...+++|++|+++.|++.+++.  .+..+++|+.|....|.++.
T Consensus       275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            9999999987543 222     3457889999999999987764  45567777777777777763

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=6.2e-12  Score=116.79  Aligned_cols=128  Identities=22%  Similarity=0.230  Sum_probs=95.0

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCc-eeEEEEEecCCeeEEEEEecCCCCH
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.++ ++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357899999999999874 77899998754432 12345779999988865554 45554432  335799999999877


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP-----VIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .+.    .     .....++.+++++++.+|   ..+     ++|+|++|.||+++ ++.++++|||.|..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643    0     011345678999999999   554     59999999999999 56899999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.32  E-value=5.1e-13  Score=121.93  Aligned_cols=130  Identities=26%  Similarity=0.253  Sum_probs=37.9

Q ss_pred             CCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCE
Q 046544           32 NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEW  111 (646)
Q Consensus        32 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  111 (646)
                      +..++++|+|++|.|+. +..... .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+|+.+.+.....+++|++
T Consensus        17 n~~~~~~L~L~~n~I~~-Ie~L~~-~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-IENLGA-TLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--T-T-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             ccccccccccccccccc-ccchhh-hhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            44455666666666643 233221 245666666666666632 2 3555666666666666666543222235666666


Q ss_pred             EEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCC-cchhccccccCcEEEe
Q 046544          112 LNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILS-KTSIGNLSHSLKDFYM  169 (646)
Q Consensus       112 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~~~L~~L~L  169 (646)
                      |+|++|+|..+..    ...++.+++|+.|+|.+|++..... ..++-...++|+.||-
T Consensus        93 L~L~~N~I~~l~~----l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   93 LYLSNNKISDLNE----LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EE-TTS---SCCC----CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EECcCCcCCChHH----hHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            6666666665432    2345566666677777776654322 1122223345666653

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.32  E-value=2e-13  Score=145.32  Aligned_cols=194  Identities=29%  Similarity=0.325  Sum_probs=84.2

Q ss_pred             CCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccc
Q 046544           83 SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH  162 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  162 (646)
                      ..++.+++..|.|.. .-..+..+.+|+.|++.+|+|..+..      .+..+++|++|++++|.|+.+.+....    .
T Consensus        72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~------~l~~~~~L~~L~ls~N~I~~i~~l~~l----~  140 (414)
T KOG0531|consen   72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN------LLSSLVNLQVLDLSFNKITKLEGLSTL----T  140 (414)
T ss_pred             HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc------chhhhhcchheeccccccccccchhhc----c
Confidence            334444444444442 11224444444555555554444321      033444455555555544443221111    1


Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccC-ccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      .|+.|++++|.|+..  ..+..++.|+.+++++|++..+.+ . ...+.+++.+++++|.+..+  ..+..+..+..+++
T Consensus       141 ~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l  215 (414)
T KOG0531|consen  141 LLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSL  215 (414)
T ss_pred             chhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhc
Confidence            133333333333321  223335556666666666654433 2 34455555556666655522  22333334444455


Q ss_pred             cCCcccccCCccccCCC--CCceeecCCCcccccccccccccccccccCCCCccc
Q 046544          242 GGNKLFGSIPACFSNLA--SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  294 (646)
                      ..|.++...+  +..+.  .|+.+++++|.+..++..+..+..+..|++.+|++.
T Consensus       216 ~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  216 LDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             ccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhcccc
Confidence            5555543222  11112  255555555555555433444444444444444443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.30  E-value=3.1e-13  Score=143.88  Aligned_cols=241  Identities=31%  Similarity=0.354  Sum_probs=133.3

Q ss_pred             CCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccc
Q 046544           83 SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH  162 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  162 (646)
                      +.++.++..++.+....-. ...+..++.++++.|.|...      ...+..+++|+.|++.+|.|..+..         
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~~------~~~l~~~~~l~~l~l~~n~i~~i~~---------  112 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAKI------LNHLSKLKSLEALDLYDNKIEKIEN---------  112 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhhh------hcccccccceeeeeccccchhhccc---------
Confidence            3455666666655532211 15667777777888888762      1235667778888888777765521         


Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                                        .+..+++|++|++++|+|+.+.+  +..++.|+.|++++|.|+.+  ..+..+++|+.++++
T Consensus       113 ------------------~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~  170 (414)
T KOG0531|consen  113 ------------------LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLS  170 (414)
T ss_pred             ------------------chhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCC
Confidence                              14556677777777777765433  34445567777777776632  234446666666677


Q ss_pred             CCcccccCC-ccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccC
Q 046544          243 GNKLFGSIP-ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI  321 (646)
Q Consensus       243 ~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  321 (646)
                      +|++..+.+ . ...+.+++.+++.+|.+..+. .+..+..+..+++..|.++...+.  ..+..               
T Consensus       171 ~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~---------------  231 (414)
T KOG0531|consen  171 YNRIVDIENDE-LSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKISKLEGL--NELVM---------------  231 (414)
T ss_pred             cchhhhhhhhh-hhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccceeccCc--ccchh---------------
Confidence            766664443 2 355566666666666665543 222233333445555554422111  01111               


Q ss_pred             ccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcce
Q 046544          322 PTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       322 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  390 (646)
                             .+|+.+++++|++. ..+..+..+..+..|++++|++...-  .+...+.+..+.+..|++.
T Consensus       232 -------~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  232 -------LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             -------HHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence                   03566666666665 33345555666666666666665321  2344455556666666655

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.29  E-value=2.8e-13  Score=128.16  Aligned_cols=133  Identities=26%  Similarity=0.393  Sum_probs=97.8

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      +-|++||||+|.|+ .+..+..-+++++.|++|+|.|.. +...++  +++|+.||||+|.++ ...++-..+.+.++|.
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~--L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQNLAE--LPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-ehhhhh--cccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            55788888888887 566777777888888888888864 444554  788888888888887 4555556677888888


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCC
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILS  153 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  153 (646)
                      |+.|.|...  ..++.|-+|..||+++|+|..+..    ...+++++.|+.+.|.+|++.+++.
T Consensus       359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~lde----V~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDE----VNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhhHhhh--hhhHhhhhheeccccccchhhHHH----hcccccccHHHHHhhcCCCccccch
Confidence            888888743  456677778888888888876543    2457778888888888888876644

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.27  E-value=2.2e-12  Score=117.78  Aligned_cols=130  Identities=27%  Similarity=0.293  Sum_probs=47.4

Q ss_pred             cCCCCCCEEECCCCcccccCCcCcc-CCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCC
Q 046544            7 SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKL   85 (646)
Q Consensus         7 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (646)
                      -+...+++|+|++|+|+.+.  .+. .+.+|+.|+|++|.|+. ++.+.  .+++|++|++++|+|+...+.....+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~-l~~l~--~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITK-LEGLP--GLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccccc--chhhhhcCCCEEECCCCCCcc-ccCcc--ChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            34455788888888887542  344 57788888888888865 34433  37788888888888884433222357888


Q ss_pred             cEEEcccCccccccC-ccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEEC
Q 046544           86 SILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHL  143 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L  143 (646)
                      ++|+|++|+|.++.. ..+..+++|++|+|.+|+++..+..  ..-.+..+++|+.||-
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~Y--R~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNY--RLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTH--HHHHHHH-TT-SEETT
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhH--HHHHHHHcChhheeCC
Confidence            888888888875432 3466778888888888888754321  2223566788888764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=1.1e-10  Score=108.82  Aligned_cols=136  Identities=21%  Similarity=0.204  Sum_probs=98.0

Q ss_pred             eeecccccceEEEEEeCC-------CcEEEEEEEeccC------------C----------chHHHH----HHHHHHHHh
Q 046544          498 NLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC------------G----------RAFKSF----AVECEMMKS  544 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~e~~~l~~  544 (646)
                      ..||.|.-+.||.|...+       +..+|||+++...            +          ...+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       4789999875211            0          011222    379999988


Q ss_pred             CCC--CCceeEEEEEecCCeeEEEEEecCCCCHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCC
Q 046544          545 IRH--RNLIKVISSCSNEEFKALVLEYKPHGSLE-KYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCLAPVIHCDLKP  620 (646)
Q Consensus       545 l~H--~niv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdlk~  620 (646)
                      +..  -++++++++    ...++||||+.++.+. ..+++.  .++..+...+..+++.++..+ |   ..++||+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  466666654    4578999999765332 223222  344455677889999999999 7   78999999999


Q ss_pred             CCEEEcCCCcEEEEeecCccccc
Q 046544          621 DNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       621 ~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      .||++++ +.++++|||.|....
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeCC
Confidence            9999974 679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.24  E-value=1.1e-12  Score=124.24  Aligned_cols=132  Identities=27%  Similarity=0.255  Sum_probs=102.5

Q ss_pred             CCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEcc
Q 046544          258 ASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLG  337 (646)
Q Consensus       258 ~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls  337 (646)
                      ..|+.+|||+|.|+.+..+..-.+.++.|++|+|.+..+  ..+..+++|+.||||+|.++.. ..+=..+-+.+.|.|+
T Consensus       284 q~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  284 QELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeehh
Confidence            467788888888888887777778888888888888733  3377788888899998888754 3344467788999999


Q ss_pred             CccCCCcccccccCCCCCCEEEccCCcCccc-CCccccCCCCCCceeCcCCcceeecc
Q 046544          338 YNRLEGSIPDSFGDLISLKFLNLSNNNLSGA-IPTSLEKLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       338 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p  394 (646)
                      +|.|...  ..+..+-+|..||+++|+|... -...+++++.|+.+.|.+|++.+.+.
T Consensus       361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9998732  3466777899999999999742 23568899999999999999997444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=4.7e-12  Score=138.80  Aligned_cols=142  Identities=25%  Similarity=0.364  Sum_probs=109.1

Q ss_pred             cceeecccccceEEEEEeC-CCcEEEEEEEec---c--CCchH-HHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          496 ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNL---Q--CGRAF-KSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~--~~~~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ....+|.|++|.|+.+... ..+.++.|.+..   .  ..... ..+..|..+-..++|+|++.....+.......-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999988777643 344444443321   1  11111 125557777888999999887776666655556699


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++ +|..++.... .+...++..+++|+..|++|+|   ..||.|||+|++|+++..+|.+||+|||.+..+
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceee
Confidence            9999 9999987652 5677788999999999999999   899999999999999999999999999988754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.2e-10  Score=104.48  Aligned_cols=132  Identities=22%  Similarity=0.298  Sum_probs=100.0

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCC--------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..+++|+-+.+|.+.+- |.++++|.-..+.-        -...+..+|+.++++++--.|....=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999773 44466664322211        1124567899999998766665555556667778899999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++|..+.+++...        ...++..+-.-+.-||   ..+|+|+|+.++||++..+. +.++|||+++.-
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999998888654        2456677778888899   99999999999999998775 999999999853

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.23  E-value=1.9e-12  Score=128.94  Aligned_cols=182  Identities=24%  Similarity=0.266  Sum_probs=104.3

Q ss_pred             cCCCCCEEEccCCccccccC-ccccCCCCCCeEEeecccccCcCc--hhhcCCCCCcEEEecCCcccccCCc-cccCCCC
Q 046544          184 NLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLDDNKLEGSIP--DSICRLTELYELELGGNKLFGSIPA-CFSNLAS  259 (646)
Q Consensus       184 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~  259 (646)
                      ++.+|+.+.|.+..+..... .....+++++.||||.|-+....|  .....+++|+.|+|+.|++...... .-..++.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            44556666666665542211 244556677777777776664322  3345677777777777777522211 1124567


Q ss_pred             CceeecCCCccc--ccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccC-ccccCCCCCCCEEEc
Q 046544          260 LRILSLSSNELT--SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI-PTEIGGLKNLEYLFL  336 (646)
Q Consensus       260 L~~L~L~~N~l~--~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~L  336 (646)
                      |+.|.|+.|.|+  ++-.....+++|+.|+|..|............+..|+.|||++|++.... -...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            888888888877  33334456777888888877533333444455666777777777665432 134556666666777


Q ss_pred             cCccCCCcc-ccc-----ccCCCCCCEEEccCCcC
Q 046544          337 GYNRLEGSI-PDS-----FGDLISLKFLNLSNNNL  365 (646)
Q Consensus       337 s~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l  365 (646)
                      +.+.+..+- |+.     -..+++|+.|+++.|+|
T Consensus       279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I  313 (505)
T KOG3207|consen  279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI  313 (505)
T ss_pred             cccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence            666665432 111     12344555555555555

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.21  E-value=8.6e-12  Score=144.14  Aligned_cols=90  Identities=12%  Similarity=0.232  Sum_probs=69.2

Q ss_pred             CCC-CCceeEEEEE-------ecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 046544          545 IRH-RNLIKVISSC-------SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC  616 (646)
Q Consensus       545 l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr  616 (646)
                      .+| +||++++++|       ...+..+.+|||+ +++|.+++......+++.++..++.||++||.|+|   +++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            344 4677777766       2223567888987 56999999766667899999999999999999999   8999999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecC
Q 046544          617 DLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       617 dlk~~Nil~~~~~~~ki~DfGl  638 (646)
                      ||||+|||++..+.+|++|||+
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~  126 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESAS  126 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccc
Confidence            9999999996544444433333

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=2e-10  Score=102.34  Aligned_cols=142  Identities=18%  Similarity=0.215  Sum_probs=106.0

Q ss_pred             cceeecccccceEEEEEeCCCcEEEEEE-EeccC-------CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          496 ENNLIGRGGFGSVYKARLGDGMEVAVKV-FNLQC-------GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ....+-||+-+.|+++.+ .|+...||. +.+.-       +-..++..+|++.+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567889999999999988 566666664 22211       122456778999999987666655555566666778999


Q ss_pred             EecCC-CCHHHHHhhCCCCCCHHHH-HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEEEeecCccc
Q 046544          568 EYKPH-GSLEKYLYSSNCILDIFQR-LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~-g~L~~~l~~~~~~l~~~~~-~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki~DfGla~~  641 (646)
                      ||++| .++.+++......-...+. ..++++|-+.+.-||   ..+|||+|+..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4888888765433333333 678999999999999   89999999999999996554   468999999764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.16  E-value=3.4e-10  Score=110.02  Aligned_cols=142  Identities=20%  Similarity=0.200  Sum_probs=108.6

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCC--CCceeEEEEEecC---CeeEEEEEecC
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRH--RNLIKVISSCSNE---EFKALVLEYKP  571 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~---~~~~lv~e~~~  571 (646)
                      +.++.|.++.||+++..+|+.+++|....... .....+.+|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678899998764432 134567889999999875  3457777776553   25689999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC------------------------------------------  609 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------  609 (646)
                      |.++.+.+..  ..++..+...++.++++++.++|...                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888765432  24566677788888888888888320                                          


Q ss_pred             -----------CCCeEecCCCCCCEEEcC--CCcEEEEeecCccc
Q 046544          610 -----------LAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKL  641 (646)
Q Consensus       610 -----------~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~  641 (646)
                                 ...++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       235799999999999988  67789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=1.6e-12  Score=126.09  Aligned_cols=133  Identities=24%  Similarity=0.281  Sum_probs=85.9

Q ss_pred             CCCceeecCCCccccccc-----ccccccccccccCCCCcccCC----CCCccCccccceEEEccccccccc----Cccc
Q 046544          258 ASLRILSLSSNELTSIPL-----TFWNLKDILQLNFSSNFLTGP----LPLEIGNLKVLIGIDFSMNNFSSV----IPTE  324 (646)
Q Consensus       258 ~~L~~L~L~~N~l~~lp~-----~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~  324 (646)
                      +.|+++..++|++..-+.     .|...+.|+.+.++.|.|...    ....|..+++|+.|||..|-++..    ....
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka  236 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA  236 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence            566677777776665442     244456666666666665421    123456677777777777776643    2345


Q ss_pred             cCCCCCCCEEEccCccCCCcccccc-----cCCCCCCEEEccCCcCcc----cCCccccCCCCCCceeCcCCcce
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSF-----GDLISLKFLNLSNNNLSG----AIPTSLEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~  390 (646)
                      +..+++|+.|+++++.++.....+|     ...++|+.|.+.+|.|+.    .+...+...+.|+.|+|++|.+.
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            6677888888888888875544333     235788888888888873    23334556788888888888883

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.14  E-value=5.9e-12  Score=131.58  Aligned_cols=141  Identities=25%  Similarity=0.292  Sum_probs=117.1

Q ss_pred             ecccccceEEEEE----eCCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEecCC
Q 046544          500 IGRGGFGSVYKAR----LGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       500 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +|+|+||+|+.++    ...|.-+|+|+.++...  +.......|..++...+ ||.+|++...++.+...+++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999875    23467789998775542  12224556888888886 99999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |++...+.... ...+.....+...++-|++++|   ..+|+|||+|++||+++.+|++|+.|||++|....
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            99998887665 3455555667778899999999   89999999999999999999999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.10  E-value=1.4e-11  Score=135.36  Aligned_cols=141  Identities=26%  Similarity=0.310  Sum_probs=117.4

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccC-CchHHHHH---HHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFA---VECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      +|...+.+|+++|=+|.+|+++.|. |+||++-++. .-..+.|.   +|++ .+-++|||++.+..+..++...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566688999999999999998887 8999987665 33344444   4455 556699999999888888888899999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      |..+ +|+|.+..+. .+...+..-|+.|++.|+.-+|   ..+|+|+|||.+||||..-.-+.++||..-|
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccC
Confidence            9966 8999987654 5667777889999999999999   9999999999999999999899999998655

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.10  E-value=7.8e-11  Score=88.51  Aligned_cols=61  Identities=39%  Similarity=0.610  Sum_probs=48.5

Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCC
Q 046544           59 PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL  119 (646)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  119 (646)
                      |+|++|++++|+|+...++.|.++++|++|++++|.|+.+.|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677888888888877777788888888888888888888778888888888888888765

...

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.10  E-value=4.5e-12  Score=123.00  Aligned_cols=145  Identities=20%  Similarity=0.192  Sum_probs=69.2

Q ss_pred             cCCCCCcEEEcccCccccccCccc----cCcCCCCEEEccCCCCCCCCCcc--------cccccCCCCCCCCEEECCCCC
Q 046544           80 FNASKLSILELSQNSFSGFIPNTF----GNLRNLEWLNLRDNYLTSSTPEL--------SFLSSLSNCKSLTFIHLSDNP  147 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~--------~~~~~l~~l~~L~~L~Ls~N~  147 (646)
                      ...++|++||||+|.+..-.+..|    .....|++|+|.+|-+.......        ........-+.|+++..++|+
T Consensus        89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr  168 (382)
T KOG1909|consen   89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR  168 (382)
T ss_pred             hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence            344566666666666653333222    34456666666666554321110        001123344677788888887


Q ss_pred             CCCcCCcch--hccccccCcEEEeecccccc----cCCcccccCCCCCEEEccCCccccc----cCccccCCCCCCeEEe
Q 046544          148 LDGILSKTS--IGNLSHSLKDFYMSNCNVSG----GIPEEITNLTNSITIDLGGNKLNGS----IPITLSKLQKLQGLGL  217 (646)
Q Consensus       148 l~~~~~~~~--~~~~~~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L  217 (646)
                      +..-.....  .....+.|+++.++.|.|..    .....|..+++|+.|||.+|-++..    ...++..+++|+.|++
T Consensus       169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l  248 (382)
T KOG1909|consen  169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL  248 (382)
T ss_pred             cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence            754322110  11111345555555555432    1223455556666666666655422    2223444445555555


Q ss_pred             ecccccC
Q 046544          218 DDNKLEG  224 (646)
Q Consensus       218 ~~N~l~~  224 (646)
                      ++|.++.
T Consensus       249 ~dcll~~  255 (382)
T KOG1909|consen  249 GDCLLEN  255 (382)
T ss_pred             ccccccc
Confidence            5555543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.05  E-value=4.4e-11  Score=111.90  Aligned_cols=136  Identities=22%  Similarity=0.429  Sum_probs=111.5

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      ..++.+...|+.|+|+|. |..+++|++....  .+..++|..|.-.++-+.||||..+.+.|.......++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            345778889999999995 4556667765442  3344678889999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          575 LEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       575 L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      |+..+++... ..+..++++++.++++|++|||+- ++-|.---+.++.++||++.+++|+
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            9999987643 567788999999999999999964 3334444789999999999888764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.99  E-value=4.9e-09  Score=103.21  Aligned_cols=144  Identities=24%  Similarity=0.380  Sum_probs=92.0

Q ss_pred             CCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCC----------CCceeEEEEEe-
Q 046544          494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRH----------RNLIKVISSCS-  558 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H----------~niv~~~~~~~-  558 (646)
                      +...+.||.|+++.||.+++. +|+++|+|++....   ....+++.+|.-....+.+          -.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456789999999999999975 69999999986543   2345566666644444322          12222222211 


Q ss_pred             --------cC---C-----eeEEEEEecCCCCHHHHHhh---CCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 046544          559 --------NE---E-----FKALVLEYKPHGSLEKYLYS---SNCI---LDIFQRLNIMIDVASALEYLHFGCLAPVIHC  616 (646)
Q Consensus       559 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~---l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr  616 (646)
                              ..   .     ..+++|+-+ .++|.+++..   ....   .....+..+..|+++.++++|   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                    11   1     225677777 4588888642   2111   223344566789999999999   8999999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecCccc
Q 046544          617 DLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       617 dlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||+|+|++++.+|.++++||+....
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r  194 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVR  194 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred             ccceeeEEEcCCCCEEEcChHHHee
Confidence            9999999999999999999987654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=7.4e-10  Score=109.26  Aligned_cols=89  Identities=28%  Similarity=0.442  Sum_probs=72.4

Q ss_pred             CCCCceeEEEEEecC---------------------------CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 046544          546 RHRNLIKVISSCSNE---------------------------EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV  598 (646)
Q Consensus       546 ~H~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  598 (646)
                      +|||||++.++|.++                           ..+|+||.-+.. +|.+|+....  .+.....-|..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            699999998876321                           246899988755 8999997764  4556677799999


Q ss_pred             HHHHHHHhcCCCCCeEecCCCCCCEEE--cCCC--cEEEEeecCcc
Q 046544          599 ASALEYLHFGCLAPVIHCDLKPDNVLL--DDNL--VAYLSDFGIAK  640 (646)
Q Consensus       599 ~~~l~~lH~~~~~~iiHrdlk~~Nil~--~~~~--~~ki~DfGla~  640 (646)
                      ++|+.|||   .++|.|||+|++|||+  |+|+  ...|+|||.+-
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            99999999   8999999999999999  3443  57899999753

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.98  E-value=3.9e-10  Score=84.69  Aligned_cols=58  Identities=34%  Similarity=0.492  Sum_probs=24.9

Q ss_pred             CCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCc
Q 046544          188 SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK  245 (646)
Q Consensus       188 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  245 (646)
                      |++|++++|+++.+++.+|.++++|++|++++|+++.+.|++|.++++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3444444444444434444444444444444444444444444444444444444443

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=8.4e-09  Score=95.92  Aligned_cols=126  Identities=27%  Similarity=0.298  Sum_probs=82.3

Q ss_pred             eEEEEEeCCCcEEEEEEEeccC-------------Cc-------------hHHHHHHHHHHHHhCCCC--CceeEEEEEe
Q 046544          507 SVYKARLGDGMEVAVKVFNLQC-------------GR-------------AFKSFAVECEMMKSIRHR--NLIKVISSCS  558 (646)
Q Consensus       507 ~V~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~e~~~l~~l~H~--niv~~~~~~~  558 (646)
                      .||.|...+|..+|+|+.+...             .+             ......+|++.|.++...  ++++++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999875321             00             023456799999999766  466666542 


Q ss_pred             cCCeeEEEEEecC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          559 NEEFKALVLEYKP--HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY-LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       559 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                         ...+||||++  |..+..+ ....  ++......++.+++..+.. +|   ..||+|+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l-~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRL-KDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCH-HHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhH-Hhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3579999998  5444443 3221  1123345677777775555 57   8899999999999999988 899999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||.|....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=2.2e-08  Score=98.93  Aligned_cols=140  Identities=16%  Similarity=0.072  Sum_probs=99.3

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCCc-hH----------HHHHHHHHHHHhCCCCCc--eeEEEEEec-----
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AF----------KSFAVECEMMKSIRHRNL--IKVISSCSN-----  559 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~H~ni--v~~~~~~~~-----  559 (646)
                      +.+-+.....|++..+ +|+.|.||......-. ..          ..+.+|...+.++...+|  +++.++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455445555777666 5778999976432210 11          136789888888744333  344445433     


Q ss_pred             CCeeEEEEEecCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-------CCc
Q 046544          560 EEFKALVLEYKPHG-SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-------NLV  630 (646)
Q Consensus       560 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-------~~~  630 (646)
                      ....++|||++++. +|.+++... ....+......++.+++..+.-||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23478999999886 798887542 223455667789999999999999   999999999999999975       468


Q ss_pred             EEEEeecCccc
Q 046544          631 AYLSDFGIAKL  641 (646)
Q Consensus       631 ~ki~DfGla~~  641 (646)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.90  E-value=6e-10  Score=126.70  Aligned_cols=129  Identities=32%  Similarity=0.387  Sum_probs=92.3

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCc--CcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNS--LLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSI   87 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (646)
                      ...+...+-+|++.. .+.+... ++|++|-+..|.  +. .++...|..++.|++|||++|.=-+.+|..++.+-+|++
T Consensus       523 ~~~rr~s~~~~~~~~-~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEH-IAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchhh-ccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            556777777787763 3333333 378888888886  33 244444556888888888887766688888888888888


Q ss_pred             EEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCC
Q 046544           88 LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP  147 (646)
Q Consensus        88 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  147 (646)
                      |+|++..+. ..|..++.|..|.+|++..+.-....+     .....+.+|++|.+..-.
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~-----~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIP-----GILLELQSLRVLRLPRSA  653 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheecccccccccccc-----chhhhcccccEEEeeccc
Confidence            888888888 567888888888888888776444322     235557888888876554

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.89  E-value=1.9e-11  Score=128.65  Aligned_cols=126  Identities=31%  Similarity=0.365  Sum_probs=56.8

Q ss_pred             cccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccC
Q 046544          283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN  362 (646)
Q Consensus       283 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  362 (646)
                      |...+.+.|.+. ....++.-++.|+.|||++|+++..  ..+..++.|++|||++|++..+.--...++ +|+.|.++|
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrn  241 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRN  241 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeecc
Confidence            344444444444 2334444444555555555555433  244455555555555555542221122222 255555555


Q ss_pred             CcCcccCCccccCCCCCCceeCcCCcceeecc--CCCCCCCCccccccCCcccc
Q 046544          363 NNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP--RGGSFGNFAAESFEGNELLC  414 (646)
Q Consensus       363 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~~~~~~~~~~~N~~~c  414 (646)
                      |.++..  ..+.+|.+|+.||+++|-|++-..  ..+.+..+..++++|||+-|
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            555422  124455555555555555543111  11223444555555555444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.84  E-value=5.7e-09  Score=109.47  Aligned_cols=98  Identities=35%  Similarity=0.557  Sum_probs=90.4

Q ss_pred             HHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCCC
Q 046544          542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV-IHCDLKP  620 (646)
Q Consensus       542 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i-iHrdlk~  620 (646)
                      |+.+.|.|+.+++|.+..++..+.|.+||..|+|.+.+......+++.-...++++++.|++|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            45789999999999999999999999999999999999987778999999999999999999999   4444 9999999


Q ss_pred             CCEEEcCCCcEEEEeecCcccc
Q 046544          621 DNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       621 ~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +|+++|....+|++|||+....
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             ccceeeeeEEEEechhhhcccc
Confidence            9999999999999999998765

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=5.1e-09  Score=119.25  Aligned_cols=108  Identities=27%  Similarity=0.368  Sum_probs=88.2

Q ss_pred             CCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCc--ccccCCccccCCCCCcEEEcccCccccccCccccCcCCC
Q 046544           32 NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN--FSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL  109 (646)
Q Consensus        32 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  109 (646)
                      +....++..+-+|.+.......   ..++|++|-+.+|.  +....+++|..++.|++||||+|.=-+..|..+++|-+|
T Consensus       521 ~~~~~rr~s~~~~~~~~~~~~~---~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEHIAGSS---ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             chhheeEEEEeccchhhccCCC---CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            3467899999999886533332   25589999999996  665666678889999999999987767889999999999


Q ss_pred             CEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCC
Q 046544          110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL  148 (646)
Q Consensus       110 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  148 (646)
                      ++|+|++..++.+|.      .+.+++.|.+|++..+.-
T Consensus       598 ryL~L~~t~I~~LP~------~l~~Lk~L~~Lnl~~~~~  630 (889)
T KOG4658|consen  598 RYLDLSDTGISHLPS------GLGNLKKLIYLNLEVTGR  630 (889)
T ss_pred             hcccccCCCccccch------HHHHHHhhheeccccccc
Confidence            999999999998654      578889999999987764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.77  E-value=3.8e-08  Score=104.37  Aligned_cols=122  Identities=20%  Similarity=0.235  Sum_probs=102.6

Q ss_pred             EeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHH
Q 046544          512 RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR  591 (646)
Q Consensus       512 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~  591 (646)
                      +..++.+|.|..++...........+.++.++.++||||+++++.++.++..|+|+|-+.  .|..++++.+    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            345788999999887766445566778899999999999999999999999999999985  5777776643    4455


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       592 ~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      .-.+.||+.||.|||.  .++++|+++.-..|+|+..|..||++|-++..
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence            5678899999999985  56899999999999999999999999987644

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.73  E-value=1.5e-10  Score=121.91  Aligned_cols=129  Identities=32%  Similarity=0.218  Sum_probs=94.4

Q ss_pred             CCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccC
Q 046544          259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGY  338 (646)
Q Consensus       259 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  338 (646)
                      .|...+.++|.|+.+..++.-++.|+.|||++|+++...  .+..++.|+.|||++|.++.+.--...++. |+.|.+++
T Consensus       165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence            467777888888887777777788888888888887543  677788888888888888854333344444 88888888


Q ss_pred             ccCCCcccccccCCCCCCEEEccCCcCcccCC-ccccCCCCCCceeCcCCcceee
Q 046544          339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP-TSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       339 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      |.++..  ..+.+|.+|+-||+++|-|.+..- .-+..|..|+.|+|.||++-+-
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            888743  246778888888888888764221 2245667788888888888763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=9.8e-08  Score=91.09  Aligned_cols=136  Identities=23%  Similarity=0.199  Sum_probs=96.9

Q ss_pred             CCcceeecccccceEEEEEeCCCcEEEEEEEeccC------------------C----chHHHHHHHHHHHHhCCCC--C
Q 046544          494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------------------G----RAFKSFAVECEMMKSIRHR--N  549 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~----~~~~~~~~e~~~l~~l~H~--n  549 (646)
                      ..++..||-|.-+.||.|....|.++|||.=+...                  .    .......+|.++|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45668899999999999999899999999532110                  0    1123456799999998654  6


Q ss_pred             ceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC
Q 046544          550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       550 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      +++.+++    +...+||||++|-.|...-.      +....-.++..|++-+.-.-   ..||||+|+.+=||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            6665544    56789999999966654321      12223344445555444444   56899999999999999999


Q ss_pred             cEEEEeecCcccc
Q 046544          630 VAYLSDFGIAKLL  642 (646)
Q Consensus       630 ~~ki~DfGla~~~  642 (646)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999876554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.64  E-value=9.6e-08  Score=102.21  Aligned_cols=141  Identities=21%  Similarity=0.179  Sum_probs=93.5

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCC----------------------c----h----HH----------HHHH
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG----------------------R----A----FK----------SFAV  537 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~----~----~~----------~~~~  537 (646)
                      +.++.++-|+||+|++.+|++||||+.+..-.                      .    .    .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999999999999998643210                      0    0    01          2334


Q ss_pred             HHHHHHhC-----CCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 046544          538 ECEMMKSI-----RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA-LEYLHFGCLA  611 (646)
Q Consensus       538 e~~~l~~l-----~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~lH~~~~~  611 (646)
                      |+.-+.++     ..+.+.-..=+++-.+...++|||++|..+.+.........+...   ++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            55555544     234443222233345667899999999888887533333455333   33333332 22222   34


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       612 ~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |++|.|..|.||+++.+|.....|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999877643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.62  E-value=2e-09  Score=90.83  Aligned_cols=130  Identities=18%  Similarity=0.243  Sum_probs=92.3

Q ss_pred             CcEEEeecccccccCCccc---ccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          164 LKDFYMSNCNVSGGIPEEI---TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       164 L~~L~L~~n~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      +..++|++|++.. ++++.   .....|+..+|++|.+...++..-...+.+++|+|++|.|+ .+|..+..++.|+.|+
T Consensus        29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            4556777777662 34443   44456777899999998555544455668899999999998 5677799999999999


Q ss_pred             ecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCC
Q 046544          241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP  296 (646)
Q Consensus       241 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  296 (646)
                      ++.|.+. ..|..+..+.++-.|+..+|.+..+|.....-+..-..++.++.+.+.
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~  161 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDE  161 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCccccc
Confidence            9999987 556667778888899999998888887644433333444455555443

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.61  E-value=4.6e-09  Score=99.99  Aligned_cols=113  Identities=26%  Similarity=0.269  Sum_probs=67.5

Q ss_pred             cCCCCCCEEECCCCcccccCC-cCcc-CCCCCCEEECcCCcCcccCCccCc--CCCCCCCEEEccCCcccccCCccccCC
Q 046544            7 SNLQNLEELDLRHNKLVGTVP-AAIF-NMSMLKLLHLQNNSLLGCLSSIAD--VRLPNLEALLLWGNNFSGTIPRFIFNA   82 (646)
Q Consensus         7 ~~l~~L~~L~L~~N~l~~~~~-~~~~-~l~~L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (646)
                      ..+.-++.|.+.++.|...-. ..|+ ..+.++.|||.+|.|+. .+.++.  ..+|.|++|+|+.|.+...+...=..+
T Consensus        42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSd-WseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~  120 (418)
T KOG2982|consen   42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISD-WSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL  120 (418)
T ss_pred             ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhcc-HHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence            344455566666666642211 1222 35678888888888753 222221  257888888888888773332221356


Q ss_pred             CCCcEEEcccCccccccC-ccccCcCCCCEEEccCCCCC
Q 046544           83 SKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLT  120 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  120 (646)
                      .+|++|-|.+..+..... ..+..+|.++.|.++.|.+.
T Consensus       121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r  159 (418)
T KOG2982|consen  121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR  159 (418)
T ss_pred             cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence            678888888877764333 23456777777777777544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=5.5e-07  Score=86.12  Aligned_cols=106  Identities=24%  Similarity=0.276  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHHhCCCC--CceeEEEEEecCC----eeEEEEEecCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 046544          533 KSFAVECEMMKSIRHR--NLIKVISSCSNEE----FKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYL  605 (646)
Q Consensus       533 ~~~~~e~~~l~~l~H~--niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l  605 (646)
                      ....+|...+..+...  .+++.+++.+...    ..++|+|++++. +|.+++..... .+......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4567788887777433  3455666655432    358999999884 79998876332 45566788999999999999


Q ss_pred             hcCCCCCeEecCCCCCCEEEcCCC---cEEEEeecCcccc
Q 046544          606 HFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLL  642 (646)
Q Consensus       606 H~~~~~~iiHrdlk~~Nil~~~~~---~~ki~DfGla~~~  642 (646)
                      |   ..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   99999999999999998776   8999999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.57  E-value=4e-08  Score=103.27  Aligned_cols=149  Identities=26%  Similarity=0.265  Sum_probs=120.8

Q ss_pred             CCCCcceeecc--cccceEEEEEe---CCCcEEEEEEEecc--CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGR--GGFGSVYKARL---GDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      ..|...+.+|.  |.+|.||.++.   .++..+|+|.-+..  .......-.+|+...+.+ .|++.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45566788899  99999999975   36788999874322  222333335577666666 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecC
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGI  638 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGl  638 (646)
                      ++-+|+| +.++..+.......++......+..+..+    |+.++|   ..+++|-|+||+||+...+ ...+.+|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999999 56899988776666788888888888888    999999   8899999999999999988 8999999999


Q ss_pred             cccccC
Q 046544          639 AKLLIG  644 (646)
Q Consensus       639 a~~~~~  644 (646)
                      ...+.+
T Consensus       270 v~~i~~  275 (524)
T KOG0601|consen  270 VSKISD  275 (524)
T ss_pred             eEEccC
Confidence            887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.56  E-value=8.1e-09  Score=113.52  Aligned_cols=151  Identities=25%  Similarity=0.318  Sum_probs=120.0

Q ss_pred             CCCCcceeecccccceEEEEEeC--CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv  566 (646)
                      ..|...+.||+|+|+.|-.+...  ....+|+|.+....  ....+....|..+-+.+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45677788999999999877643  34556777655432  233344555777777776 99999999999999999999


Q ss_pred             EEecCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCcccccC
Q 046544          567 LEYKPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIG  644 (646)
Q Consensus       567 ~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~~  644 (646)
                      +||..||++...+ .......+...+..+..|+..|+.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999888 3332245566778899999999999995  46899999999999999988 999999999987643

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.50  E-value=1.9e-08  Score=95.83  Aligned_cols=166  Identities=27%  Similarity=0.300  Sum_probs=94.2

Q ss_pred             ccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccc-cCCccccCCCCCceeecCCCcccccccccccccccc
Q 046544          206 LSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG-SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDIL  284 (646)
Q Consensus       206 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~  284 (646)
                      +.+++.|++|+|+.|++...+...-..+.+|++|-|.+..+.= .....+..+|.++.|++|.|.++.            
T Consensus        93 le~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq------------  160 (418)
T KOG2982|consen   93 LEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQ------------  160 (418)
T ss_pred             HhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhh------------
Confidence            4455556666666666553322211345566777776666531 122345566777777777775442            


Q ss_pred             cccCCCCcccCCCCC--ccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCccc-ccccCCCCCCEEEcc
Q 046544          285 QLNFSSNFLTGPLPL--EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLNLS  361 (646)
Q Consensus       285 ~L~l~~N~l~~~~~~--~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls  361 (646)
                       +++..|.+....|.  .+...+.+..+.++-|++..+       ++++..+.+..|++...-. ..+..++.+-.|+|+
T Consensus       161 -~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~  232 (418)
T KOG2982|consen  161 -LNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLG  232 (418)
T ss_pred             -hccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhc
Confidence             23333333221110  111122233334444555433       4678888888888765432 355666777788999


Q ss_pred             CCcCcc-cCCccccCCCCCCceeCcCCccee
Q 046544          362 NNNLSG-AIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       362 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      .|+|.. ..-+.+.+++.|..|.+++|++..
T Consensus       233 ~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  233 ANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             ccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            888863 233567788889999999998875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.49  E-value=1e-06  Score=90.73  Aligned_cols=137  Identities=18%  Similarity=0.176  Sum_probs=106.1

Q ss_pred             ceEEEEE-eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC----CeeEEEEEecCC-CCHHHHH
Q 046544          506 GSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYKPH-GSLEKYL  579 (646)
Q Consensus       506 g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~----~~~~lv~e~~~~-g~L~~~l  579 (646)
                      ...|++. ..+|..|+.|+++............-+++++++.|+|+|++++++.+.    ..+++|++|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            4678887 458999999999544322221223357788999999999999998743    467899999986 5776665


Q ss_pred             hhC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccCC
Q 046544          580 YSS--------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE  645 (646)
Q Consensus       580 ~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~~  645 (646)
                      ...              +...++...+.++.|+..||.++|   +.|..-+-+.+.+|+++.+.+++|+..|....+..|
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            321              234677889999999999999999   778888999999999999999999998887665443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.48  E-value=7.9e-08  Score=101.04  Aligned_cols=146  Identities=25%  Similarity=0.250  Sum_probs=114.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC--CCcEEEEEEEeccCCchHH--HHHHHHHHHHhC-CCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCGRAFK--SFAVECEMMKSI-RHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..+|.....||.|.|+.|+....+  ++..|++|...........  .-..|+.+...+ .|.+++.+...|..-...|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            356888899999999999998744  6788999976543222211  123455555555 68888988888887778889


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCcc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAK  640 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~  640 (646)
                      --|||++++........ ..+++...+++..|++.++.++|   .+.++|+|+||+||++..+ +..++.|||.++
T Consensus       344 p~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             chhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            99999999887766322 35677788899999999999999   9999999999999999875 889999999875

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=6.9e-06  Score=76.91  Aligned_cols=154  Identities=14%  Similarity=0.083  Sum_probs=107.1

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC------CchHHHHHHHHHHHHhCCCCC--ceeEEE
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------GRAFKSFAVECEMMKSIRHRN--LIKVIS  555 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~n--iv~~~~  555 (646)
                      ++.+......+...---|+|+.+-|++.... |+.+-+|.-...-      +-....|.+|+..+..+...+  +.++..
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf   88 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF   88 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence            3444444444544444577999999987764 4468888754111      223568999999998885333  444442


Q ss_pred             EEecC----CeeEEEEEecCC-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC
Q 046544          556 SCSNE----EFKALVLEYKPH-GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       556 ~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~  629 (646)
                      .....    -..++|+|-++| .+|.+++.+.. ...+......+..++++.+.-||   ..++.|+|+.+.||+++.++
T Consensus        89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g  165 (216)
T PRK09902         89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEG  165 (216)
T ss_pred             eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCC
Confidence            22221    236799997754 48888876543 24566677889999999999999   89999999999999998666


Q ss_pred             c--EEEEeecCccc
Q 046544          630 V--AYLSDFGIAKL  641 (646)
Q Consensus       630 ~--~ki~DfGla~~  641 (646)
                      .  ++++||--++.
T Consensus       166 ~~~v~lIDlEk~r~  179 (216)
T PRK09902        166 KAEAGFLDLEKSRR  179 (216)
T ss_pred             CeeEEEEEhhccch
Confidence            6  99999976553

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=7.9e-09  Score=87.26  Aligned_cols=58  Identities=24%  Similarity=0.295  Sum_probs=24.8

Q ss_pred             CCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcc
Q 046544          235 ELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFL  293 (646)
Q Consensus       235 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  293 (646)
                      .++.|+|++|.|+ .+|..+..++.|+.|+++.|.+...|..+..+.++-.|+..+|.+
T Consensus        78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~  135 (177)
T KOG4579|consen   78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPENAR  135 (177)
T ss_pred             hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCCCcc
Confidence            3444444444443 223334444444444444444444444444444444444444443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=2.3e-06  Score=81.12  Aligned_cols=154  Identities=22%  Similarity=0.166  Sum_probs=99.2

Q ss_pred             cccHHHHHHHhCCCCcce---eecccccceEEEEEeCCCcEEEEEEEeccCCch-------------------H-----H
Q 046544          481 TFSYLELCRATNGFSENN---LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-------------------F-----K  533 (646)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~-----~  533 (646)
                      ..+...+....++..+..   .|.+|.-+.||+|...++..||+|+++......                   .     .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            344555555555555544   455777788999998889999999987432100                   0     1


Q ss_pred             HHHHHHHHHHhCC--CCCceeEEEEEecCCeeEEEEEecCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 046544          534 SFAVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL  610 (646)
Q Consensus       534 ~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~  610 (646)
                      ...+|..-|+++.  +-.+++.+.+.    .-.+||||+... .-.-.+++.  .+...++..+..++++.+.-|-.  .
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~--~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK--E  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH--h
Confidence            1234666666653  33344444332    346999998542 111222222  22333567788888888887762  3


Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       611 ~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      .++||+||+.=|||+. ++.+.|+|||-|....
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7999999999999999 7899999999886543

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.42  E-value=3e-09  Score=101.26  Aligned_cols=227  Identities=21%  Similarity=0.180  Sum_probs=133.7

Q ss_pred             CCEEECCCCcccccCCcCccCC--CCCCEEECcCCcCccc-CCccCcCCCCCCCEEEccCCcccc-cCCccccCCCCCcE
Q 046544           12 LEELDLRHNKLVGTVPAAIFNM--SMLKLLHLQNNSLLGC-LSSIADVRLPNLEALLLWGNNFSG-TIPRFIFNASKLSI   87 (646)
Q Consensus        12 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~   87 (646)
                      =+.||+.+-.|.   |.+...+  .....+.+..-.+... ..+.+..--+.||+||||+-.|+. .....+..+.+|+.
T Consensus       138 W~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk~  214 (419)
T KOG2120|consen  138 WQTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLKN  214 (419)
T ss_pred             eeeeccCCCccC---hhHHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhhh
Confidence            356777766553   4444443  3455566654443221 111111112359999999999983 34556778899999


Q ss_pred             EEcccCccccccCccccCcCCCCEEEccCCC-CCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcE
Q 046544           88 LELSQNSFSGFIPNTFGNLRNLEWLNLRDNY-LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKD  166 (646)
Q Consensus        88 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  166 (646)
                      |.|.++++.+.+-..++.-.+|+.|+|+.+. +++....    --+.+|+.|.+|+|+++.+..-.....+....+.|+.
T Consensus       215 lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~----ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~  290 (419)
T KOG2120|consen  215 LSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQ----LLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQ  290 (419)
T ss_pred             ccccccccCcHHHHHHhccccceeeccccccccchhHHH----HHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhh
Confidence            9999999998888889999999999999864 4433211    1367899999999999987644333334444455666


Q ss_pred             EEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeeccc-ccCcCchhhcCCCCCcEEEecCCc
Q 046544          167 FYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK-LEGSIPDSICRLTELYELELGGNK  245 (646)
Q Consensus       167 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~  245 (646)
                      |+|+++.-.-                 ..+    .+..-....++|.+||||+|. ++...-.+|..++.|++|.++.+.
T Consensus       291 LNlsG~rrnl-----------------~~s----h~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY  349 (419)
T KOG2120|consen  291 LNLSGYRRNL-----------------QKS----HLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCY  349 (419)
T ss_pred             hhhhhhHhhh-----------------hhh----HHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhc
Confidence            6666543210                 001    111122344555555555543 333333445556666666666655


Q ss_pred             ccccCCcc---ccCCCCCceeecCCC
Q 046544          246 LFGSIPAC---FSNLASLRILSLSSN  268 (646)
Q Consensus       246 i~~~~~~~---~~~l~~L~~L~L~~N  268 (646)
                      .  ++|+.   |...|+|.+||+.++
T Consensus       350 ~--i~p~~~~~l~s~psl~yLdv~g~  373 (419)
T KOG2120|consen  350 D--IIPETLLELNSKPSLVYLDVFGC  373 (419)
T ss_pred             C--CChHHeeeeccCcceEEEEeccc
Confidence            2  44442   344566666665554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.42  E-value=4.7e-06  Score=80.71  Aligned_cols=133  Identities=14%  Similarity=0.140  Sum_probs=84.1

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCC--ceeEEEEEecCCeeEEEEEecCCCC-
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN--LIKVISSCSNEEFKALVLEYKPHGS-  574 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g~-  574 (646)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999974   24567788876433  2345678999998885433  4677777777777889999999863 


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhc-CCCCCeE
Q 046544          575 LEKYLYSSNCILDIFQRLNIMIDVASA---------------------------------------LEYLHF-GCLAPVI  614 (646)
Q Consensus       575 L~~~l~~~~~~l~~~~~~~i~~~i~~~---------------------------------------l~~lH~-~~~~~ii  614 (646)
                      +...+..     +......++.++++.                                       ..++.. .....++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2111100     000001111111111                                       122211 1123568


Q ss_pred             ecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          615 HCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       615 Hrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      |+|+.|.||++++++ +.++||+.|..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.34  E-value=3.9e-07  Score=101.06  Aligned_cols=110  Identities=30%  Similarity=0.463  Sum_probs=77.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..+|...+.|..|+||.||.++++ +.+.+|+|+-+ +.     -+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence            368899999999999999999876 47788885422 11     01110  22223333333                  


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                         ||-...++..+ .++.        +++.+++|+|   ..+|+|||+||+|.+|..-|++|++|||+.+.
T Consensus       136 ---gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ---chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhh
Confidence               44445554433 2222        2278999999   89999999999999999999999999999875

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.33  E-value=7.8e-06  Score=76.81  Aligned_cols=136  Identities=18%  Similarity=0.176  Sum_probs=87.5

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHH---------HHHHHHHHhCC---CCCceeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSF---------AVECEMMKSIR---HRNLIKVISSCSN  559 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---H~niv~~~~~~~~  559 (646)
                      .+|...+++-......|.+-.. +|+.+++|..........+.|         .+++....+++   -...+.++.+.+.
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            5677777777766666665555 578889998765443222222         23333333332   2222233333322


Q ss_pred             C-----CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          560 E-----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       560 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      .     ...+++|||++|..+.++..     +++    .++..+++++.-+|   ..|++|+|..|.|+++++++ ++++
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iI  176 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRII  176 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEE
Confidence            2     34568999999988876531     222    24456778899999   89999999999999999665 8999


Q ss_pred             eecCccc
Q 046544          635 DFGIAKL  641 (646)
Q Consensus       635 DfGla~~  641 (646)
                      ||+..+.
T Consensus       177 D~~~k~~  183 (229)
T PF06176_consen  177 DTQGKRM  183 (229)
T ss_pred             ECccccc
Confidence            9987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	646
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-30
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-04
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-04
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-24
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-07
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		2e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-07
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		7e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-04
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		3e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-04
3soa_A	444	Full-Length Human Camkii Length = 444		3e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-04
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		5e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		6e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		6e-04
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		6e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		7e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 144/483 (29%), Positives = 198/483 (40%), Gaps = 60/483 (12%)
Query: 1   EIPLEISN-LQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLP 59
           EIP  +S     L  LDL  N   G VP    + S+                    +++ 
Sbjct: 281 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 340
Query: 60  NLEALLLWGNNFSGTIPRFIFN-ASKLSILELSQNSFSG-FIPNTFGNLRN-LEWLNLRD 116
            L+ L L  N FSG +P  + N ++ L  L+LS N+FSG  +PN   N +N L+ L L++
Sbjct: 341 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 400
Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
           N  T   P      +LSNC  L  +HLS N L G +  +S+G+LS  L+D  +    + G
Sbjct: 401 NGFTGKIPP-----TLSNCSELVSLHLSFNYLSGTI-PSSLGSLSK-LRDLKLWLNMLEG 453
Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTEL 236
            IP+E+  +    T+ L  N L G IP  LS            N+L G IP  I RL  L
Sbjct: 454 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 513
Query: 237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNF------- 288
             L+L  N   G+IPA   +  SL  L L++N    +IP   +     +  NF       
Sbjct: 514 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 573
Query: 289 ---------------------------------------SSNFLTGPLPLEIGNLKVLIG 309
                                                  +S    G       N   ++ 
Sbjct: 574 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 633
Query: 310 IDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGAI 369
           +D S N  S  IP EIG +  L  L LG+N + GSIPD  GDL              G I
Sbjct: 634 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 693
Query: 370 PTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTS-- 427
           P ++  L+ L +++LS N L G IP  G F  F    F  N  LCG P  +  P      
Sbjct: 694 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGY 753
Query: 428 IHH 430
            HH
Sbjct: 754 AHH 756

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 11/143 (7%)
Query: 257 LASLRILSLSSNELTSIPLTFWNLKD----ILQLNFSSNFLTGPLPLEIGNLKVLIGIDF 312
           L SL +L LS+N ++   +  W L D    +  L  S N ++G   +++     L  +D 
Sbjct: 147 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDV 204
Query: 313 SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGAIPT- 371
           S NNFS+ IP  +G    L++L +  N+L G    +                  G IP  
Sbjct: 205 SSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 263
Query: 372 SLEKLSYLEDLNLSFNKLEGEIP 394
            L+ L YL    L+ NK  GEIP
Sbjct: 264 PLKSLQYLS---LAENKFTGEIP 283

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 142/474 (29%), Positives = 196/474 (41%), Gaps = 58/474 (12%)
Query: 1   EIPLEISN-LQNLEELDLRHNKLVGTVPAAIFNMSMXXXXXXXXXXXXXXXSSIADVRLP 59
           EIP  +S     L  LDL  N   G VP    + S+                    +++ 
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 60  NLEALLLWGNNFSGTIPRFIFN-ASKLSILELSQNSFSG-FIPNTFGNLRN-LEWLNLRD 116
            L+ L L  N FSG +P  + N ++ L  L+LS N+FSG  +PN   N +N L+ L L++
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
           N  T   P      +LSNC  L  +HLS N L G +  +S+G+LS  L+D  +    + G
Sbjct: 404 NGFTGKIPP-----TLSNCSELVSLHLSFNYLSGTI-PSSLGSLSK-LRDLKLWLNMLEG 456
Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICRLTEL 236
            IP+E+  +    T+ L  N L G IP  LS            N+L G IP  I RL  L
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516
Query: 237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNF------- 288
             L+L  N   G+IPA   +  SL  L L++N    +IP   +     +  NF       
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576
Query: 289 ---------------------------------------SSNFLTGPLPLEIGNLKVLIG 309
                                                  +S    G       N   ++ 
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 310 IDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGAI 369
           +D S N  S  IP EIG +  L  L LG+N + GSIPD  GDL              G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 370 PTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLP 423
           P ++  L+ L +++LS N L G IP  G F  F    F  N  LCG P  +  P
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 11/143 (7%)
Query: 257 LASLRILSLSSNELTSIPLTFWNLKD----ILQLNFSSNFLTGPLPLEIGNLKVLIGIDF 312
           L SL +L LS+N ++   +  W L D    +  L  S N ++G   +++     L  +D 
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDV 207
Query: 313 SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGAIPT- 371
           S NNFS+ IP  +G    L++L +  N+L G    +                  G IP  
Sbjct: 208 SSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 266
Query: 372 SLEKLSYLEDLNLSFNKLEGEIP 394
            L+ L YL    L+ NK  GEIP
Sbjct: 267 PLKSLQYLS---LAENKFTGEIP 286

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/171 (39%), Positives = 92/171 (53%), Gaps = 4/171 (2%)
Query: 480 RTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK-SFAVE 538
           + FS  EL  A++ FS  N++GRGGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---SSNCILDIFQRLNIM 595
            EM+    HRNL+++   C     + LV  Y  +GS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +  A  L YLH  C   +IH D+K  N+LLD+   A + DFG+AKL+  +D
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/171 (38%), Positives = 91/171 (53%), Gaps = 4/171 (2%)
Query: 480 RTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK-SFAVE 538
           + FS  EL  A++ F   N++GRGGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---SSNCILDIFQRLNIM 595
            EM+    HRNL+++   C     + LV  Y  +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +  A  L YLH  C   +IH D+K  N+LLD+   A + DFG+AKL+  +D
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 87/159 (54%), Gaps = 6/159 (3%)
Query: 485 LELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS 544
           ++L  ATN F    LIG G FG VYK  L DG +VA+K    +  +  + F  E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASA 601
            RH +L+ +I  C       L+ +Y  +G+L+++LY S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L YLH      +IH D+K  N+LLD+N V  ++DFGI+K
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 87/159 (54%), Gaps = 6/159 (3%)
Query: 485 LELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS 544
           ++L  ATN F    LIG G FG VYK  L DG +VA+K    +  +  + F  E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASA 601
            RH +L+ +I  C       L+ +Y  +G+L+++LY S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L YLH      +IH D+K  N+LLD+N V  ++DFGI+K
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 117/247 (47%), Gaps = 28/247 (11%)
Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGSIPDSICR 232
           N+ G IP  I  LT    + +    ++G+IP  LS            N L G++P SI  
Sbjct: 88  NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 233 LTELYELELGGNKLFGSIPACFSNLASL-RILSLSSNELT-SIPLTFWNLKDILQLNFSS 290
           L  L  +   GN++ G+IP  + + + L   +++S N LT  IP TF NL ++  ++ S 
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFG 350
           N L G   +  G+ K    I  + N+ +  +  ++G  KNL  L L  NR+ G++P    
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQG-- 263
Query: 351 DLIXXXXXXXXXXXXXGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGN 410
                                 L +L +L  LN+SFN L GEIP+GG+   F   ++  N
Sbjct: 264 ----------------------LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 411 ELLCGSP 417
           + LCGSP
Sbjct: 302 KCLCGSP 308

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK--SFAVECEMMKSIRHRNLIKVISSC 557
           IG G FG+V++A    G +VAVK+   Q   A +   F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +     ++V EY   GSL + L+ S     LD  +RL++  DVA  + YLH     P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKL 641
            DLK  N+L+D      + DFG+++L
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFK--SFAVECEMMKSIRHRNLIKVISSC 557
           IG G FG+V++A    G +VAVK+   Q   A +   F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +     ++V EY   GSL + L+ S     LD  +RL++  DVA  + YLH     P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKL 641
            +LK  N+L+D      + DFG+++L
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 22/177 (12%)
Query: 479 WRTFSYLELCRATNGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 528
           + +FS+ EL   TN F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 529 GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--- 585
               + F  E ++M   +H NL++++   S+ +   LV  Y P+GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 586 --LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 22/177 (12%)
Query: 479 WRTFSYLELCRATNGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 528
           + +FS+ EL   TN F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 529 GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--- 585
               + F  E ++M   +H NL++++   S+ +   LV  Y P+GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 586 --LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 22/177 (12%)
Query: 479 WRTFSYLELCRATNGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 528
           + +FS+ EL   TN F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 529 GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--- 585
               + F  E ++M   +H NL++++   S+ +   LV  Y P+GSL   L   +C+   
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 121
Query: 586 --LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 175

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+  +       F++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            + +   A+V ++    SL K+L+       +FQ ++I    A  ++YLH      +IH 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           D+K +N+ L + L   + DFG+A +
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATV 181

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 23/169 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-FKSFAVECEMMKSI-R 546
           N     ++IG G FG V KAR+  DG  M+ A+K       +   + FA E E++  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQR 591
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 23/169 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-FKSFAVECEMMKSI-R 546
           N     ++IG G FG V KAR+  DG  M+ A+K       +   + FA E E++  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQR 591
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 122 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 129 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 121 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 128 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 126 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 495 SENNLIGRGGFGSVYKARLGDG---MEVAVKVFNLQCGRAFKS---FAVECEMMKSIRHR 548
           +   +IG G FG VYK  L       EV V +  L+ G   K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           N+I++    S  +   ++ EY  +G+L+K+L   +    + Q + ++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 544 SIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           S++H N++K    C +   +   L++EY P+GSL  YL      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG+A++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL 197

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 544 SIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           S++H N++K    C +   +   L++EY P+GSL  YL      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 544 SIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           S++H N++K    C +   +   L++EY P+GSL  YL      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 544 SIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           S++H N++K    C +   +   L++EY P+GSL  YL      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++E+ P+GSL +YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E E++K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 544 SIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           S++H N++K    C +   +   L++EY P+GSL  YL      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 473 MPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG- 529
           +P  +T     + +   ATN  S + ++G G FG V   RL      E++V +  L+ G 
Sbjct: 15  VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 530 --RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD 587
             +  + F  E  +M    H N+I++    +  +   +V EY  +GSL+ +L   +    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 588 IFQRLNIMIDVASALEYL-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           + Q + ++  +AS ++YL   G     +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLSRVL 185

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 479 WRTFSYLELCRATNGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 528
           + +FS+ EL   TN F E       N  G GGFG VYK  + +   VAVK    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 529 GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--- 585
               + F  E ++    +H NL++++   S+ +   LV  Y P+GSL   L   +C+   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGT 118
Query: 586 --LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 172

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 497 NNLIGRGGFGSVYKA-RLGDGMEVAVKVF----NLQCGRAFKSFAVECEMMKSIRHRNLI 551
             +IG GGFG VY+A  +GD  EVAVK      +    +  ++   E ++   ++H N+I
Sbjct: 12  EEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +   C  E    LV+E+   G L + L       DI   +N  + +A  + YLH   + 
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIV 127
Query: 612 PVIHCDLKPDNVLLDD--------NLVAYLSDFGIAK 640
           P+IH DLK  N+L+          N +  ++DFG+A+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 605 L-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L   G     +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 134 LSDMG----YVHRDLAARNILINSNLVCKVSDFGLSRVL 168

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 23/169 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-FKSFAVECEMMKSI-R 546
           N     ++IG G FG V KAR+  DG  M+ A+K       +   + FA E E++  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQR 591
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L+   DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 RATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVE 538
           R    F E +L     +G+G FGSV   R   L D  G  VAVK          + F  E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E++KS++H N++K    C +   +   L++EY P+GSL  YL      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +   +EYL        IH +L   N+L+++     + DFG+ K+L
Sbjct: 123 QICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG+ ++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 42  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 605 L-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L   G     +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 161 LSDMG----YVHRDLAARNILINSNLVCKVSDFGLSRVL 195

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 5/143 (3%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKVISSC 557
           IGRG FG V+  RL  D   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           + ++   +V+E    G    +L +    L +   L ++ D A+ +EYL   C    IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 5/143 (3%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKVISSC 557
           IGRG FG V+  RL  D   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           + ++   +V+E    G    +L +    L +   L ++ D A+ +EYL   C    IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+ V +  +  G+AFK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKN--RELQIMRKLDHCNIVRL 78
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+ V +  +  G+AFK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKN--RELQIMRKLDHCNIVRL 78
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+ V +  +  G+AFK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKN--RELQIMRKLDHCNIVRL 78
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 483 SYLELCRATNGFSEN---------NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 529
           +Y E  RA   F+            +IG G  G V   RL      +V V +  L+ G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 530 -RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDI 588
            R  + F  E  +M    H N+I++    +      +V EY  +GSL+ +L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 589 FQRLNIMIDVASALEYL-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            Q + ++  V + + YL   G     +H DL   NVL+D NLV  +SDFG++++L
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG----YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 133
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVLDDQ 160

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 130
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQ 157

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 128
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQ 155

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 483 SYLELCRATNGFSEN---------NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 529
           +Y E  RA   F+            +IG G  G V   RL      +V V +  L+ G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 530 -RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDI 588
            R  + F  E  +M    H N+I++    +      +V EY  +GSL+ +L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 589 FQRLNIMIDVASALEYL-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            Q + ++  V + + YL   G     +H DL   NVL+D NLV  +SDFG++++L
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG----YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++    + DFG+A
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 11/159 (6%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V E   +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 L-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L   G     +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 LSDMGA----VHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 76/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++L   + DFG+A
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++    + DFG+A +
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 76/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++L   + DFG+A
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 76/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 148
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++L   + DFG+A
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATV 181

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 130
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 76/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 155
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++L   + DFG+A
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 11/159 (6%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V E   +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 605 L-HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L   G     +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 134 LSDMG----YVHRDLAARNILINSNLVCKVSDFGLSRVL 168

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   +   F  E E+M  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 150
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVLDDQ 177

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI 413

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKS 544
           ATN  S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M  
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
             H N+I++    +  +   +V E   +GSL+ +L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           L        +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKL 641
           DLK +N+ L ++L   + DFG+A +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY        + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY P+G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N V  ++DFG+++L+ G+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI 154

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+ L ++    + DFG+A
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI 330

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI 330

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK IRH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V+EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V+EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI 157

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRAFKSFAVECEM 541
           A N       IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           M ++ H N++K+     N     +V+E+ P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 602 LEYLHFGCLAPVIHCDLKPDNVL---LDDN--LVAYLSDFGIAK 640
           +EY+      P++H DL+  N+    LD+N  + A ++DFG+++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 500 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK     CG   +S +  E E+++++ H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C ++  K+  LV+EY P GSL  YL   +C+  + Q L     +   + YLH     
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 130
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    LV E+  HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+ +N V  +SDFG+ + ++ + 
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQ 157

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 500 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK     CG   +S +  E E+++++ H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C ++  K+  LV+EY P GSL  YL   +C+  + Q L     +   + YLH     
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 131
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 500 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK     CG   +S +  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 554 ISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C ++  K+L  V+EY P GSL  YL   +  + + Q L     +   + YLH     
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH +L   NVLLD++ +  + DFG+AK
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI 330

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI 161

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI 153

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 500 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK     CG   +S +  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 554 ISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C ++  K+L  V+EY P GSL  YL   +  + + Q L     +   + YLH     
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHS---Q 136
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH +L   NVLLD++ +  + DFG+AK
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 11/146 (7%)
Query: 504 GFGSVYKARLGD----GMEVAVKVFNLQCGRAFK---SFAVECEMMKSIRHRNLIKVISS 556
           G G+  K ++G+    G +VAVK+ N Q  R+         E + +K  RH ++IK+   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            S      +V+EY   G L  Y+     + ++  R  +   + SA++Y H      V+H 
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHR 135
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLL 642
           DLKP+NVLLD ++ A ++DFG++ ++
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 559 NEEFKALVLEYKPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI 161

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRAFKSFAVECEM 541
           A N       IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           M ++ H N++K+     N     +V+E+ P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 602 LEYLHFGCLAPVIHCDLKPDNVL---LDDN--LVAYLSDFGIAK 640
           +EY+      P++H DL+  N+    LD+N  + A ++DFG ++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI 155

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 11/146 (7%)
Query: 504 GFGSVYKARLGD----GMEVAVKVFNLQCGRAFK---SFAVECEMMKSIRHRNLIKVISS 556
           G G+  K ++G+    G +VAVK+ N Q  R+         E + +K  RH ++IK+   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
            S      +V+EY   G L  Y+     + ++  R  +   + SA++Y H      V+H 
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHR 135
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLL 642
           DLKP+NVLLD ++ A ++DFG++ ++
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 115
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 174
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 175 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 212

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 467 PSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKA-RLGDG----MEVAV 521
           PS  A  P  A  R     EL R         ++G G FG+VYK   + +G    + VA+
Sbjct: 22  PSGTA--PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAI 72
Query: 522 KVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY 580
           K+ N   G +A   F  E  +M S+ H +L++++  C +   + LV +  PHG L +Y++
Sbjct: 73  KILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
Query: 581 SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                +     LN  + +A  + YL    L   +H DL   NVL+       ++DFG+A+
Sbjct: 132 EHKDNIGSQLLLNWCVQIAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 641 LLIGED 646
           LL G++
Sbjct: 189 LLEGDE 194

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 156
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 215
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 216 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 253

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 82
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 30/171 (17%)
Query: 500 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 598
              C + +   +V EY  HG L K+L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 599 ASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           AS + YL   HF      +H DL   N L+  NL+  + DFG+++ +   D
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 113
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 172
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 173 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 210

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 111
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 111
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 498 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFK---SFAVECEMMKSIRHRNLIKV 553
           + +G G FG V   +    G +VAVK+ N Q  R+         E + +K  RH ++IK+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
               S      +V+EY   G L  Y+   N  LD  +   +   + S ++Y H      V
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H DLKP+NVLLD ++ A ++DFG++ ++
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 105
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 202

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 499 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKV 553
           +IG G FG V + RL      E  V +  L+ G   R  + F  E  +M    H N+I++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
               +N     ++ E+  +G+L+ +L  ++    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSY 139
Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFL 168

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    +++E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 133
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V+EY   G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 18  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 74
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 75  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 134 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 168

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 11  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 67
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 68  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 127 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 161

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    +++E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 137
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 138 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 89
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 131 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 85
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 144
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 182

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 17  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 73
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 74  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 133 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 167

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 96
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 155
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 193

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 497 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V + RL      E  V +  L+ G   R  + F  E  +M    H N+I
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++    +N     ++ E+  +G+L+ +L  ++    + Q + ++  +AS + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFL 166

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 90
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 149
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 187

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+      LQ  R FK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIVRL 78
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 89
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+ +L+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI 331

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+      LQ  R FK+   E ++M+ + H N++++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIVRL 79
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 138
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 175

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 19  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 75
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 76  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 135 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 169

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 125 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 21/162 (12%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L D  E VA+K   LQ  R FK+   E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLDHCNIVR 77
Query: 553 VI------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +           +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 604 YLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+      LQ  R FK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIVRL 78
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 10  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 66
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 67  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 126 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 160

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+      LQ  R FK+   E ++M+ + H N++++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIVRL 82
Query: 554 I------SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                      +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 141
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 131 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 14  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 71  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 130 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 164

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L   N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI 164

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 497 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
            + +G G FG VY+       + VAVK    +     + F  E  +MK I+H NL++++ 
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            C+ E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           H DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMM 542
           +    F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 64
Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 123
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           EYLH      +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 124 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 500 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 558 SNEEFK-ALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VH 131
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 497 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
            + +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++ 
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            C+ E    +++E+  +G+L  YL   N   +     L +   ++SA+EYL        I
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           H DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 153
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 154 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 498 NLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLI 551
            ++G G FG+VYK   + +G    + VA+K+ N   G +A   F  E  +M S+ H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +++  C +   + LV +  PHG L +Y++     +     LN  + +A  + YL    L 
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL- 138
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H DL   NVL+       ++DFG+A+LL G++
Sbjct: 139 --VHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 171

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 60
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 61  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 120 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 154

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +++E+  +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRAFKSFAVECEM 541
           A N       IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           M ++ H N++K+     N     +V+E+ P G L   L      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 602 LEYLHFGCLAPVIHCDLKPDNVL---LDDN--LVAYLSDFGIAK 640
           +EY+      P++H DL+  N+    LD+N  + A ++DF +++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 27/168 (16%)
Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASA 601
              C   +   +V EY  HG L K+L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 602 LEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + YL   HF      +H DL   N L+ +NL+  + DFG+++ +   D
Sbjct: 141 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 500 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 558 SNEEFK-ALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VH 140
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +++E+  +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMM 542
           +    F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 63
Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 122
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           EYLH      +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 123 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 151
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMM 542
           +    F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 61
Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 120
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           EYLH      +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 121 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 151
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMM 542
           +    F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 62
Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 121
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           EYLH      +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 133
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 137
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 138 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 500 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 558 SNEEFK-ALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VH 125
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 134
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 135 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 137
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 138 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 136
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             ++GRG FG V KA+     +VA+K    +  R  K+F VE   +  + H N++K+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 615 HCDLKPDNVLL-DDNLVAYLSDFGIA 639
           H DLKP N+LL     V  + DFG A
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 500 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 558 SNEEFK-ALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VH 312
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 137
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 138 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 147
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 147
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             ++GRG FG V KA+     +VA+K    +  R  K+F VE   +  + H N++K+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 615 HCDLKPDNVLL-DDNLVAYLSDFGIA 639
           H DLKP N+LL     V  + DFG A
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 19/161 (11%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +++  +IG G FG VY+A+L D  E+      LQ  R FK+   E ++M+ + H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIVRL 78
Query: 554 ----ISSCSNEE--FKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                SS   ++  +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 605 LH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI 164

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 132
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 133 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGCLAP 612
            E    ++ E+  +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 163
Query: 612 --PVI-HCDLKPDNVLLDDNLVAYLSDFGIA 639
             P I H DLK  N+L+  N    ++D G+A
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKV----FNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
            ++G+G FG   K    +  EV V      F+ +  R   +F  E ++M+ + H N++K 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLKF 72
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           I     ++    + EY   G+L   + S +      QR++   D+AS + YLH      +
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           IH DL   N L+ +N    ++DFG+A+L++ E
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 150
Query: 612 ---PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               + H DLK  N+L+  N    ++D G+A
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRD 141
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 497 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
            + +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++ 
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            C+ E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           H DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 497 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +    +  +   ++ EY  +GSL+ +L  ++    + Q + ++  + S ++YL      
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 150
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVL 181

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 78/145 (53%), Gaps = 7/145 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGCLAPVIHCD 617
            EE   ++ EY   GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  NVL+ ++L+  ++DFG+A+++
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI 160

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 23/156 (14%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G V+K R  D G  VA+K F   +     K  A+ E  M+K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR-------LNIMIDVASALEYLH-FG 608
              +    LV EY  H  L +        LD +QR        +I      A+ + H   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
           C    IH D+KP+N+L+  + V  L DFG A+LL G
Sbjct: 123 C----IHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDG-MEVAVKV-FNLQCGR--AFKSFAVECEMMKSIRH 547
           + F     +G+G FG+VY AR       VA+KV F  Q  +         E E+   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            N++++ +   +     L+LEY P G L K L  S C  D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCHG 141
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                VIH D+KP+N+LL       ++DFG
Sbjct: 142 ---KKVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAV++ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGCL 610
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 611 A-PVI-HCDLKPDNVLLDDNLVAYLSDFGIA 639
             P I H DLK  N+L+  N    ++D G+A
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAV++ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 130
Query: 612 ---PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               + H DLK  N+L+  N    ++D G+A
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 127
Query: 612 ---PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               + H DLK  N+L+  N    ++D G+A
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 125
Query: 612 ---PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               + H DLK  N+L+  N    ++D G+A
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV+EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKYIVHR 138
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS 161

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +V  AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+     ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 155
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 156 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-----ECEMMKSIRH 547
           F    ++G G F +   AR L    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHG 148
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                +IH DLKP+N+LL++++   ++DFG AK+L  E
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ E+  +G+L  YL   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IHRN 382
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGD 410

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 497 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +    +  +   ++ EY  +GSL+ +L  ++    + Q + ++  + S ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 129
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL 160

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRN 343
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGD 371

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 61
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 62  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH +L+  N+L+ D L   ++DFG+A+L+
Sbjct: 121 IE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI 155

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
           + +        LV +Y  HGSL  YL      ++    + + +  AS L +LH   +   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 124
Query: 612 ---PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               + H DLK  N+L+  N    ++D G+A
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 483 SYLELCRATNGFSEN---------NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 529
           +Y +  RA + F++           +IG G FG V   RL      +VAV +  L+ G  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 530 -RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDI 588
            +  + F  E  +M    H N++ +    +  +   +V+E+  +G+L+ +L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 589 FQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            Q + ++  +A+ + YL        +H DL   N+L++ NLV  +SDFG+++++
Sbjct: 145 IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 497 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCL 610
            +    +  +   +V EY  +GSL+ +L  ++    + Q + ++  +++ ++YL   G  
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMG-- 144
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 145 --YVHRDLAARNILINSNLVCKVSDFGLSRVL 174

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 497 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLI 551
             +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +    +  +   ++ EY  +GSL+ +L  ++    + Q + ++  + S ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 135
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL 166

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 500 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK      G   +S +  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 554 ISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C +    +L  V+EY P GSL  YL   +  + + Q L     +   + YLH     
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGCL 610
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 611 A-PVI-HCDLKPDNVLLDDNLVAYLSDFGIA 639
             P I H DLK  N+L+  N    ++D G+A
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGCL 610
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 611 A-PVI-HCDLKPDNVLLDDNLVAYLSDFGIA 639
             P I H DLK  N+L+  N    ++D G+A
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 599
              C+      +V EY  HG L ++L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 600 SALEY---LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + + Y   LHF      +H DL   N L+   LV  + DFG+++ +   D
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAF-----KSFAVECEMMKSIRHRNLIKV 553
           +G GGFG V +    D G +VA+K    QC +       + + +E ++MK + H N++  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 554 ------ISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL 605
                 +   +  +   L +EY   G L KYL  + + C L       ++ D++SAL YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 606 HFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLL 642
           H      +IH DLKP+N++L      L+  + D G AK L
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAF-----KSFAVECEMMKSIRHRNLIKV 553
           +G GGFG V +    D G +VA+K    QC +       + + +E ++MK + H N++  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 554 ------ISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL 605
                 +   +  +   L +EY   G L KYL  + + C L       ++ D++SAL YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 606 HFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLL 642
           H      +IH DLKP+N++L      L+  + D G AK L
Sbjct: 139 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 175

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 485 LELCRATNGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAFK-----SFAVE 538
           L++      + + + +G G F +VYKAR  +  + VA+K   L      K     +   E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
            ++++ + H N+I ++ +  ++   +LV ++     LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              LEYLH      ++H DLKP+N+LLD+N V  L+DFG+AK
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--AFKSFAVECEMMKSIRHRNLIKVIS 555
            LIG+G FG VY  R     EVA+++ +++       K+F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH      ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 616 CDLKPDNVLLDDNLVAYLSDFGI 638
            DLK  NV  D+  V  ++DFG+
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 78/145 (53%), Gaps = 7/145 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGCLAPVIHCD 617
            EE   ++ E+   GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  NVL+ ++L+  ++DFG+A+++
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI 159

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           ++G+G +G VY  R L + + +A+K    +  R  +    E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMI-DVASALEYLHFGCLAPVIH 615
           S   F  + +E  P GSL   L S    + D  Q +      +   L+YLH      ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 616 CDLKPDNVLLDD-NLVAYLSDFGIAKLLIG 644
            D+K DNVL++  + V  +SDFG +K L G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL        +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   L++EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS 158

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           ++G+G +G VY  R L + + +A+K    +  R  +    E  + K ++H+N+++ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMI-DVASALEYLHFGCLAPVIH 615
           S   F  + +E  P GSL   L S    + D  Q +      +   L+YLH      ++H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 616 CDLKPDNVLLDD-NLVAYLSDFGIAKLLIG 644
            D+K DNVL++  + V  +SDFG +K L G
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 8/158 (5%)
Query: 486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           E+ R T    E   +G G  G V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 604
           +H+ L+++ +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +        IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 125 IEERNY---IHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 599
              C+      +V EY  HG L ++L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 600 SALEY---LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + + Y   LHF      +H DL   N L+   LV  + DFG+++ +   D
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  ++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 500 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V   R    GD  G +VAVK    + G         E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C+ +      L++E+ P GSL++YL  +   +++ Q+L   + +   ++YL      
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---R 145
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   NVL++      + DFG+ K +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 599
              C+      +V EY  HG L ++L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 600 SALEY---LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + + Y   LHF      +H DL   N L+   LV  + DFG+++ +   D
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   L++EY   G +  YL +   + +   R      + SA++Y H      ++H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD ++   ++DFG +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS 161

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRAFKSFAVECEMMKSIRHRN 549
           F     IGRG F  VY+A  L DG+ VA   V++F+L   +A      E +++K + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 V+H D+KP NV +    V  L D G+ +  
Sbjct: 154 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 500 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V   R    GD  G +VAVK    + G         E E+++++ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              C+ +      L++E+ P GSL++YL  +   +++ Q+L   + +   ++YL      
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---R 133
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   NVL++      + DFG+ K +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 164

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 499 LIGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRAFKSFAV-ECEMMKSIRHRNLIKVIS 555
           L+G G +G V K R  D G  VA+K F      +  K  A+ E +++K +RH NL+ ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 556 SCSNEEFKALVLEYKPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            C  ++   LV E+  H  L+   L+ +     + Q+   +  + + + + H      +I
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGFCH---SHNII 146
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+KP+N+L+  + V  L DFG A+ L
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTL 174

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 492 NGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGR--------AFKSFAVECEMM 542
             +   ++IGRG    V +      G E AVK+  +   R          ++   E  ++
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 543 KSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           + +  H ++I +I S  +  F  LV +    G L  YL +    L   +  +IM  +  A
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEA 212
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           + +LH      ++H DLKP+N+LLDDN+   LSDFG +
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +H DL   N +LD+     ++DFG+A+ ++ ++
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE 188

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 26/166 (15%)
Query: 493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
            ++   +IG G FG V++A+L +  EVA+K   LQ  R FK+   E ++M+ ++H N++ 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FKN--RELQIMRIVKHPNVVD 96
Query: 553 VIS------SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI------MIDVAS 600
           + +         +E F  LVLEY P    E    +S     + Q + +      M  +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 601 ALEYLH-FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIG 644
           +L Y+H  G    + H D+KP N+LLD  + V  L DFG AK+LI 
Sbjct: 153 SLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 23/161 (14%)
Query: 499 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAF--KSFAVECEMMKSIRHRNLIKVISS 556
           LIGRG +G+VYK  L D   VAVKVF+    + F  +       +M+   H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLME---HDNIARFI-- 73
Query: 557 CSNEEFKA-------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-- 607
             +E   A       LV+EY P+GSL KYL  S    D      +   V   L YLH   
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 608 ---GCLAPVI-HCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                  P I H DL   NVL+ ++    +SDFG++  L G
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 498 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIK 552
            +IG G FG V     +L    E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +    +      ++ E+  +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFL 185

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 19/165 (11%)
Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLI 551
            ++G G FGSV +  L    G  ++VAVK   L     R  + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 552 KVISSCSNEEFKAL-----VLEYKPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 601
           +++  C     + +     +L +  +G L  YL  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +EYL        +H DL   N +L D++   ++DFG++K +   D
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 20/153 (13%)
Query: 501 GRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--IRHRNLIKVISS-- 556
            RG FG V+KA+L +   VAVK+F LQ  ++++S   E E+  +  ++H NL++ I++  
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS---EREIFSTPGMKHENLLQFIAAEK 79
Query: 557 -CSNEEFK-ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------- 607
             SN E +  L+  +   GSL  YL  +  I+   +  ++   ++  L YLH        
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 608 -GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            G    + H D K  NVLL  +L A L+DFG+A
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 4/147 (2%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VAVK+   +   +   F  E + M  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK 619
           E    +V EY  +G L  YL S    L+  Q L +  DV   + +L        IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 620 PDNVLLDDNLVAYLSDFGIAKLLIGED 646
             N L+D +L   +SDFG+ + ++ + 
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNL 550
           N +IGRG FG VY   L    G  +  AVK  N     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 551 IKVISSCSNEEFKALV-LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           + ++  C   E   LV L Y  HG L  ++ +      +   +   + VA  +++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +H DL   N +LD+     ++DFG+A+
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSIRHRNLIKVIS 555
           +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +     L+LEY P G++ + L       D  +    + ++A+AL Y H      VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHS---KRVIH 135
Query: 616 CDLKPDNVLLDDNLVAYLSDFG 637
            D+KP+N+LL  N    ++DFG
Sbjct: 136 RDIKPENLLLGSNGELKIADFG 157

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 485 LELCRATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKS 534
           L  C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 535 FAVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL 592
           F  E +++K++    ++K   +S     +   LV+EY P G L  +L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 593 NIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                +   +EYL        +H DL   N+L++      ++DFG+AKLL
Sbjct: 131 LYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 488 CRATNGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAV 537
           C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 538 ECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
           E +++K++    ++K   +S     +   LV+EY P G L  +L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +   +EYL  G     +H DL   N+L++      ++DFG+AKLL
Sbjct: 121 SQICKGMEYL--GSRR-CVHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSIRHRNLIKVIS 555
           +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +     L+LEY P G++ + L       D  +    + ++A+AL Y H      VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHS---KRVIH 135
Query: 616 CDLKPDNVLLDDNLVAYLSDFG 637
            D+KP+N+LL  N    ++DFG
Sbjct: 136 RDIKPENLLLGSNGELKIADFG 157

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
           R  + F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 548 -------------RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
                        RN +K +++   +    + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +  AL Y+H      +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G + K L       D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V+        +VA+K   L+ G  + +SF  E ++MK ++H  L+++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            E    +V EY   GSL  +L       L +   +++   VA+ + Y+        IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLL 642
           L+  N+L+ + L+  ++DFG+A+L+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI 155

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGCLAPVIHCDL 618
           E    ++ E+   GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLL 642
           +  N+L+  +LV  ++DFG+A+++
Sbjct: 138 RAANILVSASLVCKIADFGLARVI 161

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G + K L       D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 130 HS---KRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGCLAPVIHCDL 618
           E    ++ E+   GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLL 642
           +  N+L+  +LV  ++DFG+A+++
Sbjct: 311 RAANILVSASLVCKIADFGLARVI 334

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 497 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLI 551
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    C 
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 146
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H D+   N+L+       L DFG+++ +  ED
Sbjct: 147 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 179

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 467 PSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-F 524
           P N+    L +  +     +   A   F     +G+G FG+VY AR      + A+KV F
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 525 NLQCGRA--FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS 582
             Q  +A        E E+   +RH N++++     +     L+LEY P G++ + L   
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QK 127
Query: 583 NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
               D  +    + ++A+AL Y H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 497 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLI 551
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    C 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H D+   N+L+       L DFG+++ +  ED
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGCLAPVIHCDL 618
           E    ++ E+   GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 619 KPDNVLLDDNLVAYLSDFGIAKL 641
           +  N+L+  +LV  ++DFG+A++
Sbjct: 305 RAANILVSASLVCKIADFGLARV 327

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 467 PSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-F 524
           P N+    L +  +     +   A   F     +G+G FG+VY AR      + A+KV F
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 525 NLQCGRA--FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS 582
             Q  +A        E E+   +RH N++++     +     L+LEY P G++ + L   
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QK 127
Query: 583 NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
               D  +    + ++A+AL Y H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSC 557
           +G+G +G V++  L  G  VAVK+F+    R  +S+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGCL 610
                 +    L+  Y  HGSL  +L      L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 611 A-PVI-HCDLKPDNVLLDDNLVAYLSDFGIA 639
             P I H D K  NVL+  NL   ++D G+A
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 497 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSIRHRNLI 551
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    C 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 130
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H D+   N+L+       L DFG+++ +  ED
Sbjct: 131 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 163

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 544 SIRHRNLIKV--ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           ++    ++K   +S     +   LV+EY P G L  +L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        +H DL   N+L++      ++DFG+AKLL
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVF---NLQCGRAFKSFAVECEMMKSIRH 547
           + F     +G+G FG+VY AR      + A+KV     L+          E E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            N++++ +   + +   L+LE+ P G L K L   +   D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 132
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                VIH D+KP+N+L+       ++DFG
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 128
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 129 HS---KRVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 123
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 124 HS---KRVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--GRAFKSFAV 537
           F + E+ RA         IG+G FG V   +  D  ++ A+K  N Q C      ++   
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 538 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID 597
           E ++M+ + H  L+ +  S  +EE   +V++    G L  +L  +    +   +L I  +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CE 123
Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           +  AL+YL       +IH D+KPDN+LLD++   +++DF IA +L  E
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRAFKSFAVECE-MMKSIRHRNLIK 552
            +IG+G FG V  AR   + +  AVKV   +     +  K    E   ++K+++H  L+ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  S    +    VL+Y   G L  +L    C L+   R     ++ASAL YLH      
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           +++ DLKP+N+LLD      L+DFG+ K
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 141
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 142 HS---KRVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           K DN+LL  +    L+DFG    +  E 
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 130 HS---KRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           K DN+LL  +    L+DFG    +  E 
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 500 IGRGGFGSVYKARLGDGMEV-AVKVF---NLQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G+G FG+VY AR      + A+KV     L+          E E+   +RH N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              + +   L+LE+ P G L K L   +   D  +    M ++A AL Y H      VIH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 616 CDLKPDNVLLDDNLVAYLSDFG 637
            D+KP+N+L+       ++DFG
Sbjct: 138 RDIKPENLLMGYKGELKIADFG 159

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVAVK+ +       + +    E  + K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV EY   G +  YL +     +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           DLK +N+LLD +    ++DFG +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS 160

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 130 HS---KRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 127 HS---KRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 125 HS---KRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 121
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       ++DFG
Sbjct: 122 HS---KRVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           K DN+LL  +    L+DFG    +  E
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE 169

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 143
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           K DN+LL  +    L+DFG    +  E 
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQ 171

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 494 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCGRAFKSFAVECEMMKSIRH 547
           F+   ++G+G FGSV +A+L    G  ++VAVK+   ++      + F  E   MK   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 548 RNLIKVISSCSNEEFKA------LVLEYKPHGSLEKYLYSSNCILDIF-----QRLNIMI 596
            ++ K++        K       ++L +  HG L  +L +S    + F       +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           D+A  +EYL        IH DL   N +L +++   ++DFG+++ +   D
Sbjct: 145 DIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 494 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAFKSFAVECEMMK 543
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 544 SIRHRNLIKV--ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           ++    ++K   +S         LV+EY P G L  +L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +EYL        +H DL   N+L++      ++DFG+AKLL
Sbjct: 124 MEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-------GRAFKSFAVECEMMKSI 545
           F   NL+G+G F  VY+A  +  G+EVA+K+ + +         R      + C++    
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL---- 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           +H +++++ +   +  +  LVLE   +G + +YL +        +  + M  + + + YL
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H      ++H DL   N+LL  N+   ++DFG+A  L
Sbjct: 129 HS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 498 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIK 552
            +IG G FG V     +L    E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +    +      ++ E+  +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +H  L   N+L++ NLV  +SDFG+++ L
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFL 159

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
           R  + F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 548 -------------RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
                        RN +K +++   +    + +EY  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +  AL Y+H      +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 8/144 (5%)
Query: 500 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           +G G + +VYK  ++L D + VA+K   L+        A+ E  ++K ++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E+   LV EY     L++YL     I+++      +  +   L Y H      V+H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L+++     L+DFG+A+
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR 148

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 15/150 (10%)
Query: 501 GRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS---- 556
            RG FG V+KA+L +   VAVK+F +Q  +++++   E   +  ++H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-------GC 609
            S +    L+  +   GSL  +L ++  ++   +  +I   +A  L YLH        G 
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              + H D+K  NVLL +NL A ++DFG+A
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+               E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAVECEM--MKSIRHRNLIKVIS 555
           +G G FG V  A     G +VA+K+ N +   ++     +E E+  ++ +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      ++H
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 136
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD++L   ++DFG++ ++
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 490 ATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEM-----MK 543
           AT+ +     IG G +G+VYKAR    G  VA+K   +  G      +   E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 544 SIRHRNLIKVISSC----SNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDV 598
           +  H N+++++  C    ++ E K  ++       L  YL  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
              L++LH  C   ++H DLKP+N+L+       L+DFG+A++
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 490 ATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEM-----MK 543
           AT+ +     IG G +G+VYKAR    G  VA+K   +  G      +   E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 544 SIRHRNLIKVISSCS----NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDV 598
           +  H N+++++  C+    + E K  ++       L  YL  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
              L++LH  C   ++H DLKP+N+L+       L+DFG+A++
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 490 ATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEM-----MK 543
           AT+ +     IG G +G+VYKAR    G  VA+K   +  G      +   E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 544 SIRHRNLIKVISSC----SNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDV 598
           +  H N+++++  C    ++ E K  ++       L  YL  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
              L++LH  C   ++H DLKP+N+L+       L+DFG+A++
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAVECEM--MKSIRHRNLIKVIS 555
           +G G FG V  A     G +VA+K+ N +   ++     +E E+  ++ +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      ++H
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 135
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD++L   ++DFG++ ++
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAVECEM--MKSIRHRNLIKVIS 555
           +G G FG V  A     G +VA+K+ N +   ++     +E E+  ++ +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      ++H
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 126
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD++L   ++DFG++ ++
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 80/147 (54%), Gaps = 9/147 (6%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAVECEM--MKSIRHRNLIKVIS 555
           +G G FG V  A     G +VA+K+ N +   ++     +E E+  ++ +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      ++H
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 130
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD++L   ++DFG++ ++
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 70/135 (51%), Gaps = 9/135 (6%)
Query: 506 GSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--E 561
           G ++K R   G ++ VKV  ++    R  + F  EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 562 FKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVI-HCDLK 619
              L+  + P+GSL   L+  +N ++D  Q +   +D+A  + +LH   L P+I    L 
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALN 140
Query: 620 PDNVLLDDNLVAYLS 634
             +V++D+++ A +S
Sbjct: 141 SRSVMIDEDMTARIS 155

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G +G VYKA+   G  VA+K   L        S A+ E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            +E    LV E+     L+K L  +   L   Q   I I +   L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++ +    L+DFG+A+
Sbjct: 145 LKPQNLLINSDGALKLADFGLAR 167

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRAFKSFAVECEM--MKSIRHRNLIKVIS 555
           +G G FG V  A       +VA+K  + Q   ++     VE E+  +K +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             +      +V+EY   G L  Y+     + +   R      +  A+EY H      ++H
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLDDNL   ++DFG++ ++
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G +G VYKA+   G  VA+K   L        S A+ E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            +E    LV E+     L+K L  +   L   Q   I I +   L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++ +    L+DFG+A+
Sbjct: 145 LKPQNLLINSDGALKLADFGLAR 167

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       +++FG
Sbjct: 128 HS---KRVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 490 ATNGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--FKSFAVECEMMKSI 545
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           RH N++++     +     L+LEY P G++ + L       D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           H      VIH D+KP+N+LL       +++FG
Sbjct: 127 HS---KRVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 467 PSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARL---GDGMEVAV-- 521
           PS  AN  L    R F   EL +         ++G G FG+V+K      G+ +++ V  
Sbjct: 16  PSEKANKVLA---RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 522 KVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY 580
           KV   + GR +F++       + S+ H ++++++  C     + LV +Y P GSL  ++ 
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 124
Query: 581 SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                L     LN  + +A  + YL    +   +H +L   NVLL       ++DFG+A 
Sbjct: 125 QHRGALGPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVAD 181
Query: 641 LLIGED 646
           LL  +D
Sbjct: 182 LLPPDD 187

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 58/113 (51%), Gaps = 2/113 (1%)
Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLP 298
           +L  +K+F  + + FS+   L  L+L+ NE+  I    FW L  +L+LN S NFL     
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD 351
               NL  L  +D S N+  ++      GL NL+ L L  N+L+ S+PD   D
Sbjct: 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 31/175 (17%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------AFKSFAVE 538
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G         +  AV 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 539 CEMMKSIRHRNLIKVISSCS----NEEFK-ALVLEYKPHGSLEKYL-------YSSNCIL 586
              +++  H N++++   C+    + E K  LV E+     L  YL         +  I 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           D+      M  +   L++LH      V+H DLKP N+L+  +    L+DFG+A++
Sbjct: 124 DM------MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNL---QCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G GG  +VY A      ++VA+K   +   +     K F  E      + H+N++ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
               ++   LV+EY    +L +Y+  S+  L +   +N    +   +++ H      ++H
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MRIVH 134
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            D+KP N+L+D N    + DFGIAK L
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKAL 161

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++EY   G+L +YL           Y  N + +    F+ L + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+EY   GSL   + +  C +D  Q   +  +   ALE+LH      VIH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRNI 143
Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           K DN+LL  +    L+DFG    +  E 
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQ 171

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 31/175 (17%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------AFKSFAVE 538
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G         +  AV 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 539 CEMMKSIRHRNLIKVISSCS----NEEFK-ALVLEYKPHGSLEKYL-------YSSNCIL 586
              +++  H N++++   C+    + E K  LV E+     L  YL         +  I 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           D+      M  +   L++LH      V+H DLKP N+L+  +    L+DFG+A++
Sbjct: 124 DM------MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 4/141 (2%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  + G   A KV   +     + + VE E++ +  H  ++K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F     +IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  NVL+       L+DFG++
Sbjct: 136 KAGNVLMTLEGDIRLADFGVS 156

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 31/175 (17%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------AFKSFAVE 538
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G         +  AV 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 539 CEMMKSIRHRNLIKVISSCS----NEEFK-ALVLEYKPHGSLEKYL-------YSSNCIL 586
              +++  H N++++   C+    + E K  LV E+     L  YL         +  I 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           D+      M  +   L++LH      V+H DLKP N+L+  +    L+DFG+A++
Sbjct: 124 DM------MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 4/141 (2%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  + G   A KV   +     + + VE E++ +  H  ++K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F     +IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  NVL+       L+DFG++
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS 164

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 23/168 (13%)
Query: 489 RATNGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAV------ 537
            +T+GF EN     ++GRG    V +        E AVK+ ++  G +F +  V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 538 ---ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR-- 591
              E ++++ +  H N+I++  +     F  LV +    G L  YL     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +  +++V  AL  L+      ++H DLKP+N+LLDD++   L+DFG +
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 23/168 (13%)
Query: 489 RATNGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAV------ 537
            +T+GF EN     ++GRG    V +        E AVK+ ++  G +F +  V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 538 ---ECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR-- 591
              E ++++ +  H N+I++  +     F  LV +    G L  YL     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +  +++V  AL  L+      ++H DLKP+N+LLDD++   L+DFG +
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 123
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP+N+L++      L+DFG+A+
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         YS N   +  ++L      + 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP+N+L++      L+DFG+A+
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 128
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  +  +  A KV + +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++ Y   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  +  +  A KV + +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 490 ATNGF---SENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI 545
           A N F   S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H NLI++  +  ++    LV+EY   G L   +   +  L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 606 HFGCLAPVIHCDLKPDNVLL--DDNLVAYLSDFGIAK 640
           H      ++H DLKP+N+L    D     + DFG+A+
Sbjct: 204 H---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG VYKA+  +  +  A KV + +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 128
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 137 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 490 ATNGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRH 547
           +++ F +   +G G + +VYK      G+ VA+K   L       S A+ E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC----------ILDIFQRLNIMID 597
            N++++      E    LV E+     L+KY+ S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               L+ L F     ++H DLKP N+L++      L DFG+A+
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 140 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 175

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 124
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 123
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 169
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 170 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 125
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G +GSVYKA     G  VA+K   ++     +    E  +M+     +++K   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
                 +V+EY   GS+   +   N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDI 151
Query: 619 KPDNVLLDDNLVAYLSDFGIA 639
           K  N+LL+    A L+DFG+A
Sbjct: 152 KAGNILLNTEGHAKLADFGVA 172

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 124
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 125
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 123
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+  H  L+K++  ++ +  I   L I   +   L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 137 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 139 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +  + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-----------YSSNCILD---IFQRL-NI 594
           +I ++ +C+ +    +++ Y   G+L +YL           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +A  +EYL        IH DL   NVL+ +N V  ++DFG+A+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 138 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 8/176 (4%)
Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
           +IP +I   T+  +L+L  NKL       F  L  LR+L L+ N+L ++P   F  LK++
Sbjct: 30  AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 284 LQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
             L  + N L   LP+ +   L  L  +    N   S+ P     L  L YL LGYN L+
Sbjct: 88  ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 343 GSIPDSFGDLIXXXXXXXXXXXXXGAIPT-SLEKLSYLEDLNLSFNKLEGEIPRGG 397
            S+P    D +               +P  + +KL+ L+ L L  N+L+  +P G 
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+  H  L+K++  ++ +  I   L I   +   L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
           R  + F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 548 -------------RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
                        RN +K  ++   +    +  EY  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +  AL Y+H      +IH +LKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRAFKSFAVECEMMKSIRHRN 549
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-------AL 602
            I+       E    LV+EY         L S++ +L++ ++    +++A+        L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            YLH   +   IH D+K  N+LL +  +  L DFG A ++
Sbjct: 168 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+  H  L+K++  ++ +  I   L I   +   L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 498 NLIGRGGFGSVYKARL---GDGMEVAV--KVFNLQCGR-AFKSFAVECEMMKSIRHRNLI 551
            ++G G FG+V+K      G+ +++ V  KV   + GR +F++       + S+ H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +++  C     + LV +Y P GSL  ++      L     LN  + +A  + YL    + 
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM- 136
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H +L   NVLL       ++DFG+A LL  +D
Sbjct: 137 --VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNLQCG-RAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G+V+KA+  +  E VA+K   L        S A+ E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
             +++   LV E+     L+KY  S N  LD     + +  +   L + H      V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHR 125
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L++ N    L+DFG+A+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 32/169 (18%)
Query: 490 ATNGFSEN----NLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMM 542
           A+  FS+N      +G+G F  V +      G+E A K+ N +    R F+    E  + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLN 593
           + ++H N++++  S   E F  LV +    G L      +  YS    S+CI  I +   
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE--- 139
Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA 639
                  ++ Y H      ++H +LKP+N+LL          L+DFG+A
Sbjct: 140 -------SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         +S N   +  ++L      + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRAFKSFAVECEMMKSIRHRN 549
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA-------L 602
            I+       E    LV+EY         L S++ +L++ ++    +++A+        L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            YLH   +   IH D+K  N+LL +  +  L DFG A ++
Sbjct: 129 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM 165

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 490 ATNGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRAFKSFAVECEM---- 541
           AT+ +     IG G +G+VYKAR    G  VA   V+V N   G      +   E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 542 -MKSIRHRNLIKVISSCS----NEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIM 595
            +++  H N+++++  C+    + E K  ++       L  YL  +    L      ++M
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
                 L++LH  C   ++H DLKP+N+L+       L+DFG+A++
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 160
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 161 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 196

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G F  V +  ++  G E A K+ N +    R  +    E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
            S E F  LV +    G L      +  YS    S+CI  I + +N          + H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----------HCH- 120
Query: 608 GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGE 645
             L  ++H DLKP+N+LL          L+DFG+A  + G+
Sbjct: 121 --LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD 159

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 141
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 142 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 177

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 139 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 138 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 139 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 143 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 506 GSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--E 561
           G ++K R   G ++ VKV  ++    R  + F  EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 562 FKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVI-HCDLK 619
              L+  + P+GSL   L+  +N ++D  Q +   +D A    +LH   L P+I    L 
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALN 140
Query: 620 PDNVLLDDNLVAYLS 634
             +V +D++  A +S
Sbjct: 141 SRSVXIDEDXTARIS 155

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 139 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         Y  N   +  ++L      + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 28/166 (16%)
Query: 500 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRL------NI 594
           +I ++ +C+ +    +++EY   G+L +YL         Y  N   +  ++L      + 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 145
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 146 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 181

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 138 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED 132
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 133 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 168

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 140 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 175

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+ ++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP+N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 138 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 497 NNLIGRGGFGSVYKARLGDG----MEVAVKVFN-LQCGRAFKSFAVECEMMKSIRHRNLI 551
           + +IG+G FG VY     D     ++ A+K  + +   +  ++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 552 KVIS-SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +I      E    ++L Y  HG L +++ S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +H DL   N +LD++    ++DFG+A+
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G F  V +  ++  G E A K+ N +    R  +    E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
            S E F  LV +    G L      +  YS    S+CI  I + +N          + H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----------HCH- 120
Query: 608 GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGE 645
             L  ++H DLKP+N+LL          L+DFG+A  + G+
Sbjct: 121 --LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD 159

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 130 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 23/164 (14%)
Query: 493 GFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAV---------E 538
           GF EN     ++GRG    V +        E AVK+ ++  G +F +  V         E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 539 CEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR--LNIM 595
            ++++ +  H N+I++  +     F  LV +    G L  YL     + +   R  +  +
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           ++V  AL  L+      ++H DLKP+N+LLDD++   L+DFG +
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+  H  L+ ++  ++ +  I   L I   +   L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 494 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           ++  N IGRG +G V  A + G  +  A K            F  E E+MKS+ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 553 VISSCSNEEFKALVLEYKPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +  +  +     LV+E    G L E+ ++    +        IM DV SA+ Y H   +A
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 612 PVIHCDLKPDNVL-LDDNLVAYLS--DFGIA 639
              H DLKP+N L L D+  + L   DFG+A
Sbjct: 129 ---HRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+    L        S A+ E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+    L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+K++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 494 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           ++  N IGRG +G V  A + G  +  A K            F  E E+MKS+ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 553 VISSCSNEEFKALVLEYKPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +  +  +     LV+E    G L E+ ++    +        IM DV SA+ Y H   +A
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVA 145
Query: 612 PVIHCDLKPDNVL-LDDNLVAYLS--DFGIA 639
              H DLKP+N L L D+  + L   DFG+A
Sbjct: 146 ---HRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+  H  L+ ++ +S      L + +  + +  +   L + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 28/171 (16%)
Query: 491 TNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRH 547
           T+ +     IG+G F  V +  +L  G E A K+ N +    R  +    E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 598
            N++++  S S E F  LV +    G L      +  YS    S+CI  I + +      
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------ 116
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGED 646
                 LH   +  V+H DLKP+N+LL          L+DFG+A  + G+ 
Sbjct: 117 ------LHCHQMG-VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 29/181 (16%)
Query: 482 FSYLELC-RATNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAV 537
           F  +  C R T+ +     +G+G F  V +  +     E A K+ N +    R  +    
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 538 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDI 588
           E  + + ++H N++++  S S E F  LV +    G L      +  YS    S+CI  I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 139
Query: 589 FQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGE 645
            + +N          ++H      ++H DLKP+N+LL          L+DFG+A  + GE
Sbjct: 140 LESVN----------HIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 646 D 646
Sbjct: 187 Q 187

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 33/177 (18%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIK 552
           IG G FG V++AR    +       VAVK+   +     ++ F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSN----C-------------------ILDIF 589
           ++  C+  +   L+ EY  +G L ++L S +    C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 590 QRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           ++L I   VA+ + YL        +H DL   N L+ +N+V  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNLQCG-RAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G+V+KA+  +  E VA+K   L        S A+ E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
             +++   LV E+     L+KY  S N  LD     + +  +   L + H      V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHR 125
Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L++ N    L++FG+A+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+++  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 143 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 494 FSENNL-----IGRGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRAFK-SFAVECEM 541
           F  NNL     +G G FG V +A   G G E     VAVK+         K +   E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 542 MKSI-RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
           M  + +H N++ ++ +C++     ++ EY  +G L  +L   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 601 ALEYLHFGCLAP----------VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
             + LHF                IH D+   NVLL +  VA + DFG+A+ ++ +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 138 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 143 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 178

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 500 IGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVISSC 557
           +G G FG V+       G+E  +K  N    +   +    E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNC---ILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            +     +V+E    G L + + S+      L       +M  + +AL Y H      V+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 615 HCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGED 646
           H DLKP+N+L  D   +    + DFG+A+L   ++
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 171

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             ++   LV E+     L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++      ++DFG+A+
Sbjct: 126 LKPQNLLINREGELKIADFGLAR 148

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             ++   LV E+     L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++      ++DFG+A+
Sbjct: 126 LKPQNLLINREGELKIADFGLAR 148

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRHRNLIKVIS 555
           +G G FG V+  R   +G   A+KV   +     K       E  M+  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +  + +   ++++Y   G L   L  S    +   +     +V  ALEYLH      +I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP+N+LLD N    ++DFG AK +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             ++   LV E+     L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++      ++DFG+A+
Sbjct: 126 LKPQNLLINREGELKIADFGLAR 148

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISS- 556
           IG+G +G V+  +   G +VAVKVF         S+  E E+ +++  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 557 ---CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-- 611
                +     L+ +Y  +GSL  YL S+   LD    L +     S L +LH    +  
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 612 --PVI-HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
             P I H DLK  N+L+  N    ++D G+A   I +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 555 SSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +   E        +V+EY    +L   +++   +    + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +IH D+KP N+L+       + DFGIA+ +
Sbjct: 137 --IIHRDVKPANILISATNAVKVVDFGIARAI 166

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVI 554
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+     L+K++ +S      L + +  + +  +   L + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 124
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP+N+L++      L+DFG+A+
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+     L+K++ +S      L + +  + +  +   L + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 124
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP N+L++      L+DFG+A+
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHF 607
           +K++     E    LV E+     L+K++ +S      L + +  + +  +   L + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V+H DLKP+N+L++      L+DFG+A+
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 491 TNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRH 547
           ++ +     +G+G F  V +      G+E A K+ N +    R F+    E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 598
            N++++  S   E F  LV +    G L      +  YS    S+CI  I +        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA 639
             ++ Y H      ++H +LKP+N+LL          L+DFG+A
Sbjct: 117 --SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC------GRAFKSFAVECEMMKSIRHRNLIK 552
           +G G F  V K R  G G E A K    +       G + +    E  +++ IRH N+I 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N+    L+LE    G L  +L     + +  +    +  +   + YLH   +A 
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLHSKRIA- 137
Query: 613 VIHCDLKPDNVLLDDNLVA----YLSDFGIA 639
             H DLKP+N++L D  V      L DFGIA
Sbjct: 138 --HFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 143 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 494 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH 547
           F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L   +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC------GRAFKSFAVECEMMKSIRHRNLIK 552
           +G G F  V K R  G G E A K    +       G + +    E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N+    L+LE    G L  +L     + +  +    +  +   + YLH   +A 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLHSKRIA- 130
Query: 613 VIHCDLKPDNVLLDDNLVA----YLSDFGIA 639
             H DLKP+N++L D  V      L DFGIA
Sbjct: 131 --HFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 491 TNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRH 547
           ++ +     +G+G F  V +      G+E A K+ N +    R F+    E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 598
            N++++  S   E F  LV +    G L      +  YS    S+CI  I +        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA 639
             ++ Y H      ++H +LKP+N+LL          L+DFG+A
Sbjct: 117 --SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC------GRAFKSFAVECEMMKSIRHRNLIK 552
           +G G F  V K R  G G E A K    +       G + +    E  +++ IRH N+I 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N+    L+LE    G L  +L     + +  +    +  +   + YLH   +A 
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLHSKRIA- 151
Query: 613 VIHCDLKPDNVLLDDNLVA----YLSDFGIA 639
             H DLKP+N++L D  V      L DFGIA
Sbjct: 152 --HFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 555 SSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +   E        +V+EY    +L   +++   +    + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +IH D+KP N+++       + DFGIA+ +
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAI 166

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 491 TNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRH 547
           ++ +     +G+G F  V +      G+E A K+ N +    R F+    E  + + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 598
            N++++  S   E F  LV +    G L      +  YS    S+CI  I +        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 115
Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA 639
             ++ Y H      ++H +LKP+N+LL          L+DFG+A
Sbjct: 116 --SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 555 SSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +   E        +V+EY    +L   +++   +    + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +IH D+KP N+++       + DFGIA+ +
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAI 166

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLIKVI 554
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---V 458
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMK-SIRHRNLIK 552
           F   +++G G  G++    + D  +VAVK    +C   F     E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
              +  + +F+ + +E     +L++Y+   +      + + ++    S L +LH      
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 613 VIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLL 642
           ++H DLKP N+L+        + A +SDFG+ K L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 487 LCRATNGFSEN--NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS 544
           LC+  NG SE    +I +  F    K R  D         N    +  +    E  ++KS
Sbjct: 54  LCKEKNGHSEKAIKVIKKSQFD---KGRYSDD--------NKNIEKFHEEIYNEISLLKS 102
Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
           + H N+IK+     ++++  LV E+   G L + + + +   D     NIM  + S + Y
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICY 161
Query: 605 LHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIA 639
           LH      ++H D+KP+N+LL++    L   + DFG++
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCGRAFKSFAVECEMMK 543
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVAS 600
            +  R ++ +  +   +    LV+     G +  ++Y+ +     FQ    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LE+LH      +I+ DLKP+NVLLDD+    +SD G+A
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCGRAFKSFAVECEMMK 543
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVAS 600
            +  R ++ +  +   +    LV+     G +  ++Y+ +     FQ    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LE+LH      +I+ DLKP+NVLLDD+    +SD G+A
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 125
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCGRAFKSFAVECEMMK 543
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVAS 600
            +  R ++ +  +   +    LV+     G +  ++Y+ +     FQ    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LE+LH      +I+ DLKP+NVLLDD+    +SD G+A
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCGRAFKSFAVECEMMK 543
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVAS 600
            +  R ++ +  +   +    LV+     G +  ++Y+ +     FQ    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LE+LH      +I+ DLKP+NVLLDD+    +SD G+A
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 127
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 128 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 494 FSENNL-----IGRGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRAFK-SFAVECEM 541
           F  NNL     +G G FG V +A   G G E     VAVK+         K +   E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 542 MKSI-RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 600
           M  + +H N++ ++ +C++     ++ EY  +G L  +L   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 601 ALEYLHFGCLAP----------VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
             + LHF                IH D+   NVLL +  VA + DFG+A+ ++ +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 498 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN 549
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           ++ +I +        L+LEY   G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +I+ DLKP+N++L+      L+DFG+ K
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ D+K +N++LD +    ++DFG+ K
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 472 NMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARL-----GDGME-VAVKVFN 525
            MPL+   +     E+  +   F E   +G   FG VYK  L     G+  + VA+K   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 526 LQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC 584
            +  G   + F  E  +   ++H N++ ++   + ++  +++  Y  HG L ++L   + 
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 585 ILDIFQR---------------LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL 629
             D+                  ++++  +A+ +EYL       V+H DL   NVL+ D L
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL 182
Query: 630 VAYLSDFGIAKLLIGED 646
              +SD G+ + +   D
Sbjct: 183 NVKISDLGLFREVYAAD 199

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 28/162 (17%)
Query: 500 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G F  V +  ++  G E A K+ N +    R  +    E  + + ++H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
            S E    L+ +    G L      +  YS    S+CI  I + +            LH 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------------LHC 137
Query: 608 GCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGED 646
             +  V+H DLKP+N+LL   L      L+DFG+A  + GE 
Sbjct: 138 HQMG-VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 498 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN 549
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           ++ +I +        L+LEY   G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              +I+ DLKP+N++L+      L+DFG+ K
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 40/189 (21%)
Query: 494 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-FKSFAVECE 540
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--------------- 585
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 586 --------LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 638 IAKLLIGED 646
           +++ +  ED
Sbjct: 196 LSRDVYEED 204

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 40/189 (21%)
Query: 494 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-FKSFAVECE 540
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--------------- 585
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 586 --------LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                   L +   ++    ++  ++YL    L   +H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMSL---VHRDLAARNILVAEGRKMKISDFG 195
Query: 638 IAKLLIGED 646
           +++ +  ED
Sbjct: 196 LSRDVYEED 204

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           N FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 242
Query: 552 KVISS-------CSNEEFK-----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
            ++S+       C +  F      + +L+    G L  +L       +   R     ++ 
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 301
Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             LE++H      V++ DLKP N+LLD++    +SD G+A
Sbjct: 302 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 40/189 (21%)
Query: 494 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-FKSFAVECE 540
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 541 MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI--------------- 585
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 586 --------LDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 638 IAKLLIGED 646
           +++ +  ED
Sbjct: 196 LSRDVYEED 204

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKRF 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           N FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 552 KVISS-------CSNEEFK-----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
            ++S+       C +  F      + +L+    G L  +L       +   R     ++ 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             LE++H      V++ DLKP N+LLD++    +SD G+A
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 142
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           N FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 552 KVISS-------CSNEEFK-----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
            ++S+       C +  F      + +L+    G L  +L       +   R     ++ 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             LE++H      V++ DLKP N+LLD++    +SD G+A
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           N FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 552 KVISS-------CSNEEFK-----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA 599
            ++S+       C +  F      + +L+    G L  +L       +   R     ++ 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             LE++H      V++ DLKP N+LLD++    +SD G+A
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 498 NLIGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRAFK-SFAVECEMMKSI-RHRN 549
            ++G G FG V  A      + G  ++VAVK+   +   + + +   E +MM  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-------------YSSNCILDIFQRLNIMI 596
           ++ ++ +C+      L+ EY  +G L  YL             Y +   L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 597 ---------DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 32/168 (19%)
Query: 489 RATNGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGR---AFKSFAVECEM-- 541
           R T  F E  ++G G F  V+  K RL        K+F L+C +   AF+  ++E E+  
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVKQRLTG------KLFALKCIKKSPAFRDSSLENEIAV 59
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMI 596
           +K I+H N++ +     +     LV++    G L     E+ +Y+      + Q+     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----- 114
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKL 641
            V SA++YLH      ++H DLKP+N+L    ++N    ++DFG++K+
Sbjct: 115 -VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 23/154 (14%)
Query: 500 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNL 550
           +G G +GSV   Y ARL    +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 551 IKVIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           I ++     + S E+F  + L     G+    +  S  + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               A +IH DLKP NV ++++    + DFG+A+
Sbjct: 149 S---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 142
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+    S++   +     L       I   +   L+ L F   
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 497 NNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVI 554
           + L+G G +  V  A  L +G E AVK+   Q G +      E E +   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
               ++    LV E    GS+  ++       +  +   ++ DVA+AL++LH   +A   
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLHTKGIA--- 133
Query: 615 HCDLKPDNVLLD 626
           H DLKP+N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R  +   VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLESKRF 132
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS--------FAVECEMMKSIRHRN 549
            +IGRG FG V   R     + + KV+ ++    F+         F  E ++M       
Sbjct: 81  KVIGRGAFGEVQLVR----HKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           ++++  +  ++++  +V+EY P G L   L S+  + + + +     +V  AL+ +H   
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIHSMG 194
Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
           L   IH D+KPDN+LLD +    L+DFG
Sbjct: 195 L---IHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+    S++   +     L       I   +   L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             V+H DLKP N+L++      L+DFG+A+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 500 IGRGGFG-SVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           IG G FG ++      DG +  +K  N+     +  +    E  ++ +++H N+++   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIM---IDVASALEYLHFGCLAPV 613
                   +V++Y   G L K + +   +L  FQ   I+   + +  AL+++H      +
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH---DRKI 146
Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H D+K  N+ L  +    L DFGIA++L
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVF--NLQCGRAFKSFAVECEMMKSI--------RH 547
           L+G+GGFG+V+   RL D ++VA+KV   N   G +  S +V C +  ++         H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 548 RNLIKVISSCSNEEFKALVLEYK-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
             +I+++     +E   LVLE   P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 607 FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGE 645
                 V+H D+K +N+L+D     A L DFG   LL  E
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 132
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 11/137 (8%)
Query: 497 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR 548
           N  +G+G F  ++K     +GD       EV +KV +       +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           +L+     C   +   LV E+   GSL+ YL  +   ++I  +L +   +A+A+ +L   
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 609 CLAPVIHCDLKPDNVLL 625
            L   IH ++   N+LL
Sbjct: 133 TL---IHGNVCAKNILL 146

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     IG G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           F E  LIG GGFG V+KA+   DG    +K       +A +    E + +  + H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 553 V------------ISSCSNEEFKA----LVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIM 595
                         SS ++   K     + +E+   G+LE+++       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
             +   ++Y+H   L   I+ DLKP N+ L D     + DFG+ 
Sbjct: 129 EQITKGVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGDFGLV 169

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     IG G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 491 TNGFSENNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQ-----C---GRAFKSFAVECEM 541
           +  +S  + +G G FG V+ A   +   EV VK    +     C           +E  +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLN------I 594
           +  + H N+IKV+    N+ F  LV+E   HGS L+ + +     +D   RL+      I
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAF-----IDRHPRLDEPLASYI 135
Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              + SA+ YL    L  +IH D+K +N+++ ++    L DFG A  L
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 6/139 (4%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             E   +++E+   G+L   +  S   L+  Q   +   V  AL YLH      VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 168 KSDSILLTLDGRVKLSDFG 186

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS----FAVECEMMKSIRHRNLIKVI- 554
           IGRG F +VYK  L     V V    LQ  +  KS    F  E E +K ++H N+++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 555 ---SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
              S+   ++   LV E    G+L+ YL     +  I    +    +   L++LH     
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLHTR-TP 150
Query: 612 PVIHCDLKPDNVLLD---------DNLVAYLSDFGIAKLLIG 644
           P+IH DLK DN+ +          D  +A L     AK +IG
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG 192

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 132
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     IG G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMK 543
            C   + + +   IG+G FG V+KAR    G +VA+K   ++  +  F   A+ E ++++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 72
Query: 544 SIRHRNLIKVISSCSNE-----EFKA---LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++ +I  C  +       KA   LV ++  H  L   L +      + +   +M
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 131
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A+
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 498 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN 549
            ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 550 LIKVISSCSNEEFK-ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHF 607
            +  +      E K  L+L+Y   G L  +L       +    + I + ++  ALE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH- 176
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                +I+ D+K +N+LLD N    L+DFG++K  + ++
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 500 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +GRG FG V+  R+ D   G + AVK   L+  RA +  A  C  + S R   ++ +  +
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELMA--CAGLTSPR---IVPLYGA 153
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
                +  + +E    GSL + +    C+ +  + L  +      LEYLH      ++H 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLHS---RRILHG 209
Query: 617 DLKPDNVLL-DDNLVAYLSDFGIAKLL 642
           D+K DNVLL  D   A L DFG A  L
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCL 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG+AK + G
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG 193

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 500 IGRGGFGSVYKARLG-DGMEVAVK----VFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G +G V  AR    G +VA+K     F++      K    E +++K  +H N+I + 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN--AKRTLRELKILKHFKHDNIIAIK 120
Query: 555 S----SCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
                +    EFK++  VL+      L + ++SS   L +      +  +   L+Y+H  
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHS- 177
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A VIH DLKP N+L+++N    + DFG+A+
Sbjct: 178 --AQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIR 546
           R  N +     IG G FG +Y  A +  G EVA+K   L+C +       +E +  K ++
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIK---LECVKTKHPQLHIESKFYKMMQ 62
Query: 547 HRNLIKVISSCSNE-EFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
               I  I  C  E ++  +V+E   P  SLE      +    +   L +   + S +EY
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 605 LHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAK 640
           +H       IH D+KPDN L+      NLV Y+ DFG+AK
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 500 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +GRG FG V+  R+ D   G + AVK   L+  RA +  A  C  + S R   ++ +  +
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELMA--CAGLTSPR---IVPLYGA 134
Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
                +  + +E    GSL + +    C+ +  + L  +      LEYLH      ++H 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLHS---RRILHG 190
Query: 617 DLKPDNVLL-DDNLVAYLSDFGIAKLL 642
           D+K DNVLL  D   A L DFG A  L
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCL 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H DL   N ++  +    + DFG+ + +   D
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 179

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMK 543
            C   + + +   IG+G FG V+KAR    G +VA+K   ++  +  F   A+ E ++++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 72
Query: 544 SIRHRNLIKVISSCSNEEFKA--------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++ +I  C  +            LV ++  H  L   L +      + +   +M
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 131
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A+
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNL-----QCGRAFKSFAVECEMMKSIRHRNLIK 552
           +IGRG FG V   R     +V A+K+ +      +   AF  F  E ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 133
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  +  ++ +  +V+EY P G L   L S+  + + + R     +V  AL+ +H      
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 188
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFG 637
            IH D+KPDN+LLD +    L+DFG
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG+AK + G
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG 193

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H DL   N ++  +    + DFG+ + +   D
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 500 IGRGGFGSVYKARLG-DGMEVAVK----VFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G +G V  AR    G +VA+K     F++      K    E +++K  +H N+I + 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN--AKRTLRELKILKHFKHDNIIAIK 119
Query: 555 S----SCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
                +    EFK++  VL+      L + ++SS   L +      +  +   L+Y+H  
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHS- 176
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A VIH DLKP N+L+++N    + DFG+A+
Sbjct: 177 --AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 77/156 (49%), Gaps = 24/156 (15%)
Query: 500 IGRGGFGSVYKA---RLGDGMEVAVKVFN-----LQCGRAFKSFAVECEMMKSIRHRNLI 551
           +G+G +G V+K+   R G+ + V  K+F+         R F+   +  E+     H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSG---HENIV 72
Query: 552 KVIS--SCSNEEFKALVLEYKPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHF 607
            +++     N+    LV +Y     +E  L++     IL+   +  ++  +   ++YLH 
Sbjct: 73  NLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
           G L   +H D+KP N+LL+      ++DFG+++  +
Sbjct: 128 GGL---LHRDMKPSNILLNAECHVKVADFGLSRSFV 160

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H DL   N ++  +    + DFG+ + +   D
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG 193

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNL-----QCGRAFKSFAVECEMMKSIRHRNLIK 552
           +IGRG FG V   R     +V A+K+ +      +   AF  F  E ++M       +++
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  +  ++ +  +V+EY P G L   L S+  + + + R     +V  AL+ +H      
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFG 637
            IH D+KPDN+LLD +    L+DFG
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +VLEY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 194

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 498 NLIGRGGFGSVYKARLGDGMEV-AVKVFNL-----QCGRAFKSFAVECEMMKSIRHRNLI 551
            +IGRG FG V   R     +V A+K+ +      +   AF  F  E ++M       ++
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 137
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++  +  ++ +  +V+EY P G L   L S+  + + + R     +V  AL+ +H     
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SM 192
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFG 637
             IH D+KPDN+LLD +    L+DFG
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H DL   N ++  +    + DFG+ + +   D
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 5/107 (4%)
Query: 538 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
           E ++++ +RH+N+I+++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +   LEYLH      ++H D+KP N+LL       +S  G+A+ L
Sbjct: 116 CQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H DL   N ++  +    + DFG+ + +   D
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 183

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMK 543
            C   + + +   IG+G FG V+KAR    G +VA+K   ++  +  F   A+ E ++++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 72
Query: 544 SIRHRNLIKVISSCSNEEFKA--------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++ +I  C  +            LV ++  H  L   L +      + +   +M
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 131
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A+
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           YL+       +H DL   N ++  +    + DFG+ +
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           IG G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 148
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 497 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR 548
           N  +G+G F  ++K     +GD       EV +KV +       +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           +L+     C   +   LV E+   GSL+ YL  +   ++I  +L +   +A A+ +L   
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEEN 132
Query: 609 CLAPVIHCDLKPDNVLL 625
            L   IH ++   N+LL
Sbjct: 133 TL---IHGNVCAKNILL 146

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMK 543
            C   + + +   IG+G FG V+KAR    G +VA+K   ++  +  F   A+ E ++++
Sbjct: 12  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 71
Query: 544 SIRHRNLIKVISSCSNEEFKA--------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++ +I  C  +            LV ++  H  L   L +      + +   +M
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A+
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 498 NLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLI 551
            ++G G FG+VYK   + DG    + VA+KV       +A K    E  +M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           +++  C     + LV +  P+G L  ++  +   L     LN  + +A  + YL    L 
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL- 140
Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   NVL+       ++DFG+A+LL
Sbjct: 141 --VHRDLAARNVLVKSPNHVKITDFGLARLL 169

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 489 RATNGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR 546
           R T  F E   IG G FGSV+K   RL DG   A+K       R+ K  A   +   ++R
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 55
Query: 547 ----------HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---N 593
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  F+     +
Sbjct: 56  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 115
Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLL 625
           +++ V   L Y+H   L   +H D+KP N+ +
Sbjct: 116 LLLQVGRGLRYIHSMSL---VHMDIKPSNIFI 144

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 555 SSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           ++   E        +V+EY    +L   +++   +    + + ++ D   AL + H    
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +IH D+KP N+++       + DFGIA+ +
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAI 166

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 489 RATNGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR 546
           R T  F E   IG G FGSV+K   RL DG   A+K       R+ K  A   +   ++R
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 57
Query: 547 ----------HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---N 593
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  F+     +
Sbjct: 58  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLL 625
           +++ V   L Y+H   L   +H D+KP N+ +
Sbjct: 118 LLLQVGRGLRYIHSMSL---VHMDIKPSNIFI 146

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 148
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 489 RATNGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR 546
           R T  F E   IG G FGSV+K   RL DG   A+K       R+ K  A   +   ++R
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 59
Query: 547 ----------HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---N 593
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  F+     +
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLL 625
           +++ V   L Y+H   L   +H D+KP N+ +
Sbjct: 120 LLLQVGRGLRYIHSMSL---VHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 489 RATNGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR 546
           R T  F E   IG G FGSV+K   RL DG   A+K       R+ K  A   +   ++R
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 57
Query: 547 ----------HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---N 593
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  F+     +
Sbjct: 58  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLL 625
           +++ V   L Y+H   L   +H D+KP N+ +
Sbjct: 118 LLLQVGRGLRYIHSMSL---VHMDIKPSNIFI 146

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNL------ 550
           L+G G +G VYK R +  G   A+KV ++  G   +    E  M+K    HRN+      
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 551 -IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFG 608
            IK      +++   LV+E+   GS+   + ++    L       I  ++   L +LH  
Sbjct: 90  FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 146
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               VIH D+K  NVLL +N    L DFG++  L
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 500 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNL 550
           +G G +GSV   Y ARL    +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 551 IKVIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           I ++     + S E+F  + L     G+    +     + D   +  ++  +   L+Y+H
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               A +IH DLKP NV ++++    + DFG+A+
Sbjct: 141 S---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 154
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 155 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 500 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNL 550
           +G G +GSV   Y ARL    +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 551 IKVIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           I ++     + S E+F  + L     G+    +     + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               A +IH DLKP NV ++++    + DFG+A+
Sbjct: 149 S---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
            +    +GRG FG V++ +    G + AVK   L+  R  +  A  C  + S R   ++ 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA--CAGLSSPR---IVP 114
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  +     +  + +E    GSL + +    C+ +  + L  +      LEYLH      
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRR 170
Query: 613 VIHCDLKPDNVLL-DDNLVAYLSDFGIA 639
           ++H D+K DNVLL  D   A L DFG A
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 166
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 6/139 (4%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
             +   +V+E+   G+L   +  ++  ++  Q   + + V  AL YLH      VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDI 167
Query: 619 KPDNVLLDDNLVAYLSDFG 637
           K D++LL  +    LSDFG
Sbjct: 168 KSDSILLTSDGRIKLSDFG 186

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 500 IGRGGFGSVYKARLGDGME-VAVKVFNLQC------GRAFKSFAVECEMMKSIRHRNLIK 552
           +G G +G VYKA      E VA+K   L+       G A +    E  ++K ++HRN+I+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH-FGC 609
           + S   +     L+ EY     L+KY+  +    D+  R+  + +  + + + + H   C
Sbjct: 98  LKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 610 LAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAK 640
           L    H DLKP N+LL      +  V  + DFG+A+
Sbjct: 154 L----HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
            +    +GRG FG V++ +    G + AVK   L+  R  +  A  C  + S R   ++ 
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA--CAGLSSPR---IVP 130
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  +     +  + +E    GSL + +    C+ +  + L  +      LEYLH      
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRR 186
Query: 613 VIHCDLKPDNVLL-DDNLVAYLSDFGIA 639
           ++H D+K DNVLL  D   A L DFG A
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 166
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 163
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 164 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 162
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 83
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 84  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 141
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 142 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 148
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 145
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 84
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 85  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 142
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 143 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIR 546
           R    F     +GRGGFG V++A+   D    A+K   L     A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---------------SSNCILDIFQR 591
           H  +++  ++      K    + +P  S + YLY               +  C ++  +R
Sbjct: 62  HPGIVRYFNAWLE---KNTTEKLQP-SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 592 ---LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              L+I + +A A+E+LH   L   +H DLKP N+    + V  + DFG+ 
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLV 165

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 140
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 141 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 145
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 155
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 155
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 148
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +  +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPR---IVPLYGAVR 134
Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
              +  + +E    GSL + +    C+ +  + L  +      LEYLH      ++H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 190
Query: 619 KPDNVLL-DDNLVAYLSDFGIA 639
           K DNVLL  D   A L DFG A
Sbjct: 191 KADNVLLSSDGSRAALCDFGHA 212

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 150
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIR 546
           R  N +     IG G FG +Y    +  G EVA+K   L+C +       +E ++ K ++
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQ 62
Query: 547 HRNLIKVISSCSNE-EFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
               I  I  C  E ++  +V+E   P  SLE      +    +   L +   + S +EY
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 605 LHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAK 640
           +H       IH D+KPDN L+      NLV Y+ DFG+AK
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 145
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 140
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 141 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 25/169 (14%)
Query: 500 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIK 552
           +G   FG VYK  L     G+  + VA+K    +  G   + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQR---------------LNIMID 597
           ++   + ++  +++  Y  HG L ++L   +   D+                  ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +A+ +EYL       V+H DL   NVL+ D L   +SD G+ + +   D
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSF------AVECEMMKSIRHRNLIK 552
           +G G +GSV  +  +  G+++AVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 114
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 115 LLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 172
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 173 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 139
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   +    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 268
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ DLK +N++LD +    ++DFG+ K
Sbjct: 269 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 154
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 155 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 489 RATNGFSENNLIGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIR 546
           R  N +     IG G FG +Y    +  G EVA+K   L+C +       +E ++ K ++
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQ 60
Query: 547 HRNLIKVISSCSNE-EFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
               I  I  C  E ++  +V+E   P  SLE      +    +   L +   + S +EY
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 605 LHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAK 640
           +H       IH D+KPDN L+      NLV Y+ DFG+AK
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 154

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 12/152 (7%)
Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 555 SSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +   E        +V+EY    +L   +++   +    + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +IH D+KP N+++       + DFGIA+ +
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAI 166

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 487 LCRAT-NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEM 541
           + R T N F    L+G+G FG V   +    G   A+K+   +   A    A    E  +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 542 MKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 601
           +++ RH  L  +  S    +    V+EY   G L  +L       +   R     ++ SA
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSA 121
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           L+YLH      V++ DLK +N++LD +    ++DFG+ K
Sbjct: 122 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 491 TNGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVF---NLQCGRAFKSFAVECEMMKSI 545
           ++ +    ++G+G FG V   K ++  G E AVKV     ++     +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 606 HFGCLAPVIHCDLKPDNVLLD 626
           H      ++H DLKP+N+LL+
Sbjct: 143 HKN---KIVHRDLKPENLLLE 160

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 491 TNGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVF---NLQCGRAFKSFAVECEMMKSI 545
           ++ +    ++G+G FG V   K ++  G E AVKV     ++     +S   E +++K +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 606 HFGCLAPVIHCDLKPDNVLLD 626
           H      ++H DLKP+N+LL+
Sbjct: 166 HKN---KIVHRDLKPENLLLE 183

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK  +      +   R ++    E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 155
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNVLLDDNLVAY----LSDFGIA 639
             H DLKP+N++L D  +      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNV-LLDDNL---VAYLSDFGIA 639
             H DLKP+N+ LLD N+      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   +    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 265
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ DLK +N++LD +    ++DFG+ K
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 498 NLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMK------SIRHRNL 550
            ++G+G FG V  AR+ + G   AVKV  L+     +   VEC M +      +  H  L
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            ++       +    V+E+   G L  ++  S    +   R     ++ SAL +LH    
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---D 142
Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             +I+ DLK DNVLLD      L+DFG+ K
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +  S  + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+ +
Sbjct: 144 --ADIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   + +  G   A+K+ + Q     K       E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+++D      ++DFG AK + G
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 491 TNGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVF---NLQCGRAFKSFAVECEMMKSI 545
           ++ +    ++G+G FG V   K ++  G E AVKV     ++     +S   E +++K +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 606 HFGCLAPVIHCDLKPDNVLLD 626
           H      ++H DLKP+N+LL+
Sbjct: 167 HKN---KIVHRDLKPENLLLE 184

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 141/323 (43%), Gaps = 82/323 (25%)
Query: 53  IADV----RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRN 108
           IAD+     L NL  L L+ N  +   P  + N + L+ LELS N+ S    +    L +
Sbjct: 97  IADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTS 152
Query: 109 LEWLNLRDNYLTSSTP------------------ELSFLSSLSNCKSL--TFIHLSD-NP 147
           L+ L+   N +T   P                  ++S L+ L+N +SL  T   +SD  P
Sbjct: 153 LQQLSFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 212
Query: 148 LDGILSKTSIGNLS---HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI 204
           L GIL  T++  LS   + LKD          G    +TNLT+   +DL  N+++   P 
Sbjct: 213 L-GIL--TNLDELSLNGNQLKDI---------GTLASLTNLTD---LDLANNQISNLAP- 256
Query: 205 TLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILS 264
                                    +  LT+L EL+LG N++    P   + L +L  L 
Sbjct: 257 -------------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 289
Query: 265 LSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 323
           L+ N+L  I P++  NLK++  L    N ++   P  + +L  L  + FS N  S V  +
Sbjct: 290 LNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVSDV--S 343
Query: 324 EIGGLKNLEYLFLGYNRLEGSIP 346
            +  L N+ +L  G+N++    P
Sbjct: 344 SLANLTNINWLSAGHNQISDLTP 366

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 149
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 145
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 146 ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNV-LLDDNL---VAYLSDFGIA 639
             H DLKP+N+ LLD N+      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRN 549
           + +    +IG G    V  A      E VA+K  NL+ C  +      E + M    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 550 LIKVISSCSNEEFKALVLEYKPHGS---LEKYLYSS----NCILDIFQRLNIMIDVASAL 602
           ++   +S   ++   LV++    GS   + K++ +     + +LD      I+ +V   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           EYLH       IH D+K  N+LL ++    ++DFG++  L
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 166

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRN 549
           + +    +IG G    V  A      E VA+K  NL+ C  +      E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 550 LIKVISSCSNEEFKALVLEYKPHGS---LEKYLYSS----NCILDIFQRLNIMIDVASAL 602
           ++   +S   ++   LV++    GS   + K++ +     + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           EYLH       IH D+K  N+LL ++    ++DFG++  L
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 171

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 1/118 (0%)
Query: 220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFW 278
           N+++    D       L ELEL  N +    P  F+NL +LR L L SN L  IPL  F 
Sbjct: 42  NRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101
Query: 279 NLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
            L ++ +L+ S N +   L     +L  L  ++   N+   +      GL +LE L L
Sbjct: 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNV-LLDDNL---VAYLSDFGIA 639
             H DLKP+N+ LLD N+      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNV-LLDDNL---VAYLSDFGIA 639
             H DLKP+N+ LLD N+      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 129 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 173

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 122 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 140/323 (43%), Gaps = 82/323 (25%)
Query: 53  IADV----RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRN 108
           IAD+     L NL  L L+ N  +   P  + N + L+ LELS N+ S    +    L +
Sbjct: 97  IADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTS 152
Query: 109 LEWLNLRDNYLTSSTP------------------ELSFLSSLSNCKSL--TFIHLSD-NP 147
           L+ LN   N +T   P                  ++S L+ L+N +SL  T   +SD  P
Sbjct: 153 LQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 212
Query: 148 LDGILSKTSIGNLS---HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI 204
           L GIL  T++  LS   + LKD          G    +TNLT+   +DL  N+++   P 
Sbjct: 213 L-GIL--TNLDELSLNGNQLKDI---------GTLASLTNLTD---LDLANNQISNLAP- 256
Query: 205 TLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILS 264
                                    +  LT+L EL+LG N++    P   + L +L  L 
Sbjct: 257 -------------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 289
Query: 265 LSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 323
           L+ N+L  I P++  NLK++  L    N ++   P  + +L  L  + F  N  S V  +
Sbjct: 290 LNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S 343
Query: 324 EIGGLKNLEYLFLGYNRLEGSIP 346
            +  L N+ +L  G+N++    P
Sbjct: 344 SLANLTNINWLSAGHNQISDLTP 366

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 38/177 (21%)
Query: 494 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           F E  LIG GGFG V+KA+   DG    ++       +A +    E + +  + H N++ 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 553 VI-----------------------------SSCSNEEFKALVLEYKPHGSLEKYLYSSN 583
                                          SS S  +   + +E+   G+LE+++    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 584 C-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              LD    L +   +   ++Y+H   L   IH DLKP N+ L D     + DFG+ 
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKKL---IHRDLKPSNIFLVDTKQVKIGDFGLV 183

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   +    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 125
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ DLK +N++LD +    ++DFG+ K
Sbjct: 126 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 489 RATNGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSI 545
           R T  +     +G+G F  V +  ++  G E A  + N +    R  +    E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMI 596
           +H N++++  S S E    L+ +    G L      +  YS    S+CI  I + +    
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV---- 123
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGED 646
                   LH   +  V+H +LKP+N+LL   L      L+DFG+A  + GE 
Sbjct: 124 --------LHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 262 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL------EKYLYSSNCILDIFQ 590
            E E++K + H  +IK+ +    E++  +VLE    G L       K L  + C L  +Q
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            L        A++YLH      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 248 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 497 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRHRNLIK 552
             ++  GGF  VY+A+ +G G E A+K   L      K+ A+    C M K   H N+++
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 553 VISSCS---------NEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASA 601
             S+ S           EF  L+L     G L ++L    S   L     L I      A
Sbjct: 91  FCSAASIGKEESDTGQAEF--LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           ++++H     P+IH DLK +N+LL +     L DFG A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 25/176 (14%)
Query: 481 TFSYLELCRATNGFSE--NNL--IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSF 535
           TF   EL +      E   NL  +G G +GSV  A     G  VAVK    +  R F+S 
Sbjct: 3   TFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSI 58
Query: 536 A------VECEMMKSIRHRNLIKVIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNC 584
                   E  ++K ++H N+I ++     + S EEF  + L     G+ L   +  +  
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 585 ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             D  Q L  +  +   L+Y+H    A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 119 TDDHVQFL--IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 491 TNGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVF---NLQCGRAFKSFAVECEMMKSI 545
           ++ +    ++G+G FG V   K ++  G E AVKV     ++     +S   E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 606 HFGCLAPVIHCDLKPDNVLLD 626
           H      ++H DLKP+N+LL+
Sbjct: 149 HKN---KIVHRDLKPENLLLE 166

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIR 546
           ++ +    ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 547 HRNLIKVISSCSNEE----FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
           H  ++ V  +   E        +V+EY    +L   +++   +    + + ++ D   AL
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQAL 146
Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            + H      +IH D+KP N+++       + DFGIA+ +
Sbjct: 147 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 183

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H +L   N ++  +    + DFG+ + +   D
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/163 (22%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 500 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD---------IFQRLNIMIDVASALE 603
           ++   S  +   +V+E   HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL+       +H +L   N ++  +    + DFG+ + +   D
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA---VECEMMKSIRH 547
           N F    L+G+G FG V   +    G   A+K+   +   A    A    E  ++++ RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 127
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                V++ DLK +N++LD +    ++DFG+ K
Sbjct: 128 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 9/148 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              + E    +++E    G L  +L      LD+   +     +++AL YL        +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFV 133
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+   NVL+  N    L DFG+++ +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM 161

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 496 ENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKV 553
           + +++G G    V     L    E AVK+   Q G        E EM+   + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           I     E+   LV E    GS+  +++      ++   + ++ DVASAL++LH   +A  
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIA-- 133
Query: 614 IHCDLKPDNVLLDD-NLVA--YLSDFGIA 639
            H DLKP+N+L +  N V+   + DFG+ 
Sbjct: 134 -HRDLKPENILCEHPNQVSPVKICDFGLG 161

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 9/148 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              + E    +++E    G L  +L      LD+   +     +++AL YL        +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFV 133
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+   NVL+  N    L DFG+++ +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM 161

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 163
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L  ++
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 163
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 162
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + D+G+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 537 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
            E  +M+ + +  ++++I  C  E +  LV+E    G L KYL  +  + D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            V+  ++YL        +H DL   NVLL     A +SDFG++K L  ++
Sbjct: 478 QVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADE 524

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 9/148 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              + E    +++E    G L  +L      LD+   +     +++AL YL        +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---V 513
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+   NVL+  N    L DFG+++ +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM 541

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 553 VIS----SCSNEEFKALVLEYKPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
           ++     + S EEF  + L     G+ L   +       D  Q L  +  +   L+Y+H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 139
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 95
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 96  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 153
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 154 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 139
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 500 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 557 CSNEEFKAL--VLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 612 --PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              V+H DLKP NV LD      L DFG+A++L
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK------SFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +     N     L+LE    G L  +L     + +  +  + +  +   + YLH   +A 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDGVNYLHTKKIA- 137
Query: 613 VIHCDLKPDNV-LLDDNL---VAYLSDFGIA 639
             H DLKP+N+ LLD N+      L DFG+A
Sbjct: 138 --HFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 89/324 (27%), Positives = 140/324 (43%), Gaps = 85/324 (26%)
Query: 53  IADV----RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIP-------- 100
           IAD+     L NL  L L+ N  +   P  + N + L+ LELS N+ S            
Sbjct: 97  IADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQ 154
Query: 101 -----------NTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL--TFIHLSD-N 146
                          NL  LE L++  N ++    ++S L+ L+N +SL  T   +SD  
Sbjct: 155 QLNFGNQVTDLKPLANLTTLERLDISSNKVS----DISVLAKLTNLESLIATNNQISDIT 210
Query: 147 PLDGILSKTSIGNLS---HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP 203
           PL GIL  T++  LS   + LKD          G    +TNLT+   +DL  N+++   P
Sbjct: 211 PL-GIL--TNLDELSLNGNQLKDI---------GTLASLTNLTD---LDLANNQISNLAP 255
Query: 204 ITLSXXXXXXXXXXXXNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL 263
                                     +  LT+L EL+LG N++    P   + L +L  L
Sbjct: 256 --------------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNL 287
Query: 264 SLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIP 322
            L+ N+L  I P++  NLK++  L    N ++   P  + +L  L  + FS N  S V  
Sbjct: 288 ELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVSDV-- 341
Query: 323 TEIGGLKNLEYLFLGYNRLEGSIP 346
           + +  L N+ +L  G+N++    P
Sbjct: 342 SSLANLTNINWLSAGHNQISDLTP 365

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 31/195 (15%)
Query: 461 RKRGKQPSNDANMPLVAT-WRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGME- 518
           RK+       A+MP   + W+     E+          +LIG G +G V +A   D +E 
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQIPDRYEI---------RHLIGTGSYGHVCEA--YDKLEK 78
Query: 519 --VAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVISSC---SNEEFKALVL 567
             VA+K    VF   + C R  +  A+    +  + H +++KV+        E+F  L +
Sbjct: 79  RVVAIKKILRVFEDLIDCKRILREIAI----LNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD 627
             +   S  K L+ +   L       ++ ++   ++Y+H    A ++H DLKP N L++ 
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQ 191
Query: 628 NLVAYLSDFGIAKLL 642
           +    + DFG+A+ +
Sbjct: 192 DCSVKVCDFGLARTV 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 500 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 557 CSNEEFKAL--VLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 612 --PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              V+H DLKP NV LD      L DFG+A++L
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 57/119 (47%), Gaps = 7/119 (5%)
Query: 220 NKLEGSIPDSICRLTELYELELGGNKLFGSIP-ACFSNLASLRILSLSSNELTSIP-LTF 277
            KLE  + DS+  L ELY   LG N+L G++P   F +L  L +L L +N+LT +P   F
Sbjct: 53  TKLEPGVFDSLINLKELY---LGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVF 108
Query: 278 WNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
             L  + +L    N LT  LP  I  L  L  +    N   S+       L +L + +L
Sbjct: 109 DRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D+     ++DFG AK + G
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG 180

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 10/178 (5%)
Query: 471 ANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCG 529
           A    +  W T S  +     + F     +G G FG V   +  + G   A+K+ + Q  
Sbjct: 43  AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 100
Query: 530 RAFKSFAV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCIL 586
              K       E  +++++    L+K+  S  +     +V+EY   G +  +L       
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 160
Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
           +   R      +    EYLH      +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 161 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 188

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/72 (43%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNF 292
           LT LY   L GN L   +PA   NL++LR+L LS N LTS+P    +   +    F  N 
Sbjct: 249 LTRLY---LNGNSL-TELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNM 304
Query: 293 LTGPLPLEIGNL 304
           +T  LP E GNL
Sbjct: 305 VTT-LPWEFGNL 315

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 65/285 (22%)
Query: 106 LRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLK 165
           L NLE+LNL  N +T  +P       LSN   LT +++  N +  I   +++ NL++ L+
Sbjct: 65  LTNLEYLNLNGNQITDISP-------LSNLVKLTNLYIGTNKITDI---SALQNLTN-LR 113
Query: 166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSXXXXXXXXXXXXNKLEGS 225
           + Y++  N+S   P  + NLT   +++LG N  N S    LS            +K++  
Sbjct: 114 ELYLNEDNISDISP--LANLTKXYSLNLGANH-NLSDLSPLSNXTGLNYLTVTESKVKDV 170
Query: 226 IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQ 285
            P  I  LT+LY L L  N++    P   ++L SL   +   N++T I     N   +  
Sbjct: 171 TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT-PVANXTRLNS 225
Query: 286 LNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE--------------------- 324
           L   +N +T   PL   NL  L  ++   N  S +   +                     
Sbjct: 226 LKIGNNKITDLSPL--ANLSQLTWLEIGTNQISDINAVKDLTKLKXLNVGSNQISDISVL 283
Query: 325 -----------------------IGGLKNLEYLFLGYNRLEGSIP 346
                                  IGGL NL  LFL  N +    P
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRP 328

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 500 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAFKSFA------VECEMMKSIRHRNLIK 552
           +G G +GSV  A     G  VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 553 VIS----SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           ++     + S EEF  + L     G+    +     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 149
Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 500 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 557 CSNEEFKAL--VLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 612 --PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              V+H DLKP NV LD      L DFG+A++L
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 499 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAV--ECEMMKSIRHRNLIKVIS 555
           ++G+G FG V K +      E AVKV N    +   +  +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +     +V E    G L   +       +      I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 616 CDLKPDNVLLD 626
            DLKP+N+LL+
Sbjct: 145 RDLKPENILLE 155

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 232 RLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSS 290
            LT L +L LGGNKL       F+ L SL  L+LS+N+L S+P   F  L  + +L  ++
Sbjct: 50  ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109
Query: 291 NFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP 346
           N L   LP  +   L  L  +    N   SV       L +L+Y++L  N  + + P
Sbjct: 110 NQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 10/178 (5%)
Query: 471 ANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCG 529
           A    +  W T S  +     + F     +G G FG V   +  + G   A+K+ + Q  
Sbjct: 22  AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 530 RAFKSFAV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCIL 586
              K       E  +++++    L+K+  S  +     +V+EY   G +  +L       
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
           +   R      +    EYLH   L   I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 9/148 (6%)
Query: 500 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
              + E    +++E    G L  +L      LD+   +     +++AL YL        +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFV 161
Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+   NVL+  N    L DFG+++ +
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM 189

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 8/157 (5%)
Query: 492 NGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV---ECEMMKSIRH 547
           + F     +G G FG V   +  + G   A+K+ + Q     K       E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
                +I+ DLKP+N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	646
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-121
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-100
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-98
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-97
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-88
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-74
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-73
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-67
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-34
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-69
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-61
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-66
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-61
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-49
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-56
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-62
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-53
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-44
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-56
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-55
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-32
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-46
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-36
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-30
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-44
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-44
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-36
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-38
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-27
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-40
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-20
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-37
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-14
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-36
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-12
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-23
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-05
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-12
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-11
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-14
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-14
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-12
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-12
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	7e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  377 bits (970), Expect = e-121
 Identities = 134/438 (30%), Positives = 199/438 (45%), Gaps = 20/438 (4%)

Query: 1   EIPLE-ISNLQNLEELDLRHNKLVGTVPAAIFNMSM-LKLLHLQNNSLLGCL-SSIADVR 57
           E+P++ +  ++ L+ LDL  N+  G +P ++ N+S  L  L L +N+  G +  ++    
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
              L+ L L  N F+G IP  + N S+L  L LS N  SG IP++ G+L  L  L L  N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
            L    P       L   K+L  + L  N L G +    + N + +L    +SN  ++G 
Sbjct: 453 MLEGEIP-----QELMYVKTLETLILDFNDLTGEIPS-GLSNCT-NLNWISLSNNRLTGE 505

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
           IP+ I  L N   + L  N  +G+IP  L   + L  L L+ N   G+IP ++ + +   
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS--- 562

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELT---SIPLTFWNLKDILQLNFSSNFLT 294
             ++  N + G       N    +    + N L            L      N +S    
Sbjct: 563 -GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621

Query: 295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIS 354
           G       N   ++ +D S N  S  IP EIG +  L  L LG+N + GSIPD  GDL  
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681

Query: 355 LKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLC 414
           L  L+LS+N L G IP ++  L+ L +++LS N L G IP  G F  F    F  N  LC
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741

Query: 415 GSPTLQVLPCKTSIHHTS 432
           G P   +  C  S     
Sbjct: 742 GYP---LPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  321 bits (825), Expect = e-100
 Identities = 125/470 (26%), Positives = 197/470 (41%), Gaps = 24/470 (5%)

Query: 1   EIPLEI---SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR 57
              +          L+ L +  NK+ G V   +     L+ L + +N+    +  +    
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG--D 221

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
              L+ L + GN  SG   R I   ++L +L +S N F G IP     L++L++L+L +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
             T   P+         C +LT + LS N   G +     G+ S  L+   +S+ N SG 
Sbjct: 280 KFTGEIPD----FLSGACDTLTGLDLSGNHFYGAVPP-FFGSCS-LLESLALSSNNFSGE 333

Query: 178 IPEE-ITNLTNSITIDLGGNKLNGSIPITLSKL-QKLQGLGLDDNKLEGSIPDSICR--L 233
           +P + +  +     +DL  N+ +G +P +L+ L   L  L L  N   G I  ++C+   
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNF 292
             L EL L  N   G IP   SN + L  L LS N L+ +IP +  +L  +  L    N 
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 293 LTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL 352
           L G +P E+  +K L  +    N+ +  IP+ +    NL ++ L  NRL G IP   G L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNEL 412
            +L  L LSNN+ SG IP  L     L  L+L+ N   G IP   +    + +       
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSGK--IAANF 569

Query: 413 LCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYRK 462
           + G   + +             N L    +       L       +  R 
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  317 bits (815), Expect = 2e-98
 Identities = 121/412 (29%), Positives = 189/412 (45%), Gaps = 26/412 (6%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLP 59
            +   + +L  LE L L ++ + G+V       + L  L L  NSL G ++++  +    
Sbjct: 68  AVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126

Query: 60  NLEALLLWGNNFSGTIPR-FIFNASKLSILELSQNSFSGFIPNTF---GNLRNLEWLNLR 115
            L+ L +  N              + L +L+LS NS SG     +        L+ L + 
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 116 DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVS 175
            N ++           +S C +L F+ +S N     +    +G+ S +L+   +S   +S
Sbjct: 187 GNKISGDVD-------VSRCVNLEFLDVSSNNFSTGIP--FLGDCS-ALQHLDISGNKLS 236

Query: 176 GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLT 234
           G     I+  T    +++  N+  G IP     L+ LQ L L +NK  G IPD +     
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACD 294

Query: 235 ELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPL-TFWNLKDILQLNFSSNF 292
            L  L+L GN  +G++P  F + + L  L+LSSN  +  +P+ T   ++ +  L+ S N 
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354

Query: 293 LTGPLPLEIGNLKV-LIGIDFSMNNFSSVIPTEIGG--LKNLEYLFLGYNRLEGSIPDSF 349
            +G LP  + NL   L+ +D S NNFS  I   +       L+ L+L  N   G IP + 
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414

Query: 350 GDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
            +   L  L+LS N LSG IP+SL  LS L DL L  N LEGEIP+      
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ--ELMY 464

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  314 bits (806), Expect = 3e-97
 Identities = 118/400 (29%), Positives = 183/400 (45%), Gaps = 16/400 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           +    IS    L+ L++  N+ VG +P     +  L+ L L  N   G +          
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDT 295

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYL 119
           L  L L GN+F G +P F  + S L  L LS N+FSG +P +T   +R L+ L+L  N  
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355

Query: 120 TSSTPELSFLSSLSNCK-SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           +   P      SL+N   SL  + LS N   G +      N  ++L++ Y+ N   +G I
Sbjct: 356 SGELP-----ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
           P  ++N +  +++ L  N L+G+IP +L  L KL+ L L  N LEG IP  +  +  L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPL 297
           L L  N L G IP+  SN  +L  +SLS+N LT  IP     L+++  L  S+N  +G +
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530

Query: 298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKF 357
           P E+G+ + LI +D + N F+  IP  +          +  N + G       +    K 
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKE 586

Query: 358 LNLSNN--NLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR 395
            + + N     G     L +LS     N++     G    
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  291 bits (746), Expect = 2e-88
 Identities = 111/407 (27%), Positives = 179/407 (43%), Gaps = 25/407 (6%)

Query: 8   NLQNLEELDLRHNKL---VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
               +  +DL    L      V +++ +++ L+ L L N+ + G +S        +L +L
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK--CSASLTSL 105

Query: 65  LLWGNNFSGTIP--RFIFNASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLTS 121
            L  N+ SG +     + + S L  L +S N+       +    L +LE L+L  N ++ 
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
           +            C  L  + +S N + G +    +     +L+   +S+ N S GIP  
Sbjct: 166 ANV--VGWVLSDGCGELKHLAISGNKISGDV---DVSRCV-NLEFLDVSSNNFSTGIP-F 218

Query: 182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
           + + +    +D+ GNKL+G     +S   +L+ L +  N+  G IP     L  L  L L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSL 276

Query: 242 GGNKLFGSIPAC-FSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGPLPL 299
             NK  G IP        +L  L LS N    ++P  F +   +  L  SSN  +G LP+
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 300 E-IGNLKVLIGIDFSMNNFSSVIPTEIGGLK-NLEYLFLGYNRLEGSIPDSFGD--LISL 355
           + +  ++ L  +D S N FS  +P  +  L  +L  L L  N   G I  +       +L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396

Query: 356 KFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
           + L L NN  +G IP +L   S L  L+LSFN L G IP   S G+ 
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS--SLGSL 441

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  266 bits (683), Expect = 2e-84
 Identities = 88/328 (26%), Positives = 134/328 (40%), Gaps = 52/328 (15%)

Query: 90  LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
               ++ G + +T      +  L+L    L    P     SSL+N   L F+++      
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP---IPSSLANLPYLNFLYIGGIN-- 87

Query: 150 GILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKL 209
                                  N+ G IP  I  LT    + +    ++G+IP  LS++
Sbjct: 88  -----------------------NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 210 QKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNE 269
           + L  L    N L G++P SI  L  L  +   GN++ G+IP  + + + L         
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS------ 178

Query: 270 LTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK 329
                           +  S N LTG +P    NL  L  +D S N          G  K
Sbjct: 179 ----------------MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK 221

Query: 330 NLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
           N + + L  N L   +    G   +L  L+L NN + G +P  L +L +L  LN+SFN L
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 390 EGEIPRGGSFGNFAAESFEGNELLCGSP 417
            GEIP+GG+   F   ++  N+ LCGSP
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  201 bits (514), Expect = 1e-59
 Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 22/309 (7%)

Query: 1   EIPLEISNLQNL----EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCL---SSI 53
           +I  ++ N   L       D  +   +G +         +  L L   +L       SS+
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 54  ADVRLPNLEALLLWG-NNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWL 112
           A+  LP L  L + G NN  G IP  I   ++L  L ++  + SG IP+    ++ L  L
Sbjct: 73  AN--LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC 172
           +   N L+ + P      S+S+  +L  I    N + G +   S G+ S       +S  
Sbjct: 131 DFSYNALSGTLP-----PSISSLPNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRN 184

Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR 232
            ++G IP    NL N   +DL  N L G   +     +  Q + L  N L   +   +  
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL 242

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSN 291
              L  L+L  N+++G++P   + L  L  L++S N L   IP    NL+      +++N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

Query: 292 -FLTG-PLP 298
             L G PLP
Sbjct: 302 KCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  168 bits (429), Expect = 2e-47
 Identities = 69/233 (29%), Positives = 102/233 (43%), Gaps = 14/233 (6%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCL-SSIADVRLP 59
            IP  I+ L  L  L + H  + G +P  +  +  L  L    N+L G L  SI+   LP
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS--SLP 149

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLS-ILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
           NL  +   GN  SG IP    + SKL   + +S+N  +G IP TF NL NL +++L  N 
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L              + K+   IHL+ N L   L    +G    +L    + N  + G +
Sbjct: 209 LEGDAS-----VLFGSDKNTQKIHLAKNSLAFDLG--KVGLSK-NLNGLDLRNNRIYGTL 260

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC 231
           P+ +T L    ++++  N L G IP     LQ+       +NK     P   C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  249 bits (638), Expect = 3e-74
 Identities = 77/433 (17%), Positives = 141/433 (32%), Gaps = 47/433 (10%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVG----TVPAAIFNMSMLKLLHLQNNSLLGC-LSSIAD 55
            +P  I  L  LE L L  +          P  I      +             +     
Sbjct: 96  RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155

Query: 56  VRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR 115
               +L    +  +    +I +      K + +    N+ +  +      L  L    + 
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214

Query: 116 DNYLTSSTP-ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNV 174
           ++   +    E     +    +      L               NL   L D  + NC  
Sbjct: 215 NSPFVAENICEAWENENSEYAQQYKTEDL------------KWDNLK-DLTDVEVYNCPN 261

Query: 175 SGGIPEEITNLTNSITIDLGGNKL--------NGSIPITLSKLQKLQGLGLDDNKL-EGS 225
              +P  +  L     I++  N+         +          +K+Q + +  N L    
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321

Query: 226 IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFW-NLKDIL 284
           +  S+ ++ +L  LE   N+L G +PA F +   L  L+L+ N++T IP  F    + + 
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVE 380

Query: 285 QLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSV-------IPTEIGGLKNLEYLFL 336
            L+F+ N L   P   +  ++ V+  IDFS N   SV       +        N+  + L
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440

Query: 337 GYNRLEGSIPDSFGDLISLKFLNLSNNNLSG-------AIPTSLEKLSYLEDLNLSFNKL 389
             N++     + F     L  +NL  N L+            + +    L  ++L FNKL
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500

Query: 390 EGEIPRGGSFGNF 402
              +         
Sbjct: 501 TK-LSDDFRATTL 512

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  246 bits (629), Expect = 7e-73
 Identities = 63/425 (14%), Positives = 132/425 (31%), Gaps = 48/425 (11%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +   +  L  L +  + ++  V             +  + +            D  L +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENIC-----EAWENENSEYAQQYKTEDLKWD-NLKD 250

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSF--------SGFIPNTFGNLRNLEWL 112
           L  + ++       +P F+    ++ ++ ++ N                       ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC 172
            +  N L +   E    +SL   K L  +    N L+G L   + G+    L    ++  
Sbjct: 311 YIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP--AFGSEI-KLASLNLAYN 363

Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLDDNKLEG------- 224
            ++               +    NKL           +  +  +    N++         
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP--------LT 276
            +  +  +   +  + L  N++       FS  + L  ++L  N LT IP          
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483

Query: 277 FWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
           F N   +  ++   N LT          L  L+GID S N+FS   PT+      L+   
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542

Query: 336 LG------YNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
           +        NR     P+      SL  L + +N++   +   +     +  L++  N  
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPN 599

Query: 390 EGEIP 394
                
Sbjct: 600 ISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  242 bits (619), Expect = 2e-71
 Identities = 67/412 (16%), Positives = 137/412 (33%), Gaps = 51/412 (12%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIAD------ 55
             L+  NL++L ++++ +   +  +P  +  +  ++L+++  N  +       D      
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 56  -VRLPNLEALLLWGNNF-SGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLN 113
                 ++ + +  NN  +  +   +    KL +LE   N   G +P  FG+   L  LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359

Query: 114 LRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCN 173
           L  N +T               + +  +  + N L  I +     ++S  +     S   
Sbjct: 360 LAYNQITEIPANF-----CGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYNE 413

Query: 174 VSG-------GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI 226
           +          +        N  +I+L  N+++       S    L  + L  N L   I
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-I 472

Query: 227 PDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP--LTFWNLKDIL 284
           P +                        F N   L  + L  N+LT +        L  ++
Sbjct: 473 PKNS----------------LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLV 516

Query: 285 QLNFSSNFLTGPLPLEIGNLKVLIGI------DFSMNNFSSVIPTEIGGLKNLEYLFLGY 338
            ++ S N  +   P +  N   L G       D   N      P  I    +L  L +G 
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575

Query: 339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
           N +   + +      ++  L++ +N       + +          L ++K +
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  231 bits (591), Expect = 2e-67
 Identities = 57/409 (13%), Positives = 128/409 (31%), Gaps = 35/409 (8%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN---L 61
            +++   +  L L      G VP AI  ++ L++L L ++             +      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 62  EALLLWGNNFSGTIPRFIFNA--SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           E       ++  T   +      S L    ++ +     I  +         +    N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           T          ++     L   ++ ++P           N+  + ++             
Sbjct: 196 T------FVSKAVMRLTKLRQFYMGNSPFVAE-------NICEAWENENSEYAQQYKTED 242

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL--------EGSIPDSIC 231
            +  NL +   +++        +P  L  L ++Q + +  N+         +        
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302

Query: 232 RLTELYELELGGNKLF-GSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSS 290
              ++  + +G N L    +      +  L +L    N+L      F +   +  LN + 
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362

Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT-EIGGLKNLEYLFLGYNRLEG------ 343
           N +T       G  + +  + F+ N    +    +   +  +  +   YN +        
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422

Query: 344 -SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG 391
             +  +    I++  +NLSNN +S          S L  +NL  N L  
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  174 bits (444), Expect = 5e-47
 Identities = 45/312 (14%), Positives = 100/312 (32%), Gaps = 24/312 (7%)

Query: 93  NSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGIL 152
           + +      +  +   +  L+L     +   P      ++     L  + L  +      
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-----DAIGQLTELEVLALGSHGEKVNE 121

Query: 153 SKTSIGNLSH--SLKDFYMSNCNVSGGIPEEIT--NLTNSITIDLGGNKLNGSIPITLSK 208
                  +S   S +       +      +     + ++ I   +  +    SI  +   
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 209 LQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSN 268
             K   +G   N +   +  ++ RLT+L +  +G +              +         
Sbjct: 182 TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ--- 237

Query: 269 ELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV-------- 320
              +  L + NLKD+  +   +      LP  +  L  +  I+ + N   S         
Sbjct: 238 -YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 321 IPTEIGGLKNLEYLFLGYNRL-EGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
              +    + ++ +++GYN L    +  S   +  L  L    N L G +P +      L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355

Query: 380 EDLNLSFNKLEG 391
             LNL++N++  
Sbjct: 356 ASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  136 bits (345), Expect = 5e-34
 Identities = 41/260 (15%), Positives = 83/260 (31%), Gaps = 31/260 (11%)

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDS 229
            N +  G   +   N   +  +D+ G        ++L+   ++ GL L+     G +PD+
Sbjct: 45  KNWSQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDA 100

Query: 230 ICRLTELYELELGGNKLFG----SIPACFSNLASLRILSLSSNELTSIP---LTFWNLKD 282
           I +LTEL  L LG +          P   S   S                      +  D
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
           +++   +S+     +            I    NN +  +   +  L  L   ++G +   
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219

Query: 343 G-------------------SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLN 383
                               +    + +L  L  + + N      +PT L+ L  ++ +N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279

Query: 384 LSFNKLEGEIPRGGSFGNFA 403
           ++ N+          +   A
Sbjct: 280 VACNRGISGEQLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 15/99 (15%), Positives = 34/99 (34%), Gaps = 10/99 (10%)

Query: 1   EIPLEISNLQNLEELDLRH------NKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIA 54
           + P +  N   L+   +R+      N+ +   P  I     L  L + +N     +  + 
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND----IRKVN 582

Query: 55  DVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQN 93
           +   PN+  L +  N        ++    +  +  L  +
Sbjct: 583 EKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  236 bits (604), Expect = 6e-69
 Identities = 92/448 (20%), Positives = 163/448 (36%), Gaps = 37/448 (8%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSM--LKLLHLQNNSLLGCLSSIADVRL 58
           E         ++  L L +++L  T       +    L +L L  N+L   + + +   L
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWL 271

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQN---------SFSGFIPNTFGNLRNL 109
           P LE   L  NN        +     +  L L ++         S       +F  L+ L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL--DGILSKTSIGNLSHSLKDF 167
           E LN+ DN +          +  +   +L ++ LS++      + ++T +      L   
Sbjct: 332 EHLNMEDNDIPGIKS-----NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSI 226
            ++   +S    +  + L +   +DLG N++   +       L+ +  + L  NK     
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 227 PDSICRLTELYELELGGNKL--FGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDI 283
            +S   +  L  L L    L    S P+ F  L +L IL LS+N + +I       L+ +
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506

Query: 284 LQLNFSSNFLT--------GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
             L+   N L         G     +  L  L  ++   N F  +       L  L+ + 
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEK-LSYLEDLNLSFNKLEGEIP 394
           LG N L       F + +SLK LNL  N ++             L +L++ FN  +    
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

Query: 395 RGGSFGNFAAES-----FEGNELLCGSP 417
               F N+  E+        +  LC +P
Sbjct: 627 SIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  214 bits (546), Expect = 8e-61
 Identities = 97/413 (23%), Positives = 159/413 (38%), Gaps = 34/413 (8%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN 70
           + E  D  H KL   VP  +   + + +L+L +N L   L +    R   L +L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60

Query: 71  FSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLS 130
            S   P        L +L L  N  S     TF    NL  L+L  N +          +
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN-----N 115

Query: 131 SLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNS-- 188
                K+L  + LS N L       +   L  +L++  +SN  +     EE+    NS  
Sbjct: 116 PFVKQKNLITLDLSHNGLSST-KLGTQVQLE-NLQELLLSNNKIQALKSEELDIFANSSL 173

Query: 189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC---RLTELYELELGGNK 245
             ++L  N++    P     + +L GL L++ +L  S+ + +C     T +  L L  ++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233

Query: 246 LFGSIPACFSNLA--SLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
           L  +    F  L   +L +L LS N L  +   +F  L  +       N +       + 
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293

Query: 303 NLKVLIGIDFSMNNFSSVI---------PTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
            L  +  ++   +     I               LK LE+L +  N + G   + F  LI
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353

Query: 354 SLKFLNLSNNNLSGAIPTSLE----KLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
           +LK+L+LSN+  S    T+        S L  LNL+ NK+        +F   
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES--DAFSWL 404

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  233 bits (595), Expect = 2e-66
 Identities = 73/455 (16%), Positives = 139/455 (30%), Gaps = 57/455 (12%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            I   I  L  L+ +   ++       A    +                  S +   L +
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIA----VDWEDANSDYAKQYENEELSWS--NLKD 492

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGF---------IPNTFGNLRNLEW 111
           L  + L+       +P F+++  +L  L ++ N              + +       ++ 
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552

Query: 112 LNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSN 171
             +  N L       S          L  +    N +  +    + G     L D  +  
Sbjct: 553 FYMGYNNLEEFPASASL----QKMVKLGLLDCVHNKVRHL---EAFGTNV-KLTDLKLDY 604

Query: 172 CNVSGGIPEEITNLTNSIT-IDLGGNKLNGSIP--ITLSKLQKLQGLGLDDNKLEGSIPD 228
             +   IPE+    T+ +  +    NKL   IP       +  +  +    NK+     +
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662

Query: 229 -----SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP--------L 275
                   +      + L  N++       F+  + +  + LS+N +TSIP         
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722

Query: 276 TFWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYL 334
            + N   +  ++   N LT          L  L  +D S N FSS  PT+      L+  
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781

Query: 335 ------FLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK 388
                     NR+    P       SL  L + +N++   +   L     L  L+++ N 
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNP 838

Query: 389 LEGEIPRGGSFGNFAAE----SFEGNELLCGSPTL 419
               I          A      ++  + + G   L
Sbjct: 839 NI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  218 bits (558), Expect = 2e-61
 Identities = 63/407 (15%), Positives = 136/407 (33%), Gaps = 29/407 (7%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
             +++ N   +  L L      G VP AI  ++ LK+L    +S         D  L   
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            +              F+    +L++ +L Q++ +         ++    ++L+D  + +
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGN 432

Query: 122 STPELSFL-SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
            T  ++F+  ++     L  I+ +++P           N++   +D              
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYD-------NIAVDWEDANSDYAKQYENEEL 485

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEG---------SIPDSIC 231
             +NL +   ++L        +P  L  L +LQ L +  N+             + D   
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545

Query: 232 RLTELYELELGGNKLFG-SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSS 290
              ++    +G N L      A    +  L +L    N++  +   F     +  L    
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDY 604

Query: 291 NFLTGPLPLEIG-NLKVLIGIDFSMNNFSSVIPT-EIGGLKNLEYLFLGYNRLEGSIPDS 348
           N +   +P +       + G+ FS N    +        +  +  +   YN++     + 
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663

Query: 349 FGDL-----ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
              +     I+   + LS N +           S +  + LS N + 
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  183 bits (465), Expect = 5e-49
 Identities = 64/366 (17%), Positives = 112/366 (30%), Gaps = 43/366 (11%)

Query: 69  NNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSF 128
           + +       + N  +++ L L+     G +P+  G L  L+ L+   +  T S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 129 LS--------------------SLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-SLKDF 167
                                  L   + L    L  + ++       I   S  SLKD 
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 168 YMSNC-NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI 226
            + N  N    I + I  LT    I    +           +            K   + 
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENE 483

Query: 227 PDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS----------IPLT 276
             S   L +L ++EL        +P    +L  L+ L+++ N   S          +   
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

Query: 277 FWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
                 I       N L   P    +  +  L  +D   N    +     G    L  L 
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLK 601

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP--TSLEKLSYLEDLNLSFNKLEGEI 393
           L YN++E    D       ++ L  S+N L   IP   + + +  +  ++ S+NK+  E 
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 394 PRGGSF 399
                 
Sbjct: 661 RNISCS 666

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  127 bits (320), Expect = 1e-30
 Identities = 43/255 (16%), Positives = 83/255 (32%), Gaps = 15/255 (5%)

Query: 166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGS 225
           +F             ++ N      + L G    G +P  + +L +L+ L    +    S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 226 IPDSICRLTELYELELGGNKLFGSIPACF-SNLASLRILSLSSNELTSIP-------LTF 277
                         E   +++       F      L +  L  + +   P        + 
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 278 WNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLG 337
            +LKD  Q+   +N +T  +   I  L  L  I F+ + F+           + E     
Sbjct: 423 ISLKD-TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSD 475

Query: 338 YNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGG 397
           Y +   +   S+ +L  L  + L N      +P  L  L  L+ LN++ N+         
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535

Query: 398 SFGNFAAESFEGNEL 412
            +   A +   G ++
Sbjct: 536 DWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.7 bits (238), Expect = 1e-20
 Identities = 33/219 (15%), Positives = 66/219 (30%), Gaps = 16/219 (7%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSL------LGCLSSIAD 55
             ++     N   + L +N++           S +  + L NN +               
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724

Query: 56  VRLPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL 114
                L  + L  N  +     F       LS +++S N FS   P    N   L+   +
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783

Query: 115 RDNYLTSSTPELSFL-SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS-NC 172
           R          L    + ++ C SL  + +  N +  +        L+  L    ++ N 
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE-----KLTPQLYILDIADNP 838

Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQK 211
           N+S  +      +       L  +K           +++
Sbjct: 839 NISIDVTSVCPYIEAG-MYVLLYDKTQDIRGCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 19/168 (11%), Positives = 47/168 (27%), Gaps = 2/168 (1%)

Query: 257 LASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNN 316
            A    L   +    S  +           N   +       +++ N   + G+  +   
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFG 334

Query: 317 FSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAI-PTSLEK 375
               +P  IG L  L+ L  G +    S      + ++        + +        L+ 
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394

Query: 376 LSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLP 423
              L   +L  + +    P        +  S +  ++   +  +  + 
Sbjct: 395 DQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  219 bits (559), Expect = 3e-63
 Identities = 83/410 (20%), Positives = 143/410 (34%), Gaps = 19/410 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP  + N  + E L+   N L          +  L  L L    +   +          
Sbjct: 26  EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHR 82

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+ L+L  N         +     L  L   Q   S        N + LE L L  N+++
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-SLKDFYMSNCNVSGGIP 179
           S              + L  +   +N +  + SK  + +L   +     ++  N   GI 
Sbjct: 143 SIKL-----PKGFPTEKLKVLDFQNNAIHYL-SKEDMSSLQQATNLSLNLNG-NDIAGIE 195

Query: 180 EEITNLTNSITIDLGGNKLNGSIP--ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
               +     +++ GG +    I   +  S +Q L     +D   E   P     L E+ 
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

Query: 238 --ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTG 295
              + L  +  F      F   + L+ L L++  L+ +P     L  + +L  S+N    
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN 315

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTE-IGGLKNLEYLFLGYNRLEGS--IPDSFGDL 352
              +   N   L  +    N     + T  +  L+NL  L L ++ +E S        +L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
             L+ LNLS N        + ++   LE L+L+F +L+        F N 
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNL 424

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  198 bits (506), Expect = 9e-56
 Identities = 80/407 (19%), Positives = 145/407 (35%), Gaps = 25/407 (6%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKL--LHLQNNSLLGCLSSIADVRLP 59
              +    + L+ LD ++N +       + ++       L+L  N + G      D    
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD--SA 202

Query: 60  NLEALLLWGNNFSGTIPRFIFNAS--KLSILELSQNSFSGFIPNTFGNLR--NLEWLNLR 115
             ++L   G      I + + N++   L +            P  F  L   ++E +NL+
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262

Query: 116 DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVS 175
            +Y  + +       +      L  + L+   L  + S   +  LS +LK   +S     
Sbjct: 263 KHYFFNISSN-----TFHCFSGLQELDLTATHLSELPS--GLVGLS-TLKKLVLSANKFE 314

Query: 176 GGIPEEITNLTNSITIDLGGNKLNGSI-PITLSKLQKLQGLGLDDNKLEGS--IPDSICR 232
                  +N  +   + + GN     +    L  L+ L+ L L  + +E S      +  
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL--TFWNLKDILQLNFSS 290
           L+ L  L L  N+        F     L +L L+   L        F NL  +  LN S 
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434

Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG---GLKNLEYLFLGYNRLEGSIPD 347
           + L          L  L  ++   N+F      +      L  LE L L +  L      
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494

Query: 348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
           +F  L  +  ++LS+N L+ +   +L  L  +  LNL+ N +   +P
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  185 bits (472), Expect = 4e-51
 Identities = 73/372 (19%), Positives = 129/372 (34%), Gaps = 19/372 (5%)

Query: 37  KLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFS 96
           K  + +N  L    + I      + E L    N               L+ L+L++    
Sbjct: 15  KTYNCENLGL----NEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 97  GFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS 156
               +TF +   L+ L L  N L           +LS  K+L  +      +  I     
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAET-----ALSGPKALKHLFFIQTGISSI-DFIP 124

Query: 157 IGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLG 216
           + N   +L+  Y+ + ++S     +         +D   N ++      +S LQ+   L 
Sbjct: 125 LHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183

Query: 217 LDDNKLE-GSIPDSICRLTELYELELGGNKLFGSIPA--CFSNLASLRILSLSSNELTSI 273
           L+ N  +   I            L  GG +    I      S + SL + +    +   I
Sbjct: 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243

Query: 274 -PLTFWNLKD--ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN 330
            P  F  L +  +  +N   ++              L  +D +  + S  +P+ + GL  
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLST 302

Query: 331 LEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT-SLEKLSYLEDLNLSFNKL 389
           L+ L L  N+ E     S  +  SL  L++  N     + T  LE L  L +L+LS + +
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362

Query: 390 EGEIPRGGSFGN 401
           E          N
Sbjct: 363 ETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  163 bits (415), Expect = 2e-43
 Identities = 75/361 (20%), Positives = 127/361 (35%), Gaps = 16/361 (4%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN 70
           ++E ++L+ +             S L+ L L    L    S +    L  L+ L+L  N 
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG--LSTLKKLVLSANK 312

Query: 71  FSGTIPRFIFNASKLSILELSQNSFSGFI-PNTFGNLRNLEWLNLRDNYLTSSTPELSFL 129
           F         N   L+ L +  N+    +      NL NL  L+L  + + +S       
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL-- 370

Query: 130 SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI-TNLTNS 188
             L N   L  ++LS N    +    +       L+   ++   +     +    NL   
Sbjct: 371 -QLRNLSHLQSLNLSYNEPLSL-KTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI---PDSICRLTELYELELGGNK 245
             ++L  + L+ S       L  LQ L L  N          +S+  L  L  L L    
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLK 305
           L       F++L  +  + LS N LTS  +   +    + LN +SN ++  LP  +  L 
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILS 547

Query: 306 VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNL 365
               I+   N               LE+      +LE +      +   L+ + LS+  L
Sbjct: 548 QQRTINLRQNPLDCTC--SNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603

Query: 366 S 366
           S
Sbjct: 604 S 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  113 bits (284), Expect = 2e-26
 Identities = 56/274 (20%), Positives = 94/274 (34%), Gaps = 41/274 (14%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
             L++ NL +L+ L+L +N+ +     A      L+LL L    L    +      L  L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFI---PNTFGNLRNLEWLNLRDNY 118
           + L L  +    +  +       L  L L  N F        N+   L  LE L L    
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L+S         + ++ K +  + LS N L                              
Sbjct: 488 LSSIDQH-----AFTSLKMMNHVDLSHNRLTSS--------------------------S 516

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
            E +++L   I ++L  N ++  +P  L  L + + + L  N L+ +     C      E
Sbjct: 517 IEALSHLKG-IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-----CSNIYFLE 570

Query: 239 -LELGGNKLFGSIPACFSNLASLRILSLSSNELT 271
             +    KL  +      N   LR + LS   L+
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  111 bits (280), Expect = 7e-26
 Identities = 47/204 (23%), Positives = 73/204 (35%), Gaps = 6/204 (2%)

Query: 217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PL 275
            ++  L   IP ++        LE   N L       FS L +L  L L+  ++  I   
Sbjct: 19  CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
           TF +   +  L  ++N L       +   K L  + F     SS+    +   K LE L+
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLE--DLNLSFNKLEGEI 393
           LG N +             LK L+  NN +       +  L       LNL+ N + G  
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195

Query: 394 PRGGSFGNFAAESFEGNELLCGSP 417
           P       F + +F G + L    
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIF 219

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (251), Expect = 3e-22
 Identities = 30/166 (18%), Positives = 54/166 (32%), Gaps = 6/166 (3%)

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGP 296
                   L   IP    N  S   L  S N L +I   TF  L ++  L+ +   +   
Sbjct: 16  TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK 356
                 +   L  +  + N    +  T + G K L++LF     +         +  +L+
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
            L L +N++S            L+ L+   N +           + 
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK--EDMSSL 176

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  215 bits (550), Expect = 6e-62
 Identities = 87/410 (21%), Positives = 145/410 (35%), Gaps = 30/410 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKL----LHLQNNSLLGCLSSIADV 56
           ++P   SNL NLE LDL  NK+       +  +  + L    L L  N +          
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--F 197

Query: 57  RLPNLEALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSG------FIPNTFGNLRNL 109
           +   L  L L  N  S  + +      + L +  L    F        F  +    L NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
                R  YL     ++      +   +++   L    ++ +   +      H      +
Sbjct: 258 TIEEFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH----LEL 311

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL--EGSIP 227
            NC        ++ +L       L      G    +   L  L+ L L  N L  +G   
Sbjct: 312 VNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366

Query: 228 DSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI--PLTFWNLKDILQ 285
            S    T L  L+L  N +   + + F  L  L  L    + L  +     F +L++++ 
Sbjct: 367 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425

Query: 286 LNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGS 344
           L+ S              L  L  +  + N+F      +I   L+NL +L L   +LE  
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485

Query: 345 IPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
            P +F  L SL+ LN+S+NN         + L+ L+ L+ S N +     
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  200 bits (510), Expect = 2e-56
 Identities = 80/411 (19%), Positives = 134/411 (32%), Gaps = 30/411 (7%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
                 +L +L  L L  N +      A   +S L+ L     +L   L +     L  L
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTL 126

Query: 62  EALLLWGNNF-SGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLE----WLNLRD 116
           + L +  N   S  +P +  N + L  L+LS N            L  +      L+L  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHS-----LKDFYMSN 171
           N +    P             L  + L +N     + KT I  L+       +   + + 
Sbjct: 187 NPMNFIQP------GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 172 CNVSGGIPEEITNLTNSITIDLGGNKLNGS---IPITLSKLQKLQGLGLDDNKLEGSIPD 228
            N+       +  L N    +     L+     I    + L  +    L    +E     
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300

Query: 229 SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNF 288
           S         LEL   K          +L  L   S           +  +L  +  L+ 
Sbjct: 301 S--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG----NAFSEVDLPSLEFLDL 354

Query: 289 SSNFLT--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP 346
           S N L+  G           L  +D S N   + + +   GL+ LE+L   ++ L+    
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 347 DS-FGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
            S F  L +L +L++S+ +   A       LS LE L ++ N  +      
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  192 bits (491), Expect = 1e-53
 Identities = 83/427 (19%), Positives = 148/427 (34%), Gaps = 39/427 (9%)

Query: 2   IPLEISNLQNLE----ELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR 57
              ++  L  +      LDL  N +    P A   +  L  L L+NN     +       
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQG 223

Query: 58  LPNLEALLLWGNNFSGT--IPRFIFNA-SKLSILELSQNSFS------GFIPNTFGNLRN 108
           L  LE   L    F     + +F  +A   L  L + +   +        I + F  L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 109 LEWLNLRDNYLTSSTPELSFLSSLSN---------------CKSLTFIHLSDNPLDGILS 153
           +   +L    +       S+     +                KSL  +  + N      S
Sbjct: 284 VSSFSLVSVTIERVKD-FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342

Query: 154 KTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQ 213
           +  + +L     D   +  +  G   +     T+   +DL  N +   +      L++L+
Sbjct: 343 EVDLPSLEFL--DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 399

Query: 214 GLGLDDNKLEGSIPDSI-CRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS 272
            L    + L+     S+   L  L  L++       +    F+ L+SL +L ++ N    
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 273 --IPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN 330
             +P  F  L+++  L+ S   L    P    +L  L  ++ S NNF S+       L +
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519

Query: 331 LEYLFLGYNRLEGSIPDSFGDLI-SLKFLNLSNNNLSGAIPTS--LEKLSYLEDLNLSFN 387
           L+ L    N +  S          SL FLNL+ N+ +        L+ +     L +   
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579

Query: 388 KLEGEIP 394
           ++E   P
Sbjct: 580 RMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  166 bits (422), Expect = 3e-44
 Identities = 72/368 (19%), Positives = 120/368 (32%), Gaps = 31/368 (8%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
              I D    + + L L  N          F+  +L +L+LS+          + +L +L
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
             L L  N + S         + S   SL  +   +  L  + +   IG+L  +LK+  +
Sbjct: 79  STLILTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLEN-FPIGHLK-TLKELNV 131

Query: 170 SNCNVSGG-IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQ----GLGLDDNKLEG 224
           ++  +    +PE  +NLTN   +DL  NK+       L  L ++      L L  N +  
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTS-------IPLT 276
            I     +   L++L L  N    ++   C   LA L +  L   E  +           
Sbjct: 192 -IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 277 FWNLKDILQLNFSSNFL---TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEY 333
              L ++    F   +L      +      L  +            V           ++
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308

Query: 334 LFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEI 393
           L L   +           L  L F +    N       S   L  LE L+LS N L  + 
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKG 363

Query: 394 PRGGSFGN 401
               S   
Sbjct: 364 CCSQSDFG 371

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (255), Expect = 7e-23
 Identities = 29/150 (19%), Positives = 50/150 (33%), Gaps = 4/150 (2%)

Query: 253 CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDF 312
           C   + ++            IP           L+ S N L         +   L  +D 
Sbjct: 3   CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 313 SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTS 372
           S     ++       L +L  L L  N ++     +F  L SL+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 373 LEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
           +  L  L++LN++ N ++        F N 
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNL 148

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (251), Expect = 2e-22
 Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 4/180 (2%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
             +L+NL  LD+ H             +S L++L +  NS            L NL  L 
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L         P    + S L +L +S N+F       +  L +L+ L+   N++ +S   
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK- 535

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
              L       SL F++L+ N         S        +   +    +    P +   +
Sbjct: 536 -QELQHF--PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  192 bits (490), Expect = 4e-56
 Identities = 66/168 (39%), Positives = 90/168 (53%), Gaps = 4/168 (2%)

Query: 479 WRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKS-FAV 537
            + FS  EL  A++ FS  N++GRGGFG VYK RL DG  VAVK    +  +  +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 538 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---SSNCILDIFQRLNI 594
           E EM+    HRNL+++   C     + LV  Y  +GS+   L     S   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +  A  L YLH  C   +IH D+K  N+LLD+   A + DFG+AKL+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  190 bits (486), Expect = 1e-55
 Identities = 61/170 (35%), Positives = 88/170 (51%), Gaps = 6/170 (3%)

Query: 480 RTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVEC 539
                ++L  ATN F    LIG G FG VYK  L DG +VA+K    +  +  + F  E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 540 EMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMI 596
           E +   RH +L+ +I  C       L+ +Y  +G+L+++LY S+     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             A  L YLH      +IH D+K  N+LLD+N V  ++DFGI+K     D
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  190 bits (485), Expect = 9e-53
 Identities = 91/414 (21%), Positives = 150/414 (36%), Gaps = 29/414 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           ++P +I +  + + +DL  N L      +  N S L+ L L    +   +   A   L +
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHH 81

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  L+L GN      P      + L  L   +   +       G L  L+ LN+  N++ 
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKT--SIGNLSHSLKDFYMSNCNVSGGI 178
           S        +  SN  +L  + LS N +  I       +           MS   +   I
Sbjct: 142 S----CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FI 196

Query: 179 PEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGL------DDNKLEGSIPDSIC 231
            ++         + L GN  + +I    L  L  L    L      D+  LE   P  + 
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256

Query: 232 RLTELY--ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFS 289
            L ++   E  L     F      F  LA++  +SL+   +  +            L+  
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSII 315

Query: 290 SNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSF 349
              L     L++  LK L     +MN  S  I  +   L +L YL L  N L  S   S+
Sbjct: 316 RCQLKQFPTLDLPFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSY 370

Query: 350 GDL--ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
            DL   SL+ L+LS N     +  +   L  L+ L+   + L+  +    +F +
Sbjct: 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  185 bits (471), Expect = 7e-51
 Identities = 78/422 (18%), Positives = 132/422 (31%), Gaps = 41/422 (9%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKL----LHLQNNSLLGCLSSIADV 56
           ++P   SNL NL  +DL +N +       +  +         L +  N +          
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--F 201

Query: 57  RLPNLEALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSG------FIPNTFGNLRNL 109
           +   L  L L GN  S  I +      + L +  L    F        F P+    L ++
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH------- 162
                R  Y    + ++     L+N   ++ + L+   +  +                  
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLAN---VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQ 318

Query: 163 ----------SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQ-- 210
                      LK   ++    S  I  +   L +   +DL  N L+ S   + S L   
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 211 KLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNE 269
            L+ L L  N     +  +   L EL  L+   + L        F +L  L  L +S   
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435

Query: 270 LTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGG 327
                   F  L  +  L  + N         +  N   L  +D S      +       
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495

Query: 328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
           L  L+ L + +N L       +  L SL  L+ S N +  +          L   NL+ N
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555

Query: 388 KL 389
            +
Sbjct: 556 SV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  124 bits (313), Expect = 6e-30
 Identities = 54/289 (18%), Positives = 96/289 (33%), Gaps = 20/289 (6%)

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLT 186
           S    +    ++T+    D  L  +       ++  S K+  +S   +        +N +
Sbjct: 3   SLNPCIEVVPNITY-QCMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKL 246
               +DL   ++          L  L  L L  N ++   P S   LT L  L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 247 FGSIPACFSNLASLRILSLSSNELTSIPL--TFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
                     L +L+ L+++ N + S  L   F NL +++ ++ S N++      ++  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 305 K----VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLN 359
           +    V + +D S+N     I  +      L  L L  N    +I      +L  L    
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235

Query: 360 LS------NNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
           L         NL    P+ +E L  +                   F   
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 99.0 bits (247), Expect = 7e-22
 Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 4/154 (2%)

Query: 248 GSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVL 307
           GS+  C   + ++        +L+ +P           ++ S N L         N   L
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58

Query: 308 IGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG 367
             +D S     ++      GL +L  L L  N ++   P SF  L SL+ L      L+ 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 368 AIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
                + +L  L+ LN++ N +         F N
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 28/144 (19%), Positives = 49/144 (34%), Gaps = 5/144 (3%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
             +L+ L  LD+ +             ++ L  L +  NS      S       NL  L 
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L                 +L +L +S N+      + +  L +L  L+   N + +S   
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG- 538

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
                     KSL F +L++N + 
Sbjct: 539 ----ILQHFPKSLAFFNLTNNSVA 558

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  185 bits (473), Expect = 3e-52
 Identities = 91/404 (22%), Positives = 160/404 (39%), Gaps = 46/404 (11%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
            + L    +  L    +  TV     ++  +  L      +   +  +    L NL  + 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVE--YLNNLTQIN 74

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP- 124
              N  +   P  + N +KL  + ++ N  +   P    NL NL  L L +N +T   P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL 130

Query: 125 --------------ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS 170
                          +S +S+LS   SL  +   +     +     + NL+ +L+   +S
Sbjct: 131 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ----VTDLKPLANLT-TLERLDIS 185

Query: 171 NCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI 230
           +  VS      +  LTN  ++    N+++   P  L  L  L  L L+ N+L+     ++
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTL 239

Query: 231 CRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSS 290
             LT L +L+L  N++    P   S L  L  L L +N++++I      L  +  L  + 
Sbjct: 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNE 296

Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFG 350
           N L    P  I NLK L  +    NN S + P  +  L  L+ LF   N++      S  
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLA 350

Query: 351 DLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
           +L ++ +L+  +N +S   P  L  L+ +  L L+         
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  170 bits (434), Expect = 9e-47
 Identities = 85/386 (22%), Positives = 157/386 (40%), Gaps = 36/386 (9%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
            + NL  L ++ + +N++       + N++ L  L L NN +   +  + +  L NL  L
Sbjct: 85  PLKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD-IDPLKN--LTNLNRL 139

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L  N  S      +   + L  L    N  +   P    NL  LE L++  N ++    
Sbjct: 140 ELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--- 191

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
               +S L+   +L  +  ++N +  I   T +G L+ +L +  ++   +       + +
Sbjct: 192 ----ISVLAKLTNLESLIATNNQISDI---TPLGILT-NLDELSLNGNQLKD--IGTLAS 241

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
           LTN   +DL  N+++   P  LS L KL  L L  N++    P  +  LT L  LEL  N
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 297

Query: 245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
           +L    P   SNL +L  L+L  N ++ I     +L  + +L F +N ++    L   NL
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFYNNKVSDVSSL--ANL 352

Query: 305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN 364
             +  +    N  S + P  +  L  +  L L       +  +   ++     +      
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

Query: 365 LSGAIPTSLEKLSYLEDLNLSFNKLE 390
           L    P ++       + ++++N   
Sbjct: 411 LI--APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  130 bits (329), Expect = 1e-32
 Identities = 65/320 (20%), Positives = 126/320 (39%), Gaps = 28/320 (8%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLE 62
              ++NL  LE LD+  NK+  +  + +  ++ L+ L   NN +   ++ +    L NL+
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISD-ITPLGI--LTNLD 224

Query: 63  ALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS 122
            L L GN         + + + L+ L+L+ N  S   P     L  L  L L  N +++ 
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN- 279

Query: 123 TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI 182
                 +S L+   +LT + L++N L+ I   + I NL  +L    +   N+S      +
Sbjct: 280 ------ISPLAGLTALTNLELNENQLEDI---SPISNLK-NLTYLTLYFNNISD--ISPV 327

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
           ++LT    +    NK++     +L+ L  +  L    N++    P  +  LT + +L L 
Sbjct: 328 SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
                 +     +N+ S+     +       P T  +     + + + N  +        
Sbjct: 384 DQAWTNAPVNYKANV-SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSY 441

Query: 303 NLKVLIGIDFSMNNFSSVIP 322
                + I      FS  + 
Sbjct: 442 TFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  128 bits (324), Expect = 5e-32
 Identities = 68/281 (24%), Positives = 114/281 (40%), Gaps = 23/281 (8%)

Query: 114 LRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCN 173
           L    +T  TP ++ + + +         L    +   +S+T +      +         
Sbjct: 3   LGSATITQDTP-INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQ----VTTLQADRLG 57

Query: 174 VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRL 233
           +     + +  L N   I+   N+L    P  L  L KL  + +++N++    P  +  L
Sbjct: 58  IK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111

Query: 234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFL 293
           T L  L L  N++    P    NL +L  L LSSN ++ I      L  + QL+F +   
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSFGNQVT 168

Query: 294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
                  + NL  L  +D S N  S +    +  L NLE L    N++    P   G L 
Sbjct: 169 D---LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILT 221

Query: 354 SLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
           +L  L+L+ N L      +L  L+ L DL+L+ N++    P
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  178 bits (454), Expect = 1e-50
 Identities = 77/379 (20%), Positives = 155/379 (40%), Gaps = 34/379 (8%)

Query: 12  LEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNF 71
              L      +    P    +++      LQ  S+   + +  +  L ++  L++ G   
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-VVTQEE--LESITKLVVAGEKV 56

Query: 72  SGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSS 131
           + +I   I   + L  L L+ N  +   P    NL  L  L +  N +T        +S+
Sbjct: 57  A-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISA 105

Query: 132 LSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITI 191
           L N  +L  ++L+++ +  I   + + NL+  +    +   +        ++N+T    +
Sbjct: 106 LQNLTNLRELYLNEDNISDI---SPLANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYL 160

Query: 192 DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP 251
            +  +K+    PI  + L  L  L L+ N++E   P  +  LT L+      N++    P
Sbjct: 161 TVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216

Query: 252 ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGID 311
              +N+  L  L + +N++T +     NL  +  L   +N ++    +   +L  L  ++
Sbjct: 217 --VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLN 271

Query: 312 FSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT 371
              N  S +    +  L  L  LFL  N+L     +  G L +L  L LS N+++   P 
Sbjct: 272 VGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328

Query: 372 SLEKLSYLEDLNLSFNKLE 390
            L  LS ++  + +   ++
Sbjct: 329 -LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (420), Expect = 5e-46
 Identities = 87/359 (24%), Positives = 150/359 (41%), Gaps = 32/359 (8%)

Query: 36  LKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSF 95
              L      +   +   AD  L      +L   + +  +         ++ L ++    
Sbjct: 2   AATLATLPAPI-NQIFPDAD--LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56

Query: 96  SGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKT 155
           +         L NLE+LNL  N +T        +S LSN   LT +++  N +  I   +
Sbjct: 57  ASIQG--IEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITDI---S 104

Query: 156 SIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGL 215
           ++ NL+ +L++ Y++  N+S      + NLT   +++LG N    S    LS +  L  L
Sbjct: 105 ALQNLT-NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYL 160

Query: 216 GLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL 275
            + ++K++   P  I  LT+LY L L  N++    P   ++L SL   +   N++T I  
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT- 215

Query: 276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
              N+  +  L   +N +T   PL   NL  L  ++   N  S +    +  L  L+ L 
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISDINA--VKDLTKLKMLN 271

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
           +G N++         +L  L  L L+NN L       +  L+ L  L LS N +    P
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (396), Expect = 1e-42
 Identities = 69/315 (21%), Positives = 130/315 (41%), Gaps = 29/315 (9%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
           + ++     L + S +  +      L ++  L +    + S       +  +    +L +
Sbjct: 20  DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-------IQGIEYLTNLEY 70

Query: 141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG 200
           ++L+ N +  I   + + NL   L + Y+    ++      + NLTN   + L  + ++ 
Sbjct: 71  LNLNGNQITDI---SPLSNLV-KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL 260
             P  L+ L K+  L L  N    S    +  +T L  L +  +K+    P   +NL  L
Sbjct: 125 ISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179

Query: 261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV 320
             LSL+ N++  I     +L  +       N +T   P+   N+  L  +    N  + +
Sbjct: 180 YSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDL 236

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLE 380
            P  +  L  L +L +G N++     ++  DL  LK LN+ +N +S    + L  LS L 
Sbjct: 237 SP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290

Query: 381 DLNLSFNKLEGEIPR 395
            L L+ N+L  E   
Sbjct: 291 SLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (385), Expect = 4e-41
 Identities = 75/362 (20%), Positives = 142/362 (39%), Gaps = 76/362 (20%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
            I  L NLE L+L  N++  T  + + N+  L  L++  N +   +S++ +  L NL  L
Sbjct: 61  GIEYLTNLEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKITD-ISALQN--LTNLREL 115

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L  +N S   P  + N +K+  L L  N     +     N+  L +L + ++ +     
Sbjct: 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD--- 169

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
               ++ ++N   L  + L+ N ++ I                              + +
Sbjct: 170 ----VTPIANLTDLYSLSLNYNQIEDI----------------------------SPLAS 197

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
           LT+        N++    P  ++ + +L  L + +NK+    P  +  L++L  LE+G N
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253

Query: 245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
           ++   I A   +L  L++L++ SN+++ I                           + NL
Sbjct: 254 QI-SDINA-VKDLTKLKMLNVGSNQISDIS-------------------------VLNNL 286

Query: 305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN 364
             L  +  + N   +     IGGL NL  LFL  N +    P     L  +   + +N  
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

Query: 365 LS 366
           + 
Sbjct: 345 IK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  116 bits (292), Expect = 2e-28
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 22/223 (9%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
                +SN+  L  L +  +K+       I N++ L  L L  N +   +S +A   L +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIED-ISPLAS--LTS 200

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L     + N  +   P  + N ++L+ L++  N  +   P    NL  L WL +  N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
                   ++++ +   L  +++  N +  I   + + NLS  L   +++N  +     E
Sbjct: 257 D-------INAVKDLTKLKMLNVGSNQISDI---SVLNNLS-QLNSLFLNNNQLGNEDME 305

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLE 223
            I  LTN  T+ L  N +    P  L+ L K+      +  ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (420), Expect = 4e-46
 Identities = 51/330 (15%), Positives = 112/330 (33%), Gaps = 29/330 (8%)

Query: 73  GTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSL 132
           G+      ++S    L    ++      +     +     +    +        +     
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 133 SN-CKSLTFIHLSDNPLDGILSKTSIGNLSH-SLKDFYMSNCNVSGGIPEEITNLTNSIT 190
           +   ++L                  + + +        + +  +    P++   L++   
Sbjct: 62  TRTGRALKATA------------DLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQH 108

Query: 191 IDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI 250
           + +    L   +P T+ +   L+ L L  N L  ++P SI  L  L EL +        +
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166

Query: 251 PACFSN---------LASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEI 301
           P   ++         L +L+ L L    + S+P +  NL+++  L   ++ L+  L   I
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAI 225

Query: 302 GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL-GYNRLEGSIPDSFGDLISLKFLNL 360
            +L  L  +D          P   GG   L+ L L   + L  ++P     L  L+ L+L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDL 284

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
                   +P+ + +L     + +  +   
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  156 bits (396), Expect = 8e-43
 Identities = 56/374 (14%), Positives = 105/374 (28%), Gaps = 61/374 (16%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
              +    E L  + +  +      +                    ++       N +  
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SNNPQIE 61

Query: 65  LLWGNNFSGTIPRFIFNAS--KLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS 122
              G          + +A+      LEL         P+    L +L+ + +    L   
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 123 TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI 182
                   ++     L  + L+ NPL  + +  SI +L+  L++  +  C     +PE +
Sbjct: 119 -----LPDTMQQFAGLETLTLARNPLRALPA--SIASLN-RLRELSIRACPELTELPEPL 170

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
            +                        L  LQ L L+   +  S+P SI  L  L  L++ 
Sbjct: 171 AST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
            + L  ++     +L  L  L L                           L    P   G
Sbjct: 215 NSPLS-ALGPAIHHLPKLEELDLRGC----------------------TALRN-YPPIFG 250

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN 362
               L  +     +    +P +I  L  LE L L        +P     L +   + +  
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 363 N---NLSGAIPTSL 373
           +    L    P + 
Sbjct: 311 HLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (372), Expect = 1e-39
 Identities = 62/303 (20%), Positives = 106/303 (34%), Gaps = 29/303 (9%)

Query: 104 GNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHS 163
            +    E L  + +       +      LS  +       +        S     N +  
Sbjct: 9   HHSSGRENLYFQGSTALRPYHD-----VLSQWQRHYNADRN-----RWHSAWRQANSN-- 56

Query: 164 LKDFYMSNCNVSGGIPEEITNLT--NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
                           + + + T    + ++L    L    P    +L  LQ + +D   
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 222 LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS-NELTSIP------ 274
           L   +PD++ +   L  L L  N L  ++PA  ++L  LR LS+ +  ELT +P      
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 275 ---LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNL 331
                   L ++  L      +   LP  I NL+ L  +    +  S+ +   I  L  L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231

Query: 332 EYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG 391
           E L L       + P  FG    LK L L + +    +P  + +L+ LE L+L       
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 392 EIP 394
            +P
Sbjct: 292 RLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  130 bits (330), Expect = 9e-34
 Identities = 56/276 (20%), Positives = 100/276 (36%), Gaps = 38/276 (13%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
           LE +       L+LR   L    P   F +S L+ + +    L                 
Sbjct: 75  LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL----------------- 116

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
                      +P  +   + L  L L++N     +P +  +L  L  L++R     +  
Sbjct: 117 ---------MELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTEL 166

Query: 124 PE----LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           PE               +L  + L    +  + +  SI NL  +LK   + N  +S  + 
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPA--SIANLQ-NLKSLKIRNSPLS-ALG 222

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD-NKLEGSIPDSICRLTELYE 238
             I +L     +DL G     + P        L+ L L D + L  ++P  I RLT+L +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP 274
           L+L G      +P+  + L +  I+ +  +    + 
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  110 bits (277), Expect = 1e-26
 Identities = 43/247 (17%), Positives = 81/247 (32%), Gaps = 52/247 (21%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCL-SSIADVRLP 59
           E+P  +     LE L L  N L   +PA+I +++ L+ L ++    L  L   +A     
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
                L                   L  L L        +P +  NL+NL+ L +R++ L
Sbjct: 177 GEHQGL-----------------VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           ++  P                               +I +L   L++  +  C      P
Sbjct: 219 SALGP-------------------------------AIHHL-PKLEELDLRGCTALRNYP 246

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
                      + L       ++P+ + +L +L+ L L        +P  I +L     +
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306

Query: 240 ELGGNKL 246
            +  +  
Sbjct: 307 LVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 24/126 (19%), Positives = 39/126 (30%), Gaps = 25/126 (19%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +   I +L  LEELDLR    +   P      + LK L L++ S L             
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL------------- 266

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
                        T+P  I   ++L  L+L        +P+    L     + +  +   
Sbjct: 267 ------------LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

Query: 121 SSTPEL 126
                 
Sbjct: 315 QLDQHR 320

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  162 bits (413), Expect = 2e-45
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 16/179 (8%)

Query: 480 RTFSYLELCRATNGFSE------NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-- 531
            +FS+ EL   TN F E       N +G GGFG VYK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 532 --FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY--SSNCILD 587
              + F  E ++M   +H NL++++   S+ +   LV  Y P+GSL   L        L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 588 IFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+      
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  167 bits (425), Expect = 9e-45
 Identities = 89/421 (21%), Positives = 150/421 (35%), Gaps = 41/421 (9%)

Query: 3   PLEISNLQNLEELDLRHNKL-VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
              I +L+ L+EL++ HN +    +P    N++ L+ L L +N +   +       L  +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQM 175

Query: 62  EALLLW---GNNFSGTIPRFIFNASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDN 117
             L L      N    I    F   +L  L L  N  S  +       L  LE   L   
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235

Query: 118 YLTSSTPELSF-LSSLSNCKSLTFIHLSDNPLDGILSK---------------------T 155
              +      F  S+L    +LT        LD  L                        
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

Query: 156 SIGNLSH--SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQ 213
            + + S+    +   + NC        ++ +L     +    NK   +   +   L  L+
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNAF--SEVDLPSLE 350

Query: 214 GLGLDDNKLE--GSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT 271
            L L  N L   G    S    T L  L+L  N +  ++ + F  L  L  L    + L 
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409

Query: 272 SIP--LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGL 328
            +     F +L++++ L+ S              L  L  +  + N+F      +I   L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 329 KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK 388
           +NL +L L   +LE   P +F  L SL+ LN+++N L        ++L+ L+ + L  N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529

Query: 389 L 389
            
Sbjct: 530 W 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  164 bits (418), Expect = 6e-44
 Identities = 80/397 (20%), Positives = 148/397 (37%), Gaps = 23/397 (5%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
           S L +L++L      L       I ++  LK L++ +N +           L NLE L L
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 67  WGNNFSGTIPRFIFNASKLSI----LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS 122
             N         +    ++ +    L+LS N  +   P  F  +  L  L LR+N+ + +
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLN 215

Query: 123 TPELSF--LSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG-GIP 179
             +     L+ L   + +     ++  L+        G  + ++++F ++  +     I 
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275

Query: 180 EEITNLTNSITIDLGGNKLNGSIPIT-LSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
           +    LTN  +  L    +      +     Q L+ +     +          +L  L  
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF------PTLKLKSLKR 329

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT---FWNLKDILQLNFSSNFLTG 295
           L    NK  G+  +   +L SL  L LS N L+         +    +  L+ S N +  
Sbjct: 330 LTFTSNKG-GNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFGDLIS 354
            +      L+ L  +DF  +N   +    +   L+NL YL + +     +    F  L S
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 355 LKFLNLSNNNLSGAIPT-SLEKLSYLEDLNLSFNKLE 390
           L+ L ++ N+           +L  L  L+LS  +LE
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  162 bits (413), Expect = 3e-43
 Identities = 85/415 (20%), Positives = 149/415 (35%), Gaps = 30/415 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           +IP  +    + + LDL  N L      + F+   L++L L    +   +   A   L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH 77

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  L+L GN             S L  L   + + +       G+L+ L+ LN+  N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKT--SIGNLSHSLKDFYMSNCNVSGGI 178
           S           SN  +L  + LS N +  I       +  +        +S   ++  I
Sbjct: 138 S----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPIT-LSKLQKLQGLGL------DDNKLEGSIPDSIC 231
                       + L  N  + ++  T +  L  L+   L      ++  LE     ++ 
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 232 RLTELYELELGGNKL---FGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNF 288
            L  L   E     L      I   F+ L ++   SL S  +  +    +N      L  
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG-WQHLEL 311

Query: 289 SSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE--GSIP 346
            +        L++ +LK L    F+ N   +        L +LE+L L  N L   G   
Sbjct: 312 VNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCS 366

Query: 347 DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
            S     SLK+L+LS N +   + ++   L  LE L+   + L+ ++     F +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  141 bits (358), Expect = 6e-36
 Identities = 80/400 (20%), Positives = 138/400 (34%), Gaps = 44/400 (11%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKL----LHLQNNSLLGCLSSIADV- 56
           +P   SNL NLE LDL  NK+       +  +  + L    L L  N +    + I    
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM----NFIQPGA 196

Query: 57  -RLPNLEALLLWGNNFSGTIPRFIFNA-SKLSILEL------SQNSFSGFIPNTFGNLRN 108
            +   L  L L  N  S  + +      + L +  L      ++ +   F  +    L N
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 109 LEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH------ 162
           L     R  YL     ++      +   +++   L    ++ +   +      H      
Sbjct: 257 LTIEEFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314

Query: 163 -----------SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLN--GSIPITLSKL 209
                      SLK    ++ N  G    E+ +L +   +DL  N L+  G    +    
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 210 QKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPAC-FSNLASLRILSLSSN 268
             L+ L L  N +  ++  +   L +L  L+   + L        F +L +L  L +S  
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 269 ELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIG 326
                    F  L  +  L  + N        +I   L+ L  +D S      + PT   
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 327 GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS 366
            L +L+ L +  N+L+      F  L SL+ + L  N   
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  129 bits (327), Expect = 5e-32
 Identities = 85/383 (22%), Positives = 136/383 (35%), Gaps = 59/383 (15%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
              I D    + + L L  N          F+  +L +L+LS+          + +L +L
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
             L L  N + S           S   SL  +   +  L   L    IG+L  +LK+  +
Sbjct: 79  STLILTGNPIQSLALGA-----FSGLSSLQKLVAVETNLAS-LENFPIGHLK-TLKELNV 131

Query: 170 S-NCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQG----LGLDDNKLEG 224
           + N   S  +PE  +NLTN   +DL  NK+       L  L ++      L L  N +  
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTS----------- 272
            I     +   L++L L  N    ++   C   LA L +  L   E  +           
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 273 -----------------------IPLTFWNLKDILQLNFSSNFLTGPLPLEI-GNLKVLI 308
                                  I   F  L ++   +  S  +            + L 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 309 GIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS-- 366
            ++     F ++       LK+L+ L    N+   +   S  DL SL+FL+LS N LS  
Sbjct: 311 LVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFK 362

Query: 367 GAIPTSLEKLSYLEDLNLSFNKL 389
           G    S    + L+ L+LSFN +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGV 385

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  123 bits (311), Expect = 6e-30
 Identities = 64/371 (17%), Positives = 112/371 (30%), Gaps = 49/371 (13%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGC--LSSIADVR 57
            I         L +L LR+N     V       ++ L++  L          L       
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 58  LPNLEALLLWGNN------FSGTIPRFIFNASKLSILELSQNSFSGFIPNTF-GNLRNLE 110
           L  L  L +          +   I       + +S   L   +       ++    ++LE
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 111 WLNLRDNYLTSSTPE-----------LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN 159
            +N +     +   +                S  +  SL F+ LS N L      +    
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLD 218
            + SLK   +S   V   +      L     +D   + L           L+ L  L + 
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 219 DNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LT 276
                 +       L+ L  L++ GN    +     F+ L +L  L LS  +L  +    
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 277 FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
           F +L                      +L+VL   + + N   SV       L +L+ ++L
Sbjct: 490 FNSLS---------------------SLQVL---NMASNQLKSVPDGIFDRLTSLQKIWL 525

Query: 337 GYNRLEGSIPD 347
             N  + S P 
Sbjct: 526 HTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 83.2 bits (206), Expect = 7e-17
 Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 5/138 (3%)

Query: 265 LSSNELTSIPLT-FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 323
                   IP    ++ K    L+ S N L         +   L  +D S     ++   
Sbjct: 14  CMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 324 EIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLN 383
               L +L  L L  N ++     +F  L SL+ L     NL+      +  L  L++LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 384 LSFNKLEGEIPRGGSFGN 401
           ++ N ++        F N
Sbjct: 131 VAHNLIQ-SFKLPEYFSN 147

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 30/124 (24%), Positives = 46/124 (37%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            +L+NL  LD+ H             +S L++L +  NS            L NL  L L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
                    P    + S L +L ++ N         F  L +L+ + L  N    S P +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

Query: 127 SFLS 130
            +LS
Sbjct: 538 DYLS 541

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (428), Expect = 3e-44
 Identities = 90/424 (21%), Positives = 148/424 (34%), Gaps = 42/424 (9%)

Query: 7   SNLQNLEELDLRHNKLVGTV--PAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
             L +L EL L    L   V       N+  L  L L  N +       +  +L +L+++
Sbjct: 94  QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153

Query: 65  LLWGNNFSGTIPRFIFN---ASKLSILELSQNSFSGFIPNTFGNLRN------LEWLNLR 115
               N     +            LS   L+ NS    +   +G   N      LE L++ 
Sbjct: 154 DFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212

Query: 116 DNYLTSSTPELSF-------LSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFY 168
            N  T                 SL     +       + +      T  G    S++   
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272

Query: 169 MSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD 228
           +S+  V          L +   ++L  NK+N         L  LQ L L  N L      
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 229 SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP---------LTFWN 279
           +   L ++  ++L  N +       F  L  L+ L L  N LT+I          L+   
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNK 392

Query: 280 LKDILQLNFSSNFL--------TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKN 330
           L  + ++N ++N +           +   +  +  L  +  + N FSS    +      +
Sbjct: 393 LVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452

Query: 331 LEYLFLGYNRLEGSI-----PDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS 385
           LE LFLG N L+ +       D F  L  L+ L L++N L+   P     L+ L  L+L+
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512

Query: 386 FNKL 389
            N+L
Sbjct: 513 SNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (428), Expect = 3e-44
 Identities = 88/396 (22%), Positives = 142/396 (35%), Gaps = 36/396 (9%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
             L   E L L  N +     ++   +  L+LL L +      +   A   LPNL  L L
Sbjct: 21  QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 67  WGNNFSGTIPRFIF-NASKLSILELSQNSFSGFI--PNTFGNLRNLEWLNLRDNYLTSST 123
             +     +    F     L  L L     S  +     F NL+ L  L+L  N + S  
Sbjct: 81  GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-SLKDFYMSNCNVSGGIPEEI 182
              SF        SL  I  S N +  +  +  +  L   +L  F ++  ++   +  + 
Sbjct: 140 LHPSF----GKLNSLKSIDFSSNQIFLV-CEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 183 TNLTNSI------TIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
               N         +D+ GN     I             G   N +  S   S+     +
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDIT------------GNFSNAISKSQAFSLILAHHI 242

Query: 237 YELELGGNKLFGSIPACFSNLA--SLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFL 293
                G + +       F+ LA  S+R L LS   + S+    F  LKD+  LN + N +
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302

Query: 294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
                     L  L  ++ S N    +  +   GL  + Y+ L  N +      +F  L 
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 354 SLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
            L+ L+L +N L     T++  +  + D+ LS NKL
Sbjct: 363 KLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  145 bits (368), Expect = 1e-36
 Identities = 90/443 (20%), Positives = 159/443 (35%), Gaps = 49/443 (11%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKL--LHLQNNSL-----LGCLSSI 53
            +      L +L+ +D   N++       +  +    L    L  NSL     +     +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 54  ADVRLPNLEALLLWGNNFSGTIPRFIFNA------------SKLSILELSQNSFSGFIPN 101
              R   LE L + GN ++  I     NA              +       ++      N
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258

Query: 102 TFGNLR--NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN 159
           TF  L   ++  L+L   ++ S              K L  ++L+ N ++ I +  +   
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLKDLKVLNLAYNKINKI-ADEAFYG 312

Query: 160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD 219
           L  +L+   +S   +          L     IDL  N +      T   L+KLQ L L D
Sbjct: 313 LD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT--F 277
           N L      +I  +  + ++ L GNKL        +      ++ LS N L ++ +    
Sbjct: 372 NALT-----TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFL 422

Query: 278 WNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-----GGLKNL 331
             +  +  L  + N  +             L  +    N       TE+      GL +L
Sbjct: 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482

Query: 332 EYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG 391
           + L+L +N L    P  F  L +L+ L+L++N L+      L   + LE L++S N+L  
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL-- 538

Query: 392 EIPRGGSFGNFAAESFEGNELLC 414
             P    F + +      N+ +C
Sbjct: 539 LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 83.7 bits (207), Expect = 6e-17
 Identities = 38/146 (26%), Positives = 54/146 (36%), Gaps = 7/146 (4%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
             RI       LT +P     L    +L  S N++          L+ L  ++       
Sbjct: 5   DGRIAFYRFCNLTQVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61

Query: 319 SVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAI--PTSLEK 375
             I  E    L NL  L LG +++    PD+F  L  L  L L    LS A+        
Sbjct: 62  LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

Query: 376 LSYLEDLNLSFNKLEGEIPRGGSFGN 401
           L  L  L+LS N++   +    SFG 
Sbjct: 122 LKALTRLDLSKNQIR-SLYLHPSFGK 146

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 61/279 (21%), Positives = 102/279 (36%), Gaps = 30/279 (10%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
            I  + ++ ++ L  NKLV T+P          L+HL  N L         +R+P+L+ L
Sbjct: 376 TIHFIPSIPDIFLSGNKLV-TLPKINLT---ANLIHLSENRLENLDILYFLLRVPHLQIL 431

Query: 65  LLWGNNFSGTIPRFIFNA-SKLSILELSQNSF-----SGFIPNTFGNLRNLEWLNLRDNY 118
           +L  N FS        +    L  L L +N       +    + F  L +L+ L L  NY
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L S  P +      S+  +L  + L+ N L  +    S  +L  +L+   +S   +    
Sbjct: 492 LNSLPPGV-----FSHLTALRGLSLNSNRLTVL----SHNDLPANLEILDISRNQLLAPN 542

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
           P+   +L+    +D+  NK              L       N    +I      +  +Y 
Sbjct: 543 PDVFVSLS---VLDITHNKFICECE--------LSTFINWLNHTNVTIAGPPADIYCVYP 591

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTF 277
               G  LF            L+ L  S   + ++ LT 
Sbjct: 592 DSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTL 630

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  162 bits (413), Expect = 3e-43
 Identities = 84/418 (20%), Positives = 147/418 (35%), Gaps = 37/418 (8%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            +L +LE LDL  N L     +    +S LK L+L  N       +     L NL+ L +
Sbjct: 71  YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130

Query: 67  WGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
                   I R  F   + L+ LE+   S   +   +  ++R++  L L  +        
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE- 189

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGI-LSKTSIGNLSHSLKDFYMSNCNVSGG------- 177
                      S+ ++ L D  L     S   +  +S  +K        ++         
Sbjct: 190 ----IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQK--------LQGLGLDDNKLEGSIPDS 229
           +   I  L+     D   N L    P     + +        ++ L +    L   +   
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 230 ICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT----FWNLKDILQ 285
              L ++  + +  +K+F    +   +L SL  L LS N +    L           +  
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365

Query: 286 LNFSSNFLT--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG 343
           L  S N L         +  LK L  +D S N F   +P      + + +L L    +  
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR- 423

Query: 344 SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
            +        +L+ L++SNNNL  +    L +   L++L +S NKL+  +P    F  
Sbjct: 424 VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  153 bits (389), Expect = 3e-40
 Identities = 75/425 (17%), Positives = 148/425 (34%), Gaps = 50/425 (11%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
              L +L+ L+L  N        ++F N++ L+ L + N      +  I    L +L  L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS--- 121
            +   +      + + +   +  L L  +  +  +      L ++ +L LRD  L     
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 122 --------------------STPELSF---LSSLSNCKSLTFIHLSDNPLDGI--LSKTS 156
                                  + SF   L  L     L+ +   D  L+G+   + + 
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273

Query: 157 IGNLSH-------SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKL 209
              +S        +++  ++    +   +    + L     I +  +K+          L
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL 333

Query: 210 QKLQGLGLDDNKLEGSIPDS---ICRLTELYELELGGNKL--FGSIPACFSNLASLRILS 264
           + L+ L L +N +      +         L  L L  N L            L +L  L 
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393

Query: 265 LSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE 324
           +S N    +P +    + +  LN SS  +     ++    + L  +D S NN  S     
Sbjct: 394 ISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLDSFSL-- 448

Query: 325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNL 384
              L  L+ L++  N+L+ ++PD+      L  + +S N L        ++L+ L+ + L
Sbjct: 449 --FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504

Query: 385 SFNKL 389
             N  
Sbjct: 505 HTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  143 bits (362), Expect = 1e-36
 Identities = 75/401 (18%), Positives = 143/401 (35%), Gaps = 30/401 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIAD---VR 57
            IP  ++    ++ LDL  NK+       +   + L++L L+++     +++I       
Sbjct: 19  SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSS----RINTIEGDAFYS 72

Query: 58  LPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLR 115
           L +LE L L  N+ S ++    F   S L  L L  N +    + + F NL NL+ L + 
Sbjct: 73  LGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 116 DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVS 175
           +    S    + F    +   SL  + +    L       S+ ++   +    +     +
Sbjct: 132 NVETFSEIRRIDF----AGLTSLNELEIKALSLRNY-QSQSLKSI-RDIHHLTLHLSESA 185

Query: 176 GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTE 235
             +      L++   ++L    L       L   +    +     +      +S   L +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLT 294
           L    L  +++       F +     +   + +E   +  L       I +L+    +L 
Sbjct: 246 LLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299

Query: 295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS---FGD 351
             L      L+ +  I    +    V  +    LK+LE+L L  N +      +    G 
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

Query: 352 LISLKFLNLSNNNLS--GAIPTSLEKLSYLEDLNLSFNKLE 390
             SL+ L LS N+L         L  L  L  L++S N   
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  140 bits (355), Expect = 1e-35
 Identities = 59/352 (16%), Positives = 127/352 (36%), Gaps = 14/352 (3%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
            +SI       +++L L  N  +      +   + L +L L  +  +    + F +L +L
Sbjct: 17  FTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
           E L+L DN+L+S +             SL +++L  NP   +   +   NL+ +L+   +
Sbjct: 77  EHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRI 130

Query: 170 SNCNVSGGIPEE-ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD 228
            N      I       LT+   +++    L      +L  ++ +  L L  ++    +  
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 229 SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLN 287
               L+ +  LEL    L     +          +   +   + +   +F  L  +L+  
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250

Query: 288 FSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD 347
              +       +E  +  +    DF+ +    V          +  L +    L   +  
Sbjct: 251 LELS------EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSF 399
            +  L  +K + + N+ +     +  + L  LE L+LS N +  E  +  + 
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  135 bits (342), Expect = 6e-34
 Identities = 65/403 (16%), Positives = 129/403 (32%), Gaps = 45/403 (11%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLP 59
            +     NL NL+ L + + +    +    F  ++ L  L ++  SL     S +   + 
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIR 172

Query: 60  NLEALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
           ++  L L   + S  +     +  S +  LEL   + + F  +          +      
Sbjct: 173 DIHHLTL-HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 119 LTSSTPE--LSFLSSLSNCKSLTFIHLSDNPLDGI--LSKTSIGNLSH-------SLKDF 167
            +  T E     L  L     L+ +   D  L+G+   + +    +S        +++  
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP 227
           ++    +   +    + L     I +  +K+          L+ L+ L L +N +     
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 228 DS---ICRLTELYELELGGNKL--FGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD 282
            +         L  L L  N L            L +L  L +S N    +P +    + 
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEK 411

Query: 283 ILQLNFSSNFLT--------------------GPLPLEIGNLKVLIGIDFSMNNFSSVIP 322
           +  LN SS  +                         L +  L+ L     S N   ++  
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQEL---YISRNKLKTL-- 466

Query: 323 TEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNL 365
            +      L  + +  N+L+      F  L SL+ + L  N  
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 98.6 bits (246), Expect = 9e-22
 Identities = 45/278 (16%), Positives = 93/278 (33%), Gaps = 8/278 (2%)

Query: 134 NCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDL 193
           +C +             I S      L+ ++K   +S   ++     ++    N   + L
Sbjct: 3   SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 194 GGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG-SIPA 252
             +++N         L  L+ L L DN L          L+ L  L L GN      + +
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 253 CFSNLASLRILSLSS-NELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGI 310
            F NL +L+ L + +    + I  + F  L  + +L   +  L       + +++ +  +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 311 DFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
              ++  + ++      L ++ YL L    L                +       S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 371 TSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFE 408
            S  +L  L    L  +++E +       G+F     +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 82.9 bits (205), Expect = 9e-17
 Identities = 62/391 (15%), Positives = 137/391 (35%), Gaps = 49/391 (12%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
           SIP  +     +  L+L  NK+           A+L++L L S+ + +I    F++L  +
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV-IPTEIGGLKNLEYLFLGYNRLE 342
             L+ S N L+       G L  L  ++   N + ++ + +    L NL+ L +G     
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 343 GSIP-DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
             I    F  L SL  L +   +L      SL+ +  +  L L  ++    +        
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEI-FADI 194

Query: 402 FAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSLLLGIVLPLSTTLLIVVIWLILRYR 461
                           +++ L     +  T+             S   +  V   + +  
Sbjct: 195 L--------------SSVRYL----ELRDTNLAR-------FQFSPLPVDEVSSPMKKLA 229

Query: 462 KRGKQPSNDANMPLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAV 521
            RG   ++++   L+   R    L      +  + N L       S   + LG    V +
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDD-CTLNGLGDFNPSESDVVSELGKVETVTI 288

Query: 522 KVFNLQCGRAFKSFAVECEMMKSIRH----RNLIKVISSCSNEEFKALVLEYKPHGSLEK 577
           +  ++     F   +    +++ ++      + + ++    ++  K+L           +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL-----------E 337

Query: 578 YLY-SSNCILDIFQRLNIMIDVASALEYLHF 607
           +L  S N +++ + + +       +L+ L  
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.8 bits (197), Expect = 8e-16
 Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 25/211 (11%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSL--LGCLSSIADVRLPNLEA 63
           S L+ ++ + + ++K+   VP +   ++  L+ L L  N +      +S      P+L+ 
Sbjct: 307 SLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365

Query: 64  LLLWGNNFS--GTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           L+L  N+          +     L+ L++S+N+F   +P++      + +LNL    +  
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424

Query: 122 STPE----LSFLSSLSNCK---------SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFY 168
                   L  L  +SN            L  +++S N L  +       +L   L    
Sbjct: 425 VKTCIPQTLEVLD-VSNNNLDSFSLFLPRLQELYISRNKLKTL----PDASLFPVLLVMK 479

Query: 169 MSNCNVSGGIPEEITNLTNSITIDLGGNKLN 199
           +S   +          LT+   I L  N  +
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 30/144 (20%), Positives = 49/144 (34%), Gaps = 16/144 (11%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
           +  L+NL  LD+  N     +P +      ++ L+L +  +      +       LE L 
Sbjct: 383 LLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI----RVVKTCIPQTLEVLD 437

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           +  NN   +   F+     L  L +S+N        +      L  + +  N L S    
Sbjct: 438 VSNNNLD-SFSLFLPR---LQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPD- 490

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
                      SL  I L  NP D
Sbjct: 491 ----GIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 10/130 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +P      + +  L+L    +   V   I     L++L + NN+L         + LP 
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL-----DSFSLFLPR 452

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+ L +  N    T+P        L ++++S+N         F  L +L+ + L  N   
Sbjct: 453 LQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

Query: 121 SSTPELSFLS 130
            S P + +LS
Sbjct: 511 CSCPRIDYLS 520

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  155 bits (393), Expect = 8e-42
 Identities = 80/430 (18%), Positives = 148/430 (34%), Gaps = 82/430 (19%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
             E   L N + +  +++ +   +PAA+  +   ++LL+L +   +  + + A      +
Sbjct: 38  GFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ-IEEIDTYAFAYAHTI 95

Query: 62  EALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           + L +  N     +P  +F N   L++L L +N  S      F N   L  L++ +N L 
Sbjct: 96  QKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
               +           SL  + LS N L  +                             
Sbjct: 155 RIEDDT-----FQATTSLQNLQLSSNRLTHV----------------------------- 180

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
           +++ + +    ++  N L+     TL+    ++ L    N +   +   +    EL  L+
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPL 299
           L  N L         N   L  + LS NEL  I    F  ++ + +L  S+N L      
Sbjct: 233 LQHNNL-TDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV----- 285

Query: 300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLN 359
                                +      +  L+ L L +N L   +  +      L+ L 
Sbjct: 286 --------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324

Query: 360 LSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT- 418
           L +N++   +  S      L++L LS N  +        F N A  + +  +  C     
Sbjct: 325 LDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQ 380

Query: 419 -LQVLPCKTS 427
               L CK S
Sbjct: 381 LEHGLCCKES 390

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 28/174 (16%), Positives = 60/174 (34%), Gaps = 2/174 (1%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDI 283
            I  ++      Y++ +               L + +I++  ++ +  +P     + + +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG 343
             LN +   +             +  +    N    + P     +  L  L L  N L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 344 SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGG 397
                F +   L  L++SNNNL      + +  + L++L LS N+L   +    
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 1/128 (0%)

Query: 269 ELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGL 328
           E   I            ++            E   L     + F  +    +    +   
Sbjct: 9   EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68

Query: 329 KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK 388
           + +E L L   ++E     +F    +++ L +  N +    P   + +  L  L L  N 
Sbjct: 69  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 389 LEGEIPRG 396
           L   +PRG
Sbjct: 129 LS-SLPRG 135

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  155 bits (395), Expect = 1e-41
 Identities = 91/427 (21%), Positives = 155/427 (36%), Gaps = 79/427 (18%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLG---------CLS 51
           E+P+E  N+++  E     ++     P        + +  L++               LS
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 52  SIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPN---------- 101
           S+ ++  P+LE+L+   N+ +  +P    +   L +   +  + S   P           
Sbjct: 85  SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 142

Query: 102 -----TFGNLRNLEWLNLRDNYLTSSTPE-------------LSFLSSLSNCKSLTFIHL 143
                   N   L+ +++ +N L                   L  L  L N   LT I+ 
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYA 202

Query: 144 SDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP 203
            +N L        + +L  SL+     N  +      E+ NL    TI    N L  ++P
Sbjct: 203 DNNSL------KKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLP 253

Query: 204 ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL 263
                L+ L    + DN L   +P+    LT L   E   + L    P       +L  L
Sbjct: 254 DLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYL 302

Query: 264 SLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 323
           + SSNE+ S+     +L+   +LN S+N L   LP     L+ L     S N+ +  +P 
Sbjct: 303 NASSNEIRSLCDLPPSLE---ELNVSNNKLIE-LPALPPRLERL---IASFNHLAE-VPE 354

Query: 324 EIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLN 383
                 NL+ L + YN L    PD    +  L+      N+    +P   + L  L   +
Sbjct: 355 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQL---H 402

Query: 384 LSFNKLE 390
           +  N L 
Sbjct: 403 VETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  145 bits (369), Expect = 5e-38
 Identities = 84/402 (20%), Positives = 142/402 (35%), Gaps = 67/402 (16%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           E+P    +L++L   +     L            +L+ L + NN L   L  +       
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQL-EKLPELQ--NSSF 154

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+ + +  N+    +P    +   L  +    N     +P    NL  L  +   +N L 
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK 208

Query: 121 SSTPE-------------LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF 167
                             L  L  L N   LT I+  +N L       ++ +L  SL+  
Sbjct: 209 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL------KTLPDLPPSLEAL 262

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP 227
            + +  ++  +PE   +LT    +D+  N  +  +      L  L       N++  S+ 
Sbjct: 263 NVRDNYLTD-LPELPQSLTF---LDVSENIFS-GLSELPPNLYYLN---ASSNEIR-SLC 313

Query: 228 DSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLN 287
           D    L EL    +  NKL   +PA    L     L  S N L  +P    NLK   QL+
Sbjct: 314 DLPPSLEELN---VSNNKL-IELPALPPRL---ERLIASFNHLAEVPELPQNLK---QLH 363

Query: 288 FSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD 347
              N L    P    +++ L      MN+  + +P       NL+ L +  N L    PD
Sbjct: 364 VEYNPLRE-FPDIPESVEDL-----RMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPD 413

Query: 348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
                 S++ L +++  +      + E    LED     +  
Sbjct: 414 IPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  125 bits (317), Expect = 4e-31
 Identities = 73/364 (20%), Positives = 129/364 (35%), Gaps = 66/364 (18%)

Query: 54  ADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLR------ 107
            +V    L+  L   +N +  +P    N    +    + + +    P   G  R      
Sbjct: 6   RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 108 -------NLEWLNLRDNYLTSSTPELSFLSSL--------------SNCKSLTFIHLSDN 146
                      L L +  L+S       L SL               + KSL   + +  
Sbjct: 65  LRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLK 124

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL 206
                    ++ +L   L+   +SN  +   +P E+ N +    ID+  N L   +P   
Sbjct: 125 ---------ALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP 172

Query: 207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS 266
             L+ +      +N+LE  +P+ +  L  L  +    N L   +P       SL  +   
Sbjct: 173 PSLEFIA---AGNNQLE-ELPE-LQNLPFLTAIYADNNSL-KKLP---DLPLSLESIVAG 223

Query: 267 SNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG 326
           +N L  +P    NL  +  +   +N L   LP    +L+ L   +   N  +  +P    
Sbjct: 224 NNILEELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL---NVRDNYLTD-LPELPQ 277

Query: 327 GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF 386
            L  L+     ++ L    P       +L +LN S+N +  ++         LE+LN+S 
Sbjct: 278 SLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPS---LEELNVSN 326

Query: 387 NKLE 390
           NKL 
Sbjct: 327 NKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  114 bits (288), Expect = 2e-27
 Identities = 58/323 (17%), Positives = 110/323 (34%), Gaps = 53/323 (16%)

Query: 98  FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSI 157
           FI     +   L+      + LT             N KS T  + + +  +      + 
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGNG 55

Query: 158 -----------GNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL 206
                        L     +  ++N  +S  +PE   +L    ++    N L   +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELP 110

Query: 207 SKLQKLQGLGLDDNKLEGSIP---------------DSICRLTELYELELGGNKLFGSIP 251
             L+ L     +   L    P                 +   + L  +++  N L   +P
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL-KKLP 169

Query: 252 ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGID 311
                  SL  ++  +N+L  +P    NL  +  +   +N L   LP    +L+ +    
Sbjct: 170 ---DLPPSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---V 221

Query: 312 FSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT 371
              N        E+  L  L  ++   N L+ ++PD      SL+ LN+ +N L+  +P 
Sbjct: 222 AGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPE 274

Query: 372 SLEKLSYLEDLNLSFNKLEGEIP 394
             + L++L+     F+ L    P
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPP 297

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  148 bits (377), Expect = 2e-40
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 6/146 (4%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG G FG+V++A    G +VAVK+   Q         F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +     ++V EY   GSL + L+ S     LD  +RL++  DVA  + YLH     P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKL 641
            +LK  N+L+D      + DFG+++L
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL 188

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  149 bits (377), Expect = 2e-40
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 15/172 (8%)

Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM 541
                L   +       +  RG FG V+KA+L     VAVK+F +Q  ++++    E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 542 MKSIRHRNLIKVISSCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID 597
           +  ++H N+++ I +            L+  +   GSL  +L ++  ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 598 VASALEYLH-------FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +A  L YLH        G    + H D+K  NVLL +NL A ++DFG+A   
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  144 bits (366), Expect = 2e-39
 Identities = 32/148 (21%), Positives = 66/148 (44%), Gaps = 7/148 (4%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           +     G ++K R   G ++ VKV  ++    R  + F  EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 558 SNEEFK--ALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPVI 614
            +       L+  + P+GSL   L+      +D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              L   +V++D+++ A +S   +    
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF 163

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 4e-39
 Identities = 74/366 (20%), Positives = 137/366 (37%), Gaps = 55/366 (15%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLE 62
            E   L N + +  +++ +   +PAA+  +   ++LL+L +  +   + + A      ++
Sbjct: 45  FEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQ 102

Query: 63  ALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            L +  N     +P  +F N   L++L L +N  S      F N   L  L++ +N L  
Sbjct: 103 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
              +           SL  + LS N L  +                             +
Sbjct: 162 IEDDT-----FQATTSLQNLQLSSNRLTHV-----------------------------D 187

Query: 182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
           ++ + +    ++  N L+     TL+    ++ L    N +   +   +    EL  L+L
Sbjct: 188 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKL 239

Query: 242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLE 300
             N L         N   L  + LS NEL  I    F  ++ + +L  S+N L   L L 
Sbjct: 240 QHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY 296

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
              +  L  +D S N+    +         LE L+L +N +  ++        +LK L L
Sbjct: 297 GQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTL 352

Query: 361 SNNNLS 366
           S+N+  
Sbjct: 353 SHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  137 bits (346), Expect = 2e-34
 Identities = 62/339 (18%), Positives = 124/339 (36%), Gaps = 31/339 (9%)

Query: 60  NLEALLLWGNNFSGTIPRFIF------NASKLSILELSQNSFSGFIPNTFGNLRNLEWLN 113
           NL+   ++ +       + ++        +   I+    ++          + R +E LN
Sbjct: 22  NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81

Query: 114 LRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCN 173
           L D  +           + +   ++  +++  N +   L      N+   L    +   +
Sbjct: 82  LNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP-LLTVLVLERND 134

Query: 174 VSGGIPEEI-TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR 232
           +S  +P  I  N     T+ +  N L      T      LQ L L  N+L   +  S+  
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-- 190

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSN 291
           +  L+   +  N L     +  +   ++  L  S N +  +       L     L    N
Sbjct: 191 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHN 242

Query: 292 FLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD 351
            LT      + N   L+ +D S N    ++      ++ LE L++  NRL  ++      
Sbjct: 243 NLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299

Query: 352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
           + +LK L+LS+N+L   +  +  +   LE+L L  N + 
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 94.2 bits (234), Expect = 2e-20
 Identities = 39/191 (20%), Positives = 68/191 (35%), Gaps = 4/191 (2%)

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL 260
            I   L        + +D    +         L     +    + +     A   +   +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 261 RILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS 319
            +L+L+  ++  I    F     I +L    N +    P    N+ +L  +    N+ SS
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
           +          L  L +  N LE    D+F    SL+ L LS+N L+  +  SL  +  L
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSL 194

Query: 380 EDLNLSFNKLE 390
              N+S+N L 
Sbjct: 195 FHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 21/131 (16%), Positives = 40/131 (30%), Gaps = 1/131 (0%)

Query: 266 SSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI 325
              E   I            ++            E   L     + F  +    +    +
Sbjct: 12  RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71

Query: 326 GGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS 385
              + +E L L   ++E     +F    +++ L +  N +    P   + +  L  L L 
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131

Query: 386 FNKLEGEIPRG 396
            N L   +PRG
Sbjct: 132 RNDLS-SLPRG 141

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  149 bits (378), Expect = 2e-38
 Identities = 75/353 (21%), Positives = 128/353 (36%), Gaps = 50/353 (14%)

Query: 42  QNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPN 101
           ++      +  +          L +  +  + T+P  +     ++ L +  N+ +  +P 
Sbjct: 23  ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA 78

Query: 102 TFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS 161
               LR L    +  N LTS                L+        L  + S        
Sbjct: 79  LPPELRTL---EVSGNQLTS------LPVLPPGLLELSIFSNPLTHLPALPS-------- 121

Query: 162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
             L   ++    ++  +P     L     + +  N+L  S+P   S+L KL      +N+
Sbjct: 122 -GLCKLWIFGNQLTS-LPVLPPGLQE---LSVSDNQLA-SLPALPSELCKLW---AYNNQ 172

Query: 222 LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLK 281
           L  S+P     L EL    +  N+L  S+P      + L  L   +N LTS+P     LK
Sbjct: 173 LT-SLPMLPSGLQELS---VSDNQL-ASLPT---LPSELYKLWAYNNRLTSLPALPSGLK 224

Query: 282 DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL 341
              +L  S N LT  LP+    LK L     S N  +S +P        L  L +  N+L
Sbjct: 225 ---ELIVSGNRLTS-LPVLPSELKEL---MVSGNRLTS-LPMLPS---GLLSLSVYRNQL 273

Query: 342 EGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
              +P+S   L S   +NL  N LS     +L +++     +    + +    
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  146 bits (369), Expect = 4e-37
 Identities = 80/404 (19%), Positives = 143/404 (35%), Gaps = 77/404 (19%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
           +          L++  + L  T+P  +                             ++  
Sbjct: 34  MRACLNNGNAVLNVGESGL-TTLPDCLPA---------------------------HITT 65

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L++  NN + ++P       +L  LE+S N  +  +P     L  L   +    +L +  
Sbjct: 66  LVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL- 119

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                         L  + +  N L      TS+  L   L++  +S+  ++  +P   +
Sbjct: 120 -----------PSGLCKLWIFGNQL------TSLPVLPPGLQELSVSDNQLAS-LPALPS 161

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG 243
            L     +    N+L  S+P+  S LQ+L    + DN+L  S+P     L +L+      
Sbjct: 162 ELCK---LWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAY---N 210

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN 303
           N+L  S+PA     + L+ L +S N LTS+P+    LK   +L  S N LT  LP+    
Sbjct: 211 NRL-TSLPA---LPSGLKELIVSGNRLTSLPVLPSELK---ELMVSGNRLTS-LPMLPSG 262

Query: 304 LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
           L  L       N  +  +P  +  L +   + L  N L      +  ++ S    +    
Sbjct: 263 LLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

Query: 364 NLSGAIP--TSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAE 405
               A        +  +L   +      EGE      +  F  E
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  124 bits (313), Expect = 4e-30
 Identities = 68/352 (19%), Positives = 120/352 (34%), Gaps = 56/352 (15%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +P     L+    L++  N+L  ++P     +  L +       L              
Sbjct: 75  SLPALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL--------PALPSG 122

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  L ++GN  + ++P        L  L +S N  +  +P     L     L   +N LT
Sbjct: 123 LCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPALPSELCK---LWAYNNQLT 174

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
           S     S          L  + +SDN L       S+  L   L   +  N  ++  +P 
Sbjct: 175 SLPMLPS---------GLQELSVSDNQL------ASLPTLPSELYKLWAYNNRLT-SLPA 218

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
             + L     + + GN+L  S+P+  S+L++L    +  N+L  S+P     L  L    
Sbjct: 219 LPSGLK---ELIVSGNRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLSLS--- 267

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTF----WNLKDILQLNFSSNFLTGP 296
           +  N+L   +P    +L+S   ++L  N L+   L       +           +     
Sbjct: 268 VYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTE----IGGLKNLEYLFLGYNRLEGS 344
            P E   L +               P +     G   N +   L  +RL  +
Sbjct: 327 APRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  142 bits (360), Expect = 3e-38
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 16/155 (10%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-------FKSFAVECEMMKSIRHRNLI 551
           IG+GGFG V+K R + D   VA+K   L            F+ F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           K+     N     +V+E+ P G L   L      +    +L +M+D+A  +EY+      
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 612 PVIHCDLKPDNVLLD-----DNLVAYLSDFGIAKL 641
           P++H DL+  N+ L        + A ++DFG+++ 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  141 bits (358), Expect = 7e-38
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +GRG FG V KA+     +VA+K    +     K+F VE   +  + H N++K+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 560 EEFKALVLEYKPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
                LV+EY   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 618 LKPDNVLLDDN-LVAYLSDFGIAKLL 642
           LKP N+LL     V  + DFG A  +
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI 156

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  145 bits (368), Expect = 9e-38
 Identities = 55/389 (14%), Positives = 118/389 (30%), Gaps = 29/389 (7%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            +  N++ELDL  N L     A +   + L+LL+L +N L      +    L  L  L L
Sbjct: 31  QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLES--LSTLRTLDL 87

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
             N         +     +  L  + N+ S    +     +  + + L +N +T      
Sbjct: 88  NNNYVQE-----LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDL- 138

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLT 186
                      + ++ L  N +D +       +   +L+   +    +   +  ++    
Sbjct: 139 ----DEGCRSRVQYLDLKLNEIDTVNFAELAASS-DTLEHLNLQYNFIYD-VKGQV-VFA 191

Query: 187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKL 246
              T+DL  NKL   +         +  + L +NKL   I  ++     L   +L GN  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 247 -FGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
             G++   FS     R+ +++   +  +              ++ +             L
Sbjct: 250 HCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 305 KVLIGIDFSM----NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
             L   + ++     + +  +  E         +     +    I        +   L  
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
               L   +       + L+         
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (362), Expect = 6e-37
 Identities = 57/398 (14%), Positives = 115/398 (28%), Gaps = 27/398 (6%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           I     N    +   +  + L   + +   +   +K L L  N L   +S+        L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKL 60

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           E L L  N    T+   + + S L  L+L+ N              ++E L+  +N ++ 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG-GIPE 180
            +         S  +    I+L++N +  +      G  S  ++   +    +      E
Sbjct: 114 VSC--------SRGQGKKNIYLANNKITML-RDLDEGCRS-RVQYLDLKLNEIDTVNFAE 163

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
              +      ++L  N +   +        KL+ L L  NKL   +         +  + 
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE 300
           L  NKL   I        +L    L  N      L  +  K+      +   +       
Sbjct: 221 LRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGS----IPDSFGDLISLK 356
                V     +       +       L  L+         +GS    +     +    +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
            ++         I     +      L      L+ ++ 
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (354), Expect = 7e-36
 Identities = 53/358 (14%), Positives = 112/358 (31%), Gaps = 31/358 (8%)

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
               +   +  ++    +     +A  +  L+LS N  S            LE LNL  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGI----------LSKTSIGNLS----HS 163
            L            L +  +L  + L++N +  +           +  +I  +S      
Sbjct: 69  VLYE-------TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG 121

Query: 164 LKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLDDNKL 222
            K+ Y++N  ++     +    +    +DL  N+++  +     +    L+ L L  N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 223 EGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD 282
              +   +    +L  L+L  NKL   +   F + A +  +SL +N+L  I       ++
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN 238

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
           +   +   N       L     K       +      +                G    E
Sbjct: 239 LEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

Query: 343 GSIPDSFGDLISLKFLNLSNNNLSG----AIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
                    LI+LK    +  +  G     +    E  +   +++    +    +   
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQ 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  103 bits (258), Expect = 2e-23
 Identities = 48/371 (12%), Positives = 97/371 (26%), Gaps = 37/371 (9%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
           +  S  Q  + + L +NK+           S ++ L L+ N +     +        LE 
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L L  N     +   +   +KL  L+LS N  + F+   F +   + W++LR+N L    
Sbjct: 174 LNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIE 230

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
             L F  +L +        L  N       +               +   ++G   EE T
Sbjct: 231 KALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 184 NL--------------------------TNSITIDLGGNKLNGSIPITLSKLQKLQGLGL 217
                                            +   G++    +        + + +  
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDA 343

Query: 218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTF 277
              +    I     R      LE     L   +       A L      +     +    
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403

Query: 278 WNLKDILQLNFSSN-FLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL 336
                +  L      +    +  +      +   D   +  + +        K      L
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADL 463

Query: 337 GYNRLEGSIPD 347
                  ++ +
Sbjct: 464 ALASANATLQE 474

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 3/98 (3%)

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
             N         + ++    + +      N++ L L  N L             L+ LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGS 398
           S+N L       LE LS L  L+L+ N ++ E+  G S
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  144 bits (366), Expect = 1e-37
 Identities = 91/407 (22%), Positives = 151/407 (37%), Gaps = 62/407 (15%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN 70
           ++  +DL  N +      +   +  L+ L ++  +    + +     L +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 71  FSGTIPRFIFNA-SKLSILELSQNSFSGFI--PNTFGNLRNLEWLNLRDNYLTSSTPELS 127
           F   +    FN  + L +L L+Q +  G +   N F  L +LE L LRDN +    P   
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 128 FLSSLSNCKSLTFIHLSDNPLDGI-------LSKTSIGNLS-HSLKDFYMSNCNVSGGIP 179
           F     N +    + L+ N +  I               L   S+    M+   +     
Sbjct: 150 F----LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205

Query: 180 EEITNLTNSITIDLGGNKLNGSIP---ITLSKLQKLQGLGLDDNKLEG---------SIP 227
                 T+  T+DL GN    S+           K+Q L L ++   G            
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265

Query: 228 DSICR---LTELYELELGGNKLFGSIPAC-FSNLASLRILSLSSNELTSIPL-TFWNLKD 282
           +   +    + +   +L  +K+F ++    FS+   L  L+L+ NE+  I    FW L  
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRL 341
           +L+LN S NFL                           I + +   L  LE L L YN +
Sbjct: 325 LLKLNLSQNFLGS-------------------------IDSRMFENLDKLEVLDLSYNHI 359

Query: 342 EGSIP-DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
             ++   SF  L +LK L L  N L        ++L+ L+ + L  N
Sbjct: 360 R-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  111 bits (279), Expect = 3e-26
 Identities = 61/301 (20%), Positives = 107/301 (35%), Gaps = 39/301 (12%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLG-CLSSIADVRLPNLEALL 65
            L +LE L LR N +    PA+ F NM    +L L  N +   C   + + +  +   L 
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L                    + ++++               ++  L+L  N    S  +
Sbjct: 187 LSSIT----------------LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230

Query: 126 LSF-------LSSLS-NCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCN---V 174
             F       + SL  +                  + T  G  +  +K   +S      +
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL 290

Query: 175 SGGIPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSICR- 232
              +    T+L     + L  N++N  I       L  L  L L  N L GSI   +   
Sbjct: 291 LKSVFSHFTDLE---QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFEN 345

Query: 233 LTELYELELGGNKLFGSIPAC-FSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSS 290
           L +L  L+L  N +  ++    F  L +L+ L+L +N+L S+P   F  L  + ++   +
Sbjct: 346 LDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404

Query: 291 N 291
           N
Sbjct: 405 N 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 86.0 bits (213), Expect = 6e-18
 Identities = 47/253 (18%), Positives = 87/253 (34%), Gaps = 28/253 (11%)

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR-LTEL 236
           +P  +  +      DL  N +      + S+LQ LQ L ++       I ++  R L+ L
Sbjct: 28  LPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL---TFWNLKDILQLNFSSNF 292
             L+L  N+    +    F+ LA+L +L+L+   L    L    F  L  +  L    N 
Sbjct: 82  IILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 293 LTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD 351
           +    P     N++    +D + N   S+   ++   +   +  L               
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------R 186

Query: 352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNE 411
           L S+   +++   L      +  K + +  L+LS N  + E      F   A    +   
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLI 245

Query: 412 LLCGSPTLQVLPC 424
           L            
Sbjct: 246 LSNSYNMGSSFGH 258

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.4 bits (196), Expect = 8e-16
 Identities = 49/257 (19%), Positives = 86/257 (33%), Gaps = 49/257 (19%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
             +  L ++   D+    L        F  + +  L L  N     ++      +   + 
Sbjct: 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241

Query: 64  LLLWGNNFSGTIPRFIFN--------------ASKLSILELSQNSFSGFIPNTFGNLRNL 109
             L  +N       F                 AS +   +LS++     + + F +  +L
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL 301

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
           E L L  N +     + +F         L  ++LS N L  I                  
Sbjct: 302 EQLTLAQNEIN-KIDDNAF----WGLTHLLKLNLSQNFLGSI------------------ 338

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPD 228
                   + E +  L     +DL  N +  ++   +   L  L+ L LD N+L+ S+PD
Sbjct: 339 -----DSRMFENLDKLE---VLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPD 388

Query: 229 SI-CRLTELYELELGGN 244
            I  RLT L ++ L  N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 41/144 (28%), Positives = 61/144 (42%), Gaps = 16/144 (11%)

Query: 11  NLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIAD---VRLPNLEALLL 66
            ++  DL  +K+   +  ++F + + L+ L L  N +    + I D     L +L  L L
Sbjct: 276 GVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEI----NKIDDNAFWGLTHLLKLNL 330

Query: 67  WGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
             N    +I   +F    KL +L+LS N        +F  L NL+ L L  N L S  P+
Sbjct: 331 SQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPD 388

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
             F        SL  I L  NP D
Sbjct: 389 GIF----DRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 34/127 (26%), Positives = 51/127 (40%), Gaps = 5/127 (3%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
           S+  +LE+L L  N++   +    F  ++ L  L+L  N  LG + S     L  LE L 
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN-FLGSIDSRMFENLDKLEVLD 353

Query: 66  LWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
           L  N+    +    F     L  L L  N         F  L +L+ + L  N    S P
Sbjct: 354 LSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412

Query: 125 ELSFLSS 131
            + +LS 
Sbjct: 413 RIDYLSR 419

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  145 bits (367), Expect = 1e-37
 Identities = 80/357 (22%), Positives = 132/357 (36%), Gaps = 44/357 (12%)

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           +L     F   +P  I   ++  +L+L +N       + F +  +LE L L +N +++  
Sbjct: 16  VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI- 182
           P      + +N  +L  + L  N L  I                           P  + 
Sbjct: 73  PG-----AFNNLFNLRTLGLRSNRLKLI---------------------------PLGVF 100

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELYELEL 241
           T L+N   +D+  NK+   +      L  L+ L + DN L   I       L  L +L L
Sbjct: 101 TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTL 159

Query: 242 GGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPL 299
               L  SIP    S+L  L +L L    + +I   +F  L  +  L  S       +  
Sbjct: 160 EKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218

Query: 300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLN 359
                  L  +  +  N ++V    +  L  L +L L YN +         +L+ L+ + 
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278

Query: 360 LSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG--GSFGNFAAESFEGNELLC 414
           L    L+   P +   L+YL  LN+S N+L   +      S GN      + N L C
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (364), Expect = 3e-37
 Identities = 76/372 (20%), Positives = 127/372 (34%), Gaps = 69/372 (18%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIAD---VR 57
            +P  I        LDL  N++         +   L+ L L  N     +S++       
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI----VSAVEPGAFNN 78

Query: 58  LPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD 116
           L NL  L L  N     IP  +F   S L+ L++S+N     +   F +L NL+ L + D
Sbjct: 79  LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
           N L   +       + S   SL  + L    L      TSI                   
Sbjct: 138 NDLVYISHR-----AFSGLNSLEQLTLEKCNL------TSIP------------------ 168

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
              E +++L   I + L    +N     +  +L +L+ L +       ++  +      L
Sbjct: 169 --TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226

Query: 237 YELELGGNKLFGSIPAC-FSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLT 294
             L +    L  ++P     +L  LR L+LS N +++I       L  + ++      L 
Sbjct: 227 TSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

Query: 295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIS 354
                                 F         GL  L  L +  N+L       F  + +
Sbjct: 286 ----------------VVEPYAFR--------GLNYLRVLNVSGNQLTTLEESVFHSVGN 321

Query: 355 LKFLNLSNNNLS 366
           L+ L L +N L+
Sbjct: 322 LETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 30/138 (21%), Positives = 50/138 (36%), Gaps = 3/138 (2%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
             R +        ++P       +   L+   N +      E  +   L  ++ + N  S
Sbjct: 12  QDRAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY 378
           +V P     L NL  L L  NRL+      F  L +L  L++S N +   +    + L  
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 379 LEDLNLSFNKLEGEIPRG 396
           L+ L +  N L   I   
Sbjct: 130 LKSLEVGDNDLV-YISHR 146

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  141 bits (358), Expect = 1e-37
 Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 19/176 (10%)

Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM 541
            +  E     +      LIGRG +G+VYK  L D   VAVKVF+       ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58

Query: 542 MK--SIRHRNLIKVISSC-----SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
            +   + H N+ + I               LV+EY P+GSL KYL       D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116

Query: 595 MIDVASALEYLH------FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
              V   L YLH            + H DL   NVL+ ++    +SDFG++  L G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (353), Expect = 2e-37
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 15/154 (9%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRHRNLIKVIS 555
           IG GGFG VY+A    G EVAVK           +  ++   E ++   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
            C  E    LV+E+   G L + L      +     +N  + +A  + YLH   + P+IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 616 CDLKPDNVLLD--------DNLVAYLSDFGIAKL 641
            DLK  N+L+          N +  ++DFG+A+ 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE 165

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  137 bits (347), Expect = 2e-36
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH      +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKL 641
           LK +N+ L ++    + DFG+A  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATE 169

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (347), Expect = 4e-36
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 8/146 (5%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVIS 555
            LIG+G FG VY  R     EVA+++ +++       K+F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH      ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKL 641
            DLK  NV  D+  V  ++DFG+  +
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSI 178

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (345), Expect = 5e-36
 Identities = 50/328 (15%), Positives = 103/328 (31%), Gaps = 46/328 (14%)

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
               +   +  ++    +     +A  +  L+LS N  S            LE LNL  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
            L            L +  +L  + L++N +                             
Sbjct: 69  VLYE-------TLDLESLSTLRTLDLNNNYV----------------------------- 92

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
             +E+    +  T+    N ++    ++ S+ Q  + + L +NK+           + + 
Sbjct: 93  --QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147

Query: 238 ELELGGNKLFG-SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP 296
            L+L  N++   +     ++  +L  L+L  N +  +         +  L+ SSN L   
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF- 205

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE-GSIPDSFGDLISL 355
           +  E  +   +  I    N     I   +   +NLE+  L  N    G++ D F     +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 356 KFLNLSNNNLSGAIPTSLEKLSYLEDLN 383
           + +                 +  L    
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (318), Expect = 3e-32
 Identities = 56/366 (15%), Positives = 119/366 (32%), Gaps = 52/366 (14%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           I     N    +   +  + L     A++                             N+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-QALASLR------------------------QSAWNV 36

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           + L L GN  S      +   +KL +L LS N     +     +L  L  L+L +NY+  
Sbjct: 37  KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ- 93

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
                     L    S+  +H ++N +  +    S        K+ Y++N  ++     +
Sbjct: 94  ---------ELLVGPSIETLHAANNNISRV----SCSRGQ-GKKNIYLANNKITMLRDLD 139

Query: 182 ITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
               +    +DL  N+++  +     +    L+ L L  N +   +   +    +L  L+
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE 300
           L  NKL   +   F + A +  +SL +N+L  I       +++   +   N         
Sbjct: 198 LSSNKL-AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN------GFH 250

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
            G L+     +  +   +     ++ G    E              +      + + + L
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310

Query: 361 SNNNLS 366
            +++  
Sbjct: 311 GHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  108 bits (272), Expect = 4e-26
 Identities = 37/191 (19%), Positives = 74/191 (38%), Gaps = 10/191 (5%)

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL 260
           +I        + +   + D+ L+ ++         + EL+L GN L     A  +    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV 320
            +L+LSSN L        +L  +  L+ ++N++      E+     +  +  + NN S V
Sbjct: 61  ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG-AIPTSLEKLSYL 379
                   +  + ++L  N++        G    +++L+L  N +              L
Sbjct: 115 ---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 380 EDLNLSFNKLE 390
           E LNL +N + 
Sbjct: 172 EHLNLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 24/102 (23%), Positives = 39/102 (38%), Gaps = 3/102 (2%)

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK 356
           +     N         + ++    + +      N++ L L  N L             L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGS 398
            LNLS+N L       LE LS L  L+L+ N ++ E+  G S
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  135 bits (342), Expect = 1e-35
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 4/148 (2%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G+G FG   K      G  + +K          ++F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL 618
            ++    + EY   G+L   + S +      QR++   D+AS + YLH      +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDL 134

Query: 619 KPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              N L+ +N    ++DFG+A+L++ E 
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEK 162

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  135 bits (342), Expect = 1e-35
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM--MKSIRHRNLIKVIS 555
             +G+G +G V++     G  VAVK+F+ +     KS+  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 556 SCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 606
           S       +    L+  Y   GSL  YL      LD    L I++ +AS L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 + H DLK  N+L+  N    ++D G+A + 
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  135 bits (341), Expect = 3e-35
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 17/156 (10%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM--MKSIRHRNLIKVIS 555
             IG+G +G V+  +   G +VAVKVF         S+  E E+     +RH N++  I+
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 556 SCSNEEFK----ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 606
           +            L+ +Y  +GSL  YL S+   LD    L +     S L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 + H DLK  N+L+  N    ++D G+A   
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  133 bits (336), Expect = 2e-34
 Identities = 62/317 (19%), Positives = 127/317 (40%), Gaps = 32/317 (10%)

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           +L  +          +P+ +      ++L+L  N  +      F NL+NL  L L +N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           +  +P      + +    L  ++LS N L  +        +  +L++  +    ++  + 
Sbjct: 89  SKISPG-----AFAPLVKLERLYLSKNQLKELPE-----KMPKTLQELRVHENEIT-KVR 137

Query: 180 EEI-TNLTNSITIDLGGNKLNGSI--PITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
           + +   L   I ++LG N L  S         ++KL  + + D  +  +IP  +     L
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 194

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLT 294
            EL L GNK+   + A     L +L  L LS N ++++   +  N   + +L+ ++N L 
Sbjct: 195 TELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253

Query: 295 GPLPLEIGNLKVLIGIDFSMNNFSSV------IPTEIGGLKNLEYLFLGYNRLEGSI--P 346
             +P  + + K +  +    NN S++       P       +   + L  N ++     P
Sbjct: 254 K-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 347 DSFGDLISLKFLNLSNN 363
            +F  +     + L N 
Sbjct: 313 STFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  117 bits (296), Expect = 3e-29
 Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 27/273 (9%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            NL+NL  L L +NK+    P A   +  L+ L+L  N     L  + +     L+ L +
Sbjct: 73  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ----LKELPEKMPKTLQELRV 128

Query: 67  WGNNFSGTIPRFIF-NASKLSILELSQNSF--SGFIPNTFGNLRNLEWLNLRDNYLTSST 123
             N  +  + + +F   +++ ++EL  N    SG     F  ++ L ++ + D  +T+  
Sbjct: 129 HENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 187

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
             L          SLT +HL  N +  +    S+  L ++L    +S  ++S      + 
Sbjct: 188 QGL--------PPSLTELHLDGNKITKV-DAASLKGL-NNLAKLGLSFNSISAVDNGSLA 237

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC------RLTELY 237
           N  +   + L  NKL   +P  L+  + +Q + L +N +     +  C      +     
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296

Query: 238 ELELGGNKL-FGSIPAC-FSNLASLRILSLSSN 268
            + L  N + +  I    F  +     + L + 
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 41/220 (18%), Positives = 75/220 (34%), Gaps = 36/220 (16%)

Query: 7   SNLQNLEELDLRHNKL-VGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
           + L  +  ++L  N L    +    F  M  L  + + + ++    ++I     P+L  L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI----TTIPQGLPPSLTEL 197

Query: 65  LLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
            L GN  +  +        + L+ L LS NS S     +  N  +L  L+L +N L    
Sbjct: 198 HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                   L++ K +  ++L +N +  I S                         P   T
Sbjct: 257 G------GLADHKYIQVVYLHNNNISAIGSNDFCP--------------------PGYNT 290

Query: 184 NLTNSITIDLGGNKLNGSI--PITLSKLQKLQGLGLDDNK 221
              +   + L  N +      P T   +     + L + K
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 30/138 (21%), Positives = 52/138 (37%), Gaps = 30/138 (21%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
            LR++  S   L  +P                      LP +   L      D   N  +
Sbjct: 32  HLRVVQCSDLGLEKVP--------------------KDLPPDTALL------DLQNNKIT 65

Query: 319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY 378
            +   +   LKNL  L L  N++    P +F  L+ L+ L LS N L   +P  +     
Sbjct: 66  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122

Query: 379 LEDLNLSFNKLEGEIPRG 396
           L++L +  N++  ++ + 
Sbjct: 123 LQELRVHENEIT-KVRKS 139

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  129 bits (326), Expect = 3e-33
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 17/156 (10%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM--MKSIRHRNLIKVIS 555
             IG+G FG V++ +   G EVAVK+F+ +     +S+  E E+     +RH N++  I+
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 556 SCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 606
           + + +        LV +Y  HGSL  YL      + +   + + +  AS L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 + H DLK  N+L+  N    ++D G+A   
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (327), Expect = 2e-32
 Identities = 66/382 (17%), Positives = 131/382 (34%), Gaps = 48/382 (12%)

Query: 10  QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLPNLEALLLWG 68
            N         ++  T   +   ++ L  L   N+S    ++ +  + +L  L  L+   
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSS----ITDMTGIEKLTGLTKLICTS 73

Query: 69  NNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSF 128
           NN + T+   +   + L+ L    N  +         L  L +LN   N LT        
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK------- 120

Query: 129 LSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNS 188
              +S    LT+++ + N L  I     + + +  L +              ++T  T  
Sbjct: 121 -LDVSQNPLLTYLNCARNTLTEI----DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQL 172

Query: 189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG 248
            T+D   NK+     + +S+ + L  L  D N +   +   + +  +L  L+   NKL  
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-T 225

Query: 249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLI 308
            I    + L  L     S N LT +      L  +  L+     L     +++ +   LI
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLI 278

Query: 309 GIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA 368
                       +  ++     L  L      +   +         L +L L+N  L+  
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-E 332

Query: 369 IPTSLEKLSYLEDLNLSFNKLE 390
           +   +   + L+ L+     ++
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  120 bits (304), Expect = 2e-29
 Identities = 60/385 (15%), Positives = 123/385 (31%), Gaps = 70/385 (18%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
            I  L  L +L    N +  T+   +   + L  L   +N     L+++    L  L  L
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK----LTNLDVTPLTKLTYL 111

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
               N  +  +   +     L+ L  ++N+ +        +   L  L+   N   +   
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD 165

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
                  ++    LT +  S N +  +                             +++ 
Sbjct: 166 -------VTPQTQLTTLDCSFNKITEL-----------------------------DVSQ 189

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
                 ++   N +     + L++  +L  L    NKL   I   +  LT+L   +   N
Sbjct: 190 NKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVN 243

Query: 245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNL 304
            L   +    S L+ L  L     +L  I LT  +   ++              L++ + 
Sbjct: 244 PL-TELD--VSTLSKLTTLHCIQTDLLEIDLT--HNTQLIYFQAEGCRKIK--ELDVTHN 296

Query: 305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN 364
             L  +D      + +   ++     L YL+L    L   +         LK L+  N +
Sbjct: 297 TQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350

Query: 365 LSGAIPTSLEKLSYLEDLNLSFNKL 389
           +     +S+ K+  L +   +  + 
Sbjct: 351 IQDF--SSVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (296), Expect = 2e-28
 Identities = 65/374 (17%), Positives = 128/374 (34%), Gaps = 54/374 (14%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
           L++S   NL  L    NKL       +  ++ L  L+   N     L+ +   + P L  
Sbjct: 79  LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNK----LTKLDVSQNPLLTY 131

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L    N  +  I   + + ++L+ L+   N     +         L  L+   N +T   
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-- 184

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                   +S  K L  ++   N +  +     +      L     S+  ++     ++T
Sbjct: 185 ------LDVSQNKLLNRLNCDTNNITKL----DLNQNI-QLTFLDCSSNKLTE---IDVT 230

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG 243
            LT     D   N L     + +S L KL  L      L   I  +    T+L   +  G
Sbjct: 231 PLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEG 284

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN 303
            +    +    ++   L +L   +  +T + L+      ++ L  ++  LT    L++ +
Sbjct: 285 CRKIKELD--VTHNTQLYLLDCQAAGITELDLS--QNPKLVYLYLNNTELTE---LDVSH 337

Query: 304 LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
              L  +     +      + +G +  L   F    +            I++    L+NN
Sbjct: 338 NTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQ-----------TITMPKETLTNN 384

Query: 364 NLSGAIPTSLEKLS 377
           +L+ A+   L    
Sbjct: 385 SLTIAVSPDLLDQF 398

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (265), Expect = 2e-24
 Identities = 67/396 (16%), Positives = 134/396 (33%), Gaps = 47/396 (11%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
           L+++ L  L  L+   NKL       +    +L  L+   N+L    + I       L  
Sbjct: 100 LDVTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTL----TEIDVSHNTQLTE 152

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L    N     +   +   ++L+ L+ S N  +          + L  LN   N +T   
Sbjct: 153 LDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKL- 206

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                   L+    LTF+  S N L  I     +  L+  L  F  S   ++      ++
Sbjct: 207 -------DLNQNIQLTFLDCSSNKLTEI----DVTPLT-QLTYFDCSVNPLTELDVSTLS 254

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG 243
            LT   T+      L     I L+   +L     +  +    +   +   T+LY L+   
Sbjct: 255 KLT---TLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA 306

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN 303
             +   +    S    L  L L++ ELT + ++  +   +  L+  +  +       +G 
Sbjct: 307 AGI-TELD--LSQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQD-FS-SVGK 359

Query: 304 LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
           +  L     +     + +P E     +L         +   + D FG+ ++++  +    
Sbjct: 360 IPALNNNFEAEGQTIT-MPKETLTNNSLTIA------VSPDLLDQFGNPMNIEPGDGGVY 412

Query: 364 NLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSF 399
           + +    T     +    +  +F    G I    + 
Sbjct: 413 DQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTT 448

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 45/291 (15%), Positives = 90/291 (30%), Gaps = 58/291 (19%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLE 62
            L+++    L  LD   NK+   +   +    +L  L+   N+    ++ +   +   L 
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNN----ITKLDLNQNIQLT 215

Query: 63  ALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS 122
            L    N  +  I                              L  L + +   N LT  
Sbjct: 216 FLDCSSNKLT-EID--------------------------VTPLTQLTYFDCSVNPLTE- 247

Query: 123 TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI 182
                    +S    LT +H     L  I       +L+H+ +  Y            ++
Sbjct: 248 -------LDVSTLSKLTTLHCIQTDLLEI-------DLTHNTQLIYFQAEGCRKIKELDV 293

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
           T+ T    +D     +     + LS+  KL  L L++ +L   +   +   T+L  L   
Sbjct: 294 THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFL 293
              +     +    + +L     +  +  ++P         L +  S + L
Sbjct: 348 NAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS-LTIAVSPDLL 395

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  129 bits (326), Expect = 5e-32
 Identities = 76/412 (18%), Positives = 137/412 (33%), Gaps = 28/412 (6%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLW 67
             Q LE LDL HNKL   +         LK L L  N+            +  L+ L L 
Sbjct: 67  FNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 68  GNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELS 127
             +   +    I + +   +L +   ++          L++    +L   + T+      
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 128 FLSSLSNCKSLTFIHLSDNP----LDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
              S+    +L   ++            LS  +    +  L +  ++N   +      I 
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241

Query: 184 NLTNSITI--------DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTE 235
            L    T+         L G         + + L+ L    +  +             + 
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301

Query: 236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLT 294
           +       +        C S ++    L  S+N LT        +L ++  L    N L 
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

Query: 295 GPLPLEIG---NLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFG 350
             L         +K L  +D S N+ S           K+L  L +  N L  +I     
Sbjct: 362 E-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419

Query: 351 DLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
               +K L+L +N +  +IP  + KL  L++LN++ N+L+  +P  G F   
Sbjct: 420 -PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD-GIFDRL 467

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (266), Expect = 2e-24
 Identities = 64/350 (18%), Positives = 107/350 (30%), Gaps = 27/350 (7%)

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
                L +  N  S      I + SKL IL +S N       + F   + LE+L+L  N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L      +S         +L  + LS N  D +      GN+S  LK   +S  ++    
Sbjct: 81  LVK----ISC----HPTVNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEKSS 131

Query: 179 PEEITNLTN-SITIDLGGNKLNGSIPITLSKL--QKLQGLGLDDNKLEGSIPDSICRLTE 235
              I +L    + + LG        P  L     + L  +   + +    +  S+  +  
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191

Query: 236 LYELELGGNKLFGSIPACFSNLA-----------SLRILSLSSNELTSIPLTFWNLK--- 281
           L    +             S LA           +L  +  + N    I    W+     
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251

Query: 282 -DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR 340
             I  +                +LK L       + F            N+       + 
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311

Query: 341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
                      +     L+ SNN L+  +  +   L+ LE L L  N+L+
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 19/251 (7%)

Query: 159 NLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD 218
           +LS       +S   +S     +I +L+    + +  N++           Q+L+ L L 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 219 DNKLEGSIPDSICRLTELYELELGGNKLFGSIPAC--FSNLASLRILSLSSNELTSIPLT 276
            NKL   I         L  L+L  N    ++P C  F N++ L+ L LS+  L    + 
Sbjct: 78  HNKLV-KISCH--PTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 277 -FWNLKDILQLNFSSNFLTGPLP---LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE 332
              +L     L               L+  N + L  +  +   F  ++   +  + NLE
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 333 YLFLGYNRLEGSIPDSFGDLISL------KFLNLSNNNLSGAIPTSLEKL---SYLEDLN 383
              +     +         L  L        L L+N   +      + +L   + +   +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253

Query: 384 LSFNKLEGEIP 394
           +S  KL+G++ 
Sbjct: 254 ISNVKLQGQLD 264

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 10/145 (6%)

Query: 7   SNLQNLEELDLRHNKL--VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
            +L  LE L L+ N+L  +  +      M  L+ L +  NS+             +L +L
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            +  N  + TI R +    ++ +L+L  N     IP     L  L+ LN+  N L S   
Sbjct: 405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLD 149
                       SL  I L  NP D
Sbjct: 462 -----GIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 5/124 (4%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            +++L++LD+  N +              L  L++ +N L     +I     P ++ L L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT---DTIFRCLPPRIKVLDL 428

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
             N    +IP+ +     L  L ++ N         F  L +L+ + L  N    S P +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 487

Query: 127 SFLS 130
            +LS
Sbjct: 488 DYLS 491

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 311 DFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
           + S N  S +  ++I  L  L  L + +NR++      F     L++L+LS+N L     
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI-- 84

Query: 371 TSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
            S      L+ L+LSFN  +  +P    FGN
Sbjct: 85  -SCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 50/239 (20%), Positives = 81/239 (33%), Gaps = 58/239 (24%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
               N+   +   +            +S    L   NN L   +       L  LE L+L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG-HLTELETLIL 355

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
             N     + +                     I      +++L+ L++  N ++    + 
Sbjct: 356 QMNQLK-ELSK---------------------IAEMTTQMKSLQQLDISQNSVSYDEKKG 393

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLT 186
                 S  KSL  +++S N L                         +   +P  I  L 
Sbjct: 394 DC----SWTKSLLSLNMSSNILTDT----------------------IFRCLPPRIKVL- 426

Query: 187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYELELGGN 244
                DL  NK+  SIP  + KL+ LQ L +  N+L+ S+PD I  RLT L ++ L  N
Sbjct: 427 -----DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 50/232 (21%), Positives = 84/232 (36%), Gaps = 10/232 (4%)

Query: 262 ILSLSSNELTSIPLTFWNL-KDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV 320
           ++  S N L  +P    +L +    LN S N+++     +I +L  L  +  S N    +
Sbjct: 4   LVDRSKNGLIHVP---KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNL-SGAIPTSLEKLSYL 379
             +     + LEYL L +N+L   I       ++LK L+LS N   +  I      +S L
Sbjct: 61  DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117

Query: 380 EDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPC--KTSIHHTSWKNSL 437
           + L LS   LE       +  N +       E        + L      S+H     N  
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177

Query: 438 LLGIVLPLSTTLLIVVIWLILRYRKRGKQPSNDANMPLVATWRTFSYLELCR 489
              I+     T+  + +  I    +  K     + +  + T    S L L  
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  122 bits (309), Expect = 6e-31
 Identities = 76/370 (20%), Positives = 123/370 (33%), Gaps = 93/370 (25%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIAD---VR 57
            +P EIS   +   LDL++N +          +  L  L L NN     +S I +     
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN----KISKIHEKAFSP 100

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
           L  L+ L +  N+    IP  +   S L  L +  N         F  LRN+  + +  N
Sbjct: 101 LRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
            L +S  E      L     L ++ +S+  L                             
Sbjct: 158 PLENSGFEPGAFDGLK----LNYLRISEAKLT---------------------------- 185

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD-SICRLTEL 236
                                   IP  L   + L  L LD NK++ +I    + R ++L
Sbjct: 186 -----------------------GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKL 219

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTG 295
           Y L LG N++   I     S L +LR L L +N+L+ +P    +LK +  +   +N +T 
Sbjct: 220 YRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT- 277

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSI--PDSFGDLI 353
                             +N+F  V             + L  N +      P +F  + 
Sbjct: 278 ---------------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVT 320

Query: 354 SLKFLNLSNN 363
               +   N 
Sbjct: 321 DRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (284), Expect = 1e-27
 Identities = 69/349 (19%), Positives = 119/349 (34%), Gaps = 80/349 (22%)

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           +L  +          +P+ I      ++L+L  N  S    + F  L++L  L L +N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
           +    +     + S  + L  +++S N L  I       NL  SL +  + +  +   +P
Sbjct: 91  SKIHEK-----AFSPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIRK-VP 139

Query: 180 EEI-TNLTNSITIDLGGNKL-NGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
           + + + L N   I++GGN L N           KL  L + + KL   IP  +     L 
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN 196

Query: 238 ELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTG 295
           EL L  NK+  +I        + L  L L  N++  I   +   L               
Sbjct: 197 ELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP-------------- 241

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISL 355
                                              L  L L  N+L   +P    DL  L
Sbjct: 242 ----------------------------------TLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 356 KFLNLSNNNLSGAIP-------TSLEKLSYLEDLNLSFNKLE-GEIPRG 396
           + + L  NN++  +            K +Y   ++L  N +   E+   
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 29/143 (20%), Positives = 52/143 (36%), Gaps = 5/143 (3%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
            LR++  S   L ++P       D   L+  +N ++     +   L+ L  +    N  S
Sbjct: 34  HLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY 378
            +       L+ L+ L++  N L   IP       SL  L + +N +          L  
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRN 148

Query: 379 LEDLNLSFNKLEGEIPRGGSFGN 401
           +  + +  N LE      G+F  
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDG 171

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  124 bits (313), Expect = 3e-30
 Identities = 74/409 (18%), Positives = 141/409 (34%), Gaps = 24/409 (5%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLPNLEALLL 66
             Q+LE LD+ HN+L   +       + L+ L L  N     L    +   L  L  L L
Sbjct: 98  FNQDLEYLDVSHNRLQ-NISCCPM--ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153

Query: 67  WGNNF-SGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
               F    +           +L+L      G    +     N   L+L  +  +  + +
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQ 212

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
           ++   +      L+ I L+D     +++  S      +L +  + +   +     ++   
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272

Query: 186 TNSITI--------DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
                +         +           + + L+ L    + +     S         E+ 
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLT-- 294
              L  +        C  + +S   L+ + N  T         LK +  L    N L   
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392

Query: 295 GPLPLEIGNLKVLIGIDFSMNNFSS-VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
             + L   N+  L  +D S+N+ +S          +++  L L  N L GS+        
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450

Query: 354 SLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF 402
            +K L+L NN +  +IP  +  L  L++LN++ N+L+  +P  G F   
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRL 496

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  111 bits (278), Expect = 9e-26
 Identities = 72/376 (19%), Positives = 131/376 (34%), Gaps = 24/376 (6%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
           E  NL  L  L L   K    +         L  + L   S          +++PN   L
Sbjct: 141 EFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 65  LLWGN-NFSGTIPRFIFNAS----KLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
            L  + N   ++   +   +    +LS ++L+  +    +       R    LN+   ++
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC--NVSGG 177
            ++      L      + + ++++ +  +   + +        +LK   + +    V   
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 178 IPEEI-TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
             E + +         L  +       +          L    N    S+      L  L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379

Query: 237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP------LTFWNLKDILQLNFSS 290
             L L  N L  +         ++  L      L S+          W  + IL LN SS
Sbjct: 380 QTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW-AESILVLNLSS 437

Query: 291 NFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD-S 348
           N LTG +   +   +KVL   D   N   S IP ++  L+ L+ L +  N+L+ S+PD  
Sbjct: 438 NMLTGSVFRCLPPKVKVL---DLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGV 492

Query: 349 FGDLISLKFLNLSNNN 364
           F  L SL+++ L +N 
Sbjct: 493 FDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 66/351 (18%), Positives = 111/351 (31%), Gaps = 31/351 (8%)

Query: 59  PNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
           P  +AL L  N+ S  +        S+L +L LS N       + F   ++LE+L++  N
Sbjct: 52  PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
            L +    +S         SL  + LS N  D +      GNL+  L    +S       
Sbjct: 111 RLQN----ISC----CPMASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL 161

Query: 178 IPEEITNL-TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
               + +L  + I +DL    + G    +L        L L  +            +  L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNAL 220

Query: 237 YELELGGNKLFGSIPACFSNLA------------SLRILSLSSNELTSIPLTFWNLKDIL 284
             L+L   KL                        +L+ +  +      +   FW  + + 
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP-RPVE 279

Query: 285 QLNFSSNFLTGPLPLEIGN-----LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN 339
            LN  +  +T  +  E        LK L+        F             +    L  +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339

Query: 340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
                         S  FLN + N  + ++      L  L+ L L  N L+
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.0 bits (205), Expect = 8e-17
 Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 41/272 (15%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFN-----MSMLKLLHLQNNSLLGCLSSIADVRL 58
            +    + +E L++ +  +   +    F      +  L + H++N   L    ++     
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS-VF 328

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
             +   +L  ++          + S  + L  +QN F+  +      L+ L+ L L+ N 
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L +       ++ ++  K+++ +   D  L+ + S                         
Sbjct: 389 LKN----FFKVALMT--KNMSSLETLDVSLNSLNS-----------------------HA 419

Query: 179 PEEITNLTNSITI-DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
            +       SI + +L  N L GS+   L    K++ L L +N++  SIP  +  L  L 
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476

Query: 238 ELELGGNKLFGSIP-ACFSNLASLRILSLSSN 268
           EL +  N+L  S+P   F  L SL+ + L  N
Sbjct: 477 ELNVASNQL-KSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 42/146 (28%), Positives = 61/146 (41%), Gaps = 10/146 (6%)

Query: 6   ISNLQNLEELDLRHNKL--VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
            S L+ L+ L L+ N L     V     NMS L+ L +  NSL             ++  
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L L  N  +G++ R +    K+ +L+L  N     IP    +L+ L+ LN+  N L S  
Sbjct: 433 LNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVP 489

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLD 149
                        SL +I L DNP D
Sbjct: 490 D-----GVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 311 DFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
             S N+ S +   +I  L  L  L L +NR+       F     L++L++S+N L   I 
Sbjct: 58  SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS 116

Query: 371 TSLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 401
                ++ L  L+LSFN  +  +P    FGN
Sbjct: 117 CC--PMASLRHLDLSFNDFD-VLPVCKEFGN 144

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  116 bits (292), Expect = 6e-28
 Identities = 72/331 (21%), Positives = 115/331 (34%), Gaps = 86/331 (25%)

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
                ++      S  +P+ I   S    L L +N+      +TF +L +LE L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           +           + +   SL  + L DN                                
Sbjct: 111 IRQIEVG-----AFNGLASLNTLELFDN-------------------------------- 133

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELY 237
              +T + +                     L KL+ L L +N +E SIP     R+  L 
Sbjct: 134 --WLTVIPSG----------------AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLM 174

Query: 238 ELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP 296
            L+LG  K    I    F  L +L+ L+L    +  +P     L                
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLV--------------- 218

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK 356
                  L+ L   + S N+F  + P    GL +L+ L++  +++     ++F  L SL 
Sbjct: 219 ------GLEEL---EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
            LNL++NNLS         L YL +L+L  N
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  110 bits (278), Expect = 4e-26
 Identities = 63/243 (25%), Positives = 91/243 (37%), Gaps = 15/243 (6%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
           GIP     L      +L  N +      T   L  L+ L L  N +      +   L  L
Sbjct: 72  GIPSNTRYL------NLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSS-NFL 293
             LEL  N L   IP+  F  L+ LR L L +N + SIP   F  +  +++L+      L
Sbjct: 126 NTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184

Query: 294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
                     L  L  ++  M N   +    +  L  LE L +  N      P SF  L 
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242

Query: 354 SLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG--GSFGNFAAESFEGNE 411
           SLK L + N+ +S     + + L+ L +LNL+ N L   +P                 N 
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301

Query: 412 LLC 414
             C
Sbjct: 302 WNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (265), Expect = 2e-24
 Identities = 66/296 (22%), Positives = 107/296 (36%), Gaps = 68/296 (22%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLP 59
           E+P  I    N   L+L  N +   + A  F ++  L++L L  NS+             
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI------------- 111

Query: 60  NLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
                          I    F   + L+ LEL  N  +      F  L  L  L LR+N 
Sbjct: 112 -------------RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP 158

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           + S         + +   SL  + L +              L +               I
Sbjct: 159 IESIPS-----YAFNRVPSLMRLDLGELK-----------KLEY---------------I 187

Query: 179 PEEI-TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
            E     L N   ++LG   +   +P  L+ L  L+ L +  N      P S   L+ L 
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245

Query: 238 ELELGGNKLFGSIPAC-FSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
           +L +  +++   I    F  LASL  L+L+ N L+S+P   F  L+ +++L+   N
Sbjct: 246 KLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 13/146 (8%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIAD-VRLPNLEAL 64
           + + +L  LDL   K +  +    F  +  LK L+L   ++      + +   L  LE L
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI----KDMPNLTPLVGLEEL 223

Query: 65  LLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
            + GN+F   I    F   S L  L +  +  S    N F  L +L  LNL  N L+S  
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLD 149
            +L      +  + L  +HL  NP +
Sbjct: 283 HDL-----FTPLRYLVELHLHHNPWN 303

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  117 bits (295), Expect = 7e-28
 Identities = 62/297 (20%), Positives = 115/297 (38%), Gaps = 37/297 (12%)

Query: 104 GNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHS 163
            N  +L   N   N ++ +  +    S+    +       + N    +L +  I   S  
Sbjct: 8   NNNFSLS-QNSFYNTISGTYADY--FSAWDKWEKQALPGENRNEAVSLLKECLINQFSE- 63

Query: 164 LKDFYMSNCNVSGGIPEEI-TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL 222
                ++  N+S  +P+ +   +T    +++  N L  S+P   + L+ L      DN+L
Sbjct: 64  ---LQLNRLNLSS-LPDNLPPQIT---VLEITQNAL-ISLPELPASLEYLD---ACDNRL 112

Query: 223 EGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD 282
             ++P+    L  L    +  N+L   +P      A L  ++  +N+LT +P    +L+ 
Sbjct: 113 S-TLPELPASLKHLD---VDNNQL-TMLPEL---PALLEYINADNNQLTMLPELPTSLE- 163

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE----YLFLGY 338
              L+  +N LT  LP    +L+ L   D S N   S +P       + E    +     
Sbjct: 164 --VLSVRNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRE 216

Query: 339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR 395
           NR+   IP++   L     + L +N LS  I  SL + +   D +           +
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  111 bits (280), Expect = 5e-26
 Identities = 64/386 (16%), Positives = 125/386 (32%), Gaps = 66/386 (17%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
           I L I+N  +L   +  +N + GT           +   L   +    +S + +  +   
Sbjct: 3   IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
             L L   N S ++P  +    ++++LE++QN+    +P    +L   E+L+  DN L++
Sbjct: 62  SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLST 114

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
                      ++ K L    + +N L  +                           PE 
Sbjct: 115 ------LPELPASLKHL---DVDNNQLTML---------------------------PEL 138

Query: 182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
              L     I+   N+L   +P        L+ L + +N+L   +P+    L  L    +
Sbjct: 139 PALLE---YINADNNQLT-MLP---ELPTSLEVLSVRNNQLT-FLPELPESLEALD---V 187

Query: 242 GGNKLFGSIPACFSNLASLR----ILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL 297
             N L  S+PA                   N +T IP    +L     +    N L+  +
Sbjct: 188 STNLL-ESLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRI 246

Query: 298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKF 357
              +               FS     +    + L       + +    P++    +S  +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL------ADAVTAWFPENKQSDVSQIW 300

Query: 358 LNLSNNNLSGAIPTSLEKLSYLEDLN 383
               +   +      L++LS      
Sbjct: 301 HAFEHEEHANTFSAFLDRLSDTVSAR 326

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 46/229 (20%), Positives = 78/229 (34%), Gaps = 49/229 (21%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +P   ++L+    LD   N+L  T+P    +   LK L + NN     L+ + ++    
Sbjct: 94  SLPELPASLE---YLDACDNRLS-TLPELPAS---LKHLDVDNN----QLTMLPEL-PAL 141

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           LE +    N  +  +P      + L +L +  N  + F+P       +LE L++  N L 
Sbjct: 142 LEYINADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE 193

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
           S              ++  F    +N +      T                      IPE
Sbjct: 194 SLPAVPVRNHHSE--ETEIFFRCRENRI------TH---------------------IPE 224

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDS 229
            I +L  + TI L  N L+  I  +LS+                S    
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  114 bits (288), Expect = 2e-27
 Identities = 73/331 (22%), Positives = 121/331 (36%), Gaps = 86/331 (25%)

Query: 59  PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
                ++    N    +P  I   +   +L L +N       N+F +LR+LE L L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           + +         + +   +L  + L DN                                
Sbjct: 100 IRTIEIG-----AFNGLANLNTLELFDN-------------------------------- 122

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELY 237
              +T + N                     L KL+ L L +N +E SIP     R+  L 
Sbjct: 123 --RLTTIPNG----------------AFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163

Query: 238 ELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP 296
            L+LG  K    I    F  L++LR L+L+   L  IP     L                
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPL---------------- 206

Query: 297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK 356
                  L  L   D S N+ S++ P    GL +L+ L++  ++++    ++F +L SL 
Sbjct: 207 -----IKLDEL---DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
            +NL++NNL+         L +LE ++L  N
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (277), Expect = 4e-26
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 17/244 (6%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
           GI      L      +L  N++      +   L+ L+ L L  N +      +   L  L
Sbjct: 61  GISTNTRLL------NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSS-NFL 293
             LEL  N+L  +IP   F  L+ L+ L L +N + SIP   F  +  + +L+      L
Sbjct: 115 NTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173

Query: 294 TGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL 352
           +  +       L  L  ++ +M N    IP  +  L  L+ L L  N L    P SF  L
Sbjct: 174 SY-ISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG--GSFGNFAAESFEGN 410
           + L+ L +  + +      + + L  L ++NL+ N L   +P        +        N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

Query: 411 ELLC 414
              C
Sbjct: 290 PWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (258), Expect = 1e-23
 Identities = 62/271 (22%), Positives = 102/271 (37%), Gaps = 41/271 (15%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           E+P  IS   N   L+L  N++      +  ++  L++L L  N  +  +   A   L N
Sbjct: 57  EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIRTIEIGAFNGLAN 113

Query: 61  LEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD-NY 118
           L  L L+ N  + TIP   F   SKL  L L  N         F  + +L  L+L +   
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           L+  +       +     +L +++L+   L  I                           
Sbjct: 173 LSYISEG-----AFEGLSNLRYLNLAMCNLREI--------------------------- 200

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
              +T L     +DL GN L+   P +   L  LQ L +  ++++    ++   L  L E
Sbjct: 201 -PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259

Query: 239 LELGGNKLFGSIPA-CFSNLASLRILSLSSN 268
           + L  N L   +P   F+ L  L  + L  N
Sbjct: 260 INLAHNNL-TLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.0 bits (213), Expect = 6e-18
 Identities = 41/146 (28%), Positives = 61/146 (41%), Gaps = 13/146 (8%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIAD-VRLPNLEAL 64
           + + +L  LDL   K +  +    F  +S L+ L+L   +L      I +   L  L+ L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL----REIPNLTPLIKLDEL 212

Query: 65  LLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
            L GN+ S  I    F     L  L + Q+       N F NL++L  +NL  N LT   
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLD 149
            +L      +    L  IHL  NP +
Sbjct: 272 HDL-----FTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 34/147 (23%), Positives = 52/147 (35%), Gaps = 4/147 (2%)

Query: 251 PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGI 310
           P+  S       +      L  +P       +   LN   N +         +L+ L  +
Sbjct: 36  PSVCSCSNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93

Query: 311 DFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
             S N+  ++      GL NL  L L  NRL      +F  L  LK L L NN +     
Sbjct: 94  QLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 371 TSLEKLSYLEDLNLS-FNKLEGEIPRG 396
            +  ++  L  L+L    +L   I  G
Sbjct: 154 YAFNRIPSLRRLDLGELKRLS-YISEG 179

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  111 bits (279), Expect = 2e-27
 Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 10/150 (6%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLAPVIHC 616
           +    LV E+  HG L  YL +   +      L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           DL   N L+ +N V  +SDFG+ + ++ + 
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (282), Expect = 2e-27
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG+V+K           + V +KV   + G ++F++       + S+ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCL 610
           +  C     + LV +Y P GSL  ++      L     LN  + +A  + YL        
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H +L   NVLL       ++DFG+A LL  +D
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  112 bits (283), Expect = 2e-27
 Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 23/182 (12%)

Query: 474 PLVATWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGME-----VAVKVFNLQC 528
           P  A  R     E  +         ++G G FG+VYK       E     VA+K      
Sbjct: 4   PNQALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 529 G-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD 587
             +A K    E  +M S+ + ++ +++  C     + L+ +  P G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115

Query: 588 IFQRLNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 644
               LN  + +A  + YL           +H DL   NVL+       ++DFG+AKLL  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 645 ED 646
           E+
Sbjct: 170 EE 171

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  111 bits (280), Expect = 2e-27
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 11/225 (4%)

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLE--GSIPDSICRLTE 235
           +P  I   +++  ++L  NKL         KL +L  L L  N L   G    S    T 
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP--LTFWNLKDILQLNFSSNFL 293
           L  L+L  N +  ++ + F  L  L  L    + L  +     F +L++++ L+ S    
Sbjct: 80  LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138

Query: 294 TGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFGD 351
                  I   L  L  +  + N+F      +I   L+NL +L L   +LE   P +F  
Sbjct: 139 RV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197

Query: 352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
           L SL+ LN+S+NN         + L+ L+ L+ S N +     + 
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (268), Expect = 1e-25
 Identities = 59/308 (19%), Positives = 96/308 (31%), Gaps = 63/308 (20%)

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           +       + ++P  I   S  + LEL  N         F  L  L  L+L  N L+   
Sbjct: 12  IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                    ++   L ++ LS N +                             +     
Sbjct: 69  CCSQSDFGTTS---LKYLDLSFNGV---------------------------ITMSSNFL 98

Query: 184 NLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSICR-LTELYELEL 241
            L     +D   + L           L+ L  L +          + I   L+ L  L++
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKM 157

Query: 242 GGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPL 299
            GN    +     F+ L +L  L LS  +L  +    F +L                   
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS------------------ 199

Query: 300 EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI-SLKFL 358
              +L+VL   + S NNF S+       L +L+ L    N +  S          SL FL
Sbjct: 200 ---SLQVL---NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253

Query: 359 NLSNNNLS 366
           NL+ N+ +
Sbjct: 254 NLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 56/297 (18%), Positives = 101/297 (34%), Gaps = 65/297 (21%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLP 59
            +P  I    +   L+L  NKL  ++P  +F  ++ L  L L +N               
Sbjct: 21  SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSN--------------- 62

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
            L        +  GT        + L  L+LS N     + + F  L  LE L+ + + L
Sbjct: 63  GLSFKGCCSQSDFGT--------TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 113

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
              +    F     + ++L ++ +S              +                    
Sbjct: 114 KQMSEFSVF----LSLRNLIYLDISHT------------HTRV---------------AF 142

Query: 180 EEI-TNLTNSITIDLGGNKLNGSI-PITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTEL 236
             I   L++   + + GN    +  P   ++L+ L  L L   +LE  +  +    L+ L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSL 201

Query: 237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQ-LNFSSN 291
             L +  N  F      +  L SL++L  S N + +       +    L  LN + N
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 8/145 (5%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
            +L+NL  LD+ H          IF  +S L++L +  NS            L NL  L 
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 66  LWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
           L        +    FN+ S L +L +S N+F       +  L +L+ L+   N++ +S  
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLD 149
           +   L       SL F++L+ N   
Sbjct: 241 QE--LQHFP--SSLAFLNLTQNDFA 261

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (279), Expect = 3e-27
 Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 15/158 (9%)

Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
            +IGRG FG VY   L    G  +  AVK  N          F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 553 VISSCSNEEFKAL-VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 608
           ++  C   E   L VL Y  HG L  ++ +      +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                +H DL   N +LD+     ++DFG+A+ +  ++
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  110 bits (277), Expect = 3e-27
 Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 10/150 (6%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VAVK+   +   +   F  E + M  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLAPVIHC 616
           E    +V EY  +G L  YL S    L+  Q L +  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           DL   N L+D +L   +SDFG+ + ++ + 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  112 bits (283), Expect = 3e-27
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 5/149 (3%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IGRG FG V+  RL  D   VAVK             F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
           + ++   +V+E    G    +L +    L +   L ++ D A+ +EYL        IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 618 LKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           L   N L+ +  V  +SDFG+++      
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGV 267

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  110 bits (278), Expect = 4e-27
 Identities = 46/157 (29%), Positives = 61/157 (38%), Gaps = 17/157 (10%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V +       G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGC 609
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (278), Expect = 4e-27
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V   R        G +VAVK    + G         E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 608
              C+ +      L++E+ P GSL++YL  +   +++ Q+L   + +   ++YL    + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY- 147

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                +H DL   NVL++      + DFG+ K +
Sbjct: 148 -----VHRDLAARNVLVESEHQVKIGDFGLTKAI 176

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  110 bits (276), Expect = 7e-27
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +G+G FGSV   R        G  VAVK          + F  E E++KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 555 SSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGC 609
             C +   +   L++EY P+GSL  YL      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 135

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               IH DL   N+L+++     + DFG+ K+L
Sbjct: 136 ----IHRDLATRNILVENENRVKIGDFGLTKVL 164

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 7e-27
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +G+G FGSV   R        G  VAVK          + F  E E++KS++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 555 SSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGC 609
             C +   +   L++EY P+GSL  YL      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 166

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               IH DL   N+L+++     + DFG+ K+L
Sbjct: 167 ----IHRDLATRNILVENENRVKIGDFGLTKVL 195

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (275), Expect = 9e-27
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 10/150 (6%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLAPVIHC 616
           +    ++ EY  +G L  YL          Q L +  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           DL   N L++D  V  +SDFG+++ ++ ++
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  109 bits (275), Expect = 9e-27
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 15/160 (9%)

Query: 496 ENNLIGRGGFGSVYKARLGDG----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNL 550
            + +IG+G FG VY     D     ++ A+K  +     +  ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 551 IKVISSCSNEE-FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---H 606
           + +I      E    ++L Y  HG L +++ S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           F      +H DL   N +LD++    ++DFG+A+ ++  +
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDRE 178

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (276), Expect = 9e-27
 Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 11/152 (7%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +G GGF  V     L DG   A+K       +  +    E +M +   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 558 SNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCL 610
             E        L+L +   G+L   +       +     Q L +++ +   LE +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               H DLKP N+LL D     L D G     
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  109 bits (274), Expect = 1e-26
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 500 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRAFKS---FAVECEMMKSIRHRNLIKV 553
           +G G FGSV +         ++VA+KV  L+ G           E ++M  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCL 610
           I  C  E    LV+E    G L K+L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  109 bits (275), Expect = 2e-26
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 16/157 (10%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +G+G FGSV   R        G  VAVK          + F  E +++K++    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 555 SSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGC 609
                   ++  LV+EY P G L  +L      LD  + L     +   +EYL       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +H DL   N+L++      ++DFG+AKLL  + 
Sbjct: 149 ----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  109 bits (274), Expect = 2e-26
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G  G V   RL       + VA+K        R  + F  E  +M    H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
              +      +V EY  +GSL+ +L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H DL   NVL+D NLV  +SDFG++++L  + 
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (276), Expect = 2e-26
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 15/158 (9%)

Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
            +IGRG FG VY   L    G  +  AVK  N          F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 553 VISSCSNEEFKAL-VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 608
           ++  C   E   L VL Y  HG L  ++ +      +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                +H DL   N +LD+     ++DFG+A+ +  ++
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  111 bits (279), Expect = 3e-26
 Identities = 37/153 (24%), Positives = 76/153 (49%), Gaps = 12/153 (7%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
             +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYL---HFGCLAPV 613
           + E    ++ E+   GSL  +L S       + + ++    +A  + ++   ++      
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY------ 305

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           IH DL+  N+L+  +LV  ++DFG+A+++   +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE 338

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  110 bits (278), Expect = 3e-26
 Identities = 50/146 (34%), Positives = 74/146 (50%), Gaps = 14/146 (9%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG+G FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 560 EEFKA-LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAPVI 614
           E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL   +F      +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF------V 311

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAK 640
           H DL   NVL+ ++ VA +SDFG+ K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (272), Expect = 4e-26
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 16/156 (10%)

Query: 500 IGRGGFGSVYKARLGDGME-----VAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG+VYK       E     VA+K        +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCL 610
           +  C     + L+ +  P G L  Y+      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  107 bits (270), Expect = 4e-26
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 20/157 (12%)

Query: 500 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCG----RAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG+V K           VAVK+  L+              E  +M+ + +  +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGC 609
           +I  C  E +  LV+E    G L KYL   N  +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +H DL   NVLL     A +SDFG++K L  ++
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (279), Expect = 7e-26
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 500 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRAFKS---FAVECEMMKSIRHRNLIKV 553
           +G G FGSV +         ++VA+KV  L+ G           E ++M  + +  ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCL 610
           I  C  E    LV+E    G L K+L      + +     ++  V+  ++YL   +F   
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  110 bits (277), Expect = 8e-26
 Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 12/153 (7%)

Query: 498 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           + +G G +G VY+       + VAVK    +     + F  E  +MK I+H NL++++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAP 612
           C+ E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL   +F     
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----- 339

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            IH +L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (267), Expect = 9e-26
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 14/149 (9%)

Query: 500 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKVISSC 557
           +G G +G VY+       + VAVK   L+        F  E  +MK I+H NL++++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAPV 613
           + E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL   +F      
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF------ 132

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           IH DL   N L+ +N +  ++DFG+++L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM 161

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (266), Expect = 1e-25
 Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 12/151 (7%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 560 EEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAPVIH 615
           E    ++ EY  +GSL  +L + +   L I + L++   +A  + ++   ++      IH
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY------IH 132

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            DL+  N+L+ D L   ++DFG+A+L+   +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (266), Expect = 1e-25
 Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 14/148 (9%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
             IG+G FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 558 SNEEFKA-LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAP 612
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL   +F     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----- 138

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +H DL   NVL+ ++ VA +SDFG+ K
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (266), Expect = 1e-25
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 15/155 (9%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVI 554
           +G G FG VY+       G+ + VAVK     C     + F  E  +MK++ H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
                E    +++E  P+G L  YL  +   L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H D+   N+L+       L DFG+++ +  ED
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  109 bits (273), Expect = 1e-25
 Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 12/153 (7%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAPV 613
           S E    +V EY   GSL  +L       L + Q +++   +AS + Y+   ++      
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------ 301

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H DL+  N+L+ +NLV  ++DFG+A+L+   +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  109 bits (274), Expect = 2e-25
 Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 12/153 (7%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL---HFGCLAPV 613
           S E    +V EY   GSL  +L       L + Q +++   +AS + Y+   ++      
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------ 384

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H DL+  N+L+ +NLV  ++DFG+A+L+   +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNE 417

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (265), Expect = 3e-25
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 25/166 (15%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FGSV +  L    G  ++VAVK   L     R  + F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 554 ISSCSNEEFKA-----LVLEYKPHGSLEKYL-----YSSNCILDIFQRLNIMIDVASALE 603
           +  C     +      ++L +  +G L  YL      +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 604 YL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL   +F      +H DL   N +L D++   ++DFG++K +   D
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (265), Expect = 4e-25
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           IG G FG VYK  L        + VA+K        +    F  E  +M    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCL 610
               S  +   ++ EY  +G+L+K+L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  106 bits (267), Expect = 4e-25
 Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 14/151 (9%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVI 554
           +G G FG V   RL       + VA+K   +    +  + F  E  +M    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
              +  +   +V EY  +GSL+ +L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             +H DL   N+L++ NLV  +SDFG+ ++L
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVL 197

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  104 bits (262), Expect = 4e-25
 Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 25/166 (15%)

Query: 500 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI 551
           +G+G F  ++K               EV +KV +       +SF     MM  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 608
                C   +   LV E+   GSL+ YL  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 609 CLAPVIHCDLKPDNVLLD--------DNLVAYLSDFGIAKLLIGED 646
                IH ++   N+LL         +     LSD GI+  ++ +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  105 bits (263), Expect = 5e-25
 Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 19/154 (12%)

Query: 500 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V          G G  VAVK      G +    +  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 554 ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 608
              C +    +  LV+EY P GSL  YL   +  + + Q L     +   + YL   H+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHY- 155

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                IH DL   NVLLD++ +  + DFG+AK +
Sbjct: 156 -----IHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  103 bits (260), Expect = 6e-25
 Identities = 36/155 (23%), Positives = 63/155 (40%), Gaps = 15/155 (9%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V++          + VA+K           + F  E   M+   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
              +      +++E    G L  +L      LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H D+   NVL+  N    L DFG+++ +    
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  103 bits (260), Expect = 7e-25
 Identities = 60/214 (28%), Positives = 82/214 (38%), Gaps = 10/214 (4%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
           GIP     +       L GN+++     +    + L  L L  N L      +   L  L
Sbjct: 29  GIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLT 294
            +L+L  N    S+    F  L  L  L L    L  +    F  L  +  L    N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 295 GPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI 353
             LP +   +L  L  +    N  SSV      GL +L+ L L  NR+    P +F DL 
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 354 SLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
            L  L L  NNLS     +L  L  L+ L L+ N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (253), Expect = 7e-24
 Identities = 53/237 (22%), Positives = 81/237 (34%), Gaps = 37/237 (15%)

Query: 59  PNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
              + + L GN  S  +P   F     L+IL L  N  +      F  L  LE L+L DN
Sbjct: 32  AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
               S    +F         L  +HL    L        +                   G
Sbjct: 91  AQLRSVDPATF----HGLGRLHTLHLDRCGL------QEL-----------------GPG 123

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
           +   +  L     + L  N L  ++P  T   L  L  L L  N++      +   L  L
Sbjct: 124 LFRGLAALQ---YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
             L L  N++   +    F +L  L  L L +N L+++P      L+ +  L  + N
Sbjct: 180 DRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 4/210 (1%)

Query: 159 NLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD 218
            +  + +  ++    +S           N   + L  N L        + L  L+ L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 219 DNKLEGSIPDSI-CRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-L 275
           DN    S+  +    L  L+ L L    L   +    F  LA+L+ L L  N L ++P  
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
           TF +L ++  L    N ++         L  L  +    N  + V P     L  L  L+
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNL 365
           L  N L     ++   L +L++L L++N  
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 23/276 (8%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +P+ I      + + L  N++     A+      L +L L +N  L  + + A   L  
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLAL 81

Query: 61  LEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
           LE L L  N    ++    F    +L  L L +       P  F  L  L++L L+DN L
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
            +   +        +  +LT + L  N +  +  + +   L  SL    +    V+  + 
Sbjct: 142 QALPDDT-----FRDLGNLTHLFLHGNRISSV-PERAFRGLH-SLDRLLLHQNRVA-HVH 193

Query: 180 EEI-TNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
                +L   +T+ L  N L+ ++P   L+ L+ LQ L L+DN          CR   L+
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCD-----CRARPLW 247

Query: 238 ELELGGNKLFGSIPACFS--NLASLRILSLSSNELT 271
              L   +   S   C     LA   +  L++N+L 
Sbjct: 248 AW-LQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (261), Expect = 8e-25
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 7/150 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           ++G+G +G VY  R L + + +A+K    +  R  +    E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLHFGCLAPVIH 615
           S   F  + +E  P GSL   L S    L   ++        +   L+YLH      ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145

Query: 616 CDLKPDNVLLD-DNLVAYLSDFGIAKLLIG 644
            D+K DNVL++  + V  +SDFG +K L G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  103 bits (260), Expect = 9e-25
 Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 10/154 (6%)

Query: 497 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +  IGRG F +VYK       +EVA              + F  E EM+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 554 ISSCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
             S  +         LV E    G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 610 LAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLL 642
             P+IH DLK DN+ +        + D G+A L 
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (261), Expect = 9e-25
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNL--IKV 553
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLAP 612
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H  G    
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 147

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H DLKP N L+ D ++  L DFGIA  +
Sbjct: 148 IVHSDLKPANFLIVDGMLK-LIDFGIANQM 176

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  108 bits (270), Expect = 1e-24
 Identities = 31/153 (20%), Positives = 67/153 (43%), Gaps = 17/153 (11%)

Query: 499 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKVI 554
            I  GG G +Y A    + +G  V +K          ++    E + +  + H +++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 555 -----SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
                +    +    +V+EY    SL++        L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +++ DLKP+N++L +  +  L D G    +
Sbjct: 200 SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRI 231

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  104 bits (262), Expect = 2e-24
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNL--IKV 553
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLAP 612
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H  G    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG---- 175

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H DLKP N L+ D ++  L DFGIA  +
Sbjct: 176 IVHSDLKPANFLIVDGMLK-LIDFGIANQM 204

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  103 bits (259), Expect = 2e-24
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 26/167 (15%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKV 553
           +G+G FGSV +A+L    G  ++VAVK+           + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 554 ISSCSNEEFKA------LVLEYKPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASAL 602
           +        K       ++L +  HG L  +L +S        L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 603 EYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           EYL   +F      IH DL   N +L +++   ++DFG+++ +   D
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  103 bits (258), Expect = 4e-24
 Identities = 58/368 (15%), Positives = 111/368 (30%), Gaps = 61/368 (16%)

Query: 27  PAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLS 86
           P  ++ + +L ++   +       +S   +             + + +IP  +     + 
Sbjct: 2   PHTLWMVWVLGVIISLSKEESSNQAS---LSCDRNGICKGSSGSLN-SIPSGLT--EAVK 55

Query: 87  ILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
            L+LS N  +    +      NL+ L L  N + +         S S+  SL  + LS N
Sbjct: 56  SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE-----DSFSSLGSLEHLDLSYN 110

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP--I 204
            L  + S                               L++   ++L GN    ++    
Sbjct: 111 YLSNLSSSW--------------------------FKPLSSLTFLNLLGNPYK-TLGETS 143

Query: 205 TLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELYELELGGNKLFGSIPA-CFSNLASLRI 262
             S L KLQ L + +      I       LT L ELE+  + L  S       ++ ++  
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSH 202

Query: 263 LSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI 321
           L L   +   +  +       +  L      L                  F  +  S+  
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGE 246

Query: 322 PTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLED 381
              +        + +    L   +      +  L  L  S N L        ++L+ L+ 
Sbjct: 247 TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305

Query: 382 LNLSFNKL 389
           + L  N  
Sbjct: 306 IWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 50/295 (16%), Positives = 104/295 (35%), Gaps = 50/295 (16%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIAD---VRLPNLEALLLW 67
            ++ LDL +N++     + +     L+ L L +N     +++I +     L +LE L L 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG----INTIEEDSFSSLGSLEHLDLS 108

Query: 68  GNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPN-TFGNLRNLEWLNLRDNYLTSSTPE 125
            N  S  +    F   S L+ L L  N +        F +L  L+ L + +    +    
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
             F    +    L  + +  + L                        +      + I N+
Sbjct: 168 KDF----AGLTFLEELEIDASDL-----------------------QSYEPKSLKSIQNV 200

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEG----SIP----DSICRLTELY 237
           +    + L   +    + I +     ++ L L D  L+      +     +S+ +     
Sbjct: 201 S---HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSN 291
            +++    LF  +    + ++ L  L  S N+L S+P   F  L  + ++   +N
Sbjct: 258 NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 7/195 (3%)

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLAS 259
           SIP  L+  + ++ L L +N++       + R   L  L L  N +  +I    FS+L S
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGS 101

Query: 260 LRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNF 317
           L  L LS N L+++    F  L  +  LN   N         +  +L  L  +     + 
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161

Query: 318 SSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKL 376
            + I  +   GL  LE L +  + L+   P S   + ++  L L        +   ++  
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221

Query: 377 SYLEDLNLSFNKLEG 391
           S +E L L    L+ 
Sbjct: 222 SSVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 30/151 (19%), Positives = 51/151 (33%), Gaps = 15/151 (9%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
           + L  LEEL++  + L    P ++ ++  +  L L        L  I      ++E L L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ-HILLLEIFVDVTSSVECLEL 229

Query: 67  WGNNFSGT----IPRFIFNA----SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
              +        +     N+         ++++  S    +      +  L  L    N 
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQ 288

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
           L  S P+  F        SL  I L  NP D
Sbjct: 289 LK-SVPDGIF----DRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 8/131 (6%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGC----LSSIADVRLPNL 61
            ++QN+  L L   + +  +        S ++ L L++  L       LS+     L   
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

Query: 62  EAL--LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
                +   +     + + +   S L  LE S+N         F  L +L+ + L  N  
Sbjct: 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

Query: 120 TSSTPELSFLS 130
             S P + +LS
Sbjct: 314 DCSCPRIDYLS 324

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  103 bits (258), Expect = 4e-24
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNL--IKV 553
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLAP 612
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H  G    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG---- 128

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           ++H DLKP N L+ D ++  L DFGIA  +
Sbjct: 129 IVHSDLKPANFLIVDGMLK-LIDFGIANQM 157

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  101 bits (253), Expect = 5e-24
 Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 10/154 (6%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVIS 555
            IG G +G   K R   DG  +  K  +         +    E  +++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 556 SCSNEEFKAL--VLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCL 610
              +     L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 611 AP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               V+H DLKP NV LD      L DFG+A++L
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  100 bits (252), Expect = 2e-23
 Identities = 40/147 (27%), Positives = 62/147 (42%), Gaps = 11/147 (7%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             +GRG FG V++ +    G + AVK   L+  R       E      +    ++ +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGA 118

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
                +  + +E    GSL + +    C L   + L  +      LEYLH      ++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRR---ILHG 174

Query: 617 DLKPDNVLLDDN-LVAYLSDFGIAKLL 642
           D+K DNVLL  +   A L DFG A  L
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCL 201

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (260), Expect = 2e-23
 Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 15/155 (9%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG G FG V++          M VA+K           + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCLA 611
              +      +++E    G L  +L      LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +H D+   NVL+  N    L DFG+++ +    
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 15/155 (9%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRAFKSFAVECEMMKSIRHRNLIK---V 553
           ++G+G   +V++ R    G   A+KVFN +   R       E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
               +      L++E+ P GSL   L    +   L   + L ++ DV   + +L      
Sbjct: 76  EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131

Query: 612 PVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLL 642
            ++H ++KP N++     D   V  L+DFG A+ L
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
           R  + F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61

Query: 548 RNLIKVISSCSNEEFKA-------------LVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
           + +++  ++                     + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 595 MIDVASALEYLHF-GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +  AL Y+H  G    +IH DLKP N+ +D++    + DFG+AK +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 10/151 (6%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
            IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N+IK  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCLA 611
           +S   +    +VLE    G L + +        +          + + SALE++H     
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            V+H D+KP NV +    V  L D G+ +  
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 25/172 (14%)

Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
           R    F E  LIG GGFG V+KA+   DG    +K       +A +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 548 RNLIKVISSCSNEEFKA----------------LVLEYKPHGSLEKYLYSSNCI-LDIFQ 590
            N++         ++                  + +E+   G+LE+++       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            L +   +   ++Y+H      +I+ DLKP N+ L D     + DFG+   L
Sbjct: 124 ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  101 bits (253), Expect = 1e-22
 Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 52/288 (18%)

Query: 105 NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-- 162
                   NL+   +T          + +   S+  I  +++ +       S+  + +  
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 65

Query: 163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL 222
           ++   +++   ++  I + +TNL N   + L  NK+   +  +L  L+KL+ L L+ N +
Sbjct: 66  NVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI 121

Query: 223 EGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD 282
              I + +  L +L  L LG NK+  +     S L  L  LSL  N+++ I         
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIV-------- 169

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
                             +  L  L  +  S N+ S +    + GLKNL+ L L      
Sbjct: 170 -----------------PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210

Query: 343 GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
               +   +L+    +  ++ +L    P  +      E  N+ ++  E
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 6e-19
 Identities = 44/283 (15%), Positives = 96/283 (33%), Gaps = 28/283 (9%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLPNLEAL 64
                   + +L+   +   V      ++ +  +   N+     + S+  +  LPN+  L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD----IKSVQGIQYLPNVTKL 70

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L GN  +   P  + N   L  L L +N           +L+ L+ L+L  N ++    
Sbjct: 71  FLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD--- 123

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
               ++ L +   L  ++L +N +  I   T +  L+  L    + +  +S      +  
Sbjct: 124 ----INGLVHLPQLESLYLGNNKITDI---TVLSRLT-KLDTLSLEDNQISD--IVPLAG 173

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
           LT    + L  N ++  +   L+ L+ L  L L   +      +    L     ++    
Sbjct: 174 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231

Query: 245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLN 287
            L    P   S+       ++  +         +     + + 
Sbjct: 232 SLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 2e-17
 Identities = 50/276 (18%), Positives = 92/276 (33%), Gaps = 28/276 (10%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLPNLEAL 64
            + L +++++   ++ +       I  +  +  L L  N     L+ I  +  L NL  L
Sbjct: 39  QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNK----LTDIKPLTNLKNLGWL 92

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L  N         + +  KL  L L  N  S        +L  LE L L +N +T    
Sbjct: 93  FLDENKIKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD--- 145

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH--SLKDFYMSNCNVSGGIPEEI 182
               ++ LS    L  + L DN +      + I  L+    L++ Y+S  ++S      +
Sbjct: 146 ----ITVLSRLTKLDTLSLEDNQI------SDIVPLAGLTKLQNLYLSKNHIS--DLRAL 193

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
             L N   ++L   +         S L     +   D  L      S     E   ++  
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 253

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFW 278
             +    +   F    ++       +   + PL   
Sbjct: 254 LPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEV 289

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 73.6 bits (180), Expect = 7e-14
 Identities = 35/137 (25%), Positives = 59/137 (43%), Gaps = 9/137 (6%)

Query: 254 FSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFS 313
               A     +L    +T    T   L  I Q+  +++ +     ++   L  +  +  +
Sbjct: 17  DDAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLN 73

Query: 314 MNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL 373
            N  + + P  +  LKNL +LFL  N+++  +  S  DL  LK L+L +N +S      L
Sbjct: 74  GNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS--DINGL 127

Query: 374 EKLSYLEDLNLSFNKLE 390
             L  LE L L  NK+ 
Sbjct: 128 VHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 28/234 (11%), Positives = 67/234 (28%), Gaps = 27/234 (11%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV-RLPNLEAL 64
           +S L  L+ L L  N++  +    +  ++ L+ L+L  N     +S +  +  L NL+ L
Sbjct: 149 LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVL 202

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L+             N    + ++ +  S     P    +  + E  N++ +    +  
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTN- 259

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
                             +S      +    +       +         VS  +   +  
Sbjct: 260 -----------------EVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIK 302

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
                   +   K               +  G + N     +  +   L  +++
Sbjct: 303 TKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFK 356

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  100 bits (250), Expect = 1e-22
 Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMK-SIRHRNLIK 552
           F   +++G G  G++    + D  +VAVK    +C   F     E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
              +  + +F+ + +E     +L++Y+   +      + + ++    S L +LH      
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LN 138

Query: 613 VIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLLIGED 646
           ++H DLKP N+L+        + A +SDFG+ K L    
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 12/155 (7%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISS 556
           ++  GGF  VY+A+ +G G E A+K          ++   E   MK +  H N+++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 557 CS-------NEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHF 607
            S         + + L+L     G L ++L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
               P+IH DLK +N+LL +     L DFG A  +
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 15/155 (9%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRAFKSFAVECEMMKSIRHRNLIK---V 553
           ++G+G   +V++ R    G   A+KVFN +   R       E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
               +      L++E+ P GSL   L    +   L   + L ++ DV   + +L      
Sbjct: 76  EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131

Query: 612 PVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLL 642
            ++H ++KP N++     D   V  L+DFG A+ L
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 49/300 (16%), Positives = 113/300 (37%), Gaps = 35/300 (11%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
             +    +   +++ +  +     +L  +  L+     +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 141 IHLSDNPLDGILSKTSIGNLSH--SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKL 198
           + L DN +      T +  L +   + +  +S   +       I  L +  T+DL   ++
Sbjct: 68  LELKDNQI------TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119

Query: 199 NGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLA 258
               P  L+ L  LQ L LD N++  +I   +  LT L  L +G  ++   +    +NL+
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQV-SDLTP-LANLS 173

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
            L  L    N+++ I     +L ++++++  +N ++   PL   N   L  +  +    +
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTIT 230

Query: 319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY 378
           +        L     +           P +  D         ++ NL+  + + +  +SY
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAP--IAPATISDN-----GTYASPNLTWNLTSFINNVSY 283

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 60/316 (18%), Positives = 120/316 (37%), Gaps = 53/316 (16%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
              L N  ++    + +  TV     ++  +  L       +  +  +    L NL  L 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT-GVTTIEGVQY--LNNLIGLE 69

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L  N  +   P  + N +K++ LELS N            L++++ L+L    +T     
Sbjct: 70  LKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD---- 121

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
              ++ L+   +L  ++L  N +  I                              +  L
Sbjct: 122 ---VTPLAGLSNLQVLYLDLNQITNI----------------------------SPLAGL 150

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK 245
           TN   + +G  +++   P  L+ L KL  L  DDNK+   I   +  L  L E+ L  N+
Sbjct: 151 TNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQ 206

Query: 246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL-PLEIGNL 304
           +   +    +N ++L I++L++  +T+ P+ +    +++  N        P+ P  I + 
Sbjct: 207 I-SDVSP-LANTSNLFIVTLTNQTITNQPVFY--NNNLVVPNVVKGPSGAPIAPATISDN 262

Query: 305 KVLIGIDFSMNNFSSV 320
                 + + N  S +
Sbjct: 263 GTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 50/290 (17%), Positives = 105/290 (36%), Gaps = 26/290 (8%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
            ++L  +  L      +  T    +  ++ L  L L++N +   L+ + +  L  +  L 
Sbjct: 37  QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQITD-LAPLKN--LTKITELE 91

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L GN         I     +  L+L+    +   P     L NL+ L L  N +T+    
Sbjct: 92  LSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN---- 143

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
              +S L+   +L ++ + +  +  +   T + NLS  L      +  +S      + +L
Sbjct: 144 ---ISPLAGLTNLQYLSIGNAQVSDL---TPLANLS-KLTTLKADDNKISD--ISPLASL 194

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK 245
            N I + L  N+++   P  L+    L  + L +  +          L     ++     
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGA 252

Query: 246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTG 295
                PA  S+  +    +L+ N  + I    +     +    ++   +G
Sbjct: 253 PI--APATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 43/219 (19%), Positives = 88/219 (40%), Gaps = 24/219 (10%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEA 63
            +  L NL  L+L+ N++  T  A + N++ +  L L  N     L +++ +  L +++ 
Sbjct: 58  GVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNP----LKNVSAIAGLQSIKT 111

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST 123
           L L     +   P  +   S L +L L  N  +   P     L NL++L++ +  ++   
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-- 165

Query: 124 PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEIT 183
                L+ L+N   LT +   DN +  I   + + +L  +L + ++ N  +S      + 
Sbjct: 166 -----LTPLANLSKLTTLKADDNKISDI---SPLASLP-NLIEVHLKNNQISD--VSPLA 214

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL 222
           N +N   + L    +        + L     +       
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 25/166 (15%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIK 552
           +G+G FG VY+              VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL---------YSSNCILDIFQRLNIMIDVASALE 603
           ++   S  +   +++E    G L+ YL                 + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 604 YL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           YL    F      +H DL   N ++ ++    + DFG+ + +   D
Sbjct: 153 YLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 30/171 (17%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYL---------------YSSNCILDIFQRLNIMIDV 598
              C + +   +V EY  HG L K+L                 +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 599 ASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           AS + YL   HF      +H DL   N L+  NL+  + DFG+++ +   D
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 35/174 (20%), Positives = 73/174 (41%), Gaps = 19/174 (10%)

Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIR 546
           R    F     +GRGGFG V++A+   D    A+K   L     A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 547 HRNLIKVISSCSNEEFKA------------LVLEYKPHGSLEKYL--YSSNCILDIFQRL 592
           H  +++  ++   +                + ++     +L+ ++    +    +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 593 NIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +I + +A A+E+LH      ++H DLKP N+    + V  + DFG+   +  ++
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 33/168 (19%)

Query: 498 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSI-RHRNL 550
           ++IG G FG V KAR+   G  M+ A+K   ++        + FA E E++  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYL---------------YSSNCILDIFQRLNIM 595
           I ++ +C +  +  L +EY PHG+L  +L                S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 596 IDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            DVA  ++YL    F      IH DL   N+L+ +N VA ++DFG+++
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR 190

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  100 bits (249), Expect = 3e-22
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 16/156 (10%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRNLIKVI--- 554
           +G GGFG V +      G +VA+K    +   +  + + +E ++MK + H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 555 ---SSCSNEEFKALVLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGC 609
                 +  +   L +EY   G L KYL  + + C L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141

Query: 610 LAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLL 642
              +IH DLKP+N++L      L+  + D G AK L
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 35/148 (23%), Positives = 67/148 (45%), Gaps = 7/148 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVIS 555
            IG G FG     +   DG +  +K  N+     +  +    E  ++ +++H N+++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 556 SCSNEEFKALVLEYKPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           S        +V++Y   G L K +      +    Q L+  + +  AL+++H      ++
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H D+K  N+ L  +    L DFGIA++L
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 33/148 (22%), Positives = 64/148 (43%), Gaps = 8/148 (5%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
            +G+GGF   ++          A K+     L      +  ++E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
               + +F  +VLE     SL +       + +   R   +  +    +YLH      VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 137

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DLK  N+ L+++L   + DFG+A  +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV 165

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 33/148 (22%), Positives = 64/148 (43%), Gaps = 8/148 (5%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
            +G+GGF   ++          A K+     L      +  ++E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
               + +F  +VLE     SL +       + +   R   +  +    +YLH      VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DLK  N+ L+++L   + DFG+A  +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV 191

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.9 bits (237), Expect = 8e-22
 Identities = 37/148 (25%), Positives = 75/148 (50%), Gaps = 7/148 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           L+G+G F  VY+A  +  G+EVA+K+ +   +      +    E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
           +   +  +  LVLE   +G + +YL +        +  + M  + + + YLH      ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DL   N+LL  N+   ++DFG+A  L
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQL 162

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 25/166 (15%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL- 605
            I        + +++E    G L+ +L  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 606 --HFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGED 646
             HF      IH D+   N LL       VA + DFG+A+ +    
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSS--------------NCILDIFQRLNIMIDVA 599
              C+      +V EY  HG L ++L S                  L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 600 SALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + + YL   HF      +H DL   N L+   LV  + DFG+++ +   D
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 39/180 (21%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V KA             VAVK+          +    E  ++K + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSS-----------------------NCILDIF 589
           +  +CS +    L++EY  +GSL  +L  S                          L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 590 QRLNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
           + + + + ++     L  ++P  L K      L L +N L      ++   T L +L L 
Sbjct: 7   SKVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
             +L   +      L  L  L LS N+L S+PL    L  +  L+ S N LT  LPL   
Sbjct: 64  RAEL-TKLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGA- 119

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLS 361
                                   GL  L+ L+L  N L+ ++P         L+ L+L+
Sbjct: 120 --------------LR--------GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156

Query: 362 NNNLSGAIPTSL-EKLSYLEDLNLSFNKLEGEIPRG 396
           NNNL+  +P  L   L  L+ L L  N L   IP+G
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 56/195 (28%), Positives = 82/195 (42%), Gaps = 19/195 (9%)

Query: 174 VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRL 233
           +   +P++ T L       L  N L      TL    +L  L LD  +L   +      L
Sbjct: 25  LPPDLPKDTTIL------HLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTL 76

Query: 234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNF 292
             L  L+L  N+L  S+P     L +L +L +S N LTS+PL     L ++ +L    N 
Sbjct: 77  PVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 293 LTGPLPLEI----GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS 348
           L   LP  +      L+ L     + NN + +    + GL+NL+ L L  N L  +IP  
Sbjct: 136 LKT-LPPGLLTPTPKLEKL---SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 349 FGDLISLKFLNLSNN 363
           F     L F  L  N
Sbjct: 191 FFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 55/237 (23%), Positives = 84/237 (35%), Gaps = 43/237 (18%)

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN 117
           + +   +     N +  +P  +      +IL LS+N    F   T      L  LNL   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG 177
            LT        L        L  + LS N L       S+                    
Sbjct: 66  ELTK-------LQVDGTLPVLGTLDLSHNQL------QSL-------------------- 92

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTE 235
            P     L     +D+  N+L  S+P+  L  L +LQ L L  N+L+ ++P  +     +
Sbjct: 93  -PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 236 LYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSN 291
           L +L L  N L   +PA   + L +L  L L  N L +IP  F+    +       N
Sbjct: 150 LEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 43/144 (29%), Positives = 60/144 (41%), Gaps = 10/144 (6%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
             L  L  LDL HN+L  ++P     +  L +L +  N L   L   A   L  L+ L L
Sbjct: 74  GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131

Query: 67  WGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
            GN    T+P  +     KL  L L+ N+ +         L NL+ L L++N L  + P+
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
             F S       L F  L  NP  
Sbjct: 190 GFFGS-----HLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 9/148 (6%)

Query: 251 PAC-FSNLASLRILSLSSNELTSIPLTFWNL-KDILQLNFSSNFLTGPLPLEIGNLKVLI 308
           P C  S +AS   ++     LT++P    +L KD   L+ S N L       +     L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 309 GIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA 368
            ++      +  +  + G L  L  L L +N+L+ S+P     L +L  L++S N L+  
Sbjct: 59  QLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 369 IPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
              +L  L  L++L L  N+L+  +P G
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPG 142

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 47/212 (22%), Positives = 71/212 (33%), Gaps = 40/212 (18%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSI-ADVRLPNLEALLLWGN 69
           +   L L  N L     A +   + L  L+L    L    + +  D  LP L  L L  N
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL----TKLQVDGTLPVLGTLDLSHN 87

Query: 70  NFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFL 129
               ++P        L++L++S N  +         L  L+ L L+ N L +  P L  L
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL--L 144

Query: 130 SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI-TNLTNS 188
           +       L  + L++N L      T                      +P  +   L N 
Sbjct: 145 TPTPK---LEKLSLANNNL------TE---------------------LPAGLLNGLENL 174

Query: 189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDN 220
            T+ L  N L  +IP        L    L  N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 12/148 (8%)

Query: 499 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR--AFKS-FAVECEMMKSIRHRNLIK 552
            +G GG  +VY A    L   ++VA+K   +           F  E      + H+N++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +I     ++   LV+EY    +L +Y+  S+  L +   +N    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++H D+KP N+L+D N    + DFGIAK
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK 159

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 8/153 (5%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSI-RHRN 549
           F   + +G G +G V+K R   DG   AVK      +  +       E    + + +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
            +++  +        L  E     SL+++  +    L   Q    + D   AL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-- 175

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              ++H D+KP N+ L       L DFG+   L
Sbjct: 176 -QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 12/148 (8%)

Query: 499 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR--AFKS-FAVECEMMKSIRHRNLIK 552
           L+GRGG G VY+A          VA+K+ +        F++    E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +      +    + +       L   L      L   + + I+  + SAL+  H    A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             H D+KP+N+L+  +  AYL DFGIA 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIAS 182

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 38/172 (22%), Positives = 72/172 (41%), Gaps = 31/172 (18%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIK 552
           +G   FG VYK  L           VA+K    +  G   + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYL---------------YSSNCILDIFQRLNIMID 597
           ++   + ++  +++  Y  HG L ++L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 598 VASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +A+ +EYL   H       +H DL   NVL+ D L   +SD G+ + +   D
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 34/175 (19%)

Query: 500 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V  A           + + VAVK+       +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS---------------NCILDIFQRLNI 594
           +I ++ +C+ +    +++EY   G+L +YL +                   +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 595 MIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNID 211

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 34/175 (19%)

Query: 500 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRN 549
           +G G FG V  A           + + VAVK+       +       E EMMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS---------------NCILDIFQRLNI 594
           +I ++ +C+ +    +++EY   G+L +YL +                   +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 595 MIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNID 257

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 20/158 (12%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
             +G+G FG+VY AR       +A+KV     L+          E E+   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHF 607
                +     L+LEY P G++ + L           + +       + ++A+AL Y H 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
                VIH D+KP+N+LL       ++DFG +      
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.4 bits (235), Expect = 5e-21
 Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 25/166 (15%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL- 605
            I        + ++LE    G L+ +L  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 606 --HFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGED 646
             HF      IH D+   N LL       VA + DFG+A+ +    
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 4/147 (2%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +     +G G FG VYKA+    G   A KV   +     + + VE E++ +  H  ++K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           ++ +  ++    +++E+ P G+++  +   +  L   Q   +   +  AL +LH      
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---R 137

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +IH DLK  NVL+       L+DFG++
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.9 bits (236), Expect = 6e-21
 Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 27/173 (15%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECE-MMKSIRHRNLIK 552
                ++G G  G+V       G  VAVK   +          +E + + +S  H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLH 606
              S + + F  + LE     +L+  + S N   +  +        +++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 607 FGCLAPVIHCDLKPDNVLLD-------------DNLVAYLSDFGIAKLLIGED 646
                 +IH DLKP N+L+              +NL   +SDFG+ K L    
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.7 bits (235), Expect = 6e-21
 Identities = 27/179 (15%), Positives = 59/179 (32%), Gaps = 41/179 (22%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG---------------------------- 529
           ++G+    +  +A     G    V V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 530 RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY-KPHGSLEKYL------YSS 582
           +    F    +++K  + + +I+V     +    +    Y +   +L+ +        S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 583 NCILDIFQRLNIMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           +  L    RL + + V   L  LH +G    ++H  L+P +++LD     +L+ F    
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 40/174 (22%), Positives = 69/174 (39%), Gaps = 33/174 (18%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLI 551
           +GRG FG V +A             VAVK+          ++   E +++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 552 KVISSCSNEEFKALV-LEYKPHGSLEKYLYSS---------------NCILDIFQRLNIM 595
            ++ +C+      +V +E+   G+L  YL S                   L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 596 IDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             VA  +E+L           IH DL   N+LL +  V  + DFG+A+ +  + 
Sbjct: 155 FQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 6/147 (4%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           ++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
            + S    +   +V+EY   GSL   +  +   +D  Q   +  +   ALE+LH      
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---Q 136

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           VIH D+K DN+LL  +    L+DFG  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC 163

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 42/228 (18%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTE 235
            +P    NL      DL  N L      +     +LQ L L   +++ +I D     L+ 
Sbjct: 25  NLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 236 LYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFL 293
           L  L L GN +  S+    FS L+SL+ L      L S+      +LK + +LN + N +
Sbjct: 78  LSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDL 352
                L                 FS         L NLE+L L  N+++ SI       L
Sbjct: 137 QS-FKLP--------------EYFS--------NLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 353 ISLKF----LNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
             +      L+LS N ++  I     K   L++L L  N+L+  +P G
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKD 282
            IPD++        L+L  N L   + +  F +   L++L LS  E+ +I    + +L  
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 283 ILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL 341
           +  L  + N +   L L     L  L  +     N +S+    IG LK L+ L + +N +
Sbjct: 78  LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 342 EGSIP--DSFGDLISLKFLNLSNNNLSGAIP----TSLEKLSYLE-DLNLSFNKLEGEIP 394
           + S    + F +L +L+ L+LS+N +  +I       L ++  L   L+LS N +   I 
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 395 RG 396
            G
Sbjct: 194 PG 195

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 60/261 (22%), Positives = 93/261 (35%), Gaps = 60/261 (22%)

Query: 108 NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF 167
           + + L+L  N L           S  +   L  + LS   +       +I          
Sbjct: 29  STKNLDLSFNPLRHLGS-----YSFFSFPELQVLDLSRCEI------QTI---------- 67

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSI 226
                    G  + +++L+   T+ L GN +  S+ +   S L  LQ L   +  L  S+
Sbjct: 68  -------EDGAYQSLSHLS---TLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SL 115

Query: 227 PDSI-CRLTELYELELGGNKLFGSIPA--CFSNLASLRILSLSSNELTSIPL-TFWNLKD 282
            +     L  L EL +  N +  S      FSNL +L  L LSSN++ SI       L  
Sbjct: 116 ENFPIGHLKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
           +  LN S                    +D S+N  +  I         L+ L L  N+L+
Sbjct: 175 MPLLNLS--------------------LDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213

Query: 343 GSIPDSFGDLISLKFLNLSNN 363
                 F  L SL+ + L  N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 42/250 (16%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSI-ADV--R 57
           +IP  +    + + LDL  N L      + F+   L++L L    +     +I       
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI----QTIEDGAYQS 74

Query: 58  LPNLEALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD 116
           L +L  L+L GN    ++    F+  S L  L   + + +       G+L+ L+ LN+  
Sbjct: 75  LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
           N +  S     + S+L+N   L  + LS N +       SI                   
Sbjct: 134 NLIQ-SFKLPEYFSNLTN---LEHLDLSSNKI------QSI-----------------YC 166

Query: 177 GIPEEITNLTN-SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLT 234
                +  +   ++++DL  N +N  I     K  +L+ L LD N+L+ S+PD I  RLT
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLT 224

Query: 235 ELYELELGGN 244
            L ++ L  N
Sbjct: 225 SLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 36/149 (24%), Positives = 56/149 (37%), Gaps = 14/149 (9%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
           S L +L++L      L  ++      ++  LK L++ +N +           L NLE L 
Sbjct: 97  SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 66  LWGNNFSGTIPRFIF-NASKLSI----LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  N    +I         ++ +    L+LS N  +   P  F  +  L+ L L  N L 
Sbjct: 156 LSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK 213

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
           S    +          SL  I L  NP D
Sbjct: 214 SVPDGI-----FDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 31/129 (24%), Positives = 51/129 (39%), Gaps = 7/129 (5%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA-- 63
            +L+ L+EL++ HN +        F N++ L+ L L +N +   +       L  +    
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLN 179

Query: 64  --LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
             L L  N  +  I    F   +L  L L  N         F  L +L+ + L  N    
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238

Query: 122 STPELSFLS 130
           S P + +LS
Sbjct: 239 SCPRIDYLS 247

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 6/147 (4%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
                 IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  S    E   +++E+   G+L   +  S   L+  Q   +   V  AL YLH      
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQ---G 161

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           VIH D+K D++LL  +    LSDFG  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFC 188

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 30/173 (17%)

Query: 498 NLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRN 549
             +G G FG V +A           ++VAVK+          ++   E ++M  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYL-------------YSSNCILDIFQRLNIMI 596
           ++ ++ +C++     ++ EY  +G L  +L               +N        L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 597 DVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            VA  + +L   +       IH D+   NVLL +  VA + DFG+A+ ++ + 
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 34/175 (19%)

Query: 500 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRN 549
           +G G FG V  A              +VAVK+       +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS---------------NCILDIFQRLNI 594
           +I ++ +C+ +    +++EY   G+L +YL +                   L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 595 MIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              VA  +EYL           IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.8 bits (228), Expect = 3e-20
 Identities = 49/270 (18%), Positives = 87/270 (32%), Gaps = 38/270 (14%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP ++   +N  EL     KL      A      L+ + +  N +L  + +     LP 
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  + +   N              L  +           P  F NL NL++L + +  + 
Sbjct: 81  LHEIRIEKAN-------------NLLYIN----------PEAFQNLPNLQYLLISNTGIK 117

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
              P++  + SL        + + DN     + + S   LS      +++   +   I  
Sbjct: 118 HL-PDVHKIHSL----QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN 171

Query: 181 EITNLTNSITIDL-GGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR-LTELYE 238
              N T    ++L   N L                L +   ++  S+P      L +L  
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 230

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLSSN 268
                 K    +P     L +L   SL+  
Sbjct: 231 RSTYNLK---KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 39/216 (18%), Positives = 73/216 (33%), Gaps = 7/216 (3%)

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTEL 236
           IP ++    N+I +     KL        S    L+ + +  N +   I   +   L +L
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 237 YELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLT 294
           +E+ +        I    F NL +L+ L +S+  +  +P +   +    + L+   N   
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 295 GPLPLEI--GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL 352
             +      G     + +  + N    +  +   G +  E      N LE    D F   
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK 388
                L++S   +       LE L  L   +    K
Sbjct: 202 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 6e-18
 Identities = 46/261 (17%), Positives = 82/261 (31%), Gaps = 38/261 (14%)

Query: 107 RNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKD 166
           RN   L      L           + S    L  I +S N +  ++      NL   L +
Sbjct: 30  RNAIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADVFSNL-PKLHE 83

Query: 167 FYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI 226
             +   N        +  +                 P     L  LQ L + +  ++  +
Sbjct: 84  IRIEKAN-------NLLYIN----------------PEAFQNLPNLQYLLISNTGIK-HL 119

Query: 227 PDSI-CRLTELYELELGGNKLFGSIPA-CFSNLAS-LRILSLSSNELTSIPLTFWNLKDI 283
           PD       +   L++  N    +I    F  L+    IL L+ N +  I  + +N   +
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179

Query: 284 LQLNFSS-NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
            +LN S  N L              + +D S     S+    +  LK L        +  
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 237

Query: 343 GSIPDSFGDLISLKFLNLSNN 363
             +P +   L++L   +L+  
Sbjct: 238 -KLP-TLEKLVALMEASLTYP 256

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 39/180 (21%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIK 552
           IG G FG V++AR            VAVK+   +        F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSS-----------------------NCILDIF 589
           ++  C+  +   L+ EY  +G L ++L S                           L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 590 QRLNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           ++L I   VA+ + YL    F      +H DL   N L+ +N+V  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 37/175 (21%), Positives = 68/175 (38%), Gaps = 34/175 (19%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLI 551
           +G G FG V +A           M VAVK+          ++   E +++  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYL-----------------YSSNCILDIFQRLNI 594
            ++ +C+      ++ EY  +G L  +L                       LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 595 MIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              VA  + +L   +       IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 151 SYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.2 bits (226), Expect = 5e-20
 Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 24/168 (14%)

Query: 494 FSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH 547
              ++L+G G F  VY+A  GD        +  +KV        F       E +K    
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSL----EKYLYSSNCILDIFQRLNIMIDVASALE 603
              +K  S+   +    LV E   +G+L      Y  +   ++     ++  + +   +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAY-----------LSDFGIAK 640
            +H      +IH D+KPDN +L +  +             L D G + 
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.4 bits (225), Expect = 7e-20
 Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 39/180 (21%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLI 551
           +G G FG V  A        G  ++VAVK+   +      ++   E +MM  +  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYL----------------------YSSNCILDIF 589
            ++ +C+      L+ EY  +G L  YL                           +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 590 QRLNIMIDVASALEYL---HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             L     VA  +E+L           +H DL   NVL+    V  + DFG+A+ ++ + 
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 20/153 (13%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
            +G+G FG+VY AR   +   +A+KV     L+          E E+   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFG 608
           +   + +   L+LE+ P G L K L           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
               VIH D+KP+N+L+       ++DFG +  
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 28/179 (15%), Positives = 60/179 (33%), Gaps = 41/179 (22%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL----------------QCGRAFK-------- 533
           ++G+    +  +A     G    V V                      R  +        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 534 ----SFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY-KPHGSLEKYL------YSS 582
                F    +++K  + + +I+V     +    +    Y +   +L+ +        S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 583 NCILDIFQRLNIMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           +  L    RL + + V   L  LH +G    ++H  L+P +++LD     +L+ F    
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 16/152 (10%)

Query: 499 LIGRGGFGSVYKA---RLGDGMEVAVKV--FNLQCGRAFKS-FAVECEMMKSIRHRNLIK 552
           ++G GG   V+ A   R     +VAVKV   +L    +F   F  E +   ++ H  ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 553 VISSCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
           V  +   E        +V+EY    +L   +  +   +   + + ++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               +IH D+KP N+++       + DFGIA+
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 21/178 (11%), Positives = 40/178 (22%), Gaps = 40/178 (22%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
            +  G    V+  R +    + A+KVF           +           +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 555 SSC-------------------------SNEEFKALVLEYKPHGSLE------KYLYSSN 583
                                              L+L       LE       ++Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 584 CILDIFQRLNIMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
               I     +   +      L   G    ++H    PDN+ +  +    L D     
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 6/147 (4%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           F     +G G +GSVYKA     G  VA+K   ++     +    E  +M+     +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
              S        +V+EY   GS+   +   N  L   +   I+      LEYLHF     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---R 145

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            IH D+K  N+LL+    A L+DFG+A
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA 172

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 53/301 (17%), Positives = 94/301 (31%), Gaps = 41/301 (13%)

Query: 103 FGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH 162
           +G  R+LE+L  R +           + SLS    L  + +    +   +   ++  L  
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLS----LKRLTVRAARIPSRILFGALRVLGI 94

Query: 163 S-LKDFYMSNCNVSGGIPEEITNLTNS--ITIDLGGNKLNGSIPITLS----KLQKLQGL 215
           S L++  + N  V+G  P  +   T      ++L                      L+ L
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154

Query: 216 GLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP----ACFSNLASLRILSLSSNELT 271
            +          + +     L  L+L  N   G        C     +L++L+L +  + 
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214

Query: 272 SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKN 330
           +       L                          L G+D S N+               
Sbjct: 215 TPSGVCSAL--------------------AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 331 LEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
           L  L L +  L+  +P        L  L+LS N L    P S ++L  + +L+L  N   
Sbjct: 255 LNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFL 309

Query: 391 G 391
            
Sbjct: 310 D 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 51/303 (16%), Positives = 88/303 (29%), Gaps = 61/303 (20%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPA---AIFNMSMLKLLHLQNNSLLG-CLSSIADVRL 58
             +I    +L+ L +R  ++   +      +  +S L+ L L+N  + G     + +   
Sbjct: 61  FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120

Query: 59  PNLEALLLWGNNFSGTIPR----FIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL 114
           P+L  L L   +++           +    L +L ++Q     F          L  L+L
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180

Query: 115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNV 174
            DN        L          +L  + L +  +                          
Sbjct: 181 SDNPELGERG-LISALCPLKFPTLQVLALRNAGM-------------------------- 213

Query: 175 SGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR-L 233
                                   +G      +   +LQGL L  N L  +     C   
Sbjct: 214 ---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252

Query: 234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFL 293
           ++L  L L    L   +P      A L +L LS N L   P     L  +  L+   N  
Sbjct: 253 SQLNSLNLSFTGL-KQVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPF 308

Query: 294 TGP 296
              
Sbjct: 309 LDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 46/231 (19%), Positives = 74/231 (32%), Gaps = 39/231 (16%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            PL  +   +L  L+LR+                              L+ +     P L
Sbjct: 113 PPLLEATGPDLNILNLRNVSWAT---------------------RDAWLAELQQWLKPGL 151

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNT----FGNLRNLEWLNLRDN 117
           + L +   +        +     LS L+LS N   G               L+ L LR+ 
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211

Query: 118 YLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCN---V 174
            + + +   S L   +    L  + LS N L       S    S  L    +S      V
Sbjct: 212 GMETPSGVCSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QLNSLNLSFTGLKQV 268

Query: 175 SGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGS 225
             G+P +++ L      DL  N+L+   P    +L ++  L L  N    S
Sbjct: 269 PKGLPAKLSVL------DLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 41/243 (16%), Positives = 72/243 (29%), Gaps = 26/243 (10%)

Query: 172 CNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC 231
           CN S   P+  +        D+       S+   L ++         D + +      I 
Sbjct: 15  CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRV---------DTEADLGQFTDII 65

Query: 232 RLTELYELELGGNKLFGSIPACFS---NLASLRILSLSSNELT---SIPLTFWNLKDILQ 285
           +   L  L +   ++   I         ++ L+ L+L + E+T     PL      D+  
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 286 LNFSSNFLTGPLP----LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL 341
           LN  +            L+      L  +  +  +  +    ++     L  L L  N  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 342 EGSIP----DSFGDLISLKFLNLSNNN---LSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
            G              +L+ L L N      SG           L+ L+LS N L     
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 395 RGG 397
              
Sbjct: 246 APS 248

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 38/209 (18%)

Query: 87  ILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
            L+L  N  S      F  L  L  L L DN L  + P   F   L N   L  + ++DN
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF-KELKN---LETLWVTDN 95

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL 206
            L       ++                   G+ +++ NL     + L  N+L  S+P  +
Sbjct: 96  KL------QAL-----------------PIGVFDQLVNLA---ELRLDRNQLK-SLPPRV 128

Query: 207 -SKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYELELGGNKLFGSIPA-CFSNLASLRIL 263
              L KL  L L  N+L+ S+P  +  +LT L EL L  N+L   +P   F  L  L+ L
Sbjct: 129 FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTL 186

Query: 264 SLSSNELTSIPL-TFWNLKDILQLNFSSN 291
            L +N+L  +P   F +L+ +  L    N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 62/215 (28%), Positives = 87/215 (40%), Gaps = 37/215 (17%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTE 235
            IP +   L      DL  NKL+        +L KL+ L L+DNKL+ ++P  I   L  
Sbjct: 34  NIPADTKKL------DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 236 LYELELGGNKLFGSIPAC-FSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFL 293
           L  L +  NKL  ++P   F  L +L  L L  N+L S+P   F +L             
Sbjct: 87  LETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL------------- 132

Query: 294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDL 352
                     L  L       N   S+       L +L+ L L  N+L+  +P+  F  L
Sbjct: 133 --------TKLTYL---SLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKL 180

Query: 353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
             LK L L NN L      + + L  L+ L L  N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 69/217 (31%), Positives = 96/217 (44%), Gaps = 41/217 (18%)

Query: 187 NSITIDLGGNKLN---GSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG 243
           N  ++D    KL     +IP    KL       L  NKL      +  RLT+L  L L  
Sbjct: 17  NKNSVDCSSKKLTAIPSNIPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLND 70

Query: 244 NKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEI 301
           NKL  ++PA  F  L +L  L ++ N+L ++P+  F  L ++ +L    N L   LP  +
Sbjct: 71  NKL-QTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRV 128

Query: 302 GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD-SFGDLISLKFLNL 360
                          F          L  L YL LGYN L+ S+P   F  L SLK L L
Sbjct: 129 ---------------FD--------SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164

Query: 361 SNNNLSGAIPTSL-EKLSYLEDLNLSFNKLEGEIPRG 396
            NN L   +P    +KL+ L+ L L  N+L+  +P G
Sbjct: 165 YNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 43/148 (29%), Positives = 62/148 (41%), Gaps = 16/148 (10%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSI-ADV--RLPNLE 62
             L+NLE L +  NKL   +P  +F  +  L  L L  N L     S+   V   L  L 
Sbjct: 82  KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL----KSLPPRVFDSLTKLT 136

Query: 63  ALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
            L L  N    ++P+ +F+  + L  L L  N         F  L  L+ L L +N L  
Sbjct: 137 YLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLD 149
             PE +F     + + L  + L +NP D
Sbjct: 196 -VPEGAF----DSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 42/215 (19%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSI-ADV--RLPNLEALLLW 67
           + ++LDL+ NKL      A   ++ L+LL+L +N     L ++ A +   L NLE L + 
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK----LQTLPAGIFKELKNLETLWVT 93

Query: 68  GNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
            N     +P  +F+    L+ L L +N      P  F +L  L +L+L  N L  S P+ 
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI-TNL 185
            F   L++   L  + L +N L                             +PE     L
Sbjct: 152 VF-DKLTS---LKELRLYNNQL------KR---------------------VPEGAFDKL 180

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDN 220
           T   T+ L  N+L          L+KL+ L L +N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 34/166 (20%), Positives = 65/166 (39%), Gaps = 27/166 (16%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFN---LQCGRAFKSFAV--------------ECEMM 542
           + +G F  +      D    A+K +    L+  R F                   E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYL-------YSSNCILDIFQRLNIM 595
             I++   +      +N +   ++ EY  + S+ K+         +  C + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
             V ++  Y+H      + H D+KP N+L+D N    LSDFG ++ 
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 12/149 (8%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           IG G    V  A       +VA+K  NL +C  +      E + M    H N++   +S 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 558 SNEEFKALVLEYKPHGSL-------EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
             ++   LV++    GS+              + +LD      I+ +V   LEYLH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              IH D+K  N+LL ++    ++DFG++
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVS 168

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 23/147 (15%), Positives = 44/147 (29%), Gaps = 14/147 (9%)

Query: 499 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGRA--FKS-FAVECEMMKSIRHRNLIK 552
             G       ++A    L    +VA+   + Q                 +  I    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           V+          +V E+   GSL++   +S         +  M  +A+A +  H    A 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           V      P  V +  +    L+     
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM 176

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 8/150 (5%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRHRN 549
           FS+   IG G FG+VY AR + +   VA+K  +    ++   ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
            I+       E    LV+EY   GS    L      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 173

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              +IH D+K  N+LL +  +  L DFG A
Sbjct: 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 7/151 (4%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRNLI 551
           F++   IG+G FG V+K         VA+K+ +L +     +    E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           K   S   +    +++EY   GS    L      LD  Q   I+ ++   L+YLH     
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS---E 138

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             IH D+K  NVLL ++    L+DFG+A  L
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 32/190 (16%), Positives = 66/190 (34%), Gaps = 11/190 (5%)

Query: 204 ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL 263
           I  S  +      L  +        +  ++  L  + L    +   +        +++ L
Sbjct: 17  IPDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDL 71

Query: 264 SLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIP 322
           ++++   T+  P++   L ++ +L      +T      +  L  L  +D S +     I 
Sbjct: 72  TINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 323 TEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDL 382
           T+I  L  +  + L YN     I      L  LK LN+  + +       +E    L  L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186

Query: 383 NLSFNKLEGE 392
                 + G+
Sbjct: 187 YAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 9e-16
 Identities = 27/174 (15%), Positives = 62/174 (35%), Gaps = 15/174 (8%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLE 62
            +  + + +L  + L +  +  T    I     +K L + N       + I+   L NLE
Sbjct: 37  NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHA-TNYNPISG--LSNLE 91

Query: 63  ALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS 122
            L + G + +      +   + L++L++S ++    I      L  +  ++L  N   + 
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 123 TPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSG 176
                 +  L     L  +++  + +        I +    L   Y  +  + G
Sbjct: 152 ------IMPLKTLPELKSLNIQFDGVHDY---RGIEDFP-KLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 31/177 (17%), Positives = 64/177 (36%), Gaps = 10/177 (5%)

Query: 148 LDGILSKTSIGNLSHS----LKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP 203
           L+G+L ++S  N++ +    L    ++N NV+      I    N   + +         P
Sbjct: 26  LNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP 83

Query: 204 ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL 263
             +S L  L+ L +    +      ++  LT L  L++  +    SI    + L  +  +
Sbjct: 84  --ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 264 SLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV 320
            LS N   +  +    L ++  LN   + +     +E  +   L  +          
Sbjct: 142 DLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 4e-13
 Identities = 24/147 (16%), Positives = 55/147 (37%), Gaps = 13/147 (8%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLG-CLSSIADVRLPNLEAL 64
           I    N+++L + +     T    I  +S L+ L +    +    + +++   L +L  L
Sbjct: 62  IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSG--LTSLTLL 117

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            +  +    +I   I    K++ ++LS N     I      L  L+ LN++ + +     
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--- 173

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGI 151
                  + +   L  ++     + G 
Sbjct: 174 ----YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 22/128 (17%), Positives = 46/128 (35%), Gaps = 9/128 (7%)

Query: 267 SNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG 326
           S +  +IP +    K  L      +       +    +  L  I  +  N + +  T I 
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIE 63

Query: 327 GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF 386
              N++ L +         P     L +L+ L +   +++     +L  L+ L  L++S 
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 387 NKLEGEIP 394
           +  +  I 
Sbjct: 122 SAHDDSIL 129

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 29/175 (16%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRAFKSFAV-ECEMMKSI-RHRN 549
           F E   IG G FGSV+K     DG   A+K       G   +  A+ E      + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLH 606
           +++  S+ + ++   +  EY   GSL   +  +  I+  F   +  ++++ V   L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAY-------------------LSDFGIAKLL 642
                 ++H D+KP N+ +    +                     + D G    +
Sbjct: 133 S---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 53/288 (18%), Positives = 107/288 (37%), Gaps = 52/288 (18%)

Query: 105 NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-- 162
                   NL+   +T          + +   S+  I  +++ +       S+  + +  
Sbjct: 22  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 68

Query: 163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL 222
           ++   +++   ++    + + NL N   + L  NK+   +  +L  L+KL+ L L+ N +
Sbjct: 69  NVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI 124

Query: 223 EGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD 282
              I + +  L +L  L LG NK+  +     S L  L  LSL  N+++ I         
Sbjct: 125 S-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIV-------- 172

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE 342
                             +  L  L  +  S N+ S +    + GLKNL+ L L      
Sbjct: 173 -----------------PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 213

Query: 343 GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
               +   +L+    +  ++ +L    P  +      E  N+ ++  E
Sbjct: 214 NKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 48/269 (17%), Positives = 94/269 (34%), Gaps = 50/269 (18%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEAL 64
                   + +L+   +   V      ++ +  +   N+     + S+  ++ LPN+  L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD----IKSVQGIQYLPNVTKL 73

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L GN  +   P  + N   L  L L +N           +L+ L+ L+L  N ++    
Sbjct: 74  FLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD--- 126

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
               ++ L +   L  ++L +N +  I   T +  L+  L    + +          I++
Sbjct: 127 ----INGLVHLPQLESLYLGNNKITDI---TVLSRLT-KLDTLSLEDNQ--------ISD 170

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
           +                    L+ L KLQ L L  N +   +  ++  L  L  LEL   
Sbjct: 171 IVP------------------LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210

Query: 245 KLFGSIPACFSNLASLRILSLSSNELTSI 273
           +         SNL     +  +   L + 
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 28/221 (12%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEAL 64
           I  L N+ +L L  NKL    P  + N+  L  L L  N     +  ++ ++ L  L++L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK----VKDLSSLKDLKKLKSL 117

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L  N  S  I   + +  +L  L L  N  +         L  L+ L+L DN ++    
Sbjct: 118 SLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD--- 170

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH--SLKDFYMSNCNVSGGIPEEI 182
               +  L+    L  ++LS N +      + +  L+   +L    + +           
Sbjct: 171 ----IVPLAGLTKLQNLYLSKNHI------SDLRALAGLKNLDVLELFSQECLNKPINHQ 220

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLE 223
           +NL    T+      L    P  +S     +   +  +  E
Sbjct: 221 SNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 9/136 (6%)

Query: 255 SNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM 314
              A     +L    +T    T   L  I Q+  +++ +     ++   L  +  +  + 
Sbjct: 21  DAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77

Query: 315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE 374
           N  + + P  +  LKNL +LFL  N+++  +  S  DL  LK L+L +N +S      L 
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DINGLV 131

Query: 375 KLSYLEDLNLSFNKLE 390
            L  LE L L  NK+ 
Sbjct: 132 HLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 26/124 (20%), Positives = 51/124 (41%), Gaps = 10/124 (8%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEAL 64
           +S L  L+ L L  N++  +    +  ++ L+ L+L  N     +S +  +  L NL+ L
Sbjct: 152 LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVL 205

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L+             N    + ++ +  S     P    +  + E  N++ + L   T 
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH-LPEFTN 262

Query: 125 ELSF 128
           E+SF
Sbjct: 263 EVSF 266

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRAFKSFAVECEMMKSIRHRNLIK- 552
           L+G G +G V +          AVK+       +      +   E ++++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 553 --VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGC 609
             V+ +   ++   +V+EY   G  E           + Q       +   LEYLH  G 
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG- 129

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              ++H D+KP N+LL       +S  G+A+ L
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 8e-18
 Identities = 41/183 (22%), Positives = 69/183 (37%), Gaps = 46/183 (25%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAV----------------- 537
            IG+G +G V  A    D    A+KV +   L     F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 538 ------ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYKPHGSLEKYL----YSSNC 584
                 E  ++K + H N++K   V+   + +    +V E    G + +       S + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 585 ILDIFQRLNIMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
               FQ      D+   +EYLH       +IH D+KP N+L+ ++    ++DFG++    
Sbjct: 139 ARFYFQ------DLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 644 GED 646
           G D
Sbjct: 189 GSD 191

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 39/179 (21%)

Query: 489 RATNGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV------ 537
            +T+GF EN     ++GRG    V +        E AVK+ ++  G +F +  V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 538 ---ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYS----SNC 584
              E ++++ +  H N+I++  +     F  LV +    G L     EK   S       
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129

Query: 585 ILDIFQRLNIMIDVASALEYLHF-GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +  +             +  LH       ++H DLKP+N+LLDD++   L+DFG +  L
Sbjct: 130 MRALL----------EVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 16/183 (8%)

Query: 472 NMPLVATWRTFSYLELCRATN---GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 527
           +M   +  R+   ++L    +    F    L+G G +G VYK R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 528 CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKA------LVLEYKPHGSL-EKYL 579
            G   +    E  M+K    HRN+     +   +          LV+E+   GS+ +   
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 580 YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            +    L       I  ++   L +LH      VIH D+K  NVLL +N    L DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 640 KLL 642
             L
Sbjct: 177 AQL 179

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 28/158 (17%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           ++G G F  V+  +    G   A+K           S   E  ++K I+H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 558 SNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF- 607
            +     LV++    G L     E+ +Y+    S  I  +           SA++YLH  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLHEN 125

Query: 608 GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
           G    ++H DLKP+N+L    ++N    ++DFG++K+ 
Sbjct: 126 G----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 9/152 (5%)

Query: 500 IGRG--GFGSVYKAR-LGDGMEVAVKVFNL--QCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           IG+G     +V  AR    G  V V+  NL             E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           ++   +    +V  +  +GS +  +       ++      I+  V  AL+Y+H       
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGY 149

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           +H  +K  ++L+  +   YLS       +I  
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 40/215 (18%), Positives = 76/215 (35%), Gaps = 17/215 (7%)

Query: 85  LSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLS 144
              L+L +        + F NL N+  + +  +         SF     N   +T I + 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF----YNLSKVTHIEIR 88

Query: 145 DNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE--ITNLTNSITIDLGGNKLNGSI 202
           +      +   ++  L   LK   + N  +    P+   + +      +++  N    SI
Sbjct: 89  NTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 203 PI-TLSKLQK-LQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLAS 259
           P+     L      L L +N    S+       T+L  + L  NK    I    F  + S
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

Query: 260 -LRILSLSSNELTSIP-LTFWNLKDILQLNFSSNF 292
              +L +S   +T++P     +LK   +L   + +
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLK---ELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 39/208 (18%), Positives = 74/208 (35%), Gaps = 9/208 (4%)

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELYELELGG 243
             ++ T+ L    L        S L  +  + +  +     +       L+++  +E+  
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 244 NKLFGSIPA-CFSNLASLRILSLSSNELTSIP-LTFWNLKDILQ-LNFSSNFLTGPLPLE 300
            +    I       L  L+ L + +  L   P LT     DI   L  + N     +P+ 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 301 I--GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDLIS-LK 356
              G     + +    N F+S +         L+ ++L  N+    I  D+FG + S   
Sbjct: 150 AFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNL 384
            L++S  +++      LE L  L   N 
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 43/235 (18%), Positives = 75/235 (31%), Gaps = 37/235 (15%)

Query: 137 SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEI-TNLTNSITIDLGG 195
           S   + L +  L   +   +  NL + +   Y+S       +      NL+    I++  
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPN-ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 196 NKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPD--SICRLTELYELELGGNKLFGSIPA 252
            +    I    L +L  L+ LG+ +  L+   PD   +      + LE+  N    SIP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 253 -CFSNLAS-LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGI 310
             F  L +    L L +N  TS+                     G        L  +   
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQ---------------GYAFNGT------KLDAV--- 184

Query: 311 DFSMNNFSSVIPTEI--GGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLNLSN 362
             + N + +VI  +   G       L +    +  ++P      L  L   N   
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 25/120 (20%), Positives = 54/120 (45%), Gaps = 7/120 (5%)

Query: 7   SNLQNLEELDLRHNKLVGTVPA--AIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN-LEA 63
             L  L+ L + +  L    P    +++  +  +L + +N  +  +   A   L N    
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIP-NTFGNLRN-LEWLNLRDNYLTS 121
           L L+ N F+ ++  + FN +KL  + L++N +   I  + FG + +    L++    +T+
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 25/142 (17%), Positives = 44/142 (30%), Gaps = 8/142 (5%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
                 ++  ++  IP           L      L         NL  +  I  S++   
Sbjct: 12  QEEDFRVTCKDIQRIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68

Query: 319 SVIPTEI-GGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIP--TSLE 374
             + +     L  + ++ +   R    I  D+  +L  LKFL + N  L    P  T + 
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127

Query: 375 KLSYLEDLNLSFNKLEGEIPRG 396
                  L ++ N     IP  
Sbjct: 128 STDIFFILEITDNPYMTSIPVN 149

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 30/163 (18%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV--ECEMMKSIRHRNLIKVISS 556
           +G+G F  V +   +  G E A  + N +   A     +  E  + + ++H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
            S E    L+ +    G L      +  YS    S+CI  I            A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCHQ 128

Query: 608 -GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGED 646
            G    V+H +LKP+N+LL          L+DFG+A  + GE 
Sbjct: 129 MG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 30/159 (18%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G F  V +      G+E A K+ N +    R F+    E  + + ++H N++++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
              E F  LV +    G L      +  YS    S+CI  I            ++ Y H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCHS 123

Query: 608 -GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            G    ++H +LKP+N+LL          L+DFG+A  +
Sbjct: 124 NG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 26/156 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRAFKSFAVECEMMKSIRHRNL 550
           +G G FG V+ A       EV VK                      +E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 551 IKVISSCSNEEFKALVLE-YKPHGSLEKYLYSSNCILD------IFQRLNIMIDVASALE 603
           IKV+    N+ F  LV+E +     L  ++   +  LD      IF++L       SA+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQL------VSAVG 144

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           YL       +IH D+K +N+++ ++    L DFG A
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 24/195 (12%)

Query: 462 KRGKQPSNDANMPLVATWRTFSYLELCRATNGFSEN----NLIGRGGFGSVYKAR-LGDG 516
           K      ND +      W+ +    +        +       +G G FG V++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 517 MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSL- 575
                K  N        +   E  +M  + H  LI +  +  ++    L+LE+   G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 576 -----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL 629
                E Y  S +  I       N M      L+++H      ++H D+KP+N++ +   
Sbjct: 137 DRIAAEDYKMSEAEVI-------NYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 186

Query: 630 VAYL--SDFGIAKLL 642
            + +   DFG+A  L
Sbjct: 187 ASSVKIIDFGLATKL 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 30/159 (18%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G F  V +      G+E A K+ N      R F+    E  + + ++H N++++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 607
              E F  LV +    G L      +  YS    S+CI  I            ++ Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCHS 146

Query: 608 -GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
            G    ++H +LKP+N+LL          L+DFG+A  +
Sbjct: 147 NG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 17/148 (11%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEM--MKSIRHRNLIKVISS 556
           IG+G F  V  AR +  G EVA+K+ +           +  E+  MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLHFGCLA 611
              E+   L++EY   G +  YL +   + +      F+++       SA++Y H     
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQKR-- 134

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            ++H DLK +N+LLD ++   ++DFG +
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFS 161

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 36/160 (22%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G FG V K +      E AVKV N      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEY 604
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 605 LHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
           +H       ++H DLKP+N+LL   + +    + DFG++ 
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 24/153 (15%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK-- 552
            +G G FG V        G +VAVK+ N   ++          E + +K  RH ++IK  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 553 -VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 606
            VIS+   + F  +V+EY   G L  Y+     +       +FQ++       SA++Y H
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH 128

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
                 V+H DLKP+NVLLD ++ A ++DFG++
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLS 158

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRNLIK---V 553
            +G G +G V  A        VAVK+ ++ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH-F 607
                N ++  L LEY   G L   +     +        F +L       + + YLH  
Sbjct: 74  RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHGI 124

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           G    + H D+KP+N+LLD+     +SDFG+A +
Sbjct: 125 G----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 49/209 (23%), Positives = 78/209 (37%), Gaps = 44/209 (21%)

Query: 461 RKRGKQPSNDANMPLVATWRTFSYLELCRATNGFSEN----NLIGRGGFGSVYKAR-LGD 515
           +K               +      L    A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 516 GMEVAVKVFNL--------QCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALV 566
           G E AVK+  +        Q     ++   E  +++ +  H ++I +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 567 LEYKPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHF-GCLAPV 613
            +    G L             F  L            +IM  +  A+ +LH       +
Sbjct: 179 FDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN----I 221

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H DLKP+N+LLDDN+   LSDFG +  L
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHL 250

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 80.1 bits (198), Expect = 5e-16
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G+G FG V   +    G E AVKV +   ++     +S   E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 556 SCSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
              ++ +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMHK--- 144

Query: 611 APVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
             ++H DLKP+N+LL     +    + DFG++ 
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 40/181 (22%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPA--CFSNLASLRILSLSSNELTSIP-LTFWNLK 281
           ++P S+   T    L+L  N L   + A    + L +L  L LS N L  I    F  + 
Sbjct: 32  NVPQSLPSYTA--LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 282 DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNR 340
           ++  L+ SSN L                           +   +   L+ LE L L  N 
Sbjct: 89  NLRYLDLSSNHLH-------------------------TLDEFLFSDLQALEVLLLYNNH 123

Query: 341 LEGSIP-DSFGDLISLKFLNLSNNNLSGAIP----TSLEKLSYLEDLNLSFNKLEGEIPR 395
           +   +  ++F D+  L+ L LS N +S   P        KL  L  L+LS NKL+ ++P 
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL 180

Query: 396 G 396
            
Sbjct: 181 T 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 19/152 (12%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIAD---VRLPNLE 62
           + L NL  L L HN L   + +  F  +  L+ L L +N     L ++ +     L  LE
Sbjct: 61  TRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNH----LHTLDEFLFSDLQALE 115

Query: 63  ALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGN---LRNLEWLNLRDNY 118
            LLL+ N+    + R  F + ++L  L LSQN  S F      +   L  L  L+L  N 
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174

Query: 119 LTSSTPE-LSFLSSLSNCKSLTFIHLSDNPLD 149
           L       L  L +         ++L +NPL+
Sbjct: 175 LKKLPLTDLQKLPAW----VKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 43/196 (21%), Positives = 67/196 (34%), Gaps = 37/196 (18%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIP--ITLSKLQKLQGLGLDDNKLEGSIPDSI-CRL 233
            +P     L      DL  N L   +    T ++L  L  L L  N L   I       +
Sbjct: 36  SLPSYTALL------DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 234 TELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
             L  L+L  N L  ++    FS+L +L +L L +N +  +    F ++  + +L  S N
Sbjct: 88  PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146

Query: 292 FLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD 351
            ++                 F +             L  L  L L  N+L+         
Sbjct: 147 QIS----------------RFPVELIKDG-----NKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 352 LISLK--FLNLSNNNL 365
           L +     L L NN L
Sbjct: 186 LPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 59/262 (22%), Positives = 90/262 (34%), Gaps = 44/262 (16%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN 70
               L     +L   VP ++   S   LL L +N+L    +     RL NL +LLL  N+
Sbjct: 19  ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 71  FSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFL 129
            +  I    F     L  L+LS N         F +L+ LE L L +N++       +F 
Sbjct: 76  LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF- 132

Query: 130 SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSI 189
               +   L  ++LS N +                             + ++   L   +
Sbjct: 133 ---EDMAQLQKLYLSQNQIS-----------------------RFPVELIKDGNKLPKLM 166

Query: 190 TIDLGGNKLNGSIPITLSKLQKL--QGLGLDDNKLEGSIPDSICRL----TELYELELGG 243
            +DL  NKL       L KL      GL L +N L     +  C+L    +     +L  
Sbjct: 167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL-----ECDCKLYQLFSHWQYRQLSS 221

Query: 244 NKLFGSIPACFSNLASLRILSL 265
              F     C  +     I SL
Sbjct: 222 VMDFQEDLYCMHSKKLHNIFSL 243

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRHRNLIK---V 553
            +G G +G V  A        VAVK+ ++ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH-F 607
                N ++  L LEY   G L   +     +        F +L       + + YLH  
Sbjct: 74  RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHGI 124

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           G    + H D+KP+N+LLD+     +SDFG+A +
Sbjct: 125 G----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 20/152 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G G +G V   R     +E A+K+         +      E  ++K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             ++    LV+E    G L      +  ++            I+  V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLHK---H 155

Query: 612 PVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
            ++H DLKP+N+LL   + + +  + DFG++ 
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 17/156 (10%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRAFKSFAV--ECEMMKSIRHR--N 549
           L+G GGFGSVY    + D + VA+K          G       V  E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 550 LIKVISSCSNEEFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-F 607
           +I+++      +   L+LE  +P   L  ++     + +   R +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 168

Query: 608 GCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLL 642
           G    V+H D+K +N+L+D N     L DFG   LL
Sbjct: 169 G----VLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 77.2 bits (191), Expect = 9e-16
 Identities = 45/151 (29%), Positives = 63/151 (41%), Gaps = 20/151 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           IGRG +G V  A   G  +  A K            F  E E+MKS+ H N+I++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 559 NEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHF-GCLAP 612
           +     LV+E    G L      K ++  +    I +      DV SA+ Y H       
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCHKLN---- 126

Query: 613 VIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
           V H DLKP+N L      +    L DFG+A 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.4 bits (196), Expect = 9e-16
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 24/155 (15%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK-- 552
            +G G FG V   +    G +VAVK+ N   ++          E + +K  RH ++IK  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 553 -VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 606
            VIS+  ++ F  +V+EY   G L  Y+  +  +       +FQ++       S ++Y H
Sbjct: 83  QVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYCH 133

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
                 V+H DLKP+NVLLD ++ A ++DFG++ +
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTEL 236
               E          +L    +      T ++L  +  +  +++ ++ S+   I  L  +
Sbjct: 16  DAFAETIKA------NLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNV 65

Query: 237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLTG 295
             L LGGNKL   I A    L +L  L L+ N+L S+P   F  L ++ +L    N L  
Sbjct: 66  RYLALGGNKL-HDISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLIS 354
                     +  G+      F          L NL YL L +N+L+ S+P   F  L +
Sbjct: 123 ---------SLPDGV------FDK--------LTNLTYLNLAHNQLQ-SLPKGVFDKLTN 158

Query: 355 LKFLNLSNNNLSGAIPTSL-EKLSYLEDLNLSFNKLEGEIPRG 396
           L  L+LS N L  ++P  + +KL+ L+DL L  N+L+  +P G
Sbjct: 159 LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 32/214 (14%)

Query: 88  LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP 147
             L + S +  +      L +++ +   ++ + S       +  +    ++ ++ L  N 
Sbjct: 24  ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVRYLALGGNK 74

Query: 148 LDGILSKTSIGNLSHSLKDFYMSNCN------VSGGIPEEITNLTNSITIDLGGNKLNGS 201
           L        I  L   L +             +  G+ +++TNL     + L  N+L  S
Sbjct: 75  L------HDISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLK---ELVLVENQLQ-S 123

Query: 202 IPITL-SKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYELELGGNKLFGSIPA-CFSNLA 258
           +P  +  KL  L  L L  N+L+ S+P  +  +LT L EL+L  N+L  S+P   F  L 
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLT 181

Query: 259 SLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
            L+ L L  N+L S+P   F  L  +  +    N
Sbjct: 182 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 59/270 (21%), Positives = 99/270 (36%), Gaps = 70/270 (25%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
            P +        + +L+   +          ++ +  +   N+ +   +  I    LPN+
Sbjct: 13  FPDDAFA--ETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKS-VQGIQ--YLPNV 65

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
             L L GN     I       + L+ L L+ N         F  L NL+ L L +N L S
Sbjct: 66  RYLALGGNKLH-DISALK-ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS 123

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
                                                               +  G+ ++
Sbjct: 124 ----------------------------------------------------LPDGVFDK 131

Query: 182 ITNLTNSITIDLGGNKLNGSIPITL-SKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYEL 239
           +TNLT    ++L  N+L  S+P  +  KL  L  L L  N+L+ S+P+ +  +LT+L +L
Sbjct: 132 LTNLT---YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186

Query: 240 ELGGNKLFGSIP-ACFSNLASLRILSLSSN 268
            L  N+L  S+P   F  L SL+ + L  N
Sbjct: 187 RLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 26/181 (14%)

Query: 225 SIPDSI-CRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDI 283
             PD       +     L    +        + L S+  +  +++++ S+      L ++
Sbjct: 12  IFPDDAFAETIKAN---LKKKSV-TDAVT-QNELNSIDQIIANNSDIKSVQ-GIQYLPNV 65

Query: 284 LQLNFSSNFLTGPLPLEIG---NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR 340
             L    N L      +I     L  L  +  + N   S+       L NL+ L L  N+
Sbjct: 66  RYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120

Query: 341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE-----KLSYLEDLNLSFNKLEGEIPR 395
           L+      F  L +L +LNL++N L      SL      KL+ L +L+LS+N+L+  +P 
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQL-----QSLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174

Query: 396 G 396
           G
Sbjct: 175 G 175

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 10/144 (6%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFN-MSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            L NL  L L  N+L  ++P  +F+ ++ LK L L  N L      + D +L NL  L L
Sbjct: 83  ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFD-KLTNLTYLNL 140

Query: 67  WGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
             N    ++P+ +F+  + L+ L+LS N         F  L  L+ L L  N L S  P+
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
             F        SL +I L DNP D
Sbjct: 199 GVF----DRLTSLQYIWLHDNPWD 218

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 37/170 (21%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKV-----FNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           IG+G F  V +      G + AVK+     F    G + +    E  +   ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 554 ISSCSNEEFKALVLEYKPHGSL---------EKYLYS----SNCILDIFQRLNIMIDVAS 600
           + + S++    +V E+     L           ++YS    S+ +  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 601 ALEYLHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGED 646
           AL Y H       +IH D+KP  VLL   +++    L  FG+A  L    
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 29/161 (18%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRAFKSFAVECEMMKSIRHRNL 550
           +G G  G V  A       +VA+++ +         +      +   E E++K + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 551 IKVISSCSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           IK+ +    E++  +VLE    G L                  F        +  A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 606 HF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
           H  G    +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 256 HENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 27/160 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRAFKSFAVECEMMKSIRHRNL 550
           +G G  G V  A       +VA+K+ +         +      +   E E++K + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 551 IKVISSCSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYL 605
           IK+ +    E++  +VLE    G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 606 HFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
           H      +IH DLKP+NVLL   +++ +  ++DFG +K+L
Sbjct: 131 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 35/162 (21%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISS 556
           ++G G    V     L    E AVK+   Q G        E EM+   + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEY 604
              E+   LV E    GS+                +             ++ DVASAL++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 605 LHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
           LH  G    + H DLKP+N+L    +      + DF +   +
Sbjct: 127 LHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 20/152 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISS 556
           +G+G FG V K +      E AVKV N      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 557 CSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
             +     +V E    G L     ++  +S +          I+  V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMHK---H 140

Query: 612 PVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
            ++H DLKP+N+LL   + +    + DFG++ 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 22/160 (13%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
            S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  + H NLI+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 553 VISSCSNEEFKALVLEYKPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYL 605
           +  +  ++    LV+EY   G L      E Y  +  + I         M  +   + ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQICEGIRHM 203

Query: 606 HFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
           H      ++H DLKP+N+L    D   +  + DFG+A+  
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIK-IIDFGLARRY 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 20/153 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +G G FG V++      G   A K          ++   E + M  +RH  L+ +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 559 NEEFKALVLEYKPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++    ++ E+   G L      E    S    +         M  V   L ++H     
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCKGLCHMHE---N 274

Query: 612 PVIHCDLKPDNVLLDDNLVAYL--SDFGIAKLL 642
             +H DLKP+N++        L   DFG+   L
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 17/157 (10%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRAFKSFAV--ECEMMKSIR----H 547
           L+G+GGFG+V+    L D ++VA+KV      L       S     E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 548 RNLIKVISSCSNEEFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
             +I+++     +E   LVLE   P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 607 FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLL 642
                 V+H D+K +N+L+D     A L DFG   LL
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 41/211 (19%), Positives = 82/211 (38%), Gaps = 16/211 (7%)

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
                L N++  +LG   +  +  ++  +L  +Q    D++ ++ S+   +   T L EL
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68

Query: 240 ELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLP 298
            L  N++  S  +   +L  L  LS++ N L ++  +    L    +L   +N L     
Sbjct: 69  HLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELRDTDS 123

Query: 299 LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFL 358
           L   +LK L  +    N   S++   +G L  LE L L  N +  +       L  + ++
Sbjct: 124 LI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177

Query: 359 NLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
           +L+             +L     +     + 
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 47/269 (17%), Positives = 93/269 (34%), Gaps = 27/269 (10%)

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH--SLKDFYMSNCNVSGGIPEEI 182
            ++ +       +    +L    +      T + +      +++F   N N+       +
Sbjct: 8   PINQVFPDPGLANAVKQNLGKQSV------TDLVSQKELSGVQNFNGDNSNIQ--SLAGM 59

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
              TN   + L  N+++  +   L  L KL+ L ++ N+L+         L+ L+   L 
Sbjct: 60  QFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LD 114

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
            N+L         +L +L ILS+ +N+L SI      L  +  L+   N +T    L   
Sbjct: 115 NNEL--RDTDSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNTGGLT-- 169

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN 362
            LK +  ID +     +        L     +     R     P    +  S     +  
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLW 227

Query: 363 NNLSGAIPTSLEKLSYLEDLNLSFNKLEG 391
                  P   +++SY     ++  + E 
Sbjct: 228 EL-----PVYTDEVSYKFSEYINVGETEA 251

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 43/220 (19%), Positives = 77/220 (35%), Gaps = 29/220 (13%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEAL 64
              L N  + +L    +   V      +S ++  +  N++    + S+A ++   NL+ L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSN----IQSLAGMQFFTNLKEL 68

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            L  N  S   P  + + +KL  L +++N               L  L L +N L     
Sbjct: 69  HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--- 120

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH--SLKDFYMSNCNVSGGIPEEI 182
                 SL + K+L  + + +N L       SI  L     L+   +    ++      +
Sbjct: 121 ----TDSLIHLKNLEILSIRNNKL------KSIVMLGFLSKLEVLDLHGNEITN--TGGL 168

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL 222
           T L     IDL G K          +L     +   D + 
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 40/187 (21%), Positives = 69/187 (36%), Gaps = 50/187 (26%)

Query: 486 ELCRATNGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAV 537
           +L R +  F++       IG G +    +       ME AVK+ +               
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------- 64

Query: 538 ECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL---- 592
           E E +++  +H N+I +     + ++  +V E    G L               ++    
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQK 111

Query: 593 --------NIMIDVASALEYLHF-GCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIA 639
                    ++  +   +EYLH  G    V+H DLKP N+L      +     + DFG A
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFA 167

Query: 640 KLLIGED 646
           K L  E+
Sbjct: 168 KQLRAEN 174

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSI-ADV--R 57
           EIP  +   + + E+ L  N +    P A      L+ + L NN     +S +  D    
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ----ISELAPDAFQG 78

Query: 58  LPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD 116
           L +L +L+L+GN  +  +P+ +F     L +L L+ N  +    + F +L NL  L+L D
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
           N L  +  + +F    S  +++  +HL+ NP  
Sbjct: 138 NKLQ-TIAKGTF----SPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 32/121 (26%), Positives = 56/121 (46%), Gaps = 11/121 (9%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTE 235
            +PE IT +       L  N +    P   S  +KL+ + L +N++   +       L  
Sbjct: 29  NLPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 236 LYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFL 293
           L  L L GNK+   +P   F  L SL++L L++N++  + +  F +L ++  L+   N L
Sbjct: 82  LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 294 T 294
            
Sbjct: 141 Q 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 33/167 (19%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKD 282
            IP ++       E+ L  N +   IP   FS    LR + LS+N+++ +    F  L+ 
Sbjct: 25  EIPTNLPETIT--EIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS 81

Query: 283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRL 341
           +  L    N +T                          +P  +  GL +L+ L L  N++
Sbjct: 82  LNSLVLYGNKIT-------------------------ELPKSLFEGLFSLQLLLLNANKI 116

Query: 342 EGSIP-DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
              +  D+F DL +L  L+L +N L      +   L  ++ ++L+ N
Sbjct: 117 N-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 30/150 (20%)

Query: 249 SIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLTGPLPLEIGNLKVL 307
            IP       ++  + L  N +  IP   F   K + +++ S+N ++    L     +  
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE---LAPDAFQ-- 77

Query: 308 IGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLSNNNLS 366
                              GL++L  L L  N++   +P S F  L SL+ L L+ N ++
Sbjct: 78  -------------------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117

Query: 367 GAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
                + + L  L  L+L  NKL+  I +G
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 31/158 (19%), Positives = 55/158 (34%), Gaps = 33/158 (20%)

Query: 88  LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP 147
           + L QN+     P  F   + L  ++L +N ++      +F   L +   L  + L  N 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF-QGLRS---LNSLVLYGNK 91

Query: 148 LDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI-TL 206
           +      T +                    + E + +L     + L  NK+N  + +   
Sbjct: 92  I------TELPK-----------------SLFEGLFSLQ---LLLLNANKIN-CLRVDAF 124

Query: 207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
             L  L  L L DNKL+     +   L  +  + L  N
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 7/155 (4%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKS 544
            ++   +    L+G G +G V K R    G  VA+K F      +  K  A+ E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
           +RH NL+ ++  C  ++   LV E+  H ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            H      +IH D+KP+N+L+  + V  L DFG A
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 40/157 (25%), Positives = 60/157 (38%), Gaps = 30/157 (19%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV------ECEMMKSIRHRNLI 551
            IG G FG     R       VAVK          +  A+      E    +S+RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 606
           +           A+++EY   G L + + ++           FQ+L       S + Y H
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH 133

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYL--SDFGIAKL 641
                 + H DLK +N LLD +    L   DFG +K 
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 13/150 (8%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           +G G FG V+       G+E  +K  N  +     +    E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHF-GCLAPV 613
            +     +V+E    G L + + S+              +M  + +AL Y H       V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----V 145

Query: 614 IHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
           +H DLKP+N+L      +    + DFG+A+
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 499 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAV----------ECEMMKSIRH 547
           ++G G F +V  AR      E A+K+         K   +          E ++M  + H
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDH 89

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 606
              +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHG 148

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            G    +IH DLKP+N+LL++++   ++DFG AK+L  E 
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 38/165 (23%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSC 557
           +G G F    K          AVK+ +    R   +   E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYL 605
            ++    LV+E    G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 606 HF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGED 646
           H  G    V+H DLKP+N+L    +DNL   + DFG A+L   ++
Sbjct: 123 HDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 7/143 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G V+K R    G  VA+K F   +     K  A+ E  M+K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              +    LV EY  H ++   L      +      +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 617 DLKPDNVLLDDNLVAYLSDFGIA 639
           D+KP+N+L+  + V  L DFG A
Sbjct: 127 DVKPENILITKHSVIKLCDFGFA 149

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 35/154 (22%), Positives = 62/154 (40%), Gaps = 17/154 (11%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIAD---V 56
           +IP  I   Q   EL L +N+        IF  +  L+ ++  NN +    + I +    
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI----TDIEEGAFE 78

Query: 57  RLPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR 115
               +  +LL  N     +   +F     L  L L  N  +    ++F  L ++  L+L 
Sbjct: 79  GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLY 137

Query: 116 DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
           DN +T +    +F        SL+ ++L  NP +
Sbjct: 138 DNQIT-TVAPGAF----DTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 32/167 (19%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIP--ACFSNLASLRILSLSSNELTSIPL-TFWNLK 281
            IP+ I + T   EL L  N+    +     F  L  LR ++ S+N++T I    F    
Sbjct: 25  KIPEHIPQYTA--ELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81

Query: 282 DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL 341
            + ++  +SN L   +  ++               F         GL++L+ L L  NR+
Sbjct: 82  GVNEILLTSNRLEN-VQHKM---------------FK--------GLESLKTLMLRSNRI 117

Query: 342 EGSIP-DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
              +  DSF  L S++ L+L +N ++   P + + L  L  LNL  N
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 33/157 (21%)

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLT--FWNLKDILQLNFSSNFLTGPLPLEI 301
           N+    IP           L L++NE T +  T  F  L  + ++NFS+N +T    +E 
Sbjct: 20  NQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEE 74

Query: 302 GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNL 360
           G  +                     G   +  + L  NRLE ++    F  L SLK L L
Sbjct: 75  GAFE---------------------GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112

Query: 361 SNNNLSGAIPT-SLEKLSYLEDLNLSFNKLEGEIPRG 396
            +N ++  +   S   LS +  L+L  N++   +  G
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 33/183 (18%), Positives = 60/183 (32%), Gaps = 58/183 (31%)

Query: 88  LELSQNSFSGFIPN-TFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
           L L+ N F+       F  L  L  +N  +N +T    E +F    S    +  I L+ N
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAF-EGASG---VNEILLTSN 91

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPI-T 205
            L+ +                          + + + +L    T+ L  N++   +   +
Sbjct: 92  RLENV-----------------------QHKMFKGLESLK---TLMLRSNRIT-CVGNDS 124

Query: 206 LSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSL 265
              L  ++ L L DN++  ++                           F  L SL  L+L
Sbjct: 125 FIGLSSVRLLSLYDNQIT-TVAPGA-----------------------FDTLHSLSTLNL 160

Query: 266 SSN 268
            +N
Sbjct: 161 LAN 163

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 37/165 (22%), Positives = 70/165 (42%), Gaps = 31/165 (18%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKV-------------FNLQCGRAFKSFAVECEMMK 543
             +G G +G V   +      E A+KV              N    +  +    E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSL-----EKYLYSSNCILDIFQRLNIMIDV 598
           S+ H N+IK+     ++++  LV E+   G L      ++ +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
            S + YLH      ++H D+KP+N+LL   +  L   + DFG++ 
Sbjct: 156 LSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 28/157 (17%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +GRG    VY+ +  G     A+KV         K    E  ++  + H N+IK+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 558 SNEEFKALVLEYKPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFG 608
                 +LVLE    G L     EK  YS    ++ +  I            A+ YLH  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----------EAVAYLHE- 166

Query: 609 CLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
               ++H DLKP+N+L      +    ++DFG++K++
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 28/159 (17%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVK-VFNLQC--GRAFKSFAVECEMMKSIRHRNLIK---- 552
           IG G FG V++A+L +  EVA+K V   +    R       E ++M+ ++H N++     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100

Query: 553 VISSCSNEEFKA--LVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF 607
             S+   ++     LVLEY P  ++ +           + +      M  +  +L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158

Query: 608 GCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI 643
                + H D+KP N+LLD     L   L DFG AK+LI
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLK--LIDFGSAKILI 193

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 42/195 (21%), Positives = 67/195 (34%), Gaps = 52/195 (26%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN-----LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
           IG+G +G V  A         A+K+ N         +  +    E  +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL--------------------- 592
                +E++  LV+E    G L   L            +                     
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 593 ------------------NIMIDVASALEYLHF-GCLAPVIHCDLKPDNVLL--DDNLVA 631
                             NIM  + SAL YLH  G    + H D+KP+N L   + +   
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209

Query: 632 YLSDFGIAKLLIGED 646
            L DFG++K     +
Sbjct: 210 KLVDFGLSKEFYKLN 224

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 25/155 (16%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK-- 552
            +G G FG V  A       +VA+K  +   L+          E   +K +RH ++IK  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 553 -VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 606
            VI++   +    +V+EY   G L  Y+     +        FQ++        A+EY H
Sbjct: 76  DVITT-PTDIV--MVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI------ICAIEYCH 125

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
                 ++H DLKP+N+LLDDNL   ++DFG++ +
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 6/155 (3%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSI 545
                 + +   +G G +G VYKA+   G  VA+K   L        S A+ E  ++K +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H N++ +I    +E    LV E+     L+K L  +   L   Q    +  +   + + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           H      ++H DLKP N+L++ +    L+DFG+A+
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 29/155 (18%), Positives = 62/155 (40%), Gaps = 25/155 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS 558
           +GRG FG V++            K   ++ G        E  ++   RHRN++ +  S  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 559 NEEFKALVLEYKPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHF-GCL 610
           + E   ++ E+     +        +  +    +       + +  V  AL++LH     
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLHSHN-- 122

Query: 611 APVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
             + H D++P+N++      + +  + +FG A+ L
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIK-IIEFGQARQL 154

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)

Query: 485 LELCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFK----SFAV-E 538
           L++      + + + +G G F +VYKAR       VA+K   L      K      A+ E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 539 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
            ++++ + H N+I ++ +  ++   +LV ++     LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              LEYLH      ++H DLKP+N+LLD+N V  L+DFG+AK
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 42/162 (25%), Positives = 64/162 (39%), Gaps = 31/162 (19%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G F  V K R  G G E A K          + G + +    E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 553 VISSCSNEEFKALVLEYKPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 606
           +     N+    L+LE    G L     EK   +              +  +   + YLH
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH 125

Query: 607 F-GCLAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLL 642
                  + H DLKP+N++L      +  +  L DFGIA  +
Sbjct: 126 SKR----IAHFDLKPENIMLLDKNVPNPRIK-LIDFGIAHKI 162

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 69.6 bits (171), Expect = 6e-14
 Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTE 235
           GIP ++T L       L GN+    +P  LS  + L  + L +N++  ++ +     +T+
Sbjct: 28  GIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 236 LYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
           L  L L  N+L   IP   F  L SLR+LSL  N+++ +P   F +L  +  L   +N
Sbjct: 80  LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.7 bits (140), Expect = 8e-10
 Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 33/138 (23%)

Query: 13  EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFS 72
            EL L  N+    VP  + N   L L+ L NN +                          
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-------------------------- 66

Query: 73  GTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSS 131
            T+    F N ++L  L LS N      P TF  L++L  L+L  N + S  PE +F   
Sbjct: 67  STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAF--- 122

Query: 132 LSNCKSLTFIHLSDNPLD 149
            ++  +L+ + +  NPL 
Sbjct: 123 -NDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 32/142 (22%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
            +P  I R     EL L GN+    +P   SN   L ++ LS+N ++++   +F N+  +
Sbjct: 24  VLPKGIPRDVT--ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLE 342
           L L  S N L                           IP     GLK+L  L L  N + 
Sbjct: 81  LTLILSYNRLR-------------------------CIPPRTFDGLKSLRLLSLHGNDIS 115

Query: 343 GSIPD-SFGDLISLKFLNLSNN 363
             +P+ +F DL +L  L +  N
Sbjct: 116 -VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)

Query: 315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL- 373
            N  +++P E+   K+L  + L  NR+      SF ++  L  L LS N L   IP    
Sbjct: 40  GNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTF 98

Query: 374 EKLSYLEDLNLSFNKLEGEIPRG 396
           + L  L  L+L  N +   +P G
Sbjct: 99  DGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           +P E+SN ++L  +DL +N++  T+    F NM+ L  L L  N  L C+       L +
Sbjct: 46  VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR-LRCIPPRTFDGLKS 103

Query: 61  LEALLLWGNNFSGTIPRFIF-NASKLSILELSQN 93
           L  L L GN+ S  +P   F + S LS L +  N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.4 bits (176), Expect = 7e-14
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             ++   LV E+     L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125

Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L++      ++DFG+A+
Sbjct: 126 LKPQNLLINREGELKIADFGLAR 148

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 15/163 (9%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKS 544
           C   + + +   IG+G FG V+KAR    G +VA+K   ++  +  F   A+ E ++++ 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 72

Query: 545 IRHRN---LIKVISSCSNEEFKA-----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI 596
           ++H N   LI++  + ++   +      LV ++  H  L   L +      + +   +M 
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 27/160 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV------ECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 553 VISSCSNEEFKALVLEYKPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 606
           +     N     L+LE    G L     +K   S            + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 607 FGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLL 642
                 + H DLKP+N++L           L DFG+A  +
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 34/172 (19%), Positives = 63/172 (36%), Gaps = 50/172 (29%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECE---MMKSIRHRNLIKVI- 554
           +G G  G V +        + A+K+                E     ++ +  ++++++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 555 ---SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRL--------------NIMID 597
              +  +  +   +V+E    G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 598 VASALEYLHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGE 645
           +  A++YLH       + H D+KP+N+L      N +  L+DFG AK   GE
Sbjct: 126 IGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.3 bits (179), Expect = 1e-13
 Identities = 49/218 (22%), Positives = 77/218 (35%), Gaps = 21/218 (9%)

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE 238
             +          +L   K    +   L   ++LQ L  ++     +I   I  +  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397

Query: 239 LELGGNKLFGSIPACFSNLASLRILSLS------SNELTSIPLTFWNLKDILQLNFSSNF 292
           L      L       FS L ++  +  +      S  L    +      D+  L+ +   
Sbjct: 398 LLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 293 LTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL 352
           LT    LE   L ++  +D S N   + +P  +  L+ LE L    N LE ++     +L
Sbjct: 453 LTVLCHLE--QLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANL 507

Query: 353 ISLKFLNLSNNNLSG-AIPTSLEKLSYLEDLNLSFNKL 389
             L+ L L NN L   A    L     L  LNL  N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.6 bits (172), Expect = 6e-13
 Identities = 35/229 (15%), Positives = 75/229 (32%), Gaps = 9/229 (3%)

Query: 162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
             L    +++           T   +     L  ++         +  ++L    L   K
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360

Query: 222 LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLK 281
               +   +    EL ELE        +I      L  L     +    ++  L   +  
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST--LKAVDPM 417

Query: 282 DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL 341
               L+   +       +       +  +  +  + + +    +  L  + +L L +NRL
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRL 475

Query: 342 EGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
             ++P +   L  L+ L  S+N L   +   +  L  L++L L  N+L+
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.6 bits (172), Expect = 7e-13
 Identities = 47/306 (15%), Positives = 83/306 (27%), Gaps = 37/306 (12%)

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY--LTS 121
           LL+          R     ++ S + L     +        +   + W         +  
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
                 +    +  + L    LS      + S+         L+            +   
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA 394

Query: 182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
           +  L          + L    P+  + L  L+   L +N              ++  L L
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHL 448

Query: 242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEI 301
               L  ++      L  +  L LS N L ++P     L+ +  L  S N L        
Sbjct: 449 AHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE------- 499

Query: 302 GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG-SIPDSFGDLISLKFLNL 360
            N+                    +  L  L+ L L  NRL+  +          L  LNL
Sbjct: 500 -NVD------------------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540

Query: 361 SNNNLS 366
             N+L 
Sbjct: 541 QGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.0 bits (168), Expect = 2e-12
 Identities = 29/152 (19%), Positives = 57/152 (37%), Gaps = 20/152 (13%)

Query: 6   ISNLQNLEELD--------LRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV- 56
           +     L+ +D           +K +          + +++LHL +      L+ +  + 
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK----DLTVLCHLE 460

Query: 57  RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD 116
           +L  +  L L  N     +P  +     L +L+ S N+    +     NL  L+ L L +
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCN 517

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL 148
           N L       + +  L +C  L  ++L  N L
Sbjct: 518 NRLQQ----SAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 10/76 (13%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADV---- 56
            +P  ++ L+ LE L    N L       + N+  L+ L L NN     L   A +    
Sbjct: 477 ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNN----RLQQSAAIQPLV 530

Query: 57  RLPNLEALLLWGNNFS 72
             P L  L L GN+  
Sbjct: 531 SCPRLVLLNLQGNSLC 546

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 27/160 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV------ECEMMKSIRHRNLIK 552
           +G G F  V K R    G+E A K    +  RA +          E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 553 VISSCSNEEFKALVLEYKPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 606
           +     N     L+LE    G L     +K   S            + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 607 FGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLL 642
                 + H DLKP+N++L           L DFG+A  +
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 25/158 (15%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVK-VFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVI- 554
           IG G FG VY+A+L D G  VA+K V   +    R       E ++M+ + H N++++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114

Query: 555 -----SSCSNEEFKALVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
                    +E +  LVL+Y P   +     Y  +   +  I+ +L  M  +  +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAY-LSDFGIAKLLI 643
                 + H D+KP N+LLD +     L DFG AK L+
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 33/152 (21%), Positives = 67/152 (44%), Gaps = 5/152 (3%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIRHRNLI 551
           F + + +G G  G V+K      G+ +A K+ +L+   A       E +++       ++
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
               +  ++   ++ +E+   GSL++ +      +       + I V   L YL      
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH-- 151

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
            ++H D+KP N+L++      L DFG++  LI
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 70.2 bits (173), Expect = 2e-13
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 7/144 (4%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSIRHRNLIKVISS 556
           IG G +G+V+KA+       VA+K   L        S A+ E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
             +++   LV E+     L+KY  S N  LD     + +  +   L + H      V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHR 125

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAK 640
           DLKP N+L++ N    L++FG+A+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 6/143 (4%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G + +VYK +       VA+K   L+        A+ E  ++K ++H N++ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             E+   LV EY     L++YL     I+++      +  +   L Y H      V+H D
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125

Query: 618 LKPDNVLLDDNLVAYLSDFGIAK 640
           LKP N+L+++     L+DFG+A+
Sbjct: 126 LKPQNLLINERGELKLADFGLAR 148

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 31/162 (19%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G F  V K R    G++ A K          + G + +    E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 553 VISSCSNEEFKALVLEYKPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 606
           +     N+    L+LE    G L     EK   +              +  + + + YLH
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVYYLH 131

Query: 607 F-GCLAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLL 642
                  + H DLKP+N++L         +  + DFG+A  +
Sbjct: 132 SLQ----IAHFDLKPENIMLLDRNVPKPRIK-IIDFGLAHKI 168

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 20/156 (12%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVK-----VFNLQCGRAFKSFAV------ECEMMKSIRHR 548
           I  G +G+V      +G+ VA+K     V + +         +      E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 549 NLIK---VISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           N++    +             LV E      L + ++    ++        M  +   L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
            LH    A V+H DL P N+LL DN    + DF +A
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 44/165 (26%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECE---MMKSIRHRNLIKVI 554
           ++G G  G V +      G + A+K+          S     E     ++    +++ ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 555 ----SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVA 599
               +    +    +++E    G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 600 SALEYLHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
           +A+++LH       + H D+KP+N+L    + + V  L+DFG AK
Sbjct: 139 TAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 36/152 (23%), Positives = 72/152 (47%), Gaps = 21/152 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           IG G +G V +A    +   VA+K    VF   + C R  +    E  ++  + H +++K
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116

Query: 553 ---VISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              ++     E+F    +VLE       +K   +   + ++  +  ++ ++   ++Y+H 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              A ++H DLKP N L++ +    + DFG+A
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 25/158 (15%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHR-NLIKVIS 555
           +GRG F  V +      G E A K      +          E  +++  +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 556 SCSNEEFKALVLEYKPHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYLHF- 607
              N     L+LEY   G +         C+ ++ + +       ++  +   + YLH  
Sbjct: 97  VYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 608 GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL 642
                ++H DLKP N+LL          + DFG+++ +
Sbjct: 151 N----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 57/195 (29%), Positives = 79/195 (40%), Gaps = 39/195 (20%)

Query: 174 VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-CR 232
           V  GIP +   L      DL    L      T   L KL  L LD N+L+ ++   +   
Sbjct: 29  VPSGIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD 81

Query: 233 LTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSS 290
           LTEL  L L  N+L  S+P   F +L  L  L L  N+L S+P   F  L  + +L  ++
Sbjct: 82  LTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140

Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPD-S 348
           N L                           IP      L NL+ L L  N+L+ S+P  +
Sbjct: 141 NQLQ-------------------------SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGA 174

Query: 349 FGDLISLKFLNLSNN 363
           F  L  L+ + L  N
Sbjct: 175 FDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 45/144 (31%), Positives = 63/144 (43%), Gaps = 10/144 (6%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFN-MSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
            L  L  L+L +N+L  T+ A +F+ ++ L  L L NN L      + D  L  L+ L L
Sbjct: 57  GLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFD-HLTQLDKLYL 114

Query: 67  WGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
            GN    ++P  +F   +KL  L L+ N         F  L NL+ L+L  N L S  P 
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPH 172

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLD 149
            +F         L  I L  N  D
Sbjct: 173 GAF----DRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 54/175 (30%), Positives = 81/175 (46%), Gaps = 32/175 (18%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
           S+P  I   TE  +L+L    L     A F  L  L  L+L  N+L ++    F +L ++
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG 343
             L  ++N L   LPL +               F          L  L+ L+LG N+L+ 
Sbjct: 86  GTLGLANNQLAS-LPLGV---------------FDH--------LTQLDKLYLGGNQLK- 120

Query: 344 SIPDS-FGDLISLKFLNLSNNNLSGAIPTSL-EKLSYLEDLNLSFNKLEGEIPRG 396
           S+P   F  L  LK L L+ N L  +IP    +KL+ L+ L+LS N+L+  +P G
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 49/185 (26%), Positives = 68/185 (36%), Gaps = 35/185 (18%)

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS 121
           E L L     +          +KL+ L L  N         F +L  L  L L +N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 122 STPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE 181
           S P   F   L+    L  ++L  N L       S+                   G+ + 
Sbjct: 97  SLPLGVF-DHLTQ---LDKLYLGGNQL------KSL-----------------PSGVFDR 129

Query: 182 ITNLTNSITIDLGGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSI-CRLTELYEL 239
           +T L     + L  N+L  SIP     KL  LQ L L  N+L+ S+P     RL +L  +
Sbjct: 130 LTKLK---ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184

Query: 240 ELGGN 244
            L GN
Sbjct: 185 TLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 35/133 (26%), Positives = 55/133 (41%), Gaps = 7/133 (5%)

Query: 266 SSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI 325
               L S+P       + L L   S  L          L  L  ++   N   ++     
Sbjct: 22  QGKSLDSVPSGIPADTEKLDLQ--STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF 79

Query: 326 GGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLSNNNLSGAIPTSL-EKLSYLEDLN 383
             L  L  L L  N+L  S+P   F  L  L  L L  N L  ++P+ + ++L+ L++L 
Sbjct: 80  DDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELR 137

Query: 384 LSFNKLEGEIPRG 396
           L+ N+L+  IP G
Sbjct: 138 LNTNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 38/124 (30%), Positives = 56/124 (45%), Gaps = 5/124 (4%)

Query: 9   LQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLW 67
           L  L  L L +N+L  ++P  +F +++ L  L+L  N L    S + D RL  L+ L L 
Sbjct: 82  LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD-RLTKLKELRLN 139

Query: 68  GNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
            N    +IP   F+  + L  L LS N         F  L  L+ + L  N    S  E+
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEI 198

Query: 127 SFLS 130
            +LS
Sbjct: 199 LYLS 202

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 14/155 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVEC-----EMMKSIRHRNLIK 552
            IG+G FG V   +  D  ++ A+K  N Q  +  +   V       ++M+ + H  L+ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLA 611
           +  S  +EE   +V++    G L  +L  +    +   +L I  ++  AL+YL       
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR--- 135

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            +IH D+KPDN+LLD++   +++DF IA +L  E 
Sbjct: 136 -IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 14/162 (8%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEM-----MKSIRH 547
           F +  ++GRGGFG V+  ++    ++ A K   L   R  K    +  M     +  +  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEY 604
           R ++ +  +   +    LV+     G +  ++Y+ +     F   R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           LH      +I+ DLKP+NVLLDD+    +SD G+A  L    
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 11/147 (7%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVISSC 557
           +G G + +VYK      G+ VA+K   L       S A+ E  +MK ++H N++++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCLAP 612
             E    LV E+  +  L+KY+ S         L++         +   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           ++H DLKP N+L++      L DFG+A
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 25/170 (14%)

Query: 491 TNGFSENNLIGRGGFGSVYKARLGD-GMEVAVK-VFNLQCGRAFKSFAV----ECEMMKS 544
            + F    + G+G FG+V   +    GM VA+K V           F        + +  
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAV 75

Query: 545 IRHRNLIK---VISSCSNEEFK----ALVLEYKP---HGSLEKYLYSSNCILDIFQRLNI 594
           + H N+++      +    + +     +V+EY P   H     Y         I  ++  
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-F 134

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI 643
           +  +  ++  LH      V H D+KP NVL++  +    L DFG AK L 
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-FKSFAVECEM-MKSIRHRNLIKVISS 556
           +GRG +G V K R +  G  +AVK           K   ++ ++ M+++     +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGCL 610
              E    + +E     SL+K+      ++D  Q +       I + +  ALE+LH    
Sbjct: 75  LFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
             VIH D+KP NVL++      + DFGI+  L+
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 14/120 (11%)

Query: 177 GIPEEITNLTNSITIDLGGNKLNGSIPIT--LSKLQKLQGLGLDDNKLEGSIPDSIC-RL 233
            IP   T L       L  N+L   I       +L  L  L L  N+L   I  +     
Sbjct: 26  DIPLHTTEL------LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 234 TELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
           + + EL+LG NK+   I    F  L  L+ L+L  N+++ +   +F +L  +  LN +SN
Sbjct: 78  SHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.1 bits (141), Expect = 6e-10
 Identities = 37/132 (28%), Positives = 54/132 (40%), Gaps = 9/132 (6%)

Query: 19  HNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRF 78
             + +  +P  I        L L +N L    S     RLP+L  L L  N  +  I   
Sbjct: 16  TGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72

Query: 79  IF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS 137
            F  AS +  L+L +N         F  L  L+ LNL DN ++      SF     +  S
Sbjct: 73  AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSF----EHLNS 127

Query: 138 LTFIHLSDNPLD 149
           LT ++L+ NP +
Sbjct: 128 LTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 6/90 (6%)

Query: 310 IDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLSNNNLSG 367
           +  + N    +    + G L +L  L L  N+L   I  + F     ++ L L  N +  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91

Query: 368 AIPTSL-EKLSYLEDLNLSFNKLEGEIPRG 396
            I   +   L  L+ LNL  N++   +  G
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 32/148 (21%)

Query: 244 NKLFGSIPACFSNL-ASLRILSLSSNELTSIPLT--FWNLKDILQLNFSSNFLTGPLPLE 300
            +    IP    ++      L L+ NEL  I     F  L  +++L    N LTG +   
Sbjct: 17  GRGLKEIPR---DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPN 72

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD-SFGDLISLKFLN 359
                           F            +++ L LG N+++  I +  F  L  LK LN
Sbjct: 73  A---------------FEG--------ASHIQELQLGENKIK-EISNKMFLGLHQLKTLN 108

Query: 360 LSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
           L +N +S  +P S E L+ L  LNL+ N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 25/77 (32%), Positives = 34/77 (44%), Gaps = 8/77 (10%)

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPD-SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
           IP       +   L L  N L     D  FG L  L  L L  N L+G  P + E  S++
Sbjct: 27  IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 380 EDLNLSFNKLEGEIPRG 396
           ++L L  NK++ EI   
Sbjct: 81  QELQLGENKIK-EISNK 96

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 32/216 (14%), Positives = 63/216 (29%), Gaps = 58/216 (26%)

Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIR 546
           R    F     +GRGGFG V++A+   D    A+K   L     A +    E + +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKY-------------LYSSNCILDIFQRLN 593
           H  +++  ++      +    E       ++                     +D F   N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 594 IMIDVAS---------ALEYLHFGCLAP-------------------------------- 612
            +  +            ++      L                                  
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 613 --VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             ++H DLKP N+    + V  + DFG+   +  ++
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI-KVISSC 557
           IG G FG +   + L     VA+K+  ++         +E    K +   + I +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 558 SNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              ++ A+VLE    G SLE      +    +   L I I + S +EY+H   L   I+ 
Sbjct: 75  PCGKYNAMVLEL--LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IYR 129

Query: 617 DLKPDNVLL------DDNLVAYLSDFGIAK 640
           D+KP+N L+         ++ ++ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 14/153 (9%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-FKSFAVECE-MMKSIRHRNLIKVISS 556
           IGRG +GSV K      G  +AVK           K   ++ + +M+S     +++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGCL 610
              E    + +E     S +K+         +   +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKEN-- 144

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
             +IH D+KP N+LLD +    L DFGI+  L+
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 36/122 (29%), Positives = 53/122 (43%), Gaps = 10/122 (8%)

Query: 174 VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-R 232
           V  GIP     L       L  N++    P     L  L+ L L  N+L  ++P  +   
Sbjct: 34  VPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS 86

Query: 233 LTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSN 291
           LT+L  L+LG N+L   +P+  F  L  L+ L +  N+LT +P     L  +  L    N
Sbjct: 87  LTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145

Query: 292 FL 293
            L
Sbjct: 146 QL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 45/183 (24%), Positives = 63/183 (34%), Gaps = 58/183 (31%)

Query: 87  ILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
           IL L  N  +   P  F +L NL+ L L  N L +                         
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA------------------------- 78

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL 206
                                      +  G+ + +T LT    +DLG N+L   +P  +
Sbjct: 79  ---------------------------LPVGVFDSLTQLT---VLDLGTNQLT-VLPSAV 107

Query: 207 -SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSL 265
             +L  L+ L +  NKL   +P  I RLT L  L L  N+L       F  L+SL    L
Sbjct: 108 FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166

Query: 266 SSN 268
             N
Sbjct: 167 FGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)

Query: 184 NLTNSITIDLGGNKLNGSIPITL-SKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYELEL 241
           +L N   + LG N+L  ++P+ +   L +L  L L  N+L   +P ++  RL  L EL +
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119

Query: 242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
             NKL   +P     L  L  L+L  N+L SIP   F  L  +       N
Sbjct: 120 CCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 9/138 (6%)

Query: 13  EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFS 72
           + L L  N++    P    ++  LK L+L +N L      + D  L  L  L L  N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD-SLTQLTVLDLGTNQLT 101

Query: 73  GTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSS 131
             +P  +F+    L  L +  N  +  +P     L +L  L L  N L  S P  +F   
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAF--- 155

Query: 132 LSNCKSLTFIHLSDNPLD 149
                SLT  +L  NP D
Sbjct: 156 -DRLSSLTHAYLFGNPWD 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 28/164 (17%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
           S+P  I    +   L L  N++    P  F +L +L+ L L SN+L ++P+  F +L  +
Sbjct: 33  SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG 343
             L+  +N LT  LP  +               F          L +L+ LF+  N+L  
Sbjct: 91  TVLDLGTNQLTV-LPSAV---------------FDR--------LVHLKELFMCCNKLT- 125

Query: 344 SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN 387
            +P     L  L  L L  N L      + ++LS L    L  N
Sbjct: 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 31/155 (20%)

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLTGPLPLEIG 302
           +K   S+PA      + +IL L  N++T +    F +L ++ +L   SN L   LP    
Sbjct: 28  SKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LP---- 80

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLS 361
                +G+      F S        L  L  L LG N+L   +P + F  L+ LK L + 
Sbjct: 81  -----VGV------FDS--------LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMC 120

Query: 362 NNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG 396
            N L+  +P  +E+L++L  L L  N+L+  IP G
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHG 153

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.8 bits (164), Expect = 4e-12
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 19/168 (11%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC----GRAFKSFAV-ECEM 541
             AT+ +     IG G +G+VYKAR    G  VA+K   +      G       V E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 542 MKSIR---HRN---LIKVISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCI-LDIFQRL 592
           ++ +    H N   L+ V ++   +      LV E+     L  YL  +    L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 593 NIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           ++M      L++LH  C   ++H DLKP+N+L+       L+DFG+A+
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKS 544
             + + +     +G G +G VYKA        VA+K   L+         A+ E  ++K 
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89

Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
           ++HRN+I++ S   +     L+ EY  +  L+KY+   N  + +    + +  + + + +
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAY-----LSDFGIAK 640
            H       +H DLKP N+LL  +  +      + DFG+A+
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 32/170 (18%), Positives = 62/170 (36%), Gaps = 44/170 (25%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECE---MMKSIRHRNLIKVI- 554
           +G G  G V +        + A+K+                E     ++ +  ++++++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 555 ---SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVAS 600
              +  +  +   +V+E    G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 601 ALEYLHF-GCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGED 646
           A++YLH       + H D+KP+N+L      N +  L+DFG AK     +
Sbjct: 173 AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 66.0 bits (162), Expect = 5e-12
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 8/147 (5%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMKSIRHRNLIKVI 554
             IG G +G VYKAR    G  VA+K   L        S A+ E  ++K + H N++K++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAPV 613
                E    LV E+     L+K++ +S    + +    + +  +   L + H      V
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 124

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           +H DLKP N+L++      L+DFG+A+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLAR 151

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 34/150 (22%), Positives = 59/150 (39%), Gaps = 17/150 (11%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI-KVISSC 557
           IG G FG +++   L +  +VA+K    +          E    K +     I  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 558 SNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
                  LV++    G SLE  L        +         + + ++ +H   L   ++ 
Sbjct: 76  QEGLHNVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VYR 130

Query: 617 DLKPDNVLL------DDNLVAYLSDFGIAK 640
           D+KPDN L+      + N++ Y+ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 8/148 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-FKSFAVECE-MMKSIRHRNLIKVISS 556
           +G G  G V+K R    G  +AVK       +   K   ++ + ++KS     +++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHFGCLAPVIH 615
                   + +E     + +        I   I  +  + + +  AL YL       VIH
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK--EKHGVIH 148

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLLI 643
            D+KP N+LLD+     L DFGI+  L+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV 176

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 21/152 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           IGRG +G VY A        VA+K    +F   + C R  +    E  ++  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 553 ---VISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
              +I      +F    +VLE      L+K   +   + +   +  I+ ++     ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              + +IH DLKP N LL+ +    + DFG+A
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 27/165 (16%)

Query: 496 ENNLIGRGGFGSVYKAR---LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIRHRN-- 549
           E   +GRG +G VYKA+     D  + A+K             A  E  +++ ++H N  
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVI 81

Query: 550 -LIKVISSCSNEEFKALVLEYKPHGSLEKYL--------YSSNCILDIFQRLNIMIDVAS 600
            L KV  S ++ +   L+ +Y  H  L   +              L      +++  +  
Sbjct: 82  SLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY----LSDFGIAKL 641
            + YLH      V+H DLKP N+L+           ++D G A+L
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 29/162 (17%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVEC-----EMMKSIRHRNLIK 552
           +IGRG FG V   R     +V A+K+ +       K           ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVA--------SALEY 604
           +  +  ++ +  +V+EY P G L   +             ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H       IH D+KPDN+LLD +    L+DFG    +  E 
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEM-----MKSIRH 547
           F +  ++G+GGFG V   ++    ++ A K   L+  R  K       +     ++ +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 604
           R ++ +  +   ++   LVL     G L+ ++Y  +     F     +    ++   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           LH      +++ DLKP+N+LLDD+    +SD G+A 
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAV 334

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 74/433 (17%), Positives = 147/433 (33%), Gaps = 76/433 (17%)

Query: 10  QNLEELDLRHNKL-VGTVPAAIFNMSMLKLLHLQNNSLL-GCLSSIADV--RLPNLEALL 65
            +++ LD++  +L        +  +   +++ L +  L       I+      P L  L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
           L  N         +          L   S              ++ L+L++  LT +   
Sbjct: 63  LRSNELGDVGVHCVLQG-------LQTPS------------CKIQKLSLQNCCLTGAGCG 103

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDG----ILSKTSIGNLSHSLKDFYMSNCNVS----GG 177
               S+L    +L  +HLSDN L      +L +  +      L+   +  C++S      
Sbjct: 104 -VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC-RLEKLQLEYCSLSAASCEP 161

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQK-----LQGLGLDDNKLE----GSIPD 228
           +   +    +   + +  N +N +    L +  K     L+ L L+   +       +  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 229 SICRLTELYELELGGNKLFGS-----IPACFSNLASLRILSLSSNELTS-----IPLTFW 278
            +     L EL LG NKL         P      + LR L +    +T+     +     
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 279 NLKDILQLNFSSNFLTGP--------LPLEIGNLKVLIGIDFSMNNFSSV----IPTEIG 326
             + + +L+ + N L           L      L+ L        +F++       + + 
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL---WVKSCSFTAACCSHFSSVLA 338

Query: 327 GLKNLEYLFLGYNRLEGSIPDSFGDLI-----SLKFLNLSNNNLS----GAIPTSLEKLS 377
             + L  L +  NRLE +        +      L+ L L++ ++S     ++  +L    
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398

Query: 378 YLEDLNLSFNKLE 390
            L +L+LS N L 
Sbjct: 399 SLRELDLSNNCLG 411

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 36/154 (23%), Positives = 63/154 (40%), Gaps = 24/154 (15%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAV----------ECEMMKSIRH 547
            +G G FG V   +  +     A+K+ +       K   V          E  +++++  
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH- 606
             L+K+  S  +     +V+EY   G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHS 159

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                 +I+ DLKP+N+L+D      ++DFG AK
Sbjct: 160 LD----LIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 15/161 (9%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVEC--------EMMKS 544
           FS + +IGRGGFG VY  R  D  ++ A+K   L   R                  ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                ++ +  +    +  + +L+    G L  +L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           +H      V++ DLKP N+LLD++    +SD G+A     +
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 31/167 (18%)

Query: 499 LIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIR 546
            IG+GGFG +Y A       +G      VKV     G      + ++  A   ++ K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 547 HRNLIKV---------ISSCSNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMI 596
            R L  +         +   + + ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 597 DVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
            +   LEY+H       +H D+K  N+LL   + + V YL D+G+A 
Sbjct: 160 RILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 13/147 (8%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI-KVISSC 557
           IG G FG +Y    +  G EVA+K+  ++         +E ++ K ++    I  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 558 SNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
           +  ++  +V+E    G SLE      +    +   L +   + S +EY+H       IH 
Sbjct: 75  AEGDYNVMVMEL--LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF---IHR 129

Query: 617 DLKPDNVLL---DDNLVAYLSDFGIAK 640
           D+KPDN L+       + Y+ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 33/165 (20%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVEC-----EMMKSIRHRNLIK 552
           +IGRG FG V   +L +  +V A+K+  L      K     C     +++ +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID----------VASAL 602
           +  +  ++    LV++Y   G L   L           +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAI 188

Query: 603 EYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           + +H        +H D+KPDN+L+D N    L+DFG    L+ + 
Sbjct: 189 DSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 42/218 (19%), Positives = 74/218 (33%), Gaps = 71/218 (32%)

Query: 500 IGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRAFKSFAVECEMMKSI-RHRNLI 551
           +GRG FG V +A             VAVK+          ++   E +++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 552 KVISSCSNEEFKALV-LEYKPHGSLEKYL----------------------YSSNCILDI 588
            ++ +C+      +V +E+   G+L  YL                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 589 FQRLN-------------------IMIDVASALEYLHFGCLAP----------------- 612
            +RL+                     ++   A E L+   L                   
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 613 ----VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                IH DL   N+LL +  V  + DFG+A+ +  + 
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 14/149 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVEC-----EMMKSIRHRNLIK 552
            +G G FG V+  R        A+KV  L+     +   VE       M+  + H  +I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLA 611
           +  +  + +   ++++Y   G L   L  S    +   +     +V  ALEYLH      
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD--- 126

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
            +I+ DLKP+N+LLD N    ++DFG AK
Sbjct: 127 -IIYRDLKPENILLDKNGHIKITDFGFAK 154

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 17/166 (10%)

Query: 488 CRATNGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR-AFKSFAV-ECEMMK 543
           CRA   +     IG G +G V+KAR     G  VA+K   +Q G        + E  +++
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 544 SIR---HRN---LIKVISSCSNEEFKA--LVLEYKPHGSLEKYLYS-SNCILDIFQRLNI 594
            +    H N   L  V +    +      LV E+     L  YL       +      ++
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           M  +   L++LH      V+H DLKP N+L+  +    L+DFG+A+
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 13/147 (8%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI-KVISSC 557
           IG G FG +Y    +    EVA+K+ N++          E ++ + ++    I  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 558 SNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              ++  LV++    G SLE      +  L +   L +   + + +E++H       +H 
Sbjct: 73  VEGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LHR 127

Query: 617 DLKPDNVLL---DDNLVAYLSDFGIAK 640
           D+KPDN L+         Y+ DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 30/157 (19%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G +GSV  A     G +VA+K     F   +   RA++    E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87

Query: 553 ----VISSCSNEEFKA--LVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
                  + S   F    LV+ +        +            ++Q L         L+
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK-------GLK 140

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
           Y+H    A V+H DLKP N+ ++++    + DFG+A+
Sbjct: 141 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 31/166 (18%)

Query: 500 IGRGGFGSVYKAR---------LGDGMEVAVKV-------FNLQ--CGRAFKSFAVECEM 541
             R   G +Y+A               + ++K+       FN Q    RA K   V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 542 -MKSIRHRNLIKVISSCSNE-EFKALVLEYKPHG-SLEKYL-YSSNCILDIFQRLNIMID 597
            + S     +   +    ++ +++ LVL     G SL+  L  S   +L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
           +  ALE+LH       +H ++  +N+ +   D + V  L+ +G A 
Sbjct: 168 LLDALEFLHENEY---VHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 24/112 (21%), Positives = 36/112 (32%), Gaps = 9/112 (8%)

Query: 39  LHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSG 97
           L    +  L  L  +      NL  L +        +         +L  L + ++    
Sbjct: 13  LRCTRDGALDSLHHLPG--AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 98  FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
             P+ F     L  LNL  N L S + +     SL        + LS NPL 
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE------LVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.1 bits (150), Expect = 2e-10
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 3/96 (3%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLGCLSSIADVRLP 59
           +    +   +NL EL + + + +  +       +  L+ L +  +  L  ++  A    P
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTP 80

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSF 95
            L  L L  N    ++         L  L LS N  
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 9e-09
 Identities = 20/101 (19%), Positives = 34/101 (33%), Gaps = 3/101 (2%)

Query: 196 NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD-SICRLTELYELELGGNKLFGSIPA-C 253
                     L   + L  L +++ +    +    +  L EL  L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75

Query: 254 FSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLT 294
           F     L  L+LS N L S+         + +L  S N L 
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 1/70 (1%)

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPD-SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
               + G +NL  L++   +    +       L  L+ L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 380 EDLNLSFNKL 389
             LNLSFN L
Sbjct: 83  SRLNLSFNAL 92

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 2/93 (2%)

Query: 298 PLEIGNLKVLIGIDFSMNNFSSVIPTE-IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK 356
              +   + L  +          +    + GL  L  L +  + L    PD+F     L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 357 FLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
            LNLS N L      +++ LS L++L LS N L
Sbjct: 84  RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 8/59 (13%), Positives = 15/59 (25%), Gaps = 2/59 (3%)

Query: 339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT-SLEKLSYLEDLNLSFNKLEGEIPRG 396
                          +L  L + N      +    L  L  L +L +  + L   +   
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 20/114 (17%), Positives = 37/114 (32%), Gaps = 7/114 (6%)

Query: 135 CKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE-ITNLTNSITIDL 193
               + +  + +     L    +    + L + Y+ N      +    +  L     + +
Sbjct: 7   PHGSSGLRCTRDGALDSL--HHLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 194 GGNKLNGSIPI-TLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKL 246
             + L   +         +L  L L  N LE S+     +   L EL L GN L
Sbjct: 64  VKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 27/154 (17%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK- 552
           +G G +G V  A     G  VA+K    F+  L   R  +    E +++K  +H N+I  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 553 --VISSCSNEEFKA--LVLEYKPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYL 605
             +    S E F    ++ E      ++  L+   S+  + D   +   +     A++ L
Sbjct: 75  FNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQY-FIYQTLRAVKVL 128

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           H    + VIH DLKP N+L++ N    + DFG+A
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 1e-10
 Identities = 38/208 (18%), Positives = 62/208 (29%), Gaps = 57/208 (27%)

Query: 481 TFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKV--------FNLQCGRAF 532
            FS+   C  T        IG G FG V++    D   VA+K+         N    + F
Sbjct: 12  PFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 533 KSFAVECEMMKSI---------RHRNLIKVISSC-------------------------- 557
           +    E  + K +         R    I + S                            
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 558 ----SNEEFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
                 ++   +VLE++  G  LE+       +  +    +I+  + ++L          
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL--R 182

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
             H DL   NVLL    +  L      K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +IGRG F  V   ++    +V A+K+ N   +        F  E +++ +   R + ++ 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMID----------VASALEY 604
            +  +E +  LV+EY   G L   L           +    I           +  A++ 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDS 177

Query: 605 LH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H  G     +H D+KPDN+LLD      L+DFG    L  + 
Sbjct: 178 VHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 30/156 (19%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFNLQ--CGRAFKSFAVECEMMKSIRHRNLIK 552
           IG G  G V  A        VA+K     F  Q    RA++    E  +MK + H+N+I 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 553 V----ISSCSNEEFKA--LVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           +        S EEF+   +V+E         ++  L        ++Q L         ++
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +LH    A +IH DLKP N+++  +    + DFG+A
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 8/138 (5%)

Query: 13  EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFS 72
             LDL  N L          ++ L  L+L  N L    + + + +L +L  L L  N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN-KLTSLTYLNLSTNQLQ 89

Query: 73  GTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSS 131
            ++P  +F+  ++L  L L+ N         F  L  L+ L L  N L  S P+  F   
Sbjct: 90  -SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF--- 144

Query: 132 LSNCKSLTFIHLSDNPLD 149
                SL +I L DNP D
Sbjct: 145 -DRLTSLQYIWLHDNPWD 161

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 10/103 (9%)

Query: 174 VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-R 232
           V  GIP + T L      DL  N L         +L  L  L L  NKL+ S+P+ +  +
Sbjct: 22  VPTGIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNK 74

Query: 233 LTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELTSIP 274
           LT L  L L  N+L  S+P   F  L  L+ L+L++N+L S+P
Sbjct: 75  LTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQSLP 116

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 7/133 (5%)

Query: 266 SSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI 325
            S   TS+P         L L    N L          L  L  +    N   S+     
Sbjct: 15  YSQGRTSVPTGIPAQTTYLDLET--NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72

Query: 326 GGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLSNNNLSGAIPTSL-EKLSYLEDLN 383
             L +L YL L  N+L+ S+P+  F  L  LK L L+ N L  ++P  + +KL+ L+DL 
Sbjct: 73  NKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLR 130

Query: 384 LSFNKLEGEIPRG 396
           L  N+L+  +P G
Sbjct: 131 LYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 47/151 (31%), Positives = 66/151 (43%), Gaps = 13/151 (8%)

Query: 219 DNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TF 277
            ++   S+P  I   T    L+L  N L       F  L SL  L L  N+L S+P   F
Sbjct: 15  YSQGRTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72

Query: 278 WNLKDILQLNFSSNFLTGPLPLEI----GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEY 333
             L  +  LN S+N L   LP  +      LK L     + N   S+       L  L+ 
Sbjct: 73  NKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKEL---ALNTNQLQSLPDGVFDKLTQLKD 128

Query: 334 LFLGYNRLEGSIPD-SFGDLISLKFLNLSNN 363
           L L  N+L+ S+PD  F  L SL+++ L +N
Sbjct: 129 LRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 27/154 (17%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK- 552
           IG G +G V  A    + + VA+K    F     C R  +    E +++   RH N+I  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 553 --VISSCSNEEFKA--LVLEYKPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYL 605
             +I + + E+ K   +V +      +E  LY    +  + +       +  +   L+Y+
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY-FLYQILRGLKYI 144

Query: 606 HFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           H    A V+H DLKP N+LL+      + DFG+A
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKS--FAV----ECEMMKSIRHRNLIK 552
           +G G +GSV  A     G+ VAVK    +  R F+S   A     E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92

Query: 553 V----ISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           +      + S EEF    LV        L   +       D  Q   ++  +   L+Y+H
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 149

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               A +IH DLKP N+ ++++    + DFG+A
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 11/154 (7%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEM-----MKSIRHRNLIK 552
           L+G+G FG V   +        A+K+  L+         V   +     +++ RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH      
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKN 269

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           V++ DLK +N++LD +    ++DFG+ K  I + 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 40/170 (23%)

Query: 499 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRA---------FKSFAVECEMMKSIRHR 548
            IG GGFG +Y A       + A  V  ++             ++  A +  + K I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 549 NLIKV---------ISSCSNEEFKALVLEYKPHG-SLEKYL-----YSSNCILDIFQRLN 593
            L  +         ++      ++ +V+E    G  L+K       +  + +L +  R  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNGTFKKSTVLQLGIR-- 159

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 640
            M+DV   LEY+H       +H D+K  N+LL   + + V YL+D+G++ 
Sbjct: 160 -MLDV---LEYIHENEY---VHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 21/159 (13%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           ++G+G FG V  +      E+ AVK+  L+     +   VEC M+         +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLH-F 607
           ++ S     +    V+EY   G L  ++         F          ++A  L +L   
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           G    +I+ DLK DNV+LD      ++DFG+ K  I + 
Sbjct: 462 G----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.9 bits (146), Expect = 7e-10
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 14/155 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM-----KSIRHRNLIK 552
           L+G+G FG V   R        A+K+  L+         V   +      ++ RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCLA 611
           +  +    +    V+EY   G L  +L       +   R     ++ SALEYLH      
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--- 125

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            V++ D+K +N++LD +    ++DFG+ K  I + 
Sbjct: 126 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 30/156 (19%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           IG G  G V  A        VA+K     F       RA++    E  +MK + H+N+I 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125

Query: 553 VI----SSCSNEEFKA--LVLEYKP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 603
           ++       + EEF+   LV+E         ++  L        ++Q L         ++
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 178

Query: 604 YLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
           +LH    A +IH DLKP N+++  +    + DFG+A
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 15/156 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           ++G+G FG V+ A      +  A+K   L+         VEC M+       +  H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
            +  +   +E    V+EY   G L  ++ S +             ++   L++LH  G  
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHSKG-- 138

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +++ DLK DN+LLD +    ++DFG+ K  +  D
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 41/191 (21%), Positives = 73/191 (38%), Gaps = 59/191 (30%)

Query: 500 IGRGGFGSVYKARLGD-GMEVAVK-VFNLQCGRAFKSFAV-ECEMMKSIRHRNLIKVI-- 554
           +G G FG V +    + G   A+K V           +   E ++MK + H N+IK++  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 555 ------------------------------------SSCSNEEFKALVLEYKP---HGSL 575
                                                + S  ++  +++EY P   H  L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAY 632
           + ++ S   I      +  +  +  A+ ++H      + H D+KP N+L++   + L   
Sbjct: 129 KSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK-- 182

Query: 633 LSDFGIAKLLI 643
           L DFG AK LI
Sbjct: 183 LCDFGSAKKLI 193

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           +IG+G FG V  AR        AVKV  LQ     K    +  M       K+++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
            +  S    +    VL+Y   G L  +L    C L+   R     ++ASAL YLH     
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN-- 159

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +++ DLKP+N+LLD      L+DFG+ K  I  +
Sbjct: 160 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           ++G+G FG V  AR+ +  ++ AVKV  L+     +   VEC M        +  H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
           ++       +    V+E+   G L  ++  S    +   R     ++ SAL +LH  G  
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLHDKG-- 144

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +I+ DLK DNVLLD      L+DFG+ K  I   
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 15/156 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           +IGRG +  V   RL     + A+KV  ++         ++          ++  H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
            + S    E     V+EY   G L  ++     + +   R     +++ AL YLH  G  
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG-- 130

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +I+ DLK DNVLLD      L+D+G+ K  +   
Sbjct: 131 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 23/153 (15%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G +G+V  A     G +VA+K     F   L   RA++    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 553 VI----SSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 606
           ++       + ++F    LV+ +     L K +      L   +   ++  +   L Y+H
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 145

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               A +IH DLKP N+ ++++    + DFG+A
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 26/158 (16%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK--VFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVI 554
           +G GG G V+ A        VA+K  V         A +    E ++++ + H N++KV 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLY------------SSNCILDIFQRLNIMIDVASAL 602
                   +              Y+                 +L+   RL  M  +   L
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGL 133

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIA 639
           +Y+H    A V+H DLKP N+ ++ ++LV  + DFG+A
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 15/156 (9%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           +IGRG +  V   RL     + A++V  ++         ++          ++  H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCL 610
            + S    E     V+EY   G L  ++     + +   R     +++ AL YLH  G  
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG-- 173

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +I+ DLK DNVLLD      L+D+G+ K  +   
Sbjct: 174 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.2 bits (139), Expect = 6e-09
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 21/159 (13%)

Query: 499 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRAFKSFAVECEMM------KSIRHRNLI 551
           ++G+G FG V  +      E+ AVK+  L+     +   VEC M+         +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLH-F 607
           ++ S     +    V+EY   G L  ++         F          ++A  L +L   
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           G    +I+ DLK DNV+LD      ++DFG+ K  I + 
Sbjct: 141 G----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 35/150 (23%), Positives = 73/150 (48%), Gaps = 20/150 (13%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVK-VFN-----LQCGRAFKSFAVECEMMKSIR-HRNLI 551
           +G+G +G V+K+     G  VAVK +F+         R F+    E  ++  +  H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72

Query: 552 KVISSCSNEEFKA--LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
            +++    +  +   LV +Y     L   + ++  IL+   +  ++  +   ++YLH   
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
              ++H D+KP N+LL+      ++DFG++
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 32/144 (22%)

Query: 5   EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
           + +N     ELDLR  K+   +      +     +   +N +          +L     L
Sbjct: 14  QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI---------RKLDGFPLL 63

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
                              +L  L ++ N            L +L  L L +N L     
Sbjct: 64  ------------------RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV---- 101

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPL 148
           EL  L  L++ KSLT++ +  NP+
Sbjct: 102 ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 3/108 (2%)

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNF 292
                EL+L G K+   I    + L     +  S NE+  +   F  L+ +  L  ++N 
Sbjct: 18  AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNR 75

Query: 293 LTGPLPLEIGNLKVLIGIDFSMNNFSSV-IPTEIGGLKNLEYLFLGYN 339
           +          L  L  +  + N+   +     +  LK+L YL +  N
Sbjct: 76  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 22/129 (17%), Positives = 41/129 (31%), Gaps = 28/129 (21%)

Query: 262 ILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI 321
           ++ L++  +      + N     +L+     +       I NL                 
Sbjct: 1   MVKLTAELIEQAA-QYTNAVRDRELDLRGYKIP-----VIENLGAT-------------- 40

Query: 322 PTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLED 381
                 L   + +    N +   + D F  L  LK L ++NN +        + L  L +
Sbjct: 41  ------LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92

Query: 382 LNLSFNKLE 390
           L L+ N L 
Sbjct: 93  LILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 29/150 (19%), Positives = 50/150 (33%), Gaps = 38/150 (25%)

Query: 130 SSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF---YMSNCNVSGGIPEEITNLT 186
           +  +N      + L    +        I NL  +L  F     S+         EI  L 
Sbjct: 13  AQYTNAVRDRELDLRGYKI------PVIENLGATLDQFDAIDFSDN--------EIRKLD 58

Query: 187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKL 246
                                 L++L+ L +++N++          L +L EL L  N L
Sbjct: 59  G------------------FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

Query: 247 --FGSIPACFSNLASLRILSLSSNELTSIP 274
              G +    ++L SL  L +  N +T+  
Sbjct: 101 VELGDL-DPLASLKSLTYLCILRNPVTNKK 129

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 26/162 (16%)

Query: 499 LIGRGGFGSVYKARLGDGMEV----AVKVFNLQCGRAFKSF-----AVECEM----MKSI 545
           ++G+G FG V+  +   G +     A+KV         K+       V  +M    +  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 605
            H  ++K+  +   E    L+L++   G L   L       +   +  +  ++A AL++L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 142

Query: 606 H-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           H  G    +I+ DLKP+N+LLD+     L+DFG++K  I  +
Sbjct: 143 HSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 30/170 (17%), Positives = 63/170 (37%), Gaps = 39/170 (22%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR--------HRN 549
            +G G F +V+ A+ + +   VA+K+         ++   E ++++ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 550 LIKVISSCSNEEFKA-------LVLEYKPHG-SLEKYLYSSNCILDIFQRLN------IM 595
              ++    +   K        +V E    G +L   +          + +       I 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYE-----HRGIPLIYVKQIS 137

Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY------LSDFGIA 639
             +   L+Y+H  C   +IH D+KP+NVL++            ++D G A
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 30/165 (18%)

Query: 499 LIGRGGFGSVYKARL----GDGMEVAVKVFN----LQCGRAFKSFAVECEMM-----KSI 545
           ++G+GG+G V++ R       G   A+KV      ++      +             + +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASAL 602
           +H  ++ +I +        L+LEY   G L   L        IF        + +++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMAL 134

Query: 603 EYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            +LH  G    +I+ DLKP+N++L+      L+DFG+ K  I + 
Sbjct: 135 GHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 29/119 (24%), Positives = 43/119 (36%), Gaps = 10/119 (8%)

Query: 32  NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFS--GTIPRFIFNASKLSILE 89
             S +K L L N+                LE L       +    +P+      KL  LE
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLN----KLKKLE 70

Query: 90  LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL 148
           LS N  SG +        NL  LNL  N +     +LS +  L   ++L  + L +  +
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 29/134 (21%), Positives = 46/134 (34%), Gaps = 27/134 (20%)

Query: 232 RLTELYELELGGNKL-FGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSS 290
             +++ EL L  ++   G +         L  LS  +  LTSI             N   
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA------------NLP- 61

Query: 291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG-SIPDSF 349
                        L  L  ++ S N  S  +        NL +L L  N+++  S  +  
Sbjct: 62  ------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109

Query: 350 GDLISLKFLNLSNN 363
             L +LK L+L N 
Sbjct: 110 KKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 33/122 (27%), Positives = 48/122 (39%), Gaps = 16/122 (13%)

Query: 102 TFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS 161
           T  +++ L   N R N       E          + L F+   +  L      TSI NL 
Sbjct: 15  TPSDVKELVLDNSRSN-------EGKLEGLTDEFEELEFLSTINVGL------TSIANLP 61

Query: 162 H--SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLD 218
               LK   +S+  VSGG+        N   ++L GNK+   S    L KL+ L+ L L 
Sbjct: 62  KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121

Query: 219 DN 220
           + 
Sbjct: 122 NC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 24/70 (34%), Positives = 33/70 (47%), Gaps = 2/70 (2%)

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLE 380
           +       + LE+L      L  SI +    L  LK L LS+N +SG +    EK   L 
Sbjct: 34  LEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91

Query: 381 DLNLSFNKLE 390
            LNLS NK++
Sbjct: 92  HLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 20/85 (23%), Positives = 42/85 (49%), Gaps = 3/85 (3%)

Query: 190 TIDLGGNKLN-GSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG 248
            + L  ++ N G +     + ++L+ L   +  L  SI + + +L +L +LEL  N++ G
Sbjct: 21  ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSG 78

Query: 249 SIPACFSNLASLRILSLSSNELTSI 273
            +        +L  L+LS N++  +
Sbjct: 79  GLEVLAEKCPNLTHLNLSGNKIKDL 103

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 52/312 (16%), Positives = 91/312 (29%), Gaps = 69/312 (22%)

Query: 6   ISNLQNLEELDLRHNKL----VGTVPAAIFNMSMLKLLHLQNNSL-------LGCLSSIA 54
           +    +++E+ L  N +       +   I +   L++    +             L  + 
Sbjct: 28  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 55  DV--RLPNLEALLLWGNNFSGT----IPRFIFNASKLSILELSQNSFS------------ 96
               + P L  + L  N F  T    +  F+   + L  L L  N               
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 97  -GFIPNTFGNLRNLEWLNLRDNYLTS-STPELSFLSSLSNCKSLTFIHLSDNPLDGILSK 154
              +     N   L  +    N L + S  E +   +  + + L  + +  N   GI  +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA--KTFQSHRLLHTVKMVQN---GIRPE 202

Query: 155 TSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKL--NGSIPI--TLSKLQ 210
                L   L                    L     +DL  N     GS  +   L    
Sbjct: 203 GIEHLLLEGLAYC---------------QELK---VLDLQDNTFTHLGSSALAIALKSWP 244

Query: 211 KLQGLGLDDNKL--EG--SIPDSI--CRLTELYELELGGNKLFGS-----IPACFSNLAS 259
            L+ LGL+D  L   G  ++ D+        L  L L  N++               +  
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 260 LRILSLSSNELT 271
           L  L L+ N  +
Sbjct: 305 LLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 64/333 (19%), Positives = 110/333 (33%), Gaps = 71/333 (21%)

Query: 107 RNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL---------DGILSKTSI 157
            ++E  +L+ + +T+   + S  + L    S+  I LS N +         + I SK  +
Sbjct: 4   FSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62

Query: 158 GNLSHSLKDFYMSNCNVSGG-----IPEEITNLTNSITIDLGGNKL--NGSIPIT--LSK 208
                   D +              + + +       T+ L  N        P+   LSK
Sbjct: 63  EIAE--FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 209 LQKLQGLGLDDNKL-------------EGSIPDSICRLTELYELELGGNKLFG----SIP 251
              L+ L L +N L             E ++         L  +  G N+L         
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180

Query: 252 ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGID 311
             F +   L  + +  N +         ++ +L    +              LKVL   D
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPE-----GIEHLLLEGLAYC----------QELKVL---D 222

Query: 312 FSMNNFS----SVIPTEIGGLKNLEYLFLGYNRL--EG--SIPDSFGDL--ISLKFLNLS 361
              N F+    S +   +    NL  L L    L   G  ++ D+F  L  I L+ L L 
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 282

Query: 362 NNNLSG----AIPTSL-EKLSYLEDLNLSFNKL 389
            N +       + T + EK+  L  L L+ N+ 
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 41/254 (16%)

Query: 6   ISNLQNLEELDLRHNKL----VGTVPAAIFNMSMLKLLHLQNNSL-LGCLSSIADVRLPN 60
           +     L  + L  N         +   +   + L+ L+L NN L     + IA   L  
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQE 148

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG----FIPNTFGNLRNLEWLNLRD 116
           L       N               L  +   +N            TF + R L  + +  
Sbjct: 149 LAVNKKAKNA------------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 196

Query: 117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL--DGI--LSKTSIGNLSHSLKDFYMSNC 172
           N +     E   L  L+ C+ L  + L DN     G   L+         +L++  +++C
Sbjct: 197 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW--PNLRELGLNDC 254

Query: 173 NVSG----GIPEEITNLTNS--ITIDLGGNKLNGSIPITL-----SKLQKLQGLGLDDNK 221
            +S      + +  + L N    T+ L  N++      TL      K+  L  L L+ N+
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314

Query: 222 L--EGSIPDSICRL 233
              E  + D I  +
Sbjct: 315 FSEEDDVVDEIREV 328

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 55/372 (14%), Positives = 111/372 (29%), Gaps = 69/372 (18%)

Query: 61  LEALLLWGNNFSG----TIPRFIFNASKLSILELSQNSFSG----FIPNTFGNLRNLEWL 112
           +E   L  +  +     ++   +     +  + LS N+       ++     + ++LE  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 113 NLRDNYLTSSTPEL-----SFLSSLSNCKSLTFIHLSDNPL--DGILSKTSIGNLSHSLK 165
              D +      E+       L +L  C  L  + LSDN              +    L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEG- 224
             Y+ N  +    P+    +  ++       K   +          L+ +    N+LE  
Sbjct: 126 HLYLHNNGLG---PQAGAKIARALQELAVNKKAKNA--------PPLRSIICGRNRLENG 174

Query: 225 ---SIPDSICRLTELYELELGGNKL--FGSIPAC---FSNLASLRILSLSSNELT----- 271
                  +      L+ +++  N +   G         +    L++L L  N  T     
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234

Query: 272 SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNL 331
           ++ +   +  ++ +L  +   L+       G   V+       N               L
Sbjct: 235 ALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKLEN-------------IGL 276

Query: 332 EYLFLGYNRLEGSIPDSFGDLI-----SLKFLNLSNNNLS------GAIPTSLEKLSYLE 380
           + L L YN +E     +   +I      L FL L+ N  S        I          E
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 336

Query: 381 DLNLSFNKLEGE 392
              L   +   +
Sbjct: 337 LDELDDMEELTD 348

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 33/183 (18%), Positives = 59/183 (32%), Gaps = 34/183 (18%)

Query: 197 KLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSN 256
           +    +     K++    L      +E  +  ++  L     L L  N +   I +  S 
Sbjct: 16  ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSG 68

Query: 257 LASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNN 316
           + +LRILSL  N +  I         + +L  S N +       +  ++           
Sbjct: 69  MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-----SLSGIE----------- 112

Query: 317 FSSVIPTEIGGLKNLEYLFLGYNRLEG-SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEK 375
                      L NL  L++  N++      D    L  L+ L L+ N L      +   
Sbjct: 113 ----------KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNAT 162

Query: 376 LSY 378
             Y
Sbjct: 163 SEY 165

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 30/148 (20%), Positives = 48/148 (32%), Gaps = 34/148 (22%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           ++   +S L+  + L L  N +              K+  L                + N
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-------------KISSLSG--------------MEN 71

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L  L L  N     I      A  L  L +S N  +  +      L NL  L + +N +T
Sbjct: 72  LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPL 148
                   +  L+    L  + L+ NPL
Sbjct: 129 ----NWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 38/183 (20%), Positives = 70/183 (38%), Gaps = 33/183 (18%)

Query: 221 KLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWN 279
             E           ++ EL      +   + A  S L + + L+LS+N +  I  L+   
Sbjct: 13  IFEERKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--G 68

Query: 280 LKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN 339
           ++++  L+   N +      +I NL  +                       LE L++ YN
Sbjct: 69  MENLRILSLGRNLIK-----KIENLDAV--------------------ADTLEELWISYN 103

Query: 340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIP-TSLEKLSYLEDLNLSFNKLEGEIPRGGS 398
           ++  S+      L++L+ L +SNN ++       L  L  LEDL L+ N L  +     +
Sbjct: 104 QIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNA 161

Query: 399 FGN 401
              
Sbjct: 162 TSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 28/133 (21%), Positives = 49/133 (36%), Gaps = 13/133 (9%)

Query: 39  LHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGF 98
           LH     +    ++++   L   + L L  NN    I   +     L IL L +N     
Sbjct: 30  LHGMIPPIEKMDATLS--TLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK- 84

Query: 99  IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIG 158
           I N       LE L +  N + S       LS +    +L  +++S+N +        + 
Sbjct: 85  IENLDAVADTLEELWISYNQIAS-------LSGIEKLVNLRVLYMSNNKITNWGEIDKLA 137

Query: 159 NLSHSLKDFYMSN 171
            L   L+D  ++ 
Sbjct: 138 AL-DKLEDLLLAG 149

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 29/113 (25%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 36  LKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSF 95
           ++ L L N                NLE L L       ++        KL  LELS+N  
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKL-PKLKKLELSENRI 83

Query: 96  SGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL 148
            G +      L NL  LNL  N L     ++S L  L   + L  + L +  +
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 3e-05
 Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 6/115 (5%)

Query: 163 SLKDFYMSNC-NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
           ++++  + NC +  G I        N   + L    L  S+   L KL KL+ L L +N+
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82

Query: 222 LEGSIPDSICRLTELYELELGGNKL--FGSIPACFSNLASLRILSLSSNELTSIP 274
           + G +     +L  L  L L GNKL    ++      L  L+ L L + E+T++ 
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLN 136

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 3e-05
 Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 4/111 (3%)

Query: 279 NLKDILQLNFSSNFLTGPLPLEIG-NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLG 337
               + +L   +          +      L  +        SV  + +  L  L+ L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 338 YNRLEGSIPDSFGDLISLKFLNLSNNNLSG-AIPTSLEKLSYLEDLNLSFN 387
            NR+ G +      L +L  LNLS N L   +    L+KL  L+ L+L   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 8e-05
 Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 13/119 (10%)

Query: 105 NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH-- 162
               +  L L +        E       +   +L F+ L +  L       S+ NL    
Sbjct: 22  TPAAVRELVLDNCKSNDGKIE----GLTAEFVNLEFLSLINVGL------ISVSNLPKLP 71

Query: 163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLDDN 220
            LK   +S   + GG+      L N   ++L GNKL   S    L KL+ L+ L L + 
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 27/76 (35%), Positives = 34/76 (44%), Gaps = 2/76 (2%)

Query: 315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE 374
            +    I        NLE+L L    L  S+  +   L  LK L LS N + G +    E
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 375 KLSYLEDLNLSFNKLE 390
           KL  L  LNLS NKL+
Sbjct: 93  KLPNLTHLNLSGNKLK 108

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.2 bits (118), Expect = 5e-07
 Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 9/92 (9%)

Query: 202 IPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASL 260
           IP         Q L L++N++    P     L  L +L    NKL  +IP   F  L  L
Sbjct: 31  IPTDK------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQL 83

Query: 261 RILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
             L L+ N L SIP   F NLK +  +   +N
Sbjct: 84  TQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 30/84 (35%), Positives = 48/84 (57%), Gaps = 12/84 (14%)

Query: 317 FSSV---IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL 373
            +SV   IPT      + + L+L  N++    P  F  L++L+ L  ++N L+ AIPT +
Sbjct: 24  LASVPAGIPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGV 76

Query: 374 -EKLSYLEDLNLSFNKLEGEIPRG 396
            +KL+ L  L+L+ N L+  IPRG
Sbjct: 77  FDKLTQLTQLDLNDNHLKS-IPRG 99

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 37/169 (21%)

Query: 499 LIGRGGFGSVYKARLGDGMEV----AVKVFN----LQCGRAFKSFAVECEMM-----KSI 545
           ++G G +G V+  R   G +     A+KV      +Q     K+   E         + I
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 546 RHRN-LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNI------MIDV 598
           R    L+ +  +   E    L+L+Y   G L  +L          +R         + ++
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEI 168

Query: 599 ASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             ALE+LH  G    +I+ D+K +N+LLD N    L+DFG++K  + ++
Sbjct: 169 VLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 48.4 bits (116), Expect = 8e-07
 Identities = 35/92 (38%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 202 IPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASL 260
           IP T       Q L L DN++    P    RLT+L  L+L  N+L   +PA  F  L  L
Sbjct: 28  IPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQL 80

Query: 261 RILSLSSNELTSIPL-TFWNLKDILQLNFSSN 291
             LSL+ N+L SIP   F NLK +  +   +N
Sbjct: 81  TQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 12/84 (14%)

Query: 317 FSSV---IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL 373
            +SV   IPT        + L+L  N++    P  F  L  L  L+L NN L+  +P  +
Sbjct: 21  LASVPTGIPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGV 73

Query: 374 -EKLSYLEDLNLSFNKLEGEIPRG 396
            +KL+ L  L+L+ N+L+  IPRG
Sbjct: 74  FDKLTQLTQLSLNDNQLKS-IPRG 96

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 7/91 (7%)

Query: 60  NLEALLLWGNNFSGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
             + L L+ N  +  +   +F+  ++L+ L+L  N  +      F  L  L  L+L DN 
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLD 149
           L S  P  +F     N KSLT I L +NP D
Sbjct: 90  LKS-IPRGAF----DNLKSLTHIWLLNNPWD 115

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.7 bits (120), Expect = 9e-07
 Identities = 22/134 (16%), Positives = 51/134 (38%), Gaps = 17/134 (12%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIF--NMSMLKLLHLQ-NNSLLGCLSSIADV---- 56
           +      NL+ L++    L  +V   I   ++  L+ L L       G    +       
Sbjct: 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246

Query: 57  ---RLPNLEALLLWGNNFSGTIPRFIFNA---SKLSILELSQNSFSGF----IPNTFGNL 106
              R PNL+ L +        +      +    +L  +++S    +      + +    +
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306

Query: 107 RNLEWLNLRDNYLT 120
           ++L+++N++ NYL+
Sbjct: 307 KHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 9e-06
 Identities = 30/156 (19%), Positives = 49/156 (31%), Gaps = 17/156 (10%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSL-LGCLSSIADVRLPNLEAL 64
           +  +  L  L ++    +            LK L + +  L    +  I    LPNLE L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 65  LLW-------GNNFSGTIPRFIFNAS--KLSILELSQNSFSGFIPNTFGN---LRNLEWL 112
           +L+        +                 L  L +        +   F     L  LE +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL 148
           ++    LT     L  L  +   K L FI++  N L
Sbjct: 285 DISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 3e-05
 Identities = 29/144 (20%), Positives = 60/144 (41%), Gaps = 14/144 (9%)

Query: 256 NLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN 315
           ++      +L S E+ S  L    ++DIL  +  +  L     L +       G D  MN
Sbjct: 186 SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN--LEK---LVLYVGVEDYGFDGDMN 240

Query: 316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD---LISLKFLNLSNNNLSG----A 368
            F  +         NL++L +     +  + + F +   L  L+ +++S   L+      
Sbjct: 241 VFRPLFSK--DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL 298

Query: 369 IPTSLEKLSYLEDLNLSFNKLEGE 392
           +   ++K+ +L+ +N+ +N L  E
Sbjct: 299 LLDHVDKIKHLKFINMKYNYLSDE 322

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 34/151 (22%), Positives = 71/151 (47%), Gaps = 27/151 (17%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIR-HRNLIK---- 552
           +GRG +  V++A  + +  +V VK+    +  +  +    E ++++++R   N+I     
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGC 609
           V    S     ALV E+  +   ++   +    +    +++ L        AL+Y H   
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH--- 147

Query: 610 LAPVIHCDLKPDNVLLD-DNLVAYLSDFGIA 639
              ++H D+KP NV++D ++    L D+G+A
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 28/83 (33%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 213 QGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPA-CFSNLASLRILSLSSNELT 271
             L L+ NKL+        +LT+L +L L  N++  S+P   F  L  L IL L  N+L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ 89

Query: 272 SIPL-TFWNLKDILQLNFSSNFL 293
           S+P   F  L  + +L   +N L
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 36/139 (25%), Positives = 53/139 (38%), Gaps = 34/139 (24%)

Query: 13  EELDLRHNKLVGTVPAAIFN-MSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNF 71
             L+L  NKL  ++P  +F+ ++ L  L L  N +                         
Sbjct: 31  TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQI------------------------- 64

Query: 72  SGTIPRFIFNA-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLS 130
             ++P  +F+  +KL+IL L +N         F  L  L+ L L  N L  S P+  F  
Sbjct: 65  -QSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIF-- 120

Query: 131 SLSNCKSLTFIHLSDNPLD 149
                 SL  I L  NP D
Sbjct: 121 --DRLTSLQKIWLHTNPWD 137

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 7e-05
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 9/77 (11%)

Query: 321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL-EKLSYL 379
           IP+      +   L L  N+L+      F  L  L  L+LS N +  ++P  + +KL+ L
Sbjct: 26  IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 380 EDLNLSFNKLEGEIPRG 396
             L L  NKL+  +P G
Sbjct: 79  TILYLHENKLQ-SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 7e-05
 Identities = 42/141 (29%), Positives = 54/141 (38%), Gaps = 29/141 (20%)

Query: 225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDI 283
           S+P  I        LEL  NKL       F  L  L  LSLS N++ S+P   F  L  +
Sbjct: 21  SVPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG 343
             L    N L   LP  +               F          L  L+ L L  N+L+ 
Sbjct: 79  TILYLHENKLQS-LPNGV---------------FDK--------LTQLKELALDTNQLK- 113

Query: 344 SIPD-SFGDLISLKFLNLSNN 363
           S+PD  F  L SL+ + L  N
Sbjct: 114 SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 39/146 (26%), Positives = 59/146 (40%), Gaps = 29/146 (19%)

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLTGPLPLEIG 302
           +K   S+P      +S   L L SN+L S+P   F  L  + +L+ S N +   LP  + 
Sbjct: 16  SKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGV- 71

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDS-FGDLISLKFLNLS 361
                         F          L  L  L+L  N+L+ S+P+  F  L  LK L L 
Sbjct: 72  --------------FDK--------LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108

Query: 362 NNNLSGAIPTSLEKLSYLEDLNLSFN 387
            N L        ++L+ L+ + L  N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 58/445 (13%), Positives = 134/445 (30%), Gaps = 90/445 (20%)

Query: 7   SNLQNLEELDLRHNKL--VGTVPAAIFNMSMLKLLHLQNNSLLGC--LSSIADVRLPNLE 62
           +NL+ L+ +  R   +  +     A      L+ L L   S      L SI       ++
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV-THCRKIK 167

Query: 63  ALLLWGNNFSGTIPRFIF----NASKLSILELSQNSFSGF----IPNTFGNLRNLEWLNL 114
            LL+  ++FS    +++     + + L +L      F+      +     N R+L  + +
Sbjct: 168 TLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKV 227

Query: 115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSK-------------------- 154
            D  +      + F  + +N +      L+++                            
Sbjct: 228 GDFEILEL---VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE 284

Query: 155 -TSIGNLSHSLKDFYMSNCN-VSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKL 212
              +   +  ++   +      +      I    N   ++      +  + +     ++L
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344

Query: 213 QGLGLDDNKLEGSIPDSICRLTE------------LYELELGGNKL----FGSIPACFSN 256
           + L ++    E  + D    +++            L  + +  + +      SI     N
Sbjct: 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKN 404

Query: 257 LASLRILSLSS----------NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKV 306
           L   R++ L            N + S+ +    L+           LT            
Sbjct: 405 LCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR-FAFYLRQGGLT------------ 451

Query: 307 LIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL-EGSIPDSFGDLISLKFLNLSNNNL 365
               D  ++              N+ ++ LGY    +  + +      +L+ L +     
Sbjct: 452 ----DLGLSYIGQ-------YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500

Query: 366 S-GAIPTSLEKLSYLEDLNLSFNKL 389
           S  AI  ++ KL  L  L +   + 
Sbjct: 501 SERAIAAAVTKLPSLRYLWVQGYRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 38/242 (15%), Positives = 74/242 (30%), Gaps = 22/242 (9%)

Query: 2   IPLEISNLQNLEELDLRHNKLVG-TVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           +P+       + +LDL +  L        I     L++L  +N      L  +A      
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQ-YCKQ 343

Query: 61  LEALLLWGNNFSGTIPRFIF------------NASKLSILELSQNSFSGF----IPNTFG 104
           L+ L +        +                    +L  + +  +  +      I     
Sbjct: 344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403

Query: 105 NLRNLEWLNLRD-NYLTSSTPELSFLSSLSNCKSLTFIHLSDN-PLDGILSKTSIGNLSH 162
           NL +   + L     +T    +    S L  CK L              L  + IG  S 
Sbjct: 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463

Query: 163 SLKDFYMSNCNVS-GGIPEEITNLTNSITIDLGGNKL-NGSIPITLSKLQKLQGLGLDDN 220
           +++   +     S  G+ E      N   +++ G      +I   ++KL  L+ L +   
Sbjct: 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGY 523

Query: 221 KL 222
           + 
Sbjct: 524 RA 525

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 33/158 (20%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA----VECEMMKSIRHR----- 548
           +IG+G FG V KA        VA+K+      R  K F      E  +++ +R +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 549 -NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLN------IMIDVASA 601
            N+I ++ + +      +  E     +L + +  +      FQ  +          +   
Sbjct: 159 MNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKNK-----FQGFSLPLVRKFAHSILQC 212

Query: 602 LEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY--LSDFG 637
           L+ LH      +IHCDLKP+N+LL     +   + DFG
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 3e-06
 Identities = 34/193 (17%), Positives = 63/193 (32%), Gaps = 57/193 (29%)

Query: 455 WLILRYRKRGKQPSNDANM------PLVATWRTFSYLELCRA------TNGF----SENN 498
           +L+   +   +QPS    M       L    + F+   + R                  N
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152

Query: 499 LI--GRGGFGSVYKARLGDGMEVAVKV---FNLQCGRAFKSFAV---EC-------EMMK 543
           ++  G  G G   K  +      A+ V   + +QC   FK F +    C       EM++
Sbjct: 153 VLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203

Query: 544 SIRHR---NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC--ILDIFQRLNIMIDV 598
            + ++   N        SN + +   ++ +    L+   Y  NC  +L          +V
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLL---------NV 253

Query: 599 ASA--LEYLHFGC 609
            +A      +  C
Sbjct: 254 QNAKAWNAFNLSC 266

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 92/674 (13%), Positives = 197/674 (29%), Gaps = 212/674 (31%)

Query: 14  ELDLRHNKLVGTVPAAIFNMSMLKLLHLQN--NSLLGCLSSIADVRLPNLEALLLWGNNF 71
           E   ++  ++     ++F  + +     ++  +     LS   ++     + +++  +  
Sbjct: 13  EHQYQYKDIL-----SVFEDAFVDNFDCKDVQDMPKSILSK-EEI-----DHIIMSKDAV 61

Query: 72  SGTIPRFIFNASKLSILELSQNS-FSGFIPNTFGNLR-NLEWL--NLRDNYLTSSTPELS 127
           SGT    +F       L   Q      F+      LR N ++L   ++      S     
Sbjct: 62  SGT--LRLFW-----TLLSKQEEMVQKFVEEV---LRINYKFLMSPIKTEQRQPSMMTRM 111

Query: 128 FLSSLSNC---------------KSLTFIH---LSDNPLDGIL-------SKTSIGN--- 159
           ++                     +    +    L   P   +L        KT +     
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171

Query: 160 LSHSLKD------FYMS--NCNVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQ 210
           LS+ ++       F+++  NCN    + E +  L   I  +      +  +I + +  +Q
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231

Query: 211 -KLQGLGLDDNKLEGS--IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS 267
            +L+ L L     E    +  ++          L           C       +IL    
Sbjct: 232 AELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLS----------C-------KIL---- 269

Query: 268 NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGG 327
             LT+        +     +F S   T  + L+  +  + +  D   +     +      
Sbjct: 270 --LTT--------RFKQVTDFLSAATTTHISLD--HHSMTLTPDEVKSLLLKYLDCRPQD 317

Query: 328 LKNLEYLFLGYNRLEGS-IPDSFGDLISL--KFLNLSNNNLSGAIPTSLEKLS------Y 378
           L       L  N    S I +S  D ++    + +++ + L+  I +SL  L        
Sbjct: 318 LPREV---LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 379 LEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTLQVLPCKTSIHHTSWKNSL- 437
            + L++ F      IP                     +  L ++          W + + 
Sbjct: 375 FDRLSV-FPP-SAHIP---------------------TILLSLI----------WFDVIK 401

Query: 438 --LLGIVLPLSTTLLIV------VIWLILRYRKRGKQPSNDANM--PLVATWRTFSY-LE 486
             ++ +V  L    L+        I +   Y +   +  N+  +   +V       Y + 
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD-----HYNIP 456

Query: 487 LCRATNGFSENNL-------IGRGGFGSVY---KARLGDGMEVAVKVF-NLQCGRAFKSF 535
               ++      L       IG       +        + M +   VF +         F
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIG-------HHLKNIEHPERMTLFRMVFLDF-------RF 502

Query: 536 AVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH------------GSLEKYL--YS 581
                + + IRH +     S       + L   YKP+             ++  +L    
Sbjct: 503 -----LEQKIRHDSTAWNASGSILNTLQQLKF-YKPYICDNDPKYERLVNAILDFLPKIE 556

Query: 582 SNCI----LDIFQR 591
            N I     D+ + 
Sbjct: 557 ENLICSKYTDLLRI 570

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 29/161 (18%)

Query: 497 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA----VECEMMKSIRHR--- 548
           ++LIG+G FG V KA    +   VA+K+      +  K+F     +E  +++ +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 549 ---NLIKVISSCSNEEFKALVLEYKPHGSLEKYLY-----SSNCILDIFQRLNIMIDVAS 600
               ++ +           LV E      L   LY     ++   + +         + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 601 ALEYLHFGCLAPVIHCDLKPDNVLL--DDNLVAYLSDFGIA 639
           AL +L    L+ +IHCDLKP+N+LL         + DFG +
Sbjct: 169 ALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 37/155 (23%), Positives = 60/155 (38%), Gaps = 48/155 (30%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFA----VECEMMKSIRHR----- 548
            +G G FG V   + + +    AVKV      R  K +     +E +++K I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 549 NLIKVISSCSNEEFKALVLEYKPH---------GSLEKYLYSSNCILDIFQRLN------ 593
           N++K         F      Y  H          SL + +  +N     +   +      
Sbjct: 97  NIVKYHGK-----F-----MYYDHMCLIFEPLGPSLYEIITRNN-----YNGFHIEDIKL 141

Query: 594 IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN 628
             I++  AL YL       + H DLKP+N+LLDD 
Sbjct: 142 YCIEILKALNYLR---KMSLTHTDLKPENILLDDP 173

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 60/314 (19%), Positives = 111/314 (35%), Gaps = 49/314 (15%)

Query: 6   ISNLQNLEELDLRHNKL-----VGTVPAAIFNMSMLKLLHLQNNSL----LGCLSSIADV 56
            S    +  LDL  N L     V  + A     + +  L+L  NSL       L  I   
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 57  RLPNLEALLLWGNNFSGTIPRFIFNA-----SKLSILELSQNSFS-----GFIPNTFGNL 106
              N+ +L L GN  S      +          +++L+L  N FS      F        
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 107 RNLEWLNLRDNYLTSSTPELSFLSSL--SNCKSLTFIHLSDNPLD----GILSKTSIGNL 160
            ++  LNLR N L   +     L  +  +   ++  ++L  N L       L+K  + ++
Sbjct: 138 ASITSLNLRGNDLGIKS--SDELIQILAAIPANVNSLNLRGNNLASKNCAELAK-FLASI 194

Query: 161 SHSLKDFYMSNCNVS----GGIPEEITNLTNSIT-IDLGGNKLNGS----IPITLSKLQK 211
             S+    +S   +       +    +++ N +  ++L  N L+G     + +    L+ 
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 212 LQGLGLDDNKLEGSIPDSICRLTE-------LYELELGGNKLFGSIPACFSNLA-----S 259
           LQ + LD + ++    +    L         +  ++  G ++  S     SNL       
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314

Query: 260 LRILSLSSNELTSI 273
             + SL +  L   
Sbjct: 315 ADVPSLLNQCLIFA 328

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 58/332 (17%), Positives = 93/332 (28%), Gaps = 71/332 (21%)

Query: 105 NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSL 164
              ++  LNL  N L     +       +   ++T ++LS N L    S  S   L  +L
Sbjct: 49  TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFL----SYKSSDELVKTL 104

Query: 165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKL-----QKLQGLGLDD 219
                    ++               +DLG N  +        +        +  L L  
Sbjct: 105 AA---IPFTIT--------------VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRG 147

Query: 220 NKLE--------GSIPDSICRLTELYELELGGNKLFGSIPACF------SNLASLRILSL 265
           N L           +      +  L    L GN L  S           S  AS+  L L
Sbjct: 148 NDLGIKSSDELIQILAAIPANVNSLN---LRGNNL-ASKNCAELAKFLASIPASVTSLDL 203

Query: 266 SSNELTSIPLTFW------NLKDILQLNFSSNFLTGP----LPLEIGNLKVLIGIDFSMN 315
           S+N L                  ++ LN   N L GP    L L   +LK L  +    +
Sbjct: 204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263

Query: 316 NFSSVIPTEIGGL-------KNLEYLFLGYNRLEGSIPDSFGDLI-----SLKFLNLSNN 363
              ++   +   L       + +  +      +  S      +LI          +L N 
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

Query: 364 NLSGA-----IPTSLEKLSYLEDLNLSFNKLE 390
            L  A         L     L +   +   L 
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 30/146 (20%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAV-ECEMMKSIR-----HRNLIK 552
           +G G F +V+ +  +     VA+KV        +   A+ E  ++KS+R       N   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 553 VISSCSNEEFK---------ALVLEYKPHG-SLEKYLYSSNCI---LDIFQRLNIMIDVA 599
           V+     ++FK          +V E    G  L K++  SN     L   ++  I+  V 
Sbjct: 103 VVQLL--DDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVL 156

Query: 600 SALEYLHFGCLAPVIHCDLKPDNVLL 625
             L+YLH  C   +IH D+KP+N+LL
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILL 180

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 29/157 (18%), Positives = 55/157 (35%), Gaps = 50/157 (31%)

Query: 499 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRAFKSFA----VECEMMKSIRHR---- 548
            +G G FG V +         +VA+K+      R    +     +E  ++K I+ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 549 --NLIKVISSCSNEEFKALVLEYKPH---------GSLEKYLYSSNCILDIFQRLN---- 593
               + +        F      +  H          +  ++L  +N     FQ       
Sbjct: 81  KFLCVLMSDW-----F-----NFHGHMCIAFELLGKNTFEFLKENN-----FQPYPLPHV 125

Query: 594 --IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN 628
             +   +  AL +LH      + H DLKP+N+L  ++
Sbjct: 126 RHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 56/383 (14%), Positives = 114/383 (29%), Gaps = 50/383 (13%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
           +  +NL+ELDLR + +       + +        L + ++    S ++   L  L     
Sbjct: 153 ATCRNLKELDLRESDVDDVSGHWLSHFPDT-YTSLVSLNISCLASEVSFSALERLVT--- 208

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
                             L  L+L++      +         LE L              
Sbjct: 209 --------------RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254

Query: 127 SFLSS-LSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
           S LS  LS CK L  +    + +   L   ++ ++   L    +S   V           
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLP--AVYSVCSRLTTLNLSYATVQ---------- 302

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK 245
                      KL       L +  KLQ L + D   +  +        +L EL +  ++
Sbjct: 303 ------SYDLVKL-------LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSE 349

Query: 246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKD--ILQLNFSSNFLTGPLPLEIGN 303
            F   P        L  +S+   +L S+      + +  ++ +  +   +T      +  
Sbjct: 350 PFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR---FRLCI 406

Query: 304 LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
           ++       ++          +   K+L  L L     +            ++ L+++  
Sbjct: 407 IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFA 466

Query: 364 NLSGA-IPTSLEKLSYLEDLNLS 385
             S   +   L     L  L + 
Sbjct: 467 GDSDLGMHHVLSGCDSLRKLEIR 489

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 31/235 (13%), Positives = 79/235 (33%), Gaps = 44/235 (18%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGC----------LSSIAD 55
           +     L+ L +        +         L+ L +  +               L S++ 
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM 369

Query: 56  VRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR 115
              P LE++L +               +  +++ +++            N  N+    L 
Sbjct: 370 -GCPKLESVLYFCRQM-----------TNAALITIAR------------NRPNMTRFRLC 405

Query: 116 ------DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
                  +YLT    ++ F + + +CK L  + LS    D +     IG  +  ++   +
Sbjct: 406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFE--YIGTYAKKMEMLSV 463

Query: 170 SNCNVSG-GIPEEITNLTNSITIDLGG-NKLNGSIPITLSKLQKLQGLGLDDNKL 222
           +    S  G+   ++   +   +++      + ++    SKL+ ++ L +    +
Sbjct: 464 AFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 25/157 (15%), Positives = 52/157 (33%), Gaps = 50/157 (31%)

Query: 499 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRAFKSFA----VECEMMKSIRHR---- 548
            +G G FG V +       G  VAVK+      +    +      E ++++ +       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 549 --NLIKVISSCSNEEFKALVLEYKPH---------GSLEKYLYSSNCILDIFQRLN---- 593
               ++++       F     E+  H          S   ++  +      F        
Sbjct: 76  TFRCVQMLEW-----F-----EHHGHICIVFELLGLSTYDFIKENG-----FLPFRLDHI 120

Query: 594 --IMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN 628
             +   +  ++ +LH      + H DLKP+N+L   +
Sbjct: 121 RKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 27/150 (18%), Positives = 50/150 (33%), Gaps = 16/150 (10%)

Query: 497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             L+G G   +V+        E  VK   +    +FK    +    +     +   +   
Sbjct: 95  GKLMGEGKESAVFNCYSEKFGECVVKFHKVG-HTSFKKVKEK----RDYGDLHFSVLAIR 149

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASA---------LEYLHF 607
            +  EF+AL          + Y +  N +L        +  V            LE +  
Sbjct: 150 SARNEFRALQKLQGL-AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 208

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFG 637
                ++H DL   NVL+ +  + ++ DF 
Sbjct: 209 FYHRGIVHGDLSQYNVLVSEEGI-WIIDFP 237

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 21/268 (7%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
            S+    + LDL    L   V   + +  ++     ++          +  R+ +++  L
Sbjct: 43  ASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMD--L 100

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
                   T+   +   SKL  L L     S  I NT     NL  LNL      S   E
Sbjct: 101 SNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG---CSGFSE 157

Query: 126 LSFLSSLSNCKSLTFIHLSDNPL---DGILSKTSIGNLSHSLKDFYMSNCNVS---GGIP 179
            +  + LS+C  L  ++LS         +  + ++ ++S ++    +S    +     + 
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTEKHV--QVAVAHVSETITQLNLSGYRKNLQKSDLS 215

Query: 180 EEITNLTNSITIDLGG-NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD----SICRLT 234
             +    N + +DL     L         +L  LQ L L        I       +  + 
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD---IIPETLLELGEIP 272

Query: 235 ELYELELGGNKLFGSIPACFSNLASLRI 262
            L  L++ G    G++      L  L+I
Sbjct: 273 TLKTLQVFGIVPDGTLQLLKEALPHLQI 300

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 32/188 (17%), Positives = 56/188 (29%), Gaps = 20/188 (10%)

Query: 7   SNLQNLEELDLRHNKL--VGTVPAAIFNMSMLKLLHLQNNSLL--GC--LSSIADVRLPN 60
           S    L+E++L   +L   G        +   + L LQ NSL    C  L  +       
Sbjct: 98  SGRHALDEVNLASCQLDPAGLRTLLPVFLR-ARKLGLQLNSLGPEACKDLRDLLLHDQCQ 156

Query: 61  LEALLLWGNNFSGTIPRFIFNA----SKLSILELSQNSFS----GFIPNTFGNLRNLEWL 112
           +  L L  N  +      +       + ++ L L            +       R L+ L
Sbjct: 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQEL 216

Query: 113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL--DGI--LSKTSIGNLSHSLKDFY 168
           N+  N    +    +   +     SL  +HL  N L  +G   L          +     
Sbjct: 217 NVAYNGAGDTAAL-ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVS 275

Query: 169 MSNCNVSG 176
           ++      
Sbjct: 276 LTEGTAVS 283

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	646
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.98
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.92
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.92
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.92
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.92
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.91
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.91
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.91
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.91
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.9
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.9
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.9
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.9
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.9
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.9
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.9
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.9
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.9
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.9
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.89
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.89
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.89
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.89
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.88
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.88
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.87
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.87
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.87
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.82
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.82
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.77
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.76
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.73
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.7
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.62
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.61
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.52
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.5
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.35
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.34
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.95
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.61
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.5
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.39
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.96
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.95
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.87
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.59
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.52
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.49
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.42
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.18
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.17
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.07
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.05
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.8
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.73
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.46
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.8
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.43
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.14
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	80.8
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.61

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.9e-55  Score=505.39  Aligned_cols=408  Identities=34%  Similarity=0.533  Sum_probs=281.0

Q ss_pred             CCCCCCEEECCCCcccccCCcCccCC-CCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcc-ccCCCCC
Q 046544            8 NLQNLEELDLRHNKLVGTVPAAIFNM-SMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRF-IFNASKL   85 (646)
Q Consensus         8 ~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L   85 (646)
                      .+++|++|+|++|++++..|..+..+ ++|++|+|++|.+++.++.. +..+++|++|+|++|++++.+|.. +..+++|
T Consensus       267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L  345 (768)
T 3rgz_A          267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF-FGSCSLLESLALSSNNFSGELPMDTLLKMRGL  345 (768)
T ss_dssp             CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG-GGGCTTCCEEECCSSEEEEECCHHHHTTCTTC
T ss_pred             ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH-HhcCCCccEEECCCCcccCcCCHHHHhcCCCC
Confidence            56666666666666666666666554 66666666666666544432 123666666666666666555544 6666666


Q ss_pred             cEEEcccCccccccCccccCcC-CCCEEEccCCCCCCCCCcccccccCCC--CCCCCEEECCCCCCCCcCCcchhccccc
Q 046544           86 SILELSQNSFSGFIPNTFGNLR-NLEWLNLRDNYLTSSTPELSFLSSLSN--CKSLTFIHLSDNPLDGILSKTSIGNLSH  162 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~l~~--l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  162 (646)
                      ++|+|++|.+++..|..+..++ +|++|+|++|+++...     +..+..  +++|++|++++|.+.+..+.. +.. .+
T Consensus       346 ~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~-----~~~~~~~~~~~L~~L~L~~n~l~~~~p~~-l~~-l~  418 (768)
T 3rgz_A          346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI-----LPNLCQNPKNTLQELYLQNNGFTGKIPPT-LSN-CS  418 (768)
T ss_dssp             CEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEEC-----CTTTTCSTTCCCCEEECCSSEEEEECCGG-GGG-CT
T ss_pred             CEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCc-----ChhhhhcccCCccEEECCCCccccccCHH-Hhc-CC
Confidence            6666666666666666666665 6666666666665321     112222  455555666655555443322 122 23


Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +|+.|++++|.+++..|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|++++.+|..|..+++|++|+|+
T Consensus       419 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  498 (768)
T 3rgz_A          419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS  498 (768)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred             CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEcc
Confidence            45555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCcccccCCccccCCCCCceeecCCCccc-ccccccccccccccccCCCCcccCC-------------------------
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFLTGP-------------------------  296 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~l~~N~l~~~-------------------------  296 (646)
                      +|++++..|.+|+.+++|++|++++|.++ .+|..+..+++|+.|++++|.+++.                         
T Consensus       499 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~  578 (768)
T 3rgz_A          499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI  578 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEE
T ss_pred             CCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccc
Confidence            55555555555555555555555555555 4455555555555555555555544                         


Q ss_pred             ---------------------------------------------CCCccCccccceEEEcccccccccCccccCCCCCC
Q 046544          297 ---------------------------------------------LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNL  331 (646)
Q Consensus       297 ---------------------------------------------~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  331 (646)
                                                                   .|..++.+++|+.||+++|+++|.+|..|+.+++|
T Consensus       579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L  658 (768)
T 3rgz_A          579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL  658 (768)
T ss_dssp             ECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTC
T ss_pred             ccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccC
Confidence                                                         44456667889999999999999999999999999


Q ss_pred             CEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCc
Q 046544          332 EYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNE  411 (646)
Q Consensus       332 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~  411 (646)
                      +.|+|++|+++|.+|+.|+.+++|+.|||++|++++.+|..+..+++|++||+++|+++|.+|..+.+.++....+.|||
T Consensus       659 ~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~  738 (768)
T 3rgz_A          659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP  738 (768)
T ss_dssp             CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCT
T ss_pred             CEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccCCCcc
Q 046544          412 LLCGSPTLQVLPCKT  426 (646)
Q Consensus       412 ~~c~~~~~~~~~~~~  426 (646)
                      .+|+.|+.   +|..
T Consensus       739 ~Lcg~~l~---~C~~  750 (768)
T 3rgz_A          739 GLCGYPLP---RCDP  750 (768)
T ss_dssp             EEESTTSC---CCCS
T ss_pred             hhcCCCCc---CCCC
Confidence            99998864   6753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.8e-53  Score=487.36  Aligned_cols=407  Identities=35%  Similarity=0.539  Sum_probs=348.2

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      +|. ++++++|++|+|++|++++..|.+|.++++|++|+|++|.+++.++..   .+++|++|+|++|++++.+|..++.
T Consensus       216 ~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~  291 (768)
T 3rgz_A          216 IPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSG  291 (768)
T ss_dssp             CCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCT
T ss_pred             Ccc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHh
Confidence            444 899999999999999999889999999999999999999998765554   4788888888888888888888776


Q ss_pred             C-CCCcEEEcccCccccccCccccCcCCCCEEEccCCCCC-CCCCcccccccCCCCCCCCEEECCCCCCCCcCCcch---
Q 046544           82 A-SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT-SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS---  156 (646)
Q Consensus        82 l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~---  156 (646)
                      . ++|++|+|++|++++..|..|+++++|++|+|++|+++ .++..     .+.++++|++|++++|++.+..+...   
T Consensus       292 ~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~-----~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l  366 (768)
T 3rgz_A          292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD-----TLLKMRGLKVLDLSFNEFSGELPESLTNL  366 (768)
T ss_dssp             TCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH-----HHTTCTTCCEEECCSSEEEECCCTTHHHH
T ss_pred             hcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH-----HHhcCCCCCEEeCcCCccCccccHHHHhh
Confidence            5 88888888888888888888888888888888888887 43321     25667777777777777654332211   


Q ss_pred             ----------------------hccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCe
Q 046544          157 ----------------------IGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQG  214 (646)
Q Consensus       157 ----------------------~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  214 (646)
                                            .....++|++|++++|.+++.+|..+.++++|++|++++|++++..|..|.++++|++
T Consensus       367 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  446 (768)
T 3rgz_A          367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD  446 (768)
T ss_dssp             TTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred             hcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCE
Confidence                                  1111346888888888888888999999999999999999999999999999999999


Q ss_pred             EEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccc-ccccccccccccccccCCCCcc
Q 046544          215 LGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDILQLNFSSNFL  293 (646)
Q Consensus       215 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~l~~N~l  293 (646)
                      |++++|.+.+.+|..|..+++|++|++++|++++..|..|.++++|++|++++|+++ .+|.++..+++|+.|++++|.+
T Consensus       447 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  526 (768)
T 3rgz_A          447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF  526 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             EECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcc
Confidence            999999999999999999999999999999999999999999999999999999998 7788899999999999999999


Q ss_pred             cCCCCCccCccccceEEEcccccccccCccc-------------------------------------------------
Q 046544          294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE-------------------------------------------------  324 (646)
Q Consensus       294 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-------------------------------------------------  324 (646)
                      ++.+|..++.+++|+.|++++|.+++.+|..                                                 
T Consensus       527 ~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  606 (768)
T 3rgz_A          527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR  606 (768)
T ss_dssp             EEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGG
T ss_pred             cCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhc
Confidence            9999999999999999999999988766643                                                 


Q ss_pred             ---------------------cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCcee
Q 046544          325 ---------------------IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLN  383 (646)
Q Consensus       325 ---------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  383 (646)
                                           |+.+++|++|+|++|+++|.+|..|+.+++|+.|+|++|++++.+|..++.+++|+.||
T Consensus       607 l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~Ld  686 (768)
T 3rgz_A          607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD  686 (768)
T ss_dssp             GGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             cccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEE
Confidence                                 34467899999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcceeeccCC-CCCCCCccccccCCccccCCC
Q 046544          384 LSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       384 L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      |++|+++|.+|.. ..++.++.+++++|++...-|
T Consensus       687 Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             CCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             CCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            9999999999876 558889999999998765333

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-51  Score=472.76  Aligned_cols=411  Identities=21%  Similarity=0.218  Sum_probs=304.7

Q ss_pred             CccccCCCCCCEEECCCCcc-cccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcc--c
Q 046544            3 PLEISNLQNLEELDLRHNKL-VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRF--I   79 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~   79 (646)
                      |..|+++++|++|||++|.+ ..+.|.+|.++++|++|+|++|.|++..+. .+..+++|++|+|++|.+++..|..  |
T Consensus        41 ~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  119 (844)
T 3j0a_A           41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-AFQGLFHLFELRLYFCGLSDAVLKDGYF  119 (844)
T ss_dssp             SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-SSCSCSSCCCEECTTCCCSSCCSTTCCC
T ss_pred             hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-HccCCcccCEeeCcCCCCCcccccCccc
Confidence            45566666677777766643 333466666666677777776666654333 1224666666666666666544433  6


Q ss_pred             cCCCCCcEEEcccCccccccC-ccccCcCCCCEEEccCCCCCCCCCccc---------------------ccccCCCCC-
Q 046544           80 FNASKLSILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLTSSTPELS---------------------FLSSLSNCK-  136 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~---------------------~~~~l~~l~-  136 (646)
                      .++++|++|+|++|.+++..+ ..|+++++|++|+|++|.++...+...                     .+..+..+. 
T Consensus       120 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~  199 (844)
T 3j0a_A          120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN  199 (844)
T ss_dssp             SSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC
T ss_pred             cccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCC
Confidence            666666666666666665543 356666666666666666655432210                     111223333 


Q ss_pred             -----CCCEEECCCCCCCCcCCcchhc-----------------------------------c-ccccCcEEEeeccccc
Q 046544          137 -----SLTFIHLSDNPLDGILSKTSIG-----------------------------------N-LSHSLKDFYMSNCNVS  175 (646)
Q Consensus       137 -----~L~~L~Ls~N~l~~~~~~~~~~-----------------------------------~-~~~~L~~L~L~~n~l~  175 (646)
                           +|++|++++|.+.+..+.....                                   . ...+|+.|++++|.+.
T Consensus       200 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~  279 (844)
T 3j0a_A          200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF  279 (844)
T ss_dssp             TTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCC
T ss_pred             ccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCccc
Confidence                 3899999999776433322111                                   0 1257999999999999


Q ss_pred             ccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCcccc
Q 046544          176 GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFS  255 (646)
Q Consensus       176 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  255 (646)
                      +..|..|..+++|+.|+|++|++.+..|..|.++++|++|+|++|++++..|.+|.++++|++|++++|++.+..+..|.
T Consensus       280 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  359 (844)
T 3j0a_A          280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK  359 (844)
T ss_dssp             EECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSC
T ss_pred             ccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhc
Confidence            99999999999999999999999999999999999999999999999988899999999999999999999988888899


Q ss_pred             CCCCCceeecCCCccccccc-----------------------------------------ccccccccccccCCCCccc
Q 046544          256 NLASLRILSLSSNELTSIPL-----------------------------------------TFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       256 ~l~~L~~L~L~~N~l~~lp~-----------------------------------------~~~~l~~L~~L~l~~N~l~  294 (646)
                      ++++|++|+|++|.++.++.                                         .+..+++|+.|++++|.++
T Consensus       360 ~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~  439 (844)
T 3j0a_A          360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS  439 (844)
T ss_dssp             SCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred             CCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence            99999999999988876542                                         0224566777777777776


Q ss_pred             CCCCC-ccCccccceEEEccccccc-----ccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCccc
Q 046544          295 GPLPL-EIGNLKVLIGIDFSMNNFS-----SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA  368 (646)
Q Consensus       295 ~~~~~-~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  368 (646)
                      +..+. .+..+++|+.|++++|.++     +..+..|.++++|+.|+|++|++++.+|..|.++++|+.|+|++|+|++.
T Consensus       440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l  519 (844)
T 3j0a_A          440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL  519 (844)
T ss_dssp             CCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSC
T ss_pred             ccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCcc
Confidence            54433 3555677778888888776     34456688899999999999999988889999999999999999999977


Q ss_pred             CCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC
Q 046544          369 IPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       369 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      .|..+.  ++|+.|+|++|++++.+|..  +..++.+++++|||.|+|+.
T Consensus       520 ~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          520 SHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred             Chhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence            777666  88999999999999887765  56899999999999999975

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.3e-50  Score=452.25  Aligned_cols=412  Identities=21%  Similarity=0.205  Sum_probs=298.3

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNA   82 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (646)
                      |..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..+. .+..+++|++|+|++|++++..+..|.++
T Consensus        50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~l~~~~~~~l  128 (606)
T 3t6q_A           50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-ALSGPKALKHLFFIQTGISSIDFIPLHNQ  128 (606)
T ss_dssp             TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-TTSSCTTCCEEECTTSCCSCGGGSCCTTC
T ss_pred             hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-hhcccccccEeeccccCcccCCcchhccC
Confidence            55677777777777777777766777777777777777777777654332 22236666666666666665555556666


Q ss_pred             CCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCC--------------------------CCccc---------
Q 046544           83 SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSS--------------------------TPELS---------  127 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------------------------~~~~~---------  127 (646)
                      ++|++|+|++|++.++.+..+.++++|++|+|++|+++..                          ++...         
T Consensus       129 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~  208 (606)
T 3t6q_A          129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN  208 (606)
T ss_dssp             TTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEE
T ss_pred             CcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccc
Confidence            6666666666666554433344455555555555554432                          22110         


Q ss_pred             -------------------------------------------------------------ccccCCCCCCCCEEECCCC
Q 046544          128 -------------------------------------------------------------FLSSLSNCKSLTFIHLSDN  146 (646)
Q Consensus       128 -------------------------------------------------------------~~~~l~~l~~L~~L~Ls~N  146 (646)
                                                                                   .+..|+++++|++|++++|
T Consensus       209 l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  288 (606)
T 3t6q_A          209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT  288 (606)
T ss_dssp             CTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTS
T ss_pred             cCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCC
Confidence                                                                         0112555666777777777


Q ss_pred             CCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccC-ccccCCCCCCeEEeecccccCc
Q 046544          147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLDDNKLEGS  225 (646)
Q Consensus       147 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  225 (646)
                      +++.++..  +.. .++|++|++++|.+.+..|..+..+++|++|++++|.+.+..| ..+..+++|++|++++|.+.+.
T Consensus       289 ~l~~lp~~--l~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~  365 (606)
T 3t6q_A          289 HLSELPSG--LVG-LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS  365 (606)
T ss_dssp             CCSCCCSS--CCS-CTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEE
T ss_pred             ccCCCChh--hcc-cccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccc
Confidence            66655432  222 2467777777777777667777777777777777777764443 4477788888888888888765


Q ss_pred             C--chhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccc-cc-ccccccccccccCCCCcccCCCCCcc
Q 046544          226 I--PDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PL-TFWNLKDILQLNFSSNFLTGPLPLEI  301 (646)
Q Consensus       226 ~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~-~~~~l~~L~~L~l~~N~l~~~~~~~~  301 (646)
                      .  +..+..+++|++|++++|++.+..|..|..+++|+.|++++|.++.. |. .+..+++|+.|++++|.+++..|..+
T Consensus       366 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  445 (606)
T 3t6q_A          366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF  445 (606)
T ss_dssp             EESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred             cCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence            5  67788888888888888888888888888888888888888888855 33 47788888999999998888888888


Q ss_pred             CccccceEEEccccccccc---CccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCC
Q 046544          302 GNLKVLIGIDFSMNNFSSV---IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY  378 (646)
Q Consensus       302 ~~l~~L~~L~ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  378 (646)
                      ..+++|+.|++++|.+++.   .+..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..+..++.
T Consensus       446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~  525 (606)
T 3t6q_A          446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG  525 (606)
T ss_dssp             TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred             hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence            8899999999999988763   3356888899999999999999888889999999999999999999888999999999


Q ss_pred             CCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCCCc
Q 046544          379 LEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSPTL  419 (646)
Q Consensus       379 L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~~~  419 (646)
                      | .|++++|++++.+|.. ..++.++.+++++|||.|+|+..
T Consensus       526 L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             C-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             c-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            9 9999999999877764 44778899999999999988753

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.3e-50  Score=450.09  Aligned_cols=411  Identities=23%  Similarity=0.237  Sum_probs=314.7

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      ++|..+.  +++++|+|++|+++++.+.+|.++++|++|+|++|.+++..+. .+..+++|++|+|++|++++..|..|.
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~  101 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK-AWHGLHHLSNLILTGNPIQSFSPGSFS  101 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT-TTTTCTTCCEEECTTCCCCCCCTTSST
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHH-HhhchhhcCEeECCCCcccccChhhcC
Confidence            3566554  7888888888888888888888888888888888888765443 233588888888888888887788888


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcch--hc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS--IG  158 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~--~~  158 (646)
                      ++++|++|+|++|.++++.+..|+++++|++|+|++|+++...    ++..|+++++|++|++++|+++++.+..+  ..
T Consensus       102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  177 (606)
T 3vq2_A          102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK----LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR  177 (606)
T ss_dssp             TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCC----CCGGGGTCTTCCEEECCSSCCCEECTTTTHHHH
T ss_pred             CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccccee----chHhHhhcCCCCEEEccCCcceecChhhhhhhh
Confidence            8888888888888888887788888888888888888887632    34457788888888888888877654321  11


Q ss_pred             ccc-----------------------ccCcEEEeecccccc---------------------------------------
Q 046544          159 NLS-----------------------HSLKDFYMSNCNVSG---------------------------------------  176 (646)
Q Consensus       159 ~~~-----------------------~~L~~L~L~~n~l~~---------------------------------------  176 (646)
                      .+.                       .+|+.|++++|.+++                                       
T Consensus       178 ~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~  257 (606)
T 3vq2_A          178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG  257 (606)
T ss_dssp             HCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTT
T ss_pred             ccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhh
Confidence            111                       134555555554320                                       


Q ss_pred             -------------------cCCc---------------------ccccCCCCCEEEccCCccccccC-------------
Q 046544          177 -------------------GIPE---------------------EITNLTNSITIDLGGNKLNGSIP-------------  203 (646)
Q Consensus       177 -------------------~~p~---------------------~~~~l~~L~~L~L~~N~l~~~~~-------------  203 (646)
                                         ..|.                     .+..+++|+.|++++|++. .+|             
T Consensus       258 l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~  336 (606)
T 3vq2_A          258 LCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLT  336 (606)
T ss_dssp             GGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEE
T ss_pred             hhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCCCccceeecc
Confidence                               0000                     2333344455555555442 222             


Q ss_pred             -------ccccCCCCCCeEEeecccccCc--CchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccc
Q 046544          204 -------ITLSKLQKLQGLGLDDNKLEGS--IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP  274 (646)
Q Consensus       204 -------~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp  274 (646)
                             ..+..+++|++|++++|++++.  .|..+..+++|++|++++|.+.+ .|..|.++++|+.|++++|.++.++
T Consensus       337 ~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~  415 (606)
T 3vq2_A          337 MNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT  415 (606)
T ss_dssp             SCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTT
T ss_pred             CCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCcc
Confidence                   1344556667777777777654  37778888888888888888875 4577888889999999999888765


Q ss_pred             c--ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccc-cCccccCCCCCCCEEEccCccCCCcccccccC
Q 046544          275 L--TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS-VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD  351 (646)
Q Consensus       275 ~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  351 (646)
                      .  .+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++ ..|..|+.+++|++|++++|++++..|..|..
T Consensus       416 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  495 (606)
T 3vq2_A          416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT  495 (606)
T ss_dssp             TTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             ChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcc
Confidence            3  67888999999999999998888999999999999999999987 47889999999999999999999888999999


Q ss_pred             CCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCC-CCccccccCCccccCCCCcc
Q 046544          352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFG-NFAAESFEGNELLCGSPTLQ  420 (646)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~~~~~~~~~N~~~c~~~~~~  420 (646)
                      +++|++|+|++|++++..|..|..+++|++|++++|+++..++....+. +++.+++++|||.|+|+..+
T Consensus       496 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             CTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             cccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            9999999999999998889999999999999999999996444444454 58999999999999998753

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=8.7e-49  Score=445.49  Aligned_cols=411  Identities=25%  Similarity=0.262  Sum_probs=295.2

Q ss_pred             CCc-cccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            2 IPL-EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         2 ip~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +|. .|+.+++|++|+|++|+++++.|.+|.++++|++|+|++|.+++.++.. +..+++|++|+|++|++++..+..+.
T Consensus        88 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~  166 (680)
T 1ziw_A           88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT-QVQLENLQELLLSNNKIQALKSEELD  166 (680)
T ss_dssp             CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCS-SSCCTTCCEEECCSSCCCCBCHHHHG
T ss_pred             cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchh-hcccccCCEEEccCCcccccCHHHhh
Confidence            444 4777777777777777777666677777777777777777776543331 12355566666665555544443322


Q ss_pred             --CCCCCcEEEcccCcccc---------------------------------------------------ccCccccCcC
Q 046544           81 --NASKLSILELSQNSFSG---------------------------------------------------FIPNTFGNLR  107 (646)
Q Consensus        81 --~l~~L~~L~Ls~N~l~~---------------------------------------------------~~~~~~~~l~  107 (646)
                        .+++|++|++++|.+++                                                   ..|.+|.+++
T Consensus       167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~  246 (680)
T 1ziw_A          167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK  246 (680)
T ss_dssp             GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred             ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence              22334444444443333                                                   3333344433


Q ss_pred             C--CCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcch-----------------------------
Q 046544          108 N--LEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS-----------------------------  156 (646)
Q Consensus       108 ~--L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~-----------------------------  156 (646)
                      .  |++|+|++|+++..++     ..|+++++|++|++++|++.++.+..+                             
T Consensus       247 ~~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~  321 (680)
T 1ziw_A          247 WTNLTMLDLSYNNLNVVGN-----DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID  321 (680)
T ss_dssp             GSCCCEEECTTSCCCEECT-----TTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred             cCCCCEEECCCCCcCccCc-----ccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence            2  6666666665554432     235566666666666666655432211                             


Q ss_pred             --hccccccCcEEEeecccccccCCcccccCCCCCEEEccC----------------------------CccccccCccc
Q 046544          157 --IGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGG----------------------------NKLNGSIPITL  206 (646)
Q Consensus       157 --~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~----------------------------N~l~~~~~~~~  206 (646)
                        .....++|++|++++|.+++..|..|.++++|++|++++                            |++.+..|.+|
T Consensus       322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~  401 (680)
T 1ziw_A          322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF  401 (680)
T ss_dssp             TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred             hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence              001124677888888888877777777766666666554                            45555667777


Q ss_pred             cCCCCCCeEEeecccccCcCc-hhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccc---ccccccccccc
Q 046544          207 SKLQKLQGLGLDDNKLEGSIP-DSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT---SIPLTFWNLKD  282 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~---~lp~~~~~l~~  282 (646)
                      ..+++|+.|++++|++.+.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++   .+|..|..+++
T Consensus       402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~  481 (680)
T 1ziw_A          402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN  481 (680)
T ss_dssp             TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred             hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence            777888888888888775444 67778888888888888887777778888888888888888775   45778889999


Q ss_pred             cccccCCCCcccCCCCCccCccccceEEEcccccccccCc--------cccCCCCCCCEEEccCccCCCcccccccCCCC
Q 046544          283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIP--------TEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIS  354 (646)
Q Consensus       283 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  354 (646)
                      |+.|++++|.+++..+..|.++++|+.|++++|.++++.+        ..|+++++|++|+|++|+++.+.+..|.++++
T Consensus       482 L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~  561 (680)
T 1ziw_A          482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE  561 (680)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccC
Confidence            9999999999998888889999999999999999987633        34788999999999999999766678999999


Q ss_pred             CCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCC--CCCCCccccccCCccccCCCC
Q 046544          355 LKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGG--SFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      |+.|+|++|++++..+..|..+++|+.|+|++|++++.+|...  .++.++.+++++|||.|+|+.
T Consensus       562 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999998888888999999999999999998776542  478899999999999999985

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.6e-48  Score=433.64  Aligned_cols=404  Identities=22%  Similarity=0.220  Sum_probs=317.0

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      ++|..+.  +++++|+|++|+|+++.|.+|.++++|++|+|++|.+++..+. .+..+++|++|+|++|++++..|..|.
T Consensus        26 ~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~  102 (606)
T 3t6q_A           26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED-TFQSQHRLDTLVLTANPLIFMAETALS  102 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTT-TTTTCTTCCEEECTTCCCSEECTTTTS
T ss_pred             cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChh-hccCccccCeeeCCCCcccccChhhhc
Confidence            4677765  4799999999999999999999999999999999999875443 334699999999999999999999999


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNL  160 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  160 (646)
                      ++++|++|+|++|+++++.|..|+++++|++|+|++|+++.++..     .+.++++|++|++++|.++++.+.. ++.+
T Consensus       103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l  176 (606)
T 3t6q_A          103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP-----KGFPTEKLKVLDFQNNAIHYLSKED-MSSL  176 (606)
T ss_dssp             SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCC-----TTCCCTTCCEEECCSSCCCEECHHH-HHTT
T ss_pred             ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcc-----cccCCcccCEEEcccCcccccChhh-hhhh
Confidence            999999999999999998889999999999999999999986421     2334667777777777665543211 1110


Q ss_pred             c----------------------------------------------------------------------------ccC
Q 046544          161 S----------------------------------------------------------------------------HSL  164 (646)
Q Consensus       161 ~----------------------------------------------------------------------------~~L  164 (646)
                      .                                                                            .++
T Consensus       177 ~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L  256 (606)
T 3t6q_A          177 QQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV  256 (606)
T ss_dssp             TTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEE
T ss_pred             cccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCce
Confidence            0                                                                            146


Q ss_pred             cEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCC
Q 046544          165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       165 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                      +.|++++|.+++..+..|..+++|++|++++|+++ .+|..+.++++|++|++++|++.+..|..+..+++|++|++++|
T Consensus       257 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  335 (606)
T 3t6q_A          257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN  335 (606)
T ss_dssp             EEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSC
T ss_pred             eEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCC
Confidence            66777777777766777778888888888888887 55667788888888888888888777778888888888888888


Q ss_pred             cccccCC-ccccCCCCCceeecCCCccccc---ccccccccccccccCCCCcccCCCCCccCccccceEEEccccccccc
Q 046544          245 KLFGSIP-ACFSNLASLRILSLSSNELTSI---PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       245 ~i~~~~~-~~~~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  320 (646)
                      .+.+..| ..|..+++|++|++++|.++.+   |..+..+++|+.|++++|.+.+..|..|..+++|+.|++++|.+++.
T Consensus       336 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  415 (606)
T 3t6q_A          336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK  415 (606)
T ss_dssp             SSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECC
T ss_pred             CcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCc
Confidence            8774443 4577888888888888888765   45677788888888888888877778888888888888888888776


Q ss_pred             Ccc-ccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCccc---CCccccCCCCCCceeCcCCcceeeccCC
Q 046544          321 IPT-EIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA---IPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       321 ~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      .|. .|..+++|++|++++|.+++..|..|..+++|++|++++|++++.   .+..+..+++|++|++++|++++.+|..
T Consensus       416 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  495 (606)
T 3t6q_A          416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA  495 (606)
T ss_dssp             TTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTT
T ss_pred             ccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhh
Confidence            554 477888888888888888877788888888888888888888752   3356778888888888888888776654


Q ss_pred             -CCCCCCccccccCCcccc
Q 046544          397 -GSFGNFAAESFEGNELLC  414 (646)
Q Consensus       397 -~~~~~~~~~~~~~N~~~c  414 (646)
                       ..++.++.+++++|.+..
T Consensus       496 ~~~l~~L~~L~Ls~N~l~~  514 (606)
T 3t6q_A          496 FTSLKMMNHVDLSHNRLTS  514 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCG
T ss_pred             hccccCCCEEECCCCccCc
Confidence             457778888888886543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=431.59  Aligned_cols=411  Identities=23%  Similarity=0.261  Sum_probs=317.7

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +||..+.  +++++|||++|+++++.+.+|.++++|++|+|++|++++..+. .+..+++|++|+|++|++++..|..|.
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSHLSTLILTGNPIQSLALGAFS   97 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcc-cccCchhCCEEeCcCCcCCccCHhhhc
Confidence            3566553  5788888888888887788888888888888888888764333 333578888888888888877778888


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcch--hc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTS--IG  158 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~--~~  158 (646)
                      ++++|++|++++|+++++.+..|+++++|++|+|++|.++.+.    ++..|+++++|++|++++|+++++.+...  ..
T Consensus        98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~----lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  173 (570)
T 2z63_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK----LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH  173 (570)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCC----CCGGGGGCTTCCEEECTTSCCCEECGGGGHHHH
T ss_pred             CccccccccccccccccCCCccccccccccEEecCCCccceec----ChhhhcccCCCCEEeCcCCccceecHHHccchh
Confidence            8888888888888888776667888888888888888887642    23457778888888888887766543211  00


Q ss_pred             ccc-----------------------ccCcEEEeecc-------------------------------------------
Q 046544          159 NLS-----------------------HSLKDFYMSNC-------------------------------------------  172 (646)
Q Consensus       159 ~~~-----------------------~~L~~L~L~~n-------------------------------------------  172 (646)
                      .+.                       .+|+.|++++|                                           
T Consensus       174 ~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~  253 (570)
T 2z63_A          174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG  253 (570)
T ss_dssp             TCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGG
T ss_pred             ccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcc
Confidence            000                       02333333333                                           


Q ss_pred             ---------------cccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhh-------
Q 046544          173 ---------------NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI-------  230 (646)
Q Consensus       173 ---------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------  230 (646)
                                     .+.+..|..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+.......+       
T Consensus       254 l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~  331 (570)
T 2z63_A          254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLT  331 (570)
T ss_dssp             GGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEE
T ss_pred             ccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEe
Confidence                           223334455555667777777777666 345555555 55666665555552221111       


Q ss_pred             ------------cCCCCCcEEEecCCcccccC--CccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCC
Q 046544          231 ------------CRLTELYELELGGNKLFGSI--PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP  296 (646)
Q Consensus       231 ------------~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  296 (646)
                                  ..+++|++|++++|++++..  +..+.++++|++|++++|.++.+|..+..+++|+.|++++|.+.+.
T Consensus       332 l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~  411 (570)
T 2z63_A          332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQM  411 (570)
T ss_dssp             EESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESC
T ss_pred             CcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccc
Confidence                        56788899999999987654  6778899999999999999999988889999999999999999987


Q ss_pred             CC-CccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC-CcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          297 LP-LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE-GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       297 ~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                      .+ ..+..+++|+.|++++|.+++..|..|.++++|++|++++|+++ +.+|..|..+++|++|++++|++++..|..|.
T Consensus       412 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~  491 (570)
T 2z63_A          412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN  491 (570)
T ss_dssp             TTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             cchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence            66 57899999999999999999999999999999999999999997 57899999999999999999999998899999


Q ss_pred             CCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCCCcc
Q 046544          375 KLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSPTLQ  420 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~~~~  420 (646)
                      .+++|++|++++|++++.+|.. ..++.++.+++++|++.|+|+..+
T Consensus       492 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            9999999999999999977764 568899999999999999988643

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.9e-49  Score=440.80  Aligned_cols=353  Identities=20%  Similarity=0.274  Sum_probs=219.5

Q ss_pred             CCcCccCCCCCCEEECcCCcCcc------------------cCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcE
Q 046544           26 VPAAIFNMSMLKLLHLQNNSLLG------------------CLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSI   87 (646)
Q Consensus        26 ~~~~~~~l~~L~~L~L~~N~l~~------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (646)
                      +|.+|.++++|++|+|++|.+++                  .++.+.+..+++|++|+|++|++.+.+|..|+++++|++
T Consensus       198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  277 (636)
T 4eco_A          198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL  277 (636)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred             CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence            56666667777777777777666                  334444223666777777777766666666666777777


Q ss_pred             EEcccCc-ccc-ccCccccCc------CCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcc
Q 046544           88 LELSQNS-FSG-FIPNTFGNL------RNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN  159 (646)
Q Consensus        88 L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~  159 (646)
                      |+|++|+ +++ ..|..++.+      ++|++|+|++|+++.+|..    ..++++++|++|++++|++.+..+  .++.
T Consensus       278 L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~----~~l~~l~~L~~L~L~~N~l~g~ip--~~~~  351 (636)
T 4eco_A          278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP--AFGS  351 (636)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH----HHHTTCTTCCEEECCSCCCEEECC--CCEE
T ss_pred             EECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch----hhhccCCCCCEEeCcCCcCccchh--hhCC
Confidence            7777776 665 556666555      6677777777766643320    035666667777777776663322  2332


Q ss_pred             ccccCcEEEeecccccccCCcccccCCC-CCEEEccCCccccccCccccCCC--CCCeEEeecccccCcCchhhc-----
Q 046544          160 LSHSLKDFYMSNCNVSGGIPEEITNLTN-SITIDLGGNKLNGSIPITLSKLQ--KLQGLGLDDNKLEGSIPDSIC-----  231 (646)
Q Consensus       160 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-----  231 (646)
                      + ++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++|++++|++.+..|..|.     
T Consensus       352 l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~  428 (636)
T 4eco_A          352 E-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT  428 (636)
T ss_dssp             E-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred             C-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccc
Confidence            2 35666666666666 45666666666 666666666666 4555555443  666666666666666666666     


Q ss_pred             --CCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccc--------cccccccCCCCcccCCCCCcc
Q 046544          232 --RLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNL--------KDILQLNFSSNFLTGPLPLEI  301 (646)
Q Consensus       232 --~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l--------~~L~~L~l~~N~l~~~~~~~~  301 (646)
                        .+++|++|+|++|+++.+.+..+..+++|++|+|++|.++.+|..++..        ++|+.|++++|.++ .+|..+
T Consensus       429 ~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~  507 (636)
T 4eco_A          429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDF  507 (636)
T ss_dssp             CCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGG
T ss_pred             cccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhh
Confidence              5666666666666666544445555666666666666666666543332        26666666666666 455555


Q ss_pred             C--ccccceEEEcccccccccCccccCCCCCCCEEEc------cCccCCCcccccccCCCCCCEEEccCCcCcccCCccc
Q 046544          302 G--NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL------GYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSL  373 (646)
Q Consensus       302 ~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  373 (646)
                      .  .+++|+.|++++|++++ +|..+..+++|++|+|      ++|++.+.+|..+..+++|++|+|++|+++ .+|..+
T Consensus       508 ~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~  585 (636)
T 4eco_A          508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI  585 (636)
T ss_dssp             STTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCC
T ss_pred             hhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhH
Confidence            4  66666666666666665 5666666666666666      345556666666666666666666666663 555554


Q ss_pred             cCCCCCCceeCcCCcceee
Q 046544          374 EKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       374 ~~l~~L~~L~L~~N~l~~~  392 (646)
                      .  ++|+.|++++|++.+.
T Consensus       586 ~--~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          586 T--PNISVLDIKDNPNISI  602 (636)
T ss_dssp             C--TTCCEEECCSCTTCEE
T ss_pred             h--CcCCEEECcCCCCccc
Confidence            4  5666666666666653

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.2e-49  Score=440.19  Aligned_cols=396  Identities=18%  Similarity=0.234  Sum_probs=341.4

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcC-------------------------------------------
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSL-------------------------------------------   46 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------------------------   46 (646)
                      ..++.|+|++|++++.+|.+|+++++|++|+|++|.+                                           
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~  160 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD  160 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence            4788999999999999999999999999999999954                                           


Q ss_pred             -----------------------------------cccCCccCcCCCCCCCEEEccCCccccc-----------------
Q 046544           47 -----------------------------------LGCLSSIADVRLPNLEALLLWGNNFSGT-----------------   74 (646)
Q Consensus        47 -----------------------------------~~~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------   74 (646)
                                                         ++ +|. ....+++|++|+|++|++++.                 
T Consensus       161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~  238 (636)
T 4eco_A          161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY  238 (636)
T ss_dssp             HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence                                               23 222 123489999999999999985                 


Q ss_pred             CCcccc--CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCC-CCC--CCCcccccccCCCCCCCCEEECCCCCCC
Q 046544           75 IPRFIF--NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY-LTS--STPELSFLSSLSNCKSLTFIHLSDNPLD  149 (646)
Q Consensus        75 ~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~--~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  149 (646)
                      +|..++  ++++|++|+|++|.+.+..|..|+++++|++|+|++|+ ++.  +|..+.....+..+++|++|++++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            899998  99999999999999999999999999999999999998 874  4333211112334599999999999999


Q ss_pred             CcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCC-CCeEEeecccccCcCch
Q 046544          150 GILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQK-LQGLGLDDNKLEGSIPD  228 (646)
Q Consensus       150 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~  228 (646)
                      .++....++.+ ++|++|++++|+++|.+| .+..+++|++|++++|++. .+|..+..+++ |++|++++|+++ .+|.
T Consensus       319 ~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~  394 (636)
T 4eco_A          319 TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPN  394 (636)
T ss_dssp             SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCS
T ss_pred             ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccch
Confidence            76542245554 589999999999998888 9999999999999999999 77888999999 999999999999 7888


Q ss_pred             hhcCCC--CCcEEEecCCcccccCCcccc-------CCCCCceeecCCCcccccccccc-cccccccccCCCCcccCCCC
Q 046544          229 SICRLT--ELYELELGGNKLFGSIPACFS-------NLASLRILSLSSNELTSIPLTFW-NLKDILQLNFSSNFLTGPLP  298 (646)
Q Consensus       229 ~~~~l~--~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~l~~N~l~~~~~  298 (646)
                      .+..++  +|++|++++|++.+..|..|.       .+++|++|++++|.++.+|..++ .+++|+.|++++|.++...+
T Consensus       395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~  474 (636)
T 4eco_A          395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK  474 (636)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred             hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence            887765  899999999999999999888       88899999999999999998755 58999999999999995444


Q ss_pred             CccCcc-------ccceEEEcccccccccCccccC--CCCCCCEEEccCccCCCcccccccCCCCCCEEEc------cCC
Q 046544          299 LEIGNL-------KVLIGIDFSMNNFSSVIPTEIG--GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL------SNN  363 (646)
Q Consensus       299 ~~~~~l-------~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N  363 (646)
                      ..+...       ++|+.|++++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      ++|
T Consensus       475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N  552 (636)
T 4eco_A          475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN  552 (636)
T ss_dssp             SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCC
T ss_pred             HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccC
Confidence            444433       39999999999999 5677776  99999999999999997 8999999999999999      568


Q ss_pred             cCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccC
Q 046544          364 NLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCG  415 (646)
Q Consensus       364 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~  415 (646)
                      ++.+.+|..+..+++|++|+|++|++ +.+|... .+.++.+++++|++.|-
T Consensus       553 ~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          553 RTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISI  602 (636)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEE
T ss_pred             cccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccc
Confidence            88899999999999999999999999 5677653 38999999999999883

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.6e-48  Score=440.70  Aligned_cols=349  Identities=17%  Similarity=0.223  Sum_probs=242.1

Q ss_pred             CCCCCCEEEccCCcccc-----------------cCCcccc--CCCCCcEEEcccCccccccCccccCcCCCCEEEccCC
Q 046544           57 RLPNLEALLLWGNNFSG-----------------TIPRFIF--NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDN  117 (646)
Q Consensus        57 ~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  117 (646)
                      .+++|++|+|++|+|++                 .+|..++  ++++|++|+|++|.+.+..|..|+++++|++|+|++|
T Consensus       446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N  525 (876)
T 4ecn_A          446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN  525 (876)
T ss_dssp             GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred             cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence            46777888888888776                 3677766  7777888888888777777777777888888888877


Q ss_pred             C-CCC--CCCcccccc-cCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEc
Q 046544          118 Y-LTS--STPELSFLS-SLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDL  193 (646)
Q Consensus       118 ~-l~~--~~~~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  193 (646)
                      + ++.  +|..+.... .+..+++|++|+|++|.++.++....++.+ ++|+.|+|++|.++ .+| .+..+++|+.|+|
T Consensus       526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L-~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L  602 (876)
T 4ecn_A          526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKM-VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL  602 (876)
T ss_dssp             TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTC-TTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred             CCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcC-CCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence            7 654  333222111 445566788888888877755431234443 46777888888777 556 7777777888888


Q ss_pred             cCCccccccCccccCCCC-CCeEEeecccccCcCchhhcCCCC--CcEEEecCCcccccCCccc---c--CCCCCceeec
Q 046544          194 GGNKLNGSIPITLSKLQK-LQGLGLDDNKLEGSIPDSICRLTE--LYELELGGNKLFGSIPACF---S--NLASLRILSL  265 (646)
Q Consensus       194 ~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~i~~~~~~~~---~--~l~~L~~L~L  265 (646)
                      ++|++. .+|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|+|
T Consensus       603 s~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~L  680 (876)
T 4ecn_A          603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL  680 (876)
T ss_dssp             CSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEEC
T ss_pred             cCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEc
Confidence            888777 66666777777 888888888777 56666666544  7788888887776555332   1  2347777888


Q ss_pred             CCCcccccccccc-cccccccccCCCCcccCCCCCccCc-------cccceEEEcccccccccCccccC--CCCCCCEEE
Q 046544          266 SSNELTSIPLTFW-NLKDILQLNFSSNFLTGPLPLEIGN-------LKVLIGIDFSMNNFSSVIPTEIG--GLKNLEYLF  335 (646)
Q Consensus       266 ~~N~l~~lp~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~-------l~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~  335 (646)
                      ++|.++.+|..++ .+++|+.|++++|.++...+..+..       +++|+.|+|++|+++ .+|..+.  .+++|+.|+
T Consensus       681 s~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~  759 (876)
T 4ecn_A          681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD  759 (876)
T ss_dssp             CSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEE
T ss_pred             cCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEE
Confidence            8887777776554 6777778888887777333333322       237778888888777 4566665  777788888


Q ss_pred             ccCccCCCcccccccCCCCCCEEEccC------CcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccC
Q 046544          336 LGYNRLEGSIPDSFGDLISLKFLNLSN------NNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEG  409 (646)
Q Consensus       336 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~  409 (646)
                      |++|++++ +|..+..+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|... .+.++.+++++
T Consensus       760 Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l-~~~L~~LdLs~  836 (876)
T 4ecn_A          760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL-TPQLYILDIAD  836 (876)
T ss_dssp             CCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CSSSCEEECCS
T ss_pred             eCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhh-cCCCCEEECCC
Confidence            88888775 577777777888887765      667777777777778888888888887 4566552 35777777777


Q ss_pred             Ccccc
Q 046544          410 NELLC  414 (646)
Q Consensus       410 N~~~c  414 (646)
                      |++..
T Consensus       837 N~l~~  841 (876)
T 4ecn_A          837 NPNIS  841 (876)
T ss_dssp             CTTCE
T ss_pred             CCCCc
Confidence            77644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2e-46  Score=426.04  Aligned_cols=380  Identities=24%  Similarity=0.230  Sum_probs=195.2

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      ||..+.  +++++|+|++|+++++.+.+|.++++|++|+|++|.+++..+. .+..+++|++|+|++|++++..+..|.+
T Consensus        19 ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~l~~~~~~~   95 (680)
T 1ziw_A           19 VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE-LCQKLPMLKVLNLQHNELSQLSDKTFAF   95 (680)
T ss_dssp             CCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTT-HHHHCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHH-HHhcccCcCEEECCCCccCccChhhhcc
Confidence            455443  5666666666666666666666666666666666666654333 1223666666666666666555556666


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcccc
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS  161 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  161 (646)
                      +++|++|+|++|.++++.|..|+++++|++|+|++|.++..++     ..+.++++|++|++++|.++++.+......-.
T Consensus        96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~  170 (680)
T 1ziw_A           96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL-----GTQVQLENLQELLLSNNKIQALKSEELDIFAN  170 (680)
T ss_dssp             CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCC-----CSSSCCTTCCEEECCSSCCCCBCHHHHGGGTT
T ss_pred             CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCc-----hhhcccccCCEEEccCCcccccCHHHhhcccc
Confidence            6666666666666666666666666666666666666665533     23556666666666666665554322111111


Q ss_pred             ccCcEEEeecccccccCCcccccC---------------------------CCCCEEEccCCccccccCccccCCCC--C
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNL---------------------------TNSITIDLGGNKLNGSIPITLSKLQK--L  212 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~--L  212 (646)
                      ++|+.|++++|.+++..|..+..+                           ++|+.|++++|++.+..|.+|.+++.  |
T Consensus       171 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L  250 (680)
T 1ziw_A          171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL  250 (680)
T ss_dssp             CEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCC
T ss_pred             ccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCC
Confidence            345555555555555544444332                           23344444444444444444444432  5


Q ss_pred             CeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCcc---------------------------------ccCCCC
Q 046544          213 QGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPAC---------------------------------FSNLAS  259 (646)
Q Consensus       213 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~---------------------------------~~~l~~  259 (646)
                      ++|++++|++++..|.+|..+++|++|++++|++.+..|..                                 |..+++
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~  330 (680)
T 1ziw_A          251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC  330 (680)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTT
T ss_pred             CEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCC
Confidence            55555555544444444444455555555555444444444                                 445555


Q ss_pred             CceeecCCCccccccc-ccccccccccccCCCCcccCC--CCCccCcc--ccceEEEcccccccccCccccCCCCCCCEE
Q 046544          260 LRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGP--LPLEIGNL--KVLIGIDFSMNNFSSVIPTEIGGLKNLEYL  334 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l--~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  334 (646)
                      |++|++++|.++.++. .|.++++|++|++++|.+...  .+..|..+  +.|+.|++++|+++++.|..|+.+++|++|
T Consensus       331 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  410 (680)
T 1ziw_A          331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL  410 (680)
T ss_dssp             CCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEE
Confidence            5555555555554432 344444444444443332110  00111111  123333334444444445555555555555


Q ss_pred             EccCccCCCccc-ccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcc
Q 046544          335 FLGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL  389 (646)
Q Consensus       335 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  389 (646)
                      ++++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+
T Consensus       411 ~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l  466 (680)
T 1ziw_A          411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL  466 (680)
T ss_dssp             ECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCC
T ss_pred             eCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccc
Confidence            555555544333 4555555555555555555444444444444444444444443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6.9e-47  Score=424.06  Aligned_cols=389  Identities=21%  Similarity=0.196  Sum_probs=319.9

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNA   82 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (646)
                      |..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|.+++.++. .+..+++|++|+|++|.+++..+..|+++
T Consensus        49 ~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  127 (606)
T 3vq2_A           49 SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-SFSGLTSLENLVAVETKLASLESFPIGQL  127 (606)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT-SSTTCTTCCEEECTTSCCCCSSSSCCTTC
T ss_pred             hhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh-hcCCcccCCEEEccCCccccccccccCCC
Confidence            44788999999999999999988899999999999999999999875443 23358999999999999998887889999


Q ss_pred             CCCcEEEcccCccccc-cCccccCcCCCCEEEccCCCCCCCCCcc-cc---------------------cccCCCCCCCC
Q 046544           83 SKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPEL-SF---------------------LSSLSNCKSLT  139 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~---------------------~~~l~~l~~L~  139 (646)
                      ++|++|+|++|.+.+. .|..|+++++|++|+|++|+++..++.. ..                     +.......+|+
T Consensus       128 ~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~  207 (606)
T 3vq2_A          128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLH  207 (606)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred             CCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceee
Confidence            9999999999999864 4888999999999999999988765431 00                     00011112455


Q ss_pred             EEECCCCCCCCcCCc-----------------------------------------------------------------
Q 046544          140 FIHLSDNPLDGILSK-----------------------------------------------------------------  154 (646)
Q Consensus       140 ~L~Ls~N~l~~~~~~-----------------------------------------------------------------  154 (646)
                      +|++++|.+.+....                                                                 
T Consensus       208 ~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L  287 (606)
T 3vq2_A          208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV  287 (606)
T ss_dssp             EEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTC
T ss_pred             eeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCC
Confidence            555555544200000                                                                 


Q ss_pred             -------------chhccccccCcEEEeecccccccCCc--------------------ccccCCCCCEEEccCCccccc
Q 046544          155 -------------TSIGNLSHSLKDFYMSNCNVSGGIPE--------------------EITNLTNSITIDLGGNKLNGS  201 (646)
Q Consensus       155 -------------~~~~~~~~~L~~L~L~~n~l~~~~p~--------------------~~~~l~~L~~L~L~~N~l~~~  201 (646)
                                   ..+.. .++|++|++++|.+. .+|.                    .+..+++|++|++++|++++.
T Consensus       288 ~~L~l~~~~~~~l~~l~~-~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~  365 (606)
T 3vq2_A          288 SAMSLAGVSIKYLEDVPK-HFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFS  365 (606)
T ss_dssp             SEEEEESCCCCCCCCCCT-TCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEE
T ss_pred             CEEEecCccchhhhhccc-cccCCEEEcccccCc-ccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCC
Confidence                         00000 125666666666663 3332                    355678888889999999876


Q ss_pred             c--CccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCC-ccccCCCCCceeecCCCcccc-ccccc
Q 046544          202 I--PITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP-ACFSNLASLRILSLSSNELTS-IPLTF  277 (646)
Q Consensus       202 ~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~-lp~~~  277 (646)
                      .  |..+..+++|++|++++|.+.+ +|..|..+++|++|++++|++.+..| ..|.++++|++|++++|.++. .|..+
T Consensus       366 ~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  444 (606)
T 3vq2_A          366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF  444 (606)
T ss_dssp             EECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred             cchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhh
Confidence            3  8889999999999999999995 66889999999999999999998887 789999999999999999996 46778


Q ss_pred             ccccccccccCCCCcccC-CCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCC
Q 046544          278 WNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLK  356 (646)
Q Consensus       278 ~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  356 (646)
                      ..+++|+.|++++|.+++ ..|..++.+++|+.|++++|.+++..|..|+++++|++|++++|++++.+|..|..+++|+
T Consensus       445 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  524 (606)
T 3vq2_A          445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS  524 (606)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred             cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence            999999999999999997 4789999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEccCCcCcccCCccccCCC-CCCceeCcCCcceeeccCC
Q 046544          357 FLNLSNNNLSGAIPTSLEKLS-YLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       357 ~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~  396 (646)
                      +|+|++|+++ .+|..+..++ +|++|++++|++.|.++..
T Consensus       525 ~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          525 TLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             EEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             EEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            9999999999 6777799997 5999999999999988754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=438.80  Aligned_cols=408  Identities=24%  Similarity=0.200  Sum_probs=326.1

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +||.   -.+++++|||++|+|+++.|..|.++++|++|+|++|.+.+.++...+..+++|++|+|++|.|++..|..|.
T Consensus        18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~   94 (844)
T 3j0a_A           18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ   94 (844)
T ss_dssp             CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred             CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence            3665   4589999999999999999999999999999999999776556555556799999999999999999999999


Q ss_pred             CCCCCcEEEcccCccccccCcc--ccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhc
Q 046544           81 NASKLSILELSQNSFSGFIPNT--FGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIG  158 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  158 (646)
                      ++++|++|+|++|.+++..|..  |+++++|++|+|++|.++..++    +..|+++++|++|++++|.++++.+.....
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~----~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~  170 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL----HPSFGKLNSLKSIDFSSNQIFLVCEHELEP  170 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC----CGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc----chhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence            9999999999999999865554  9999999999999999988743    235889999999999999998765443211


Q ss_pred             cccc------------------------------cCcEEEeecccccccCCccccc------------------------
Q 046544          159 NLSH------------------------------SLKDFYMSNCNVSGGIPEEITN------------------------  184 (646)
Q Consensus       159 ~~~~------------------------------~L~~L~L~~n~l~~~~p~~~~~------------------------  184 (646)
                      -..+                              .|+.|++++|.+++..|..+..                        
T Consensus       171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence            0001                              2667777777665544443332                        


Q ss_pred             --------------CCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccC
Q 046544          185 --------------LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI  250 (646)
Q Consensus       185 --------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  250 (646)
                                    .++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|.+|.++++|++|+|++|++.+..
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  330 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY  330 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence                          157888888888888888888888888999999999888888888888888999999999888888


Q ss_pred             CccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCC------------------C------------
Q 046544          251 PACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLP------------------L------------  299 (646)
Q Consensus       251 ~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~------------------~------------  299 (646)
                      |..|.++++|+.|++++|.++.++. .|..+++|+.|++++|.+++...                  .            
T Consensus       331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~  410 (844)
T 3j0a_A          331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE  410 (844)
T ss_dssp             SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCS
T ss_pred             HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeeccc
Confidence            8888888899999999998887765 57778888888888887764211                  0            


Q ss_pred             ----------ccCccccceEEEcccccccccCcc-ccCCCCCCCEEEccCccCC-----CcccccccCCCCCCEEEccCC
Q 046544          300 ----------EIGNLKVLIGIDFSMNNFSSVIPT-EIGGLKNLEYLFLGYNRLE-----GSIPDSFGDLISLKFLNLSNN  363 (646)
Q Consensus       300 ----------~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N  363 (646)
                                .+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++     +..+..|.++++|+.|+|++|
T Consensus       411 N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N  490 (844)
T 3j0a_A          411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN  490 (844)
T ss_dssp             CCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHH
T ss_pred             CccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCC
Confidence                      122556667777777777654433 3555677777777777775     344567889999999999999


Q ss_pred             cCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCC
Q 046544          364 NLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS  416 (646)
Q Consensus       364 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~  416 (646)
                      ++++..|..|..+++|+.|+|++|++++.+|.... ..++.+++++|.+..-.
T Consensus       491 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~  542 (844)
T 3j0a_A          491 YLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN  542 (844)
T ss_dssp             HHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred             cccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence            99999999999999999999999999986665544 88999999999876643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.4e-46  Score=417.43  Aligned_cols=412  Identities=22%  Similarity=0.246  Sum_probs=317.9

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +||..+.  +++++|||++|+|+++.+.+|.++++|++|+|++|+|++.++ .++..+++|++|+|++|+|++..++.|.
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~-~~f~~L~~L~~L~Ls~N~l~~l~~~~f~  121 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLALGAFS  121 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcCh-hHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence            4666553  589999999999999999999999999999999999987444 4445699999999999999988889999


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchh--c
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSI--G  158 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~--~  158 (646)
                      ++++|++|+|++|+|+++.+..|+++++|++|+|++|+++..+    .+..++++++|++|++++|+++++.+...-  .
T Consensus       122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~  197 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK----LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH  197 (635)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC----CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH
T ss_pred             CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCC----CchhhccchhhhhhcccCccccccccccccchh
Confidence            9999999999999999998889999999999999999998764    234578899999999999999877543211  1


Q ss_pred             cccccCcEEEeecccccccCC-----------------------------------------------------------
Q 046544          159 NLSHSLKDFYMSNCNVSGGIP-----------------------------------------------------------  179 (646)
Q Consensus       159 ~~~~~L~~L~L~~n~l~~~~p-----------------------------------------------------------  179 (646)
                      .+......++++.|.+....+                                                           
T Consensus       198 ~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~  277 (635)
T 4g8a_A          198 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG  277 (635)
T ss_dssp             TCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGG
T ss_pred             hhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccc
Confidence            111111122222222211111                                                           


Q ss_pred             --------------------------------------------cccccCCCCCEEEccCCccccccCcc----------
Q 046544          180 --------------------------------------------EEITNLTNSITIDLGGNKLNGSIPIT----------  205 (646)
Q Consensus       180 --------------------------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~----------  205 (646)
                                                                  ..+....+++.|++++|.+....+..          
T Consensus       278 ~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~  357 (635)
T 4g8a_A          278 LCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT  357 (635)
T ss_dssp             GGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEE
T ss_pred             ccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccc
Confidence                                                        11222334455555555544332221          


Q ss_pred             ---------ccCCCCCCeEEeecccccC--cCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccc
Q 046544          206 ---------LSKLQKLQGLGLDDNKLEG--SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP  274 (646)
Q Consensus       206 ---------~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp  274 (646)
                               +..+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.+++++|.....+
T Consensus       358 ~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~  436 (635)
T 4g8a_A          358 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS  436 (635)
T ss_dssp             SCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTT
T ss_pred             cccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccc
Confidence                     1234455566666665532  334455556666666666666553 3455777888888888888776543


Q ss_pred             --cccccccccccccCCCCcccCCCCCccCccccceEEEcccccc-cccCccccCCCCCCCEEEccCccCCCcccccccC
Q 046544          275 --LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNF-SSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD  351 (646)
Q Consensus       275 --~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  351 (646)
                        ..|..+++++.++++.|.+.+..+..+..++.|+.|++++|.+ .+..|..|..+++|++|+|++|++++.+|..|.+
T Consensus       437 ~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~  516 (635)
T 4g8a_A          437 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS  516 (635)
T ss_dssp             SSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcC
Confidence              3577889999999999999999999999999999999999974 4567889999999999999999999999999999


Q ss_pred             CCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCC-CC-CCCccccccCCccccCCCCcc
Q 046544          352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGG-SF-GNFAAESFEGNELLCGSPTLQ  420 (646)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~-~~~~~~~~~~N~~~c~~~~~~  420 (646)
                      +++|++|+|++|+|++..|..|..+++|++|||++|++++.+|... .+ ++++.+++++|||.|+|...+
T Consensus       517 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~  587 (635)
T 4g8a_A          517 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS  587 (635)
T ss_dssp             CTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHH
T ss_pred             CCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHH
Confidence            9999999999999999999999999999999999999999888763 34 689999999999999997643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.6e-46  Score=416.00  Aligned_cols=398  Identities=22%  Similarity=0.249  Sum_probs=302.4

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +||..+.  ++|++|+|++|+++++.|.+|.++++|++|+|++|++++.++. .+..+++|++|+|++|++++..|..|.
T Consensus        19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~   95 (549)
T 2z81_A           19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD-AFYSLGSLEHLDLSDNHLSSLSSSWFG   95 (549)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTSCCCSCCHHHHT
T ss_pred             cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh-hccccccCCEEECCCCccCccCHHHhc
Confidence            3666654  7899999999999888888899999999999999998875543 233588999999999999888777788


Q ss_pred             CCCCCcEEEcccCccccc-cCccccCcCCCCEEEccCCC-CCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhc
Q 046544           81 NASKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNY-LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIG  158 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  158 (646)
                      ++++|++|+|++|.++++ .|..|+++++|++|++++|. +..+++     ..|.++++|++|++++|.+++..+.. +.
T Consensus        96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~-l~  169 (549)
T 2z81_A           96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR-----IDFAGLTSLNELEIKALSLRNYQSQS-LK  169 (549)
T ss_dssp             TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT-----TTTTTCCEEEEEEEEETTCCEECTTT-TT
T ss_pred             cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCH-----hhhhcccccCeeeccCCcccccChhh-hh
Confidence            899999999999998864 46778889999999999987 444432     35778888888888888887654332 11


Q ss_pred             c-----------------------ccccCcEEEeecccccccC--C-cccccCCCCCEEEccCCccccccCc--------
Q 046544          159 N-----------------------LSHSLKDFYMSNCNVSGGI--P-EEITNLTNSITIDLGGNKLNGSIPI--------  204 (646)
Q Consensus       159 ~-----------------------~~~~L~~L~L~~n~l~~~~--p-~~~~~l~~L~~L~L~~N~l~~~~~~--------  204 (646)
                      .                       ..++|++|++++|++++..  | .....+++|+.|++++|.+.+..+.        
T Consensus       170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~  249 (549)
T 2z81_A          170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY  249 (549)
T ss_dssp             TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred             ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence            1                       1245666666666666531  1 1112233333333333332211000        


Q ss_pred             -------------------------------------------------------cccCCCCCCeEEeecccccCcCchh
Q 046544          205 -------------------------------------------------------TLSKLQKLQGLGLDDNKLEGSIPDS  229 (646)
Q Consensus       205 -------------------------------------------------------~~~~l~~L~~L~L~~N~l~~~~~~~  229 (646)
                                                                             .+...++|+.|++++|.+. .+|..
T Consensus       250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~  328 (549)
T 2z81_A          250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS  328 (549)
T ss_dssp             CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHH
T ss_pred             hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHH
Confidence                                                                   0112246777888888877 45555


Q ss_pred             h-cCCCCCcEEEecCCcccccCC---ccccCCCCCceeecCCCccccccc---ccccccccccccCCCCcccCCCCCccC
Q 046544          230 I-CRLTELYELELGGNKLFGSIP---ACFSNLASLRILSLSSNELTSIPL---TFWNLKDILQLNFSSNFLTGPLPLEIG  302 (646)
Q Consensus       230 ~-~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~lp~---~~~~l~~L~~L~l~~N~l~~~~~~~~~  302 (646)
                      + ..+++|++|++++|++.+..|   ..++.+++|++|++++|+++.+|.   .+..+++|++|++++|.++ .+|..+.
T Consensus       329 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~  407 (549)
T 2z81_A          329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ  407 (549)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCC
T ss_pred             HHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhc
Confidence            5 679999999999999987664   347889999999999999998863   4788999999999999998 5788899


Q ss_pred             ccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCce
Q 046544          303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDL  382 (646)
Q Consensus       303 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  382 (646)
                      .+++|+.|++++|.++++ |..+  .++|++|++++|++++.+    ..+++|++|+|++|+|+ .+|. ...+++|++|
T Consensus       408 ~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L  478 (549)
T 2z81_A          408 WPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVM  478 (549)
T ss_dssp             CCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEE
T ss_pred             ccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEE
Confidence            999999999999999864 3333  268999999999998653    57899999999999998 6676 4679999999


Q ss_pred             eCcCCcceeeccCC-CCCCCCccccccCCccccCCCC
Q 046544          383 NLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       383 ~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      +|++|++++.+|.. ..+..++.+++++|+|.|+|+.
T Consensus       479 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             ECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             ecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99999999987764 5688999999999999998873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.2e-46  Score=426.29  Aligned_cols=380  Identities=19%  Similarity=0.211  Sum_probs=308.0

Q ss_pred             CCcCccCCCCCCEEECcCCcCcc------------------cCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcE
Q 046544           26 VPAAIFNMSMLKLLHLQNNSLLG------------------CLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSI   87 (646)
Q Consensus        26 ~~~~~~~l~~L~~L~L~~N~l~~------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (646)
                      +|..|.++++|++|+|++|+|++                  .++.+.+..+++|++|+|++|++.+.+|..|+++++|++
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            67889999999999999999988                  455565446899999999999999999999999999999


Q ss_pred             EEcccCc-ccc-ccCccccCcC-------CCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhc
Q 046544           88 LELSQNS-FSG-FIPNTFGNLR-------NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIG  158 (646)
Q Consensus        88 L~Ls~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  158 (646)
                      |+|++|+ +++ ..|..|+.++       +|++|+|++|+++.+|.    ...++++++|++|+|++|++..++   .++
T Consensus       520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~----~~~l~~L~~L~~L~Ls~N~l~~lp---~~~  592 (876)
T 4ecn_A          520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA----SASLQKMVKLGLLDCVHNKVRHLE---AFG  592 (876)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC----HHHHTTCTTCCEEECTTSCCCBCC---CCC
T ss_pred             EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC----hhhhhcCCCCCEEECCCCCcccch---hhc
Confidence            9999998 887 6777666655       99999999999986543    015788999999999999998654   333


Q ss_pred             cccccCcEEEeecccccccCCcccccCCC-CCEEEccCCccccccCccccCCCC--CCeEEeecccccCcCchhh---c-
Q 046544          159 NLSHSLKDFYMSNCNVSGGIPEEITNLTN-SITIDLGGNKLNGSIPITLSKLQK--LQGLGLDDNKLEGSIPDSI---C-  231 (646)
Q Consensus       159 ~~~~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~-  231 (646)
                      .+ ++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+.+|...   . 
T Consensus       593 ~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~  669 (876)
T 4ecn_A          593 TN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD  669 (876)
T ss_dssp             TT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTT
T ss_pred             CC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhcc
Confidence            33 57999999999999 77888999998 999999999998 66777777654  9999999999987665432   2 


Q ss_pred             -CCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccc--------cccccccCCCCcccCCCCCccC
Q 046544          232 -RLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNL--------KDILQLNFSSNFLTGPLPLEIG  302 (646)
Q Consensus       232 -~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l--------~~L~~L~l~~N~l~~~~~~~~~  302 (646)
                       .+++|+.|+|++|++..+.+..+..+++|+.|+|++|.|+.+|..++..        ++|+.|++++|.++ .+|..+.
T Consensus       670 ~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~  748 (876)
T 4ecn_A          670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR  748 (876)
T ss_dssp             CCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGS
T ss_pred             ccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhh
Confidence             3458999999999998555555668899999999999999998765543        38999999999998 6777776


Q ss_pred             --ccccceEEEcccccccccCccccCCCCCCCEEEccC------ccCCCcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          303 --NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGY------NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       303 --~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                        .+++|+.|+|++|.+++ +|..++.+++|+.|+|++      |++.+.+|..|..+++|+.|+|++|++ +.+|..+.
T Consensus       749 ~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~  826 (876)
T 4ecn_A          749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT  826 (876)
T ss_dssp             TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred             hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc
Confidence              89999999999999997 688888999999999976      778888999999999999999999999 57887765


Q ss_pred             CCCCCCceeCcCCcceeeccCCC-CCCCCccccccCCcccc--CCCCcc
Q 046544          375 KLSYLEDLNLSFNKLEGEIPRGG-SFGNFAAESFEGNELLC--GSPTLQ  420 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~~p~~~-~~~~~~~~~~~~N~~~c--~~~~~~  420 (646)
                        ++|+.|+|++|++....+... .........+.+|++.|  +|+...
T Consensus       827 --~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~L~  873 (876)
T 4ecn_A          827 --PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG  873 (876)
T ss_dssp             --SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGGGC
T ss_pred             --CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCCcc
Confidence              689999999999987554331 12234445666776655  777654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=407.65  Aligned_cols=391  Identities=21%  Similarity=0.206  Sum_probs=312.0

Q ss_pred             CCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEc
Q 046544           11 NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILEL   90 (646)
Q Consensus        11 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (646)
                      .....+-++.+++. +|..+.  +++++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus         8 ~~~~~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L   83 (570)
T 2z63_A            8 PNITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL   83 (570)
T ss_dssp             TTTEEECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECT-TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEeCCCCccc-cCCCcc--ccccEEEccCCccCccCh-hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeC
Confidence            35678888888884 555543  579999999999987544 34446999999999999999998999999999999999


Q ss_pred             ccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEee
Q 046544           91 SQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS  170 (646)
Q Consensus        91 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~  170 (646)
                      ++|.++++.|.+|+++++|++|++++|+++.+++.     .++++++|++|++++|.+.++.-...++++ ++|++|+++
T Consensus        84 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-----~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l-~~L~~L~l~  157 (570)
T 2z63_A           84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKLPEYFSNL-TNLEHLDLS  157 (570)
T ss_dssp             TTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTC-----SCTTCTTCCEEECCSSCCCCCCCCGGGGGC-TTCCEEECT
T ss_pred             cCCcCCccCHhhhcCccccccccccccccccCCCc-----cccccccccEEecCCCccceecChhhhccc-CCCCEEeCc
Confidence            99999999999999999999999999999987643     488999999999999999875433345544 589999999


Q ss_pred             cccccccCCcccccCCCC----CEEEccCCccccccCcccc---------------------------------------
Q 046544          171 NCNVSGGIPEEITNLTNS----ITIDLGGNKLNGSIPITLS---------------------------------------  207 (646)
Q Consensus       171 ~n~l~~~~p~~~~~l~~L----~~L~L~~N~l~~~~~~~~~---------------------------------------  207 (646)
                      +|.+++..|..+..+++|    +.|++++|.+.+..|..|.                                       
T Consensus       158 ~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~  237 (570)
T 2z63_A          158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF  237 (570)
T ss_dssp             TSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEEC
T ss_pred             CCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccc
Confidence            999999888999988888    8899999988776665443                                       


Q ss_pred             ------------------------------------------CCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCc
Q 046544          208 ------------------------------------------KLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK  245 (646)
Q Consensus       208 ------------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  245 (646)
                                                                .+++|++|++++|.+. .+|..+..+ +|++|++++|.
T Consensus       238 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~  315 (570)
T 2z63_A          238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCK  315 (570)
T ss_dssp             CCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCB
T ss_pred             cCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCc
Confidence                                                      3455666666666665 355555555 55555555555


Q ss_pred             ccccCCccc-------------------cCCCCCceeecCCCccccc---ccccccccccccccCCCCcccCCCCCccCc
Q 046544          246 LFGSIPACF-------------------SNLASLRILSLSSNELTSI---PLTFWNLKDILQLNFSSNFLTGPLPLEIGN  303 (646)
Q Consensus       246 i~~~~~~~~-------------------~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  303 (646)
                      +.......+                   ..+++|+.|++++|.++.+   |..+..+++|+.|++++|.+.+..+. +..
T Consensus       316 ~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~  394 (570)
T 2z63_A          316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLG  394 (570)
T ss_dssp             CSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EET
T ss_pred             ccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccc
Confidence            542222111                   4567777788888877755   45677788888888888888765444 888


Q ss_pred             cccceEEEcccccccccCc-cccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc-ccCCccccCCCCCCc
Q 046544          304 LKVLIGIDFSMNNFSSVIP-TEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS-GAIPTSLEKLSYLED  381 (646)
Q Consensus       304 l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~  381 (646)
                      +++|+.|++++|.+++..| ..|..+++|++|++++|++.+..|..|..+++|++|++++|+++ +.+|..+..+++|++
T Consensus       395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~  474 (570)
T 2z63_A          395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  474 (570)
T ss_dssp             CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence            8999999999999887766 57888999999999999998888889999999999999999987 578889999999999


Q ss_pred             eeCcCCcceeeccCC-CCCCCCccccccCCcccc
Q 046544          382 LNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLC  414 (646)
Q Consensus       382 L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c  414 (646)
                      |++++|++++..|.. ..+++++.+++++|.+..
T Consensus       475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  508 (570)
T 2z63_A          475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS  508 (570)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             EECCCCccccCChhhhhcccCCCEEeCCCCcCCC
Confidence            999999999876755 557888999999987654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=405.16  Aligned_cols=398  Identities=21%  Similarity=0.242  Sum_probs=294.7

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      +||..+.  ++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+. .+..+++|++|+|++|+|++ +|..  
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~--   87 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-VFKFNQELEYLDLSHNKLVK-ISCH--   87 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-GGTTCTTCCEEECCSSCCCE-EECC--
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH-HhhcccCCCEEecCCCceee-cCcc--
Confidence            3677666  7888888888888887778888888888888888888775443 22358888888888888884 4444  


Q ss_pred             CCCCCcEEEcccCccccc-cCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCC--CEEECCCCCC--CCcCCcc
Q 046544           81 NASKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL--TFIHLSDNPL--DGILSKT  155 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~  155 (646)
                      .+++|++|+|++|.++++ .|..|+++++|++|+|++|+++..        .+.++++|  ++|++++|.+  .+..+..
T Consensus        88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--------~~~~l~~L~L~~L~l~~n~l~~~~~~~~~  159 (520)
T 2z7x_B           88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--------SVLPIAHLNISKVLLVLGETYGEKEDPEG  159 (520)
T ss_dssp             CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--------GGGGGTTSCEEEEEEEECTTTTSSCCTTT
T ss_pred             ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh--------hccccccceeeEEEeeccccccccccccc
Confidence            788888888888888874 577888888888888888888652        35556666  8888888888  3332221


Q ss_pred             hhccc-------------------------cccCcEEEeeccc-------ccccCCcccccCC-----------------
Q 046544          156 SIGNL-------------------------SHSLKDFYMSNCN-------VSGGIPEEITNLT-----------------  186 (646)
Q Consensus       156 ~~~~~-------------------------~~~L~~L~L~~n~-------l~~~~p~~~~~l~-----------------  186 (646)
                       +..+                         .++|+.+++++|.       +.+.+| .+..++                 
T Consensus       160 -l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~  237 (520)
T 2z7x_B          160 -LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSF  237 (520)
T ss_dssp             -TTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHH
T ss_pred             -ccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHH
Confidence             1111                         1234444444443       222222 233333                 


Q ss_pred             ----------CCCEEEccCCccccccCccc-----cCCCCCCeEEeecccccCcCchhhcCC---CCCcEEEecCCcccc
Q 046544          187 ----------NSITIDLGGNKLNGSIPITL-----SKLQKLQGLGLDDNKLEGSIPDSICRL---TELYELELGGNKLFG  248 (646)
Q Consensus       187 ----------~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~i~~  248 (646)
                                +|++|++++|++.+..|..+     .++++|+.+++++|.+ ...+..+..+   ++|+.|++++|.+..
T Consensus       238 ~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~  316 (520)
T 2z7x_B          238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVH  316 (520)
T ss_dssp             HHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred             HHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccc
Confidence                      55555566666655555555     5566666666666666 2222344333   557777777777653


Q ss_pred             cCCccccCCCCCceeecCCCcccc-cccccccccccccccCCCCcccC--CCCCccCccccceEEEcccccccccCc-cc
Q 046544          249 SIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTG--PLPLEIGNLKVLIGIDFSMNNFSSVIP-TE  324 (646)
Q Consensus       249 ~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~  324 (646)
                      ..  .+..+++|++|++++|.++. +|..+..+++|+.|++++|.+++  ..|..++.+++|+.|++++|.+++..| ..
T Consensus       317 ~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~  394 (520)
T 2z7x_B          317 ML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD  394 (520)
T ss_dssp             CC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS
T ss_pred             cc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch
Confidence            22  13688999999999999996 68889999999999999999986  456779999999999999999998444 46


Q ss_pred             cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC-CCCCCCCc
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR-GGSFGNFA  403 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~~~  403 (646)
                      |..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|++++|++++.++. ...++.++
T Consensus       395 ~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~  471 (520)
T 2z7x_B          395 CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQ  471 (520)
T ss_dssp             CCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCccc
Confidence            89999999999999999888887765  79999999999999 7888888999999999999999964444 45678899


Q ss_pred             cccccCCccccCCCCcc
Q 046544          404 AESFEGNELLCGSPTLQ  420 (646)
Q Consensus       404 ~~~~~~N~~~c~~~~~~  420 (646)
                      .+++++|++.|+|+..+
T Consensus       472 ~L~l~~N~~~c~c~~~~  488 (520)
T 2z7x_B          472 KIWLHTNPWDCSCPRID  488 (520)
T ss_dssp             EEECCSSCBCCCHHHHH
T ss_pred             EEECcCCCCcccCCchH
Confidence            99999999999887543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.3e-45  Score=394.18  Aligned_cols=374  Identities=22%  Similarity=0.224  Sum_probs=225.6

Q ss_pred             EEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccc-cCCccccCCCCCcEEEccc
Q 046544           14 ELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSG-TIPRFIFNASKLSILELSQ   92 (646)
Q Consensus        14 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~   92 (646)
                      .++.++++++. +|. +  .++|++|+|++|.|++..+. .+..+++|++|+|++|.+.+ ..+..|.++++|++|+|++
T Consensus        14 ~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45555555553 222 1  14555555555555543222 11235555555555555542 2344555555666666666


Q ss_pred             CccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecc
Q 046544           93 NSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC  172 (646)
Q Consensus        93 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n  172 (646)
                      |+++++.|..|+++++|++|+|++|+++...+   ....|.++++|++|++++|++.++.+...+..+ ++|++|++++|
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l-~~L~~L~L~~n  164 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVL---SGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM-RRFHVLDLTFN  164 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHH---HSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGC-TTCCEEECTTC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCcccc---CcccccCcccCCEEECCCCccCccCcccccCCC-CcccEEeCCCC
Confidence            66555555555556666666666665544210   011255555666666666665555443333332 35666666666


Q ss_pred             cccccCCcccccC--CCCCEEEccCCccccccCccc--------cCCCCCCeEEeecccccCcCchhhcCC---CCCcEE
Q 046544          173 NVSGGIPEEITNL--TNSITIDLGGNKLNGSIPITL--------SKLQKLQGLGLDDNKLEGSIPDSICRL---TELYEL  239 (646)
Q Consensus       173 ~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~--------~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L  239 (646)
                      .+++..|..+..+  .+++.|++++|.+.+..+..+        ..+++|++|++++|++.+..|..+...   ++|+.|
T Consensus       165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L  244 (455)
T 3v47_A          165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL  244 (455)
T ss_dssp             CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred             cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence            6666666666555  567777777777766554432        355677888888888777777766554   677888


Q ss_pred             EecCCccccc----------CCccccCC--CCCceeecCCCccccc-ccccccccccccccCCCCcccCCCCCccCcccc
Q 046544          240 ELGGNKLFGS----------IPACFSNL--ASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKV  306 (646)
Q Consensus       240 ~L~~N~i~~~----------~~~~~~~l--~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  306 (646)
                      ++++|.+.+.          .+..+.++  ++|+.|++++|.++.+ |..+..+++|+.|++++|.+++..|..|..+++
T Consensus       245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  324 (455)
T 3v47_A          245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH  324 (455)
T ss_dssp             ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence            8887765432          12222222  4677777777776644 445666667777777777776666666777777


Q ss_pred             ceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcC
Q 046544          307 LIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF  386 (646)
Q Consensus       307 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  386 (646)
                      |+.|++++|.+++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|++++
T Consensus       325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  404 (455)
T 3v47_A          325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT  404 (455)
T ss_dssp             CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence            77777777777766667777777777777777777766677777777777777777777765555667777777777777


Q ss_pred             CcceeeccCC
Q 046544          387 NKLEGEIPRG  396 (646)
Q Consensus       387 N~l~~~~p~~  396 (646)
                      |+++|.+|..
T Consensus       405 N~l~~~~~~~  414 (455)
T 3v47_A          405 NPWDCSCPRI  414 (455)
T ss_dssp             SCBCCCTTTT
T ss_pred             CCcccCCCcc
Confidence            7777766643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=7e-45  Score=402.89  Aligned_cols=383  Identities=22%  Similarity=0.233  Sum_probs=306.0

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCccccc-CCccccC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGT-IPRFIFN   81 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~   81 (646)
                      |..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|.+++.++. .+..+++|++|+|++|++++. .|..+.+
T Consensus        43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~  121 (549)
T 2z81_A           43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-WFGPLSSLKYLNLMGNPYQTLGVTSLFPN  121 (549)
T ss_dssp             SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-HHTTCTTCCEEECTTCCCSSSCSSCSCTT
T ss_pred             hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-HhccCCCCcEEECCCCcccccchhhhhhc
Confidence            67799999999999999999999999999999999999999999876554 123589999999999999863 5678999


Q ss_pred             CCCCcEEEcccCc-cccccCccccCcCCCCEEEccCCCCCCCCCcc-cccc------------------cCCCCCCCCEE
Q 046544           82 ASKLSILELSQNS-FSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL-SFLS------------------SLSNCKSLTFI  141 (646)
Q Consensus        82 l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~------------------~l~~l~~L~~L  141 (646)
                      +++|++|++++|. +..+.+..|.++++|++|++++|+++...+.. ....                  .+..+++|++|
T Consensus       122 l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  201 (549)
T 2z81_A          122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL  201 (549)
T ss_dssp             CTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEE
T ss_pred             cCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEE
Confidence            9999999999998 56666678999999999999999988643321 0000                  01347889999


Q ss_pred             ECCCCCCCCcCCc-chhcccccc----------------------------CcEEEeecccccccC--------------
Q 046544          142 HLSDNPLDGILSK-TSIGNLSHS----------------------------LKDFYMSNCNVSGGI--------------  178 (646)
Q Consensus       142 ~Ls~N~l~~~~~~-~~~~~~~~~----------------------------L~~L~L~~n~l~~~~--------------  178 (646)
                      ++++|++++.... ..+.....+                            |+.+++++|.+.+..              
T Consensus       202 ~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~  281 (549)
T 2z81_A          202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG  281 (549)
T ss_dssp             EEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT
T ss_pred             EccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhc
Confidence            9999998875211 111111233                            444444444443310              


Q ss_pred             ---------------------CcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCch---hhcCCC
Q 046544          179 ---------------------PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD---SICRLT  234 (646)
Q Consensus       179 ---------------------p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~  234 (646)
                                           +..+...++|+.|++++|++..++...+.++++|++|++++|++.+..|.   .+..++
T Consensus       282 ~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~  361 (549)
T 2z81_A          282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP  361 (549)
T ss_dssp             TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSST
T ss_pred             ccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccc
Confidence                                 01122345788899999998844334446899999999999999987653   378899


Q ss_pred             CCcEEEecCCcccccCC--ccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEc
Q 046544          235 ELYELELGGNKLFGSIP--ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDF  312 (646)
Q Consensus       235 ~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  312 (646)
                      +|++|+|++|++++..+  ..+..+++|++|++++|+++.+|..+..+++|++|++++|.+++ +|..+  .++|+.|++
T Consensus       362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~L  438 (549)
T 2z81_A          362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDV  438 (549)
T ss_dssp             TCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEEC
T ss_pred             cCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchh--cCCceEEEC
Confidence            99999999999986643  56899999999999999999999999999999999999999985 34333  268999999


Q ss_pred             ccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          313 SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       313 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      ++|++++..    ..+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++..|..+..+++|+.|++++|+++|.
T Consensus       439 s~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          439 SNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            999999753    57899999999999999 5665 46799999999999999999999999999999999999999999


Q ss_pred             ccC
Q 046544          393 IPR  395 (646)
Q Consensus       393 ~p~  395 (646)
                      +|.
T Consensus       513 ~~~  515 (549)
T 2z81_A          513 CPR  515 (549)
T ss_dssp             HHH
T ss_pred             Ccc
Confidence            884

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3e-44  Score=398.52  Aligned_cols=182  Identities=22%  Similarity=0.289  Sum_probs=153.8

Q ss_pred             CCCcEEEecCCcccccCCccccCCCCCceeecCCCcccc-cccccccccccccccCCCCcccCCC--CCccCccccceEE
Q 046544          234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IPLTFWNLKDILQLNFSSNFLTGPL--PLEIGNLKVLIGI  310 (646)
Q Consensus       234 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L  310 (646)
                      .+|++|++++|.+....  .+..+++|++|++++|.++. +|..+..+++|+.|++++|.+++..  |..+..+++|+.|
T Consensus       331 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L  408 (562)
T 3a79_B          331 MNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL  408 (562)
T ss_dssp             CCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE
T ss_pred             CcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE
Confidence            45778888888775322  23788999999999999996 6788999999999999999998743  4678999999999


Q ss_pred             Ecccccccc-cCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcc
Q 046544          311 DFSMNNFSS-VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL  389 (646)
Q Consensus       311 ~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  389 (646)
                      ++++|.+++ +.+..|..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++
T Consensus       409 ~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l  485 (562)
T 3a79_B          409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL  485 (562)
T ss_dssp             ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCC
T ss_pred             ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCC
Confidence            999999998 5555689999999999999999887776665  79999999999999 6777777999999999999999


Q ss_pred             eeeccC-CCCCCCCccccccCCccccCCCCcc
Q 046544          390 EGEIPR-GGSFGNFAAESFEGNELLCGSPTLQ  420 (646)
Q Consensus       390 ~~~~p~-~~~~~~~~~~~~~~N~~~c~~~~~~  420 (646)
                      ++.++. ...++.++.+++++|||.|+|+..+
T Consensus       486 ~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  517 (562)
T 3a79_B          486 KSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR  517 (562)
T ss_dssp             CCCCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred             CCCCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence            965444 4568889999999999999887543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.7e-44  Score=386.78  Aligned_cols=372  Identities=20%  Similarity=0.169  Sum_probs=324.1

Q ss_pred             CCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccc-cccCccccCcCCCCEEEc
Q 046544           36 LKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFS-GFIPNTFGNLRNLEWLNL  114 (646)
Q Consensus        36 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L  114 (646)
                      -+.++.+++.++..+. +    .++|++|+|++|.|++..|..|.++++|++|+|++|.+. .+.+..|.++++|++|+|
T Consensus        12 ~~~~~c~~~~l~~lp~-l----~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L   86 (455)
T 3v47_A           12 GYNAICINRGLHQVPE-L----PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL   86 (455)
T ss_dssp             TTEEECCSSCCSSCCC-C----CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred             ccccCcCCCCcccCCC-C----CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence            3568888998876443 2    478999999999999999999999999999999999997 456788999999999999


Q ss_pred             cCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcc-hhccccccCcEEEeecccccccCCcc-cccCCCCCEEE
Q 046544          115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKT-SIGNLSHSLKDFYMSNCNVSGGIPEE-ITNLTNSITID  192 (646)
Q Consensus       115 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~~~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~  192 (646)
                      ++|+++...+     ..|+++++|++|++++|.+++..+.. .+.. .++|++|+|++|.+++..|.. +..+++|++|+
T Consensus        87 s~n~l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  160 (455)
T 3v47_A           87 DYNQFLQLET-----GAFNGLANLEVLTLTQCNLDGAVLSGNFFKP-LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD  160 (455)
T ss_dssp             TTCTTCEECT-----TTTTTCTTCCEEECTTSCCBTHHHHSSTTTT-CTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEE
T ss_pred             CCCccCccCh-----hhccCcccCCEEeCCCCCCCccccCcccccC-cccCCEEECCCCccCccCcccccCCCCcccEEe
Confidence            9999987643     46899999999999999998742222 2333 358999999999999988876 89999999999


Q ss_pred             ccCCccccccCccccCC--CCCCeEEeecccccCcCchh--------hcCCCCCcEEEecCCcccccCCccccCC---CC
Q 046544          193 LGGNKLNGSIPITLSKL--QKLQGLGLDDNKLEGSIPDS--------ICRLTELYELELGGNKLFGSIPACFSNL---AS  259 (646)
Q Consensus       193 L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~  259 (646)
                      +++|++.+..|..+..+  .+|+.|++++|.+.+..+..        +..+++|++|++++|++.+..|..+...   ++
T Consensus       161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~  240 (455)
T 3v47_A          161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK  240 (455)
T ss_dssp             CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred             CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence            99999999999988877  78999999999999766554        3367899999999999998888777655   89


Q ss_pred             CceeecCCCcccccc-----------ccccc--ccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccC
Q 046544          260 LRILSLSSNELTSIP-----------LTFWN--LKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG  326 (646)
Q Consensus       260 L~~L~L~~N~l~~lp-----------~~~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  326 (646)
                      |+.|++++|.+....           ..+..  .++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..|+
T Consensus       241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  320 (455)
T 3v47_A          241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW  320 (455)
T ss_dssp             EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             eeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhc
Confidence            999999998655321           11222  36899999999999999999999999999999999999999999999


Q ss_pred             CCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC-CCCCCCccc
Q 046544          327 GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAE  405 (646)
Q Consensus       327 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~  405 (646)
                      ++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|++++|++++.++.. ..++.++.+
T Consensus       321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  400 (455)
T 3v47_A          321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKI  400 (455)
T ss_dssp             TCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEE
Confidence            9999999999999999888999999999999999999999998999999999999999999999866654 568899999


Q ss_pred             cccCCccccCCCC
Q 046544          406 SFEGNELLCGSPT  418 (646)
Q Consensus       406 ~~~~N~~~c~~~~  418 (646)
                      ++++|++.|+||.
T Consensus       401 ~l~~N~l~~~~~~  413 (455)
T 3v47_A          401 WLHTNPWDCSCPR  413 (455)
T ss_dssp             ECCSSCBCCCTTT
T ss_pred             EccCCCcccCCCc
Confidence            9999999999984

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=394.02  Aligned_cols=380  Identities=20%  Similarity=0.195  Sum_probs=313.1

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccc-cCCccccC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSG-TIPRFIFN   81 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~   81 (646)
                      |..|+.+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++.+..    .+++|++|+|++|++++ ..|..|++
T Consensus        38 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~----~l~~L~~L~L~~N~l~~~~~p~~~~~  113 (520)
T 2z7x_B           38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH----PTVNLKHLDLSFNAFDALPICKEFGN  113 (520)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC----CCCCCSEEECCSSCCSSCCCCGGGGG
T ss_pred             hhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc----ccCCccEEeccCCccccccchhhhcc
Confidence            35799999999999999999999999999999999999999999864433    58999999999999997 47899999


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCC--CEEEccCCCC--CCCCCc-ccc--------------------cccCCCCC
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNL--EWLNLRDNYL--TSSTPE-LSF--------------------LSSLSNCK  136 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~-~~~--------------------~~~l~~l~  136 (646)
                      +++|++|+|++|.|++   ..|..+++|  ++|+|++|.+  ....+. +..                    ...+.+++
T Consensus       114 l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~  190 (520)
T 2z7x_B          114 MSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA  190 (520)
T ss_dssp             CTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCS
T ss_pred             CCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhccc
Confidence            9999999999999986   468888888  9999999999  433221 110                    01233456


Q ss_pred             CCCEEECCCCC------------------------------CCCcCCcchhc-cccccCcEEEeecccccccCCccc---
Q 046544          137 SLTFIHLSDNP------------------------------LDGILSKTSIG-NLSHSLKDFYMSNCNVSGGIPEEI---  182 (646)
Q Consensus       137 ~L~~L~Ls~N~------------------------------l~~~~~~~~~~-~~~~~L~~L~L~~n~l~~~~p~~~---  182 (646)
                      +|+.|++++|.                              +.+........ ...++|++|++++|++++.+|..+   
T Consensus       191 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~  270 (520)
T 2z7x_B          191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY  270 (520)
T ss_dssp             EEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC
T ss_pred             ceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc
Confidence            66666666664                              21100000000 001379999999999998899988   


Q ss_pred             --ccCCCCCEEEccCCccccccCccccCC---CCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCC
Q 046544          183 --TNLTNSITIDLGGNKLNGSIPITLSKL---QKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNL  257 (646)
Q Consensus       183 --~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  257 (646)
                        ..+++|+.+++++|.+ ..++..+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++..|..++++
T Consensus       271 ~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  347 (520)
T 2z7x_B          271 SGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHL  347 (520)
T ss_dssp             CSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCC
T ss_pred             ccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccC
Confidence              9999999999999999 3433555554   68999999999987533  12688999999999999999899999999


Q ss_pred             CCCceeecCCCccccc---ccccccccccccccCCCCcccCCCCC-ccCccccceEEEcccccccccCccccCCCCCCCE
Q 046544          258 ASLRILSLSSNELTSI---PLTFWNLKDILQLNFSSNFLTGPLPL-EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEY  333 (646)
Q Consensus       258 ~~L~~L~L~~N~l~~l---p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  333 (646)
                      ++|++|++++|+++.+   |..+..+++|+.|++++|.+++.+|. .+..+++|+.|++++|.+++..|..+.  ++|+.
T Consensus       348 ~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~  425 (520)
T 2z7x_B          348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKV  425 (520)
T ss_dssp             SSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCE
T ss_pred             CCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCE
Confidence            9999999999999964   46788999999999999999985554 588999999999999999988887765  79999


Q ss_pred             EEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC
Q 046544          334 LFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       334 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      |++++|+++ .+|..+..+++|++|+|++|+++...+..+..+++|++|++++|+++|.++.
T Consensus       426 L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             EECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            999999999 6777777999999999999999954444499999999999999999998774

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=385.76  Aligned_cols=374  Identities=20%  Similarity=0.173  Sum_probs=259.0

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      ||..+.  ++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+. .+..+++|++|+|++|+|+. +|..  .
T Consensus        46 ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~--~  119 (562)
T 3a79_B           46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH-VFLFNQDLEYLDVSHNRLQN-ISCC--P  119 (562)
T ss_dssp             CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT-TTTTCTTCCEEECTTSCCCE-ECSC--C
T ss_pred             CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH-HhCCCCCCCEEECCCCcCCc-cCcc--c
Confidence            455443  6677777777777766666777777777777777777654333 22346777777777777773 4433  6


Q ss_pred             CCCCcEEEcccCcccccc-CccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCC--CEEECCCCCC--CCcCCcch
Q 046544           82 ASKLSILELSQNSFSGFI-PNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL--TFIHLSDNPL--DGILSKTS  156 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~~  156 (646)
                      +++|++|+|++|+++++. |..|+++++|++|+|++|+++..        .+.++++|  ++|++++|.+  ++..+.. 
T Consensus       120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--------~~~~l~~L~L~~L~L~~n~l~~~~~~~~~-  190 (562)
T 3a79_B          120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--------DLLPVAHLHLSCILLDLVSYHIKGGETES-  190 (562)
T ss_dssp             CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--------TTGGGTTSCEEEEEEEESSCCCCSSSCCE-
T ss_pred             cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC--------chhhhhhceeeEEEeecccccccccCccc-
Confidence            677777777777777643 46677777777777777776642        12333333  7777777766  3332211 


Q ss_pred             hccc-------------------------cccCcEEEeeccc----------------------------cccc----CC
Q 046544          157 IGNL-------------------------SHSLKDFYMSNCN----------------------------VSGG----IP  179 (646)
Q Consensus       157 ~~~~-------------------------~~~L~~L~L~~n~----------------------------l~~~----~p  179 (646)
                      +..+                         .++|+.+++++|.                            +++.    .+
T Consensus       191 l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~  270 (562)
T 3a79_B          191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF  270 (562)
T ss_dssp             EEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHH
T ss_pred             ccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHH
Confidence            1110                         0122222222221                            0000    00


Q ss_pred             cccccCCCCCEEEccCCccccccCccc-----cCC--------------------------CCCCeEEeecccccCcCch
Q 046544          180 EEITNLTNSITIDLGGNKLNGSIPITL-----SKL--------------------------QKLQGLGLDDNKLEGSIPD  228 (646)
Q Consensus       180 ~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l--------------------------~~L~~L~L~~N~l~~~~~~  228 (646)
                      .. ...++|++|++++|++.+.+|..+     ..+                          .+|++|++++|.+....  
T Consensus       271 ~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--  347 (562)
T 3a79_B          271 QF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--  347 (562)
T ss_dssp             HH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--
T ss_pred             Hh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--
Confidence            00 001245555555555554444443     222                          45777888888775322  


Q ss_pred             hhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccc---cccccccccccccCCCCcccCCC-CCccCcc
Q 046544          229 SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP---LTFWNLKDILQLNFSSNFLTGPL-PLEIGNL  304 (646)
Q Consensus       229 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp---~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l  304 (646)
                      .+..+++|++|++++|++++..|..|.++++|++|++++|+++.+|   ..+..+++|+.|++++|.+++.+ +..+..+
T Consensus       348 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l  427 (562)
T 3a79_B          348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA  427 (562)
T ss_dssp             CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred             CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence            1268899999999999999989999999999999999999999765   46889999999999999999844 4568899


Q ss_pred             ccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeC
Q 046544          305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNL  384 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  384 (646)
                      ++|+.|++++|.+++..|..+.  ++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|+.|++
T Consensus       428 ~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l  504 (562)
T 3a79_B          428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL  504 (562)
T ss_dssp             TTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEEC
T ss_pred             ccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEe
Confidence            9999999999999987776654  79999999999999 56766679999999999999999544444999999999999


Q ss_pred             cCCcceeeccCC
Q 046544          385 SFNKLEGEIPRG  396 (646)
Q Consensus       385 ~~N~l~~~~p~~  396 (646)
                      ++|+++|.+|..
T Consensus       505 ~~N~~~c~c~~~  516 (562)
T 3a79_B          505 HDNPWDCTCPGI  516 (562)
T ss_dssp             CSCCBCCCHHHH
T ss_pred             cCCCcCCCcchH
Confidence            999999988754

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=378.20  Aligned_cols=347  Identities=22%  Similarity=0.218  Sum_probs=270.8

Q ss_pred             CEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccC
Q 046544           37 KLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD  116 (646)
Q Consensus        37 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  116 (646)
                      +.++.++++++..+..+    .+++++|+|++|+|++..+..|.++++|++|+|++|.|+++.|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~~ip~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFVAVPEGI----PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCSSCCSCC----CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCcCCCCC----CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            46677777776544333    34778888888888877788888888888888888888888888888888888888888


Q ss_pred             CCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCC
Q 046544          117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGN  196 (646)
Q Consensus       117 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  196 (646)
                      |+++.+++.     .|.++++|++|+|++|++.++                          .|..|..+++|+.|++++|
T Consensus        90 n~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~--------------------------~~~~~~~l~~L~~L~l~~n  138 (477)
T 2id5_A           90 NRLKLIPLG-----VFTGLSNLTKLDISENKIVIL--------------------------LDYMFQDLYNLKSLEVGDN  138 (477)
T ss_dssp             SCCCSCCTT-----SSTTCTTCCEEECTTSCCCEE--------------------------CTTTTTTCTTCCEEEECCT
T ss_pred             CcCCccCcc-----cccCCCCCCEEECCCCccccC--------------------------ChhHccccccCCEEECCCC
Confidence            888877543     367778888877777776543                          4556677778888888888


Q ss_pred             ccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccc-cccc
Q 046544          197 KLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPL  275 (646)
Q Consensus       197 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~  275 (646)
                      ++.+..+..|.++++|++|++++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+. .+|.
T Consensus       139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  218 (477)
T 2id5_A          139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP  218 (477)
T ss_dssp             TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred             ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence            887777777888888888888888888777777888888888888888888777777888888888888887544 6666


Q ss_pred             ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCC
Q 046544          276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISL  355 (646)
Q Consensus       276 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  355 (646)
                      ......+|+.|++++|.+++..+..+..+++|+.|++++|.++++.+..|.++++|++|+|++|++++..|..|..+++|
T Consensus       219 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (477)
T 2id5_A          219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL  298 (477)
T ss_dssp             TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred             ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence            66666688888888888876555678888888888888888888888888888888888888888888888888888888


Q ss_pred             CEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC
Q 046544          356 KFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       356 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      +.|+|++|++++..+..|..+++|++|+|++|++.|.++....+.......+.++...|..|.
T Consensus       299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            999999888887777778888888899999998888766543333444556777888886653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-41  Score=382.47  Aligned_cols=389  Identities=22%  Similarity=0.203  Sum_probs=317.8

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNA   82 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (646)
                      |.+|+++++|++|||++|+|+++.|.+|.++++|++|+|++|+|++.++. .+..+++|++|+|++|+|++..+..|+++
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~-~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L  147 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-AFSGLSSLQKLVAVETNLASLENFPIGHL  147 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG-GGTTCTTCCEEECTTSCCCCSTTCCCTTC
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH-HhcCCCCCCEEECCCCcCCCCChhhhhcC
Confidence            35799999999999999999999999999999999999999999875443 34469999999999999998888899999


Q ss_pred             CCCcEEEcccCccccc-cCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCC-CCCEEECCCCCCCCcCCcch----
Q 046544           83 SKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCK-SLTFIHLSDNPLDGILSKTS----  156 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~----  156 (646)
                      ++|++|+|++|.++++ .|..++.+++|++|+|++|+|+.+++..  ...+.+++ .+..++++.|.+..+.+..+    
T Consensus       148 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~  225 (635)
T 4g8a_A          148 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD--LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR  225 (635)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG--GHHHHTCTTCCCEEECTTCCCCEECTTTTTTCE
T ss_pred             cccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc--ccchhhhhhhhhhhhcccCcccccCcccccchh
Confidence            9999999999999865 4778899999999999999998765431  01111111 11233333333322110000    


Q ss_pred             --------------------------------------------------------------------------------
Q 046544          157 --------------------------------------------------------------------------------  156 (646)
Q Consensus       157 --------------------------------------------------------------------------------  156 (646)
                                                                                                      
T Consensus       226 ~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~  305 (635)
T 4g8a_A          226 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCL  305 (635)
T ss_dssp             EEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGG
T ss_pred             hhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhh
Confidence                                                                                            


Q ss_pred             -----------------hccccccCcEEEeecccccccCCc-------------------ccccCCCCCEEEccCCcccc
Q 046544          157 -----------------IGNLSHSLKDFYMSNCNVSGGIPE-------------------EITNLTNSITIDLGGNKLNG  200 (646)
Q Consensus       157 -----------------~~~~~~~L~~L~L~~n~l~~~~p~-------------------~~~~l~~L~~L~L~~N~l~~  200 (646)
                                       .......++.|++.+|.+.+..+.                   ....+++|+.|++++|.+..
T Consensus       306 ~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~  385 (635)
T 4g8a_A          306 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF  385 (635)
T ss_dssp             TTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBE
T ss_pred             cccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccc
Confidence                             000112466777777766544332                   23457899999999999864


Q ss_pred             --ccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCC-ccccCCCCCceeecCCCccccc-ccc
Q 046544          201 --SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP-ACFSNLASLRILSLSSNELTSI-PLT  276 (646)
Q Consensus       201 --~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~  276 (646)
                        ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|......+ ..|.++++++.++++.|.++.+ |..
T Consensus       386 ~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~  464 (635)
T 4g8a_A          386 KGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI  464 (635)
T ss_dssp             EEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred             ccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccc
Confidence              45667788899999999999988 456678899999999999998765544 5789999999999999999966 456


Q ss_pred             cccccccccccCCCCcc-cCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCC
Q 046544          277 FWNLKDILQLNFSSNFL-TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISL  355 (646)
Q Consensus       277 ~~~l~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  355 (646)
                      +..++.++.|++++|.+ .+..|..|..+++|+.|+|++|+++++.|..|+++++|++|+|++|+|++..|..|.++++|
T Consensus       465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  544 (635)
T 4g8a_A          465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  544 (635)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred             cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence            77899999999999975 45678899999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEEccCCcCcccCCccccCC-CCCCceeCcCCcceeeccC
Q 046544          356 KFLNLSNNNLSGAIPTSLEKL-SYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       356 ~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~  395 (646)
                      ++|||++|+|++..|..|..+ ++|++|+|++|+++|.+..
T Consensus       545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            999999999999999999998 6899999999999998874

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.1e-41  Score=363.12  Aligned_cols=347  Identities=26%  Similarity=0.397  Sum_probs=271.1

Q ss_pred             CCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcE
Q 046544            8 NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSI   87 (646)
Q Consensus         8 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (646)
                      .++++++|++++|.++.+ | .+..+++|++|+|++|.+++.++   +..+++|++|++++|.+++..+  +..+++|++
T Consensus        44 ~l~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HhccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh---hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            367889999999988753 4 37888999999999999877544   3458899999999999986655  888899999


Q ss_pred             EEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEE
Q 046544           88 LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF  167 (646)
Q Consensus        88 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  167 (646)
                      |++++|.++++.+  +.++++|++|++++|.++.++       .+.++++|++|+++ |.+.++.+   +..+ ++|++|
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-------~~~~l~~L~~L~l~-~~~~~~~~---~~~l-~~L~~L  182 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-------ALSGLTSLQQLSFG-NQVTDLKP---LANL-TTLERL  182 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG-------GGTTCTTCSEEEEE-ESCCCCGG---GTTC-TTCCEE
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh-------hhccCCcccEeecC-CcccCchh---hccC-CCCCEE
Confidence            9999999887644  888999999999999888753       37788889999886 55554432   3332 578888


Q ss_pred             EeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccc
Q 046544          168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLF  247 (646)
Q Consensus       168 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  247 (646)
                      ++++|.+.+.  ..+..+++|++|++++|++.+..|  +..+++|++|++++|++++.  ..+..+++|++|++++|++.
T Consensus       183 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~  256 (466)
T 1o6v_A          183 DISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS  256 (466)
T ss_dssp             ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             ECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc
Confidence            8888888754  457788888888888888876655  66788888888888888753  45778888888888888887


Q ss_pred             ccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCC
Q 046544          248 GSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGG  327 (646)
Q Consensus       248 ~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  327 (646)
                      +..+  +..+++|+.|++++|.++.+|. +..+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..|  ++.
T Consensus       257 ~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~  329 (466)
T 1o6v_A          257 NLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS  329 (466)
T ss_dssp             CCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred             cchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence            6554  7788888888888888887775 7778888888888888876544  7778888888888888887655  677


Q ss_pred             CCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       328 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      +++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++.
T Consensus       330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            88888888888888764  467788888888888888887666  77888888888888888863

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.4e-41  Score=360.68  Aligned_cols=356  Identities=25%  Similarity=0.301  Sum_probs=267.3

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCC-------------CEEECcCCcCcccCCccCcCCCCCCCEEEcc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSML-------------KLLHLQNNSLLGCLSSIADVRLPNLEALLLW   67 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~   67 (646)
                      +||++|+++++|++|++++|++++..|..++++++|             ++|++++|.+++.+. .    .++|++|+++
T Consensus        25 ~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~-~----~~~L~~L~l~   99 (454)
T 1jl5_A           25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE-L----PPHLESLVAS   99 (454)
T ss_dssp             ---------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS-C----CTTCSEEECC
T ss_pred             hCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC-C----cCCCCEEEcc
Confidence            479999999999999999999999999999988865             999999999987433 2    4689999999


Q ss_pred             CCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCC
Q 046544           68 GNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP  147 (646)
Q Consensus        68 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  147 (646)
                      +|++++ +|..   +++|++|++++|+++++.. .   .++|++|++++|+++.++       .|+++++|++|++++|+
T Consensus       100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~~lp-------~~~~l~~L~~L~l~~N~  164 (454)
T 1jl5_A          100 CNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLEKLP-------ELQNSSFLKIIDVDNNS  164 (454)
T ss_dssp             SSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSC
T ss_pred             CCcCCc-cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCCCCc-------ccCCCCCCCEEECCCCc
Confidence            999997 5653   4789999999999996432 1   278999999999998754       37899999999999999


Q ss_pred             CCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCc
Q 046544          148 LDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP  227 (646)
Q Consensus       148 l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  227 (646)
                      +++++..      ..+|++|++++|++++ +| .+..+++|+.|++++|++++. |...   ++|++|++++|.++ .+|
T Consensus       165 l~~lp~~------~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~~---~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          165 LKKLPDL------PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDLP---LSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             CSCCCCC------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCCC---TTCCEEECCSSCCS-SCC
T ss_pred             CcccCCC------cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCCc---CcccEEECcCCcCC-ccc
Confidence            9986532      2489999999999997 45 689999999999999999864 3322   58999999999999 566


Q ss_pred             hhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccc
Q 046544          228 DSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVL  307 (646)
Q Consensus       228 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  307 (646)
                       .|..+++|++|++++|++++ +|..   +++|+.|++++|.++.+|..   .++|+.|++++|.+++. |..   .++|
T Consensus       232 -~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L  299 (454)
T 1jl5_A          232 -ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGL-SEL---PPNL  299 (454)
T ss_dssp             -CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEE-SCC---CTTC
T ss_pred             -ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCcc---cCcCCEEECcCCccCcc-cCc---CCcC
Confidence             48999999999999999986 3433   47899999999999998864   37899999999999862 211   2578


Q ss_pred             eEEEcccccccccCccccCCC-CCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcC
Q 046544          308 IGIDFSMNNFSSVIPTEIGGL-KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF  386 (646)
Q Consensus       308 ~~L~ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  386 (646)
                      +.|++++|.++++.     .+ ++|++|++++|++++ +|..   +++|++|++++|+++ .+|.   .+++|++|++++
T Consensus       300 ~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~  366 (454)
T 1jl5_A          300 YYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEY  366 (454)
T ss_dssp             CEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred             CEEECcCCcCCccc-----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCC
Confidence            88899998888632     23 588899999998885 4543   578889999999888 4565   468888999999


Q ss_pred             Cccee--eccCC-CCC-------------CCCccccccCCcccc
Q 046544          387 NKLEG--EIPRG-GSF-------------GNFAAESFEGNELLC  414 (646)
Q Consensus       387 N~l~~--~~p~~-~~~-------------~~~~~~~~~~N~~~c  414 (646)
                      |++++  .+|.. ..+             .+++.+++++|++.+
T Consensus       367 N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          367 NPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             SCCSSCCCCCTTCCEEECCC------------------------
T ss_pred             CCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence            99888  55544 223             567888888888765

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=358.80  Aligned_cols=349  Identities=23%  Similarity=0.183  Sum_probs=275.6

Q ss_pred             CCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcc
Q 046544           12 LEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELS   91 (646)
Q Consensus        12 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls   91 (646)
                      -+.++.++++++. +|..+.  +++++|+|++|+|++..+. .+..+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCSS-CCSCCC--TTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcCc-CCCCCC--CCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            4688999999984 555543  5899999999999875443 33458999999999999999889999999999999999


Q ss_pred             cCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeec
Q 046544           92 QNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSN  171 (646)
Q Consensus        92 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~  171 (646)
                      +|+++++.+..|.++++|++|+|++|+++..++     ..|.++++|++|++++|.+.++                    
T Consensus        89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-----~~~~~l~~L~~L~l~~n~l~~~--------------------  143 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLD-----YMFQDLYNLKSLEVGDNDLVYI--------------------  143 (477)
T ss_dssp             SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECT-----TTTTTCTTCCEEEECCTTCCEE--------------------
T ss_pred             CCcCCccCcccccCCCCCCEEECCCCccccCCh-----hHccccccCCEEECCCCcccee--------------------
Confidence            999998888889999999999999999987644     3578888888888888877654                    


Q ss_pred             ccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCC
Q 046544          172 CNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIP  251 (646)
Q Consensus       172 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  251 (646)
                            .|..|..+++|+.|++++|++++..+..|.++++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+..|
T Consensus       144 ------~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~  217 (477)
T 2id5_A          144 ------SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT  217 (477)
T ss_dssp             ------CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEEC
T ss_pred             ------ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccC
Confidence                  34556667777777777777776666667777777777777777776666677777777777777777665555


Q ss_pred             ccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCC
Q 046544          252 ACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN  330 (646)
Q Consensus       252 ~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  330 (646)
                      .......+|+.|++++|.++.+|. .+..+++|+.|++++|.+++..+..|..+++|+.|++++|.++++.|..|.++++
T Consensus       218 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  297 (477)
T 2id5_A          218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY  297 (477)
T ss_dssp             TTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred             cccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence            555555577778888887777774 5667778888888888887777778888999999999999999998999999999


Q ss_pred             CCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          331 LEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       331 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      |++|+|++|++++..+..|..+++|+.|+|++|.++..-+ ...-......+.+.++...|..|..
T Consensus       298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR-LLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG-GHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc-hHhHHhhhhccccCccCceeCCchH
Confidence            9999999999998888889999999999999999984322 1111233455677788888877754

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.5e-39  Score=352.11  Aligned_cols=333  Identities=28%  Similarity=0.430  Sum_probs=292.5

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            2 IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         2 ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      +| .+..+++|++|+|++|++++..+  +.++++|++|+|++|.+++..+   +..+++|++|+|++|.+++..+  +..
T Consensus        61 l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~L~~n~l~~~~~--~~~  132 (466)
T 1o6v_A           61 ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNNQITDIDP--LKN  132 (466)
T ss_dssp             CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred             Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh---hcCCCCCCEEECCCCCCCCChH--HcC
Confidence            44 37889999999999999997665  9999999999999999987554   3459999999999999996644  899


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcccc
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS  161 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  161 (646)
                      +++|++|++++|.+.++.  .+.++++|++|+++ |.+...       ..+.++++|++|++++|.+.++..   +.. .
T Consensus       133 l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~-------~~~~~l~~L~~L~l~~n~l~~~~~---l~~-l  198 (466)
T 1o6v_A          133 LTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL-------KPLANLTTLERLDISSNKVSDISV---LAK-L  198 (466)
T ss_dssp             CTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC-------GGGTTCTTCCEEECCSSCCCCCGG---GGG-C
T ss_pred             CCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc-------hhhccCCCCCEEECcCCcCCCChh---hcc-C
Confidence            999999999999999753  59999999999997 555543       238899999999999999988732   333 3


Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      ++|+.|++++|.+.+..|  +..+++|+.|++++|++.+.  ..+..+++|++|++++|.+.+..+  +..+++|++|++
T Consensus       199 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l  272 (466)
T 1o6v_A          199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL  272 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred             CCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEEC
Confidence            589999999999998655  78899999999999999865  468899999999999999997655  899999999999


Q ss_pred             cCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccC
Q 046544          242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI  321 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  321 (646)
                      ++|++++..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|.+++..|  +..+++|+.|++++|.+++. 
T Consensus       273 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-  346 (466)
T 1o6v_A          273 GANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-  346 (466)
T ss_dssp             CSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred             CCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-
Confidence            9999987655  8899999999999999999876 7889999999999999998766  78999999999999999976 


Q ss_pred             ccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCcc
Q 046544          322 PTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTS  372 (646)
Q Consensus       322 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  372 (646)
                       ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++ .|..
T Consensus       347 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          347 -SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             -GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             -hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence             578999999999999999998877  8999999999999999995 4433

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.7e-39  Score=349.37  Aligned_cols=342  Identities=18%  Similarity=0.153  Sum_probs=250.8

Q ss_pred             CccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCC
Q 046544            3 PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNA   82 (646)
Q Consensus         3 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l   82 (646)
                      |.+++++++|++|++++|+++++ | .|..+++|++|+|++|++++. +   ...+++|++|+|++|++++. +  +..+
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            45678899999999999999975 4 799999999999999999874 2   34589999999999999975 3  8899


Q ss_pred             CCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccc
Q 046544           83 SKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSH  162 (646)
Q Consensus        83 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  162 (646)
                      ++|++|++++|+++++ |  ++.+++|++|++++|+++.++        ++++++|++|++++|+..+..+   +.. .+
T Consensus       106 ~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~--------l~~l~~L~~L~l~~n~~~~~~~---~~~-l~  170 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEID--------VSHNTQLTELDCHLNKKITKLD---VTP-QT  170 (457)
T ss_dssp             TTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCC--------CTTCTTCCEEECTTCSCCCCCC---CTT-CT
T ss_pred             CcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceec--------cccCCcCCEEECCCCCcccccc---ccc-CC
Confidence            9999999999999975 3  899999999999999999852        6789999999999995433222   222 35


Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +|++|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|++|+++
T Consensus       171 ~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~  241 (457)
T 3bz5_A          171 QLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS  241 (457)
T ss_dssp             TCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred             cCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEee
Confidence            899999999999984 4  88899999999999999976   48889999999999999997 55  8899999999999


Q ss_pred             CCcccccCCccccCCCCCceeecCCCccccccc---------ccccccccccccCCCCcccCCCCCc--------cCccc
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPL---------TFWNLKDILQLNFSSNFLTGPLPLE--------IGNLK  305 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~---------~~~~l~~L~~L~l~~N~l~~~~~~~--------~~~l~  305 (646)
                      +|++++..+..   +++|+.|++++|.++.+..         .+..+++|+.|++++|...+.+|..        +.+++
T Consensus       242 ~N~l~~~~~~~---l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~  318 (457)
T 3bz5_A          242 VNPLTELDVST---LSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNP  318 (457)
T ss_dssp             SSCCSCCCCTT---CTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred             CCcCCCcCHHH---CCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcc
Confidence            99999876544   4555555555544332211         1345677777777777765544432        33344


Q ss_pred             cceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCc
Q 046544          306 VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS  385 (646)
Q Consensus       306 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  385 (646)
                      +|+.|++++|++++.   .++.+++|+.|++++|++++        ++.|..|++++|.++|.     ..+..|+.++++
T Consensus       319 ~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~  382 (457)
T 3bz5_A          319 KLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLT  382 (457)
T ss_dssp             TCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCB
T ss_pred             cCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccc
Confidence            555555555555543   14555555555555555543        12334444555555543     123445566666


Q ss_pred             CCcceeeccCC
Q 046544          386 FNKLEGEIPRG  396 (646)
Q Consensus       386 ~N~l~~~~p~~  396 (646)
                      +|+++|.+|..
T Consensus       383 ~N~l~g~ip~~  393 (457)
T 3bz5_A          383 NNSLTIAVSPD  393 (457)
T ss_dssp             TTBEEEECCTT
T ss_pred             cCcEEEEcChh
Confidence            66666666643

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-38  Score=336.40  Aligned_cols=336  Identities=20%  Similarity=0.187  Sum_probs=230.9

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      ++++++|++++|.++...+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|.++.+++.     .|+++++
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~  118 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPL  118 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH-----HhcCCCC
Confidence            45555555555555544444455555555555555555555555555555555555555555554332     3455555


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |++|++++|+++.+++.. +.. .++|++|++++|.+++..|..+..+++|++|++++|++++.   .+..+++|+.|++
T Consensus       119 L~~L~L~~n~l~~l~~~~-~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l  193 (390)
T 3o6n_A          119 LTVLVLERNDLSSLPRGI-FHN-TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV  193 (390)
T ss_dssp             CCEEECCSSCCCCCCTTT-TTT-CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEEC
T ss_pred             CCEEECCCCccCcCCHHH-hcC-CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeec
Confidence            555555555555443221 111 23455555555555555667777888888888888888754   2556678888888


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      ++|.+++.     ...++|++|++++|.+......   ..++|+.|++++|.++..+ .+..+++|+.|++++|.+++..
T Consensus       194 ~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~  264 (390)
T 3o6n_A          194 SYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIM  264 (390)
T ss_dssp             CSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEE
T ss_pred             cccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcC
Confidence            88887742     2345788888888888755332   2468888888888888764 6777888888888888888877


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCC
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS  377 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  377 (646)
                      |..|..+++|+.|++++|++++. |..+..+++|++|++++|+++ .+|..+..+++|+.|+|++|+++.. |  +..++
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~  339 (390)
T 3o6n_A          265 YHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHH  339 (390)
T ss_dssp             SGGGTTCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTC
T ss_pred             hhHccccccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhc
Confidence            88888888999999999988864 566678889999999999988 5666788888999999999998854 3  67788


Q ss_pred             CCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC
Q 046544          378 YLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       378 ~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      +|+.|++++|++++..... .+..+....+.+++..|.++.
T Consensus       340 ~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~~  379 (390)
T 3o6n_A          340 TLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDY  379 (390)
T ss_dssp             CCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCTTC
T ss_pred             cCCEEEcCCCCccchhHHH-HHHHHHhhcccccCceecccc
Confidence            8999999999998754332 244555566777887887654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2e-38  Score=335.45  Aligned_cols=314  Identities=18%  Similarity=0.219  Sum_probs=278.5

Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNL  160 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  160 (646)
                      .+++++.|++++|.+..+++..|..+++|++|+|++|.++.+++     ..|.++++|++|++++|.++++++.. +.. 
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~-  115 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT-----YAFAYAHTIQKLYMGFNAIRYLPPHV-FQN-  115 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECT-----TTTTTCTTCCEEECCSSCCCCCCTTT-TTT-
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccCh-----hhccCCCCcCEEECCCCCCCcCCHHH-hcC-
Confidence            46889999999999998888889999999999999999988754     35899999999999999999886543 333 


Q ss_pred             cccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          161 SHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       161 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      .++|++|++++|.++...+..|..+++|++|++++|++.+..|..|.++++|++|++++|++++.   .+..+++|+.|+
T Consensus       116 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~  192 (390)
T 3o6n_A          116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHAN  192 (390)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEE
T ss_pred             CCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceee
Confidence            35899999999999987777789999999999999999999999999999999999999999965   366789999999


Q ss_pred             ecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEccccccccc
Q 046544          241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       241 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  320 (646)
                      +++|.+.+.     ...++|+.|++++|.++.+|...  .++|+.|++++|.+++.  ..+..+++|+.|++++|.+++.
T Consensus       193 l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~  263 (390)
T 3o6n_A          193 VSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKI  263 (390)
T ss_dssp             CCSSCCSEE-----ECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEE
T ss_pred             ccccccccc-----CCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCc
Confidence            999998753     34468999999999999987654  47899999999999864  5789999999999999999999


Q ss_pred             CccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCC
Q 046544          321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFG  400 (646)
Q Consensus       321 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  400 (646)
                      .|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+++.. | ...+.
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~-~~~~~  339 (390)
T 3o6n_A          264 MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K-LSTHH  339 (390)
T ss_dssp             ESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C-CCTTC
T ss_pred             ChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C-chhhc
Confidence            99999999999999999999984 6777889999999999999998 6777889999999999999999875 3 45578


Q ss_pred             CCccccccCCccccCCC
Q 046544          401 NFAAESFEGNELLCGSP  417 (646)
Q Consensus       401 ~~~~~~~~~N~~~c~~~  417 (646)
                      .++.+++++|+|.|++.
T Consensus       340 ~L~~L~l~~N~~~~~~~  356 (390)
T 3o6n_A          340 TLKNLTLSHNDWDCNSL  356 (390)
T ss_dssp             CCSEEECCSSCEEHHHH
T ss_pred             cCCEEEcCCCCccchhH
Confidence            99999999999999653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.8e-38  Score=338.51  Aligned_cols=348  Identities=27%  Similarity=0.278  Sum_probs=266.7

Q ss_pred             CCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCc-cCcCCCCC-------------CCEEEccCCcccc
Q 046544            8 NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSS-IADVRLPN-------------LEALLLWGNNFSG   73 (646)
Q Consensus         8 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~-------------L~~L~L~~N~l~~   73 (646)
                      +.+.|++|++++|++ +.+|.+|+++++|++|++++|.+++.++. +..  +.+             +++|++++|.+++
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~--l~~L~~l~l~~c~~~~l~~L~l~~~~l~~   85 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGE--QREMAVSRLRDCLDRQAHELELNNLGLSS   85 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCC--CHHHHHHHHHHHHHHTCSEEECTTSCCSC
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCccccc--chhcchhhhhhhhccCCCEEEecCCcccc
Confidence            468999999999999 68899999999999999999999876655 433  544             5999999999996


Q ss_pred             cCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCC
Q 046544           74 TIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILS  153 (646)
Q Consensus        74 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  153 (646)
                       +|..   .++|++|++++|.++++ |..   +++|++|++++|+++.++..         .++|++|++++|++++++ 
T Consensus        86 -lp~~---~~~L~~L~l~~n~l~~l-p~~---~~~L~~L~l~~n~l~~l~~~---------~~~L~~L~L~~n~l~~lp-  147 (454)
T 1jl5_A           86 -LPEL---PPHLESLVASCNSLTEL-PEL---PQSLKSLLVDNNNLKALSDL---------PPLLEYLGVSNNQLEKLP-  147 (454)
T ss_dssp             -CCSC---CTTCSEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSCCCSC---------CTTCCEEECCSSCCSSCC-
T ss_pred             -CCCC---cCCCCEEEccCCcCCcc-ccc---cCCCcEEECCCCccCcccCC---------CCCCCEEECcCCCCCCCc-
Confidence             4442   47899999999999984 543   48999999999999886431         268999999999999875 


Q ss_pred             cchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCC
Q 046544          154 KTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRL  233 (646)
Q Consensus       154 ~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  233 (646)
                        .++.+ ++|++|++++|++++ +|..+   ++|++|++++|++++. | .+.++++|++|++++|++++ +|..   .
T Consensus       148 --~~~~l-~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~-l~~~---~  214 (454)
T 1jl5_A          148 --ELQNS-SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK-LPDL---P  214 (454)
T ss_dssp             --CCTTC-TTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCCC---C
T ss_pred             --ccCCC-CCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc-CCCC---c
Confidence              24443 589999999999997 45543   5899999999999974 5 69999999999999999996 4443   2


Q ss_pred             CCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcc
Q 046544          234 TELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFS  313 (646)
Q Consensus       234 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls  313 (646)
                      ++|++|++++|++. .+| .|+.+++|++|++++|+++.+|..   +++|+.|++++|.+++ +|..   .++|+.|+++
T Consensus       215 ~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls  285 (454)
T 1jl5_A          215 LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVS  285 (454)
T ss_dssp             TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECc
Confidence            58999999999998 556 489999999999999999999864   3789999999999996 4543   3789999999


Q ss_pred             cccccccCccccCCCCCCCEEEccCccCCCcccccccCC-CCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          314 MNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL-ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       314 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      +|.++++. ..   .++|++|++++|++++ ++    .+ ++|+.|++++|++++ +|..   +++|++|++++|++++ 
T Consensus       286 ~N~l~~l~-~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-  351 (454)
T 1jl5_A          286 ENIFSGLS-EL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-  351 (454)
T ss_dssp             SSCCSEES-CC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-
T ss_pred             CCccCccc-Cc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-
Confidence            99999742 11   2689999999999985 33    23 589999999999996 6654   5899999999999996 


Q ss_pred             ccCCCCCCCCccccccCCcccc
Q 046544          393 IPRGGSFGNFAAESFEGNELLC  414 (646)
Q Consensus       393 ~p~~~~~~~~~~~~~~~N~~~c  414 (646)
                      +|.  .+..++.+++++|++.+
T Consensus       352 lp~--~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          352 VPE--LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             CCC--CCTTCCEEECCSSCCSS
T ss_pred             ccc--hhhhccEEECCCCCCCc
Confidence            565  47899999999999877

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.5e-38  Score=350.20  Aligned_cols=337  Identities=20%  Similarity=0.180  Sum_probs=259.2

Q ss_pred             CCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCE
Q 046544           32 NMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEW  111 (646)
Q Consensus        32 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  111 (646)
                      .+++++.|++++|.+...++.. +..+++|++|+|++|.|++..|..|..+++|++|+|++|.|+++.|..|+++++|++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  127 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAAL-LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  127 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHH-HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCceEEEeeCCCCCCcCHHH-HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence            3567788888888776644432 224677888888888887777777788888888888888888777777788888888


Q ss_pred             EEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEE
Q 046544          112 LNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITI  191 (646)
Q Consensus       112 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  191 (646)
                      |+|++|.|+.+++.     .|+++++|++|+|++|.+.+                          ..|..|..+++|++|
T Consensus       128 L~L~~n~l~~l~~~-----~~~~l~~L~~L~Ls~N~l~~--------------------------~~~~~~~~l~~L~~L  176 (597)
T 3oja_B          128 LVLERNDLSSLPRG-----IFHNTPKLTTLSMSNNNLER--------------------------IEDDTFQATTSLQNL  176 (597)
T ss_dssp             EECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCB--------------------------CCTTTTTTCTTCCEE
T ss_pred             EEeeCCCCCCCCHH-----HhccCCCCCEEEeeCCcCCC--------------------------CChhhhhcCCcCcEE
Confidence            88888888776543     25667777777777666654                          345667777888888


Q ss_pred             EccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccc
Q 046544          192 DLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELT  271 (646)
Q Consensus       192 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  271 (646)
                      ++++|.+++..   +..+++|+.|++++|.+++.     ...++|+.|++++|.+....+..+   ++|+.|+|++|.++
T Consensus       177 ~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~  245 (597)
T 3oja_B          177 QLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLT  245 (597)
T ss_dssp             ECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCC
T ss_pred             ECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCC
Confidence            88888877653   45567788888888877742     334578888888888875544332   57888888888888


Q ss_pred             ccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccC
Q 046544          272 SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD  351 (646)
Q Consensus       272 ~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  351 (646)
                      .. ..+..+++|+.|++++|.+++..|..|+.+++|+.|+|++|.++++ |..+..+++|+.|+|++|+++ .+|..+..
T Consensus       246 ~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~  322 (597)
T 3oja_B          246 DT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  322 (597)
T ss_dssp             CC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             CC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCccccc
Confidence            75 4677888899999999999888888999999999999999999974 667788999999999999999 57778899


Q ss_pred             CCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCC
Q 046544          352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      +++|+.|+|++|.+++. |  +..+++|+.|++++|+++|.++.. .+..+....+.+++..|+.+.
T Consensus       323 l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          323 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCCCCCTTC
T ss_pred             CCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHH-HHHHHhhhccccccccCCcch
Confidence            99999999999999854 3  677889999999999999865433 245555566788888897643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.7e-37  Score=333.72  Aligned_cols=344  Identities=22%  Similarity=0.260  Sum_probs=275.7

Q ss_pred             cccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccC
Q 046544           21 KLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIP  100 (646)
Q Consensus        21 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  100 (646)
                      ......+..+.++++|++|+|++|.+++. +.+  ..+++|++|+|++|++++. |  +..+++|++|++++|+|+++ |
T Consensus        29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l--~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~  101 (457)
T 3bz5_A           29 EMQATDTISEEQLATLTSLDCHNSSITDM-TGI--EKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D  101 (457)
T ss_dssp             TCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTG--GGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C
T ss_pred             CcCcccccChhHcCCCCEEEccCCCcccC-hhh--cccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e
Confidence            34445566788999999999999999875 443  3589999999999999975 4  88999999999999999986 3


Q ss_pred             ccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCc
Q 046544          101 NTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE  180 (646)
Q Consensus       101 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~  180 (646)
                        |+++++|++|+|++|+++.++        ++++++|++|++++|+++++.    ++. .++|++|++++|...+.+  
T Consensus       102 --~~~l~~L~~L~L~~N~l~~l~--------~~~l~~L~~L~l~~N~l~~l~----l~~-l~~L~~L~l~~n~~~~~~--  164 (457)
T 3bz5_A          102 --VTPLTKLTYLNCDTNKLTKLD--------VSQNPLLTYLNCARNTLTEID----VSH-NTQLTELDCHLNKKITKL--  164 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSCCC--------CTTCTTCCEEECTTSCCSCCC----CTT-CTTCCEEECTTCSCCCCC--
T ss_pred             --cCCCCcCCEEECCCCcCCeec--------CCCCCcCCEEECCCCccceec----ccc-CCcCCEEECCCCCccccc--
Confidence              899999999999999998852        788999999999999999873    333 357999999999665554  


Q ss_pred             ccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCC
Q 046544          181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL  260 (646)
Q Consensus       181 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  260 (646)
                      .+..+++|+.|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  ++.+++|
T Consensus       165 ~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L  235 (457)
T 3bz5_A          165 DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQL  235 (457)
T ss_dssp             CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred             ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence            488899999999999999975 4  88899999999999999975   38899999999999999997 45  8899999


Q ss_pred             ceeecCCCccccccc-cccccc-------ccccccCCCCcccCCCCCccCccccceEEEcccccccccCcc--------c
Q 046544          261 RILSLSSNELTSIPL-TFWNLK-------DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT--------E  324 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~-~~~~l~-------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~--------~  324 (646)
                      ++|++++|.++.+|. .+..++       +|+.|++++|.+.+.+|  ++.+++|+.|++++|...+.+|.        .
T Consensus       236 ~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~  313 (457)
T 3bz5_A          236 TYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELD  313 (457)
T ss_dssp             SEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCC
T ss_pred             CEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEec
Confidence            999999999998874 233333       45667777777666555  46778888889988876665553        2


Q ss_pred             cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCcc
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAA  404 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~  404 (646)
                      ++++++|++|++++|++++. +  ++.+++|+.|++++|++++        ++.|..|++++|.++|. +   .+..+..
T Consensus       314 l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~---~~~~l~~  378 (457)
T 3bz5_A          314 LSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G---QTITMPK  378 (457)
T ss_dssp             CTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E---EEEECCC
T ss_pred             hhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c---eeeecCc
Confidence            55667788888888888864 2  7788888888888888875        24566777888888875 2   2345566


Q ss_pred             ccccCCcccc
Q 046544          405 ESFEGNELLC  414 (646)
Q Consensus       405 ~~~~~N~~~c  414 (646)
                      ++++.|.+..
T Consensus       379 l~l~~N~l~g  388 (457)
T 3bz5_A          379 ETLTNNSLTI  388 (457)
T ss_dssp             BCCBTTBEEE
T ss_pred             cccccCcEEE
Confidence            6777777553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.7e-38  Score=349.51  Aligned_cols=314  Identities=19%  Similarity=0.215  Sum_probs=277.5

Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCC
Q 046544           57 RLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCK  136 (646)
Q Consensus        57 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~  136 (646)
                      .+++++.|++++|.++..++..|..+++|++|+|++|.|+++.|..|+++++|++|+|++|.|+.+++.     .|++++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~  123 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVP  123 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCT
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCC
Confidence            477899999999999988777888899999999999999988888999999999999999999887653     478888


Q ss_pred             CCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEE
Q 046544          137 SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLG  216 (646)
Q Consensus       137 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  216 (646)
                      +|++|+|++|.++++                          .+..|.++++|++|+|++|.+.+.+|..|.++++|++|+
T Consensus       124 ~L~~L~L~~n~l~~l--------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  177 (597)
T 3oja_B          124 LLTVLVLERNDLSSL--------------------------PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ  177 (597)
T ss_dssp             TCCEEECCSSCCCCC--------------------------CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             CCCEEEeeCCCCCCC--------------------------CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence            888888888877643                          445678899999999999999999999999999999999


Q ss_pred             eecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCC
Q 046544          217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGP  296 (646)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  296 (646)
                      +++|.+++..   +..+++|+.|++++|.+.+.     ...++|+.|++++|.++.+|..+.  ++|+.|++++|.+++ 
T Consensus       178 L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~-  246 (597)
T 3oja_B          178 LSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD-  246 (597)
T ss_dssp             CTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC-
T ss_pred             CcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC-
Confidence            9999999753   56688999999999999753     345689999999999998886553  689999999999986 


Q ss_pred             CCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCC
Q 046544          297 LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKL  376 (646)
Q Consensus       297 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  376 (646)
                       +..+..+++|+.|++++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+
T Consensus       247 -~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l  323 (597)
T 3oja_B          247 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  323 (597)
T ss_dssp             -CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             -ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccC
Confidence             4778999999999999999999999999999999999999999995 6778888999999999999999 678888999


Q ss_pred             CCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCC
Q 046544          377 SYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       377 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      ++|+.|+|++|++++..  ...++.++.+++++|+|.|+|.
T Consensus       324 ~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~~  362 (597)
T 3oja_B          324 DRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL  362 (597)
T ss_dssp             TTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred             CCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChhH
Confidence            99999999999999753  4457899999999999999763

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.3e-37  Score=319.88  Aligned_cols=307  Identities=24%  Similarity=0.351  Sum_probs=211.4

Q ss_pred             ccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCC
Q 046544           30 IFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL  109 (646)
Q Consensus        30 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  109 (646)
                      +..+++|++|++++|.+... +.+.  .+++|++|++++|++++..+  +..+++|++|++++|.++++  +.|.++++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~~~~--~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-QGIE--YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-TTGG--GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccccc-hhhh--hcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence            44566777777777777542 3332  36677777777777764433  66677777777777776653  246677777


Q ss_pred             CEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCC
Q 046544          110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSI  189 (646)
Q Consensus       110 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~  189 (646)
                      ++|++++|.++..++       +.++++|++|++++|....                          . +..+..+++|+
T Consensus       113 ~~L~l~~n~i~~~~~-------~~~l~~L~~L~l~~n~~~~--------------------------~-~~~~~~l~~L~  158 (347)
T 4fmz_A          113 RELYLNEDNISDISP-------LANLTKMYSLNLGANHNLS--------------------------D-LSPLSNMTGLN  158 (347)
T ss_dssp             SEEECTTSCCCCCGG-------GTTCTTCCEEECTTCTTCC--------------------------C-CGGGTTCTTCC
T ss_pred             CEEECcCCcccCchh-------hccCCceeEEECCCCCCcc--------------------------c-ccchhhCCCCc
Confidence            777777777665421       5566666666666664322                          1 22366667777


Q ss_pred             EEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCc
Q 046544          190 TIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNE  269 (646)
Q Consensus       190 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  269 (646)
                      +|++++|.+.+..+  +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.
T Consensus       159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~  232 (347)
T 4fmz_A          159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK  232 (347)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred             EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence            77777777765444  6677777777777777764433  6677777777777777765443  6677777777777777


Q ss_pred             ccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccc
Q 046544          270 LTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSF  349 (646)
Q Consensus       270 l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  349 (646)
                      ++.+|. +..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++.  ..+..+++|++|++++|++++..|..|
T Consensus       233 l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l  307 (347)
T 4fmz_A          233 ITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI  307 (347)
T ss_dssp             CCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred             cCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence            777765 66777777777777777653  3567777888888888888765  457778888888888888887888888


Q ss_pred             cCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcce
Q 046544          350 GDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       350 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  390 (646)
                      ..+++|+.|++++|++++..|  +..+++|++|++++|+++
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            888888888888888886655  778888888888888875

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.6e-37  Score=319.67  Aligned_cols=307  Identities=25%  Similarity=0.366  Sum_probs=244.6

Q ss_pred             ccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCC
Q 046544            6 ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKL   85 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (646)
                      +..+++|++|++++|.++.+ | .+..+++|++|+|++|.+++..+   +..+++|++|+|++|.+++.  ..+..+++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITDI--SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence            45788999999999999854 3 48899999999999999987443   44599999999999999953  368999999


Q ss_pred             cEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCc
Q 046544           86 SILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLK  165 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  165 (646)
                      ++|++++|.+.++.+  +..+++|++|++++|......      ..+.++++|++|++++|.+.++.+            
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~------~~~~~l~~L~~L~l~~~~~~~~~~------------  172 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL------SPLSNMTGLNYLTVTESKVKDVTP------------  172 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC------GGGTTCTTCCEEECCSSCCCCCGG------------
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc------cchhhCCCCcEEEecCCCcCCchh------------
Confidence            999999999997654  999999999999999655432      347889999999999998865421            


Q ss_pred             EEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCc
Q 046544          166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK  245 (646)
Q Consensus       166 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  245 (646)
                                      +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|+
T Consensus       173 ----------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~  232 (347)
T 4fmz_A          173 ----------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK  232 (347)
T ss_dssp             ----------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred             ----------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence                            5566677777777777765443  6677777777777777775444  6777777777777777


Q ss_pred             ccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCcccc
Q 046544          246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI  325 (646)
Q Consensus       246 i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  325 (646)
                      +++..+  +..+++|+.|++++|.++.++ .+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..|..|
T Consensus       233 l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l  307 (347)
T 4fmz_A          233 ITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI  307 (347)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred             cCCCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence            765444  777777888888888777764 566777888888888887754  357788899999999999998888889


Q ss_pred             CCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          326 GGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       326 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      +.+++|++|++++|++++..|  +..+++|++|++++|.|+
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999999999997766  888999999999999886

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.1e-37  Score=316.94  Aligned_cols=256  Identities=32%  Similarity=0.524  Sum_probs=242.9

Q ss_pred             ccCcEEEeecccccc--cCCcccccCCCCCEEEccC-CccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcE
Q 046544          162 HSLKDFYMSNCNVSG--GIPEEITNLTNSITIDLGG-NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE  238 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  238 (646)
                      .+++.|+|++|.+++  .+|..+.++++|++|++++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            468889999999988  8899999999999999995 9999999999999999999999999999999999999999999


Q ss_pred             EEecCCcccccCCccccCCCCCceeecCCCccc-cccccccccc-ccccccCCCCcccCCCCCccCccccceEEEccccc
Q 046544          239 LELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLK-DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNN  316 (646)
Q Consensus       239 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~  316 (646)
                      |+|++|++++..|..|..+++|++|++++|.++ .+|..+..++ .|+.|++++|.+++..|..+..++ |+.|++++|.
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            999999999999999999999999999999999 8899999998 999999999999999999999998 9999999999


Q ss_pred             ccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          317 FSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       317 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      +++..|..|+.+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            9999999999999999999999999976665 889999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccccccCCccccCCCCc
Q 046544          397 GSFGNFAAESFEGNELLCGSPTL  419 (646)
Q Consensus       397 ~~~~~~~~~~~~~N~~~c~~~~~  419 (646)
                      ..++.++.+++.+|++.|+.|..
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTTSS
T ss_pred             ccccccChHHhcCCCCccCCCCC
Confidence            88999999999999999998764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.3e-35  Score=304.75  Aligned_cols=288  Identities=24%  Similarity=0.284  Sum_probs=163.1

Q ss_pred             CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEc
Q 046544           35 MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL  114 (646)
Q Consensus        35 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  114 (646)
                      +++.+++++|.++..+..+    .++|++|+|++|++++..|..|.++++|++|+|++|+++++.|..|+++++|++|+|
T Consensus        34 ~l~~l~~~~~~l~~ip~~~----~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAVPKEI----SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCSSCCSCC----CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCccccCCCC----CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            5777777777776533322    246777777777777666667777777777777777777666667777777777777


Q ss_pred             cCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEcc
Q 046544          115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLG  194 (646)
Q Consensus       115 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  194 (646)
                      ++|+++.++..+      .  ++|++|++++|++.                          +..+..+..+++|++|+++
T Consensus       110 ~~n~l~~l~~~~------~--~~L~~L~l~~n~i~--------------------------~~~~~~~~~l~~L~~L~l~  155 (332)
T 2ft3_A          110 SKNHLVEIPPNL------P--SSLVELRIHDNRIR--------------------------KVPKGVFSGLRNMNCIEMG  155 (332)
T ss_dssp             CSSCCCSCCSSC------C--TTCCEEECCSSCCC--------------------------CCCSGGGSSCSSCCEEECC
T ss_pred             CCCcCCccCccc------c--ccCCEEECCCCccC--------------------------ccCHhHhCCCccCCEEECC
Confidence            777776554321      1  44555555544443                          3344556666777777777


Q ss_pred             CCcccc--ccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccc
Q 046544          195 GNKLNG--SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS  272 (646)
Q Consensus       195 ~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  272 (646)
                      +|.++.  ..|..|..+ +|++|++++|++++ +|..+.  ++|++|++++|++++..+..|.++++|+.|++++|.++.
T Consensus       156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~  231 (332)
T 2ft3_A          156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM  231 (332)
T ss_dssp             SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred             CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence            776642  455555555 66666666666653 333222  355555555555554444555555555555555555544


Q ss_pred             cccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCC
Q 046544          273 IPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL  352 (646)
Q Consensus       273 lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  352 (646)
                      +                       .+..+..+++|+.|++++|.++ .+|..+..+++|++|++++|++++..+..|...
T Consensus       232 ~-----------------------~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~  287 (332)
T 2ft3_A          232 I-----------------------ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV  287 (332)
T ss_dssp             C-----------------------CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred             C-----------------------ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccc
Confidence            4                       3334444444555555555554 234445555555555555555554444444432


Q ss_pred             ------CCCCEEEccCCcCc--ccCCccccCCCCCCceeCcCCc
Q 046544          353 ------ISLKFLNLSNNNLS--GAIPTSLEKLSYLEDLNLSFNK  388 (646)
Q Consensus       353 ------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~  388 (646)
                            ++|+.|++++|.+.  +..|..|..+++|+.+++++|+
T Consensus       288 ~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                  44566666666655  4555566666666666666653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2e-35  Score=305.27  Aligned_cols=297  Identities=25%  Similarity=0.263  Sum_probs=223.2

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      .+++.+++++|+++. +|..+.  ++|++|+|++|.+++.++. .+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus        33 c~l~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKD-DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCccc-cCCCCC--CCCeEEECCCCcCCccCHh-HhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            379999999999984 555553  6899999999999875443 334599999999999999999899999999999999


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEe
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      |++|+++.+.+..+   ++|++|++++|+++.+++.     .|.++++|++|++++|.++..                  
T Consensus       109 L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~------------------  162 (332)
T 2ft3_A          109 ISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKG-----VFSGLRNMNCIEMGGNPLENS------------------  162 (332)
T ss_dssp             CCSSCCCSCCSSCC---TTCCEEECCSSCCCCCCSG-----GGSSCSSCCEEECCSCCCBGG------------------
T ss_pred             CCCCcCCccCcccc---ccCCEEECCCCccCccCHh-----HhCCCccCCEEECCCCccccC------------------
Confidence            99999996655444   8999999999999987653     478899999999999988642                  


Q ss_pred             ecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       170 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                            +..|..+..+ +|+.|++++|++++. |..+.  ++|++|++++|.+++..+..|..+++|++|+|++|++++.
T Consensus       163 ------~~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~  232 (332)
T 2ft3_A          163 ------GFEPGAFDGL-KLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI  232 (332)
T ss_dssp             ------GSCTTSSCSC-CCSCCBCCSSBCSSC-CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred             ------CCCcccccCC-ccCEEECcCCCCCcc-Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence                  1234555666 777788888887754 33332  5788888888888877778888888888888888888877


Q ss_pred             CCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCC
Q 046544          250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK  329 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  329 (646)
                      .+..|..+++|+.|++++|.++.+|..+..+++|+.|++++|.+++..+..|.....                  -....
T Consensus       233 ~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~  294 (332)
T 2ft3_A          233 ENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRA  294 (332)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSC
T ss_pred             ChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------ccccc
Confidence            777888888888888888888888877777777777777777776555444433210                  01134


Q ss_pred             CCCEEEccCccCC--CcccccccCCCCCCEEEccCCc
Q 046544          330 NLEYLFLGYNRLE--GSIPDSFGDLISLKFLNLSNNN  364 (646)
Q Consensus       330 ~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~  364 (646)
                      .|+.|++++|++.  +..|..|..+++|+.+++++|+
T Consensus       295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            5666777777665  4566667777777777777664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.1e-35  Score=301.37  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=142.6

Q ss_pred             CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEc
Q 046544           35 MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL  114 (646)
Q Consensus        35 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  114 (646)
                      +++.++++++.++..+..+    .++|++|+|++|++++..+..|.++++|++|+|++|.++++.|..|+++++|++|+|
T Consensus        32 ~l~~l~~~~~~l~~lp~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           32 HLRVVQCSDLGLEKVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             ETTEEECTTSCCCSCCCSC----CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCeEEEecCCCccccCccC----CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            5667777777665533222    246667777777776666666667777777777777777666666777777777777


Q ss_pred             cCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEcc
Q 046544          115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLG  194 (646)
Q Consensus       115 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  194 (646)
                      ++|+++.++..+        .++|++|++++|.+.                          +..+..+..+++|++|+++
T Consensus       108 s~n~l~~l~~~~--------~~~L~~L~l~~n~l~--------------------------~~~~~~~~~l~~L~~L~l~  153 (330)
T 1xku_A          108 SKNQLKELPEKM--------PKTLQELRVHENEIT--------------------------KVRKSVFNGLNQMIVVELG  153 (330)
T ss_dssp             CSSCCSBCCSSC--------CTTCCEEECCSSCCC--------------------------BBCHHHHTTCTTCCEEECC
T ss_pred             CCCcCCccChhh--------cccccEEECCCCccc--------------------------ccCHhHhcCCccccEEECC
Confidence            777666554321        145555555555544                          3444556666666666666


Q ss_pred             CCcccc--ccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccc
Q 046544          195 GNKLNG--SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS  272 (646)
Q Consensus       195 ~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  272 (646)
                      +|.+..  ..+..|.++++|++|++++|.++. +|..+.  ++|++|++++|++++..+..|.++++|+.|++++|.++.
T Consensus       154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  230 (330)
T 1xku_A          154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  230 (330)
T ss_dssp             SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence            666643  455566666666666666666663 333332  566666666666666556666666666666666666655


Q ss_pred             ccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCcccc
Q 046544          273 IPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI  325 (646)
Q Consensus       273 lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  325 (646)
                      ++. .+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.++++.+..|
T Consensus       231 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f  283 (330)
T 1xku_A          231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF  283 (330)
T ss_dssp             ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred             eChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence            443 3444444444444444444 233334444444444444444444333333

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.4e-34  Score=298.74  Aligned_cols=298  Identities=22%  Similarity=0.211  Sum_probs=237.7

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      .++++++++++.++. +|..+.  ++|++|+|++|+|++.++. .+..+++|++|+|++|++++..|..|..+++|++|+
T Consensus        31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDG-DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTT-TTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChh-hhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            378999999999985 555553  6899999999999875543 334599999999999999988899999999999999


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEe
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      |++|+++.+... +.  ++|++|++++|+++.+++     ..|.++++|++|++++|.+...                  
T Consensus       107 Ls~n~l~~l~~~-~~--~~L~~L~l~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~l~~~------------------  160 (330)
T 1xku_A          107 LSKNQLKELPEK-MP--KTLQELRVHENEITKVRK-----SVFNGLNQMIVVELGTNPLKSS------------------  160 (330)
T ss_dssp             CCSSCCSBCCSS-CC--TTCCEEECCSSCCCBBCH-----HHHTTCTTCCEEECCSSCCCGG------------------
T ss_pred             CCCCcCCccChh-hc--ccccEEECCCCcccccCH-----hHhcCCccccEEECCCCcCCcc------------------
Confidence            999999965444 33  799999999999998753     3478899999999999988642                  


Q ss_pred             ecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       170 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                            +..+..+..+++|+.|++++|+++.. |..+.  ++|++|++++|++++..|..|..+++|++|+|++|++++.
T Consensus       161 ------~~~~~~~~~l~~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  231 (330)
T 1xku_A          161 ------GIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  231 (330)
T ss_dssp             ------GBCTTGGGGCTTCCEEECCSSCCCSC-CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             ------CcChhhccCCCCcCEEECCCCccccC-Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence                  13466788889999999999998854 43333  7899999999999988888999999999999999999988


Q ss_pred             CCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCC
Q 046544          250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK  329 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  329 (646)
                      .+..|..+++|+.|++++|.++.+|..+..+++|++|++++|.+++..+..|....                  .....+
T Consensus       232 ~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~  293 (330)
T 1xku_A          232 DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKA  293 (330)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSC
T ss_pred             ChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccc
Confidence            88889999999999999999999999898999999999999999877766664331                  011234


Q ss_pred             CCCEEEccCccCCC--cccccccCCCCCCEEEccCCc
Q 046544          330 NLEYLFLGYNRLEG--SIPDSFGDLISLKFLNLSNNN  364 (646)
Q Consensus       330 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  364 (646)
                      .|+.|++++|++..  ..|..|..+.+++.++|++|+
T Consensus       294 ~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cccceEeecCcccccccCccccccccceeEEEecccC
Confidence            56667777776653  456677777777777777764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3.5e-38  Score=341.31  Aligned_cols=359  Identities=20%  Similarity=0.211  Sum_probs=219.9

Q ss_pred             CCCCEEECCCCcccccCCcC-ccCCCCCCEEECcCCcCccc----CCccCcCCCCCCCEEEccCCcccccCCcccc-CCC
Q 046544           10 QNLEELDLRHNKLVGTVPAA-IFNMSMLKLLHLQNNSLLGC----LSSIADVRLPNLEALLLWGNNFSGTIPRFIF-NAS   83 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~   83 (646)
                      ++|++|||++|+++...... +..+++|++|+|++|.++..    ++. ....+++|++|+|++|.+++..+..+. .++
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHH-HHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            45677777777776443333 66677777777777776531    111 111256666666666666543333222 233


Q ss_pred             ----CCcEEEcccCcccc----ccCccccCcCCCCEEEccCCCCCCCCCccccccc-CCCCCCCCEEECCCCCCCCcCCc
Q 046544           84 ----KLSILELSQNSFSG----FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSS-LSNCKSLTFIHLSDNPLDGILSK  154 (646)
Q Consensus        84 ----~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~  154 (646)
                          +|++|+|++|.|+.    ..+..|..+++|++|+|++|.++...... +... ....++|++|++++|.++.....
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~~~l~~~~~~L~~L~L~~n~l~~~~~~  160 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASCE  160 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-HHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence                46666666666663    23555666666666666666654321110 0001 22234555555555555432110


Q ss_pred             chhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCcccc-----CCCCCCeEEeecccccCc----
Q 046544          155 TSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLS-----KLQKLQGLGLDDNKLEGS----  225 (646)
Q Consensus       155 ~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----  225 (646)
                                            .++..+..+++|++|++++|.+.+..+..+.     ..++|++|++++|.+++.    
T Consensus       161 ----------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  218 (461)
T 1z7x_W          161 ----------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD  218 (461)
T ss_dssp             ----------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHH
T ss_pred             ----------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHH
Confidence                                  1244555667777777777776654444333     245777777777777653    


Q ss_pred             CchhhcCCCCCcEEEecCCcccccC-----CccccCCCCCceeecCCCcccc-----cccccccccccccccCCCCcccC
Q 046544          226 IPDSICRLTELYELELGGNKLFGSI-----PACFSNLASLRILSLSSNELTS-----IPLTFWNLKDILQLNFSSNFLTG  295 (646)
Q Consensus       226 ~~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~l~~N~l~~  295 (646)
                      ++..+..+++|++|++++|++.+..     +..+..+++|++|++++|.++.     ++..+..+++|+.|++++|.+++
T Consensus       219 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~  298 (461)
T 1z7x_W          219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD  298 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred             HHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch
Confidence            4566666777777777777765432     2333456777777777777775     55566667777777777777654


Q ss_pred             CCCCccCc-----cccceEEEccccccccc----CccccCCCCCCCEEEccCccCCCcccccccC-----CCCCCEEEcc
Q 046544          296 PLPLEIGN-----LKVLIGIDFSMNNFSSV----IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD-----LISLKFLNLS  361 (646)
Q Consensus       296 ~~~~~~~~-----l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls  361 (646)
                      ..+..+..     .++|+.|++++|.+++.    .+..+..+++|++|++++|++++..+..+..     .++|++|+|+
T Consensus       299 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  378 (461)
T 1z7x_W          299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA  378 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECC
Confidence            33333332     25788888888887765    3555667788888888888887665554443     5688888888


Q ss_pred             CCcCcc----cCCccccCCCCCCceeCcCCcceee
Q 046544          362 NNNLSG----AIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       362 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      +|++++    .+|..+..+++|++|++++|++++.
T Consensus       379 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             CCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            888875    6777788888888888888888753

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.1e-34  Score=296.62  Aligned_cols=188  Identities=31%  Similarity=0.492  Sum_probs=131.3

Q ss_pred             CCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCC-CCcEEEecCCcccccCCccccC
Q 046544          178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLT-ELYELELGGNKLFGSIPACFSN  256 (646)
Q Consensus       178 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~  256 (646)
                      .|..+..+++|++|++++|++.+..|..|..+++|++|++++|++++.+|..+..++ +|++|++++|++++..|..|..
T Consensus       117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~  196 (313)
T 1ogq_A          117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN  196 (313)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred             CCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC
Confidence            444455555555555555555555555555555555555555555555555555554 5555555555555444444444


Q ss_pred             CCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEc
Q 046544          257 LASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL  336 (646)
Q Consensus       257 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  336 (646)
                      +                       + |+.|++++|.+++..|..|..+++|+.|++++|.+++..|. +..+++|++|+|
T Consensus       197 l-----------------------~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L  251 (313)
T 1ogq_A          197 L-----------------------N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL  251 (313)
T ss_dssp             C-----------------------C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred             C-----------------------c-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence            4                       3 55555555555555666677777888888888888766555 788899999999


Q ss_pred             cCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          337 GYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       337 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      ++|++++.+|..|..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+.-+
T Consensus       252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc  305 (313)
T 1ogq_A          252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLC  305 (313)
T ss_dssp             CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred             cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCcc
Confidence            999999899999999999999999999999988886 889999999999999443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3.1e-37  Score=333.84  Aligned_cols=366  Identities=20%  Similarity=0.166  Sum_probs=236.5

Q ss_pred             ccCCCCCCEEECCCCcccc----cCCcCccCCCCCCEEECcCCcCcccCCccCcCCCC----CCCEEEccCCcccc----
Q 046544            6 ISNLQNLEELDLRHNKLVG----TVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLP----NLEALLLWGNNFSG----   73 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~----~L~~L~L~~N~l~~----   73 (646)
                      +..+++|++|+|++|++++    .++.++..+++|++|+|++|.+...........++    +|++|+|++|+++.    
T Consensus        24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  103 (461)
T 1z7x_W           24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  103 (461)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence            5678999999999999984    34678888999999999999996532211111244    79999999999994    


Q ss_pred             cCCccccCCCCCcEEEcccCccccccCcccc-----CcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCC
Q 046544           74 TIPRFIFNASKLSILELSQNSFSGFIPNTFG-----NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPL  148 (646)
Q Consensus        74 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  148 (646)
                      .++..+..+++|++|+|++|.+++..+..+.     ..++|++|+|++|+++...... ++..+..+++|++|++++|.+
T Consensus       104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~-l~~~l~~~~~L~~L~L~~n~i  182 (461)
T 1z7x_W          104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP-LASVLRAKPDFKELTVSNNDI  182 (461)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH-HHHHHHHCTTCCEEECCSSBC
T ss_pred             HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH-HHHHHhhCCCCCEEECcCCCc
Confidence            5688999999999999999999865554433     3568999999999998643211 344567789999999999998


Q ss_pred             CCcCCcchhccc---cccCcEEEeeccccccc----CCcccccCCCCCEEEccCCcccccc-----CccccCCCCCCeEE
Q 046544          149 DGILSKTSIGNL---SHSLKDFYMSNCNVSGG----IPEEITNLTNSITIDLGGNKLNGSI-----PITLSKLQKLQGLG  216 (646)
Q Consensus       149 ~~~~~~~~~~~~---~~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~  216 (646)
                      ...........+   .++|++|++++|.+++.    ++..+..+++|++|++++|++.+..     +..+..+++|++|+
T Consensus       183 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~  262 (461)
T 1z7x_W          183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW  262 (461)
T ss_dssp             HHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             chHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEE
Confidence            653222111111   23677777777766653    3555666666666676666665432     22233456666666


Q ss_pred             eecccccCc----CchhhcCCCCCcEEEecCCcccccCCccccC-----CCCCceeecCCCccccccccccccccccccc
Q 046544          217 LDDNKLEGS----IPDSICRLTELYELELGGNKLFGSIPACFSN-----LASLRILSLSSNELTSIPLTFWNLKDILQLN  287 (646)
Q Consensus       217 L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~  287 (646)
                      +++|.+++.    ++..+..+++|++|++++|.+.+..+..+..     .++|+.|++++|.++.....           
T Consensus       263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-----------  331 (461)
T 1z7x_W          263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS-----------  331 (461)
T ss_dssp             CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-----------
T ss_pred             CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH-----------
Confidence            666666543    3455555666666666666665433332222     24555555555555432100           


Q ss_pred             CCCCcccCCCCCccCccccceEEEcccccccccCccccCC-----CCCCCEEEccCccCCC----cccccccCCCCCCEE
Q 046544          288 FSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGG-----LKNLEYLFLGYNRLEG----SIPDSFGDLISLKFL  358 (646)
Q Consensus       288 l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L  358 (646)
                              .++..+..+++|+.|++++|.+++..+..+..     .++|++|++++|++++    .+|..+..+++|++|
T Consensus       332 --------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L  403 (461)
T 1z7x_W          332 --------HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL  403 (461)
T ss_dssp             --------HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred             --------HHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEE
Confidence                    02333444566666666666665544433321     5678888888888875    567777778888888


Q ss_pred             EccCCcCcccCCcccc-----CCCCCCceeCcCCccee
Q 046544          359 NLSNNNLSGAIPTSLE-----KLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       359 ~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~  391 (646)
                      ++++|++++.....+.     ....|+.|++.++.+..
T Consensus       404 ~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             ECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence            8888888754222221     23456777776666654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.1e-34  Score=287.26  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=133.6

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999863      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          566 VLEYKPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                      |||||++|+|.+++...+            ..+++.++..|+.||++||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            46899999999999999999999   889999999999999999999999


Q ss_pred             EeecCccccc
Q 046544          634 SDFGIAKLLI  643 (646)
Q Consensus       634 ~DfGla~~~~  643 (646)
                      +|||+|+...
T Consensus       170 ~DFGla~~~~  179 (299)
T 4asz_A          170 GDFGMSRDVY  179 (299)
T ss_dssp             CCCSCHHHHT
T ss_pred             CCcccceecC
Confidence            9999998653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-33  Score=287.16  Aligned_cols=148  Identities=27%  Similarity=0.331  Sum_probs=136.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|+..+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999975 79999999998766555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++...  .+++.++..++.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.+.+
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999764  5899999999999999999999   88999999999999999999999999999997653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-33  Score=286.20  Aligned_cols=149  Identities=23%  Similarity=0.400  Sum_probs=130.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999964 69999999998653  3345689999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+||+|.+++...+ ..+++.++..|+.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999997654 45789999999999999999999   8999999999999999999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-33  Score=282.71  Aligned_cols=148  Identities=30%  Similarity=0.452  Sum_probs=136.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999864 79999999997542   334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+||+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            9999999999997754 6899999999999999999999   8999999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=286.84  Aligned_cols=149  Identities=29%  Similarity=0.476  Sum_probs=130.4

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|...++||+|+||+||+|+++      +++.||||+++.......++|.+|++++++++|||||+++++|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35667789999999999999864      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          566 VLEYKPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      |||||++|+|.++++...              ..+++.++..|+.||++||+|||   .++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997642              35899999999999999999999   8899999999999999999999


Q ss_pred             EEEeecCccccc
Q 046544          632 YLSDFGIAKLLI  643 (646)
Q Consensus       632 ki~DfGla~~~~  643 (646)
                      ||+|||+|+.+.
T Consensus       198 Ki~DFGla~~~~  209 (329)
T 4aoj_A          198 KIGDFGMSRDIY  209 (329)
T ss_dssp             EECCCC------
T ss_pred             EEcccccceecc
Confidence            999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.9e-33  Score=289.03  Aligned_cols=148  Identities=27%  Similarity=0.331  Sum_probs=137.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|+..+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56899999999999999999965 69999999998776666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++...  .+++.++..|+.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999999999765  4899999999999999999999   88999999999999999999999999999997653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-33  Score=278.37  Aligned_cols=146  Identities=29%  Similarity=0.511  Sum_probs=130.4

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++++..++||+|+||+||+|++++  .||||+++...  ....++|.+|++++++++|||||++++++.. +..|+||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567888999999999999998753  59999987543  3445789999999999999999999998864 568999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||+|.+++...+..+++.++..|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+...
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999877778999999999999999999999   8899999999999999999999999999998753

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-32  Score=284.77  Aligned_cols=280  Identities=19%  Similarity=0.165  Sum_probs=165.6

Q ss_pred             CCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCE
Q 046544           61 LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF  140 (646)
Q Consensus        61 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~  140 (646)
                      ....++++|.++ .+|..+.  ++|++|++++|.++++.+..|.++++|++|+|++|+++.+++     ..|.++++|++
T Consensus        33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~  104 (353)
T 2z80_A           33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE-----DSFSSLGSLEH  104 (353)
T ss_dssp             TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT-----TTTTTCTTCCE
T ss_pred             CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH-----hhcCCCCCCCE
Confidence            334455555555 2333322  245555555555555544455555555555555555554322     23445555555


Q ss_pred             EECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccC-ccccCCCCCCeEEeec
Q 046544          141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLDD  219 (646)
Q Consensus       141 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~  219 (646)
                      |++++|+++++                          .+..+..+++|++|++++|++++..+ ..|.++++|++|++++
T Consensus       105 L~Ls~n~l~~~--------------------------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~  158 (353)
T 2z80_A          105 LDLSYNYLSNL--------------------------SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN  158 (353)
T ss_dssp             EECCSSCCSSC--------------------------CHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEE
T ss_pred             EECCCCcCCcC--------------------------CHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCC
Confidence            55555544332                          12334555556666666666654443 4566666666666666


Q ss_pred             c-cccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccc-cccccccccCCCCcccCCC
Q 046544          220 N-KLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFW-NLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       220 N-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~l~~N~l~~~~  297 (646)
                      | .+.+..+..|.++++|++|++++|++.+..|..|..+++|++|++++|.++.+|..+. .+++|+.|++++|.+++..
T Consensus       159 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~  238 (353)
T 2z80_A          159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH  238 (353)
T ss_dssp             SSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred             CccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence            6 3555556666777777777777777766666777777777777777777766655432 3455555555555555433


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCC----cccccccCCCCCCEEEccCCcCcccCCccc
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG----SIPDSFGDLISLKFLNLSNNNLSGAIPTSL  373 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  373 (646)
                      +..+..                     ......++.+++++|.+++    .+|+.+..+++|+.|+|++|+++...+..|
T Consensus       239 ~~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~  297 (353)
T 2z80_A          239 FSELST---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIF  297 (353)
T ss_dssp             CC---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             cccccc---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHH
Confidence            222111                     1123456666666666654    467788888999999999999984444446


Q ss_pred             cCCCCCCceeCcCCcceeeccC
Q 046544          374 EKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       374 ~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      ..+++|++|++++|+++|.+|.
T Consensus       298 ~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          298 DRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             TTCTTCCEEECCSSCBCCCHHH
T ss_pred             hcCCCCCEEEeeCCCccCcCCC
Confidence            8899999999999999988773

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.98  E-value=8.6e-33  Score=279.52  Aligned_cols=148  Identities=25%  Similarity=0.430  Sum_probs=130.6

Q ss_pred             CCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++..+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|..++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556789999999999999863      46889999987543 3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc
Q 046544          566 VLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV  630 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~  630 (646)
                      |||||++|+|.+++....               ..+++.++.+|+.|||+||+|||   +++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532               35899999999999999999999   889999999999999999999


Q ss_pred             EEEEeecCccccc
Q 046544          631 AYLSDFGIAKLLI  643 (646)
Q Consensus       631 ~ki~DfGla~~~~  643 (646)
                      +||+|||+|+.+.
T Consensus       184 ~Ki~DFGlar~~~  196 (308)
T 4gt4_A          184 VKISDLGLFREVY  196 (308)
T ss_dssp             EEECCSCCBCGGG
T ss_pred             EEECCcccceecc
Confidence            9999999998763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.98  E-value=3e-32  Score=269.86  Aligned_cols=148  Identities=26%  Similarity=0.473  Sum_probs=127.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999864 79999999997543   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||| +|+|.+++...+ .+++.++..++.|++.|++|+|   +++|+||||||+|||+++++.+||+|||+|+...
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 679999998765 6899999999999999999999   8899999999999999999999999999998764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=4.7e-32  Score=276.61  Aligned_cols=254  Identities=20%  Similarity=0.185  Sum_probs=184.2

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccc--cCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGS--IPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      ++++|++++|+++...+..|..+++|++|++++|+++..  .+..+..+++|++|++++|.+. .+|..+..+++|++|+
T Consensus        29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~  107 (306)
T 2z66_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD  107 (306)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred             CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence            344444444444444445567777777777777777633  2556666777777777777777 4556677777778888


Q ss_pred             ecCCcccccCC-ccccCCCCCceeecCCCccccc-ccccccccccccccCCCCcccC-CCCCccCccccceEEEcccccc
Q 046544          241 LGGNKLFGSIP-ACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNF  317 (646)
Q Consensus       241 L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l  317 (646)
                      +++|++.+..+ ..|..+++|++|++++|.++.+ |..+..+++|+.|++++|.+++ ..|..+..+++|+.|++++|.+
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  187 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  187 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence            87777776554 5677777788888887777754 3456677777888888887765 5677788888888888888888


Q ss_pred             cccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCC-CCCceeCcCCcceeeccCC
Q 046544          318 SSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS-YLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       318 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~  396 (646)
                      ++..|..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++.++..
T Consensus       188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~  267 (306)
T 2z66_A          188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ  267 (306)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGH
T ss_pred             CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChH
Confidence            888888888888888888888888877777888888889999998888888888888884 8888999999888865532


Q ss_pred             C---CCCCCccccccCCccccCCC
Q 046544          397 G---SFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       397 ~---~~~~~~~~~~~~N~~~c~~~  417 (646)
                      .   .+...+.+....+...|..|
T Consensus       268 ~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          268 SFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             HHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             HHHHHHHhhhhhhccccccccCCc
Confidence            1   12233344455666666544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=8e-32  Score=274.92  Aligned_cols=212  Identities=22%  Similarity=0.289  Sum_probs=132.7

Q ss_pred             cCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCc-hhhcCCCCCcEEEecCCcccccCCccccCCCCCce
Q 046544          184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP-DSICRLTELYELELGGNKLFGSIPACFSNLASLRI  262 (646)
Q Consensus       184 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  262 (646)
                      .+++|++|++++|.+.+ .|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++.+..+..|.++++|++
T Consensus        76 ~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  154 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  154 (306)
T ss_dssp             SCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred             cccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence            33444444444444442 22334444445555555554443332 34455555555555555555555555555555555


Q ss_pred             eecCCCcccc--cccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          263 LSLSSNELTS--IPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       263 L~L~~N~l~~--lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      |++++|.++.  +|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..|..+++|++|++++|+
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            5555555543  45555555556666666666665556667777788888888888887777778888888899999888


Q ss_pred             CCCcccccccCCC-CCCEEEccCCcCcccCC--ccccCCCCCCceeCcCCcceeeccCC
Q 046544          341 LEGSIPDSFGDLI-SLKFLNLSNNNLSGAIP--TSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       341 l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      +++..|..+..++ +|+.|+|++|.+++.-+  .....+...+.+.+..+.+.|..|..
T Consensus       235 l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~  293 (306)
T 2z66_A          235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD  293 (306)
T ss_dssp             CCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred             CcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence            8888888888884 89999999998875322  12233445666777888888887765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=2e-31  Score=287.24  Aligned_cols=251  Identities=23%  Similarity=0.256  Sum_probs=208.2

Q ss_pred             CCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEE
Q 046544          137 SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLG  216 (646)
Q Consensus       137 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  216 (646)
                      ....++.+++.++.++..     ++.+++.|+|++|++++..|..|.++++|+.|+|++|+++++.+..|.++++|++|+
T Consensus        55 ~~~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  129 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQG-----IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLE  129 (452)
T ss_dssp             SSCEEECCSSCCSSCCSC-----CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCcEEEECCCCcCccCCC-----CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEE
Confidence            457889999998887642     346789999999999988888899999999999999999888888899999999999


Q ss_pred             eecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCC-Cccccccc-ccccccccccccCCCCccc
Q 046544          217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS-NELTSIPL-TFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~L~l~~N~l~  294 (646)
                      |++|+|++..+..|..+++|++|+|++|++..+.+..|.++++|+.|++++ |.+..+|. .|.++++|+.|++++|.++
T Consensus       130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  209 (452)
T 3zyi_A          130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK  209 (452)
T ss_dssp             CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence            999999887777888899999999999999888888888899999999988 56777765 4777888888888888887


Q ss_pred             CCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       295 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                      +. | .+..+++|+.|++++|.++++.|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|.
T Consensus       210 ~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  287 (452)
T 3zyi_A          210 DM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT  287 (452)
T ss_dssp             SC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred             cc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence            54 3 477788888888888888888788888888888888888888877778888888888888888888877777778


Q ss_pred             CCCCCCceeCcCCcceeecc
Q 046544          375 KLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~~p  394 (646)
                      .+++|+.|+|++|++.|.+.
T Consensus       288 ~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          288 PLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TCTTCCEEECCSSCEECSTT
T ss_pred             cccCCCEEEccCCCcCCCCC
Confidence            88888888888888877654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=2.5e-32  Score=277.49  Aligned_cols=143  Identities=27%  Similarity=0.357  Sum_probs=129.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|+..++||+|+||+||+|+++ +|+.||||+++.+..     ..+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            46778899999999999999965 699999999986532     246999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      +||+|.++++..+ .+++.++..++.||+.||+|||   +++||||||||+|||++.++ .+||+|||+|+.+.
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999998754 6899999999999999999999   89999999999999999887 69999999999764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=285.90  Aligned_cols=251  Identities=23%  Similarity=0.256  Sum_probs=204.8

Q ss_pred             CCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEE
Q 046544          137 SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLG  216 (646)
Q Consensus       137 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  216 (646)
                      ....++.+++.++.++..     ++..++.|+|++|++++..+..|.++++|++|+|++|++.++.+..|.++++|++|+
T Consensus        44 ~~~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~  118 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDG-----ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE  118 (440)
T ss_dssp             TSCEEECCSCCCSSCCSC-----CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred             CCCEEEeCCCCcCcCCCC-----CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence            467889999998887653     235788899999998888888888888899999999888888888888888889999


Q ss_pred             eecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCC-Cccccccc-ccccccccccccCCCCccc
Q 046544          217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS-NELTSIPL-TFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~L~l~~N~l~  294 (646)
                      |++|+|++..+..|..+++|++|+|++|+|....+..|.++++|+.|++++ |.+..+|. .|.++++|+.|++++|.++
T Consensus       119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  198 (440)
T 3zyj_A          119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR  198 (440)
T ss_dssp             CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred             CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence            988888877777888888888888888888888778888888888888888 55667765 5777888888888888887


Q ss_pred             CCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCcccc
Q 046544          295 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE  374 (646)
Q Consensus       295 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  374 (646)
                      . +| .+..+++|+.|++++|.++++.|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.
T Consensus       199 ~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  276 (440)
T 3zyj_A          199 E-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT  276 (440)
T ss_dssp             S-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred             c-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence            4 33 477788888888888888887788888888888888888888877777888888888888888888877777777


Q ss_pred             CCCCCCceeCcCCcceeecc
Q 046544          375 KLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       375 ~l~~L~~L~L~~N~l~~~~p  394 (646)
                      .+++|+.|+|++|++.|.+.
T Consensus       277 ~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          277 PLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             SCTTCCEEECCSSCEECSST
T ss_pred             cccCCCEEEcCCCCccCCCC
Confidence            88888888888888877654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.3e-32  Score=283.65  Aligned_cols=255  Identities=20%  Similarity=0.178  Sum_probs=218.8

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +|++|++++|++++..+..+.++++|++|++++|++++..|..|.++++|++|++++|++++..+..|.++++|++|+++
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  132 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL  132 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence            45666666666666666788999999999999999999889999999999999999999997777779999999999999


Q ss_pred             CCcccccCC-ccccCCCCCceeecCCC-cccccc-cccccccccccccCCCCcccCCCCCccCccccceEEEcccccccc
Q 046544          243 GNKLFGSIP-ACFSNLASLRILSLSSN-ELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS  319 (646)
Q Consensus       243 ~N~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  319 (646)
                      +|++++..+ ..|.++++|++|++++| .++.++ ..+.++++|+.|++++|.+++..|..+..+++|+.|++++|.++.
T Consensus       133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~  212 (353)
T 2z80_A          133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL  212 (353)
T ss_dssp             TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred             CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence            999986655 58999999999999999 588775 578899999999999999998889999999999999999999987


Q ss_pred             cCccccCCCCCCCEEEccCccCCCccccccc---CCCCCCEEEccCCcCcc----cCCccccCCCCCCceeCcCCcceee
Q 046544          320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFG---DLISLKFLNLSNNNLSG----AIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       320 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      ..+..+..+++|+.|++++|++++..+..+.   ....++.++|++|.+++    .+|..+..+++|++|++++|+++..
T Consensus       213 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i  292 (353)
T 2z80_A          213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV  292 (353)
T ss_dssp             HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCC
T ss_pred             chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCcc
Confidence            6655666789999999999999987665443   46778999999999886    4788899999999999999999964


Q ss_pred             ccCC-CCCCCCccccccCCccccCCC
Q 046544          393 IPRG-GSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       393 ~p~~-~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      ++.. ..+++++.+++++|++.|+|+
T Consensus       293 ~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          293 PDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            4433 568899999999999999886

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=4.8e-31  Score=284.28  Aligned_cols=248  Identities=22%  Similarity=0.217  Sum_probs=176.8

Q ss_pred             CCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCC
Q 046544          108 NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTN  187 (646)
Q Consensus       108 ~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~  187 (646)
                      ....++.+++.++.+|.++        .+++++|+|++|.++++.+.. +.. .++|+.|+|++|++++..|..|.++++
T Consensus        55 ~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~-~~~-l~~L~~L~Ls~n~i~~~~~~~~~~l~~  124 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGI--------PSNTRYLNLMENNIQMIQADT-FRH-LHHLEVLQLGRNSIRQIEVGAFNGLAS  124 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCEECTTT-TTT-CTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCcEEEECCCCcCccCCCC--------CCCccEEECcCCcCceECHHH-cCC-CCCCCEEECCCCccCCcChhhccCccc
Confidence            4566777777777766542        156777777777777664432 222 246777777777777777777777777


Q ss_pred             CCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecC-CcccccCCccccCCCCCceeecC
Q 046544          188 SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG-NKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       188 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      |++|+|++|++++.++..|.++++|++|+|++|+|+...+..|..+++|++|++++ |.+..+.+..|.++++|++|+|+
T Consensus       125 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  204 (452)
T 3zyi_A          125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG  204 (452)
T ss_dssp             CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECT
T ss_pred             CCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECC
Confidence            77777777777776666777777777777777777766666777777777777777 45555555567777777777777


Q ss_pred             CCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCccc
Q 046544          267 SNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP  346 (646)
Q Consensus       267 ~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  346 (646)
                      +|.++.+| .+..+++|+.|++++|.+++..|..|.++++|+.|++++|.++++.|..|.++++|+.|+|++|++++..+
T Consensus       205 ~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  283 (452)
T 3zyi_A          205 MCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH  283 (452)
T ss_dssp             TSCCSSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCcccccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh
Confidence            77777776 46667777777777777777777777777777777777777777777777777777777777777776666


Q ss_pred             ccccCCCCCCEEEccCCcCc
Q 046544          347 DSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       347 ~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      ..|..+++|+.|+|++|.+.
T Consensus       284 ~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          284 DLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TSSTTCTTCCEEECCSSCEE
T ss_pred             HHhccccCCCEEEccCCCcC
Confidence            67777777777777777765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=9.7e-33  Score=277.21  Aligned_cols=148  Identities=26%  Similarity=0.345  Sum_probs=127.5

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    47899999997543  2233468889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||||+||+|.+++...+ .+++.++..++.|++.||+|+|   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999997754 6899999999999999999999   8899999999999999999999999999998754

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=7.1e-31  Score=281.93  Aligned_cols=249  Identities=21%  Similarity=0.226  Sum_probs=205.2

Q ss_pred             CCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCC
Q 046544          107 RNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLT  186 (646)
Q Consensus       107 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~  186 (646)
                      .....++.+++.++.+|.++        .++++.|+|++|+++.+.+.. +.. .++|++|+|++|.+++..+..|.+++
T Consensus        43 ~~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~-~~~-l~~L~~L~Ls~n~i~~i~~~~~~~l~  112 (440)
T 3zyj_A           43 NQFSKVICVRKNLREVPDGI--------STNTRLLNLHENQIQIIKVNS-FKH-LRHLEILQLSRNHIRTIEIGAFNGLA  112 (440)
T ss_dssp             TTSCEEECCSCCCSSCCSCC--------CTTCSEEECCSCCCCEECTTT-TSS-CSSCCEEECCSSCCCEECGGGGTTCS
T ss_pred             CCCCEEEeCCCCcCcCCCCC--------CCCCcEEEccCCcCCeeCHHH-hhC-CCCCCEEECCCCcCCccChhhccCCc
Confidence            34678888888888877653        267888888888888775433 333 35788888888888888888888888


Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecC-CcccccCCccccCCCCCceeec
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG-NKLFGSIPACFSNLASLRILSL  265 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L  265 (646)
                      +|++|+|++|+++++.+..|..+++|++|+|++|+|+...+..|..+++|++|+|++ |.+..+.+..|.++++|++|++
T Consensus       113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L  192 (440)
T 3zyj_A          113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL  192 (440)
T ss_dssp             SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEEC
T ss_pred             cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecC
Confidence            888888888888877777888888888888888888877777888888888888888 5566566667888888888888


Q ss_pred             CCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcc
Q 046544          266 SSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSI  345 (646)
Q Consensus       266 ~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  345 (646)
                      ++|.++.+| .+..+++|+.|++++|.+++..|..|.++++|+.|++++|.++++.+..|.++++|++|+|++|++++..
T Consensus       193 ~~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  271 (440)
T 3zyj_A          193 AMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP  271 (440)
T ss_dssp             TTSCCSSCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCC
T ss_pred             CCCcCcccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccC
Confidence            888888887 4777888888888888888888888888888888888888888888888888888888888888888877


Q ss_pred             cccccCCCCCCEEEccCCcCc
Q 046544          346 PDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       346 p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      +..|..+++|+.|+|++|.+.
T Consensus       272 ~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          272 HDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTTTSSCTTCCEEECCSSCEE
T ss_pred             hhHhccccCCCEEEcCCCCcc
Confidence            788888888888888888876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=1e-31  Score=268.39  Aligned_cols=145  Identities=28%  Similarity=0.396  Sum_probs=127.3

Q ss_pred             CcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeEEEE
Q 046544          495 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKALVL  567 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~  567 (646)
                      ...++||+|+||+||+|++. +++.||+|++....  ....+.|.+|++++++++|||||++++++.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999865 68999999997543  3345679999999999999999999999865    34589999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEc-CCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~  643 (646)
                      |||+||+|.+++...+ .+++..+..++.||+.||+|||   +++  ||||||||+|||++ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999997654 6899999999999999999999   666  99999999999997 47999999999998653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=9.4e-32  Score=271.21  Aligned_cols=149  Identities=23%  Similarity=0.417  Sum_probs=125.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCC--------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--------  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--------  561 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|++++++++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999965 799999999976543 34567899999999999999999999987543        


Q ss_pred             ----eeEEEEEecCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          562 ----FKALVLEYKPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       562 ----~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                          ..|+|||||+||+|.+++.....  ..++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                47999999999999999976542  3456668899999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+|+.+.
T Consensus       162 FGla~~~~  169 (299)
T 4g31_A          162 FGLVTAMD  169 (299)
T ss_dssp             CCCC----
T ss_pred             CccceecC
Confidence            99998764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=2.9e-31  Score=267.90  Aligned_cols=251  Identities=24%  Similarity=0.232  Sum_probs=141.7

Q ss_pred             CEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEee
Q 046544          139 TFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD  218 (646)
Q Consensus       139 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  218 (646)
                      ++++.+++.++.++..     .++++++|++++|.+++..+..|..+++|++|++++|++++..|..|.++++|++|+++
T Consensus        14 ~~~~c~~~~l~~ip~~-----~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   88 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (285)
T ss_dssp             CEEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             eEEEcCcCCcccCCcC-----CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence            5666776666655321     12345555555555555555555555555555555555555555555555555555555


Q ss_pred             ccc-ccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCC
Q 046544          219 DNK-LEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       219 ~N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      +|. +....|..|..+++|++|++++|++++..+..|.++++|++|++++|.++.                       ..
T Consensus        89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~  145 (285)
T 1ozn_A           89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-----------------------LP  145 (285)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-----------------------CC
T ss_pred             CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc-----------------------cC
Confidence            554 444444555555555555555555554444445555555555555554444                       44


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCC
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS  377 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  377 (646)
                      +..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++..|..|..+++|+.|++++|++++..+..+..++
T Consensus       146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  225 (285)
T 1ozn_A          146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence            44455566666666666666655555566666666666666666666666666666666666666666655555566666


Q ss_pred             CCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCC
Q 046544          378 YLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       378 ~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      +|++|++++|++.+.++....+..++......+.+.|..|
T Consensus       226 ~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             ccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            6666666666666655543333334444455555555433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=3.7e-31  Score=268.14  Aligned_cols=148  Identities=29%  Similarity=0.414  Sum_probs=124.9

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC----eeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----FKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----~~~lv~  567 (646)
                      ++|...+.||+|+||+||+|++ +|+.||||+++..... ...+.+|+..+.+++|||||++++++..++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3567789999999999999998 5899999998754321 122334566667889999999999998653    579999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||++|+|.++++..  .+++..+.+++.|+++||+|+|+.     +.++||||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999875  488999999999999999999943     2349999999999999999999999999999875


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       159 ~  159 (303)
T 3hmm_A          159 D  159 (303)
T ss_dssp             E
T ss_pred             c
Confidence            4

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.3e-30  Score=263.03  Aligned_cols=254  Identities=21%  Similarity=0.224  Sum_probs=204.3

Q ss_pred             CCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCC
Q 046544          109 LEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNS  188 (646)
Q Consensus       109 L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L  188 (646)
                      -++++++++.++.+|.++        .++|++|++++|.++++++.. +.. .++|++|++++|.+++..|..+..+++|
T Consensus        13 ~~~~~c~~~~l~~ip~~~--------~~~l~~L~l~~n~i~~~~~~~-~~~-~~~L~~L~l~~n~l~~~~~~~~~~l~~L   82 (285)
T 1ozn_A           13 KVTTSCPQQGLQAVPVGI--------PAASQRIFLHGNRISHVPAAS-FRA-CRNLTILWLHSNVLARIDAAAFTGLALL   82 (285)
T ss_dssp             SCEEECCSSCCSSCCTTC--------CTTCSEEECTTSCCCEECTTT-TTT-CTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CeEEEcCcCCcccCCcCC--------CCCceEEEeeCCcCCccCHHH-ccc-CCCCCEEECCCCccceeCHhhcCCccCC
Confidence            478999999999986542        468999999999999876543 333 3589999999999999999999999999


Q ss_pred             CEEEccCCc-cccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCC
Q 046544          189 ITIDLGGNK-LNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS  267 (646)
Q Consensus       189 ~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  267 (646)
                      ++|++++|+ +....|..|..+++|++|++++|.+++..|..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus        83 ~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  162 (285)
T 1ozn_A           83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG  162 (285)
T ss_dssp             CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence            999999997 8888899999999999999999999998899999999999999999999988888899999999999999


Q ss_pred             CcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccc
Q 046544          268 NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD  347 (646)
Q Consensus       268 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  347 (646)
                      |.++.+|..                       .|..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..+.
T Consensus       163 n~l~~~~~~-----------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  219 (285)
T 1ozn_A          163 NRISSVPER-----------------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE  219 (285)
T ss_dssp             SCCCEECTT-----------------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred             CcccccCHH-----------------------HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHH
Confidence            998877642                       234455566666666666666677777777778888888887776667


Q ss_pred             cccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       348 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      .|..+++|+.|++++|.+....+.. .-...++.+..+.|.+.|..|..
T Consensus       220 ~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          220 ALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred             HcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence            7777888888888888776433221 11233455667778888877765

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=2.1e-30  Score=266.50  Aligned_cols=226  Identities=20%  Similarity=0.254  Sum_probs=194.4

Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      ..++.|+|++|.++ .+|..+..+++|++|+|++|.+. .+|..+.++++|++|+|++|+++ .+|..|..+++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            45677777777776 45666777888888888888888 67778888888888888888888 66888888888888888


Q ss_pred             cCCcccccCCccccC---------CCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEc
Q 046544          242 GGNKLFGSIPACFSN---------LASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDF  312 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~---------l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  312 (646)
                      ++|.+.+..|..+..         +++|++|++++|.++.+|..+..+++|+.|++++|.+++ +|..+..+++|+.|++
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL  236 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence            888777777776554         899999999999999999888899999999999999985 5567889999999999


Q ss_pred             ccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          313 SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       313 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      ++|++.+..|..|+++++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence            9999999999999999999999999999998999999999999999999999999999999999999999998887764

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=2e-29  Score=278.95  Aligned_cols=268  Identities=25%  Similarity=0.240  Sum_probs=152.1

Q ss_pred             CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEc
Q 046544           35 MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNL  114 (646)
Q Consensus        35 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  114 (646)
                      ++++|++++|.|+..+..+.    ++|++|+|++|+|+. +|.   .+++|++|+|++|+|+++++    .+++|++|+|
T Consensus        41 ~l~~L~ls~n~L~~lp~~l~----~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~L  108 (622)
T 3g06_A           41 GNAVLNVGESGLTTLPDCLP----AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSI  108 (622)
T ss_dssp             CCCEEECCSSCCSCCCSCCC----TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEE
T ss_pred             CCcEEEecCCCcCccChhhC----CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEEC
Confidence            46666666666654332222    466666666666663 333   34566666666666664322    4556666666


Q ss_pred             cCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEcc
Q 046544          115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLG  194 (646)
Q Consensus       115 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  194 (646)
                      ++|+|+.++.         .+++|+.|++++|+++.++                           ..   +++|++|+++
T Consensus       109 s~N~l~~l~~---------~l~~L~~L~L~~N~l~~lp---------------------------~~---l~~L~~L~Ls  149 (622)
T 3g06_A          109 FSNPLTHLPA---------LPSGLCKLWIFGNQLTSLP---------------------------VL---PPGLQELSVS  149 (622)
T ss_dssp             CSCCCCCCCC---------CCTTCCEEECCSSCCSCCC---------------------------CC---CTTCCEEECC
T ss_pred             cCCcCCCCCC---------CCCCcCEEECCCCCCCcCC---------------------------CC---CCCCCEEECc
Confidence            6666655432         2345555555555554432                           11   2556666666


Q ss_pred             CCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccc
Q 046544          195 GNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP  274 (646)
Q Consensus       195 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp  274 (646)
                      +|+++++ |.   .+++|+.|++++|.|++ +|   ..+++|+.|++++|+|+++ |..   +++|+.|++++|.++.+|
T Consensus       150 ~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~~---~~~L~~L~L~~N~l~~l~  217 (622)
T 3g06_A          150 DNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSLP  217 (622)
T ss_dssp             SSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC
T ss_pred             CCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-CCc---cchhhEEECcCCcccccC
Confidence            6666543 22   23456666666666664 33   3345666666666666542 222   356666777777666666


Q ss_pred             cccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCC
Q 046544          275 LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLIS  354 (646)
Q Consensus       275 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  354 (646)
                      ..   +++|+.|++++|.+++ +|   ..+++|+.|++++|.++++ |.   .+++|+.|+|++|+|+ .+|..|..+++
T Consensus       218 ~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~  285 (622)
T 3g06_A          218 AL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSS  285 (622)
T ss_dssp             CC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred             CC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence            42   2556666666666654 33   3345666666666666643 22   4566777777777776 45666667777


Q ss_pred             CCEEEccCCcCcccCCccccCCC
Q 046544          355 LKFLNLSNNNLSGAIPTSLEKLS  377 (646)
Q Consensus       355 L~~L~Ls~N~l~~~~p~~~~~l~  377 (646)
                      |+.|+|++|.+++..|..+..++
T Consensus       286 L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          286 ETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCEEEecCCCCCCcCHHHHHhcc
Confidence            77777777777666666555443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=2.7e-29  Score=277.87  Aligned_cols=269  Identities=22%  Similarity=0.248  Sum_probs=182.0

Q ss_pred             CCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEE
Q 046544           10 QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILE   89 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~   89 (646)
                      .++++|++++|+|+ .+|..+.  ++|++|+|++|.|+..+.     .+++|++|+|++|+|++ +|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~-----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA-----LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC-----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC-----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            46899999999999 5566555  899999999999986433     37899999999999995 554   679999999


Q ss_pred             cccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEe
Q 046544           90 LSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        90 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      |++|.|+++.+    .+++|++|++++|+|+.++..         +++|++|++++|++++++.      ...+|+.|++
T Consensus       108 Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~~---------l~~L~~L~Ls~N~l~~l~~------~~~~L~~L~L  168 (622)
T 3g06_A          108 IFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASLPA------LPSELCKLWA  168 (622)
T ss_dssp             ECSCCCCCCCC----CCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSCCCC------CCTTCCEEEC
T ss_pred             CcCCcCCCCCC----CCCCcCEEECCCCCCCcCCCC---------CCCCCEEECcCCcCCCcCC------ccCCCCEEEC
Confidence            99999997644    678999999999999987642         4889999999999987642      1245666666


Q ss_pred             ecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       170 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                      ++|.+++. |   ..+++|+.|++++|+++++++    .+++|+.|++++|.++. +|.   .+                
T Consensus       169 ~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~-l~~---~~----------------  220 (622)
T 3g06_A          169 YNNQLTSL-P---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTS-LPA---LP----------------  220 (622)
T ss_dssp             CSSCCSCC-C---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS-CCC---CC----------------
T ss_pred             CCCCCCCC-c---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccc-cCC---CC----------------
Confidence            66666642 2   334555555666555553221    12445555555555542 221   12                


Q ss_pred             CCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCC
Q 046544          250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLK  329 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  329 (646)
                              ++|+.|++++|.|+.+|   ..+++|+.|++++|.+++ +|.   .+++|+.|++++|.++ .+|..|..++
T Consensus       221 --------~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~  284 (622)
T 3g06_A          221 --------SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS  284 (622)
T ss_dssp             --------TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred             --------CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence                    44455555555555444   223445555555555542 222   3456667777777777 3466677777


Q ss_pred             CCCEEEccCccCCCcccccccCCC
Q 046544          330 NLEYLFLGYNRLEGSIPDSFGDLI  353 (646)
Q Consensus       330 ~L~~L~Ls~N~l~~~~p~~~~~l~  353 (646)
                      +|+.|+|++|++++..|..+..++
T Consensus       285 ~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          285 SETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ccCEEEecCCCCCCcCHHHHHhcc
Confidence            777777777777777777666554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=7.3e-31  Score=270.10  Aligned_cols=158  Identities=25%  Similarity=0.393  Sum_probs=135.8

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCC-CCceeEEE
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRH-RNLIKVIS  555 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H-~niv~~~~  555 (646)
                      ..+++...++|+..+.||+|+||+||+|++.      +++.||||++..... ...++|.+|++++++++| ||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            3455555678999999999999999999853      246899999976543 345679999999999965 89999999


Q ss_pred             EEecC-CeeEEEEEecCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 046544          556 SCSNE-EFKALVLEYKPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK  619 (646)
Q Consensus       556 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk  619 (646)
                      +|..+ +..++|||||++|+|.++++..               ...+++.++..++.|||+||+|||   +++|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccC
Confidence            99765 5689999999999999999753               235789999999999999999999   8899999999


Q ss_pred             CCCEEEcCCCcEEEEeecCcccccC
Q 046544          620 PDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       620 ~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |+|||+++++.+||+|||+|+.+..
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~  237 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYK  237 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTT
T ss_pred             ccceeeCCCCCEEECcchhhhhccc
Confidence            9999999999999999999997643

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=3.6e-32  Score=278.71  Aligned_cols=266  Identities=19%  Similarity=0.145  Sum_probs=142.1

Q ss_pred             EEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEE
Q 046544           63 ALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIH  142 (646)
Q Consensus        63 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~  142 (646)
                      .++++.+.+...++..+..+++|++|+|++|.|+++.|..|.++++|++|+|++|+++..+       .+.++++|++|+
T Consensus        14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L~   86 (317)
T 3o53_A           14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLD   86 (317)
T ss_dssp             EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEEE
T ss_pred             EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEEE
Confidence            3444445554444444444555555555555555555555555555666666555554421       145555555555


Q ss_pred             CCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccc
Q 046544          143 LSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKL  222 (646)
Q Consensus       143 Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  222 (646)
                      +++|++++++.                               .++|++|++++|++++..+..   +++|++|++++|++
T Consensus        87 Ls~n~l~~l~~-------------------------------~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l  132 (317)
T 3o53_A           87 LNNNYVQELLV-------------------------------GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKI  132 (317)
T ss_dssp             CCSSEEEEEEE-------------------------------CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCC
T ss_pred             CcCCccccccC-------------------------------CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCC
Confidence            55555443311                               123333333333333332222   23344444444444


Q ss_pred             cCcCchhhcCCCCCcEEEecCCcccccCCccc-cCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCcc
Q 046544          223 EGSIPDSICRLTELYELELGGNKLFGSIPACF-SNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEI  301 (646)
Q Consensus       223 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  301 (646)
                      ++..+..|..+++|++|+|++|++++..+..+ ..+++|++|++++|.++.+|... .+++|+.|++++|.+++. |..+
T Consensus       133 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l-~~~~  210 (317)
T 3o53_A          133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFM-GPEF  210 (317)
T ss_dssp             CSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEE-CGGG
T ss_pred             CCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcc-hhhh
Confidence            44444444444444444444444444433333 23445555555555554443221 244555555555555532 2335


Q ss_pred             CccccceEEEcccccccccCccccCCCCCCCEEEccCccCC-CcccccccCCCCCCEEEccC-CcCcccCCcc
Q 046544          302 GNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE-GSIPDSFGDLISLKFLNLSN-NNLSGAIPTS  372 (646)
Q Consensus       302 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~  372 (646)
                      ..+++|+.|++++|.+++ +|..+..+++|+.|++++|++. +.+|..+..+++|+.|++++ +.+++..|..
T Consensus       211 ~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          211 QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             GGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             cccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            566666777777777764 4666778888888888888887 67778888888888888884 4566555543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.2e-29  Score=261.00  Aligned_cols=185  Identities=19%  Similarity=0.251  Sum_probs=142.3

Q ss_pred             cccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhh---------cCCCCCcEEEecCCcccccC
Q 046544          180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSI---------CRLTELYELELGGNKLFGSI  250 (646)
Q Consensus       180 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------~~l~~L~~L~L~~N~i~~~~  250 (646)
                      ..+..+++|++|+|++|+++ .+|..+.++++|++|++++|.+.+.+|..+         .++++|++|+|++|+++ .+
T Consensus       121 ~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~l  198 (328)
T 4fcg_A          121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SL  198 (328)
T ss_dssp             SCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CC
T ss_pred             HHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cc
Confidence            33444444444444444444 334444455555555555544444444443         44888888888888887 66


Q ss_pred             CccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCC
Q 046544          251 PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN  330 (646)
Q Consensus       251 ~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  330 (646)
                      |..+.++++|++|++++|.++.+|..+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++.+..|..++.+++
T Consensus       199 p~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~  278 (328)
T 4fcg_A          199 PASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ  278 (328)
T ss_dssp             CGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTT
T ss_pred             hHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCC
Confidence            77788888888888888888888888888888888888888888888889999999999999999999999999999999


Q ss_pred             CCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          331 LEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       331 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      |++|+|++|++.+.+|+.++.+++|+.+++..|.+.
T Consensus       279 L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            999999999999999999999999999999988775

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=9.1e-32  Score=275.76  Aligned_cols=236  Identities=21%  Similarity=0.206  Sum_probs=120.4

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      +++|++|+|++|++++..|..|..+++|++|+|++|.+++..+  |..+++|++|+|++|+++.++          ..++
T Consensus        33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~----------~~~~  100 (317)
T 3o53_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----------VGPS  100 (317)
T ss_dssp             GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE----------ECTT
T ss_pred             CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc----------CCCC
Confidence            3455555555555555555555555556666666665554433  555566666666666555432          1255


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccc-cCCCCCCeEE
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL-SKLQKLQGLG  216 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~  216 (646)
                      |++|++++|+++++....     .++|++|++++|++++..|..+..+++|++|++++|++.+..+..+ ..+++|++|+
T Consensus       101 L~~L~l~~n~l~~~~~~~-----~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  175 (317)
T 3o53_A          101 IETLHAANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (317)
T ss_dssp             CCEEECCSSCCSEEEECC-----CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             cCEEECCCCccCCcCccc-----cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence            666666666555442211     1234444444444444444455555555556666655555544444 2455555555


Q ss_pred             eecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCccc-C
Q 046544          217 LDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLT-G  295 (646)
Q Consensus       217 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~-~  295 (646)
                      |++|.+++..+  ...+++|++|+|++|++++..+ .|..+++|+.|++++|.++.+|..+..+++|+.|++++|.+. +
T Consensus       176 L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             CCCCcCccccc--ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence            55555553311  2235555555555555553332 255555555555555555555554444555555555555544 3


Q ss_pred             CCCCccCccccceEEEcc
Q 046544          296 PLPLEIGNLKVLIGIDFS  313 (646)
Q Consensus       296 ~~~~~~~~l~~L~~L~ls  313 (646)
                      ..|..+..++.|+.++++
T Consensus       253 ~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          253 TLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             HHHHHHHTCHHHHHHHHH
T ss_pred             CHHHHHhccccceEEECC
Confidence            334444444444444444

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=264.79  Aligned_cols=147  Identities=29%  Similarity=0.408  Sum_probs=130.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEec------CCe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSN------EEF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------~~~  562 (646)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999965 799999999975432  334678899999999999999999998764      357


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+|||||+ |+|.+++...+ .+++..+..+++||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 68999987654 7899999999999999999999   899999999999999999999999999999876


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       209 ~  209 (398)
T 4b99_A          209 C  209 (398)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=8.5e-31  Score=267.89  Aligned_cols=202  Identities=19%  Similarity=0.226  Sum_probs=135.5

Q ss_pred             cCCCCCEEEccCCccccccCccc--cCCCCCCeEEeecccccCcCchhhcCC-----CCCcEEEecCCcccccCCccccC
Q 046544          184 NLTNSITIDLGGNKLNGSIPITL--SKLQKLQGLGLDDNKLEGSIPDSICRL-----TELYELELGGNKLFGSIPACFSN  256 (646)
Q Consensus       184 ~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~  256 (646)
                      ++++|++|++++|++++..|..+  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++.+..+..|++
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            56666666666666666556554  6666666666666666655 5556555     66666777777666666666666


Q ss_pred             CCCCceeecCCCcccc---ccccc--ccccccccccCCCCcccCC---CCCccCccccceEEEcccccccccCc-cccCC
Q 046544          257 LASLRILSLSSNELTS---IPLTF--WNLKDILQLNFSSNFLTGP---LPLEIGNLKVLIGIDFSMNNFSSVIP-TEIGG  327 (646)
Q Consensus       257 l~~L~~L~L~~N~l~~---lp~~~--~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~  327 (646)
                      +++|++|++++|++..   +|..+  ..+++|++|++++|.+++.   ....+..+++|+.|++++|.+++..| ..+..
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            6667777777666543   23333  5666666666666666521   11233456777777777777777664 45666


Q ss_pred             CCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          328 LKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       328 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +++|++|+|++|+++ .+|..+.  ++|++|||++|+|++. |. +..+++|++|++++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            788888888888887 5666555  7788888888888755 55 7788888888888888875

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.8e-30  Score=263.10  Aligned_cols=246  Identities=21%  Similarity=0.195  Sum_probs=143.8

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCcccc-ccCcccc-------CcCCCCEEEccCCCCCCCCCccccc
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSG-FIPNTFG-------NLRNLEWLNLRDNYLTSSTPELSFL  129 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~  129 (646)
                      .++|++|++++|.+  .+|..+...  |+.|+|++|.+.. ..|..+.       ++++|++|+|++|+++...+     
T Consensus        42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----  112 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP-----  112 (312)
T ss_dssp             EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC-----
T ss_pred             CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH-----
Confidence            34455555555555  344433332  5555666666532 2333333       45666666666666653211     


Q ss_pred             ccC--CCCCCCCEEECCCCCCCCcCCcchhccc----cccCcEEEeecccccccCCcccccCCCCCEEEccCCccccc--
Q 046544          130 SSL--SNCKSLTFIHLSDNPLDGILSKTSIGNL----SHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGS--  201 (646)
Q Consensus       130 ~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~~~~----~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--  201 (646)
                      ..+  .++++|++|++++|+++++ + ..+..+    .++|++|+|++|++.+..|..+..+++|++|++++|++.+.  
T Consensus       113 ~~~~~~~l~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  190 (312)
T 1wwl_A          113 PPLLEATGPDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG  190 (312)
T ss_dssp             CCSSSCCSCCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH
T ss_pred             HHHHHhcCCCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH
Confidence            112  5556666666666666555 1 222222    14566667777777666677777888888888888876554  


Q ss_pred             cCccc--cCCCCCCeEEeecccccC---cCchhhcCCCCCcEEEecCCcccccCC-ccccCCCCCceeecCCCccccccc
Q 046544          202 IPITL--SKLQKLQGLGLDDNKLEG---SIPDSICRLTELYELELGGNKLFGSIP-ACFSNLASLRILSLSSNELTSIPL  275 (646)
Q Consensus       202 ~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~lp~  275 (646)
                      .|..+  ..+++|++|+|++|+|++   .....+..+++|++|+|++|++++..| ..+..+++|++|+|++|.|+++|.
T Consensus       191 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~  270 (312)
T 1wwl_A          191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK  270 (312)
T ss_dssp             HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCS
T ss_pred             HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhh
Confidence            22233  677778888888887773   222344567777777777777776554 455667777777777777777766


Q ss_pred             ccccccccccccCCCCcccCCCCCccCccccceEEEccccccc
Q 046544          276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS  318 (646)
Q Consensus       276 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  318 (646)
                      .+.  ++|+.|++++|++++. |. +..+++|+.|++++|.++
T Consensus       271 ~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          271 GLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             SCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             hcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            554  5555555555555543 33 455555555555555544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=6.4e-29  Score=271.13  Aligned_cols=149  Identities=24%  Similarity=0.318  Sum_probs=130.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHH---HHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFA---VECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++.+..   ........   .++++++.++|||||++++++.+++..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56899999999999999999965 69999999997532   11222233   3466777889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +|||||+||+|.+++...+ .+++..+..+++||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999998754 6899999999999999999999   89999999999999999999999999999987653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=9.2e-32  Score=300.39  Aligned_cols=400  Identities=16%  Similarity=0.123  Sum_probs=202.7

Q ss_pred             ccCCCCCCEEECCCCcc---cccCCcCcc------------CCCCCCEEECcCCcCcccCCc-cCcCCCC-CCCEEEccC
Q 046544            6 ISNLQNLEELDLRHNKL---VGTVPAAIF------------NMSMLKLLHLQNNSLLGCLSS-IADVRLP-NLEALLLWG   68 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l---~~~~~~~~~------------~l~~L~~L~L~~N~l~~~~~~-~~~~~l~-~L~~L~L~~   68 (646)
                      +..+++|++|+|+++.-   .+..|..+.            .+++|++|+|++|.+++.... +.. .++ +|++|+|++
T Consensus        69 ~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~-~~~~~L~~L~L~~  147 (592)
T 3ogk_B           69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAK-ARADDLETLKLDK  147 (592)
T ss_dssp             HHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHH-HHGGGCCEEEEES
T ss_pred             HHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHH-hccccCcEEECcC
Confidence            45667778888876542   123333333            567788888887776532211 111 123 377777777


Q ss_pred             Cc-ccc-cCCccccCCCCCcEEEcccCcccccc----CccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEE
Q 046544           69 NN-FSG-TIPRFIFNASKLSILELSQNSFSGFI----PNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIH  142 (646)
Q Consensus        69 N~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~  142 (646)
                      |. ++. ..+.....+++|++|+|++|.+++..    +..+..+++|++|+|++|.++...... +...+.++++|++|+
T Consensus       148 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~-l~~~~~~~~~L~~L~  226 (592)
T 3ogk_B          148 CSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKD-LETIARNCRSLVSVK  226 (592)
T ss_dssp             CEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHH-HHHHHHHCTTCCEEE
T ss_pred             CCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHH-HHHHHhhCCCCcEEe
Confidence            75 221 12222345677777777777776542    223456677777777777776332111 233345677777777


Q ss_pred             CCCCCCCCcCCcchhccccccCcEEEeeccccc---ccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeec
Q 046544          143 LSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVS---GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD  219 (646)
Q Consensus       143 Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  219 (646)
                      +++|.+.+++  ..+..+ ++|++|+++.+...   ...+..+..+++|+.|+++++... ..|..+..+++|++|+|++
T Consensus       227 L~~~~~~~l~--~~~~~~-~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~  302 (592)
T 3ogk_B          227 VGDFEILELV--GFFKAA-ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY  302 (592)
T ss_dssp             CSSCBGGGGH--HHHHHC-TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred             ccCccHHHHH--HHHhhh-hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence            7777776542  222222 46677776643322   123344455556666666554322 3444555555666666666


Q ss_pred             ccccCcCc-hhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCC-----------Ccccc--ccccccccccccc
Q 046544          220 NKLEGSIP-DSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS-----------NELTS--IPLTFWNLKDILQ  285 (646)
Q Consensus       220 N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-----------N~l~~--lp~~~~~l~~L~~  285 (646)
                      |.+++... ..+..+++|++|+++++-..+..+..+..+++|+.|++++           |.++.  ++..+..+++|++
T Consensus       303 ~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  382 (592)
T 3ogk_B          303 ALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY  382 (592)
T ss_dssp             CCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSE
T ss_pred             CcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeE
Confidence            65543222 2245555666666652221222223334455566666652           34442  2222233555555


Q ss_pred             ccCCCCcccCCCCCccCc-cccceEEEcc----ccccccc-----CccccCCCCCCCEEEccCc--cCCCccccccc-CC
Q 046544          286 LNFSSNFLTGPLPLEIGN-LKVLIGIDFS----MNNFSSV-----IPTEIGGLKNLEYLFLGYN--RLEGSIPDSFG-DL  352 (646)
Q Consensus       286 L~l~~N~l~~~~~~~~~~-l~~L~~L~ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l  352 (646)
                      |+++.|.+++..+..+.. +++|+.|+++    .|.+++.     .+..+.++++|++|++++|  .+++..+..+. .+
T Consensus       383 L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~  462 (592)
T 3ogk_B          383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYS  462 (592)
T ss_dssp             EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSC
T ss_pred             EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhC
Confidence            555555555443333333 5555555554    4444432     2222444555555555432  24433333332 24


Q ss_pred             CCCCEEEccCCcCcc-cCCccccCCCCCCceeCcCCcceee-ccCC-CCCCCCccccccCCc
Q 046544          353 ISLKFLNLSNNNLSG-AIPTSLEKLSYLEDLNLSFNKLEGE-IPRG-GSFGNFAAESFEGNE  411 (646)
Q Consensus       353 ~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~-~~~~~~~~~~~~~N~  411 (646)
                      ++|+.|++++|++++ .++..+..+++|++|++++|++++. ++.. ..+++++.+++++|+
T Consensus       463 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             TTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             ccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            555555555555554 2333344555555555555555432 1211 124455555555555

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=5.2e-29  Score=258.04  Aligned_cols=147  Identities=24%  Similarity=0.314  Sum_probs=130.6

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      ....++|++.+.||+|+||+||+|+.+    +++.||+|.+....  ...++.+|+++++.+ +|||||++++++.+++.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            344578999999999999999999753    47889999886543  335678999999998 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKL  641 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~~  641 (646)
                      .|+|||||+||+|.+++.    .+++.++..+++|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999999984    4789999999999999999999   8999999999999999876 8999999999986


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       168 ~~  169 (361)
T 4f9c_A          168 TH  169 (361)
T ss_dssp             CT
T ss_pred             cC
Confidence            53

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=8.5e-29  Score=272.08  Aligned_cols=150  Identities=21%  Similarity=0.318  Sum_probs=138.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999865 79999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC--CcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN--LVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~--~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++......+++.++..+++||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999776667999999999999999999999   8899999999999999854  8999999999998754

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=5.3e-29  Score=269.95  Aligned_cols=242  Identities=19%  Similarity=0.167  Sum_probs=192.0

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +|+.|+|++|.+++..|..|..+++|++|+|++|.+++.+|  |..+++|++|+|++|.|++..+     .++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            45666666666666667788888999999999999887665  8888899999999998885443     3789999999


Q ss_pred             CCcccccCCccccCCCCCceeecCCCccccc-ccccccccccccccCCCCcccCCCCCccC-ccccceEEEccccccccc
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIG-NLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~  320 (646)
                      +|.|++..+..   +++|+.|+|++|.++.+ |..+..+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus       108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            99988766543   57889999999999877 45678888999999999999887787776 789999999999999876


Q ss_pred             CccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee-eccCC-CC
Q 046544          321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG-EIPRG-GS  398 (646)
Q Consensus       321 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~-~~  398 (646)
                      .+  +..+++|++|+|++|++++.+ ..|..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++.+ .+|.. ..
T Consensus       185 ~~--~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~  260 (487)
T 3oja_A          185 KG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK  260 (487)
T ss_dssp             EC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred             cc--cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence            33  446899999999999999644 458899999999999999985 67788899999999999999983 33332 44


Q ss_pred             CCCCcccccc-------CCccccCCCC
Q 046544          399 FGNFAAESFE-------GNELLCGSPT  418 (646)
Q Consensus       399 ~~~~~~~~~~-------~N~~~c~~~~  418 (646)
                      +..+..+++.       +|++.|.++.
T Consensus       261 l~~L~~l~~~~~~~~~~~~~~~c~~~~  287 (487)
T 3oja_A          261 NQRVQTVAKQTVKKLTGQNEEECTVPT  287 (487)
T ss_dssp             CHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred             CCCCcEEeccccccccCCCcccccCCc
Confidence            5556666664       7888887654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=4.1e-28  Score=243.51  Aligned_cols=209  Identities=27%  Similarity=0.309  Sum_probs=137.2

Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecC
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      ++++|++++|++++..+..|.++++|++|++++|++++..+.+|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45566666666665555556666666666666666665555556666666666666666665555666666666666666


Q ss_pred             CCccccccc-ccccccccccccCCCCcccCC-CCCccCccccceEEEcccccccccCccccCCCCCCC----EEEccCcc
Q 046544          267 SNELTSIPL-TFWNLKDILQLNFSSNFLTGP-LPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE----YLFLGYNR  340 (646)
Q Consensus       267 ~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  340 (646)
                      +|.++.++. .+..+++|++|++++|.+++. +|..+..+++|+.|++++|.++++.+..|..+++|+    +|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            666665543 455556666666666666543 366666677777777777777766666666666665    78888888


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      +++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|+++|.+|..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            87555555443 47888888888888666666778888888888888888766643

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=9.4e-29  Score=267.99  Aligned_cols=222  Identities=23%  Similarity=0.215  Sum_probs=198.1

Q ss_pred             cCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCcee
Q 046544          184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL  263 (646)
Q Consensus       184 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  263 (646)
                      ..++|+.|+|++|.+++.+|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|++..+     .++|++|
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            34489999999999999989999999999999999999997666  9999999999999999986543     3899999


Q ss_pred             ecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccC-CCCCCCEEEccCccCC
Q 046544          264 SLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIG-GLKNLEYLFLGYNRLE  342 (646)
Q Consensus       264 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~  342 (646)
                      ++++|.++.+|..  .+++|+.|++++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|++|+|++|.++
T Consensus       105 ~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          105 HAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             ECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             ECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            9999999988754  468899999999999999899999999999999999999998888886 7999999999999999


Q ss_pred             CcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCC
Q 046544          343 GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       343 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      +..+  +..+++|+.|+|++|.|++.. ..+..+++|+.|+|++|++++.++....++.+..+++++|++.|++.
T Consensus       183 ~~~~--~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~  254 (487)
T 3oja_A          183 DVKG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL  254 (487)
T ss_dssp             EEEC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred             cccc--cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence            6633  446999999999999999654 45999999999999999999865555678899999999999998643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=3.5e-31  Score=295.70  Aligned_cols=375  Identities=15%  Similarity=0.106  Sum_probs=277.9

Q ss_pred             CCCCCCEEECCCCcccccCCcCccCC--CCCCEEECcCCcC-cc-cCCccCcCCCCCCCEEEccCCccccc----CCccc
Q 046544            8 NLQNLEELDLRHNKLVGTVPAAIFNM--SMLKLLHLQNNSL-LG-CLSSIADVRLPNLEALLLWGNNFSGT----IPRFI   79 (646)
Q Consensus         8 ~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l-~~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~   79 (646)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|.- +. .+..+. ..+++|++|+|++|.+++.    ++..+
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~-~~~~~L~~L~L~~~~~~~~~~~~l~~~~  188 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV-THCRKIKTLLMEESSFSEKDGKWLHELA  188 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHH-HHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHH-hhCCCCCEEECccccccCcchhHHHHHH
Confidence            78999999999999887666666663  4599999999872 11 011111 1478999999999998765    33455


Q ss_pred             cCCCCCcEEEcccCcccc----ccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCc-CC-
Q 046544           80 FNASKLSILELSQNSFSG----FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGI-LS-  153 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~-  153 (646)
                      ..+++|++|++++|.+++    ..+..+.++++|++|+|++|.+..+      +..+.++++|++|+++.+..... .. 
T Consensus       189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l------~~~~~~~~~L~~L~l~~~~~~~~~~~~  262 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILEL------VGFFKAAANLEEFCGGSLNEDIGMPEK  262 (592)
T ss_dssp             HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGG------HHHHHHCTTCCEEEECBCCCCTTCTTS
T ss_pred             hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHH------HHHHhhhhHHHhhcccccccccchHHH
Confidence            678999999999999973    3345567889999999999998764      34577889999999986432210 00 


Q ss_pred             cchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccC-ccccCCCCCCeEEeecccccCcCchhhcC
Q 046544          154 KTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIP-ITLSKLQKLQGLGLDDNKLEGSIPDSICR  232 (646)
Q Consensus       154 ~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  232 (646)
                      ...+. ..++|+.++++++... .+|..+..+++|++|++++|.+++... ..+..+++|++|+++++...+.++..+..
T Consensus       263 ~~~l~-~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~  340 (592)
T 3ogk_B          263 YMNLV-FPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY  340 (592)
T ss_dssp             SSCCC-CCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHH
T ss_pred             HHHhh-ccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHh
Confidence            11112 2357999999886433 567888899999999999999865544 34688999999999944333344555577


Q ss_pred             CCCCcEEEec-----------CCcccccC-CccccCCCCCceeecCCCcccc-ccccccc-ccccccccCC----CCccc
Q 046544          233 LTELYELELG-----------GNKLFGSI-PACFSNLASLRILSLSSNELTS-IPLTFWN-LKDILQLNFS----SNFLT  294 (646)
Q Consensus       233 l~~L~~L~L~-----------~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~-l~~L~~L~l~----~N~l~  294 (646)
                      +++|++|+++           .|.+++.. +..+.++++|++|+++.|.++. .+..+.. +++|+.|+++    .|.++
T Consensus       341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~  420 (592)
T 3ogk_B          341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT  420 (592)
T ss_dssp             CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred             CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence            8999999999           36666432 2335568999999999999884 3344444 7899999996    67777


Q ss_pred             CC-----CCCccCccccceEEEccccc--ccccCccccC-CCCCCCEEEccCccCCCc-ccccccCCCCCCEEEccCCcC
Q 046544          295 GP-----LPLEIGNLKVLIGIDFSMNN--FSSVIPTEIG-GLKNLEYLFLGYNRLEGS-IPDSFGDLISLKFLNLSNNNL  365 (646)
Q Consensus       295 ~~-----~~~~~~~l~~L~~L~ls~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l  365 (646)
                      +.     ++..+.++++|+.|++++|.  +++..+..+. .+++|++|++++|++++. .+..+.++++|+.|+|++|.+
T Consensus       421 ~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l  500 (592)
T 3ogk_B          421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF  500 (592)
T ss_dssp             SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred             CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence            54     23336678999999998543  6655555444 478999999999999863 455668899999999999998


Q ss_pred             ccc-CCccccCCCCCCceeCcCCccee
Q 046544          366 SGA-IPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       366 ~~~-~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      ++. ++..+..+++|++|+|++|+++.
T Consensus       501 ~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          501 SERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             BHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             cHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            754 44555689999999999999875

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=2e-27  Score=239.83  Aligned_cols=205  Identities=24%  Similarity=0.201  Sum_probs=125.5

Q ss_pred             ccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCC
Q 046544          181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL  260 (646)
Q Consensus       181 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  260 (646)
                      .+.++++++++++++|.++.+++. +.  ++++.|+|++|.+++..+..|..+++|++|+|++|.|++..+.  ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~ip~~-~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCCcCCCC-CC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            356677888888888888754433 32  5777888888888777777777888888888888887755442  667777


Q ss_pred             ceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      ++|++++|.++.+|..+..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|+
T Consensus        80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            77777777777777666666666666666666665555555555555555555555555544455555555555555555


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.++|++|++.|
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            55444444455555555555555554 344444444444444444444433

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=4.4e-27  Score=237.30  Aligned_cols=210  Identities=27%  Similarity=0.276  Sum_probs=187.7

Q ss_pred             cccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccc
Q 046544          205 TLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDIL  284 (646)
Q Consensus       205 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~  284 (646)
                      .+.++++++++++++|.++. +|..+.  ++++.|+|++|++++..+..|.++++|++|++++|.|+.+|.. ..+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred             cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence            46788899999999999994 555443  6899999999999988899999999999999999999998765 7889999


Q ss_pred             cccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCc
Q 046544          285 QLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN  364 (646)
Q Consensus       285 ~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  364 (646)
                      .|++++|.++ .+|..+..+++|+.|++++|+++++.|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            9999999998 578889999999999999999999888999999999999999999998888889999999999999999


Q ss_pred             CcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCCc
Q 046544          365 LSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTL  419 (646)
Q Consensus       365 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~~  419 (646)
                      |++..+..|..+++|+.|+|++|+++..++.......++.+++.+|||.|+|...
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~~  214 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEIL  214 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCccH
Confidence            9977777889999999999999999965555556778999999999999988653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=3e-27  Score=237.16  Aligned_cols=205  Identities=21%  Similarity=0.205  Sum_probs=168.5

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      ++++|++++|++++..+..|.++++|++|++++|++.+..+..|.++++|++|++++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45555555555555566677888888888888888887777788888888888888888887777888888888888888


Q ss_pred             CCcccccCCccccCCCCCceeecCCCcccc--cccccccccccccccCCCCcccCCCCCccCccccce----EEEccccc
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTS--IPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLI----GIDFSMNN  316 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~ls~N~  316 (646)
                      +|++.+..+..|..+++|++|++++|.++.  +|..+..+++|+.|++++|.+++..+..+..++.|+    .|++++|.
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            888887777778888888888888888886  577788888888888888888877777777777776    89999999


Q ss_pred             ccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCccc
Q 046544          317 FSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA  368 (646)
Q Consensus       317 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  368 (646)
                      ++++.+..+.. .+|++|++++|++++..+..|..+++|+.|+|++|++++.
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence            99877766655 4899999999999988778889999999999999999854

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=9.8e-27  Score=232.56  Aligned_cols=205  Identities=28%  Similarity=0.346  Sum_probs=138.6

Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecC
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      +.+.+++++|+++. +|..+.  +++++|++++|++++..+.+|..+++|++|+|++|+++.+.+..|.++++|++|+++
T Consensus        17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            34566666666663 333332  456666666666666555566666667777777776665555666666677777777


Q ss_pred             CCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcc
Q 046544          267 SNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSI  345 (646)
Q Consensus       267 ~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  345 (646)
                      +|.++.+|. .|..+++|++|++++|.+++..+..|..+++|+.|++++|.++++.+..|+.+++|++|++++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            776666654 3455666666666666666666666677777777777777777766666777777777777777777666


Q ss_pred             cccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeecc
Q 046544          346 PDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       346 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  394 (646)
                      +..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+.++
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            6677777777777777777776666667777777777777777766554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.95  E-value=4.9e-28  Score=257.55  Aligned_cols=157  Identities=24%  Similarity=0.286  Sum_probs=139.6

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEec
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSN  559 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  559 (646)
                      +.++....++|+..++||+|+||+||+|+.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556688999999999999999999976 58899999997532   2223447889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      ++..|+|||||+||+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+|||++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999876667999999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       223 ~~~~  226 (437)
T 4aw2_A          223 LKLM  226 (437)
T ss_dssp             EECC
T ss_pred             hhcc
Confidence            8654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.7e-26  Score=230.76  Aligned_cols=206  Identities=29%  Similarity=0.373  Sum_probs=187.6

Q ss_pred             CCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccc-cccccccccccC
Q 046544          210 QKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNF  288 (646)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l  288 (646)
                      .+.+.++++++.++. +|..+.  +++++|+|++|++++..+..|.++++|++|++++|.++.+|.. |..+++|++|++
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            367899999999994 665554  5899999999999988888999999999999999999999875 578999999999


Q ss_pred             CCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCccc
Q 046544          289 SSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA  368 (646)
Q Consensus       289 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  368 (646)
                      ++|.+++..+..|..+++|+.|++++|.+++..+..|+.+++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            99999988888899999999999999999999999999999999999999999988888899999999999999999988


Q ss_pred             CCccccCCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCCC
Q 046544          369 IPTSLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       369 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      .+..|..+++|++|++++|++++.++.. ..+..++.+++++|||.|+|+.
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            8888999999999999999999866543 4578899999999999998863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=1.5e-26  Score=236.37  Aligned_cols=149  Identities=26%  Similarity=0.446  Sum_probs=138.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|...+.||+|+||+||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57888999999999999999975 68999999987665566778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            999999999987778999999999999999999999   8899999999999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=2.6e-26  Score=232.90  Aligned_cols=147  Identities=30%  Similarity=0.404  Sum_probs=136.1

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            5799999999999999999985 479999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A          100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999775  4889999999999999999999   8899999999999999999999999999988654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=1.7e-26  Score=237.32  Aligned_cols=149  Identities=27%  Similarity=0.448  Sum_probs=135.7

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ..+|+..+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997 579999999997653  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999997654 5899999999999999999999   8899999999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=4.6e-26  Score=233.71  Aligned_cols=159  Identities=28%  Similarity=0.313  Sum_probs=142.8

Q ss_pred             ccccHHHHHHHhCC----------CCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCC
Q 046544          480 RTFSYLELCRATNG----------FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR  548 (646)
Q Consensus       480 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~  548 (646)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45778888877764          666789999999999999976 7999999999877666667889999999999999


Q ss_pred             CceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC
Q 046544          549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN  628 (646)
Q Consensus       549 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~  628 (646)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998654  5899999999999999999999   8899999999999999999


Q ss_pred             CcEEEEeecCccccc
Q 046544          629 LVAYLSDFGIAKLLI  643 (646)
Q Consensus       629 ~~~ki~DfGla~~~~  643 (646)
                      +.+||+|||+++.+.
T Consensus       178 ~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          178 GRVKLSDFGFCAQIS  192 (321)
T ss_dssp             CCEEECCCTTCEECC
T ss_pred             CcEEEeeeeeeeecc
Confidence            999999999988754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=9.1e-27  Score=246.03  Aligned_cols=157  Identities=25%  Similarity=0.312  Sum_probs=139.4

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEec
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSN  559 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  559 (646)
                      +.+.....++|+..+.||+|+||+||+|+.+ +|+.||+|++....   ....+.+.+|+.++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455678999999999999999999975 79999999997532   2233457889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      ++..|+||||++||+|.+++...+..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876557899999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       210 ~~~~  213 (412)
T 2vd5_A          210 LKLR  213 (412)
T ss_dssp             EECC
T ss_pred             eecc
Confidence            8764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=1.1e-26  Score=238.49  Aligned_cols=156  Identities=38%  Similarity=0.612  Sum_probs=141.6

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      +.++...+++|+..+.||+|+||.||+|++++|+.||+|++........+.+.+|+++++.++||||+++++++...+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34445567899999999999999999999888999999998876666678899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          564 ALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ++||||+++|+|.+++....   ..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999986543   35889999999999999999999   8899999999999999999999999999998


Q ss_pred             cc
Q 046544          641 LL  642 (646)
Q Consensus       641 ~~  642 (646)
                      ..
T Consensus       188 ~~  189 (321)
T 2qkw_B          188 KG  189 (321)
T ss_dssp             EC
T ss_pred             cc
Confidence            64

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=3.5e-26  Score=235.03  Aligned_cols=149  Identities=30%  Similarity=0.500  Sum_probs=134.8

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|++.    .+..||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46778899999999999999874    35569999997653 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999877678999999999999999999999   8899999999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=3.8e-26  Score=235.40  Aligned_cols=147  Identities=27%  Similarity=0.360  Sum_probs=133.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999965 6999999999754   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||++||+|.+++...+ .+++..+..++.||+.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            9999999999987654 6889999999999999999999   889999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=1.8e-26  Score=243.55  Aligned_cols=154  Identities=25%  Similarity=0.311  Sum_probs=136.2

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecC
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE  560 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  560 (646)
                      .++....++|+..+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445578999999999999999999975 68999999997531   22234578899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      +..|+|||||+||+|.+++...  .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999765  4889999999999999999999   8899999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       217 ~~~  219 (410)
T 3v8s_A          217 KMN  219 (410)
T ss_dssp             ECC
T ss_pred             eec
Confidence            764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=4.6e-26  Score=236.30  Aligned_cols=148  Identities=28%  Similarity=0.345  Sum_probs=133.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999965 68999999997542   23446678899999988 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||||++||+|.+++...+ .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999997654 6899999999999999999999   889999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=6.6e-26  Score=226.47  Aligned_cols=148  Identities=29%  Similarity=0.454  Sum_probs=136.5

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|++.+++.||+|++..... ..+++.+|++++++++||||+++++++..++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57888999999999999999998899999999975533 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            99999999877777899999999999999999999   8899999999999999999999999999998653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1e-25  Score=231.04  Aligned_cols=149  Identities=20%  Similarity=0.302  Sum_probs=135.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367899999999999999999865 68999999987543 3446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC--CCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~~~  643 (646)
                      ++||+|.+++......+++.++..++.|++.|++|||   ..+|+||||||+||+++.  ++.+||+|||+|+.+.
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999876667999999999999999999999   889999999999999986  7899999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=3.2e-26  Score=239.71  Aligned_cols=149  Identities=28%  Similarity=0.522  Sum_probs=129.5

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .+|+..+.||+|+||.||+|+..    ++..||||+++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47889999999999999999864    57789999987653 33456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|+|.+++...+..+++.++..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999887777999999999999999999999   8899999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=6.2e-26  Score=237.35  Aligned_cols=149  Identities=29%  Similarity=0.512  Sum_probs=132.9

Q ss_pred             CCCCcceeecccccceEEEEEe--------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ++|+..+.||+|+||.||+|++        .++..||||+++... ....+.+.+|+++++.+ +||||+++++++..++
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            5788899999999999999985        235679999987553 23456789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..|+||||+++|+|.+++....               ..+++.++..++.|++.||+|||   .++|+||||||+||+++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence            9999999999999999998653               24788999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      .++.+||+|||+|+.+.
T Consensus       238 ~~~~~kl~DFG~a~~~~  254 (370)
T 2psq_A          238 ENNVMKIADFGLARDIN  254 (370)
T ss_dssp             TTCCEEECCCSSCEETT
T ss_pred             CCCCEEEccccCCcccC
Confidence            99999999999998654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.93  E-value=3.6e-26  Score=235.19  Aligned_cols=166  Identities=39%  Similarity=0.590  Sum_probs=145.7

Q ss_pred             ccccccHHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEE
Q 046544          478 TWRTFSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISS  556 (646)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~  556 (646)
                      ....+++.++....++|+..+.||+|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3467888999999999999999999999999999988899999999875432 223468899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 046544          557 CSNEEFKALVLEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYL  633 (646)
Q Consensus       557 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki  633 (646)
                      +...+..++||||+++|+|.+++....   ..+++..+..++.|++.|++|||..+..+|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997653   34899999999999999999999433339999999999999999999999


Q ss_pred             EeecCccccc
Q 046544          634 SDFGIAKLLI  643 (646)
Q Consensus       634 ~DfGla~~~~  643 (646)
                      +|||+|+.+.
T Consensus       176 ~Dfg~~~~~~  185 (326)
T 3uim_A          176 GDFGLAKLMD  185 (326)
T ss_dssp             CCCSSCEECC
T ss_pred             ccCccccccC
Confidence            9999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=9.7e-26  Score=230.59  Aligned_cols=148  Identities=28%  Similarity=0.369  Sum_probs=134.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999965 69999999997542   234567788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+...
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999998754 6889999999999999999999   8999999999999999999999999999998653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=7.4e-26  Score=221.91  Aligned_cols=196  Identities=19%  Similarity=0.258  Sum_probs=105.3

Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeeccc-ccCcCchhhcCCCCCcEEEecC-CcccccCCccccCCCCCceee
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK-LEGSIPDSICRLTELYELELGG-NKLFGSIPACFSNLASLRILS  264 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~  264 (646)
                      ++++|++++|+++++++..|.++++|++|++++|+ ++.+.+.+|.++++|++|++++ |+++++.+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            45555555555555555555555555555555554 5544444555555555555555 555555555555555555555


Q ss_pred             cCCCcccccccccccccccc---cccCCCC-cccCCCCCccCccccce-EEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          265 LSSNELTSIPLTFWNLKDIL---QLNFSSN-FLTGPLPLEIGNLKVLI-GIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       265 L~~N~l~~lp~~~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      +++|.++.+|. +..+++|+   .|++++| .+++..+..|..+++|+ .|++++|.++.+.+..|.. ++|+.|++++|
T Consensus       112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence            55555555554 44444444   5555555 44444444455555555 5555555555444444444 55666666666


Q ss_pred             c-CCCcccccccCC-CCCCEEEccCCcCcccCCccccCCCCCCceeCcCC
Q 046544          340 R-LEGSIPDSFGDL-ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN  387 (646)
Q Consensus       340 ~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  387 (646)
                      + +++..+..|..+ ++|+.|++++|++++ +|..  .+++|+.|+++++
T Consensus       190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             TTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            3 554445555555 566666666666653 2222  3455555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=6.5e-26  Score=226.80  Aligned_cols=227  Identities=24%  Similarity=0.272  Sum_probs=123.5

Q ss_pred             CcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccC
Q 046544           85 LSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSL  164 (646)
Q Consensus        85 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L  164 (646)
                      +..++++.+.+.+.  ..+..+++|+.|++++|.++.++       .+..+++|++|++++|.++++             
T Consensus        21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~-------~l~~l~~L~~L~l~~n~l~~~-------------   78 (272)
T 3rfs_A           21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQ-------GIQYLPNVRYLALGGNKLHDI-------------   78 (272)
T ss_dssp             HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCCT-------TGGGCTTCCEEECTTSCCCCC-------------
T ss_pred             HHHHHhcCcccccc--cccccccceeeeeeCCCCccccc-------ccccCCCCcEEECCCCCCCCc-------------
Confidence            33444444444433  22445555666666655555432       234445555555555544322             


Q ss_pred             cEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCC
Q 046544          165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       165 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                                     ..+..+++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|
T Consensus        79 ---------------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  143 (272)
T 3rfs_A           79 ---------------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN  143 (272)
T ss_dssp             ---------------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ---------------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCC
Confidence                           12344445555555555555444444455555555555555555444444455555555555555


Q ss_pred             cccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccc
Q 046544          245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE  324 (646)
Q Consensus       245 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  324 (646)
                      ++++..+..|..+++|+.|++++|.++.                       ..+..+..+++|+.|++++|.+++..|..
T Consensus       144 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  200 (272)
T 3rfs_A          144 QLQSLPKGVFDKLTNLTELDLSYNQLQS-----------------------LPEGVFDKLTQLKDLRLYQNQLKSVPDGV  200 (272)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCC-----------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             ccCccCHHHhccCccCCEEECCCCCcCc-----------------------cCHHHhcCCccCCEEECCCCcCCccCHHH
Confidence            5544444444444444444444444443                       33444555666666666666666666666


Q ss_pred             cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCC
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSY  378 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  378 (646)
                      |+.+++|++|++++|++.+.       +++|+.|+++.|.++|.+|.+++.++.
T Consensus       201 ~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          201 FDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            77777777777777776633       446777778888888888877765543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=9e-26  Score=225.35  Aligned_cols=149  Identities=30%  Similarity=0.426  Sum_probs=136.7

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++++++||||+++++++..++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            357889999999999999999998888999999975543 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence            999999999876666899999999999999999999   8899999999999999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=1.1e-25  Score=229.84  Aligned_cols=148  Identities=26%  Similarity=0.401  Sum_probs=133.3

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+..+|+.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            6789999999999999999999889999999987543  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++ ++.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            975 898888877777999999999999999999999   8899999999999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=1.9e-25  Score=232.37  Aligned_cols=149  Identities=26%  Similarity=0.384  Sum_probs=134.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      .+.|+..+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357899999999999999999965 699999999986532      1346789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIA  639 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla  639 (646)
                      ++||||++||+|.+++...+ .+++..+..++.||+.|++|||   ..+|+||||||+||++++++    .+||+|||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 6899999999999999999999   88999999999999998776    7999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       167 ~~~~  170 (361)
T 2yab_A          167 HEIE  170 (361)
T ss_dssp             EECC
T ss_pred             eEcC
Confidence            8764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=9.6e-26  Score=233.03  Aligned_cols=151  Identities=24%  Similarity=0.351  Sum_probs=133.6

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      ....++|+..+.||+|+||+||+|+.+ +|+.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345578999999999999999999975 68999999997542   23446678899999876 99999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+||||++||+|.+++...+ .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999997654 5899999999999999999999   889999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.93  E-value=1.5e-25  Score=230.89  Aligned_cols=151  Identities=23%  Similarity=0.396  Sum_probs=130.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-------  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-------  561 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357889999999999999999976 79999999997554 345578899999999999999999999886543       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHHhhCCC--CCCHH
Q 046544          562 --------------------------------------------------FKALVLEYKPHGSLEKYLYSSNC--ILDIF  589 (646)
Q Consensus       562 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~l~~~  589 (646)
                                                                        ..++|||||++|+|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999986542  34566


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          590 QRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       590 ~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      .+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.+..
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  216 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  216 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSC
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCccccccc
Confidence            78899999999999999   88999999999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=3.4e-26  Score=240.17  Aligned_cols=150  Identities=29%  Similarity=0.448  Sum_probs=135.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|++. +++.||||+++.... ...+++.+|+++++.++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357888999999999999999976 789999999875432 234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++|+|.+++...+..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+...
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999876666899999999999999999999   8899999999999999999999999999998643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=9.8e-26  Score=235.87  Aligned_cols=148  Identities=28%  Similarity=0.371  Sum_probs=134.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57889999999999999999865 68999999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++.... .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999997654 6899999999999999999999   8899999999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.93  E-value=3.4e-26  Score=231.83  Aligned_cols=149  Identities=31%  Similarity=0.504  Sum_probs=133.4

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  564 (646)
                      ++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5788999999999999999984     36889999999876666667899999999999999999999998654  4589


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999887667899999999999999999999   8899999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=1.2e-25  Score=227.60  Aligned_cols=148  Identities=27%  Similarity=0.437  Sum_probs=134.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57899999999999999999865 68999999986543   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999997654 6899999999999999999999   8899999999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=8.8e-26  Score=237.02  Aligned_cols=147  Identities=27%  Similarity=0.313  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||+||+|+.+ +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+++..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57899999999999999999965 68899999998653   22335678899999876 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||++||+|.+++...+ .+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999987654 6899999999999999999999   889999999999999999999999999999863

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.3e-25  Score=224.52  Aligned_cols=205  Identities=26%  Similarity=0.281  Sum_probs=172.3

Q ss_pred             ccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCC
Q 046544          181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL  260 (646)
Q Consensus       181 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  260 (646)
                      ....+++|+.|++++|.+...  ..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++..+..|.++++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            355677788888888887643  3477788888888888888753  467888888888888888887777778888888


Q ss_pred             ceeecCCCcccccccc-cccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          261 RILSLSSNELTSIPLT-FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      ++|++++|.++.+|.. |..+++|++|++++|.+++..+..+..+++|+.|++++|++++..+..|+.+++|++|++++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            8888888888877654 677888888888888888777778889999999999999999888888999999999999999


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      ++++..|..|..+++|+.|++++|.+.+.       ++.|+.+++..|.++|.+|..
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            99988888899999999999999988744       557899999999999998876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.93  E-value=1.8e-25  Score=234.61  Aligned_cols=150  Identities=21%  Similarity=0.328  Sum_probs=136.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            57899999999999999999865 68999999998765555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC--CCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~~~~  644 (646)
                      ++|+|.+++...+..+++..+..++.|++.||+|||   ..+|+||||||+||+++.  .+.+||+|||+|+.+..
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999876667899999999999999999999   889999999999999974  57899999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=1.5e-25  Score=231.98  Aligned_cols=147  Identities=28%  Similarity=0.314  Sum_probs=132.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++++ +||||+++++++.+++..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57889999999999999999975 68999999998653   23345678899999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||++||+|.+++...+ .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999997654 6899999999999999999999   889999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=1.5e-25  Score=232.27  Aligned_cols=148  Identities=24%  Similarity=0.340  Sum_probs=134.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999975 69999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceecc
Confidence            9999999999997654 5899999999999999999999   8899999999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=1.4e-25  Score=225.89  Aligned_cols=149  Identities=26%  Similarity=0.443  Sum_probs=133.7

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|++.++..||+|++..... ..+++.+|+++++.++||||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            467888999999999999999998889999999975533 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999875567899999999999999999999   8899999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=1.1e-25  Score=230.96  Aligned_cols=148  Identities=24%  Similarity=0.354  Sum_probs=131.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999875 789999999975532 234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999986553 6899999999999999999999   889999999999999999999999999999765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=3.6e-25  Score=223.96  Aligned_cols=148  Identities=28%  Similarity=0.411  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999975 68999999997553  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++ ++.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            9975 777777766668999999999999999999999   8899999999999999999999999999998653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=1.4e-25  Score=230.65  Aligned_cols=147  Identities=26%  Similarity=0.393  Sum_probs=125.5

Q ss_pred             CCCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||.||+|+.    .+|+.||+|+++...    ......+.+|+++++.++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            6789999999999999999986    478999999987542    22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+||||++||+|.+++...+ .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999997654 5788999999999999999999   889999999999999999999999999998764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=6e-27  Score=244.54  Aligned_cols=112  Identities=22%  Similarity=0.256  Sum_probs=56.4

Q ss_pred             CCcEEEecCCcccccCCcccc----CC-CCCceeecCCCcccc-----ccccccc-ccccccccCCCCcccCCCC----C
Q 046544          235 ELYELELGGNKLFGSIPACFS----NL-ASLRILSLSSNELTS-----IPLTFWN-LKDILQLNFSSNFLTGPLP----L  299 (646)
Q Consensus       235 ~L~~L~L~~N~i~~~~~~~~~----~l-~~L~~L~L~~N~l~~-----lp~~~~~-l~~L~~L~l~~N~l~~~~~----~  299 (646)
                      +|++|+|++|++++..+..+.    .+ ++|++|+|++|.|+.     ++..+.. .++|+.|++++|.+++..+    .
T Consensus       168 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  247 (362)
T 3goz_A          168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL  247 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred             cccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHH
Confidence            455555555555443332222    22 355555555555554     3333333 2345555555555543322    2


Q ss_pred             ccCccccceEEEcccccccccCc-------cccCCCCCCCEEEccCccCCCccc
Q 046544          300 EIGNLKVLIGIDFSMNNFSSVIP-------TEIGGLKNLEYLFLGYNRLEGSIP  346 (646)
Q Consensus       300 ~~~~l~~L~~L~ls~N~l~~~~~-------~~~~~l~~L~~L~Ls~N~l~~~~p  346 (646)
                      .+..+++|+.|++++|.+.++.+       ..+..+++|+.|++++|++.+..+
T Consensus       248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          248 LKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             TTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            33455666666666666443322       345566667777777777665433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=1.5e-25  Score=226.25  Aligned_cols=147  Identities=26%  Similarity=0.407  Sum_probs=133.8

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+..+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57889999999999999999988899999999875432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++ +|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+|+..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            975 999999877667899999999999999999999   889999999999999999999999999998764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=3.3e-28  Score=271.65  Aligned_cols=378  Identities=16%  Similarity=0.151  Sum_probs=254.4

Q ss_pred             ccCCCCCCEEECCCCccc---ccCCcC------------ccCCCCCCEEECcCCcCcccCCc-cCcCCCCCCCEEEccCC
Q 046544            6 ISNLQNLEELDLRHNKLV---GTVPAA------------IFNMSMLKLLHLQNNSLLGCLSS-IADVRLPNLEALLLWGN   69 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l~---~~~~~~------------~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N   69 (646)
                      +..+++|++|+|++|.-.   +..|..            +..+++|++|+|++|.+++.... +. ..+++|++|+|++|
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~-~~~~~L~~L~L~~~  140 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIA-KSFKNFKVLVLSSC  140 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHH-HHCTTCCEEEEESC
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHH-HhCCCCcEEeCCCc
Confidence            456788999999887622   122222            34678899999999887643222 21 13788999999988


Q ss_pred             -ccccc-CCccccCCCCCcEEEcccCccccccCcccc----CcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEEC
Q 046544           70 -NFSGT-IPRFIFNASKLSILELSQNSFSGFIPNTFG----NLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHL  143 (646)
Q Consensus        70 -~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L  143 (646)
                       .++.. ++..+..+++|++|+|++|.+++..+..+.    .+++|++|++++|. ..+.... +...+.++++|++|++
T Consensus       141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~-l~~l~~~~~~L~~L~L  218 (594)
T 2p1m_B          141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSA-LERLVTRCPNLKSLKL  218 (594)
T ss_dssp             EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHH-HHHHHHHCTTCCEEEC
T ss_pred             CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHH-HHHHHHhCCCCcEEec
Confidence             55532 444555788999999999988765554443    56689999998887 2221110 1112345688889998


Q ss_pred             CCC-CCCCcCCcchhccccccCcEEEeeccc--------------------------cc----ccCCcccccCCCCCEEE
Q 046544          144 SDN-PLDGILSKTSIGNLSHSLKDFYMSNCN--------------------------VS----GGIPEEITNLTNSITID  192 (646)
Q Consensus       144 s~N-~l~~~~~~~~~~~~~~~L~~L~L~~n~--------------------------l~----~~~p~~~~~l~~L~~L~  192 (646)
                      ++| .+.++  ...+. -.++|++|+++.+.                          +.    +.+|..+..+++|++|+
T Consensus       219 ~~~~~~~~l--~~~~~-~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~  295 (594)
T 2p1m_B          219 NRAVPLEKL--ATLLQ-RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLN  295 (594)
T ss_dssp             CTTSCHHHH--HHHHH-HCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEE
T ss_pred             CCCCcHHHH--HHHHh-cCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEE
Confidence            888 22221  11111 12456666654431                          11    12344445779999999


Q ss_pred             ccCCccccccC-ccccCCCCCCeEEeecccccCc-CchhhcCCCCCcEEEecC---------CcccccCCccc-cCCCCC
Q 046544          193 LGGNKLNGSIP-ITLSKLQKLQGLGLDDNKLEGS-IPDSICRLTELYELELGG---------NKLFGSIPACF-SNLASL  260 (646)
Q Consensus       193 L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~i~~~~~~~~-~~l~~L  260 (646)
                      +++|.+++... ..+..+++|++|++++| +... .+.....+++|++|++++         +.+++.....+ .++++|
T Consensus       296 L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L  374 (594)
T 2p1m_B          296 LSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL  374 (594)
T ss_dssp             CTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTC
T ss_pred             ccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhH
Confidence            99999775433 33568899999999998 4422 233334589999999943         55554333333 348899


Q ss_pred             ceeecCCCccccc-ccccc-cccccccccCC--C----CcccCCCC-----CccCccccceEEEcccccccccCccccCC
Q 046544          261 RILSLSSNELTSI-PLTFW-NLKDILQLNFS--S----NFLTGPLP-----LEIGNLKVLIGIDFSMNNFSSVIPTEIGG  327 (646)
Q Consensus       261 ~~L~L~~N~l~~l-p~~~~-~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  327 (646)
                      +.|+++.|.++.. +..+. .+++|+.|+++  +    |.+++...     ..+..+++|+.|++++ .+++..+..++.
T Consensus       375 ~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~  453 (594)
T 2p1m_B          375 ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT  453 (594)
T ss_dssp             CEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH
T ss_pred             HHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH
Confidence            9999999998843 23333 57899999998  4    55553211     1256788999999987 677665555555


Q ss_pred             -CCCCCEEEccCccCCCcccccc-cCCCCCCEEEccCCcCcccCCc-cccCCCCCCceeCcCCccee
Q 046544          328 -LKNLEYLFLGYNRLEGSIPDSF-GDLISLKFLNLSNNNLSGAIPT-SLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       328 -l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~  391 (646)
                       +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. ....+++|++|++++|+++.
T Consensus       454 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          454 YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence             8899999999999987666555 6789999999999999755443 44568999999999999853

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.92  E-value=9.2e-25  Score=222.60  Aligned_cols=161  Identities=35%  Similarity=0.531  Sum_probs=144.2

Q ss_pred             cccccHHHHHHHhCCCCcc------eeecccccceEEEEEeCCCcEEEEEEEeccC----CchHHHHHHHHHHHHhCCCC
Q 046544          479 WRTFSYLELCRATNGFSEN------NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRHR  548 (646)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~  548 (646)
                      ...+++.++..++++|...      +.||+|+||.||+|+. +++.||+|++....    ....+.+.+|+++++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4678899999999998877      8999999999999987 68899999987532    23456789999999999999


Q ss_pred             CceeEEEEEecCCeeEEEEEecCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       549 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ||+++++++...+..++||||+++|+|.+++...  ...+++..+..++.|++.|++|||   ..+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998643  346899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      .++.+||+|||+|+...
T Consensus       168 ~~~~~kl~Dfg~~~~~~  184 (307)
T 2nru_A          168 EAFTAKISDFGLARASE  184 (307)
T ss_dssp             TTCCEEECCCTTCEECC
T ss_pred             CCCcEEEeecccccccc
Confidence            99999999999987653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.92  E-value=2.3e-25  Score=230.89  Aligned_cols=149  Identities=23%  Similarity=0.257  Sum_probs=133.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~  564 (646)
                      ..++|+..+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|..+++.+ +||+|+++++++...+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3468999999999999999999976 58899999997542   23456778899999988 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||++||+|.+++...+ .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997654 5899999999999999999999   889999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.92  E-value=2.1e-25  Score=227.43  Aligned_cols=148  Identities=32%  Similarity=0.520  Sum_probs=129.2

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ..+|+..+.||+|+||.||+|+. +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            35788899999999999999987 68899999987554  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++|+|.+++.....  .+++..+..++.|++.|++|||   ..+  |+||||||+||+++.++.+||+|||+|+..
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999976542  3889999999999999999999   778  999999999999999999999999999754

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=228.76  Aligned_cols=200  Identities=19%  Similarity=0.159  Sum_probs=113.7

Q ss_pred             CCCCEEEccCCccccccCccc--cCCCCCCeEEeecccccCcCc----hhhcCCCCCcEEEecCCcccccCCccccCCCC
Q 046544          186 TNSITIDLGGNKLNGSIPITL--SKLQKLQGLGLDDNKLEGSIP----DSICRLTELYELELGGNKLFGSIPACFSNLAS  259 (646)
Q Consensus       186 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  259 (646)
                      ++|++|++++|.+.+..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++.+..+..|+++++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            345555555555554544444  455555555555555554332    23334555555555555555555555555555


Q ss_pred             CceeecCCCcccc---ccc--ccccccccccccCCCCcccCCCCC----ccCccccceEEEcccccccccCccccCCC--
Q 046544          260 LRILSLSSNELTS---IPL--TFWNLKDILQLNFSSNFLTGPLPL----EIGNLKVLIGIDFSMNNFSSVIPTEIGGL--  328 (646)
Q Consensus       260 L~~L~L~~N~l~~---lp~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~ls~N~l~~~~~~~~~~l--  328 (646)
                      |++|+|++|++..   ++.  .+..+++|++|++++|.++. ++.    .++.+++|+.|++++|.+++..|..+..+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            5555555555432   221  12345555555555555542 111    23455666666666666666655555554  


Q ss_pred             -CCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          329 -KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       329 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                       ++|++|+|++|+++ .+|..+.  ++|++|||++|+|++. |. +..+++|+.|+|++|+++.
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence             57777777777777 4555553  6788888888888743 33 5677788888888887763

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=5e-25  Score=224.43  Aligned_cols=193  Identities=26%  Similarity=0.369  Sum_probs=104.3

Q ss_pred             cCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCcee
Q 046544          184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL  263 (646)
Q Consensus       184 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  263 (646)
                      .+++|+.|++++|.+... | .+..+++|++|++++|.+++..+  +..+++|++|+|++|++++.  ..+..+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            344455555555555432 2 34445555555555555553322  55555555555555555432  235555555555


Q ss_pred             ecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCC
Q 046544          264 SLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG  343 (646)
Q Consensus       264 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  343 (646)
                      ++++|.++.+|. +..+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++
T Consensus       113 ~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          113 DLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             ECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             ECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence            555555555443 4455555555555555554332  5555666666666666654433  5666666666666666664


Q ss_pred             cccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          344 SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       344 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      ..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             Chh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            433  5666666666666666664332  5666666666666666655

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=2.7e-25  Score=232.61  Aligned_cols=146  Identities=25%  Similarity=0.423  Sum_probs=127.6

Q ss_pred             CcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCC
Q 046544          495 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  573 (646)
                      ...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33578999999999999864 69999999998766556678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE--cCCCcEEEEeecCccccc
Q 046544          574 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL--DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       574 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~--~~~~~~ki~DfGla~~~~  643 (646)
                      +|.+++......+++..+..++.|++.||+|||   ..+|+||||||+||++  +.++.+||+|||+|+.+.
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            999999876667899999999999999999999   8899999999999999  567899999999998764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=1.2e-27  Score=267.06  Aligned_cols=393  Identities=13%  Similarity=0.123  Sum_probs=278.6

Q ss_pred             CEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCC---c-c----------CcCCCCCCCEEEccCCcccccCCcc
Q 046544           13 EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLS---S-I----------ADVRLPNLEALLLWGNNFSGTIPRF   78 (646)
Q Consensus        13 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~-~----------~~~~l~~L~~L~L~~N~l~~~~~~~   78 (646)
                      ..+++++..-. ..+..+..+++|++|+|++|.......   . +          ....+++|++|+|++|.+++..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            45666555432 334567788999999999986322111   0 0          0124789999999999999877777


Q ss_pred             cc-CCCCCcEEEcccC-ccccc-cCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcc
Q 046544           79 IF-NASKLSILELSQN-SFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKT  155 (646)
Q Consensus        79 ~~-~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  155 (646)
                      +. .+++|++|+|++| .++.. .+..+.++++|++|+|++|.++...... +......+++|++|++++|. ..+ ...
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~-l~~~~~~~~~L~~L~l~~~~-~~~-~~~  201 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHW-LSHFPDTYTSLVSLNISCLA-SEV-SFS  201 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGG-GGGSCTTCCCCCEEECTTCC-SCC-CHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHH-HHHHhhcCCcCcEEEecccC-CcC-CHH
Confidence            75 6899999999999 56543 3444568999999999999987754332 22334578999999999997 222 111


Q ss_pred             hhc---cccccCcEEEeecc-cccccCCcccccCCCCCEEEccCCc--------------------------ccc----c
Q 046544          156 SIG---NLSHSLKDFYMSNC-NVSGGIPEEITNLTNSITIDLGGNK--------------------------LNG----S  201 (646)
Q Consensus       156 ~~~---~~~~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~--------------------------l~~----~  201 (646)
                      .+.   .-.++|+.|++++| .+.+ +|..+..+++|+.|+++.+.                          +..    .
T Consensus       202 ~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~  280 (594)
T 2p1m_B          202 ALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY  280 (594)
T ss_dssp             HHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGG
T ss_pred             HHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhh
Confidence            221   11468999999999 4444 77888888999999866552                          111    1


Q ss_pred             cCccccCCCCCCeEEeecccccCcCc-hhhcCCCCCcEEEecCCccccc-CCccccCCCCCceeecC---------CCcc
Q 046544          202 IPITLSKLQKLQGLGLDDNKLEGSIP-DSICRLTELYELELGGNKLFGS-IPACFSNLASLRILSLS---------SNEL  270 (646)
Q Consensus       202 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~---------~N~l  270 (646)
                      .+..+..+++|++|++++|.+++... ..+..+++|++|++++| +... .+.....+++|+.|+++         .+.+
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l  359 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL  359 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence            23333467899999999999775432 33568999999999999 5422 23334468999999994         3455


Q ss_pred             cccc-ccc-ccccccccccCCCCcccCCCCCccC-ccccceEEEcc--c----ccccccC-----ccccCCCCCCCEEEc
Q 046544          271 TSIP-LTF-WNLKDILQLNFSSNFLTGPLPLEIG-NLKVLIGIDFS--M----NNFSSVI-----PTEIGGLKNLEYLFL  336 (646)
Q Consensus       271 ~~lp-~~~-~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~ls--~----N~l~~~~-----~~~~~~l~~L~~L~L  336 (646)
                      +... ..+ ..+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    |.+++..     +..+..+++|+.|++
T Consensus       360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L  439 (594)
T 2p1m_B          360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL  439 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred             CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence            5321 122 3478999999988988765555554 58899999999  4    5666322     223667899999999


Q ss_pred             cCccCCCcccccccC-CCCCCEEEccCCcCcccCCccc-cCCCCCCceeCcCCcceeeccC-C-CCCCCCccccccCCcc
Q 046544          337 GYNRLEGSIPDSFGD-LISLKFLNLSNNNLSGAIPTSL-EKLSYLEDLNLSFNKLEGEIPR-G-GSFGNFAAESFEGNEL  412 (646)
Q Consensus       337 s~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~-~~~~~~~~~~~~~N~~  412 (646)
                      ++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|++|++++|++++..+. . ..+++++.+++++|+.
T Consensus       440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            88 777666666665 8999999999999987655555 6799999999999999654332 2 3367899999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.92  E-value=6.9e-25  Score=225.43  Aligned_cols=148  Identities=26%  Similarity=0.385  Sum_probs=133.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888999999999999999975 689999999975432      23567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla~  640 (646)
                      +||||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++    .+||+|||+|+
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999997643 6899999999999999999999   88999999999999998877    89999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       167 ~~~  169 (326)
T 2y0a_A          167 KID  169 (326)
T ss_dssp             ECC
T ss_pred             ECC
Confidence            763

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=2.8e-25  Score=225.47  Aligned_cols=148  Identities=25%  Similarity=0.371  Sum_probs=127.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--------------------------chHHHHHHHHHHHH
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--------------------------RAFKSFAVECEMMK  543 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  543 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999864 689999999875421                          12356889999999


Q ss_pred             hCCCCCceeEEEEEec--CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 046544          544 SIRHRNLIKVISSCSN--EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPD  621 (646)
Q Consensus       544 ~l~H~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~  621 (646)
                      .++||||+++++++..  .+..++||||+++|+|.++...  ..+++..+..++.|++.||+|||   ..+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999987  5678999999999999887543  36899999999999999999999   889999999999


Q ss_pred             CEEEcCCCcEEEEeecCccccc
Q 046544          622 NVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       622 Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++.++.+||+|||+|+.+.
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~  188 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFK  188 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECS
T ss_pred             HEEECCCCCEEEecCCCccccc
Confidence            9999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=4.1e-25  Score=235.89  Aligned_cols=151  Identities=23%  Similarity=0.346  Sum_probs=133.3

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3467899999999999999999864 799999999986542  3446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~  643 (646)
                      |||++||+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++   .++.+||+|||+|+.+.
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998764 6899999999999999999999   88999999999999998   46789999999998764


Q ss_pred             C
Q 046544          644 G  644 (646)
Q Consensus       644 ~  644 (646)
                      +
T Consensus       165 ~  165 (444)
T 3soa_A          165 G  165 (444)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=4.3e-25  Score=230.19  Aligned_cols=149  Identities=23%  Similarity=0.458  Sum_probs=133.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999865 68999999998653  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC---CcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~---~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.+   +.+||+|||+|+...
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999987654 6899999999999999999999   8899999999999999754   469999999998764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.92  E-value=5.6e-25  Score=228.41  Aligned_cols=241  Identities=17%  Similarity=0.139  Sum_probs=147.4

Q ss_pred             CEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEE
Q 046544           62 EALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFI  141 (646)
Q Consensus        62 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L  141 (646)
                      ++++.++|+++ .+|..+  .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.                   
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~-------------------   69 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV-------------------   69 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCE-------------------
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCc-------------------
Confidence            34555566665 344433  24566666666666655555666666666666666655331                   


Q ss_pred             ECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCE-EEccCCccccccCccccCCCCCCeEEeecc
Q 046544          142 HLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSIT-IDLGGNKLNGSIPITLSKLQKLQGLGLDDN  220 (646)
Q Consensus       142 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  220 (646)
                                                         +.+.+|.+++++.. +++++|++..+.|.+|.++++|++|++++|
T Consensus        70 -----------------------------------i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n  114 (350)
T 4ay9_X           70 -----------------------------------IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT  114 (350)
T ss_dssp             -----------------------------------ECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred             -----------------------------------cChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccc
Confidence                                               11233444444443 444556666666667777777777777777


Q ss_pred             cccCcCchhhcCCCCCcEEEecC-CcccccCCccccCCC-CCceeecCCCcccccccccccccccccccCCC-CcccCCC
Q 046544          221 KLEGSIPDSICRLTELYELELGG-NKLFGSIPACFSNLA-SLRILSLSSNELTSIPLTFWNLKDILQLNFSS-NFLTGPL  297 (646)
Q Consensus       221 ~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~-N~l~~~~  297 (646)
                      +|+...+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+++|...+...+|+.+++++ |.++.+.
T Consensus       115 ~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~  194 (350)
T 4ay9_X          115 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP  194 (350)
T ss_dssp             CCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCC
T ss_pred             ccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCC
Confidence            77766666666666777777754 566666666777664 57778888888888877666666777777764 5565544


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc-cCCCcccccccCCCCCCEEEccCCc
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN-RLEGSIPDSFGDLISLKFLNLSNNN  364 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~  364 (646)
                      +..|..+++|+.||+++|+|+.+.+..|.   +|+.|.+.++ .++ .+| .+..+++|+.++++++.
T Consensus       195 ~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          195 NDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             HHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence            55667777777777777777765544443   4444444333 333 344 36667777777776553

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=2.6e-25  Score=228.27  Aligned_cols=145  Identities=30%  Similarity=0.426  Sum_probs=128.5

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC----eeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----FKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            67899999999999999999875 7899999997543 23345567899999999999999999998753    469999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA----------PVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~----------~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      ||+++|+|.+++...  .+++..+..++.|++.|++|||   ..          +|+||||||+||+++.++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999775  4899999999999999999999   77          99999999999999999999999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +|+.+.
T Consensus       177 ~a~~~~  182 (322)
T 3soc_A          177 LALKFE  182 (322)
T ss_dssp             TCEEEC
T ss_pred             cccccc
Confidence            997653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=4.1e-25  Score=237.49  Aligned_cols=148  Identities=30%  Similarity=0.468  Sum_probs=134.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999975 79999999997542   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            9999999999997643 6899999999999999999999   8999999999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=2.5e-25  Score=229.09  Aligned_cols=148  Identities=28%  Similarity=0.451  Sum_probs=132.6

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|...+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999996 578999999987532   22335788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+ +|++.+++...+ .+++.++..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+|+...
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 779999887654 6899999999999999999999   8899999999999999999999999999998654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.92  E-value=4.8e-25  Score=226.01  Aligned_cols=150  Identities=28%  Similarity=0.426  Sum_probs=132.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC--eeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--FKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56889999999999999999975 58999999997543 234567889999999999999999999988765  789999


Q ss_pred             EecCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~----~~~~~~ki~DfGla~~  641 (646)
                      ||+++|+|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999997643  23899999999999999999999   8899999999999999    7788899999999987


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      +..
T Consensus       166 ~~~  168 (319)
T 4euu_A          166 LED  168 (319)
T ss_dssp             CCT
T ss_pred             cCC
Confidence            643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=3.1e-25  Score=224.04  Aligned_cols=149  Identities=27%  Similarity=0.411  Sum_probs=134.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CC-------cEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DG-------MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||.||+|+.. ++       ..||+|++........+.+.+|+++++.++||||+++++++..++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            57888999999999999999854 33       57999999776666678899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc--------EEEEe
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV--------AYLSD  635 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~--------~ki~D  635 (646)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.        +||+|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999887666899999999999999999999   889999999999999988776        99999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++...
T Consensus       165 fg~~~~~~  172 (289)
T 4fvq_A          165 PGISITVL  172 (289)
T ss_dssp             CCSCTTTS
T ss_pred             Cccccccc
Confidence            99997653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=5.3e-25  Score=239.91  Aligned_cols=149  Identities=24%  Similarity=0.369  Sum_probs=134.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888999999999999999975 79999999997542   233466789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++...+ ..+++..+..++.||+.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999987654 34899999999999999999999   8899999999999999999999999999998764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=9.9e-25  Score=213.85  Aligned_cols=197  Identities=20%  Similarity=0.191  Sum_probs=159.7

Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCc-cccccCccccCCCCCCeEEeec-ccccCcCchhhcCCCCCcEE
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNK-LNGSIPITLSKLQKLQGLGLDD-NKLEGSIPDSICRLTELYEL  239 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L  239 (646)
                      .++++|++++|++++..+..|.++++|++|++++|+ ++++.+..|.++++|++|++++ |++++..+.+|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            467777777777777777788888888888888886 8877777888888888888888 88887777788888888888


Q ss_pred             EecCCcccccCCccccCCCCCc---eeecCCC-ccccccc-ccccccccc-cccCCCCcccCCCCCccCccccceEEEcc
Q 046544          240 ELGGNKLFGSIPACFSNLASLR---ILSLSSN-ELTSIPL-TFWNLKDIL-QLNFSSNFLTGPLPLEIGNLKVLIGIDFS  313 (646)
Q Consensus       240 ~L~~N~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~lp~-~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~ls  313 (646)
                      ++++|++++ +|. |..+++|+   +|++++| .++.+|. .|.++++|+ .|++++|.++...+..|.. ++|+.|+++
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            888888876 454 77888887   8888888 8888876 477788888 8888888888544455555 889999999


Q ss_pred             ccc-ccccCccccCCC-CCCCEEEccCccCCCcccccccCCCCCCEEEccCCc
Q 046544          314 MNN-FSSVIPTEIGGL-KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNN  364 (646)
Q Consensus       314 ~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  364 (646)
                      +|. ++++.+..|.++ ++|+.|++++|++++..+.   .+++|+.|+++++.
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            994 998888889999 9999999999999855444   57789999998873

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=5.9e-25  Score=219.21  Aligned_cols=147  Identities=29%  Similarity=0.444  Sum_probs=136.0

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888999999999999999988889999999976543 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999887667899999999999999999999   889999999999999999999999999999865

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=5.8e-25  Score=225.16  Aligned_cols=149  Identities=26%  Similarity=0.420  Sum_probs=119.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999864 68999999997654 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++ |+|.+++....     ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886532     35889999999999999999999   8899999999999999999999999999998653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=5.7e-25  Score=223.56  Aligned_cols=149  Identities=27%  Similarity=0.501  Sum_probs=131.2

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  563 (646)
                      ..|+..+.||+|+||.||+|++     .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578899999999999999983     368999999987543 33457789999999999999999999999877  668


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667899999999999999999999   8899999999999999999999999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=3.6e-25  Score=229.96  Aligned_cols=149  Identities=23%  Similarity=0.356  Sum_probs=131.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-----CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....     ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56899999999999999999865 68999999987431     2245778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc---EEEEeecCc
Q 046544          566 VLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV---AYLSDFGIA  639 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~---~ki~DfGla  639 (646)
                      |||||+||+|.+++...   +..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.   +||+|||+|
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998887543   335899999999999999999999   889999999999999976554   999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       181 ~~~~  184 (351)
T 3c0i_A          181 IQLG  184 (351)
T ss_dssp             EECC
T ss_pred             eEec
Confidence            8764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.92  E-value=2e-25  Score=232.80  Aligned_cols=160  Identities=24%  Similarity=0.419  Sum_probs=137.9

Q ss_pred             cccHHHHHHHhCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCcee
Q 046544          481 TFSYLELCRATNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIK  552 (646)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~  552 (646)
                      .+...++....++|+..+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            444556666678999999999999999999973      2468899999976543 3446789999999999 8999999


Q ss_pred             EEEEEecCC-eeEEEEEecCCCCHHHHHhhCCC-----------------------------------------------
Q 046544          553 VISSCSNEE-FKALVLEYKPHGSLEKYLYSSNC-----------------------------------------------  584 (646)
Q Consensus       553 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  584 (646)
                      +++++...+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999976532                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          585 ------------------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       585 ------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                                        .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                              1788999999999999999999   8899999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=8.1e-25  Score=219.53  Aligned_cols=149  Identities=30%  Similarity=0.383  Sum_probs=135.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            357889999999999999999865 5789999999876656678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||+|+.+.
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999987654 5899999999999999999999   8899999999999999   788999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.92  E-value=5.7e-25  Score=226.64  Aligned_cols=146  Identities=25%  Similarity=0.323  Sum_probs=132.1

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++.....  .+.+.+|+++++.+ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            6789999999999999999996 5799999999875532  24578899999999 999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc-----EEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV-----AYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~-----~ki~DfGla~~~~  643 (646)
                      + +++|.+++...+..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.     +||+|||+|+.+.
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9 99999999876668999999999999999999999   889999999999999998887     9999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=6.8e-25  Score=228.66  Aligned_cols=147  Identities=24%  Similarity=0.298  Sum_probs=130.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            367999999999999999999975 789999999975432 236688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc--EEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV--AYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~--~ki~DfGla~~~  642 (646)
                      +++|+|.+++...+ .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.  +||+|||+|+..
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999987654 5899999999999999999999   889999999999999987665  999999998743

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.92  E-value=4.1e-25  Score=240.07  Aligned_cols=149  Identities=28%  Similarity=0.504  Sum_probs=135.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|+..+.||+|+||.||+|++. ++..||||+++... ...+.|.+|++++++++||||+++++++...+..++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            56788899999999999999976 48899999987543 34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+.+.+
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999998643 46889999999999999999999   88999999999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=3.1e-25  Score=231.62  Aligned_cols=147  Identities=31%  Similarity=0.387  Sum_probs=123.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHH-HHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEM-MKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||+||+|+.+ +++.||+|++....   ....+.+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57899999999999999999975 68899999997653   2233456667776 5778999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||++||+|.+++...+ .+++..+..++.||+.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus       118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999997654 6788999999999999999999   889999999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=3.4e-25  Score=229.60  Aligned_cols=152  Identities=28%  Similarity=0.450  Sum_probs=135.4

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE  560 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  560 (646)
                      ....++|+..+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+++++.++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            334578999999999999999999864      358899999976543 3356789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD  617 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd  617 (646)
                      +..++||||+++|+|.+++....                       ..+++.++..++.|+++|++|||   +++|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            99999999999999999997642                       46889999999999999999999   88999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCcccc
Q 046544          618 LKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       618 lk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+||+++.++.+||+|||+++.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~  224 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNI  224 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             CCcceEEECCCCeEEEeecCCCccc
Confidence            9999999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=5.4e-25  Score=231.46  Aligned_cols=149  Identities=30%  Similarity=0.486  Sum_probs=133.2

Q ss_pred             CCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ++|+..+.||+|+||.||+|+..        .+..||+|++..... ...+++.+|+++++.+ +||||+++++++..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            57888999999999999999852        246799999976543 3456788999999999 9999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence            9999999999999999998654               35899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCccccc
Q 046544          627 DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~  643 (646)
                      .++.+||+|||+|+.+.
T Consensus       226 ~~~~~kL~DFG~a~~~~  242 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIH  242 (382)
T ss_dssp             TTCCEEECSCSCCCCSS
T ss_pred             CCCcEEEcccCcccccc
Confidence            99999999999998654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=3.8e-25  Score=231.27  Aligned_cols=146  Identities=21%  Similarity=0.288  Sum_probs=129.1

Q ss_pred             hCCCCcceeecccccceEEEEE------eCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC---CCCceeEEEEEecCC
Q 046544          491 TNGFSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR---HRNLIKVISSCSNEE  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~  561 (646)
                      .++|...+.||+|+||.||+|.      ..+++.||+|++...   ...++.+|+++++.++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            3678899999999999999994      346889999998754   3456778888888886   999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC----------
Q 046544          562 FKALVLEYKPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD----------  627 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~----------  627 (646)
                      ..++|||||++|+|.+++..    ....+++..+..++.|++.||+|||   +++|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999975    3456899999999999999999999   889999999999999988          


Q ss_pred             -CCcEEEEeecCcccc
Q 046544          628 -NLVAYLSDFGIAKLL  642 (646)
Q Consensus       628 -~~~~ki~DfGla~~~  642 (646)
                       ++.+||+|||+|+.+
T Consensus       218 ~~~~~kl~DFG~a~~~  233 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDM  233 (365)
T ss_dssp             -CTTEEECCCTTCEEG
T ss_pred             ccCCEEEeeCchhhhh
Confidence             899999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=3.8e-25  Score=237.96  Aligned_cols=148  Identities=25%  Similarity=0.467  Sum_probs=133.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|+++++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            36788899999999999999999888999999997543 34678999999999999999999999986 56789999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999997542 25788899999999999999999   8899999999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.92  E-value=1e-24  Score=230.06  Aligned_cols=149  Identities=20%  Similarity=0.263  Sum_probs=134.6

Q ss_pred             hCCCCcceeeccc--ccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|+..+.||+|  +||.||+|+.. +|+.||||++....  ....+.+.+|+++++.++|||||++++++..++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678999999999  99999999976 79999999998653  2334678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||||++|+|.+++... ...+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999765 246899999999999999999999   889999999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.92  E-value=5.9e-25  Score=226.21  Aligned_cols=149  Identities=28%  Similarity=0.427  Sum_probs=134.6

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999984     3688999999987665666789999999999999999999998874  46689


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999876556899999999999999999999   8899999999999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.92  E-value=7.8e-25  Score=223.83  Aligned_cols=150  Identities=25%  Similarity=0.443  Sum_probs=133.5

Q ss_pred             hCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      .++|...+.||+|+||.||+|+.      .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788999999999999999985      245889999987543 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 046544          564 ALVLEYKPHGSLEKYLYSSNC-----------------------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKP  620 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~  620 (646)
                      ++||||+++|+|.+++.....                       .+++.++..++.|++.|++|||   .++|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999986532                       3788899999999999999999   88999999999


Q ss_pred             CCEEEcCCCcEEEEeecCccccc
Q 046544          621 DNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       621 ~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||+++.++.+||+|||+|+...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~  201 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVY  201 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECT
T ss_pred             heEEEcCCCCEEEcccccccccc
Confidence            99999999999999999998653

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=9.7e-25  Score=222.71  Aligned_cols=201  Identities=16%  Similarity=0.201  Sum_probs=172.5

Q ss_pred             ccCcEEEeecccccccCCccc--ccCCCCCEEEccCCccccccC----ccccCCCCCCeEEeecccccCcCchhhcCCCC
Q 046544          162 HSLKDFYMSNCNVSGGIPEEI--TNLTNSITIDLGGNKLNGSIP----ITLSKLQKLQGLGLDDNKLEGSIPDSICRLTE  235 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  235 (646)
                      ++|++|++++|.+.+..|..+  ..+++|++|++++|++.+..+    ..+..+++|++|+|++|++.+..|..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            358888888888888888887  889999999999999987555    44567899999999999999888899999999


Q ss_pred             CcEEEecCCccccc---C-CccccCCCCCceeecCCCcccccccc----cccccccccccCCCCcccCCCCCccCcc---
Q 046544          236 LYELELGGNKLFGS---I-PACFSNLASLRILSLSSNELTSIPLT----FWNLKDILQLNFSSNFLTGPLPLEIGNL---  304 (646)
Q Consensus       236 L~~L~L~~N~i~~~---~-~~~~~~l~~L~~L~L~~N~l~~lp~~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l---  304 (646)
                      |++|+|++|++.+.   . +..+..+++|++|+|++|.++.+|..    +..+++|++|++++|.+++..|..+..+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            99999999998652   2 33457899999999999999877653    4678999999999999998888888777   


Q ss_pred             ccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcc
Q 046544          305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                      ++|+.|++++|+++. +|..+.  ++|++|+|++|++++. |. +..+++|+.|+|++|+|+.
T Consensus       251 ~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          251 SALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            699999999999995 566664  7999999999999965 33 7889999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=2.3e-25  Score=227.53  Aligned_cols=149  Identities=24%  Similarity=0.408  Sum_probs=129.3

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe----
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF----  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----  562 (646)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++.....   ...+.+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999996 5789999999976532   234578899999999999999999999876543    


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+||||++||+|.+++...+ .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 6899999999999999999999   889999999999999999999999999999865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       167 ~  167 (311)
T 3ork_A          167 A  167 (311)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=9.9e-25  Score=234.34  Aligned_cols=146  Identities=34%  Similarity=0.479  Sum_probs=131.3

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-eeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|++. |+.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            357888899999999999999985 7899999997543  4578999999999999999999999987665 79999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++...+. .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+..
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            999999999987543 4689999999999999999999   889999999999999999999999999999854

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=1.1e-24  Score=236.70  Aligned_cols=149  Identities=27%  Similarity=0.412  Sum_probs=134.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999975 69999999997542   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++||+|.+++....   ..+++..+..++.||+.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999987642   46899999999999999999999   8899999999999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=2.9e-25  Score=238.54  Aligned_cols=147  Identities=27%  Similarity=0.347  Sum_probs=124.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++...   .......+.+|+++++.++||||+++++++...+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            57899999999999999999864 6899999999753   2334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   . ++|+||||||+||+++.++.+||+|||+|+..
T Consensus       228 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          228 EYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             CCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             eeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999987654 6899999999999999999999   6 89999999999999999999999999999864

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=3.9e-26  Score=238.37  Aligned_cols=213  Identities=18%  Similarity=0.215  Sum_probs=114.8

Q ss_pred             cccccCC-CCCEEEccCCccccccCccccCC-----CCCCeEEeecccccCcCchhhcC----C-CCCcEEEecCCcccc
Q 046544          180 EEITNLT-NSITIDLGGNKLNGSIPITLSKL-----QKLQGLGLDDNKLEGSIPDSICR----L-TELYELELGGNKLFG  248 (646)
Q Consensus       180 ~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~L~~N~i~~  248 (646)
                      +.+..++ +|++|+|++|++++..+..+..+     ++|++|+|++|++++..+..+..    + ++|++|+|++|++++
T Consensus        44 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  123 (362)
T 3goz_A           44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS  123 (362)
T ss_dssp             HHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred             HHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence            4444555 55555555555555444444443     55555666665555444443322    2 556666666666554


Q ss_pred             cCCcccc----C-CCCCceeecCCCcccc-----ccccccccc-ccccccCCCCcccCCCCCccCc----c-ccceEEEc
Q 046544          249 SIPACFS----N-LASLRILSLSSNELTS-----IPLTFWNLK-DILQLNFSSNFLTGPLPLEIGN----L-KVLIGIDF  312 (646)
Q Consensus       249 ~~~~~~~----~-l~~L~~L~L~~N~l~~-----lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~----l-~~L~~L~l  312 (646)
                      ..+..+.    . .++|++|+|++|.++.     ++..+...+ +|++|++++|.+++..+..+..    . ++|+.||+
T Consensus       124 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L  203 (362)
T 3goz_A          124 KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL  203 (362)
T ss_dssp             SCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEEC
T ss_pred             HHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEEC
Confidence            4443322    2 1356666666666552     222233333 5666666666665444433332    2 46666666


Q ss_pred             cccccccc----CccccCC-CCCCCEEEccCccCCCccc----ccccCCCCCCEEEccCCcCccc-------CCccccCC
Q 046544          313 SMNNFSSV----IPTEIGG-LKNLEYLFLGYNRLEGSIP----DSFGDLISLKFLNLSNNNLSGA-------IPTSLEKL  376 (646)
Q Consensus       313 s~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l  376 (646)
                      ++|.+++.    ++..+.. .++|++|+|++|++++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+
T Consensus       204 s~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l  283 (362)
T 3goz_A          204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI  283 (362)
T ss_dssp             TTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTC
T ss_pred             CCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccC
Confidence            66666652    2333433 3467777777777765444    3345567777777777774322       23355566


Q ss_pred             CCCCceeCcCCcceee
Q 046544          377 SYLEDLNLSFNKLEGE  392 (646)
Q Consensus       377 ~~L~~L~L~~N~l~~~  392 (646)
                      ++|+.||+++|++...
T Consensus       284 ~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          284 QKIILVDKNGKEIHPS  299 (362)
T ss_dssp             CEEEEECTTSCBCCGG
T ss_pred             CceEEEecCCCcCCCc
Confidence            6777777777776643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=7.6e-25  Score=223.67  Aligned_cols=148  Identities=24%  Similarity=0.256  Sum_probs=129.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..++||+|+||+||+|+.. +|+.||||++.....  .....+..|+..+..+ +||||+++++++..++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57899999999999999999976 799999999865432  2334455666666555 9999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+ +++|.+++...+..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999 67999998877777999999999999999999999   8899999999999999999999999999988653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.1e-24  Score=225.96  Aligned_cols=151  Identities=28%  Similarity=0.487  Sum_probs=131.7

Q ss_pred             HhCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ..++|...+.||+|+||.||+|+.      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            446889999999999999999985      246689999997543 33456789999999999 9999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLK  619 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk  619 (646)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||   ..+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976542                      3788899999999999999999   8899999999


Q ss_pred             CCCEEEcCCCcEEEEeecCccccc
Q 046544          620 PDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       620 ~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||+++.++.+||+|||+|+.+.
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~  223 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIM  223 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGG
T ss_pred             hhhEEEcCCCcEEeCCCccCcccc
Confidence            999999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.4e-24  Score=217.97  Aligned_cols=150  Identities=26%  Similarity=0.475  Sum_probs=135.9

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35789999999999999999986 479999999997542   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999887667899999999999999999999   8899999999999999999999999999998653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=223.63  Aligned_cols=149  Identities=31%  Similarity=0.501  Sum_probs=134.6

Q ss_pred             CCCCcceeecccccceEEEEEe-----CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC--eeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--FKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~  564 (646)
                      ++|+..+.||+|+||.||+|++     .+|+.||+|++........+.+.+|+++++.++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4688899999999999999984     368999999998766666778999999999999999999999987654  689


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999887667899999999999999999999   8899999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=7.1e-25  Score=220.48  Aligned_cols=149  Identities=24%  Similarity=0.373  Sum_probs=125.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|+..+.||+|+||.||+|+..    .+..||+|++..... ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            367889999999999999999864    256799998875432 34567889999999999999999999974 567899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999877667899999999999999999999   8899999999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.91  E-value=7.5e-25  Score=236.24  Aligned_cols=147  Identities=23%  Similarity=0.380  Sum_probs=121.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Cee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~  563 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ....+++.+|+++++.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999865 78999999987543  23456788999999999999999999998543     568


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||||+ +|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       133 ~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            9999998 56999998765 36899999999999999999999   8899999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.91  E-value=5.1e-25  Score=230.24  Aligned_cols=148  Identities=26%  Similarity=0.457  Sum_probs=130.0

Q ss_pred             CCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999843      46789999987543 334457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEEEe
Q 046544          565 LVLEYKPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSD  635 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki~D  635 (646)
                      +||||+++|+|.+++...+      ..+++.++..++.|++.||+|||   +++|+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997643      35889999999999999999999   88999999999999998554   599999


Q ss_pred             ecCcccc
Q 046544          636 FGIAKLL  642 (646)
Q Consensus       636 fGla~~~  642 (646)
                      ||+|+.+
T Consensus       228 FG~a~~~  234 (367)
T 3l9p_A          228 FGMARDI  234 (367)
T ss_dssp             CHHHHHH
T ss_pred             Ccccccc
Confidence            9999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=225.73  Aligned_cols=147  Identities=24%  Similarity=0.365  Sum_probs=122.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            367889999999999999999976 58899999997543  335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++...+ .+++.++..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|||+|+...
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999987654 6899999999999999999999   889999999999999975   8899999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=6e-25  Score=236.19  Aligned_cols=148  Identities=28%  Similarity=0.485  Sum_probs=131.0

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|++.++..||||+++... ...+++.+|++++++++||||+++++++.. +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            35688899999999999999999888889999987543 335689999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++... +..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999753 245889999999999999999999   8899999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.91  E-value=2.3e-24  Score=220.15  Aligned_cols=148  Identities=29%  Similarity=0.396  Sum_probs=133.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999975 599999999865533  234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++++.+++... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            99999998887654 36899999999999999999999   8899999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=7.5e-25  Score=224.98  Aligned_cols=151  Identities=28%  Similarity=0.533  Sum_probs=121.6

Q ss_pred             HhCCCCcceeecccccceEEEEEeCC-C---cEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLGD-G---MEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      ..++|+..+.||+|+||.||+|+... +   ..||||+++..  .....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34689999999999999999998653 3   27999998754  344567899999999999999999999999877655


Q ss_pred             ------EEEEEecCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          564 ------ALVLEYKPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       564 ------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                            ++||||+++|+|.+++....     ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432     25889999999999999999999   88999999999999999999999


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+|+.+.
T Consensus       178 l~Dfg~a~~~~  188 (323)
T 3qup_A          178 VADFGLSRKIY  188 (323)
T ss_dssp             ECCCCC-----
T ss_pred             Eeecccccccc
Confidence            99999998653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.91  E-value=5.2e-26  Score=235.02  Aligned_cols=148  Identities=21%  Similarity=0.286  Sum_probs=124.5

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--------CchHHHHHHHHHHHHhCC---------CCCceeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------GRAFKSFAVECEMMKSIR---------HRNLIKV  553 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~~  553 (646)
                      .++|+..+.||+|+||+||+|+. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 78999999998653        223477889999998885         8888887


Q ss_pred             EEEEe------------------------------cCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 046544          554 ISSCS------------------------------NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE  603 (646)
Q Consensus       554 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~  603 (646)
                      .+++.                              ..+..|+|||||++|++.+.+..  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            77643                              26789999999999977666644  35799999999999999999


Q ss_pred             HHhcCCCCCeEecCCCCCCEEEcCCC--------------------cEEEEeecCccccc
Q 046544          604 YLHFGCLAPVIHCDLKPDNVLLDDNL--------------------VAYLSDFGIAKLLI  643 (646)
Q Consensus       604 ~lH~~~~~~iiHrdlk~~Nil~~~~~--------------------~~ki~DfGla~~~~  643 (646)
                      |||+  +++|+||||||+|||++.++                    .+||+|||+|+...
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~  233 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER  233 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence            9992  36899999999999999876                    99999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=1.3e-24  Score=225.14  Aligned_cols=148  Identities=30%  Similarity=0.407  Sum_probs=132.4

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +.|+..+.||+|+||.||+|+. .+|+.||||++.....   ...+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999986 5799999999975532   23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+. |++.+++......+++..+..++.|+++||+|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9997 5888888766667899999999999999999999   8899999999999999999999999999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.91  E-value=1.4e-24  Score=221.94  Aligned_cols=151  Identities=26%  Similarity=0.420  Sum_probs=134.6

Q ss_pred             hCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      .++|+..+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36788999999999999999984      2578899999976543 3456789999999999 99999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          563 KALVLEYKPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      .++||||+++|+|.+++.....                 .+++..+..++.|++.|++|||   .++|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976542                 4889999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccccC
Q 046544          626 DDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~~  644 (646)
                      +.++.+||+|||+|+....
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~  197 (313)
T 1t46_A          179 THGRITKICDFGLARDIKN  197 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTS
T ss_pred             cCCCCEEEccccccccccc
Confidence            9999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=2.3e-24  Score=220.61  Aligned_cols=147  Identities=27%  Similarity=0.358  Sum_probs=130.6

Q ss_pred             CCCCcc-eeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      +.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567764 78999999999999854 7999999999876655667889999999985 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc---EEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~---~ki~DfGla~~~  642 (646)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.   +||+|||+++.+
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999997654 6889999999999999999999   889999999999999987765   999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.91  E-value=1.7e-24  Score=223.42  Aligned_cols=150  Identities=29%  Similarity=0.508  Sum_probs=132.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC--------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecC
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNE  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  560 (646)
                      .++|+..+.||+|+||.||+|++.        +++.||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367889999999999999999863        467899999875532 3456788999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   ..+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999997653               24788999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCccccc
Q 046544          626 DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~  643 (646)
                      +.++.+||+|||+|+...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~  208 (334)
T 2pvf_A          191 TENNVMKIADFGLARDIN  208 (334)
T ss_dssp             CTTCCEEECCCTTCEECT
T ss_pred             cCCCCEEEcccccccccc
Confidence            999999999999998654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.91  E-value=1.5e-24  Score=218.55  Aligned_cols=149  Identities=28%  Similarity=0.406  Sum_probs=131.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999865 68999999987654 33457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~  643 (646)
                      +++|+|.+++...   +..+++..+..++.|++.|++|||   ..+|+||||||+||++   +.++.+||+|||+|+.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988543   356899999999999999999999   8899999999999999   456789999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=1.3e-24  Score=220.85  Aligned_cols=148  Identities=26%  Similarity=0.401  Sum_probs=132.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            367899999999999999999975 5899999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999998876667899999999999999999999   88999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.91  E-value=9e-25  Score=225.37  Aligned_cols=150  Identities=29%  Similarity=0.421  Sum_probs=133.2

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--------chHHHHHHHHHHHHhCCCCCceeEEEEEecC
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--------RAFKSFAVECEMMKSIRHRNLIKVISSCSNE  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  560 (646)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++.....        ...+.+.+|+++++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999854 689999999986531        1234567899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          561 EFKALVLEYKPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       561 ~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999987654 6899999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       178 ~~~~  181 (335)
T 3dls_A          178 AYLE  181 (335)
T ss_dssp             EECC
T ss_pred             eECC
Confidence            8764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.91  E-value=2.7e-24  Score=216.79  Aligned_cols=150  Identities=23%  Similarity=0.375  Sum_probs=132.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  .....++.+|+..+..+ +||||+++++++..++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467889999999999999999975 79999999998643  33456788999999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC----------------
Q 046544          567 LEYKPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD----------------  627 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~----------------  627 (646)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||   .++|+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642   46899999999999999999999   889999999999999984                


Q ss_pred             ---CCcEEEEeecCccccc
Q 046544          628 ---NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ---~~~~ki~DfGla~~~~  643 (646)
                         ...+||+|||.++...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~  185 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRIS  185 (289)
T ss_dssp             ---CCCEEECCCTTCEETT
T ss_pred             cCCceEEEEcccccccccC
Confidence               4479999999988764

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=1.5e-26  Score=243.98  Aligned_cols=93  Identities=27%  Similarity=0.309  Sum_probs=53.9

Q ss_pred             cCccccceEEEccccccc----ccCccccCCCCCCCEEEccCccCCCc----cccccc--CCCCCCEEEccCCcCcc---
Q 046544          301 IGNLKVLIGIDFSMNNFS----SVIPTEIGGLKNLEYLFLGYNRLEGS----IPDSFG--DLISLKFLNLSNNNLSG---  367 (646)
Q Consensus       301 ~~~l~~L~~L~ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~---  367 (646)
                      +..+++|+.|+|++|.++    +.+|..+..+++|++|+|++|++++.    +|..+.  .+++|+.|+|++|.+++   
T Consensus       212 l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~  291 (386)
T 2ca6_A          212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV  291 (386)
T ss_dssp             GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred             hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHH
Confidence            334444444555555443    33455556666666666666666544    344442  26667777777777765   


Q ss_pred             -cCCccc-cCCCCCCceeCcCCcceeec
Q 046544          368 -AIPTSL-EKLSYLEDLNLSFNKLEGEI  393 (646)
Q Consensus       368 -~~p~~~-~~l~~L~~L~L~~N~l~~~~  393 (646)
                       .+|..+ .++++|+.|++++|++++..
T Consensus       292 ~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          292 RTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHHHHHhcCCCceEEEccCCcCCcch
Confidence             355555 45677777777777776543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=2.6e-24  Score=218.53  Aligned_cols=147  Identities=31%  Similarity=0.486  Sum_probs=126.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHh--CCCCCceeEEEEEecC----CeeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--IRHRNLIKVISSCSNE----EFKA  564 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~----~~~~  564 (646)
                      .++|+..+.||+|+||.||+|+. +|+.||||++...   ..+.+.+|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            36799999999999999999988 6899999998643   33556667777766  7999999999986543    4589


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      +||||+++|+|.+++...  .+++..+..++.|++.|++|||..     +.++|+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  589999999999999999999932     2578999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +...
T Consensus       161 ~~~~  164 (301)
T 3q4u_A          161 VMHS  164 (301)
T ss_dssp             EEEE
T ss_pred             eecc
Confidence            7653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.91  E-value=8e-25  Score=219.81  Aligned_cols=148  Identities=26%  Similarity=0.476  Sum_probs=132.0

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            36788999999999999999998888899999987543 34578899999999999999999999886 45689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+||+|||+++...
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            9999999986532 25889999999999999999999   8899999999999999999999999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=2.7e-24  Score=220.70  Aligned_cols=148  Identities=26%  Similarity=0.389  Sum_probs=133.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            56889999999999999999965 689999999975432      13567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla~  640 (646)
                      +||||+++++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++    .+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            9999999999999997653 6889999999999999999999   88999999999999999887    79999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       168 ~~~  170 (321)
T 2a2a_A          168 EIE  170 (321)
T ss_dssp             ECC
T ss_pred             ecC
Confidence            754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.8e-24  Score=223.11  Aligned_cols=149  Identities=28%  Similarity=0.503  Sum_probs=129.6

Q ss_pred             CCCCcceeecccccceEEEEEeCC-----CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|+...     +..||+|++..... .....+.+|+++++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456778999999999999998542     34699999975533 344578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999887678999999999999999999999   8899999999999999999999999999998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=4.3e-24  Score=219.34  Aligned_cols=140  Identities=26%  Similarity=0.329  Sum_probs=125.3

Q ss_pred             ceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          497 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .+.||+|+||.||+|+.. +|+.||||++...   ....+.+|+.+++.+. ||||+++++++..++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 6899999999743   3456778999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEEEeecCccccc
Q 046544          575 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLI  643 (646)
Q Consensus       575 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki~DfGla~~~~  643 (646)
                      |.+++...+ .+++.++..++.|++.|++|||   .++|+||||||+||+++.++   .+||+|||+|+...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999998764 6899999999999999999999   88999999999999997665   89999999998653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=1.9e-24  Score=230.92  Aligned_cols=148  Identities=25%  Similarity=0.374  Sum_probs=131.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Ce
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  562 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....  ....+++.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            368999999999999999999865 68899999997543  23456789999999999999999999998776     56


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+||||++ |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999998764 36899999999999999999999   889999999999999999999999999999876


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       180 ~  180 (432)
T 3n9x_A          180 N  180 (432)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=1.1e-24  Score=224.25  Aligned_cols=148  Identities=28%  Similarity=0.443  Sum_probs=126.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcE----EEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888999999999999999854 4443    5777765432 344578999999999999999999999998765 789


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999887778999999999999999999999   8899999999999999999999999999998654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=6e-25  Score=221.77  Aligned_cols=151  Identities=28%  Similarity=0.502  Sum_probs=136.1

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ..++|+..+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4467889999999999999999976 58899999987543 345788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...+
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999998643 45899999999999999999999   88999999999999999999999999999987643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=229.91  Aligned_cols=149  Identities=28%  Similarity=0.428  Sum_probs=131.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC--eeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--FKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56889999999999999999975 59999999997543 234567889999999999999999999998765  679999


Q ss_pred             EecCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecCccc
Q 046544          568 EYKPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKL  641 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~----~~~~~~ki~DfGla~~  641 (646)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||   ..+|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999997643  23899999999999999999999   8899999999999999    7788899999999987


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      +.
T Consensus       166 ~~  167 (396)
T 4eut_A          166 LE  167 (396)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=3.7e-24  Score=216.74  Aligned_cols=148  Identities=22%  Similarity=0.339  Sum_probs=133.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            57889999999999999999975 58899999987543   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++.... .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        95 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             ECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999887643 6889999999999999999999   8899999999999999999999999999998653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.4e-25  Score=231.77  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=136.0

Q ss_pred             CCEEECCCCcccccCCcCccCC--CCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCccccc-CCccccCCCCCcEE
Q 046544           12 LEELDLRHNKLVGTVPAAIFNM--SMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGT-IPRFIFNASKLSIL   88 (646)
Q Consensus        12 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L   88 (646)
                      ++.||+++|++.   +..+..+  ++++.|++++|.+.+.++...  .+++|++|+|++|.+++. .+..+..+++|++|
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~--~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCC--CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhc--cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            556666666554   3444444  566666666666655444432  255666666666665543 55555556666666


Q ss_pred             EcccCccccccCccccCcCCCCEEEccCC-CCCCCCCcccccccCCCCCCCCEEECCCC-CCCCcCCcchhccccccCcE
Q 046544           89 ELSQNSFSGFIPNTFGNLRNLEWLNLRDN-YLTSSTPELSFLSSLSNCKSLTFIHLSDN-PLDGILSKTSIGNLSHSLKD  166 (646)
Q Consensus        89 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~~~L~~  166 (646)
                      +|++|.+++..+..|+.+++|++|+|++| .++..    .++..+.++++|++|++++| .+++.               
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~----~l~~~~~~~~~L~~L~l~~~~~l~~~---------------  184 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF----ALQTLLSSCSRLDELNLSWCFDFTEK---------------  184 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH----HHHHHHHHCTTCCEEECCCCTTCCHH---------------
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH----HHHHHHhcCCCCCEEcCCCCCCcChH---------------
Confidence            66666655555555555566666666655 34321    01122344455555555555 44321               


Q ss_pred             EEeecccccccCCcccccCC-CCCEEEccCC--ccc-cccCccccCCCCCCeEEeeccc-ccCcCchhhcCCCCCcEEEe
Q 046544          167 FYMSNCNVSGGIPEEITNLT-NSITIDLGGN--KLN-GSIPITLSKLQKLQGLGLDDNK-LEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       167 L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L  241 (646)
                                ..+..+..++ +|++|++++|  .++ +..|..+..+++|++|++++|. +++..+..+..+++|++|++
T Consensus       185 ----------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l  254 (336)
T 2ast_B          185 ----------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL  254 (336)
T ss_dssp             ----------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred             ----------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeC
Confidence                      1244455666 6666666666  333 2344455566666666666666 55555566666667777777


Q ss_pred             cCCc-ccccCCccccCCCCCceeecCCCccccccc-ccccc-cccccccCCCCcccCCCCCccC
Q 046544          242 GGNK-LFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNL-KDILQLNFSSNFLTGPLPLEIG  302 (646)
Q Consensus       242 ~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l-~~L~~L~l~~N~l~~~~~~~~~  302 (646)
                      ++|. +.......+.++++|+.|++++|    ++. .+..+ ..+..|++++|.+++..|..++
T Consensus       255 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          255 SRCYDIIPETLLELGEIPTLKTLQVFGI----VPDGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTS----SCTTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CCCCCCCHHHHHHHhcCCCCCEEeccCc----cCHHHHHHHHhhCcceEEecccCccccCCccc
Confidence            6664 22221224566666777777666    322 22222 2355555566666555555443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=6.9e-24  Score=209.45  Aligned_cols=178  Identities=26%  Similarity=0.326  Sum_probs=89.0

Q ss_pred             CCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCC
Q 046544          188 SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSS  267 (646)
Q Consensus       188 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  267 (646)
                      .++++++++.++.+ |..+.  ++++.|+|++|.+++..+.+|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        16 ~~~l~~~~~~l~~~-p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLDSV-PSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCSSC-CSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcccc-CCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            34455555555532 22222  3555666666666555555566666666666666666555555555556666666665


Q ss_pred             CcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccc
Q 046544          268 NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD  347 (646)
Q Consensus       268 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  347 (646)
                      |.++.+|.                       ..|..+++|+.|++++|.++++.+..|..+++|++|+|++|++++..+.
T Consensus        93 n~l~~~~~-----------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  149 (251)
T 3m19_A           93 NQLASLPL-----------------------GVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG  149 (251)
T ss_dssp             SCCCCCCT-----------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CcccccCh-----------------------hHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH
Confidence            55554442                       2223333333444444444433333444444444444444444444444


Q ss_pred             cccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       348 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      .|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++
T Consensus       150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            44444455555555555544444444445555555555555544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=2.2e-24  Score=220.81  Aligned_cols=148  Identities=24%  Similarity=0.306  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEe----cCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS----NEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~----~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+++++.++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            5789999999999999999996 579999999987766566678899999999999999999999987    33578999


Q ss_pred             EEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++|+|.+++..   .+..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999876   3457899999999999999999999   889999999999999999999999999987754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=2e-24  Score=216.94  Aligned_cols=148  Identities=28%  Similarity=0.426  Sum_probs=132.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            367889999999999999999865 57899999986532   12245788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||++...
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999987654 5889999999999999999999   899999999999999999999999999988654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=3.3e-24  Score=221.33  Aligned_cols=148  Identities=22%  Similarity=0.339  Sum_probs=133.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57889999999999999999975 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++.... .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus       121 e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             CCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999987643 6889999999999999999999   8899999999999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=4.1e-24  Score=215.60  Aligned_cols=147  Identities=31%  Similarity=0.506  Sum_probs=129.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc-------hHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR-------AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++......       ..+.+.+|++++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67889999999999999999974 7899999998654321       1267889999999999999999999987665  


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEcCCCc-----EEEEee
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLDDNLV-----AYLSDF  636 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~~~~~-----~ki~Df  636 (646)
                      ++||||+++|+|.+++......+++..+..++.|++.|++|||   ..+  |+||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999999999877778999999999999999999999   778  999999999999987776     999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+|+...
T Consensus       174 g~~~~~~  180 (287)
T 4f0f_A          174 GLSQQSV  180 (287)
T ss_dssp             TTCBCCS
T ss_pred             Ccccccc
Confidence            9998543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.5e-24  Score=225.02  Aligned_cols=152  Identities=29%  Similarity=0.443  Sum_probs=127.9

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-----chHHHHHHHHHHHHhCCCCCceeEEEEEecCC
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE  561 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  561 (646)
                      ....++|+..+.||+|+||.||+|+.. +|+.||+|++.....     ...+.+.+|+++++.++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999965 689999999874321     11346789999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..++||||+++ ++.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999976 899998877667888899999999999999999   88999999999999999999999999999987


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      +.
T Consensus       162 ~~  163 (346)
T 1ua2_A          162 FG  163 (346)
T ss_dssp             TT
T ss_pred             cc
Confidence            64

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=5.1e-24  Score=214.51  Aligned_cols=149  Identities=23%  Similarity=0.454  Sum_probs=132.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999865 68999999997553  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc---EEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~---~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.   +||+|||+|+...
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999998887654 6899999999999999999999   889999999999999976554   9999999997654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=1e-24  Score=224.26  Aligned_cols=148  Identities=26%  Similarity=0.407  Sum_probs=128.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcE----EEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57888999999999999999864 4443    7888775443 233456778999999999999999999886 456889


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++...+..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999876667888899999999999999999   8899999999999999999999999999998764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=7.5e-24  Score=209.16  Aligned_cols=180  Identities=26%  Similarity=0.339  Sum_probs=143.1

Q ss_pred             CcEEEecCCcccccCCccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEccc
Q 046544          236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM  314 (646)
Q Consensus       236 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~  314 (646)
                      .++++++++.++. +|..+.  ++++.|++++|.++.++. .|.++++|++|++++|.+++..+..|..+++|+.|++++
T Consensus        16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            4455555555552 232222  455666666666665543 455566666666666666666677788889999999999


Q ss_pred             ccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeecc
Q 046544          315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       315 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  394 (646)
                      |.+++..+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++.+|
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            99998888999999999999999999998888889999999999999999998877789999999999999999998776


Q ss_pred             CC-CCCCCCccccccCCccccC-CCC
Q 046544          395 RG-GSFGNFAAESFEGNELLCG-SPT  418 (646)
Q Consensus       395 ~~-~~~~~~~~~~~~~N~~~c~-~~~  418 (646)
                      .. ..++.++.+++++|++.|+ |..
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c~~~~~  198 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDCSRCEI  198 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCTTSTTH
T ss_pred             HHHhCCCCCCEEEeeCCceeCCcccc
Confidence            44 5688999999999999997 443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.91  E-value=5.7e-25  Score=225.80  Aligned_cols=153  Identities=22%  Similarity=0.399  Sum_probs=134.2

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEec
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSN  559 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  559 (646)
                      +....++|+..+.||+|+||.||+|+..      +++.||+|++..... .....+.+|+++++.++||||+++++++..
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3344578999999999999999999753      367899999875433 344578899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV  630 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~  630 (646)
                      .+..++||||+++|+|.+++...+         ..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence            999999999999999999987532         35688999999999999999999   889999999999999999999


Q ss_pred             EEEEeecCcccc
Q 046544          631 AYLSDFGIAKLL  642 (646)
Q Consensus       631 ~ki~DfGla~~~  642 (646)
                      +||+|||+|+..
T Consensus       177 ~kl~Dfg~~~~~  188 (322)
T 1p4o_A          177 VKIGDFGMTRDI  188 (322)
T ss_dssp             EEECCTTCCCGG
T ss_pred             EEECcCcccccc
Confidence            999999999865

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=1e-24  Score=224.08  Aligned_cols=148  Identities=26%  Similarity=0.436  Sum_probs=129.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|...+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999975 7899999998754322 122455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++ |++.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            97 5999999887777999999999999999999999   8899999999999999999999999999987643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.8e-24  Score=215.88  Aligned_cols=148  Identities=26%  Similarity=0.429  Sum_probs=130.7

Q ss_pred             CCCCcce-eecccccceEEEEEeC---CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENN-LIGRGGFGSVYKARLG---DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|...+ .||+|+||.||+|.+.   +++.||+|+++.... ...+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455555 8999999999999853   578899999986533 3456789999999999999999999999 45568999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999877667999999999999999999999   8899999999999999999999999999998764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=2.6e-24  Score=224.75  Aligned_cols=157  Identities=23%  Similarity=0.280  Sum_probs=135.3

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC-----------chHHHHHHHHHHHHhCCCCCc
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-----------RAFKSFAVECEMMKSIRHRNL  550 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~H~ni  550 (646)
                      ....++....++|+..+.||+|+||.||+|+..+|+.||||++.....           ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677788899999999999999999999988899999999864321           123678999999999999999


Q ss_pred             eeEEEEEec-----CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          551 IKVISSCSN-----EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       551 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      +++++++..     ....|+||||++ |++.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999999853     346899999997 5899998877767999999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccc
Q 046544          626 DDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~  642 (646)
                      +.++.+||+|||+|+..
T Consensus       168 ~~~~~~kl~Dfg~~~~~  184 (362)
T 3pg1_A          168 ADNNDITICDFNLARED  184 (362)
T ss_dssp             CTTCCEEECCTTC----
T ss_pred             cCCCCEEEEecCccccc
Confidence            99999999999999754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.91  E-value=1.2e-24  Score=238.56  Aligned_cols=148  Identities=28%  Similarity=0.485  Sum_probs=132.9

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++||||+++++++.. +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            35688899999999999999999888889999997554 335689999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++... +..+++.++..++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999753 245889999999999999999999   8899999999999999999999999999998754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.91  E-value=2.4e-24  Score=239.63  Aligned_cols=141  Identities=27%  Similarity=0.437  Sum_probs=127.7

Q ss_pred             eecccccceEEEEEeC---CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          499 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       499 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .||+|+||.||+|.++   ++..||||+++... ....+++.+|+++++.++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   46779999997653 3456789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          575 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       575 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99999877777999999999999999999999   8899999999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=2e-24  Score=223.96  Aligned_cols=152  Identities=28%  Similarity=0.392  Sum_probs=130.8

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc-----CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-----CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE  561 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  561 (646)
                      ....++|+..+.||+|+||.||+|+.. +++.||+|++...     .....+.+.+|+++++.++||||+++++++...+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            345678999999999999999999864 6889999998753     2345678899999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 046544          562 FKALVLEYKPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIMIDVASAL  602 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l  602 (646)
                      ..++||||++||+|.+++...                                       ...+++..+..++.|++.|+
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521                                       11235667788999999999


Q ss_pred             HHHhcCCCCCeEecCCCCCCEEEcCCC--cEEEEeecCcccc
Q 046544          603 EYLHFGCLAPVIHCDLKPDNVLLDDNL--VAYLSDFGIAKLL  642 (646)
Q Consensus       603 ~~lH~~~~~~iiHrdlk~~Nil~~~~~--~~ki~DfGla~~~  642 (646)
                      +|||   ..+|+||||||+||+++.++  .+||+|||+|+.+
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~  220 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF  220 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence            9999   88999999999999998766  8999999999865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.4e-24  Score=227.12  Aligned_cols=148  Identities=29%  Similarity=0.489  Sum_probs=124.0

Q ss_pred             CCCcceeecccccceEEEEEeC--CC--cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCeeEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFKALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv  566 (646)
                      .|...+.||+|+||.||+|++.  ++  ..||+|.+.... ....+++.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999853  32  468999886543 3456789999999999999999999998754 4678999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|+|.+++......+++..+..++.|+++|++|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999877777899999999999999999999   8899999999999999999999999999998653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.91  E-value=3.9e-24  Score=220.97  Aligned_cols=145  Identities=26%  Similarity=0.407  Sum_probs=127.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++......    ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457899999999999999999865 6899999999765432    34688888887 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC----CcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~----~~~ki~DfGla~~~~  643 (646)
                      |++||+|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||++.++    +.+||+|||+|+.+.
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            999999999997654 6899999999999999999999   8899999999999998432    359999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=2.3e-24  Score=218.73  Aligned_cols=149  Identities=29%  Similarity=0.480  Sum_probs=130.2

Q ss_pred             CCCCcceeecccccceEEEEEeCC----CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEe-cCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCS-NEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~-~~~~~~l  565 (646)
                      .+|+..+.||+|+||.||+|+..+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457888999999999999998542    34689998875433 34567899999999999999999999865 4567899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999877777899999999999999999999   8899999999999999999999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=5.5e-24  Score=222.24  Aligned_cols=155  Identities=29%  Similarity=0.443  Sum_probs=136.7

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--------chHHHHHHHHHHHHhC-CCCCceeEE
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--------RAFKSFAVECEMMKSI-RHRNLIKVI  554 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~~~  554 (646)
                      .......++|+..+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334445577999999999999999999975 799999999976532        1135678899999999 899999999


Q ss_pred             EEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       555 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      +++...+..++||||++||+|.+++.... .+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999997643 6899999999999999999999   8899999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+++.+.
T Consensus       243 DfG~~~~~~  251 (365)
T 2y7j_A          243 DFGFSCHLE  251 (365)
T ss_dssp             CCTTCEECC
T ss_pred             ecCcccccC
Confidence            999988764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=8.5e-25  Score=227.53  Aligned_cols=147  Identities=26%  Similarity=0.359  Sum_probs=131.4

Q ss_pred             CCCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          492 NGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      ++|+..+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|+++++.+ +||||+++++++..++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5789999999999999999986    368999999986432    22345567899999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999997654 6889999999999999999999   889999999999999999999999999999865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.91  E-value=9.4e-24  Score=214.06  Aligned_cols=146  Identities=20%  Similarity=0.260  Sum_probs=131.9

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|++....  ..+.+.+|+.+++.+ +|++++++++++......++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            5799999999999999999996 579999999987543  234577899999999 899999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc-----EEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV-----AYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~-----~ki~DfGla~~~~  643 (646)
                      + +++|.+++...+..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.     +||+|||+|+.+.
T Consensus        88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9 99999999887767999999999999999999999   899999999999999987765     9999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=4.4e-24  Score=214.01  Aligned_cols=149  Identities=30%  Similarity=0.458  Sum_probs=134.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999975 79999999987542   23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999997654 5889999999999999999999   8899999999999999999999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=6.6e-24  Score=213.56  Aligned_cols=148  Identities=28%  Similarity=0.398  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC------chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999976 699999999875431      23578899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla~  640 (646)
                      +||||+++++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997643 6899999999999999999999   88999999999999998776    89999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       161 ~~~  163 (283)
T 3bhy_A          161 KIE  163 (283)
T ss_dssp             ECC
T ss_pred             ecc
Confidence            653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=1e-23  Score=213.40  Aligned_cols=149  Identities=28%  Similarity=0.400  Sum_probs=130.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34566679999999999999964 68899999998776666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~~~~  643 (646)
                      ++++|.+++....  ...++..+..++.|++.|++|||   ..+|+||||||+||+++. ++.+||+|||+++...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999999998653  24568888899999999999999   889999999999999987 8999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.91  E-value=4.4e-24  Score=213.96  Aligned_cols=148  Identities=24%  Similarity=0.350  Sum_probs=134.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467899999999999999999975 68999999997553 3445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++++|.+++... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999998654 36889999999999999999999   889999999999999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=3.1e-24  Score=218.05  Aligned_cols=149  Identities=26%  Similarity=0.424  Sum_probs=132.6

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec----------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN----------  559 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----------  559 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++... ....+.+.+|+++++.++||||+++++++..          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457889999999999999999964 7999999998643 2345678899999999999999999998764          


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          560 ---EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       560 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                         .+..++||||+++|+|.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               35689999999999999999877667788899999999999999999   889999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+++...
T Consensus       161 g~~~~~~  167 (303)
T 1zy4_A          161 GLAKNVH  167 (303)
T ss_dssp             CCCSCTT
T ss_pred             cchhhcc
Confidence            9998653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=7.4e-24  Score=231.12  Aligned_cols=149  Identities=26%  Similarity=0.430  Sum_probs=130.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-------------chHHHHHHHHHHHHhCCCCCceeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-------------RAFKSFAVECEMMKSIRHRNLIKVISS  556 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~~~~~  556 (646)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.....             ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999965 688999999875421             234678899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEE
Q 046544          557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYL  633 (646)
Q Consensus       557 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki  633 (646)
                      +...+..|+|||||+||+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999987654 6899999999999999999999   88999999999999998765   6999


Q ss_pred             EeecCccccc
Q 046544          634 SDFGIAKLLI  643 (646)
Q Consensus       634 ~DfGla~~~~  643 (646)
                      +|||+|+.+.
T Consensus       191 ~Dfg~a~~~~  200 (504)
T 3q5i_A          191 VDFGLSSFFS  200 (504)
T ss_dssp             CCCTTCEECC
T ss_pred             EECCCCEEcC
Confidence            9999998764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=8.2e-24  Score=214.57  Aligned_cols=150  Identities=27%  Similarity=0.411  Sum_probs=134.1

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---------chHHHHHHHHHHHHhCC-CCCceeEEEEEe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---------RAFKSFAVECEMMKSIR-HRNLIKVISSCS  558 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~~~~~~~  558 (646)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++.....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3478999999999999999999975 689999999975431         22356788999999995 999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecC
Q 046544          559 NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGI  638 (646)
Q Consensus       559 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGl  638 (646)
                      ..+..++||||+++++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999997653 6889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      ++.+.
T Consensus       171 ~~~~~  175 (298)
T 1phk_A          171 SCQLD  175 (298)
T ss_dssp             CEECC
T ss_pred             hhhcC
Confidence            98653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=4.2e-24  Score=239.92  Aligned_cols=149  Identities=23%  Similarity=0.252  Sum_probs=133.5

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc---CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~  564 (646)
                      ..++|+..+.||+|+||+||+|+.. +++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4468999999999999999999965 6889999999754   233456778899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+|||   ..+||||||||+|||++.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999998754 6899999999999999999999   889999999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.91  E-value=8.6e-24  Score=216.57  Aligned_cols=145  Identities=31%  Similarity=0.516  Sum_probs=129.8

Q ss_pred             CCcceeecccccceEEEEEeC-----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEE
Q 046544          494 FSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKAL  565 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  565 (646)
                      |+..+.||+|+||.||+|.+.     +++.||||++..... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999988642     688999999986543 3456789999999999999999999999874  57899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++....  +++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999997654  889999999999999999999   8899999999999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=1.1e-23  Score=214.29  Aligned_cols=147  Identities=29%  Similarity=0.392  Sum_probs=133.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999864 68999999998654 34567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence            9999999998653  5899999999999999999999   8899999999999999999999999999997654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=9.6e-24  Score=218.01  Aligned_cols=146  Identities=31%  Similarity=0.453  Sum_probs=126.7

Q ss_pred             HHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC--CCCCceeEEEEEecC----Ce
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI--RHRNLIKVISSCSNE----EF  562 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~~~~~~~~~----~~  562 (646)
                      ...++|+..+.||+|+||.||+|+.. |+.||||++....   ...+.+|.+++...  +||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34468999999999999999999985 8999999986432   23445566666554  999999999999877    68


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCCEEEcCCCcEEEE
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA--------PVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--------~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      .++||||+++|+|.+++...  .+++..+..++.|++.|++|||   ..        +|+||||||+||+++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            89999999999999999765  4889999999999999999999   66        99999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+|+.+.
T Consensus       185 Dfg~a~~~~  193 (337)
T 3mdy_A          185 DLGLAVKFI  193 (337)
T ss_dssp             CCTTCEECC
T ss_pred             eCCCceeec
Confidence            999997653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=1.5e-23  Score=213.54  Aligned_cols=192  Identities=23%  Similarity=0.369  Sum_probs=150.6

Q ss_pred             CcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecC
Q 046544          164 LKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG  243 (646)
Q Consensus       164 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  243 (646)
                      |++|++++|.+... | .+..+++|++|++++|++.+..+  +..+++|++|++++|++++.  ..+..+++|++|++++
T Consensus        43 L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~  116 (308)
T 1h6u_A           43 ITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTS  116 (308)
T ss_dssp             CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTT
T ss_pred             cCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCC
Confidence            44444444444432 2 46777888888888888876655  78888888888888888753  3688888888888888


Q ss_pred             CcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCcc
Q 046544          244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT  323 (646)
Q Consensus       244 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  323 (646)
                      |++++..  .+..+++|+.|++++|.++.++. +..+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..+ 
T Consensus       117 n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-  190 (308)
T 1h6u_A          117 TQITDVT--PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-  190 (308)
T ss_dssp             SCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-
T ss_pred             CCCCCch--hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh-
Confidence            8887643  27888888888888888888775 7788888888888888886444  8888999999999999987654 


Q ss_pred             ccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCc
Q 046544          324 EIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT  371 (646)
Q Consensus       324 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  371 (646)
                       +..+++|++|++++|++++..+  +..+++|+.|+|++|++++ .|.
T Consensus       191 -l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~-~~~  234 (308)
T 1h6u_A          191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN-QPV  234 (308)
T ss_dssp             -GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC-CCE
T ss_pred             -hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec-CCe
Confidence             8889999999999999986653  8999999999999999984 443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=3.4e-24  Score=223.66  Aligned_cols=159  Identities=28%  Similarity=0.332  Sum_probs=137.6

Q ss_pred             ccccHHHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-----CCCceeE
Q 046544          480 RTFSYLELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-----HRNLIKV  553 (646)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~~  553 (646)
                      ..+++.+.....++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+..|+++++.++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            44555555556689999999999999999999974 6899999998643 233456778999999986     9999999


Q ss_pred             EEEEecCCeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-----
Q 046544          554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-----  627 (646)
Q Consensus       554 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-----  627 (646)
                      ++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 889999998654 35889999999999999999999   889999999999999975     


Q ss_pred             --------------------CCcEEEEeecCccccc
Q 046544          628 --------------------NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 --------------------~~~~ki~DfGla~~~~  643 (646)
                                          ++.+||+|||+|+...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  213 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS  213 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecC
Confidence                                7899999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=2e-24  Score=225.66  Aligned_cols=149  Identities=21%  Similarity=0.325  Sum_probs=126.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCC------CcEEEEEEEeccCCch-----------HHHHHHHHHHHHhCCCCCceeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCGRA-----------FKSFAVECEMMKSIRHRNLIKV  553 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~H~niv~~  553 (646)
                      .++|+..+.||+|+||.||+|++..      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3579999999999999999998754      4789999987554211           1123446667778899999999


Q ss_pred             EEEEecC----CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--C
Q 046544          554 ISSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--D  627 (646)
Q Consensus       554 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~  627 (646)
                      ++++...    ...++||||+ |++|.+++......+++..+..++.|++.||+|||   ..+|+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998765    4589999999 99999999887678999999999999999999999   88999999999999998  8


Q ss_pred             CCcEEEEeecCccccc
Q 046544          628 NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ~~~~ki~DfGla~~~~  643 (646)
                      ++.+||+|||+|+.+.
T Consensus       190 ~~~~kl~DFG~a~~~~  205 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYC  205 (364)
T ss_dssp             TTCEEECCCTTCEESS
T ss_pred             CCeEEEEECCcceecc
Confidence            8999999999997653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=6.2e-24  Score=223.95  Aligned_cols=147  Identities=22%  Similarity=0.402  Sum_probs=122.3

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCC-CCCceeEEEEEecCC--ee
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEE--FK  563 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~--~~  563 (646)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+.+++.+. ||||+++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999864 79999999986442  334567889999999997 999999999997654  68


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|||||+ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 5899998764  5889999999999999999999   889999999999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=4.9e-24  Score=220.80  Aligned_cols=147  Identities=23%  Similarity=0.368  Sum_probs=130.8

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCC--CCceeEEEEEecCCeeEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRH--RNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~~~~lv  566 (646)
                      .++|+..+.||+|+||.||+|...+++.||||++.....  ...+.+.+|+++++.++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            356889999999999999999988899999999975532  344678899999999976  9999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||| .+|+|.+++.... .+++.++..++.|++.||+|||   ..+|+||||||+||+++ ++.+||+|||+|+.+.
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            995 5889999998754 6889999999999999999999   88999999999999997 5789999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=6.7e-24  Score=213.68  Aligned_cols=147  Identities=29%  Similarity=0.433  Sum_probs=132.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999875 68899999987532   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999997654 5889999999999999999999   889999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=4.5e-24  Score=213.29  Aligned_cols=146  Identities=30%  Similarity=0.486  Sum_probs=122.1

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC----chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG----RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|++. |+.||+|++.....    ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999974 88999999865432    23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCCEEEcC--------CCcEEEEee
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP---VIHCDLKPDNVLLDD--------NLVAYLSDF  636 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~---iiHrdlk~~Nil~~~--------~~~~ki~Df  636 (646)
                      ||+++++|.+++...  .+++..+..++.|++.|++|||   ..+   |+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998643  6899999999999999999999   666   999999999999985        678999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+|+.+.
T Consensus       161 g~~~~~~  167 (271)
T 3dtc_A          161 GLAREWH  167 (271)
T ss_dssp             CC-----
T ss_pred             Ccccccc
Confidence            9998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=4.9e-24  Score=231.95  Aligned_cols=148  Identities=24%  Similarity=0.386  Sum_probs=128.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46889999999999999999975 68999999997553  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~~~~  643 (646)
                      ||++|+|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|||+|+.+.
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999887654 6889999999999999999999   889999999999999975   4569999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.90  E-value=4.7e-24  Score=231.68  Aligned_cols=148  Identities=26%  Similarity=0.430  Sum_probs=133.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999975 79999999997543   334678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||++   +.++.+||+|||+|+.+.
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999987654 6899999999999999999999   8899999999999999   467899999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=9.1e-24  Score=215.95  Aligned_cols=149  Identities=30%  Similarity=0.395  Sum_probs=130.1

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++....  ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467999999999999999999875 58999999997653  34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999765567899999999999999999999   8899999999999999999999999999997653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.90  E-value=1.1e-23  Score=214.80  Aligned_cols=150  Identities=29%  Similarity=0.460  Sum_probs=126.6

Q ss_pred             HhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-----CchHHHHHHHHHHHHhC---CCCCceeEEEEEecC
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSI---RHRNLIKVISSCSNE  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~  560 (646)
                      ..++|+..+.||+|+||+||+|+. .+|+.||+|++....     ......+.+|+++++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999996 478999999987432     11234667788877766   499999999999876


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          561 E-----FKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       561 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      .     ..++||||+. |+|.+++..... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999996 599999977643 4899999999999999999999   8899999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+|+...
T Consensus       163 Dfg~a~~~~  171 (308)
T 3g33_A          163 DFGLARIYS  171 (308)
T ss_dssp             SCSCTTTST
T ss_pred             eCccccccC
Confidence            999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.90  E-value=3.5e-24  Score=227.90  Aligned_cols=150  Identities=26%  Similarity=0.338  Sum_probs=128.3

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--------CchHHHHHHHHHHHHhCCCCCceeEEEEEec
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRAFKSFAVECEMMKSIRHRNLIKVISSCSN  559 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  559 (646)
                      ...++|...+.||+|+||.||+|... +++.||+|++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999865 68999999987542        1122357889999999999999999999864


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC---CcEEEEee
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN---LVAYLSDF  636 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~---~~~ki~Df  636 (646)
                       +..++||||+++|+|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45799999999999999887554 6899999999999999999999   8899999999999999654   45999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+|+.+.
T Consensus       287 G~a~~~~  293 (419)
T 3i6u_A          287 GHSKILG  293 (419)
T ss_dssp             STTTSCC
T ss_pred             ccceecC
Confidence            9998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=4.6e-24  Score=217.11  Aligned_cols=148  Identities=24%  Similarity=0.392  Sum_probs=130.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357889999999999999999975 7999999999866544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~  642 (646)
                      +++++|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||++   +.++.+||+|||+++..
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999987654 6889999999999999999999   8899999999999999   77889999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.90  E-value=6.4e-24  Score=220.72  Aligned_cols=149  Identities=26%  Similarity=0.427  Sum_probs=131.5

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC-------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE-------  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  560 (646)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++.....  .....+.+|+++++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36789999999999999999997 4799999999865432  2345778999999999999999999998873       


Q ss_pred             -CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          561 -EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       561 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                       +..++||||+++ ++.+.+......+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence             468999999975 888888777667999999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       172 ~~~~  175 (351)
T 3mi9_A          172 RAFS  175 (351)
T ss_dssp             EECC
T ss_pred             cccc
Confidence            8653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=4.7e-24  Score=216.30  Aligned_cols=147  Identities=25%  Similarity=0.430  Sum_probs=129.3

Q ss_pred             CCCcceeecccccceEEEEEeC-C---CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCee-EEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK-ALV  566 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~-~lv  566 (646)
                      .|...+.||+|+||.||+|++. +   +..||+|++..... ...+.+.+|+++++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556689999999999999853 2   33799999875433 3456789999999999999999999999876655 999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+.+|+|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999887777899999999999999999999   889999999999999999999999999999755

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.90  E-value=2.1e-24  Score=222.72  Aligned_cols=152  Identities=26%  Similarity=0.404  Sum_probs=133.3

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-C-----CcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecC
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-D-----GMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNE  560 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  560 (646)
                      ...++|+..+.||+|+||.||+|+.. +     ++.||+|++..... ...+.+.+|+++++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            34578999999999999999999864 2     34799999976543 3456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC
Q 046544          561 EFKALVLEYKPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD  627 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~  627 (646)
                      +..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   ..+|+||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECC
Confidence            9999999999999999998753             235789999999999999999999   889999999999999999


Q ss_pred             CCcEEEEeecCccccc
Q 046544          628 NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ~~~~ki~DfGla~~~~  643 (646)
                      ++.+||+|||+|+.+.
T Consensus       200 ~~~~kl~Dfg~~~~~~  215 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIM  215 (333)
T ss_dssp             GGEEEBCCCGGGCCGG
T ss_pred             CCeEEECccccccccc
Confidence            9999999999998653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.90  E-value=6.8e-24  Score=211.84  Aligned_cols=147  Identities=22%  Similarity=0.415  Sum_probs=131.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC--CeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE--EFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+++ ++.||+|++....  ....+.+.+|+.+++.++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57889999999999999999984 8899999997653  23456789999999999999999999999887  7789999


Q ss_pred             EecCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          568 EYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+++|+|.+++..... .+++..+..++.|++.|++|||   ..+  |+||||||+||+++.++.++++|||++...
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            99999999999987653 5899999999999999999999   777  999999999999999999999999887543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=5.2e-24  Score=231.30  Aligned_cols=148  Identities=26%  Similarity=0.414  Sum_probs=132.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++...+..|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            57899999999999999999975 79999999987432  3345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~  643 (646)
                      ||++|+|.+++...+ .+++..+..++.|++.|+.|||   ..+|+||||||+||+++   .++.+||+|||+|+.+.
T Consensus       102 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999887654 6899999999999999999999   88999999999999995   45689999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.90  E-value=5.9e-24  Score=216.98  Aligned_cols=149  Identities=29%  Similarity=0.449  Sum_probs=126.8

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+|+..+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5789999999999999999986 479999999997532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++|+|.+++..   ....+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999864   3456899999999999999999999   8899999999999999999999999999987653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.90  E-value=5.8e-24  Score=216.91  Aligned_cols=151  Identities=24%  Similarity=0.301  Sum_probs=130.9

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            33478999999999999999999965 689999999875432   23467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++++|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999997654 6889999999999999999999   8899999999999999999999999999987653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.90  E-value=3e-24  Score=219.73  Aligned_cols=159  Identities=25%  Similarity=0.414  Sum_probs=136.4

Q ss_pred             ccHHHHHHHhCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeE
Q 046544          482 FSYLELCRATNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKV  553 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~  553 (646)
                      +...++....++|+..+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+++++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33445555567899999999999999999974      3568899999976543 3446788999999999 79999999


Q ss_pred             EEEEecCC-eeEEEEEecCCCCHHHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 046544          554 ISSCSNEE-FKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQRLNIMIDVASALEYLHFGCLAPVIHCD  617 (646)
Q Consensus       554 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd  617 (646)
                      ++++...+ ..++||||+++|+|.+++......               +++..+..++.|++.|++|||   ..+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99988764 589999999999999999865432               788999999999999999999   88999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCccccc
Q 046544          618 LKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       618 lk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+||+++.++.+||+|||+|+.+.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~  199 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIY  199 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             CccceEEECCCCCEEECCCccccccc
Confidence            99999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=6.9e-24  Score=218.61  Aligned_cols=148  Identities=28%  Similarity=0.450  Sum_probs=129.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc--hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR--AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++......  ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57889999999999999999975 5899999998755432  34567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |++++++.++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            99998888876544 36899999999999999999999   8899999999999999999999999999997653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.90  E-value=4e-24  Score=223.14  Aligned_cols=147  Identities=22%  Similarity=0.330  Sum_probs=133.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56889999999999999999975 689999999986533 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++...+ .+++..+..++.|++.|++|||   .. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999997654 5889999999999999999999   64 8999999999999999999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.90  E-value=3.5e-24  Score=220.55  Aligned_cols=150  Identities=25%  Similarity=0.427  Sum_probs=128.1

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ...++|+..+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|+++++.++||||+++++++..++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44568999999999999999999864 789999999875432  234567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-----CCCcEEEEeecCcc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-----DNLVAYLSDFGIAK  640 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-----~~~~~ki~DfGla~  640 (646)
                      ||||+++ +|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++     ..+.+||+|||+|+
T Consensus       111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999975 9999997765 5899999999999999999999   88999999999999994     55569999999997


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       186 ~~~  188 (329)
T 3gbz_A          186 AFG  188 (329)
T ss_dssp             HHC
T ss_pred             ccC
Confidence            653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=4.9e-24  Score=214.34  Aligned_cols=149  Identities=26%  Similarity=0.455  Sum_probs=130.8

Q ss_pred             hCCCCcceeecccccceEEEEEeCC----CcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|...+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|+++++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3678899999999999999998532    3469999987653 2345678999999999999999999999865 45789


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++++|.+++...+..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++...
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999876667899999999999999999999   8899999999999999999999999999998654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=1.3e-23  Score=218.18  Aligned_cols=182  Identities=14%  Similarity=0.069  Sum_probs=105.9

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccc-cCccccCCCCCCe-EEeecccccCcCchhhcCCCCCcEEE
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGS-IPITLSKLQKLQG-LGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      ++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+.+|.+++++++ +.++.|+|+.+.|++|..+++|++|+
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            455555555555555556677777777777777776443 3456677766654 45556777766677777777777777


Q ss_pred             ecCCcccccCCccccCCCCCceeecCC-Cccccccc-cccccc-ccccccCCCCcccCCCCCccCccccceEEEccc-cc
Q 046544          241 LGGNKLFGSIPACFSNLASLRILSLSS-NELTSIPL-TFWNLK-DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM-NN  316 (646)
Q Consensus       241 L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~-N~  316 (646)
                      +++|++....+..+....++..|++++ |.+..+|. .|..+. .++.|++++|.|+.+.+..| ...+|+.+++++ |.
T Consensus       111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~  189 (350)
T 4ay9_X          111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNN  189 (350)
T ss_dssp             EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTT
T ss_pred             ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCc
Confidence            777777666666666666666676644 45666654 233332 35555555555553322222 334455555543 44


Q ss_pred             ccccCccccCCCCCCCEEEccCccCCCcc
Q 046544          317 FSSVIPTEIGGLKNLEYLFLGYNRLEGSI  345 (646)
Q Consensus       317 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  345 (646)
                      ++.+.+..|+++++|++|+|++|+|+..+
T Consensus       190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp  218 (350)
T 4ay9_X          190 LEELPNDVFHGASGPVILDISRTRIHSLP  218 (350)
T ss_dssp             CCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred             ccCCCHHHhccCcccchhhcCCCCcCccC
Confidence            44444445555555555555555555333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=4.9e-24  Score=215.27  Aligned_cols=146  Identities=27%  Similarity=0.476  Sum_probs=124.1

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+..  ..||+|++....  ....+.+.+|+++++.++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            367999999999999999999864  359999987554  23456789999999999999999999965 4556899999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+++++|.+++......+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999877778999999999999999999999   889999999999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=8.1e-24  Score=223.51  Aligned_cols=144  Identities=22%  Similarity=0.340  Sum_probs=123.7

Q ss_pred             CCCCcc-eeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHH-HhCCCCCceeEEEEEec----CCeeE
Q 046544          492 NGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMM-KSIRHRNLIKVISSCSN----EEFKA  564 (646)
Q Consensus       492 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~----~~~~~  564 (646)
                      ++|... +.||+|+||+||+|+.. +|+.||||++...     ..+.+|++++ +..+||||+++++++..    .+..|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456555 78999999999999865 6899999998632     4567788887 45589999999998875    56789


Q ss_pred             EEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~  640 (646)
                      +|||||+||+|.+++.... ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.   ++.+||+|||+|+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998754 36899999999999999999999   889999999999999987   7899999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       213 ~~~  215 (400)
T 1nxk_A          213 ETT  215 (400)
T ss_dssp             ECC
T ss_pred             ccC
Confidence            654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=9e-24  Score=217.35  Aligned_cols=147  Identities=35%  Similarity=0.616  Sum_probs=129.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcE--EEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGME--VAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||.||+|+.. +|..  ||+|.+.... ....+.+.+|+++++++ +||||+++++++..++..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57889999999999999999854 5664  4999887532 33456788999999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          567 LEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      |||+++|+|.+++....               ..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653               36899999999999999999999   8899999999999999999999


Q ss_pred             EEEeecCccc
Q 046544          632 YLSDFGIAKL  641 (646)
Q Consensus       632 ki~DfGla~~  641 (646)
                      ||+|||+++.
T Consensus       182 kL~Dfg~~~~  191 (327)
T 1fvr_A          182 KIADFGLSRG  191 (327)
T ss_dssp             EECCTTCEES
T ss_pred             EEcccCcCcc
Confidence            9999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=8.3e-24  Score=222.76  Aligned_cols=146  Identities=23%  Similarity=0.365  Sum_probs=129.9

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCC--CCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIR--HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+|+..+.||+|+||.||+|...+++.||||++....  ....+.+.+|+++++.++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            3589999999999999999998889999999997653  234567899999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      | +.+++|.+++.... .+++.++..++.||+.||+|||   ..+|+||||||+||+++ ++.+||+|||+|+.+.
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            9 56889999998765 6788899999999999999999   88999999999999996 5789999999998763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.90  E-value=6.9e-24  Score=213.43  Aligned_cols=146  Identities=27%  Similarity=0.471  Sum_probs=129.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec----------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN----------  559 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----------  559 (646)
                      ..+|+..+.||+|+||.||+|+.. +|+.||+|++....    +.+.+|+++++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            357889999999999999999976 79999999997553    345689999999999999999998854          


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          560 ------EEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       560 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                            ....++||||+++|+|.+++... ...+++..+..++.|++.|+.|||   ..+|+||||||+||++++++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  34579999999999999999754 246899999999999999999999   88999999999999999999999


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+++.+.
T Consensus       163 l~Dfg~~~~~~  173 (284)
T 2a19_B          163 IGDFGLVTSLK  173 (284)
T ss_dssp             ECCCTTCEESS
T ss_pred             ECcchhheecc
Confidence            99999988764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1.2e-23  Score=221.29  Aligned_cols=147  Identities=27%  Similarity=0.401  Sum_probs=124.0

Q ss_pred             HHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC-------
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-------  560 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  560 (646)
                      ...++|+..+.||+|+||.||+|+. .+|+.||||++......    ..+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999986 47999999998754322    23699999999999999999998443       


Q ss_pred             -------------------------------CeeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 046544          561 -------------------------------EFKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH  606 (646)
Q Consensus       561 -------------------------------~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH  606 (646)
                                                     ...++||||+++ +|.+.+..   .+..+++..+..++.|++.||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           348899999974 87777653   3457899999999999999999999


Q ss_pred             cCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCccccc
Q 046544          607 FGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       607 ~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~  643 (646)
                         +.+|+||||||+||+++ .++.+||+|||+|+.+.
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  193 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI  193 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC
Confidence               89999999999999998 68999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.90  E-value=7e-24  Score=216.72  Aligned_cols=152  Identities=29%  Similarity=0.509  Sum_probs=124.9

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC-
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE-  561 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-  561 (646)
                      ...++|...+.||+|+||.||+|+..    +++.||+|+++...  ....+.+.+|+.++++++||||+++++++...+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34467888999999999999999753    35689999987553  334567899999999999999999999998764 


Q ss_pred             ----eeEEEEEecCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEE
Q 046544          562 ----FKALVLEYKPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAY  632 (646)
Q Consensus       562 ----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~k  632 (646)
                          ..++||||+++|+|.+++..     ....+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                35999999999999999853     2346899999999999999999999   88999999999999999999999


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+|+.+.
T Consensus       188 l~Dfg~~~~~~  198 (313)
T 3brb_A          188 VADFGLSKKIY  198 (313)
T ss_dssp             ECSCSCC----
T ss_pred             EeecCcceecc
Confidence            99999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.90  E-value=5.5e-24  Score=228.96  Aligned_cols=146  Identities=25%  Similarity=0.309  Sum_probs=125.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecC------C
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------E  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~  561 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999865 6899999999754  233456788999999999999999999999655      3


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999976 57766643   4789999999999999999999   88999999999999999999999999999986


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       214 ~~  215 (464)
T 3ttj_A          214 AG  215 (464)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=5e-24  Score=222.62  Aligned_cols=147  Identities=26%  Similarity=0.371  Sum_probs=124.1

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  561 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....  ....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            367899999999999999999964 79999999986543  233567889999999999999999999997763      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999999764  5889999999999999999999   88999999999999999999999999999987


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       178 ~~  179 (367)
T 1cm8_A          178 AD  179 (367)
T ss_dssp             CC
T ss_pred             cc
Confidence            53

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=5.2e-24  Score=218.97  Aligned_cols=148  Identities=28%  Similarity=0.444  Sum_probs=127.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcE----EEEEEEecc-CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57899999999999999999864 4543    577766543 2345678899999999999999999999998765 789


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            99999999999999887778999999999999999999999   8899999999999999999999999999998753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=3.1e-24  Score=218.16  Aligned_cols=151  Identities=26%  Similarity=0.365  Sum_probs=119.3

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999854 68999999886543 33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          567 LEYKPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                      |||+++|+|.+++..       ....+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999874       2346899999999999999999999   889999999999999999999999999998


Q ss_pred             ccc
Q 046544          640 KLL  642 (646)
Q Consensus       640 ~~~  642 (646)
                      +.+
T Consensus       169 ~~~  171 (303)
T 2vwi_A          169 AFL  171 (303)
T ss_dssp             HHC
T ss_pred             hee
Confidence            764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.90  E-value=3.5e-24  Score=222.39  Aligned_cols=149  Identities=23%  Similarity=0.384  Sum_probs=133.5

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCc-----------------hHHHHHHHHHHHHhCCCCCceeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-----------------AFKSFAVECEMMKSIRHRNLIKV  553 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~H~niv~~  553 (646)
                      .++|+..+.||+|+||.||+|+. +|+.||+|++......                 ..+.+.+|+++++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999999 8999999998743211                 11788999999999999999999


Q ss_pred             EEEEecCCeeEEEEEecCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEE
Q 046544          554 ISSCSNEEFKALVLEYKPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLL  625 (646)
Q Consensus       554 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~  625 (646)
                      ++++...+..++||||+++|+|.++      +... ...+++..+..++.|++.|++|||   . ++|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 457899999999999999999999   7 899999999999999


Q ss_pred             cCCCcEEEEeecCccccc
Q 046544          626 DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~  643 (646)
                      +.++.+||+|||+++...
T Consensus       186 ~~~~~~kl~dfg~~~~~~  203 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMV  203 (348)
T ss_dssp             CTTSCEEECCCTTCEECB
T ss_pred             cCCCcEEEeccccccccc
Confidence            999999999999998753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=1.1e-23  Score=212.05  Aligned_cols=143  Identities=15%  Similarity=0.044  Sum_probs=127.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999975 589999999976532   23467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ||++|++|.+++...   ....++.+++.|++.||+|||   ..+|+||||||+||+++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999998543   355678899999999999999   8899999999999999999999999887543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=2e-25  Score=235.33  Aligned_cols=238  Identities=17%  Similarity=0.204  Sum_probs=165.6

Q ss_pred             CCcccccCCCCCEEEccCCccccccC----ccccCCCCCCeEEeeccc---ccCcCchhh-------cCCCCCcEEEecC
Q 046544          178 IPEEITNLTNSITIDLGGNKLNGSIP----ITLSKLQKLQGLGLDDNK---LEGSIPDSI-------CRLTELYELELGG  243 (646)
Q Consensus       178 ~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~---l~~~~~~~~-------~~l~~L~~L~L~~  243 (646)
                      ++..+..+++|++|+|++|.+....+    ..+..+++|++|+|++|.   +.+.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            44555666666666666666665433    235566666777666643   333444443       5667777777777


Q ss_pred             Ccccc----cCCccccCCCCCceeecCCCccccc-----ccccccc---------cccccccCCCCccc-CCCC---Ccc
Q 046544          244 NKLFG----SIPACFSNLASLRILSLSSNELTSI-----PLTFWNL---------KDILQLNFSSNFLT-GPLP---LEI  301 (646)
Q Consensus       244 N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~l-----p~~~~~l---------~~L~~L~l~~N~l~-~~~~---~~~  301 (646)
                      |++.+    .++..+..+++|++|+|++|.++..     +..+..+         ++|++|++++|.++ +..+   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            77765    3555666677777777777776532     2223333         67777777777775 2233   356


Q ss_pred             CccccceEEEcccccccc-----cCccccCCCCCCCEEEccCccCC----CcccccccCCCCCCEEEccCCcCccc----
Q 046544          302 GNLKVLIGIDFSMNNFSS-----VIPTEIGGLKNLEYLFLGYNRLE----GSIPDSFGDLISLKFLNLSNNNLSGA----  368 (646)
Q Consensus       302 ~~l~~L~~L~ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----  368 (646)
                      ..+++|+.|++++|.++.     ..|..+..+++|+.|+|++|.++    ..+|..+..+++|+.|+|++|++++.    
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  263 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  263 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence            677788888888888872     34457888999999999999995    56788899999999999999999865    


Q ss_pred             CCccccC--CCCCCceeCcCCccee----eccCC--CCCCCCccccccCCccccC
Q 046544          369 IPTSLEK--LSYLEDLNLSFNKLEG----EIPRG--GSFGNFAAESFEGNELLCG  415 (646)
Q Consensus       369 ~p~~~~~--l~~L~~L~L~~N~l~~----~~p~~--~~~~~~~~~~~~~N~~~c~  415 (646)
                      +|..+..  +++|+.|+|++|++++    .+|..  ..+++++.+++++|++.+.
T Consensus       264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            5666644  8999999999999998    35554  2368899999999986643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=1.4e-24  Score=227.89  Aligned_cols=148  Identities=18%  Similarity=0.217  Sum_probs=122.8

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEecc---CCchHHHHHHHH---HHHHhCCCCCceeEE-------EE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRAFKSFAVEC---EMMKSIRHRNLIKVI-------SS  556 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~H~niv~~~-------~~  556 (646)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+   +.++.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688899999999999999996 46999999999743   334567888999   455566899999988       66


Q ss_pred             EecCC-----------------eeEEEEEecCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 046544          557 CSNEE-----------------FKALVLEYKPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGCLAPV  613 (646)
Q Consensus       557 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~~~~i  613 (646)
                      +..++                 ..|+||||+ +|+|.+++...+.      .+++..+..++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65553                 278999999 6799999976431      1224778889999999999999   8899


Q ss_pred             EecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       614 iHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||||||+||+++.++.+||+|||+|+..
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~  256 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD  256 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheec
Confidence            99999999999999999999999999864

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=6.3e-25  Score=226.88  Aligned_cols=230  Identities=20%  Similarity=0.213  Sum_probs=162.5

Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccc-cCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGS-IPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      ..++.|++++|.+.+..+. +..+++|++|++++|.+.+. .+..+..+++|++|++++|.+++..+..+..+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            3455566666666555444 44577777777777777655 666677777788888888877777777777778888888


Q ss_pred             ecCC-ccccc-CCccccCCCCCceeecCCC-cccc--ccccccccc-ccccccCCCCc--cc-CCCCCccCccccceEEE
Q 046544          241 LGGN-KLFGS-IPACFSNLASLRILSLSSN-ELTS--IPLTFWNLK-DILQLNFSSNF--LT-GPLPLEIGNLKVLIGID  311 (646)
Q Consensus       241 L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~--lp~~~~~l~-~L~~L~l~~N~--l~-~~~~~~~~~l~~L~~L~  311 (646)
                      +++| .+++. .+..+.++++|++|++++| .++.  ++..+..++ +|++|++++|.  ++ +.++..+..+++|+.|+
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~  228 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD  228 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence            8887 56542 4556777778888888888 7774  566666777 78888888873  43 33455667788888888


Q ss_pred             ccccc-ccccCccccCCCCCCCEEEccCcc-CCCcccccccCCCCCCEEEccCCcCcccCCccccCC-CCCCceeCcCCc
Q 046544          312 FSMNN-FSSVIPTEIGGLKNLEYLFLGYNR-LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKL-SYLEDLNLSFNK  388 (646)
Q Consensus       312 ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~  388 (646)
                      +++|. +++..+..+..+++|++|++++|. +.......++.+++|+.|++++| ++.   ..+..+ ..++.|++++|+
T Consensus       229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~  304 (336)
T 2ast_B          229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSH  304 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCC
T ss_pred             CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEeccc
Confidence            88888 676777788888899999998885 33222236788889999999988 432   234444 347777889999


Q ss_pred             ceeeccCC
Q 046544          389 LEGEIPRG  396 (646)
Q Consensus       389 l~~~~p~~  396 (646)
                      +++..|..
T Consensus       305 l~~~~~~~  312 (336)
T 2ast_B          305 FTTIARPT  312 (336)
T ss_dssp             SCCTTCSS
T ss_pred             CccccCCc
Confidence            98877655

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=1.3e-23  Score=212.45  Aligned_cols=147  Identities=27%  Similarity=0.410  Sum_probs=128.3

Q ss_pred             CCCCcce-eecccccceEEEEEe---CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENN-LIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|...+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5677777 999999999999964   247889999987543  23356789999999999999999999999 5567899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++++|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        95 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999998754 6889999999999999999999   8899999999999999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=1.2e-23  Score=215.98  Aligned_cols=148  Identities=27%  Similarity=0.361  Sum_probs=126.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--------CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  561 (646)
                      .++|...+.||+|+||.||+|+.. +++.||||++....        ......+.+|+++++.++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357899999999999999999865 68999999986432        112345788999999999999999999987665


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC---cEEEEeecC
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL---VAYLSDFGI  638 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~---~~ki~DfGl  638 (646)
                       .++||||+++|+|.+++.... .+++..+..++.|++.|++|||   .++|+||||||+||+++.++   .+||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999999987543 6899999999999999999999   88999999999999998655   499999999


Q ss_pred             ccccc
Q 046544          639 AKLLI  643 (646)
Q Consensus       639 a~~~~  643 (646)
                      ++...
T Consensus       164 ~~~~~  168 (322)
T 2ycf_A          164 SKILG  168 (322)
T ss_dssp             CEECC
T ss_pred             ceecc
Confidence            98754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=1.7e-23  Score=216.04  Aligned_cols=144  Identities=35%  Similarity=0.529  Sum_probs=121.8

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHH--HHhCCCCCceeEEEEEec-----CCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEM--MKSIRHRNLIKVISSCSN-----EEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~~~~~~~~-----~~~~  563 (646)
                      .++|+..+.||+|+||.||+|+. +++.||||++....   ...+..|.++  ++.++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36889999999999999999987 68999999997543   2334444444  456899999999975532     2357


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCEEEcCCCcEEEE
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA---------PVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---------~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      ++||||+++|+|.+++....  .++..+..++.|++.||+|||   ..         +|+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997764  588889999999999999999   66         99999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+|+.+.
T Consensus       163 DFG~a~~~~  171 (336)
T 3g2f_A          163 DFGLSMRLT  171 (336)
T ss_dssp             CCTTCEECS
T ss_pred             eccceeecc
Confidence            999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=1.2e-23  Score=214.31  Aligned_cols=146  Identities=30%  Similarity=0.457  Sum_probs=124.0

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||.||+|++. ++.||+|++...  ...+.+.+|++++++++||||+++++++..  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56888999999999999999984 788999988643  345788999999999999999999998763  4799999999


Q ss_pred             CCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc-EEEEeecCcccc
Q 046544          572 HGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV-AYLSDFGIAKLL  642 (646)
Q Consensus       572 ~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~-~ki~DfGla~~~  642 (646)
                      +|+|.+++.....  .+++..+..++.|+++|++|||+.+.++|+||||||+||+++.++. +||+|||+|+..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            9999999976542  4678889999999999999999433389999999999999988776 799999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=2.2e-23  Score=210.50  Aligned_cols=147  Identities=28%  Similarity=0.384  Sum_probs=128.6

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~l  565 (646)
                      .|...+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677889999999999999864 68899999987543  3345678899999999999999999998865    356899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEc-CCCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~  642 (646)
                      ||||+++|+|.+++.... .+++..+..++.|++.|+.|||   ..+  |+||||||+||+++ .++.+||+|||+|+..
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997653 5889999999999999999999   777  99999999999997 7899999999999754


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       183 ~  183 (290)
T 1t4h_A          183 R  183 (290)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=1e-23  Score=235.18  Aligned_cols=141  Identities=28%  Similarity=0.427  Sum_probs=125.4

Q ss_pred             eeecccccceEEEEEeC---CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      +.||+|+||.||+|.+.   +++.||||+++...  ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            57999999999999643   46889999997543  2345789999999999999999999999975 458899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+|.+++.... .+++..+..++.||+.||+|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            99999997654 6899999999999999999999   8899999999999999999999999999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=2.5e-23  Score=214.26  Aligned_cols=142  Identities=24%  Similarity=0.405  Sum_probs=127.3

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEec--CCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSN--EEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~--~~~~~lv~  567 (646)
                      ++|+..+.||+|+||.||+|+. .+++.||+|++...   ..+.+.+|+++++.++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5788999999999999999986 47899999998743   3467889999999997 9999999999987  56789999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~~  643 (646)
                      ||+++++|.+++..    +++..+..++.|++.|++|||   ..+|+||||||+||+++.++ .+||+|||+|+.+.
T Consensus       113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998853    788899999999999999999   88999999999999999766 89999999998654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.90  E-value=1.7e-23  Score=214.34  Aligned_cols=145  Identities=28%  Similarity=0.411  Sum_probs=124.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEe------------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCS------------  558 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~------------  558 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            67899999999999999999976 58999999998766666778899999999999999999999874            


Q ss_pred             --cCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEe
Q 046544          559 --NEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSD  635 (646)
Q Consensus       559 --~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~D  635 (646)
                        ..+..++||||++ |+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++ +++.+||+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence              3467899999997 5999998653  5889999999999999999999   88999999999999997 577999999


Q ss_pred             ecCcccc
Q 046544          636 FGIAKLL  642 (646)
Q Consensus       636 fGla~~~  642 (646)
                      ||+|+..
T Consensus       165 fg~~~~~  171 (320)
T 2i6l_A          165 FGLARIM  171 (320)
T ss_dssp             CTTCBCC
T ss_pred             Ccccccc
Confidence            9999865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=2.5e-23  Score=211.10  Aligned_cols=145  Identities=23%  Similarity=0.353  Sum_probs=126.9

Q ss_pred             CCCCcc-eeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHH-HhCCCCCceeEEEEEec----CCeeE
Q 046544          492 NGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMM-KSIRHRNLIKVISSCSN----EEFKA  564 (646)
Q Consensus       492 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~----~~~~~  564 (646)
                      ++|... +.||+|+||.||+|+. .+++.||+|++...     ..+.+|++++ +..+||||+++++++..    +...+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 7899999999999986 47899999998632     4567788887 66699999999999876    67789


Q ss_pred             EEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~  640 (646)
                      +||||+++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|||+|+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998764 36899999999999999999999   889999999999999987   7899999999998


Q ss_pred             cccC
Q 046544          641 LLIG  644 (646)
Q Consensus       641 ~~~~  644 (646)
                      ...+
T Consensus       169 ~~~~  172 (299)
T 3m2w_A          169 ETTG  172 (299)
T ss_dssp             ECTT
T ss_pred             cccc
Confidence            7653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.90  E-value=7.5e-24  Score=212.66  Aligned_cols=150  Identities=27%  Similarity=0.410  Sum_probs=130.5

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~l  565 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467889999999999999999875 68999999998653  2345678899999999999999999998753  568999


Q ss_pred             EEEecCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEEcCCCcEEEEeec
Q 046544          566 VLEYKPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCLAP-----VIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      ||||+++|+|.+++...   ...+++..+..++.|++.|++|||   ..+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   235899999999999999999999   666     9999999999999999999999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +++...
T Consensus       162 ~~~~~~  167 (279)
T 2w5a_A          162 LARILN  167 (279)
T ss_dssp             HHHHC-
T ss_pred             hheeec
Confidence            987653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=7.4e-24  Score=217.87  Aligned_cols=152  Identities=30%  Similarity=0.405  Sum_probs=133.2

Q ss_pred             HHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEec-----
Q 046544          487 LCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSN-----  559 (646)
Q Consensus       487 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~-----  559 (646)
                      +....++|+..+.||+|+||.||+|+.. +|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3345578999999999999999999974 789999999975533 346788999999998 89999999999976     


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          560 -EEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       560 -~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                       .+..++||||+++|+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence             467899999999999999998653 46889999999999999999999   8899999999999999999999999999


Q ss_pred             Ccccc
Q 046544          638 IAKLL  642 (646)
Q Consensus       638 la~~~  642 (646)
                      +++.+
T Consensus       175 ~~~~~  179 (326)
T 2x7f_A          175 VSAQL  179 (326)
T ss_dssp             TTC--
T ss_pred             Cceec
Confidence            98765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.90  E-value=9.4e-24  Score=213.29  Aligned_cols=148  Identities=28%  Similarity=0.392  Sum_probs=124.1

Q ss_pred             CCCCcceeecccccceEEEEEeC--CCc--EEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|++.  +++  .||+|+++..   .....+.+.+|+++++.++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57889999999999999999853  333  6899988754   2344578899999999999999999999998765 88


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||||+++|+|.+++......+++..+..++.|++.|+.|||   ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999999876567899999999999999999999   8899999999999999999999999999998764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.90  E-value=7.8e-24  Score=232.65  Aligned_cols=138  Identities=22%  Similarity=0.156  Sum_probs=111.3

Q ss_pred             ecccccceEEEEE-eCCCcEEEEEEEeccC----------CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEE
Q 046544          500 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC----------GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       500 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+.|+.|.+..++ .-.|+.||+|++....          +...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666666554 3358889999997542          12345789999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||++||+|.+++...+ .+++.   +|+.||+.||+|+|   ++|||||||||+|||++++|.+||+|||+|+.+.+
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999998764 55543   58999999999999   89999999999999999999999999999997643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=1.1e-23  Score=216.78  Aligned_cols=148  Identities=26%  Similarity=0.457  Sum_probs=127.9

Q ss_pred             CCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||.||+|++      .+++.||||++.... .....++.+|+.++++++||||+++++++...+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            6799999999999999999983      257789999987543 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEe
Q 046544          565 LVLEYKPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSD  635 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~D  635 (646)
                      +||||+++|+|.+++....      ..+++..+..++.|++.|+.|||   ..+|+||||||+||+++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            9999999999999998754      34888999999999999999999   889999999999999984   45699999


Q ss_pred             ecCcccc
Q 046544          636 FGIAKLL  642 (646)
Q Consensus       636 fGla~~~  642 (646)
                      ||+++..
T Consensus       187 fg~~~~~  193 (327)
T 2yfx_A          187 FGMARDI  193 (327)
T ss_dssp             CHHHHHH
T ss_pred             ccccccc
Confidence            9998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.89  E-value=2.2e-23  Score=215.19  Aligned_cols=148  Identities=28%  Similarity=0.353  Sum_probs=130.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEe--------cCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCS--------NEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~--------~~~  561 (646)
                      .+|+..+.||+|+||.||+|++. +|+.||+|++........+.+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47889999999999999999964 78999999987666556678899999999996 999999999984        334


Q ss_pred             eeEEEEEecCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEcCCCcEEEEeec
Q 046544          562 FKALVLEYKPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      ..++||||+. |+|.+++..  ....+++..+..++.|++.|++|||   ..+  |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            5799999995 699998865  3456899999999999999999999   777  9999999999999999999999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +++.+.
T Consensus       184 ~~~~~~  189 (337)
T 3ll6_A          184 SATTIS  189 (337)
T ss_dssp             TCBCCS
T ss_pred             cceecc
Confidence            998754

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.89  E-value=2e-23  Score=211.88  Aligned_cols=147  Identities=29%  Similarity=0.455  Sum_probs=129.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57889999999999999999975 68999999986543  2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |++ |+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  153 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  153 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence            997 59999987653 46889999999999999999999   889999999999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.89  E-value=7.8e-23  Score=211.65  Aligned_cols=150  Identities=29%  Similarity=0.468  Sum_probs=131.4

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHh--CCCCCceeEEEEEecCC----
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKS--IRHRNLIKVISSCSNEE----  561 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~~----  561 (646)
                      ....++|+..+.||+|+||.||+|+. +|+.||||++...   ..+.+.+|+++++.  ++||||+++++++...+    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            44457899999999999999999998 5899999998643   34567789998887  79999999999998876    


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----CLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      ..++||||+++|+|.+++...  .+++..+..++.|++.|++|||..     +..+|+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            789999999999999999765  488999999999999999999932     1468999999999999999999999999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |+|+...
T Consensus       192 g~~~~~~  198 (342)
T 1b6c_B          192 GLAVRHD  198 (342)
T ss_dssp             TTCEEEE
T ss_pred             CCceecc
Confidence            9997653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.89  E-value=1.8e-23  Score=211.07  Aligned_cols=149  Identities=25%  Similarity=0.287  Sum_probs=120.2

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCc-h-HHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR-A-FKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++...... . .+.+.++...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            36788999999999999999996 47999999998755322 2 223444555578889999999999999999999999


Q ss_pred             EecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++ ++.+++..   .+..+++..+..++.|++.|++|||   .. +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 88777654   4457899999999999999999999   76 99999999999999999999999999998653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.89  E-value=2e-23  Score=214.62  Aligned_cols=156  Identities=21%  Similarity=0.284  Sum_probs=134.5

Q ss_pred             HHHHHHhCCCCcc-eeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhC-CCCCceeEEEEEec
Q 046544          485 LELCRATNGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSI-RHRNLIKVISSCSN  559 (646)
Q Consensus       485 ~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  559 (646)
                      .......++|... +.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.+++.+ +||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344555667776 89999999999999865 69999999987543  23356788999999999 56999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEe
Q 046544          560 EEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSD  635 (646)
Q Consensus       560 ~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~D  635 (646)
                      .+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||   ..+|+||||||+||+++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999998653 356899999999999999999999   889999999999999987   78999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+|+.+.
T Consensus       178 fg~a~~~~  185 (327)
T 3lm5_A          178 FGMSRKIG  185 (327)
T ss_dssp             GGGCEEC-
T ss_pred             CccccccC
Confidence            99998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=8.7e-24  Score=212.15  Aligned_cols=146  Identities=34%  Similarity=0.476  Sum_probs=125.2

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC-CeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-EFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||.||+|+. +|+.||+|++....  ..+.+.+|+++++.++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            36788999999999999999987 48899999986543  456789999999999999999999987655 478999999


Q ss_pred             cCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          570 KPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +++|+|.+++..... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            999999999976432 3788889999999999999999   889999999999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=9.6e-24  Score=218.81  Aligned_cols=146  Identities=25%  Similarity=0.299  Sum_probs=122.1

Q ss_pred             CCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCCc-----------hHHHHHHHHHHHHhCCCCCceeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGR-----------AFKSFAVECEMMKSIRHRNLIKVISS  556 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~niv~~~~~  556 (646)
                      ++|+..+.||+|+||.||+|+..    ++..||+|++......           ..+.+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57899999999999999999975    5778999998765421           11346678889999999999999999


Q ss_pred             Eec----CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC--c
Q 046544          557 CSN----EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL--V  630 (646)
Q Consensus       557 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~--~  630 (646)
                      +..    ....|+||||+ +++|.+++...+ .+++.++..++.|++.||+|||   ..+|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            987    67899999999 999999997655 7899999999999999999999   88999999999999998777  9


Q ss_pred             EEEEeecCcccc
Q 046544          631 AYLSDFGIAKLL  642 (646)
Q Consensus       631 ~ki~DfGla~~~  642 (646)
                      +||+|||+|+.+
T Consensus       192 ~kL~Dfg~a~~~  203 (345)
T 2v62_A          192 VYLADYGLSYRY  203 (345)
T ss_dssp             EEECCCTTCEES
T ss_pred             EEEEeCCCceec
Confidence            999999999765

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.89  E-value=4.4e-23  Score=209.87  Aligned_cols=149  Identities=24%  Similarity=0.394  Sum_probs=128.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC----CchHHHHHHHHHHHHhCCCCCceeEEEEEe--cCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRHRNLIKVISSCS--NEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~--~~~~~  563 (646)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....    ....+.+.+|+++++.++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999964 68999999997542    234567899999999999999999999984  44578


Q ss_pred             EEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ++||||++++ +.+++... ...+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77776653 346899999999999999999999   889999999999999999999999999999865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       160 ~  160 (305)
T 2wtk_C          160 H  160 (305)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=4.5e-23  Score=215.93  Aligned_cols=146  Identities=24%  Similarity=0.303  Sum_probs=125.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  561 (646)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999865 68999999997543  234467889999999999999999999997664      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..|+||||+++ ++.+++..   .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78888753   4789999999999999999999   88999999999999999999999999999986


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       177 ~~  178 (371)
T 2xrw_A          177 AG  178 (371)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.89  E-value=3.9e-23  Score=215.88  Aligned_cols=147  Identities=24%  Similarity=0.326  Sum_probs=129.9

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Cee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~  563 (646)
                      ..+|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            367999999999999999999865 688999999975432 3346788999999999999999999998765     368


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||++ |+|.+++...  .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 5999998765  4899999999999999999999   8899999999999999999999999999998653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=5.6e-23  Score=207.25  Aligned_cols=151  Identities=25%  Similarity=0.402  Sum_probs=133.9

Q ss_pred             HHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            33468999999999999999999975 68999999987543  3445788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~~~  642 (646)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|||+++..
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999999886654 5889999999999999999999   889999999999999975   347999999999865


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       175 ~  175 (287)
T 2wei_A          175 Q  175 (287)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=3.4e-23  Score=231.77  Aligned_cols=149  Identities=25%  Similarity=0.376  Sum_probs=131.7

Q ss_pred             hCCCCcceeecccccceEEEEEeC----CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .++|+..+.||+|+||.||+|++.    .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            456888899999999999999864    256799998875433 33467899999999999999999999984 566899


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+++|+|.+++...+..+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999877667899999999999999999999   8899999999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.89  E-value=5.2e-23  Score=208.34  Aligned_cols=148  Identities=28%  Similarity=0.444  Sum_probs=125.2

Q ss_pred             HhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEE-ecCCeeEEEE
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC-SNEEFKALVL  567 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~-~~~~~~~lv~  567 (646)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|++.....  .+.+.+|+++++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            447899999999999999999996 5789999998765432  24577899999999888777666555 5667889999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~  643 (646)
                      ||+ +++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++   ++++.+||+|||+|+.+.
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999999876667999999999999999999999   8899999999999999   788999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.89  E-value=1.4e-23  Score=219.14  Aligned_cols=147  Identities=24%  Similarity=0.337  Sum_probs=115.4

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------C
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------E  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~  561 (646)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999985 468999999986543  23456788999999999999999999998754      5


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..|+||||+ +++|.+++..  ..+++..+..++.|+++|++|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899998865  35899999999999999999999   88999999999999999999999999999986


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       182 ~~  183 (367)
T 2fst_X          182 TA  183 (367)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=5.6e-23  Score=213.75  Aligned_cols=147  Identities=24%  Similarity=0.352  Sum_probs=130.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Cee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~  563 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            367899999999999999999975 689999999975432 3345788999999999999999999987754     678


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999998764  5899999999999999999999   8899999999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.89  E-value=1.8e-23  Score=218.94  Aligned_cols=148  Identities=11%  Similarity=0.074  Sum_probs=111.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhC--CCCCceeEE-------EEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSI--RHRNLIKVI-------SSCS  558 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~H~niv~~~-------~~~~  558 (646)
                      ..|+..+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999965 789999999987543   2345667775444444  699988855       3443


Q ss_pred             cC-----------------CeeEEEEEecCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEe
Q 046544          559 NE-----------------EFKALVLEYKPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGCLAPVIH  615 (646)
Q Consensus       559 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~~iiH  615 (646)
                      .+                 ...|+||||++ |+|.+++...+..+++..+      ..++.|++.||+|||   +++|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            32                 33799999998 8999999865434455555      678899999999999   889999


Q ss_pred             cCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          616 CDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       616 rdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||||+|||++.++.+||+|||+|+...
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~  245 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVG  245 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETT
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecC
Confidence            9999999999999999999999998653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.89  E-value=8.9e-23  Score=206.66  Aligned_cols=147  Identities=28%  Similarity=0.447  Sum_probs=128.3

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEE-ecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC-SNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~-~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++.....  .+.+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 5799999999875543  24688999999999988766555554 56678899999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~  643 (646)
                      |+ +++|.+++......+++..+..++.|++.|++|||   .++|+||||||+||++   ++++.+||+|||+|+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 89999999876667999999999999999999999   8899999999999999   478899999999998754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=1.1e-23  Score=219.13  Aligned_cols=143  Identities=18%  Similarity=0.241  Sum_probs=125.2

Q ss_pred             CCCCcceeecccccceEEEEEeCC---------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCcee----------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK----------  552 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~----------  552 (646)
                      ++|+..+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578999999999999999998653         788999998744     45778999999999999987          


Q ss_pred             -----EEEEEec-CCeeEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          553 -----VISSCSN-EEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       553 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                           +++++.. ++..++||||+ +++|.+++... ...+++..+..++.|++.||+|||   ..+|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5667765 67899999999 99999999875 347899999999999999999999   8899999999999999


Q ss_pred             cCCC--cEEEEeecCccccc
Q 046544          626 DDNL--VAYLSDFGIAKLLI  643 (646)
Q Consensus       626 ~~~~--~~ki~DfGla~~~~  643 (646)
                      +.++  .+||+|||+|+.+.
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~  212 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYC  212 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSS
T ss_pred             cCCCCceEEEecCcceeecc
Confidence            9988  99999999997653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.89  E-value=9.5e-23  Score=219.47  Aligned_cols=148  Identities=25%  Similarity=0.382  Sum_probs=129.7

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC-CCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH-RNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||.||+|+. .+++.||||++.....  .+++.+|+++++.++| ++|+.+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36799999999999999999996 4799999998875543  2457889999999976 566677777778888999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~---~~~~~~ki~DfGla~~~~~  644 (646)
                      |+ +++|.+++......+++..+..|+.||+.||+|||   .++|+||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 89999999876678999999999999999999999   8899999999999999   5889999999999987643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=5.5e-23  Score=216.87  Aligned_cols=144  Identities=31%  Similarity=0.453  Sum_probs=120.9

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------eeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------FKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------~~~l  565 (646)
                      .+|+..+.||+|+||.||+|+...+..||+|.+......    ..+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468899999999999999999877777999988644322    236999999999999999999986543      3789


Q ss_pred             EEEecCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecCccc
Q 046544          566 VLEYKPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKL  641 (646)
Q Consensus       566 v~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfGla~~  641 (646)
                      ||||++++ +.+.+.   .....+++..+..++.|++.||+|||   ..+|+||||||+||+++ .++.+||+|||+|+.
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999875 443332   23457899999999999999999999   88999999999999999 799999999999987


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      +.
T Consensus       192 ~~  193 (394)
T 4e7w_A          192 LI  193 (394)
T ss_dssp             CC
T ss_pred             cc
Confidence            53

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=6.2e-23  Score=218.30  Aligned_cols=144  Identities=30%  Similarity=0.470  Sum_probs=121.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC------CeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------EFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~~~  564 (646)
                      .+|+..+.||+|+||.||+|++. +|+.||||++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 699999999875432    234699999999999999999988542      2467


Q ss_pred             EEEEecCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~  640 (646)
                      +||||+++ ++.+.+.   .....+++..+..++.|+++||+|||   ..+|+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 6666554   33457899999999999999999999   8999999999999999954 678999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       206 ~~~  208 (420)
T 1j1b_A          206 QLV  208 (420)
T ss_dssp             ECC
T ss_pred             hcc
Confidence            754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=2e-23  Score=213.30  Aligned_cols=154  Identities=27%  Similarity=0.358  Sum_probs=124.1

Q ss_pred             HHHHHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCc------hHHHHHHHHHHHHhC----CCCCceeEE
Q 046544          486 ELCRATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR------AFKSFAVECEMMKSI----RHRNLIKVI  554 (646)
Q Consensus       486 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~H~niv~~~  554 (646)
                      +.....++|+..+.||+|+||.||+|+. .+++.||+|++......      ....+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445567899999999999999999986 46899999998754321      223456789999888    899999999


Q ss_pred             EEEecCCeeEEEEEe-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEE
Q 046544          555 SSCSNEEFKALVLEY-KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAY  632 (646)
Q Consensus       555 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~k  632 (646)
                      +++...+..++|||| +.+++|.+++...+ .+++..+..++.|++.|++|||   ..+|+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999997654 6899999999999999999999   88999999999999999 889999


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+++.+.
T Consensus       181 l~dfg~~~~~~  191 (312)
T 2iwi_A          181 LIDFGSGALLH  191 (312)
T ss_dssp             ECCCSSCEECC
T ss_pred             EEEcchhhhcc
Confidence            99999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.88  E-value=8.1e-23  Score=210.05  Aligned_cols=151  Identities=30%  Similarity=0.455  Sum_probs=128.2

Q ss_pred             HHhCCCCcceeecccccceEEEEEe--CCCcEEEEEEEeccCC--chHHHHHHHHHHHHhC---CCCCceeEEEEEe---
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSI---RHRNLIKVISSCS---  558 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~~~~~~~---  558 (646)
                      ...++|+..+.||+|+||.||+|+.  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999997  3688999999875432  2223566777777665   8999999999987   


Q ss_pred             --cCCeeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          559 --NEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       559 --~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                        .....++||||++ |+|.+++.... ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              4567899999997 59999997654 35899999999999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++...
T Consensus       164 fg~~~~~~  171 (326)
T 1blx_A          164 FGLARIYS  171 (326)
T ss_dssp             CCSCCCCC
T ss_pred             Cccccccc
Confidence            99998653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=7.2e-23  Score=214.33  Aligned_cols=146  Identities=24%  Similarity=0.342  Sum_probs=126.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCee----
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK----  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~----  563 (646)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            368899999999999999999865 699999999976432  3356788999999999999999999999877654    


Q ss_pred             --EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          564 --ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       564 --~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                        ++||||+. ++|.+++..   .+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588887733   4899999999999999999999   88999999999999999999999999999986


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       194 ~~  195 (371)
T 4exu_A          194 AD  195 (371)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.88  E-value=6.4e-23  Score=231.78  Aligned_cols=145  Identities=22%  Similarity=0.359  Sum_probs=125.9

Q ss_pred             CCCCcceeecccccceEEEEEeC--CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe-----e
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF-----K  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-----~  563 (646)
                      ++|++.+.||+|+||.||+|++.  +|+.||||++..... ...+.+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999975  689999998865432 344578899999999999999999999987655     6


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+||||++|++|.+++..   .+++.++..++.||+.||+|+|   .++|+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987754   5899999999999999999999   8899999999999999876 89999999998764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=2e-22  Score=214.97  Aligned_cols=147  Identities=23%  Similarity=0.325  Sum_probs=128.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhC------CCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSI------RHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~~~~~~~~~~~~~  564 (646)
                      .+|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.+      .|+||+++++++...+..+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            57899999999999999999865 6899999998753 23345677888888776      5779999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc--EEEEeecCccc
Q 046544          565 LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV--AYLSDFGIAKL  641 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~--~ki~DfGla~~  641 (646)
                      +||||+. ++|.+++.... ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.  +||+|||+|+.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999996 59999987654 35899999999999999999999   889999999999999998887  99999999976


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      ..
T Consensus       252 ~~  253 (429)
T 3kvw_A          252 EH  253 (429)
T ss_dssp             TT
T ss_pred             cC
Confidence            43

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.88  E-value=1.3e-22  Score=207.23  Aligned_cols=149  Identities=23%  Similarity=0.355  Sum_probs=131.0

Q ss_pred             HHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCC--CCCceeEEEEEecCCeeE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIR--HRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~  564 (646)
                      ...++|+..+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++  ||||+++++++..++..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            3446799999999999999999998889999999997553  234567889999999997  599999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +||| +.+++|.+++.... .+++..+..++.|+++|+.|||   ..+|+||||||+||++++ +.+||+|||+++.+.
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            9999 55889999998764 6889999999999999999999   889999999999999975 799999999998653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=2.1e-22  Score=207.14  Aligned_cols=148  Identities=26%  Similarity=0.339  Sum_probs=126.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC-chHHHHHHHHH-HHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RAFKSFAVECE-MMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++..... ....++.+|+. +++.++||||+++++++..++..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999975 799999999986543 23345666666 6777899999999999999999999999


Q ss_pred             ecCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+++ ++.+++..    ....+++..+..++.|++.|+.|||   .. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9975 78777753    2457899999999999999999999   77 99999999999999999999999999998653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=1.1e-22  Score=215.60  Aligned_cols=144  Identities=26%  Similarity=0.386  Sum_probs=115.0

Q ss_pred             CCc-ceeecccccceEEEEEeC---CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEEEE
Q 046544          494 FSE-NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKALVL  567 (646)
Q Consensus       494 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~  567 (646)
                      |.. .++||+|+||.||+|+..   +++.||+|++....  ..+.+.+|+++++.++||||+++++++..  ....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            544 568999999999999965   57889999986443  23567899999999999999999999954  67899999


Q ss_pred             EecCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE----cCCCcEEEEe
Q 046544          568 EYKPHGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL----DDNLVAYLSD  635 (646)
Q Consensus       568 e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~----~~~~~~ki~D  635 (646)
                      ||+++ +|.+++...        ...+++..+..++.|++.||+|||   ..+|+||||||+||++    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99965 888877532        124889999999999999999999   8899999999999999    6778999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+|+.+.
T Consensus       176 fg~a~~~~  183 (405)
T 3rgf_A          176 MGFARLFN  183 (405)
T ss_dssp             TTCCC---
T ss_pred             CCCceecC
Confidence            99998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=1.2e-22  Score=214.84  Aligned_cols=133  Identities=26%  Similarity=0.330  Sum_probs=113.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC--------CCCceeEEEEEe----
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR--------HRNLIKVISSCS----  558 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~~~~~~~----  558 (646)
                      ++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            67999999999999999999864 6899999998743 234567889999999885        788999999987    


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCC
Q 046544          559 NEEFKALVLEYKPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNL  629 (646)
Q Consensus       559 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~  629 (646)
                      .....++||||+ ++++.+++... ...+++..+..++.|++.||+|||   .+ +|+||||||+|||++.++
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccc
Confidence            456789999999 55666666544 356899999999999999999999   76 999999999999998775

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.88  E-value=3.5e-22  Score=208.37  Aligned_cols=156  Identities=24%  Similarity=0.327  Sum_probs=119.0

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCC--
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE--  561 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--  561 (646)
                      .+.....++|+..+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999975 68999999986543 22345677888889999999999999986533  


Q ss_pred             -----eeEEEEEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEE
Q 046544          562 -----FKALVLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAY  632 (646)
Q Consensus       562 -----~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~k  632 (646)
                           ..++||||+++ ++.+.+..   ....+++..+..++.|++.|+.|+|.. .++|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999986 55544432   345688899999999999999999943 679999999999999996 89999


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+|+.+.
T Consensus       173 l~Dfg~a~~~~  183 (360)
T 3e3p_A          173 LCDFGSAKKLS  183 (360)
T ss_dssp             ECCCTTCBCCC
T ss_pred             EeeCCCceecC
Confidence            99999998764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.88  E-value=2e-23  Score=213.82  Aligned_cols=148  Identities=26%  Similarity=0.473  Sum_probs=128.5

Q ss_pred             HHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ...++|+..+.||+|+||.||+|+.+.  .||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345788999999999999999998754  49999987543  23345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |||+++++|.+++...+..+++..+..++.|++.|++|||   ..+|+||||||+||+++ ++.+||+|||+|+..
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999877667899999999999999999999   88999999999999998 679999999997754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=1e-22  Score=208.77  Aligned_cols=151  Identities=25%  Similarity=0.341  Sum_probs=131.7

Q ss_pred             HHhCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCc------hHHHHHHHHHHHHhCC--CCCceeEEEEEec
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR------AFKSFAVECEMMKSIR--HRNLIKVISSCSN  559 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--H~niv~~~~~~~~  559 (646)
                      ...++|+..+.||+|+||.||+|+. .+++.||||++......      ..+.+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3446899999999999999999986 47899999999755321      2245667999999996  5999999999999


Q ss_pred             CCeeEEEEEecCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc-CCCcEEEEeec
Q 046544          560 EEFKALVLEYKPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFG  637 (646)
Q Consensus       560 ~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~-~~~~~ki~DfG  637 (646)
                      ++..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999986 89999987643 6889999999999999999999   88999999999999999 78999999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +++.+.
T Consensus       196 ~~~~~~  201 (320)
T 3a99_A          196 SGALLK  201 (320)
T ss_dssp             TCEECC
T ss_pred             cccccc
Confidence            998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.87  E-value=1.1e-22  Score=211.53  Aligned_cols=144  Identities=24%  Similarity=0.352  Sum_probs=126.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecCCe------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEF------  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~------  562 (646)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            67889999999999999999865 699999999975432  234678899999999999999999999987654      


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++||||++ |+|.+++..   .+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            499999997 588887643   4899999999999999999999   889999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.87  E-value=3.4e-22  Score=206.38  Aligned_cols=147  Identities=20%  Similarity=0.305  Sum_probs=128.6

Q ss_pred             CCCCcceeecccccceEEEEEe--CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCC------CceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR------NLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~------niv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||.||+|..  .+++.||+|+++.. ....+.+.+|+++++.++|+      +|+++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            6899999999999999999986  36889999998643 23456788899999888665      499999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---------------
Q 046544          564 ALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---------------  627 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---------------  627 (646)
                      ++||||+ +++|.+++...+ ..+++..+..++.|++.||+|||   .++|+||||||+||+++.               
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999 889999997764 36789999999999999999999   889999999999999987               


Q ss_pred             ----CCcEEEEeecCccccc
Q 046544          628 ----NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ----~~~~ki~DfGla~~~~  643 (646)
                          ++.+||+|||+|+...
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~  188 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDD  188 (339)
T ss_dssp             EEESCCCEEECCCSSCEETT
T ss_pred             ccccCCCceEeeCcccccCc
Confidence                6689999999998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.87  E-value=5e-22  Score=204.96  Aligned_cols=146  Identities=22%  Similarity=0.320  Sum_probs=120.4

Q ss_pred             hCCCCcc-eeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeE
Q 046544          491 TNGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKA  564 (646)
Q Consensus       491 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~  564 (646)
                      .++|... +.||+|+||.||+|+.. +|+.||+|++....    +........++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            3678874 56999999999999976 69999999986431    112223334667799999999999876    44589


Q ss_pred             EEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~  640 (646)
                      +||||+++|+|.+++.... ..+++.++..++.|++.|++|||   ..+|+||||||+||+++.   ++.+||+|||+|+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998764 36899999999999999999999   889999999999999975   4569999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       180 ~~~  182 (336)
T 3fhr_A          180 ETT  182 (336)
T ss_dssp             EC-
T ss_pred             ecc
Confidence            653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=4.6e-22  Score=199.26  Aligned_cols=145  Identities=17%  Similarity=0.130  Sum_probs=116.0

Q ss_pred             HHHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCC------------------chHHHHHHHHHHHHhC
Q 046544          484 YLELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RAFKSFAVECEMMKSI  545 (646)
Q Consensus       484 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l  545 (646)
                      ...+......|...+.||+|+||.||+|+..+|+.||+|+++....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444555567788899999999999999997799999999864321                  1345688999999999


Q ss_pred             CCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       546 ~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      +|+++   .+++.. +..|+||||++||+|.+ +..       .....++.|++.|++|+|   ..+|+||||||+||++
T Consensus       162 ~~~~v---~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 QGLAV---PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             TTSSS---CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             cCCCc---CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence            85444   444332 55799999999999998 422       124569999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccccC
Q 046544          626 DDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~~  644 (646)
                      + ++.+||+|||+|+....
T Consensus       227 ~-~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             E-TTEEEECCCTTCEETTS
T ss_pred             E-CCcEEEEECCCCeECCC
Confidence            9 99999999999987643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=3.1e-22  Score=204.89  Aligned_cols=149  Identities=24%  Similarity=0.288  Sum_probs=118.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc-hH-HHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR-AF-KSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++...... .. +.+..+..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367888999999999999999975 7899999999865432 22 23444555678889999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+ ++.+..+.......+++..+..++.|++.|+.|||   .. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 55666666554557899999999999999999999   74 99999999999999999999999999997653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=4e-22  Score=217.80  Aligned_cols=147  Identities=28%  Similarity=0.335  Sum_probs=69.5

Q ss_pred             CCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCC
Q 046544          210 QKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFS  289 (646)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~  289 (646)
                      ++|++|+|++|+|++ +|. |..  +|++|+|++|+|++ +|.   .+++|+.|+|++|.|+.+|.   .+++|+.|+++
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls  168 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVR  168 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECC
Confidence            444444444444443 232 322  44444444444443 222   33444444444444444443   23444444444


Q ss_pred             CCcccCCCCCccCccccceEEEcccccccccCccccCCCCCC-------CEEEccCccCCCcccccccCCCCCCEEEccC
Q 046544          290 SNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNL-------EYLFLGYNRLEGSIPDSFGDLISLKFLNLSN  362 (646)
Q Consensus       290 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  362 (646)
                      +|.+++ +|. |.  ++|+.|++++|.|+. +|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus       169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~  239 (571)
T 3cvr_A          169 NNQLTF-LPE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED  239 (571)
T ss_dssp             SSCCSC-CCC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS
T ss_pred             CCCCCC-cch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC
Confidence            444443 222 33  445555555555552 222 332  44       66666666666 3455555566666666666


Q ss_pred             CcCcccCCccccCC
Q 046544          363 NNLSGAIPTSLEKL  376 (646)
Q Consensus       363 N~l~~~~p~~~~~l  376 (646)
                      |++++.+|..+..+
T Consensus       240 N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          240 NPLSSRIRESLSQQ  253 (571)
T ss_dssp             SSCCHHHHHHHHHH
T ss_pred             CcCCCcCHHHHHHh
Confidence            66666666655543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=5.4e-22  Score=189.88  Aligned_cols=156  Identities=29%  Similarity=0.319  Sum_probs=81.0

Q ss_pred             CCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCC
Q 046544          211 KLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSS  290 (646)
Q Consensus       211 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~  290 (646)
                      +|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|.++.+|.               
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------------   93 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN---------------   93 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT---------------
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCH---------------
Confidence            45555555555554444445555555555555555554444445555555555555555554432               


Q ss_pred             CcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCC
Q 046544          291 NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP  370 (646)
Q Consensus       291 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  370 (646)
                              ..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|.+.+   
T Consensus        94 --------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---  162 (208)
T 2o6s_A           94 --------GVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---  162 (208)
T ss_dssp             --------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred             --------hHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence                    233344444444444444444444445555555555555555554444445555555555555555442   


Q ss_pred             ccccCCCCCCceeCcCCcceeeccCC
Q 046544          371 TSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       371 ~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                          .++.|+.|+++.|+++|.+|..
T Consensus       163 ----~~~~l~~L~~~~n~~~g~ip~~  184 (208)
T 2o6s_A          163 ----TCPGIRYLSEWINKHSGVVRNS  184 (208)
T ss_dssp             ----CTTTTHHHHHHHHHCTTTBBCT
T ss_pred             ----CCCCHHHHHHHHHhCCceeecc
Confidence                2345555556666666555543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.87  E-value=2e-22  Score=214.67  Aligned_cols=145  Identities=25%  Similarity=0.435  Sum_probs=122.5

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++.+ +|||||++++++...+..|+|||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            45888899999999997655566899999999865432   2346799999999 8999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-----~~~~ki~DfGla~~~~  643 (646)
                      + |+|.+++........+..+..++.|++.||+|||   +.+|+||||||+||+++.     ...+||+|||+|+.+.
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 5999999877655555567889999999999999   889999999999999953     3468899999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.87  E-value=8.4e-22  Score=207.14  Aligned_cols=151  Identities=25%  Similarity=0.343  Sum_probs=128.5

Q ss_pred             HhCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CC-----CceeEEEEEecCCe
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HR-----NLIKVISSCSNEEF  562 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~~~~~~~~~~~  562 (646)
                      ..++|+..+.||+|+||+||+|+.. +++.||||++... ....+++.+|+++++.++ |+     +|+++++++..++.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3478999999999999999999865 6889999998743 233456778888888874 55     49999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--CCCcEEEEeecCc
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--DNLVAYLSDFGIA  639 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~~~~~ki~DfGla  639 (646)
                      .++||||++ |+|.+++.... ..+++..+..++.|++.|+.|||+. ..+|+||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999998764 4689999999999999999999942 47899999999999994  5788999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +...
T Consensus       209 ~~~~  212 (382)
T 2vx3_A          209 CQLG  212 (382)
T ss_dssp             EETT
T ss_pred             eecc
Confidence            8753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=4.5e-22  Score=212.60  Aligned_cols=144  Identities=27%  Similarity=0.370  Sum_probs=119.3

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++..++..|+|||||.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            45557889999999998776668999999998754   235678899999876 89999999999999999999999995


Q ss_pred             CCCHHHHHhhCCCCC------CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-------------CcEE
Q 046544          572 HGSLEKYLYSSNCIL------DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-------------LVAY  632 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l------~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-------------~~~k  632 (646)
                       |+|.+++.......      ++..+..++.|++.||+|||   +.+|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999997654211      22235679999999999999   8899999999999999754             4899


Q ss_pred             EEeecCccccc
Q 046544          633 LSDFGIAKLLI  643 (646)
Q Consensus       633 i~DfGla~~~~  643 (646)
                      |+|||+|+.+.
T Consensus       169 L~DFG~a~~~~  179 (434)
T 2rio_A          169 ISDFGLCKKLD  179 (434)
T ss_dssp             ECCCTTCEECC
T ss_pred             EcccccceecC
Confidence            99999998764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=1.2e-21  Score=187.44  Aligned_cols=130  Identities=27%  Similarity=0.282  Sum_probs=69.6

Q ss_pred             CcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecC
Q 046544          164 LKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG  243 (646)
Q Consensus       164 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  243 (646)
                      +++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus        30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  109 (208)
T 2o6s_A           30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT  109 (208)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence            33333333333333444455556666666666666655555555566666666666666555555555556666666666


Q ss_pred             CcccccCCccccCCCCCceeecCCCcccccccc-cccccccccccCCCCcc
Q 046544          244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLT-FWNLKDILQLNFSSNFL  293 (646)
Q Consensus       244 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l  293 (646)
                      |++++..+..|..+++|++|++++|.++.+|.. +..+++|+.|++++|.+
T Consensus       110 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A          110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             CcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            665555555555555555555555555555432 33444444444444443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=6.4e-22  Score=190.91  Aligned_cols=152  Identities=22%  Similarity=0.327  Sum_probs=73.3

Q ss_pred             cEEEecCCcccccCCccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccc
Q 046544          237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN  315 (646)
Q Consensus       237 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N  315 (646)
                      +.+++++|.++.+ |..+.  ++|+.|++++|.|+.+|. .|..+++|+.|++++|.+++..|..|.++++|+.|+|++|
T Consensus        14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            3455555555422 22222  345555555555555443 3444455555555555554444444555555555555555


Q ss_pred             cccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       316 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      .++++.+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            5544444444445555555555555544444444445555555555555544444444444444444444444444

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.86  E-value=1.3e-22  Score=223.35  Aligned_cols=150  Identities=30%  Similarity=0.464  Sum_probs=128.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEec------CCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSN------EEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------~~~  562 (646)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999864 68999999987543 3345678999999999999999999998765      667


Q ss_pred             eEEEEEecCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCc---EEEEeec
Q 046544          563 KALVLEYKPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLV---AYLSDFG  637 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~---~ki~DfG  637 (646)
                      .++||||++||+|.+++....  ..+++..+..++.|++.|++|||   ..+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998654  25788889999999999999999   889999999999999986654   9999999


Q ss_pred             Cccccc
Q 046544          638 IAKLLI  643 (646)
Q Consensus       638 la~~~~  643 (646)
                      +|+...
T Consensus       170 ~a~~~~  175 (676)
T 3qa8_A          170 YAKELD  175 (676)
T ss_dssp             CCCBTT
T ss_pred             cccccc
Confidence            998754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=8.9e-22  Score=215.03  Aligned_cols=183  Identities=26%  Similarity=0.294  Sum_probs=157.0

Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecC
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      +++.|++++|.+++ +|..+  .++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999997 45444  278999999999999 566   457899999999999997 555 665  99999999


Q ss_pred             CCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCccc
Q 046544          267 SNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP  346 (646)
Q Consensus       267 ~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  346 (646)
                      +|.|+.+|.   .+++|+.|++++|.+++ +|.   .+++|+.|++++|.+++ +|. |.  ++|+.|+|++|+|+ .+|
T Consensus       129 ~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp  196 (571)
T 3cvr_A          129 NNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP  196 (571)
T ss_dssp             SSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred             CCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence            999999997   68999999999999997 554   57899999999999998 555 66  89999999999999 566


Q ss_pred             ccccCCCCC-------CEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          347 DSFGDLISL-------KFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       347 ~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      . |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..
T Consensus       197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~  249 (571)
T 3cvr_A          197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES  249 (571)
T ss_dssp             C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred             h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence            6 665  77       99999999999 68888888999999999999999987753

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=4.3e-22  Score=192.14  Aligned_cols=136  Identities=27%  Similarity=0.315  Sum_probs=99.3

Q ss_pred             CceeecCCCccccccc--ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEcc
Q 046544          260 LRILSLSSNELTSIPL--TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLG  337 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls  337 (646)
                      ++.|+|++|.|+.++.  .|..+++|+.|++++|.+++..+..|..+++|+.|++++|.++++.+..|+++++|++|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            3444455554444421  24445555555555555555555567777777788888888877777778888888888888


Q ss_pred             CccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC
Q 046544          338 YNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       338 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      +|++++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+++|.++.
T Consensus       114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A          114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            8888887788888888888888888888887788888888888888888888887664

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=1.2e-21  Score=203.70  Aligned_cols=147  Identities=22%  Similarity=0.327  Sum_probs=126.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CC-cEEEEEEEeccCCchHHHHHHHHHHHHhCCCCC------ceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DG-MEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN------LIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||.||+|+.. ++ +.||+|+++.. ....+.+.+|+++++.++|++      ++.+.+++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            68999999999999999999864 44 78999998743 234567788999999987765      99999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE-----------------
Q 046544          564 ALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL-----------------  625 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~-----------------  625 (646)
                      ++||||+ ++++.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||++                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence            9999999 567777776554 46899999999999999999999   8899999999999999                 


Q ss_pred             --cCCCcEEEEeecCccccc
Q 046544          626 --DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       626 --~~~~~~ki~DfGla~~~~  643 (646)
                        +.++.+||+|||+|+...
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~  193 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDH  193 (355)
T ss_dssp             EEESCCCEEECCCTTCEETT
T ss_pred             cccCCCcEEEeecCcccccc
Confidence              567899999999998643

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=9.5e-22  Score=189.74  Aligned_cols=151  Identities=23%  Similarity=0.280  Sum_probs=90.4

Q ss_pred             CeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccc-ccccccccccccccCCCC
Q 046544          213 QGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSN  291 (646)
Q Consensus       213 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N  291 (646)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|.|+.+ |..|.++++|++|++++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            35566666665 3343332  4566666666666655555666666666666666666655 445556666666666666


Q ss_pred             cccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          292 FLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       292 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      .++...+..|..+++|+.|+|++|.++++.|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            666555555566666666666666666665666666666666666666666555555666666666666666654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=8.1e-22  Score=206.57  Aligned_cols=147  Identities=19%  Similarity=0.296  Sum_probs=126.5

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-----------CCCceeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-----------HRNLIKVISSCSN  559 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~~~~~~~~  559 (646)
                      .+|+..+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            6799999999999999999996 47899999998743 233467788999998876           8999999999876


Q ss_pred             CC----eeEEEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEEc------C
Q 046544          560 EE----FKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLA-PVIHCDLKPDNVLLD------D  627 (646)
Q Consensus       560 ~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~iiHrdlk~~Nil~~------~  627 (646)
                      .+    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   .+ +|+||||||+||+++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 889999997643 45899999999999999999999   76 999999999999994      4


Q ss_pred             CCcEEEEeecCccccc
Q 046544          628 NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       628 ~~~~ki~DfGla~~~~  643 (646)
                      .+.+||+|||+|+...
T Consensus       174 ~~~~kl~Dfg~a~~~~  189 (373)
T 1q8y_A          174 LIQIKIADLGNACWYD  189 (373)
T ss_dssp             EEEEEECCCTTCEETT
T ss_pred             cceEEEcccccccccC
Confidence            4589999999998654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=2.6e-21  Score=186.67  Aligned_cols=159  Identities=23%  Similarity=0.214  Sum_probs=144.2

Q ss_pred             CceeecCCCcccccccccccccccccccCCCCcccCCCC-CccCccccceEEEcccccccccCccccCCCCCCCEEEccC
Q 046544          260 LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLP-LEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGY  338 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  338 (646)
                      -+.+++++|.++++|..+.  ..++.|++++|.+++..+ ..|..+++|+.|++++|.++++.+..|+++++|++|+|++
T Consensus        13 ~~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           13 GTTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TTEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            3589999999999998664  356899999999998755 5689999999999999999999889999999999999999


Q ss_pred             ccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCC
Q 046544          339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       339 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      |++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|.. ..+.+++.+++++|+|.|+|+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            9999999999999999999999999999999999999999999999999999986755 558899999999999999887


Q ss_pred             Ccc
Q 046544          418 TLQ  420 (646)
Q Consensus       418 ~~~  420 (646)
                      ..+
T Consensus       171 l~~  173 (220)
T 2v70_A          171 LAW  173 (220)
T ss_dssp             GHH
T ss_pred             hHH
Confidence            643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=1.4e-21  Score=213.47  Aligned_cols=135  Identities=19%  Similarity=0.240  Sum_probs=106.7

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCC--c------hHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--R------AFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ...+.||+|+||.||+|+. .++.+|+|....+..  .      ..+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 578889998654321  1      134578999999999999999555555567778999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |||++|++|.+++..         +..++.|+++|++|||   +++|+||||||+||+++.  .+||+|||+|+....
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999865         4579999999999999   889999999999999998  999999999998643

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=1.5e-21  Score=203.36  Aligned_cols=180  Identities=27%  Similarity=0.270  Sum_probs=116.1

Q ss_pred             CEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhc-CCCCCcEEEecCCcccccCCccccCCCCCceeecCC
Q 046544          189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC-RLTELYELELGGNKLFGSIPACFSNLASLRILSLSS  267 (646)
Q Consensus       189 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  267 (646)
                      +.+++++|.++.+ |..+.  ..++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~i-P~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPNV-PQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSSC-CSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCcc-CccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            4677777777643 33332  3466677777777666666665 666677777777766666666666666666666666


Q ss_pred             CcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccc
Q 046544          268 NELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPD  347 (646)
Q Consensus       268 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  347 (646)
                      |+|+.+|                       +..|..+++|+.|+|++|.++++.|..|.++++|+.|+|++|+|++..+.
T Consensus        98 N~l~~~~-----------------------~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~  154 (361)
T 2xot_A           98 NHLHTLD-----------------------EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE  154 (361)
T ss_dssp             SCCCEEC-----------------------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred             CcCCcCC-----------------------HHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence            6666554                       33455556666666666666666666777777777777777777755555


Q ss_pred             cc---cCCCCCCEEEccCCcCcccCCccccCCCC--CCceeCcCCcceeecc
Q 046544          348 SF---GDLISLKFLNLSNNNLSGAIPTSLEKLSY--LEDLNLSFNKLEGEIP  394 (646)
Q Consensus       348 ~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p  394 (646)
                      .|   ..+++|+.|||++|+|++..+..+..++.  ++.|+|++|++.|.+.
T Consensus       155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            55   45777777777777777555566666665  3677777777776543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.85  E-value=2.8e-21  Score=194.94  Aligned_cols=172  Identities=26%  Similarity=0.314  Sum_probs=96.4

Q ss_pred             ccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCce
Q 046544          183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRI  262 (646)
Q Consensus       183 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  262 (646)
                      ..+++|+.|++++|.+... + .+..+++|++|++++|++++..+  +..+++|++|++++|++++. + .+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCE
Confidence            3445555555555555533 1 24445555555555555554332  55555555555555555432 1 2444555555


Q ss_pred             eecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC
Q 046544          263 LSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       263 L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      |++++|.++.+                         ..+..+++|+.|++++|.+++.  ..++.+++|+.|++++|+++
T Consensus       117 L~L~~n~i~~~-------------------------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~  169 (291)
T 1h6t_A          117 LSLEHNGISDI-------------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  169 (291)
T ss_dssp             EECTTSCCCCC-------------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             EECCCCcCCCC-------------------------hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence            55555554443                         2344555566666666666544  45666667777777777776


Q ss_pred             CcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          343 GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       343 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +..|  +..+++|+.|++++|++++ +| .+..+++|+.|++++|+++.
T Consensus       170 ~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          170 DIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             cchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            5444  6666777777777777764 33 36667777777777777664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.85  E-value=1.5e-21  Score=215.73  Aligned_cols=173  Identities=25%  Similarity=0.379  Sum_probs=91.5

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      +++|+.|+|++|.|+.. + .+..+++|+.|+|++|+|+++.|  |..+++|++|+|++|.|+.++       .+..+++
T Consensus        42 L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-------~l~~l~~  110 (605)
T 1m9s_A           42 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS-------SLKDLKK  110 (605)
T ss_dssp             HTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT-------TSTTCTT
T ss_pred             CCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh-------hhccCCC
Confidence            44444455555544422 2 24445555555555555554433  555555555555555554432       2445555


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |++|+|++|++.++..   +..+ ++|+.|+|++|.+++.  ..+..+++|+.|+|++|++.+..|  +..+++|+.|+|
T Consensus       111 L~~L~Ls~N~l~~l~~---l~~l-~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L  182 (605)
T 1m9s_A          111 LKSLSLEHNGISDING---LVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  182 (605)
T ss_dssp             CCEEECTTSCCCCCGG---GGGC-TTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCEEEecCCCCCCCcc---ccCC-CccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence            5555555555544311   1111 2333344444444332  345666677777777777765555  666677777777


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIP  251 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  251 (646)
                      ++|+|++.  ..+..+++|+.|+|++|++.+...
T Consensus       183 s~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          183 SKNHISDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             CSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             cCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            77776643  346666777777777777664433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=4.1e-21  Score=193.70  Aligned_cols=189  Identities=25%  Similarity=0.366  Sum_probs=139.9

Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      +..+.+..+.+.++.....    .++|+.|++++|.+...  +.+..+++|++|++++|++++..+  +.++++|++|++
T Consensus        26 ~~~~~l~~~~~~~~~~~~~----l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVTQNE----LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHTTCSCTTSEECHHH----HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHhcCCCcccccchhh----cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            3444566666665433322    25799999999999875  348999999999999999998766  999999999999


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      ++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|.++.++ .+..+++|+.|++         
T Consensus        98 ~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L---------  163 (291)
T 1h6t_A           98 DENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSL---------  163 (291)
T ss_dssp             CSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEEC---------
T ss_pred             CCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcch-hhccCCCCCEEEc---------
Confidence            99999863  3499999999999999999864  46888999999999999988763 4444555555554         


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcc
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                                     ++|.+++..|  +..+++|+.|++++|++++. | .+..+++|+.|++++|+++.
T Consensus       164 ---------------~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          164 ---------------EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             ---------------CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ---------------cCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence                           4454444433  56666666666666666643 2 36667777777777777663

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=1.6e-20  Score=182.36  Aligned_cols=154  Identities=24%  Similarity=0.310  Sum_probs=77.2

Q ss_pred             cEEEecCCcccccCCccccCCCCCceeecCCCccccc-ccccccccccccccCCCCcccCCCCCccCccccceEEEcccc
Q 046544          237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN  315 (646)
Q Consensus       237 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N  315 (646)
                      +.++.+++++.. +|..+.  ++|++|+|++|.++.+ |..|..+++|+.|++++|.++...+..|..+++|+.|+|++|
T Consensus        22 ~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            445555555542 222221  4555555555555544 333445555555555555554444444455555555555555


Q ss_pred             cccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeecc
Q 046544          316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       316 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  394 (646)
                      .++++.+..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|+++|.++
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            555444444555555555555555555 344445555555555555555554444445555555555555555554433

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=9.7e-21  Score=209.14  Aligned_cols=172  Identities=24%  Similarity=0.323  Sum_probs=91.3

Q ss_pred             ccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCce
Q 046544          183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRI  262 (646)
Q Consensus       183 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  262 (646)
                      ..+++|+.|++++|.+....  .+..+++|+.|+|++|+|.+..|  +..+++|+.|+|++|.+.+. + .+..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCE
Confidence            34455555555555554321  34555555555555555554333  55555555555555555432 1 4555555555


Q ss_pred             eecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC
Q 046544          263 LSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       263 L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      |+|++|.|+.+| .+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|+|+
T Consensus       114 L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~  188 (605)
T 1m9s_A          114 LSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  188 (605)
T ss_dssp             EECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             EEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence            555555555543 344555555555555555543  345555555555555555555444  555566666666666665


Q ss_pred             CcccccccCCCCCCEEEccCCcCcc
Q 046544          343 GSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       343 ~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                      +.  +.+..+++|+.|+|++|++++
T Consensus       189 ~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          189 DL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             BC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             CC--hHHccCCCCCEEEccCCcCcC
Confidence            43  235555666666666665554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=1.2e-20  Score=196.46  Aligned_cols=160  Identities=26%  Similarity=0.227  Sum_probs=108.5

Q ss_pred             cCcEEEeecccccccCCcccc-cCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          163 SLKDFYMSNCNVSGGIPEEIT-NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      .++.|+|++|+|++..+..+. .+++|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            345555555555555566666 7777888888888887777777777888888888888887776777777888888888


Q ss_pred             cCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccC
Q 046544          242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVI  321 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  321 (646)
                      ++|+|.++.+..|.++++|+.|+|++|.|+.+|..++.                    .+..+++|+.|+|++|+|+++.
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~--------------------~~~~l~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK--------------------DGNKLPKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC------------------------CTTCCEEECCSSCCCCCC
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhc--------------------CcccCCcCCEEECCCCCCCccC
Confidence            88888777777777777888888888877777654321                    0133455555555555555555


Q ss_pred             ccccCCCCC--CCEEEccCccCC
Q 046544          322 PTEIGGLKN--LEYLFLGYNRLE  342 (646)
Q Consensus       322 ~~~~~~l~~--L~~L~Ls~N~l~  342 (646)
                      +..|..++.  |+.|+|++|++.
T Consensus       180 ~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          180 LTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             HHHHHHSCHHHHTTEECCSSCEE
T ss_pred             HHHhhhccHhhcceEEecCCCcc
Confidence            555555555  367777777765

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1e-19  Score=176.66  Aligned_cols=155  Identities=23%  Similarity=0.248  Sum_probs=94.5

Q ss_pred             CceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          260 LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      .+.++.+++.++.+|..+.  ++|+.|++++|.+++..|..|..+++|+.|+|++|.++++.+..|..+++|++|+|++|
T Consensus        21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            4556666666666665443  55666666666666655666666666666666666666555555666666666666666


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC-CCCCCCccccccCCccccCCC
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      ++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.++.. ..+..++.+++.+|+|.|+|+
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            666555555666666666666666666 45556666666666666666666544332 335556666666666666554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.82  E-value=1.7e-20  Score=176.94  Aligned_cols=155  Identities=25%  Similarity=0.331  Sum_probs=103.6

Q ss_pred             ceeecCCCcccccccccccccccccccCCCCcccCCCCC-ccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPL-EIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      +++++++|.++++|..+..  +++.|++++|.+++..+. .|..+++|+.|++++|.++++.|..|+++++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            4566666666666654433  566666666666654443 3667777777777777777777777777777777777777


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCC
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      ++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+++|.++.......+....+.++...|..|
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            777777777777777777777777777777777777777777777777777766543222223333445555566544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.82  E-value=1.2e-20  Score=200.09  Aligned_cols=147  Identities=19%  Similarity=0.200  Sum_probs=112.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCC-CCce---------------
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRH-RNLI---------------  551 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H-~niv---------------  551 (646)
                      ..|...+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| +++.               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45777899999999999999954 799999999874332   235678899999999987 2211               


Q ss_pred             ------eEEEEEec-----CCeeEEEEEecCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 046544          552 ------KVISSCSN-----EEFKALVLEYKPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI  614 (646)
Q Consensus       552 ------~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii  614 (646)
                            .+..++..     ....+++|+++ +++|.+++.      ..+..+++..+..++.|+++||+|||   +++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                  11111111     12356777765 679999884      22345677788999999999999999   88999


Q ss_pred             ecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       615 Hrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||||||+|||++.++.+||+|||+|+..
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~  261 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRD  261 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred             cCCcccceEEEecCCeEEEEeccceeec
Confidence            9999999999999999999999998864

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=6e-21  Score=189.39  Aligned_cols=170  Identities=24%  Similarity=0.337  Sum_probs=100.8

Q ss_pred             CCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceee
Q 046544          185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILS  264 (646)
Q Consensus       185 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  264 (646)
                      +.++..+++++|.+++..  .+..+++|++|++++|.++. +| .+..+++|++|+|++|+|++..+  +.++++|+.|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            344455556666665443  35556666666666666653 33 45666666666666666654443  66666666666


Q ss_pred             cCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCc
Q 046544          265 LSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGS  344 (646)
Q Consensus       265 L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  344 (646)
                      +++|+++.+|....                          ++|+.|++++|.+++.  ..++.+++|+.|++++|++++.
T Consensus        92 L~~N~l~~l~~~~~--------------------------~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~  143 (263)
T 1xeu_A           92 VNRNRLKNLNGIPS--------------------------ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI  143 (263)
T ss_dssp             CCSSCCSCCTTCCC--------------------------SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC
T ss_pred             CCCCccCCcCcccc--------------------------CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC
Confidence            66666665543111                          4455555555555543  2466666666666666666643


Q ss_pred             ccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          345 IPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       345 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                       + .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       144 -~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          144 -V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence             2 466666677777777766644  4566667777777777776654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=2e-20  Score=185.57  Aligned_cols=170  Identities=22%  Similarity=0.299  Sum_probs=84.8

Q ss_pred             CCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEE
Q 046544           33 MSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWL  112 (646)
Q Consensus        33 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  112 (646)
                      +.+++.+++++|.+++.. ..  ..+++|++|++++|.++. ++ .+..+++|++|+|++|+|+++.+  |.++++|++|
T Consensus        18 l~~l~~l~l~~~~i~~~~-~~--~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV-SQ--KELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE-CH--HHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHhcCCCccccc-ch--hhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            344455555555554322 11  124455555555555542 22 34444555555555555554333  4445555555


Q ss_pred             EccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEE
Q 046544          113 NLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITID  192 (646)
Q Consensus       113 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  192 (646)
                      +|++|+++.+++       +.. ++|++|+++                          +|++++.  +.+..+++|+.|+
T Consensus        91 ~L~~N~l~~l~~-------~~~-~~L~~L~L~--------------------------~N~l~~~--~~l~~l~~L~~L~  134 (263)
T 1xeu_A           91 SVNRNRLKNLNG-------IPS-ACLSRLFLD--------------------------NNELRDT--DSLIHLKNLEILS  134 (263)
T ss_dssp             ECCSSCCSCCTT-------CCC-SSCCEEECC--------------------------SSCCSBS--GGGTTCTTCCEEE
T ss_pred             ECCCCccCCcCc-------ccc-CcccEEEcc--------------------------CCccCCC--hhhcCcccccEEE
Confidence            555555444321       111 334444443                          3333332  2355666666666


Q ss_pred             ccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          193 LGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       193 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                      +++|++++..  .+..+++|++|++++|++++.  ..+..+++|+.|++++|++...
T Consensus       135 Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          135 IRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCCcCCCCh--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            6666666542  455666666666666666644  4555666666666666666543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=1.3e-22  Score=222.89  Aligned_cols=191  Identities=23%  Similarity=0.211  Sum_probs=111.3

Q ss_pred             ccCCCCCEEEccCCccccccCccccCCCCCCeEEeeccc-------------ccCcCchhhcCCCCCcEEE-ecCCcccc
Q 046544          183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK-------------LEGSIPDSICRLTELYELE-LGGNKLFG  248 (646)
Q Consensus       183 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~i~~  248 (646)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            34556666666666665 445556666666666665543             3445666666666676666 5555432 


Q ss_pred             cCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCC
Q 046544          249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGL  328 (646)
Q Consensus       249 ~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  328 (646)
                                +|+.+.+++|.++.+|.     ..|+.|++++|.+++ +|. ++.+++|+.|+|++|.++ .+|..|+.+
T Consensus       424 ----------~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  485 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL  485 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             ----------hhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence                      23344444444444432     135556666666654 343 666666666666666666 345566666


Q ss_pred             CCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccC-CccccCCCCCCceeCcCCcceeeccC
Q 046544          329 KNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAI-PTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       329 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      ++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|.
T Consensus       486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            666666666666664 34 5666666666666666666554 66666666666666666666655443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.80  E-value=3.8e-20  Score=190.31  Aligned_cols=103  Identities=12%  Similarity=0.075  Sum_probs=72.8

Q ss_pred             ccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCC-EEEccCccCCCcccccccCCCCCCEE
Q 046544          280 LKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE-YLFLGYNRLEGSIPDSFGDLISLKFL  358 (646)
Q Consensus       280 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L  358 (646)
                      +++|+.+++++|.++.+.+.+|.++++|+.+++++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            456666666666666555666777777777777766 6666677777777777 777777 6665666777777777777


Q ss_pred             EccCCcCcccCCccccCCCCCCceeC
Q 046544          359 NLSNNNLSGAIPTSLEKLSYLEDLNL  384 (646)
Q Consensus       359 ~Ls~N~l~~~~p~~~~~l~~L~~L~L  384 (646)
                      ++++|+++...+.+|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            77777777666677777777777653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=1.3e-20  Score=213.36  Aligned_cols=161  Identities=21%  Similarity=0.219  Sum_probs=100.3

Q ss_pred             eecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccc
Q 046544          169 MSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG  248 (646)
Q Consensus       169 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~  248 (646)
                      +..|.+. ..|+.+..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|+ 
T Consensus       208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-  283 (727)
T 4b8c_D          208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred             cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence            3444444 45677777778888888888877 44555557777888888888877 66777777888888888888877 


Q ss_pred             cCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCcccc-ceEEEcccccccccCccccCC
Q 046544          249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKV-LIGIDFSMNNFSSVIPTEIGG  327 (646)
Q Consensus       249 ~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~~~~~~~  327 (646)
                      .+|..|+++++|++|+|++|.|+.+|..|..+++|+.|+|++|.+++.+|..+..+.. +..+++++|.+++..|..   
T Consensus       284 ~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~---  360 (727)
T 4b8c_D          284 SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE---  360 (727)
T ss_dssp             SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---
T ss_pred             ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc---
Confidence            5577777778888888888888777777777777777777777777776666655422 233667777777666543   


Q ss_pred             CCCCCEEEccCc
Q 046544          328 LKNLEYLFLGYN  339 (646)
Q Consensus       328 l~~L~~L~Ls~N  339 (646)
                         |+.|++++|
T Consensus       361 ---l~~l~l~~n  369 (727)
T 4b8c_D          361 ---RRFIEINTD  369 (727)
T ss_dssp             ------------
T ss_pred             ---cceeEeecc
Confidence               445555555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=1.9e-21  Score=213.58  Aligned_cols=189  Identities=19%  Similarity=0.177  Sum_probs=154.9

Q ss_pred             cCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCc-------------ccccCCccccCCCCCceee-cCCCcccc
Q 046544          207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK-------------LFGSIPACFSNLASLRILS-LSSNELTS  272 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------i~~~~~~~~~~l~~L~~L~-L~~N~l~~  272 (646)
                      ...++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+..|..++++++|+.|+ ++.|.+  
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence            55788999999999998 778999999999999997775             4456666777777777777 666644  


Q ss_pred             cccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCC
Q 046544          273 IPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDL  352 (646)
Q Consensus       273 lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  352 (646)
                              ..|..+.+++|.++...+      ..|+.|++++|.++++ |. |+.+++|+.|+|++|+|+ .+|..|+.+
T Consensus       423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  485 (567)
T 1dce_A          423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAAL  485 (567)
T ss_dssp             --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             --------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcC
Confidence                    344556666777664322      2488999999999974 55 999999999999999999 788999999


Q ss_pred             CCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeec-cC-CCCCCCCccccccCCccccCCC
Q 046544          353 ISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEI-PR-GGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~-~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      ++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.+ |. ...++.++.+++++|++...++
T Consensus       486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            999999999999996 67 8999999999999999999984 54 4668999999999999765444

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.79  E-value=1.5e-19  Score=171.22  Aligned_cols=154  Identities=19%  Similarity=0.255  Sum_probs=97.9

Q ss_pred             cCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccc
Q 046544          207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQL  286 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  286 (646)
                      ..+++|++|++++|.++ .+| .+..+++|++|++++|.+..  +..+..+++|++|++++|.++               
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~---------------  101 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT---------------  101 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCB---------------
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccC---------------
Confidence            44556666666666666 333 45566666666666665432  224555555555555555544               


Q ss_pred             cCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc-CCCcccccccCCCCCCEEEccCCcC
Q 046544          287 NFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR-LEGSIPDSFGDLISLKFLNLSNNNL  365 (646)
Q Consensus       287 ~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l  365 (646)
                              +..+..+..+++|+.|++++|.+++..|..++.+++|++|++++|+ ++. +| .+..+++|+.|++++|++
T Consensus       102 --------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i  171 (197)
T 4ezg_A          102 --------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGV  171 (197)
T ss_dssp             --------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCC
T ss_pred             --------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCC
Confidence                    3444556666777777777777776667777778888888888887 653 44 577788888888888888


Q ss_pred             cccCCccccCCCCCCceeCcCCccee
Q 046544          366 SGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       366 ~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      ++ ++ .+..+++|+.|++++|++.+
T Consensus       172 ~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          172 HD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CC-CT-TGGGCSSCCEEEECBC----
T ss_pred             cC-hH-HhccCCCCCEEEeeCcccCC
Confidence            74 33 67778888888888887754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=5.3e-20  Score=182.00  Aligned_cols=140  Identities=21%  Similarity=0.239  Sum_probs=107.6

Q ss_pred             CCCcceeecccccceEEEEEe-CCCcE--EEEEEEeccCCc------------------------hHHHHHHHHHHHHhC
Q 046544          493 GFSENNLIGRGGFGSVYKARL-GDGME--VAVKVFNLQCGR------------------------AFKSFAVECEMMKSI  545 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  545 (646)
                      -|+..+.||+|+||.||+|+. .+|+.  ||||+++.....                        ....+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            366789999999999999997 68988  999987543111                        013578899999999


Q ss_pred             CCCCc--eeEEEEEecCCeeEEEEEecCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 046544          546 RHRNL--IKVISSCSNEEFKALVLEYKPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDL  618 (646)
Q Consensus       546 ~H~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl  618 (646)
                      +|+++  +.++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|+.|+|.  ..+|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88754  344432    356899999942 3    67776533    1234567899999999999993  358999999


Q ss_pred             CCCCEEEcCCCcEEEEeecCcccccC
Q 046544          619 KPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       619 k~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||+|||+++  .++|+|||+|.....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETTS
T ss_pred             CHHHEEEcC--cEEEEECcccccCCC
Confidence            999999998  899999999987643

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.79  E-value=1.7e-20  Score=212.33  Aligned_cols=190  Identities=26%  Similarity=0.279  Sum_probs=92.0

Q ss_pred             EEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcc
Q 046544          191 IDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNEL  270 (646)
Q Consensus       191 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  270 (646)
                      ++++.|++. .++..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|
T Consensus       206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            345555555 55666777777777777777776 45555556777777777777776 5566677777777777777777


Q ss_pred             cccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCC-CCEEEccCccCCCcccccc
Q 046544          271 TSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN-LEYLFLGYNRLEGSIPDSF  349 (646)
Q Consensus       271 ~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~  349 (646)
                      +.+|..|..+++|++|+|++|.++ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..++|++|.+++.+|.. 
T Consensus       283 ~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-  360 (727)
T 4b8c_D          283 TSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-  360 (727)
T ss_dssp             SSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             CccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence            777766767777777777777665 45555666666666777766666666655543321 123566666666655543 


Q ss_pred             cCCCCCCEEEccCC--------cCcccCCccccCCCCCCceeCcCCcce
Q 046544          350 GDLISLKFLNLSNN--------NLSGAIPTSLEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       350 ~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~L~~N~l~  390 (646)
                           |+.|+++.|        .+.+..+..+..+..++...++.|-+.
T Consensus       361 -----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          361 -----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ----------------------------------------------CCC
T ss_pred             -----cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence                 344555555        233333334444455555555555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=2.5e-19  Score=184.11  Aligned_cols=264  Identities=16%  Similarity=0.133  Sum_probs=143.7

Q ss_pred             CCCCCEEECCCCcccccCCcCccC-CCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccC------
Q 046544            9 LQNLEELDLRHNKLVGTVPAAIFN-MSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN------   81 (646)
Q Consensus         9 l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------   81 (646)
                      +.++++|.++++ +....-..+.. +++|++|||++|+|......  ...++.+..+.+..|.   ..+..|.+      
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~--~~~~~~~~~~~~~~~~---I~~~aF~~~~~~~~   97 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGK--AGTYPNGKFYIYMANF---VPAYAFSNVVNGVT   97 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEES--SSSSGGGCCEEECTTE---ECTTTTEEEETTEE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCc--cccccccccccccccc---cCHHHhcccccccc
Confidence            567888888875 22222223333 78899999999998721111  1113335566666663   44566667      


Q ss_pred             --CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCC----CCCcCCcc
Q 046544           82 --ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNP----LDGILSKT  155 (646)
Q Consensus        82 --l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~----l~~~~~~~  155 (646)
                        +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++.+++.     +|.++.++..+.+..+.    ...+....
T Consensus        98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~-----aF~~~~~l~~l~~~~~~~~~~~~~i~~~~  171 (329)
T 3sb4_A           98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPE-----ALADSVTAIFIPLGSSDAYRFKNRWEHFA  171 (329)
T ss_dssp             EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTT-----SSCTTTCEEEECTTCTHHHHTSTTTTTSC
T ss_pred             cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchh-----hhcCCCceEEecCcchhhhhccccccccc
Confidence              88888888888 88888888888888888888888888877654     47777777777766532    11111111


Q ss_pred             hhcc------------------------ccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCC
Q 046544          156 SIGN------------------------LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQK  211 (646)
Q Consensus       156 ~~~~------------------------~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  211 (646)
                      +...                        ...++..+.+.++-...........+++|+.++|++|+++.+.+.+|.++.+
T Consensus       172 f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~  251 (329)
T 3sb4_A          172 FIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY  251 (329)
T ss_dssp             EEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred             cccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence            1110                        0112223333222111000000112455555555555555555555555555


Q ss_pred             CCeEEeecccccCcCchhhcCCCCCc-EEEecCCcccccCCccccCCCCCceeecCCCccccccc-ccccccccccc
Q 046544          212 LQGLGLDDNKLEGSIPDSICRLTELY-ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQL  286 (646)
Q Consensus       212 L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L  286 (646)
                      |+.++|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++.++. .|.++++|+.+
T Consensus       252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            555555555 4444555555555555 555555 4444445555555555555555555555543 34444444443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=1.2e-18  Score=164.84  Aligned_cols=150  Identities=16%  Similarity=0.224  Sum_probs=69.1

Q ss_pred             CCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceee
Q 046544          185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILS  264 (646)
Q Consensus       185 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  264 (646)
                      +++|+.|++++|.+... | .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..|+.+++|++|+
T Consensus        43 l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVTDL-T-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCSCC-T-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCccCh-H-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            33444444444444421 2 24444444444444443331  12344444444444444444444444444444444444


Q ss_pred             cCCCcccc-cccccccccccccccCCCCc-ccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC
Q 046544          265 LSSNELTS-IPLTFWNLKDILQLNFSSNF-LTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       265 L~~N~l~~-lp~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      +++|.++. .|..+..+++|+.|++++|. ++ .+| .+..+++|+.|++++|.+++..  .+..+++|+.|++++|++.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC---
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcccC
Confidence            44444442 23344444444444444444 33 222 3455555555555555555432  4556666666666666654

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=8.1e-19  Score=165.33  Aligned_cols=175  Identities=23%  Similarity=0.290  Sum_probs=122.0

Q ss_pred             cEEEecCCcccccCCccccCCCCCceeecCCCcccccccc--cccccccccccCCCCcccCCCCCccCccccceEEEccc
Q 046544          237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLT--FWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM  314 (646)
Q Consensus       237 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~  314 (646)
                      +++++++|+++ .+|..+.  .+|++|++++|.++.++..  |..+++|+.|++++|.+++..|..|.++++|+.|++++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45666666664 3333332  2666777777777666542  66677777777777777777777888888888888888


Q ss_pred             ccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCc-cccCCCCCCceeCcCCcceeec
Q 046544          315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT-SLEKLSYLEDLNLSFNKLEGEI  393 (646)
Q Consensus       315 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~  393 (646)
                      |+++++.+..|+++++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+. ++.  ..++...+..+...+..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCC
Confidence            888888888888899999999999999988888899999999999999998865442 111  11233345555555555


Q ss_pred             cCCCCCCCCccccccCCccccCCCC
Q 046544          394 PRGGSFGNFAAESFEGNELLCGSPT  418 (646)
Q Consensus       394 p~~~~~~~~~~~~~~~N~~~c~~~~  418 (646)
                      |..  +......++..+.+.|..+.
T Consensus       166 P~~--l~~~~l~~l~~~~~~C~~~~  188 (192)
T 1w8a_A          166 PSK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             STT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             ChH--HcCCChhhCcHhhcCcCCCC
Confidence            543  44455556777888886543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.77  E-value=5.4e-19  Score=166.51  Aligned_cols=131  Identities=30%  Similarity=0.408  Sum_probs=102.8

Q ss_pred             ceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      +++++++|.++++|..+.  ++|+.|++++|.++ .+|..|..+++|+.|++++|.++++.+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            456677777777765543  46677777777776 455677777788888888888887777888888888888888888


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeecc
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP  394 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  394 (646)
                      |++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            888888888888888888888888887666778888888888888888887655

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.76  E-value=2.5e-17  Score=173.06  Aligned_cols=265  Identities=9%  Similarity=0.095  Sum_probs=157.7

Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCC
Q 046544           59 PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL  138 (646)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  138 (646)
                      ..++.+.+.+ .++.+...+|.+. +|+.+++..| ++.+...+|.+. +|+.+.+.+ .++.+..     .+|.+|++|
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~-----~aF~~c~~L  182 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKE-----DIFYYCYNL  182 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECS-----STTTTCTTC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehH-----HHhhCcccC
Confidence            4566666654 3554566666664 6777777666 666777777773 577777765 5555543     247777777


Q ss_pred             CEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEee
Q 046544          139 TFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD  218 (646)
Q Consensus       139 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  218 (646)
                      +.+++++|.++.++...+.   ..+|+.+.+.++ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+.
T Consensus       183 ~~l~l~~n~l~~I~~~aF~---~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp  256 (401)
T 4fdw_A          183 KKADLSKTKITKLPASTFV---YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP  256 (401)
T ss_dssp             CEEECTTSCCSEECTTTTT---TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE
T ss_pred             CeeecCCCcceEechhhEe---ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC
Confidence            7777777777666544332   134555555422 44444555555555555555543 34344445554 455555552


Q ss_pred             cccccCcCchhhcCCCCCcEEEecCCccc-----ccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcc
Q 046544          219 DNKLEGSIPDSICRLTELYELELGGNKLF-----GSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFL  293 (646)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-----~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  293 (646)
                       +.++.+.+.+|.++++|+.+++.+|.+.     .+.+.+|                       .++++|+.+++.+ .+
T Consensus       257 -~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF-----------------------~~c~~L~~l~l~~-~i  311 (401)
T 4fdw_A          257 -NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCL-----------------------EGCPKLARFEIPE-SI  311 (401)
T ss_dssp             -TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTT-----------------------TTCTTCCEECCCT-TC
T ss_pred             -CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHh-----------------------hCCccCCeEEeCC-ce
Confidence             3334344455555555555555544443     2333444                       4455555555552 24


Q ss_pred             cCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCC-CCCEEEccCCcCc
Q 046544          294 TGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI-SLKFLNLSNNNLS  366 (646)
Q Consensus       294 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  366 (646)
                      +.+...+|.++++|+.+++..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       312 ~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          312 RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            4445566777777777777444 666777788888 888888888887767777787774 6778888777654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.76  E-value=5e-17  Score=170.71  Aligned_cols=263  Identities=13%  Similarity=0.147  Sum_probs=180.2

Q ss_pred             CCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcE
Q 046544            8 NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSI   87 (646)
Q Consensus         8 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~   87 (646)
                      ....++.+.+-+ .++.+.+.+|.+. +|+.+.|..| ++. +...+|.. .+|+.+.+.. .++...+.+|.++++|+.
T Consensus       111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~-I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~  184 (401)
T 4fdw_A          111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKS-IGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK  184 (401)
T ss_dssp             ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCE-ECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred             ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccE-ECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence            346778888765 4777888899885 7999999877 654 45545544 4799999986 777788888999999999


Q ss_pred             EEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEE
Q 046544           88 LELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF  167 (646)
Q Consensus        88 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  167 (646)
                      ++|++|.++.+...+|. ..+|+.+.|..+ ++.++.     .+|.+|++|+.+++..| ++.+....+.+   .+|+.+
T Consensus       185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~-----~aF~~~~~L~~l~l~~~-l~~I~~~aF~~---~~L~~i  253 (401)
T 4fdw_A          185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGS-----QAFLKTSQLKTIEIPEN-VSTIGQEAFRE---SGITTV  253 (401)
T ss_dssp             EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECT-----TTTTTCTTCCCEECCTT-CCEECTTTTTT---CCCSEE
T ss_pred             eecCCCcceEechhhEe-ecccCEEEeCCc-hheehh-----hHhhCCCCCCEEecCCC-ccCcccccccc---CCccEE
Confidence            99999999988888888 488999999854 776654     35888999999999875 55554444433   467777


Q ss_pred             EeecccccccCCcccccCCCCCEEEccCCccc-----cccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLN-----GSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       168 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      .+ .+.++.+...+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+++.+ .++.+...+|.++++|+.++|.
T Consensus       254 ~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          254 KL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             EE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEEC
T ss_pred             Ee-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEEC
Confidence            77 34566566667777777777777666654     45566666666777776663 3555666666666667766664


Q ss_pred             CCcccccCCccccCCCCCceeecCCCccccccc-cccccc-ccccccCCCC
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLK-DILQLNFSSN  291 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~-~L~~L~l~~N  291 (646)
                      .| ++.+.+.+|.++ +|+.+++++|.+..++. .|.+++ ++..|++..+
T Consensus       332 ~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~  380 (401)
T 4fdw_A          332 AN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE  380 (401)
T ss_dssp             TT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred             cc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence            44 555566666666 66666666666665543 233332 3344444443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.73  E-value=1.7e-17  Score=154.17  Aligned_cols=134  Identities=25%  Similarity=0.277  Sum_probs=113.2

Q ss_pred             CceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          260 LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      .+.+++++|.++.+|..+.  ++|+.|++++|.+++..+..|..+++|+.|++++|.++++.+..|+.+++|++|++++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4677778888887775543  57888888888888777777888899999999999998887788899999999999999


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      ++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++.+|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            99988778889999999999999999977776778899999999999999987764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=2.4e-17  Score=151.69  Aligned_cols=132  Identities=20%  Similarity=0.130  Sum_probs=85.1

Q ss_pred             CCCceeecCCCccc--ccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEE
Q 046544          258 ASLRILSLSSNELT--SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF  335 (646)
Q Consensus       258 ~~L~~L~L~~N~l~--~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  335 (646)
                      ++|+.|++++|.++  .+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            34444555555444  4444444455555555555555443  4556666777777777777766666666677777777


Q ss_pred             ccCccCCCccc-ccccCCCCCCEEEccCCcCcccCC---ccccCCCCCCceeCcCCccee
Q 046544          336 LGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIP---TSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       336 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +++|++++..+ ..+..+++|+.|++++|++++..+   ..+..+++|++|++++|.+..
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            77777775432 677777778888888887775444   367777788888888777764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.70  E-value=3.9e-17  Score=150.25  Aligned_cols=130  Identities=25%  Similarity=0.297  Sum_probs=73.9

Q ss_pred             cCcEEEeeccccc-ccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          163 SLKDFYMSNCNVS-GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       163 ~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      +++.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+|
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            4444555555544 34455556666666666666666544  55566666666666666666555555555666666666


Q ss_pred             cCCcccccCC-ccccCCCCCceeecCCCccccccc----ccccccccccccCCCCccc
Q 046544          242 GGNKLFGSIP-ACFSNLASLRILSLSSNELTSIPL----TFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       242 ~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~lp~----~~~~l~~L~~L~l~~N~l~  294 (646)
                      ++|++++..+ ..+..+++|++|++++|.++.+|.    .+..+++|+.|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6666654322 455566666666666666665554    3444555555555555444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.70  E-value=8.5e-17  Score=151.43  Aligned_cols=128  Identities=23%  Similarity=0.296  Sum_probs=105.3

Q ss_pred             cEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEccccc
Q 046544          237 YELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNN  316 (646)
Q Consensus       237 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~  316 (646)
                      +.+++++|.++.+ |..+.  ++|+.|++++|.|+.+|..|.++++|+.|++++|.+++..+..|.++++|+.|+|++|.
T Consensus        13 ~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSC-CSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4667777777633 33332  46778888888888787777778888888888888887777888899999999999999


Q ss_pred             ccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcc
Q 046544          317 FSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       317 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                      ++++.|..|.++++|++|+|++|+++...+..|..+++|+.|+|++|.+..
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            999888899999999999999999997777789999999999999999874

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.69  E-value=8.7e-16  Score=161.77  Aligned_cols=317  Identities=14%  Similarity=0.076  Sum_probs=173.5

Q ss_pred             ccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCc
Q 046544           22 LVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPN  101 (646)
Q Consensus        22 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  101 (646)
                      ++.+...+|.++++|+.+.|..+ ++. +...+|..+++|+.++|..+ ++.....+|.++.+|+.+.+..+ +..+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~-I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VRE-IGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCE-ECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccC-cchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            45566677777777777777643 443 45555556677777777644 55456666777777777666544 4446666


Q ss_pred             cccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcc
Q 046544          102 TFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEE  181 (646)
Q Consensus       102 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~  181 (646)
                      +|.+...++.......  ..+.     ..+|.++++|+.+.+.++. ..                          +...+
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~-----~~aF~~c~~L~~i~l~~~~-~~--------------------------I~~~~  180 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIG-----DEAFATCESLEYVSLPDSM-ET--------------------------LHNGL  180 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEEC-----TTTTTTCTTCCEEECCTTC-CE--------------------------ECTTT
T ss_pred             eeecccccccccCccc--cccc-----hhhhcccCCCcEEecCCcc-ce--------------------------ecccc
Confidence            6666654433332222  1111     1246677777777665432 21                          22344


Q ss_pred             cccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCc
Q 046544          182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLR  261 (646)
Q Consensus       182 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  261 (646)
                      |.++++|+.+++..| +..+...+|.++..|+.+.+..+...  +.+.+....+|+.+.+..+ +..+....|.++.+|+
T Consensus       181 F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~  256 (394)
T 4fs7_A          181 FSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLE  256 (394)
T ss_dssp             TTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred             ccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccce
Confidence            555555555555544 34344555555555555555544332  2222333345555555433 2334445555566666


Q ss_pred             eeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccC
Q 046544          262 ILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL  341 (646)
Q Consensus       262 ~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  341 (646)
                      .+.+..+..+--...|.....++.+....+.+   ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.+++.++ +
T Consensus       257 ~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v  331 (394)
T 4fs7_A          257 SISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V  331 (394)
T ss_dssp             EEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             eEEcCCCcceeeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence            66655543322223444555555555444432   2245556666666666543 55555566666666666666543 5


Q ss_pred             CCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcC
Q 046544          342 EGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSF  386 (646)
Q Consensus       342 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  386 (646)
                      +.+...+|.++++|+.+++..| ++.....+|.++.+|+.+++..
T Consensus       332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~  375 (394)
T 4fs7_A          332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK  375 (394)
T ss_dssp             CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred             cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence            5455566666666666666655 5545556666666666666643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.3e-17  Score=170.99  Aligned_cols=145  Identities=14%  Similarity=0.145  Sum_probs=103.6

Q ss_pred             HHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--------------CchHH--------HHHHHHHHHH
Q 046544          486 ELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------------GRAFK--------SFAVECEMMK  543 (646)
Q Consensus       486 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~--------~~~~e~~~l~  543 (646)
                      .+.....-|.+.+.||+|+||.||+|...+|+.||||+++...              .....        ...+|...+.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            3334344589999999999999999998899999999875321              00011        1234666777


Q ss_pred             hCCCCCceeEEEEEecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 046544          544 SIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNV  623 (646)
Q Consensus       544 ~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni  623 (646)
                      ++.+.++.-..-+...  ..++||||++|+++.++...     +  ....++.|++.++.|+|   ..+||||||||.||
T Consensus       169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLA---KHGLIHGDFNEFNI  236 (397)
T ss_dssp             HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred             HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHE
Confidence            7755544322111111  24799999999888765321     1  24568899999999999   88999999999999


Q ss_pred             EEcCCC----------cEEEEeecCcccc
Q 046544          624 LLDDNL----------VAYLSDFGIAKLL  642 (646)
Q Consensus       624 l~~~~~----------~~ki~DfGla~~~  642 (646)
                      |+++++          .+.|+||+-|...
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccC
Confidence            998766          4899999976543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.68  E-value=1.8e-15  Score=159.27  Aligned_cols=328  Identities=14%  Similarity=0.116  Sum_probs=215.2

Q ss_pred             cccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCC
Q 046544            5 EISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASK   84 (646)
Q Consensus         5 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~   84 (646)
                      +|.++.+|+++.|.. .++.+...+|.++++|+.++|..+ ++. +...++..+.+|+.+.+..+ ++.....+|.+...
T Consensus        66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM-IGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE-ccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            478899999999974 488889999999999999999866 543 55666677889999888765 55577778877765


Q ss_pred             CcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccC
Q 046544           85 LSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSL  164 (646)
Q Consensus        85 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L  164 (646)
                      ++.....  .+..+...+|.++.+|+.+.+.++. ..++.     ..|.++++|+.+++..| ++.+             
T Consensus       142 ~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~-----~~F~~c~~L~~i~l~~~-~~~I-------------  199 (394)
T 4fs7_A          142 KEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHN-----GLFSGCGKLKSIKLPRN-LKII-------------  199 (394)
T ss_dssp             SEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECT-----TTTTTCTTCCBCCCCTT-CCEE-------------
T ss_pred             cccccCc--cccccchhhhcccCCCcEEecCCcc-ceecc-----ccccCCCCceEEEcCCC-ceEe-------------
Confidence            4444333  3344667889999999999997653 44433     35888999998888765 3333             


Q ss_pred             cEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCC
Q 046544          165 KDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       165 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                                   ...+|.++..|+.+.+..+...  +...+....+|+.+.+..+. +.+...+|.++.+|+.+.+..+
T Consensus       200 -------------~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          200 -------------RDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             -------------CTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCT
T ss_pred             -------------CchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCC
Confidence                         2234455555555555444332  12222333556666655432 2244555666666666666655


Q ss_pred             cccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccc
Q 046544          245 KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTE  324 (646)
Q Consensus       245 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  324 (646)
                      ... +....|.++..++.+....+.+..  ..|..+.+|+.+.+.++ ++.+...+|.++++|+.+++..+ ++.+...+
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             cce-eeccccccccccceeccCceeecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence            433 555566666666666655543221  24555666666666544 44455667777777777777643 66677778


Q ss_pred             cCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCce
Q 046544          325 IGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDL  382 (646)
Q Consensus       325 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  382 (646)
                      |.++.+|+.+++..| ++.+...+|.++++|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            888888888888776 66566778888888888888765 33 334567777776654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=4.9e-17  Score=146.33  Aligned_cols=127  Identities=19%  Similarity=0.124  Sum_probs=83.0

Q ss_pred             CCCceeecCCCccc--ccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEE
Q 046544          258 ASLRILSLSSNELT--SIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF  335 (646)
Q Consensus       258 ~~L~~L~L~~N~l~--~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  335 (646)
                      ++|+.|++++|.++  .+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..|..++.+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34444444444444  4444444444555555555555443  4556666777777777777766667677778888888


Q ss_pred             ccCccCCCc-ccccccCCCCCCEEEccCCcCcccCC---ccccCCCCCCceeCcC
Q 046544          336 LGYNRLEGS-IPDSFGDLISLKFLNLSNNNLSGAIP---TSLEKLSYLEDLNLSF  386 (646)
Q Consensus       336 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~  386 (646)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.||+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            888888764 34777888888888888888876555   4677888888887763

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=9.5e-17  Score=144.46  Aligned_cols=126  Identities=23%  Similarity=0.271  Sum_probs=93.8

Q ss_pred             ccCcEEEeeccccc-ccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          162 HSLKDFYMSNCNVS-GGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       162 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      ++++.|++++|.++ +.+|..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666666 45667777888888888888888765  6677788888888888888876777777788888888


Q ss_pred             ecCCccccc-CCccccCCCCCceeecCCCccccccc----ccccccccccccCC
Q 046544          241 LGGNKLFGS-IPACFSNLASLRILSLSSNELTSIPL----TFWNLKDILQLNFS  289 (646)
Q Consensus       241 L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~lp~----~~~~l~~L~~L~l~  289 (646)
                      +++|++++. .+..++.+++|++|++++|.++.+|.    .+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            888888764 23677778888888888888877765    45666777777665

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=1.5e-15  Score=140.98  Aligned_cols=110  Identities=25%  Similarity=0.248  Sum_probs=76.4

Q ss_pred             cCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec
Q 046544          163 SLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG  242 (646)
Q Consensus       163 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  242 (646)
                      +++.|++++|++++..+..+..+++|++|++++|++++.++..|..+++|++|++++|+|++..+..|..+++|++|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            34444444444444455566777777777777777776666667777777777777777776666667777777777777


Q ss_pred             CCcccccCCccccCCCCCceeecCCCcccc
Q 046544          243 GNKLFGSIPACFSNLASLRILSLSSNELTS  272 (646)
Q Consensus       243 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  272 (646)
                      +|++++..+..|..+++|++|++++|.+..
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            777776666666777777777777777663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.63  E-value=2.2e-16  Score=146.40  Aligned_cols=133  Identities=20%  Similarity=0.185  Sum_probs=92.3

Q ss_pred             ccCCCCCceeecCCCccccccccccccc-ccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCC
Q 046544          254 FSNLASLRILSLSSNELTSIPLTFWNLK-DILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLE  332 (646)
Q Consensus       254 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  332 (646)
                      +.++++|+.|++++|.++.+|. +..+. +|+.|++++|.+++.  ..+..+++|+.|++++|.++++.+..|+.+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            3444555555555555555542 22322 555666666655543  4566777788888888888776656667888888


Q ss_pred             EEEccCccCCCcccc--cccCCCCCCEEEccCCcCcccCCc----cccCCCCCCceeCcCCccee
Q 046544          333 YLFLGYNRLEGSIPD--SFGDLISLKFLNLSNNNLSGAIPT----SLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       333 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +|++++|+++. +|.  .+..+++|+.|++++|.++ ..|.    .+..+++|+.||+++|....
T Consensus        92 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            88888888864 454  7888888888888888887 4555    37888888999888888764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.63  E-value=2.8e-18  Score=162.51  Aligned_cols=129  Identities=26%  Similarity=0.278  Sum_probs=64.3

Q ss_pred             CCCCeEEeecccccCcCch------hhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccccccccccccc
Q 046544          210 QKLQGLGLDDNKLEGSIPD------SICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDI  283 (646)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L  283 (646)
                      ..++.++++.+.+.+..|.      .|..+++|++|++++|++++ +| .+.++++|++|++++|.++.+|..+..+++|
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L   95 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTL   95 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHC
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcC
Confidence            3444444444444443333      66666666666666666664 34 5666666666666666666665544444455


Q ss_pred             ccccCCCCcccCCCCCccCccccceEEEcccccccccCc-cccCCCCCCCEEEccCccCC
Q 046544          284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIP-TEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       284 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      +.|++++|.+++ +| .+..+++|+.|++++|.+++..+ ..+..+++|++|++++|+++
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~  153 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence            555555544443 12 23344444444444444443221 23444444444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.62  E-value=2.9e-16  Score=145.56  Aligned_cols=111  Identities=23%  Similarity=0.227  Sum_probs=63.9

Q ss_pred             ccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCC
Q 046544          181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL  260 (646)
Q Consensus       181 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  260 (646)
                      .+.++++|+.|++++|+++.+ |......++|++|++++|.|++.  ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            345556666666666666643 33222223666666666666643  456666666666666666665555555666666


Q ss_pred             ceeecCCCccccccc--ccccccccccccCCCCccc
Q 046544          261 RILSLSSNELTSIPL--TFWNLKDILQLNFSSNFLT  294 (646)
Q Consensus       261 ~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~  294 (646)
                      ++|++++|.++.+|.  .+..+++|+.|++++|.++
T Consensus        91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            666666666666554  4444445555555555444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.61  E-value=3.4e-18  Score=161.95  Aligned_cols=155  Identities=22%  Similarity=0.284  Sum_probs=115.9

Q ss_pred             hcCCCCCcEEEecCCcccccCCc------cccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCc
Q 046544          230 ICRLTELYELELGGNKLFGSIPA------CFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN  303 (646)
Q Consensus       230 ~~~l~~L~~L~L~~N~i~~~~~~------~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  303 (646)
                      +.....++.++++.+.+.+..|.      .|..+++|++|++++|.++.+| .+..+++|+.|++++|.++ .+|..+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            55566777888888888777666      7888888888888888888887 7777888888888888887 45666677


Q ss_pred             cccceEEEcccccccccCccccCCCCCCCEEEccCccCCCccc-ccccCCCCCCEEEccCCcCcccCCcc----------
Q 046544          304 LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIPTS----------  372 (646)
Q Consensus       304 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------  372 (646)
                      +++|+.|++++|.++++ | .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..          
T Consensus        92 ~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~  169 (198)
T 1ds9_A           92 ADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             HHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred             CCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence            77888888888888764 3 57777788888888888875433 46777788888888888877665542          


Q ss_pred             ccCCCCCCceeCcCCcce
Q 046544          373 LEKLSYLEDLNLSFNKLE  390 (646)
Q Consensus       373 ~~~l~~L~~L~L~~N~l~  390 (646)
                      +..+++|+.||  +|+++
T Consensus       170 ~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          170 VKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHCSSCSEEC--CGGGT
T ss_pred             HHhCCCcEEEC--CcccC
Confidence            66777777765  55554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=5.9e-15  Score=135.74  Aligned_cols=90  Identities=21%  Similarity=0.199  Sum_probs=63.2

Q ss_pred             ccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeC
Q 046544          305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNL  384 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  384 (646)
                      +.|+.|+|++|.++++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            44556666666666666666777777777777777777666666777777777777777777666666777777777777


Q ss_pred             cCCcceeecc
Q 046544          385 SFNKLEGEIP  394 (646)
Q Consensus       385 ~~N~l~~~~p  394 (646)
                      ++|++++.++
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            7777776655

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=1.1e-14  Score=134.06  Aligned_cols=108  Identities=25%  Similarity=0.228  Sum_probs=95.6

Q ss_pred             CCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccC
Q 046544          259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGY  338 (646)
Q Consensus       259 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~  338 (646)
                      +.+.+++++|.++++|..+.  ++|+.|++++|.+++..|..|..+++|+.|+|++|+++++.+..|.++++|++|+|++
T Consensus        10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            35778888888888887664  7888899999999888888899999999999999999988888899999999999999


Q ss_pred             ccCCCcccccccCCCCCCEEEccCCcCccc
Q 046544          339 NRLEGSIPDSFGDLISLKFLNLSNNNLSGA  368 (646)
Q Consensus       339 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  368 (646)
                      |+|++..+..|..+++|+.|+|++|.++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            999988888899999999999999999854

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.5e-14  Score=133.44  Aligned_cols=90  Identities=22%  Similarity=0.279  Sum_probs=55.8

Q ss_pred             ccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeC
Q 046544          305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNL  384 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  384 (646)
                      +.|+.|+|++|.++++.|..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            34555555555555555566666666666666666666555555666666666666666666555555666666666666


Q ss_pred             cCCcceeecc
Q 046544          385 SFNKLEGEIP  394 (646)
Q Consensus       385 ~~N~l~~~~p  394 (646)
                      ++|++.+.++
T Consensus       113 ~~N~~~c~~~  122 (174)
T 2r9u_A          113 YNNPWDCECR  122 (174)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCcccccc
Confidence            6666665443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=2.5e-14  Score=131.96  Aligned_cols=106  Identities=24%  Similarity=0.243  Sum_probs=92.5

Q ss_pred             CceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          260 LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      -+.+++++|.++++|..+.  ++|+.|++++|.+++..|..|..+++|+.|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            3678888888888887664  78888888888888888888999999999999999999887788899999999999999


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcc
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                      +|++..+..|..+++|+.|+|++|.+..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccc
Confidence            9997777779999999999999999984

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.52  E-value=1.8e-12  Score=136.26  Aligned_cols=335  Identities=14%  Similarity=0.137  Sum_probs=174.1

Q ss_pred             ccccCCcCccCCC-CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCc---ccccCCccccCCCCCcEEEcccCcccc
Q 046544           22 LVGTVPAAIFNMS-MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNN---FSGTIPRFIFNASKLSILELSQNSFSG   97 (646)
Q Consensus        22 l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~   97 (646)
                      ++.+...+|.+.+ .|+.+.+-.+ ++. +...+|..+.+|+.+.++.|.   ++.....+|.++.+|+.+.+..+ ++.
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~-Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTE-IGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCE-ECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeE-EhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence            3445556666663 4777777543 432 445555566677777776553   55555666777777777666544 454


Q ss_pred             ccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeeccccccc
Q 046544           98 FIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGG  177 (646)
Q Consensus        98 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~  177 (646)
                      +...+|.++.+|+.+.+..+ ++.+..     ..|.++.+|+.+.+.++ +..+....+..   ..|+.+.+..+- ...
T Consensus       128 I~~~aF~~c~~L~~i~lp~~-~~~I~~-----~~F~~c~~L~~i~~~~~-~~~I~~~aF~~---~~l~~i~ip~~~-~~i  196 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEG-VTSVAD-----GMFSYCYSLHTVTLPDS-VTAIEERAFTG---TALTQIHIPAKV-TRI  196 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECT-----TTTTTCTTCCEEECCTT-CCEECTTTTTT---CCCSEEEECTTC-CEE
T ss_pred             ehhhhhhhhcccccccccce-eeeecc-----cceecccccccccccce-eeEeccccccc---cceeEEEECCcc-ccc
Confidence            66667777777777777543 333322     24666777777776544 33333222211   235555544322 223


Q ss_pred             CCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCC
Q 046544          178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNL  257 (646)
Q Consensus       178 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  257 (646)
                      ...+|.++.++.......+.........+........-           ...+.....+..+.+. +.+..+...+|.++
T Consensus       197 ~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c  264 (394)
T 4gt6_A          197 GTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYA-----------LIRYPSQREDPAFKIP-NGVARIETHAFDSC  264 (394)
T ss_dssp             CTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEE-----------EEECCTTCCCSEEECC-TTEEEECTTTTTTC
T ss_pred             ccchhhhccccceecccccccccccceeeccccccccc-----------ccccccccccceEEcC-CcceEcccceeeec
Confidence            34455555555555544443321111111110000000           0001112223333332 22333445566666


Q ss_pred             CCCceeecCCCcccccc-cccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEc
Q 046544          258 ASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFL  336 (646)
Q Consensus       258 ~~L~~L~L~~N~l~~lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  336 (646)
                      .+|+.+.+.++.. .++ ..|.+++.|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+
T Consensus       265 ~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i  341 (394)
T 4gt6_A          265 AYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI  341 (394)
T ss_dssp             SSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             ccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence            6666666654432 332 245556666666664 3344445566777777777777643 55566677777777777777


Q ss_pred             cCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcc
Q 046544          337 GYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL  389 (646)
Q Consensus       337 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  389 (646)
                      ..+ ++.+...+|.++++|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            544 555666777777778877777775432   3456667777777665544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.50  E-value=1.6e-12  Score=136.63  Aligned_cols=328  Identities=12%  Similarity=0.137  Sum_probs=199.1

Q ss_pred             ccCCC-CCCEEECCCCcccccCCcCccCCCCCCEEECcCCc---CcccCCccCcCCCCCCCEEEccCCcccccCCccccC
Q 046544            6 ISNLQ-NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNS---LLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFN   81 (646)
Q Consensus         6 ~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   81 (646)
                      |.+.+ .|+.+.+-.+ ++.+...+|.++++|+.+.++.|.   ++. +...+|..+.+|+.+.+..+ ++......|..
T Consensus        59 F~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~-Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~  135 (394)
T 4gt6_A           59 FCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKK-IGRQAFMFCSELTDIPILDS-VTEIDSEAFHH  135 (394)
T ss_dssp             TTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCE-ECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred             ccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeE-echhhchhcccceeeccCCc-cceehhhhhhh
Confidence            55664 5999999754 888999999999999999998874   433 45566667889998888765 55577888999


Q ss_pred             CCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcccc
Q 046544           82 ASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLS  161 (646)
Q Consensus        82 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  161 (646)
                      +.+|+.+.+..+ +..+...+|.+..+|+.+.+..+ ++.+...     +|.+ .+|+.+.+..+-. .+....+..  .
T Consensus       136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~-----aF~~-~~l~~i~ip~~~~-~i~~~af~~--c  204 (394)
T 4gt6_A          136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER-----AFTG-TALTQIHIPAKVT-RIGTNAFSE--C  204 (394)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTT-CCCSEEEECTTCC-EECTTTTTT--C
T ss_pred             hcccccccccce-eeeecccceecccccccccccce-eeEeccc-----cccc-cceeEEEECCccc-ccccchhhh--c
Confidence            999999999755 55588889999999999999765 5554432     3443 5688888865532 222222211  2


Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      ..++......+......-..+........           ....+.....+..+.+.. .+..+...+|.++.+|+.+.+
T Consensus       205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~l  272 (394)
T 4gt6_A          205 FALSTITSDSESYPAIDNVLYEKSANGDY-----------ALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKM  272 (394)
T ss_dssp             TTCCEEEECCSSSCBSSSCEEEECTTSCE-----------EEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEEC
T ss_pred             cccceecccccccccccceeecccccccc-----------cccccccccccceEEcCC-cceEcccceeeecccccEEec
Confidence            34555555444333211111111110000           000111222333333332 223344555666666666666


Q ss_pred             cCCcccccCCccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEccccccccc
Q 046544          242 GGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  320 (646)
                      ..+.. .+...+|.++++|+.+.+. +.+++++. .|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus       273 p~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I  348 (394)
T 4gt6_A          273 PDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKI  348 (394)
T ss_dssp             CTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBC
T ss_pred             ccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEE
Confidence            54433 2555566666666666664 44555544 4555666666666544 44455677888888888888644 7767


Q ss_pred             CccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       321 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      ...+|.++.+|+.+++.+|...   -..|....+|+.+.+..|.+.
T Consensus       349 ~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          349 PESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             CGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC-----------
T ss_pred             hHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCEE
Confidence            7788888899999998887653   246777788888888776543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.43  E-value=1.5e-13  Score=142.02  Aligned_cols=93  Identities=26%  Similarity=0.233  Sum_probs=54.3

Q ss_pred             cCccccceEEEccc-ccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCC
Q 046544          301 IGNLKVLIGIDFSM-NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL  379 (646)
Q Consensus       301 ~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  379 (646)
                      +..+++|+.|+|++ |.|+++.+..|+++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..+..|..++ |
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L  105 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L  105 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence            44455555555553 555555555566666666666666666655555666666666666666666654444455444 6


Q ss_pred             CceeCcCCcceeecc
Q 046544          380 EDLNLSFNKLEGEIP  394 (646)
Q Consensus       380 ~~L~L~~N~l~~~~p  394 (646)
                      +.|+|++|+|.+.++
T Consensus       106 ~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A          106 QELVLSGNPLHCSCA  120 (347)
T ss_dssp             CEEECCSSCCCCCGG
T ss_pred             eEEEeeCCCccCCCc
Confidence            666666666665443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=8e-16  Score=159.93  Aligned_cols=150  Identities=15%  Similarity=0.095  Sum_probs=73.8

Q ss_pred             CCCCEEEccCCcccccCCcccc-CCCCCcEEEcccCccccccCccc-----cCcCCCCEEEccCCCCCCCCCcccccccC
Q 046544           59 PNLEALLLWGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTF-----GNLRNLEWLNLRDNYLTSSTPELSFLSSL  132 (646)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~l  132 (646)
                      ++|++|+|++|.|+......+. .+++|++|+|++|.|++.....+     ...++|++|+|++|.|+...... +...+
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~-l~~~L  179 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAV-LMEGL  179 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHH-HHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHH-HHHHH
Confidence            4566666666665533222222 34456666666666654433333     23456666677666665421111 22334


Q ss_pred             CCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCcccccc----CccccC
Q 046544          133 SNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSI----PITLSK  208 (646)
Q Consensus       133 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~  208 (646)
                      ..+++|++|+|++|.|......                      .++..+...++|++|+|++|.|+...    +..+..
T Consensus       180 ~~~~~L~~L~Ls~N~l~~~g~~----------------------~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~  237 (372)
T 3un9_A          180 AGNTSVTHLSLLHTGLGDEGLE----------------------LLAAQLDRNRQLQELNVAYNGAGDTAALALARAARE  237 (372)
T ss_dssp             HTCSSCCEEECTTSSCHHHHHH----------------------HHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHH
T ss_pred             hcCCCcCEEeCCCCCCCcHHHH----------------------HHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHh
Confidence            5566677777777766432100                      11233344445555555555554321    222334


Q ss_pred             CCCCCeEEeecccccCcCchhhc
Q 046544          209 LQKLQGLGLDDNKLEGSIPDSIC  231 (646)
Q Consensus       209 l~~L~~L~L~~N~l~~~~~~~~~  231 (646)
                      .++|++|+|++|.|++.....+.
T Consensus       238 ~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          238 HPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             CSSCCEEECTTSSCCHHHHHHHH
T ss_pred             CCCCCEEeccCCCCCHHHHHHHH
Confidence            45566666666666544444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.41  E-value=1.6e-13  Score=141.74  Aligned_cols=132  Identities=19%  Similarity=0.116  Sum_probs=93.6

Q ss_pred             eeecCCC-cccccccccccccccccccCCC-CcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          262 ILSLSSN-ELTSIPLTFWNLKDILQLNFSS-NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       262 ~L~L~~N-~l~~lp~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      .++++++ .|+.+|. +..+++|+.|+|++ |.+++..+..|.++++|+.|+|++|+|+++.|..|+++++|++|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            4566776 7777777 77777777777775 7777766677888888888888888888888888888888888888888


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCC-ccccCCCCCCceeCcCCcceeeccC
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIP-TSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      +|++.++..|..++ |+.|+|++|.+...-. .+|..+.......+..+.++|..|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            88877777777666 8888888888874221 1222222223334455667665554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.35  E-value=2.9e-14  Score=148.14  Aligned_cols=162  Identities=18%  Similarity=0.171  Sum_probs=95.6

Q ss_pred             CCCCeEEeecccccCcCchhhcCC-----CCCcEEEecCCcccccCCccc-cCCCCCceeecCCCccccccc-ccccccc
Q 046544          210 QKLQGLGLDDNKLEGSIPDSICRL-----TELYELELGGNKLFGSIPACF-SNLASLRILSLSSNELTSIPL-TFWNLKD  282 (646)
Q Consensus       210 ~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~lp~-~~~~l~~  282 (646)
                      +.|+.|+|++|.|+......+...     ++|++|+|++|.++......+ ..+++|+.|+|++|.|+.... .+..   
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~---  148 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD---  148 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH---
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH---
Confidence            456666666666664333333322     456666666666643322222 234455556666555543221 1110   


Q ss_pred             cccccCCCCcccCCCCCcc-CccccceEEEccccccccc----CccccCCCCCCCEEEccCccCCCcc----cccccCCC
Q 046544          283 ILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNFSSV----IPTEIGGLKNLEYLFLGYNRLEGSI----PDSFGDLI  353 (646)
Q Consensus       283 L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~  353 (646)
                                       .+ ...+.|+.|+|++|.++..    ++..+..+++|++|+|++|.|++..    +..+...+
T Consensus       149 -----------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          149 -----------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             -----------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             -----------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence                             01 1234566777777766542    2334466778888888888887532    55667777


Q ss_pred             CCCEEEccCCcCccc----CCccccCCCCCCceeCcCCccee
Q 046544          354 SLKFLNLSNNNLSGA----IPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       354 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +|++|+|++|.|+..    ++..+...++|++|+|++|+++.
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            888888888888753    33445566888888888888875

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.34  E-value=8.4e-11  Score=122.87  Aligned_cols=315  Identities=10%  Similarity=0.059  Sum_probs=159.2

Q ss_pred             ccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCC
Q 046544            6 ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKL   85 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (646)
                      +..-.+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++. +...+|... +|+.+.+..+ ++.....+|.. .+|
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~-Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L  115 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTS-IGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL  115 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCE-ECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceE-echhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence            33445677777753 366677777777777777777644 443 444444443 5666666543 44344445544 367


Q ss_pred             cEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCc
Q 046544           86 SILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLK  165 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  165 (646)
                      +.+++..+ +..+...+|.+. +|+...+-.+ ++.+..     ..|.++.+++...+..+..........         
T Consensus       116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~-----~~f~~~~~l~~~~~~~~~~~~~~~~~~---------  178 (379)
T 4h09_A          116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKD-----GIGYKAENLEKIEVSSNNKNYVAENYV---------  178 (379)
T ss_dssp             SEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECS-----CTTTTCTTCCEEEECTTCSSEEEETTE---------
T ss_pred             ccccCCCc-cccccccccccc-eeeeeeccce-eecccc-----chhcccccccccccccccceeecccce---------
Confidence            77777654 333555566554 4555554432 333221     235666667666665544322110000         


Q ss_pred             EEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCc
Q 046544          166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK  245 (646)
Q Consensus       166 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  245 (646)
                        ....+.   .....+.....+..+.+..+.- ......+....+|+.+.+..+ +..+...+|.++.+|+.+.+..+ 
T Consensus       179 --~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-  250 (379)
T 4h09_A          179 --LYNKNK---TILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-  250 (379)
T ss_dssp             --EEETTS---SEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-
T ss_pred             --eccccc---ceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-
Confidence              000000   0112223333334333333221 133344444455555555433 22244444555555555555443 


Q ss_pred             ccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCcccc
Q 046544          246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEI  325 (646)
Q Consensus       246 i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  325 (646)
                      ++.+...+|.++.+|+.+.+..+ ++.                       .....|.++++|+.+++.++.++.+...+|
T Consensus       251 v~~I~~~aF~~~~~l~~i~l~~~-i~~-----------------------i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF  306 (379)
T 4h09_A          251 VTSIGSFLLQNCTALKTLNFYAK-VKT-----------------------VPYLLCSGCSNLTKVVMDNSAIETLEPRVF  306 (379)
T ss_dssp             CCEECTTTTTTCTTCCEEEECCC-CSE-----------------------ECTTTTTTCTTCCEEEECCTTCCEECTTTT
T ss_pred             ccEeCccccceeehhcccccccc-cee-----------------------ccccccccccccccccccccccceehhhhh
Confidence            33344445555555555544322 332                       333455556666666666666665666666


Q ss_pred             CCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCC
Q 046544          326 GGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS  377 (646)
Q Consensus       326 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  377 (646)
                      .++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+-..+|.+..
T Consensus       307 ~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          307 MDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             TTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred             cCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence            66666776666544 55455566777777777766544 5545555665553

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=3.5e-12  Score=126.18  Aligned_cols=146  Identities=14%  Similarity=0.056  Sum_probs=113.7

Q ss_pred             HHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEE
Q 046544          489 RATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       489 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ....+|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..++++++++...+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            44567888888888899999999754 6789999987532222345788999999884 677889999998888999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG---------------------------------------  608 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------------------------------------  608 (646)
                      ||++|.++.+.+..      ......++.+++++++.||..                                       
T Consensus        90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999876321      112346888999999999951                                       


Q ss_pred             -----------------CCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          609 -----------------CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       609 -----------------~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                                       ....++|+|++|.||+++++..+.|+||+.|..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             014589999999999998776678999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.30  E-value=2.1e-10  Score=119.85  Aligned_cols=299  Identities=13%  Similarity=0.107  Sum_probs=175.1

Q ss_pred             CCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCC
Q 046544           59 PNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL  138 (646)
Q Consensus        59 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  138 (646)
                      .+|+.+.+.. .++.....+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...     +|.++ +|
T Consensus        46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~-----aF~~~-~L  115 (379)
T 4h09_A           46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDY-----VFQGT-DL  115 (379)
T ss_dssp             GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTT-----TTTTC-CC
T ss_pred             cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccc-----eeccC-Cc
Confidence            3455555543 344455556666666666666543 555666666665 4555555432 3333221     23333 56


Q ss_pred             CEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEee
Q 046544          139 TFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD  218 (646)
Q Consensus       139 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  218 (646)
                      +.+.+..+ +..+....+..   .+++...+.. .++.+...+|....+++.+.+..+.........+           .
T Consensus       116 ~~i~lp~~-~~~i~~~~F~~---~~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-----------~  179 (379)
T 4h09_A          116 DDFEFPGA-TTEIGNYIFYN---SSVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-----------L  179 (379)
T ss_dssp             SEEECCTT-CCEECTTTTTT---CCCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-----------E
T ss_pred             ccccCCCc-ccccccccccc---ceeeeeeccc-eeeccccchhcccccccccccccccceeecccce-----------e
Confidence            66666543 22222111111   1233333322 2222334445555555555544433221110000           0


Q ss_pred             cccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccc-cccccccccccccCCCCcccCCC
Q 046544          219 DNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP-LTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       219 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      .+.. ......+.....+....+..+.. ......|....+|+.+.+..+ ++.++ ..|.+...|+.+.+..+ ++.+.
T Consensus       180 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~  255 (379)
T 4h09_A          180 YNKN-KTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIG  255 (379)
T ss_dssp             EETT-SSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEEC
T ss_pred             cccc-cceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeC
Confidence            0000 11223344445555555544332 245556666777777777544 44443 34666777777777665 44456


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCC
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS  377 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  377 (646)
                      ..+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|.++ ++.+-..+|.+++
T Consensus       256 ~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~  333 (379)
T 4h09_A          256 SFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK  333 (379)
T ss_dssp             TTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             ccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence            678888899999998654 66677789999999999999999998778899999999999999866 7767778999999


Q ss_pred             CCCceeCcCCcce
Q 046544          378 YLEDLNLSFNKLE  390 (646)
Q Consensus       378 ~L~~L~L~~N~l~  390 (646)
                      +|+.+.+..+ ++
T Consensus       334 ~L~~i~ip~~-v~  345 (379)
T 4h09_A          334 ALSTISYPKS-IT  345 (379)
T ss_dssp             TCCCCCCCTT-CC
T ss_pred             CCCEEEECCc-cC
Confidence            9999998765 44

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=3.6e-11  Score=118.62  Aligned_cols=137  Identities=16%  Similarity=0.075  Sum_probs=100.7

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCC--ceeEEEEEecCCeeEEEEEec
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN--LIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++......+.|..+.||++...+|+.+++|+....   ....+.+|+++++.+++.+  +++++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333456669999998777888999987643   2245678999998885444  566888888888899999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC-----------------------------------------  609 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----------------------------------------  609 (646)
                      +|.++.  .. .   .+   ...++.++++.+..+|...                                         
T Consensus        98 ~G~~l~--~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  21 1   12   2357788888888888421                                         


Q ss_pred             --------------CCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          610 --------------LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       610 --------------~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                                    ...++|+|++|.||++++++.++|+|||.|..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          11299999999999998877778999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=1e-09  Score=113.60  Aligned_cols=143  Identities=14%  Similarity=0.160  Sum_probs=105.3

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEe--ccC-CchHHHHHHHHHHHHhCC--CCCceeEEEEEecC---CeeEEE
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFN--LQC-GRAFKSFAVECEMMKSIR--HRNLIKVISSCSNE---EFKALV  566 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~---~~~~lv  566 (646)
                      ...+.++.|.++.||+.+..+ ..+++|+..  ... ......+.+|+++++.++  +..+++++.++...   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            345788999999999998754 578888765  322 122346778999999886  45678888888766   458999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC-------------------------------------  609 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------  609 (646)
                      |||++|..+.+...   ..++..+...++.++++++..||...                                     
T Consensus       120 me~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987754211   23567778889999999999999520                                     


Q ss_pred             ------------------CCCeEecCCCCCCEEEcCCC--cEEEEeecCccc
Q 046544          610 ------------------LAPVIHCDLKPDNVLLDDNL--VAYLSDFGIAKL  641 (646)
Q Consensus       610 ------------------~~~iiHrdlk~~Nil~~~~~--~~ki~DfGla~~  641 (646)
                                        ...++|+|+++.||+++.++  .+.|+||+.|..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              25699999999999998765  368999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.95  E-value=1.5e-10  Score=119.23  Aligned_cols=84  Identities=21%  Similarity=0.216  Sum_probs=59.6

Q ss_pred             ccccceEEEcccccccccCcccc---CCCCCCCEEEccCccCCCcc----cccccCCCCCCEEEccCCcCcccCCccccC
Q 046544          303 NLKVLIGIDFSMNNFSSVIPTEI---GGLKNLEYLFLGYNRLEGSI----PDSFGDLISLKFLNLSNNNLSGAIPTSLEK  375 (646)
Q Consensus       303 ~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  375 (646)
                      .+++|+.|+|++|.++...+..+   ..+++|++|+|+.|.+.+..    +..+..+++|+.|+|++|.|+...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            46788888888888764333222   35788999999999988643    333456789999999999988654444443


Q ss_pred             -CCCCCceeCcCCc
Q 046544          376 -LSYLEDLNLSFNK  388 (646)
Q Consensus       376 -l~~L~~L~L~~N~  388 (646)
                       +  ...+++++|+
T Consensus       330 al--g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL--PMKIDVSDSQ  341 (362)
T ss_dssp             HC--CSEEECCSBC
T ss_pred             Hc--CCEEEecCCc
Confidence             3  4668998887

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.88  E-value=4.5e-10  Score=115.61  Aligned_cols=184  Identities=18%  Similarity=0.213  Sum_probs=104.2

Q ss_pred             CCCCEEEccCCcccc-c-------cCccccCCCCCCeEEeeccccc---------CcCchhhcCCCCCcEEEecCCcccc
Q 046544          186 TNSITIDLGGNKLNG-S-------IPITLSKLQKLQGLGLDDNKLE---------GSIPDSICRLTELYELELGGNKLFG  248 (646)
Q Consensus       186 ~~L~~L~L~~N~l~~-~-------~~~~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~i~~  248 (646)
                      +.++.|.+......+ .       ...+...+++|+.|.+.++...         +.++..+..+++|+.|+|++|.-. 
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence            345667777554331 1       1122345677888877655321         123345566677777777766311 


Q ss_pred             cCCccccCCCCCceeecCCCcccccc-cccc--cccccccccCCC--CcccCCCCCccCccccceEEEcccccccccCcc
Q 046544          249 SIPACFSNLASLRILSLSSNELTSIP-LTFW--NLKDILQLNFSS--NFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT  323 (646)
Q Consensus       249 ~~~~~~~~l~~L~~L~L~~N~l~~lp-~~~~--~l~~L~~L~l~~--N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  323 (646)
                      ..+. +. +++|+.|++..|.++.-. ..+.  .+++|+.|+|+.  |...+.  .                .+..+ ..
T Consensus       186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~--~----------------~~~~l-~~  244 (362)
T 2ra8_A          186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD--G----------------DMNVF-RP  244 (362)
T ss_dssp             BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCC--S----------------CGGGT-GG
T ss_pred             eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccc--h----------------hHHHH-HH
Confidence            1122 32 566777777666654211 1111  344444444431  111100  0                01111 11


Q ss_pred             cc--CCCCCCCEEEccCccCCCcccccc---cCCCCCCEEEccCCcCccc----CCccccCCCCCCceeCcCCccee
Q 046544          324 EI--GGLKNLEYLFLGYNRLEGSIPDSF---GDLISLKFLNLSNNNLSGA----IPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       324 ~~--~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      .+  ..+++|+.|+|++|.+.+..+..+   ..+++|++|+|+.|.+++.    ++..+..+++|+.|+|++|.++.
T Consensus       245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            12  357899999999999875444333   3578999999999999864    34445667999999999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.50  E-value=2.7e-07  Score=92.91  Aligned_cols=136  Identities=21%  Similarity=0.218  Sum_probs=97.4

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhC-CCCC--ceeEEEEEecCC---eeEEEEEec
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSI-RHRN--LIKVISSCSNEE---FKALVLEYK  570 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~n--iv~~~~~~~~~~---~~~lv~e~~  570 (646)
                      .+.++.|.+..||+..    ..+++|+....  .....+.+|+++++.+ .+..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999763    45888875422  3346788899999887 3333  445555543333   458999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------  608 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------------------------  608 (646)
                      +|.++.+....   .++..+...++.++++.++.+|..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654332   356667777888888888888841                                          


Q ss_pred             -------------CCCCeEecCCCCCCEEEcC--CCcEEEEeecCccc
Q 046544          609 -------------CLAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKL  641 (646)
Q Consensus       609 -------------~~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~  641 (646)
                                   ....++|+|++|.||++++  +..+.++||+.|..
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                         1135799999999999987  56788999998764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=1.3e-08  Score=94.41  Aligned_cols=62  Identities=16%  Similarity=0.192  Sum_probs=26.2

Q ss_pred             CCCCCEEEccCCccccc----cCccccCCCCCCeEEe--ecccccCc----CchhhcCCCCCcEEEecCCcc
Q 046544          185 LTNSITIDLGGNKLNGS----IPITLSKLQKLQGLGL--DDNKLEGS----IPDSICRLTELYELELGGNKL  246 (646)
Q Consensus       185 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i  246 (646)
                      .++|++|+|++|.|...    +...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+
T Consensus        92 n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A           92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence            34444444444444322    1223333444555555  44444432    122233334455555555544

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.48  E-value=1.9e-08  Score=98.10  Aligned_cols=79  Identities=24%  Similarity=0.301  Sum_probs=40.1

Q ss_pred             cccceEEEccccccccc--CccccCCCCCCCEEEccCccCCCcc-cccccCCCCCCEEEccCCcCcccCCc-------cc
Q 046544          304 LKVLIGIDFSMNNFSSV--IPTEIGGLKNLEYLFLGYNRLEGSI-PDSFGDLISLKFLNLSNNNLSGAIPT-------SL  373 (646)
Q Consensus       304 l~~L~~L~ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~  373 (646)
                      +++|+.|+|++|+|+++  +|..++.+++|+.|+|++|+|++.. -+.+..+ +|++|+|++|.+++..|.       .+
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il  247 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIR  247 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHHH
Confidence            44555555555555542  2344445566666666666665431 1122222 566666666666554441       34


Q ss_pred             cCCCCCCcee
Q 046544          374 EKLSYLEDLN  383 (646)
Q Consensus       374 ~~l~~L~~L~  383 (646)
                      ..+++|+.||
T Consensus       248 ~~~P~L~~LD  257 (267)
T 3rw6_A          248 ERFPKLLRLD  257 (267)
T ss_dssp             HHCTTCCEES
T ss_pred             HHCcccCeEC
Confidence            5556665554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=3.5e-08  Score=91.47  Aligned_cols=92  Identities=14%  Similarity=0.135  Sum_probs=51.2

Q ss_pred             cccccCCCCCEEEccCC-ccccc----cCccccCCCCCCeEEeecccccCc----CchhhcCCCCCcEEEecCCccccc-
Q 046544          180 EEITNLTNSITIDLGGN-KLNGS----IPITLSKLQKLQGLGLDDNKLEGS----IPDSICRLTELYELELGGNKLFGS-  249 (646)
Q Consensus       180 ~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~-  249 (646)
                      ..+...++|++|+|++| .+...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|... 
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            34455566666666666 66432    223344456666666666666532    233344445666666666666532 


Q ss_pred             ---CCccccCCCCCceeec--CCCccc
Q 046544          250 ---IPACFSNLASLRILSL--SSNELT  271 (646)
Q Consensus       250 ---~~~~~~~l~~L~~L~L--~~N~l~  271 (646)
                         +...+...++|++|+|  ++|.|.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence               2334455556666666  556665

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.5e-06  Score=87.40  Aligned_cols=136  Identities=14%  Similarity=0.091  Sum_probs=93.2

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCC---CceeEEEEEe-cCCeeEEEEEecCC
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR---NLIKVISSCS-NEEFKALVLEYKPH  572 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~  572 (646)
                      .+.++.|....||+.    |..+++|+..  .......+.+|+++++.+++.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            466888888899987    5668888742  223346788999999998653   3567777764 45668899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  608 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------  608 (646)
                      ..+.+....   .++..+...++.++++.+..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887663221   123444445555555555555521                                            


Q ss_pred             -------------CCCCeEecCCCCCCEEEcC---CCc-EEEEeecCccc
Q 046544          609 -------------CLAPVIHCDLKPDNVLLDD---NLV-AYLSDFGIAKL  641 (646)
Q Consensus       609 -------------~~~~iiHrdlk~~Nil~~~---~~~-~ki~DfGla~~  641 (646)
                                   ....++|+|+++.||+++.   ++. +.|+||+.|..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1345799999999999987   344 58999998754

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.39  E-value=7.1e-08  Score=94.06  Aligned_cols=61  Identities=26%  Similarity=0.374  Sum_probs=26.3

Q ss_pred             CCCCCeEEeecccccC--cCchhhcCCCCCcEEEecCCcccccCCccccCCC--CCceeecCCCccc
Q 046544          209 LQKLQGLGLDDNKLEG--SIPDSICRLTELYELELGGNKLFGSIPACFSNLA--SLRILSLSSNELT  271 (646)
Q Consensus       209 l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~  271 (646)
                      +++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+.
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence            3444444444444443  2223344444455555555544432  1122222  4555555555544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=3.9e-06  Score=82.71  Aligned_cols=135  Identities=18%  Similarity=0.071  Sum_probs=96.3

Q ss_pred             eecccccc-eEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          499 LIGRGGFG-SVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       499 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      .+..|..| .||+.... ++..+++|+....   ....+.+|+..++.+. +--+.++++++...+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 68987754 4677899986533   3456778999888774 33467888899888999999999999888


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----------------------------------------------  608 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----------------------------------------------  608 (646)
                      .+......     .....++.+++..+.-||..                                               
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77653321     12334556666666666621                                               


Q ss_pred             --------CCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          609 --------CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       609 --------~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                              ....++|+|+.+.||++++++.+-|+||+.|..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    011379999999999999888788999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=1.8e-06  Score=89.03  Aligned_cols=80  Identities=6%  Similarity=-0.068  Sum_probs=55.1

Q ss_pred             ceee-cccccceEEEEEeC-------CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCC-C--CCceeEEEEEecC--
Q 046544          497 NNLI-GRGGFGSVYKARLG-------DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIR-H--RNLIKVISSCSNE--  560 (646)
Q Consensus       497 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H--~niv~~~~~~~~~--  560 (646)
                      .+.+ +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.++ +  -.+.+++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3667 88889999988754       26678889765332   101245677888888774 2  3567788877655  


Q ss_pred             -CeeEEEEEecCCCCHH
Q 046544          561 -EFKALVLEYKPHGSLE  576 (646)
Q Consensus       561 -~~~~lv~e~~~~g~L~  576 (646)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             4578999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.96  E-value=2.7e-05  Score=81.36  Aligned_cols=75  Identities=16%  Similarity=0.123  Sum_probs=49.6

Q ss_pred             ceeecccccceEEEEEeC-CCcEEEEEEEeccCC-------chHHHHHHHHHHHHhCCC--C-CceeEEEEEecCCeeEE
Q 046544          497 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-------RAFKSFAVECEMMKSIRH--R-NLIKVISSCSNEEFKAL  565 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H--~-niv~~~~~~~~~~~~~l  565 (646)
                      .+.+|.|.++.||+++.. +++.|++|.......       ....++..|+++++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567899999999999754 568899997653211       123456778888887632  3 34466654  3445689


Q ss_pred             EEEecCCC
Q 046544          566 VLEYKPHG  573 (646)
Q Consensus       566 v~e~~~~g  573 (646)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.95  E-value=4e-06  Score=75.75  Aligned_cols=84  Identities=19%  Similarity=0.135  Sum_probs=61.6

Q ss_pred             ccceEEEcccccccccCccccCCCCCCCEEEccCcc-CCCcccccccCC----CCCCEEEccCC-cCcccCCccccCCCC
Q 046544          305 KVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR-LEGSIPDSFGDL----ISLKFLNLSNN-NLSGAIPTSLEKLSY  378 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N-~l~~~~p~~~~~l~~  378 (646)
                      ..|+.||++++.++...-..+.++++|++|+|++|. +++..-..++.+    ++|+.|+|++| +||..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            467888888888776666677788888888888885 665555556654    36888888887 477654456777888


Q ss_pred             CCceeCcCCc
Q 046544          379 LEDLNLSFNK  388 (646)
Q Consensus       379 L~~L~L~~N~  388 (646)
                      |++|++++.+
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888888765

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.87  E-value=5.7e-06  Score=74.71  Aligned_cols=83  Identities=16%  Similarity=0.128  Sum_probs=48.8

Q ss_pred             CCCEEEccCCccccccCccccCCCCCCeEEeeccc-ccCcCchhhcCC----CCCcEEEecCCc-ccccCCccccCCCCC
Q 046544          187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK-LEGSIPDSICRL----TELYELELGGNK-LFGSIPACFSNLASL  260 (646)
Q Consensus       187 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~~~~~~l~~L  260 (646)
                      .|+.||++++.++...-..+.++++|++|+|++|. |++..-..+..+    ++|++|+|++|. |+...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45666666666554444455666677777777764 554333344443    257777777764 554444455666777


Q ss_pred             ceeecCCCc
Q 046544          261 RILSLSSNE  269 (646)
Q Consensus       261 ~~L~L~~N~  269 (646)
                      +.|+++++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            777777663

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=5.2e-05  Score=77.30  Aligned_cols=140  Identities=15%  Similarity=0.112  Sum_probs=77.9

Q ss_pred             ceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC--CCCceeEEE------EEecCCeeEEEEE
Q 046544          497 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR--HRNLIKVIS------SCSNEEFKALVLE  568 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~~~~------~~~~~~~~~lv~e  568 (646)
                      .+.++.|..+.||+....+| .+++|+....    ......|..+++.+.  .-.+++++.      +....+..++|||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677899999987555 4889988742    123334555554442  112333332      1124567899999


Q ss_pred             ecCCCCHH-----------HH---Hhh--CCC--C---------CCHHHH------------------------------
Q 046544          569 YKPHGSLE-----------KY---LYS--SNC--I---------LDIFQR------------------------------  591 (646)
Q Consensus       569 ~~~~g~L~-----------~~---l~~--~~~--~---------l~~~~~------------------------------  591 (646)
                      |++|..+.           +.   ++.  ...  +         ..|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986431           00   110  100  0         112110                              


Q ss_pred             -HHHHHHHHHHHHHHhc----------CCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          592 -LNIMIDVASALEYLHF----------GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       592 -~~i~~~i~~~l~~lH~----------~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                       ..+..++.+++++++.          .....++|+|+++.||+++.++.+.++||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0111223345666652          0256899999999999998788999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=0.00016  Score=72.37  Aligned_cols=138  Identities=13%  Similarity=0.096  Sum_probs=91.8

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC---CCCceeEEEEEecCCeeEEEEEecC
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ...+.++.|.+..+|+... ++..+++|+....   ....+.+|++.++.+.   ...+++++.++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3457789999999999886 4677889987643   3456788998888873   3668889988888888999999999


Q ss_pred             CCCHH--------HH---HhhCCC---------------------CCCHHHHH---HHHH----------------HHHH
Q 046544          572 HGSLE--------KY---LYSSNC---------------------ILDIFQRL---NIMI----------------DVAS  600 (646)
Q Consensus       572 ~g~L~--------~~---l~~~~~---------------------~l~~~~~~---~i~~----------------~i~~  600 (646)
                      |..+.        +.   ++....                     .-+|.+..   ++..                ++++
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87541        11   111110                     01343221   1111                1111


Q ss_pred             H-HHHHh-cCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 046544          601 A-LEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFG  637 (646)
Q Consensus       601 ~-l~~lH-~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfG  637 (646)
                      . ...+. ....+.++|+|+.+.|++++.++ +.|.||+
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 12332 12246799999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.59  E-value=0.00024  Score=70.47  Aligned_cols=78  Identities=15%  Similarity=0.114  Sum_probs=56.9

Q ss_pred             CCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC---CCceeEEEEEecCCeeEEEEEe
Q 046544          493 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH---RNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .....+.+|.|..+.||+.+..+|+.|.+|+...........|.+|++.|+.+.-   --+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3455678899999999999999999999998765443334567889999888742   2345555542    34789999


Q ss_pred             cCCCC
Q 046544          570 KPHGS  574 (646)
Q Consensus       570 ~~~g~  574 (646)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.52  E-value=2e-05  Score=72.49  Aligned_cols=87  Identities=16%  Similarity=0.190  Sum_probs=44.4

Q ss_pred             CCCCEEEccCC-cccc----cCCccccCCCCCcEEEcccCccccccCccc----cCcCCCCEEEccCCCCCCCCCccccc
Q 046544           59 PNLEALLLWGN-NFSG----TIPRFIFNASKLSILELSQNSFSGFIPNTF----GNLRNLEWLNLRDNYLTSSTPELSFL  129 (646)
Q Consensus        59 ~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~  129 (646)
                      +.|++|+|++| +|..    .+-+.+..-+.|+.|+|++|+|.+.....+    ..-+.|++|+|++|.|...... .+.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~-ala  119 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA-RLL  119 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH-HHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH-HHH
Confidence            34555555553 4432    123344455566666666666664332222    2335566666666666532211 123


Q ss_pred             ccCCCCCCCCEEECCCC
Q 046544          130 SSLSNCKSLTFIHLSDN  146 (646)
Q Consensus       130 ~~l~~l~~L~~L~Ls~N  146 (646)
                      ..+..-+.|++|+|++|
T Consensus       120 ~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          120 RSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHTTTTCCCSEEECCCC
T ss_pred             HHHhhCCceeEEECCCC
Confidence            34555556666666644

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.49  E-value=0.00035  Score=73.42  Aligned_cols=74  Identities=11%  Similarity=0.059  Sum_probs=45.7

Q ss_pred             cceeecccccceEEEEEeCCCcEEEEEEEecc----CCc-----hHHHHHHHHHHHH-hCCCCCceeEEEEEecCCeeEE
Q 046544          496 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ----CGR-----AFKSFAVECEMMK-SIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~-----~~~~~~~e~~~l~-~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      ..+.+|.|..+.||++.. +++.++||.....    ...     ....+..|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            357789999999999965 5678999943211    000     2223333433222 22334567777665  466789


Q ss_pred             EEEec-CC
Q 046544          566 VLEYK-PH  572 (646)
Q Consensus       566 v~e~~-~~  572 (646)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.42  E-value=0.00021  Score=61.40  Aligned_cols=57  Identities=28%  Similarity=0.350  Sum_probs=29.2

Q ss_pred             EEEccCccCC-CcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          333 YLFLGYNRLE-GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       333 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            4555555554 12332221  245666666666665555555666666555555554444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.23  E-value=0.0011  Score=66.88  Aligned_cols=156  Identities=16%  Similarity=0.120  Sum_probs=84.0

Q ss_pred             ccHHHHHHHhCCCCc-----ceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCC--ceeEE
Q 046544          482 FSYLELCRATNGFSE-----NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN--LIKVI  554 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~~~  554 (646)
                      .+.+++......|..     .+.++.|....+|+....+| .+++|+.....  ..+.+..|..+++.+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            334455555555543     34567788889999987655 57889886521  1234455777766653212  23333


Q ss_pred             EE------EecCCeeEEEEEecCCCCHHH----H----------Hhh----CCCC----CC---HHHHHH----------
Q 046544          555 SS------CSNEEFKALVLEYKPHGSLEK----Y----------LYS----SNCI----LD---IFQRLN----------  593 (646)
Q Consensus       555 ~~------~~~~~~~~lv~e~~~~g~L~~----~----------l~~----~~~~----l~---~~~~~~----------  593 (646)
                      ..      ....+..+++|+|++|..+..    .          ++.    ....    ..   |.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999999864310    0          111    0000    01   111000          


Q ss_pred             --HHHHHHHHHHHHhc----CCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          594 --IMIDVASALEYLHF----GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       594 --i~~~i~~~l~~lH~----~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                        +...+.+.+++++.    ....+++|+|+.+.||++++++.+.++||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              00113334455441    123578999999999999987667899998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.18  E-value=0.0025  Score=64.46  Aligned_cols=139  Identities=12%  Similarity=0.080  Sum_probs=71.6

Q ss_pred             eeecccccce-EEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC--CCCceeEEEEEecCCeeEEEEEecCCCC
Q 046544          498 NLIGRGGFGS-VYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       498 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      +.++.|.... +|+....+|+.+++|.......   ..+..|+.+++.+.  .-.+.+++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4455555444 6677654467777775543221   22334666665553  223556776644444  68999997766


Q ss_pred             HHHHHhhCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 046544          575 LEKYLYSSN-------------------------CILDIFQRL-------N-I------------MIDVASALEYLH---  606 (646)
Q Consensus       575 L~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~~i~~~l~~lH---  606 (646)
                      +.+.+....                         ...+.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         011111100       0 0            001111222221   


Q ss_pred             cCCCCCeEecCCCCCCEEEcCC----CcEEEEeecCccc
Q 046544          607 FGCLAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKL  641 (646)
Q Consensus       607 ~~~~~~iiHrdlk~~Nil~~~~----~~~ki~DfGla~~  641 (646)
                      ......++|+|+.+.||+++.+    +.+.|+||+.|..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125679999999999999874    6899999998764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.17  E-value=5.6e-05  Score=69.56  Aligned_cols=13  Identities=8%  Similarity=0.010  Sum_probs=6.0

Q ss_pred             CCCCcEEEecCCc
Q 046544          233 LTELYELELGGNK  245 (646)
Q Consensus       233 l~~L~~L~L~~N~  245 (646)
                      -+.|+.|+++.|.
T Consensus       156 N~tL~~L~l~~~~  168 (197)
T 1pgv_A          156 NESLLRVGISFAS  168 (197)
T ss_dssp             CSSCCEEECCCCC
T ss_pred             CCCcCeEeccCCC
Confidence            3444445444443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.07  E-value=0.0012  Score=65.76  Aligned_cols=74  Identities=11%  Similarity=0.087  Sum_probs=44.8

Q ss_pred             CCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCc-eeEEEEEecCCeeEEEEEec-C
Q 046544          494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYK-P  571 (646)
Q Consensus       494 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~-~  571 (646)
                      +...+.++.|....+|+.     ..+++|+....... .....+|+.+++.+....+ .+++++.  .+.-++|+||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            344678999999999998     45888887643221 1122457777766632222 4555443  33357899999 6


Q ss_pred             CCCH
Q 046544          572 HGSL  575 (646)
Q Consensus       572 ~g~L  575 (646)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.05  E-value=0.0009  Score=57.41  Aligned_cols=57  Identities=16%  Similarity=0.189  Sum_probs=36.0

Q ss_pred             EEEccCCccc-ccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCC
Q 046544           63 ALLLWGNNFS-GTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTS  121 (646)
Q Consensus        63 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  121 (646)
                      .++.+++.++ ..+|..+  .++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.-
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            4555555554 1233322  2357777777777777777777777777777777777653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.0033  Score=63.32  Aligned_cols=75  Identities=11%  Similarity=0.059  Sum_probs=48.5

Q ss_pred             eeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCC--CceeEEEE-----EecCCeeEEEEEec
Q 046544          498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHR--NLIKVISS-----CSNEEFKALVLEYK  570 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~~~~~-----~~~~~~~~lv~e~~  570 (646)
                      ..++ |....||+....+|+.+++|...... .....+..|..+++.++..  .+++++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889998877677789999986332 1234566677777766322  23444432     12245668899999


Q ss_pred             CCCC
Q 046544          571 PHGS  574 (646)
Q Consensus       571 ~~g~  574 (646)
                      +|..
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.80  E-value=0.0035  Score=64.42  Aligned_cols=140  Identities=14%  Similarity=0.149  Sum_probs=80.3

Q ss_pred             ceeecccccceEEEEEeC--------CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEE
Q 046544          497 NNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+.+..|-...+|++...        +++.|++|+..... .......+|.++++.+. +.-..++++++..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888899998864        24789999864322 23455668999888773 3223566666543    2999


Q ss_pred             EecCCCCHHH--------------HH---hhCC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 046544          568 EYKPHGSLEK--------------YL---YSSN----CILD--IFQRLNIMIDVAS-------------------ALEYL  605 (646)
Q Consensus       568 e~~~~g~L~~--------------~l---~~~~----~~l~--~~~~~~i~~~i~~-------------------~l~~l  605 (646)
                      ||++|.++..              .+   +...    ....  +.+..++..++..                   .+.++
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999854421              00   1111    1111  2333334333211                   22333


Q ss_pred             h-----cCCCCCeEecCCCCCCEEEcCC----CcEEEEeecCccc
Q 046544          606 H-----FGCLAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKL  641 (646)
Q Consensus       606 H-----~~~~~~iiHrdlk~~Nil~~~~----~~~ki~DfGla~~  641 (646)
                      .     ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     1223468999999999999876    7899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.73  E-value=0.0033  Score=65.95  Aligned_cols=72  Identities=19%  Similarity=0.221  Sum_probs=48.7

Q ss_pred             ceeecccccceEEEEEeCC--------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCc-eeEEEEEecCCeeEEEE
Q 046544          497 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL-IKVISSCSNEEFKALVL  567 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~  567 (646)
                      .+.++.|....||++...+        ++.|++|+.....  ....+.+|..+++.+...++ +++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4668888889999998653        5789999884321  12455678888887743333 56666553  2  3899


Q ss_pred             EecCCCC
Q 046544          568 EYKPHGS  574 (646)
Q Consensus       568 e~~~~g~  574 (646)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.46  E-value=0.011  Score=62.49  Aligned_cols=74  Identities=11%  Similarity=0.096  Sum_probs=47.8

Q ss_pred             ceeecccccceEEEEEeCC-CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCc-eeEEEEEecCCeeEEEEEecCCCC
Q 046544          497 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYKPHGS  574 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~  574 (646)
                      .+.|+.|-...+|++...+ +..|++|+........ -...+|..+++.+...++ +++++++.  +  ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678888889999998765 5788899875432211 112478888888864444 56777662  2  25999998744


Q ss_pred             H
Q 046544          575 L  575 (646)
Q Consensus       575 L  575 (646)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.0062  Score=62.51  Aligned_cols=73  Identities=11%  Similarity=0.169  Sum_probs=43.3

Q ss_pred             ceeecccccceEEEEEeCC---------CcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCC-ceeEEEEEecCCeeEEE
Q 046544          497 NNLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRN-LIKVISSCSNEEFKALV  566 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~~~~lv  566 (646)
                      .+.++.|....+|+....+         +..+++|+...... .......|.++++.+...+ ++++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567788888999988653         26788888754322 1112356777777764323 44666544  2  2689


Q ss_pred             EEecCCCC
Q 046544          567 LEYKPHGS  574 (646)
Q Consensus       567 ~e~~~~g~  574 (646)
                      |||++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.25  E-value=0.039  Score=55.77  Aligned_cols=32  Identities=25%  Similarity=0.399  Sum_probs=27.6

Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       610 ~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35689999999999999888899999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.80  E-value=0.22  Score=51.74  Aligned_cols=73  Identities=11%  Similarity=0.193  Sum_probs=46.7

Q ss_pred             ceeecccccceEEEEEeCC--------CcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEE
Q 046544          497 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+.+..|-...+|+....+        ++.|++|+....... .-+..+|.++++.+. +.-..++++.+  .  -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3567778888999998653        578999986543221 112346888777763 22245566533  2  26899


Q ss_pred             EecCCCC
Q 046544          568 EYKPHGS  574 (646)
Q Consensus       568 e~~~~g~  574 (646)
                      ||++|.+
T Consensus       150 efI~G~~  156 (424)
T 3mes_A          150 EFIDGEP  156 (424)
T ss_dssp             ECCCSEE
T ss_pred             EEeCCcc
Confidence            9999865

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.43  E-value=0.49  Score=31.14  Aligned_cols=6  Identities=33%  Similarity=0.711  Sum_probs=2.2

Q ss_pred             cchhhh
Q 046544          437 LLLGIV  442 (646)
Q Consensus       437 ~~~~i~  442 (646)
                      ++.+++
T Consensus        13 IA~gVV   18 (44)
T 2ks1_B           13 IATGMV   18 (44)
T ss_dssp             STHHHH
T ss_pred             EEeehh
Confidence            333333

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.14  E-value=0.4  Score=49.48  Aligned_cols=30  Identities=27%  Similarity=0.373  Sum_probs=24.7

Q ss_pred             CeEecCCCCCCEEE------cCCCcEEEEeecCccc
Q 046544          612 PVIHCDLKPDNVLL------DDNLVAYLSDFGIAKL  641 (646)
Q Consensus       612 ~iiHrdlk~~Nil~------~~~~~~ki~DfGla~~  641 (646)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      3467799999987753

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=80.80  E-value=1.1  Score=29.45  Aligned_cols=7  Identities=14%  Similarity=0.420  Sum_probs=2.7

Q ss_pred             chhhhhh
Q 046544          438 LLGIVLP  444 (646)
Q Consensus       438 ~~~i~~~  444 (646)
                      ++++++.
T Consensus        14 Ia~~vVG   20 (44)
T 2jwa_A           14 IISAVVG   20 (44)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            3333343

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.61  E-value=0.17  Score=53.42  Aligned_cols=60  Identities=8%  Similarity=0.045  Sum_probs=17.0

Q ss_pred             cceeecccccceEEEEEeCC-CcEEEE------EEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEe
Q 046544          496 ENNLIGRGGFGSVYKARLGD-GMEVAV------KVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCS  558 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  558 (646)
                      ..+.+|   ||+||+|.+.. ..+||+      |..+...  ......+.+|+.+++..+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345566   99999998754 467888      6554321  223456888999999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	646
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-32
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-32
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-24
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-23
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-13
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	9e-04
d1kvza_	107	d.5.1.1 (A:) Amphibian cytotoxic ribonuclease {Bul	0.003

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (368), Expect = 8e-40
 Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 17/176 (9%)

Query: 481 TFSYLELCRATNGFSEN---------NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ 527
            F++ +   A   F++           +IG G FG V    L       + VA+K     
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 528 -CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCIL 586
              +  + F  E  +M    H N+I +    +      ++ E+  +GSL+ +L  ++   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 587 DIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            + Q + ++  +A+ ++YL        +H DL   N+L++ NLV  +SDFG+++ L
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-39
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVIS 555
             IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             +     A+V ++    SL  +L+      ++ + ++I    A  ++YLH      +IH
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLK +N+ L ++L   + DFG+A + 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVK 154

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 6e-38
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 4/150 (2%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             +G G FG VYKA+     +  A KV + +     + + VE +++ S  H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
              E    +++E+   G+++  +      L   Q   +      AL YLH      +IH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           DLK  N+L   +    L+DFG++       
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI 164

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 36/163 (22%), Positives = 74/163 (45%), Gaps = 7/163 (4%)

Query: 485 LELCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKS-FAVECEMM 542
           +EL    + F + + +G G  G V+K      G+ +A K+ +L+   A ++    E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 543 KSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
                  ++    +  ++   ++ +E+   GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
            YL       ++H D+KP N+L++      L DFG++  LI  
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-37
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 8/151 (5%)

Query: 500 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLIKVIS 555
           +G G FGSV +         ++VA+KV      +A  +    E ++M  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
            C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +H
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            DL   NVLL +   A +SDFG++K L  +D
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADD 163

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-36
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 6/150 (4%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
                 +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCLAP 612
            +  + E    ++ EY  +GSL  +L + + I L I + L++   +A  + ++       
Sbjct: 74  YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            IH DL+  N+L+ D L   ++DFG+A+L+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI 159

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 8/153 (5%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRAFKSFAVECEMMKSIRHRN 549
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
            I+       E    LV+EY    + +         L   +   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS-- 133

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-35
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 4/153 (2%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
            +    +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
              C+ +    ++ EY  +G L  YL          Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +H DL   N L++D  V  +SDFG+++ ++ ++
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 4/153 (2%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
            +    IG G FG V+     +  +VA+K        + + F  E E+M  + H  L+++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
              C  +    LV E+  HG L  YL +   +      L + +DV   + YL   C   V
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           IH DL   N L+ +N V  +SDFG+ + ++ + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  129 bits (326), Expect = 1e-33
 Identities = 31/147 (21%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +G G FG V++      G   A K          ++   E + M  +RH  L+ +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            ++    ++ E+   G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149

Query: 618 LKPDNVLL--DDNLVAYLSDFGIAKLL 642
           LKP+N++     +    L DFG+   L
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHL 176

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 6/155 (3%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
            +  + +G G +G VY+       + VAVK          + F  E  +MK I+H NL++
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLA 611
           ++  C+ E    ++ E+  +G+L  YL   N   +     L +   ++SA+EYL      
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 134

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             IH DL   N L+ +N +  ++DFG+++L+ G+ 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 11/164 (6%)

Query: 489 RATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSI 545
           RA + +     IG G +G   K R   DG  +  K  +         +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 546 RHRNLIKVISSCSNEEFKAL--VLEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVAS 600
           +H N+++      +     L  V+EY   G L   +         LD    L +M  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 601 ALEYLH--FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           AL+  H        V+H DLKP NV LD      L DFG+A++L
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-33
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 6/150 (4%)

Query: 494 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKV 553
                 +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIF-QRLNIMIDVASALEYLHFGCLAP 612
            +  S E    +V EY   GSL  +L           Q +++   +AS + Y+       
Sbjct: 78  YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            +H DL+  N+L+ +NLV  ++DFG+A+L+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLI 163

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 49/147 (33%), Positives = 70/147 (47%), Gaps = 8/147 (5%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
             IG+G FG V       G +VAVK          ++F  E  +M  +RH NL++++   
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 558 SNEEFK-ALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
             E+    +V EY   GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DL   NVL+ ++ VA +SDFG+ K  
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA 153

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 13/152 (8%)

Query: 500 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN 559
           IG+G FG V++ +   G EVAVK+F+ +  R++     E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 560 EEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA---- 611
           +        LV +Y  HGSL  YL      + +   + + +  AS L +LH   +     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 612 -PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             + H DLK  N+L+  N    ++D G+A   
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-33
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 10/155 (6%)

Query: 496 ENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNL 550
           E+  +G G FG+V K           VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +++I  C  E +  LV+E    G L KYL  +   +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           +  +H DL   NVLL     A +SDFG++K L  +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 498 NLIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
             +G+G FG+VY AR       +A+KV     L+          E E+   +RH N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
                +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H      V
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 645
           IH D+KP+N+LL       ++DFG +      
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 33/178 (18%)

Query: 499 LIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSI-RHRNL 550
           ++G G FG V  A        G  ++VAVK+   +   +  ++   E +MM  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSN----------------------CILDI 588
           + ++ +C+      L+ EY  +G L  YL S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 589 FQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              L     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ + 
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 2e-32
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 10/159 (6%)

Query: 494 FSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRAFKSFAVECEMMKSIRH 547
           F E+      +G G +G V  A        VAVK+ ++ +     ++   E  + K + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            N++K          + L LEY   G L   +   +  +           + + + YLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                + H D+KP+N+LLD+     +SDFG+A +    +
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 4e-32
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 8/157 (5%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRN 549
           F    ++G G F +V  AR L    E A+K+     +           E ++M  + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
            +K+  +  ++E     L Y  +G L KY+       D         ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKG 128

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +IH DLKP+N+LL++++   ++DFG AK+L  E 
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-32
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)

Query: 494 FSENNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRH 547
            +   +IG G FG VYK  L        + VA+K        +    F  E  +M    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            N+I++    S  +   ++ EY  +G+L+K+L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                 +H DL   N+L++ NLV  +SDFG++++L
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  124 bits (313), Expect = 7e-32
 Identities = 32/147 (21%), Positives = 62/147 (42%), Gaps = 6/147 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +G G FG V++      G     K  N        +   E  +M  + H  LI +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            ++    L+LE+   G L   + + +  +   + +N M      L+++H      ++H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLD 152

Query: 618 LKPDNVLLD--DNLVAYLSDFGIAKLL 642
           +KP+N++ +        + DFG+A  L
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL 179

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-32
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 6/150 (4%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISS 556
             IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHC 616
               +   +V+EY   GSL   +  +    D  Q   +  +   ALE+LH      VIH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHS---NQVIHR 140

Query: 617 DLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           D+K DN+LL  +    L+DFG    +  E 
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-31
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 10/154 (6%)

Query: 497 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKV 553
           +  IGRG F +VYK       +EVA      +       + F  E EM+K ++H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 554 ISSC----SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
             S       ++   LV E    G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 610 LAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLL 642
             P+IH DLK DN+ +        + D G+A L 
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (303), Expect = 4e-31
 Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 35/195 (17%)

Query: 482 FSYLELCRATNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAF-KS 534
              LE  R  N       IG G FG V++AR            VAVK+   +        
Sbjct: 5   LLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62

Query: 535 FAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC---------- 584
           F  E  +M    + N++K++  C+  +   L+ EY  +G L ++L S +           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 585 -------------ILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA 631
                         L   ++L I   VA+ + YL        +H DL   N L+ +N+V 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 179

Query: 632 YLSDFGIAKLLIGED 646
            ++DFG+++ +   D
Sbjct: 180 KIADFGLSRNIYSAD 194

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 45/154 (29%), Positives = 60/154 (38%), Gaps = 11/154 (7%)

Query: 500 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +G G FG V +       G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 553 VISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
           +         K +V E  P GSL   L        +       + VA  + YL       
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131

Query: 613 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
            IH DL   N+LL    +  + DFG+ + L   D
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 9/156 (5%)

Query: 497 NNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLI 551
           N +IGRG FG VY   L    G  +  AVK  N          F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 552 KVISSCSNEEFKA-LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            ++  C   E    +VL Y  HG L  ++ +      +   +   + VA  +    F   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              +H DL   N +LD+     ++DFG+A+ +  ++
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 9/149 (6%)

Query: 499 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRAFKS-FAVECEMMKSIRHRNLIKV 553
            IG G FG V++          + VA+K        + +  F  E   M+   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
           I   + E    +++E    G L  +L      LD+   +     +++AL YL        
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H D+   NVL+  N    L DFG+++ +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM 158

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-30
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 10/159 (6%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKV-----FNLQCGRAFKSFAVECEMMKSIRH 547
           F +  ++G G FG+VYK   + +G +V + V           +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
            ++ +++  C     + L+ +  P G L  Y+      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                ++H DL   NVL+       ++DFG+AKLL  E+
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  119 bits (299), Expect = 6e-30
 Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 11/158 (6%)

Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRAFKSFAVECEMMKS 544
           N FS + +IGRGGFG VY  R    G   A+K  +       Q      +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 545 IRHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
                ++ +  +    +  + +L+    G L  +L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H      V++ DLKP N+LLD++    +SD G+A   
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 28/178 (15%)

Query: 494 FSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSI- 545
            S    +G G FG V +A           M VAVK+          ++   E +++  + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 546 RHRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSS-----------------NCILDI 588
            H N++ ++ +C+      ++ EY  +G L  +L                       LD+
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 589 FQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
              L+    VA  + +L        IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 23/170 (13%)

Query: 492 NGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGR-AFKSFAVECEMMKSI-R 546
           N     ++IG G FG V KAR+   G  M+ A+K       +   + FA E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCI---------------LDIFQR 591
           H N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 592 LNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++ 
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (285), Expect = 9e-29
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 19/164 (11%)

Query: 494 FSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAF---------KSFAVEC 539
           F EN     ++GRG    V +        E AVK+ ++  G +F         ++   E 
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 540 EMMKSIR-HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDV 598
           ++++ +  H N+I++  +     F  LV +    G L  YL +    L   +   IM  +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119

Query: 599 ASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
              +  LH      ++H DLKP+N+LLDD++   L+DFG +  L
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 31/147 (21%), Positives = 66/147 (44%), Gaps = 7/147 (4%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +GRG FG V++            K   ++ G        E  ++   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
            + E   ++ E+     + + + +S   L+  + ++ +  V  AL++LH      + H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127

Query: 618 LKPDNVLLD--DNLVAYLSDFGIAKLL 642
           ++P+N++     +    + +FG A+ L
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL 154

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (282), Expect = 4e-28
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKV 553
             +G G FG V+  R   +G   A+KV     +   +  +    E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 554 ISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
             +  + +   ++++Y   G     L   +             +V  ALEYLH      +
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDI 125

Query: 614 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           I+ DLKP+N+LLD N    ++DFG AK +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYV 154

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 6/147 (4%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVIS 555
             IG G +G VYKA+   G   A+K   L+        +   E  ++K ++H N++K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
               ++   LV E+     L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLH 123

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            DLKP N+L++      ++DFG+A+  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF 150

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (277), Expect = 2e-27
 Identities = 28/147 (19%), Positives = 55/147 (37%), Gaps = 3/147 (2%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHRNLIKVIS 555
           +++G G F  V  A        VA+K    +       S   E  ++  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
              +     L+++    G L   +              ++  V  A++YLH   +     
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAKLL 642
                    LD++    +SDFG++K+ 
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKME 160

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-26
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 17/163 (10%)

Query: 494 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIK 552
           +++  +IG G FG VY+A+L   G  VA+K          +    E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 553 VISSC------SNEEFKALVLEYKPHGSLE--KYLYSSNCILDIFQRLNIMIDVASALEY 604
           +           +E +  LVL+Y P       ++   +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 605 LHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGED 646
           +H      + H D+KP N+LLD D  V  L DFG AK L+  +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 32/169 (18%), Positives = 67/169 (39%), Gaps = 19/169 (11%)

Query: 494 FSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIR 546
            + +  +G+G FG VY+              VA+K  N     R    F  E  +MK   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 547 HRNLIKVISSCSNEEFKALVLEYKPHGSLEKYLY---------SSNCILDIFQRLNIMID 597
             ++++++   S  +   +++E    G L+ YL                 + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 598 VASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +A  + YL+       +H DL   N ++ ++    + DFG+ + +   D
Sbjct: 142 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 9/158 (5%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECE-MMKSIRHR 548
           F  + ++G+G FG V+ A         A+K      +      +   VE   +  +  H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
            L  +  +   +E    V+EY   G L  ++ S +   D+ +      ++   L++LH  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS- 121

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +++ DLK DN+LLD +    ++DFG+ K  +  D
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 36/156 (23%), Positives = 67/156 (42%), Gaps = 12/156 (7%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR---AFKSFAVECEMMKSIRHRNLIKVI 554
           ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ H  ++ V 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 555 SSCSNEEFKA----LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
            +   E        +V+EY    +L   +++    +   + + ++ D   AL +      
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFS---HQ 129

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +IH D+KP N+++       + DFGIA+ +    
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 3e-26
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 10/151 (6%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-----GRAFKSFAVECEMMKSIRHRNLI 551
           + +G G F +VYKAR       VA+K   L           ++   E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            ++ +  ++   +LV ++     LE  +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 612 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
            ++H DLKP+N+LLD+N V  L+DFG+AK  
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-26
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 8/159 (5%)

Query: 492 NGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---FKSFAVECEMMKSIRH 547
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 607
             L  +  +    +    V+EY   G L  +L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 608 GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
                V++ D+K +N++LD +    ++DFG+ K  I + 
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 9e-26
 Identities = 35/158 (22%), Positives = 69/158 (43%), Gaps = 11/158 (6%)

Query: 491 TNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAF-KSFAVECEMMKSIRHR 548
              ++  + IG G +G V  A    + + VA+K  +    + + +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 549 NLIKVISSCSNEEFKAL----VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 604
           N+I +         + +    ++ +     L K L + +  L        +  +   L+Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124

Query: 605 LHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           +H    A V+H DLKP N+LL+      + DFG+A++ 
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 1e-25
 Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 6/156 (3%)

Query: 494 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNL 550
           F +   IG G +G VYKAR    G  VA+K   L         +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 551 IKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL 610
           +K++     E    LV E+      +    S+   + +    + +  +   L + H    
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 611 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             V+H DLKP N+L++      L+DFG+A+      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-25
 Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 28/174 (16%)

Query: 498 NLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RH 547
             +G G FG V  A              +VAVK+       +       E EMMK I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYL---------------YSSNCILDIFQRL 592
           +N+I ++ +C+ +    +++EY   G+L +YL               ++    L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 593 NIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
           +    VA  +EYL        IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 9e-25
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 15/168 (8%)

Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCG-----RAFKSFAVEC 539
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G      +        
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 540 EMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYKPHGSLEKYLYSSNCILDIFQRLNI 594
             +++  H N++++   C+           LV E+                +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 595 MIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           M  +   L++LH      V+H DLKP N+L+  +    L+DFG+A++ 
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 166

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  104 bits (259), Expect = 1e-24
 Identities = 75/387 (19%), Positives = 143/387 (36%), Gaps = 28/387 (7%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
           + L    +  L    +  TV     ++  +  L      +   +  +    L NL  +  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSIDGVE--YLNNLTQINF 73

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLE------WLNLRDNYLT 120
             N  +   P  + N +KL  + ++ N  +   P                  ++      
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
           ++   L   S+  +  S      S   L      T +  L++      +   +       
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
            +  LTN  ++    N+++   P+ +     L  L L+ N+L+     ++  LT L +L+
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE 300
           L  N++    P   S L  L  L L +N++++I      L  +  L  + N L    P  
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDISP-- 302

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
           I NLK L  +    NN S + P  +  L  L+ LF   N++      S  +L ++ +L+ 
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFN 387
            +N +S   P  L  L+ +  L L+  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 84.7 bits (208), Expect = 3e-18
 Identities = 68/358 (18%), Positives = 132/358 (36%), Gaps = 36/358 (10%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALL 65
           +  L NL +++  +N+L    P  + N++ L  + + NN                    +
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ-------------------I 100

Query: 66  LWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPE 125
                 +              I ++        +     +   +  ++      +     
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 126 LSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNL 185
                +     +        +     +S  S+     +L+    +N  +S   P  I   
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL-- 218

Query: 186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNK 245
           TN   + L GN+L      TL+ L  L  L L +N++    P  +  LT+L EL+LG N+
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 246 LFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLK 305
           +    P   + L +L  L L+ N+L  I     NLK++  L    N ++   P  + +L 
Sbjct: 275 ISNISP--LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLT 329

Query: 306 VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
            L  + F+ N  S    + +  L N+ +L  G+N++    P    +L  +  L L++ 
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 68.5 bits (166), Expect = 7e-13
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 32/163 (19%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLG-------------- 48
              +++L NL +LDL +N++    P  +  ++ L  L L  N +                
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

Query: 49  -----CLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTF 103
                         L NL  L L+ NN S   P  + + +KL  L  + N  S    ++ 
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 104 GNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
            NL N+ WL+   N ++  TP       L+N   +T + L+D 
Sbjct: 348 ANLTNINWLSAGHNQISDLTP-------LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.3 bits (163), Expect = 2e-12
 Identities = 57/340 (16%), Positives = 111/340 (32%), Gaps = 45/340 (13%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
             ++     L + + +  +  +  +L  +  L      + S       +  +    +LT 
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 70

Query: 141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG 200
           I+ S+N L  I    ++  L   L +               +T LT         + L  
Sbjct: 71  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS---------IP 251
              +   +L       +       S+              L                   
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 252 ACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGID 311
           +  + L +L  L  ++N+++ I      L ++ +L+ + N L     L   +L  L  +D
Sbjct: 191 SVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTL--ASLTNLTDLD 247

Query: 312 FSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP--------------------DSFGD 351
            + N  S++ P  + GL  L  L LG N++    P                        +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 352 LISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG 391
           L +L +L L  NN+S   P  +  L+ L+ L  + NK+  
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.9 bits (123), Expect = 1e-07
 Identities = 50/274 (18%), Positives = 91/274 (33%), Gaps = 24/274 (8%)

Query: 133 SNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITID 192
           +         L    +   +S+T +  ++            +     + +  L N   I+
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTT----LQADRLGIKS--IDGVEYLNNLTQIN 72

Query: 193 LGGNKLNGSIPIT-LSKLQKL-QGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI 250
              N+L    P+  L+KL  +        +    +   ++  LT         + L    
Sbjct: 73  FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 251 PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN------- 303
                 L+S  I  +S+    +          +  L   +N  T        N       
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 304 ---LKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
              L  L  +  + N  S + P  I    NL+ L L  N+L+     +   L +L  L+L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIP 394
           +NN +S   P  L  L+ L +L L  N++    P
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 7/92 (7%)

Query: 226 IPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQ 285
             D+   L E  +  LG   +  ++    ++L  +  L      + SI      L ++ Q
Sbjct: 16  FTDTA--LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID-GVEYLNNLTQ 70

Query: 286 LNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNF 317
           +NFS+N LT   PL   NL  L+ I  + N  
Sbjct: 71  INFSNNQLTDITPL--KNLTKLVDILMNNNQI 100

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 10/44 (22%), Positives = 20/44 (45%), Gaps = 2/44 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNN 44
                ++NL N+  L   HN++    P  + N++ +  L L + 
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (257), Expect = 1e-24
 Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 8/145 (5%)

Query: 500 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
           +G G FG V   +    G   A+K+ +   +   +  +    E  +++++    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 556 SCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIH 615
           S  +     +V+EY   G +  +L                  +    EYLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHS---LDLIY 164

Query: 616 CDLKPDNVLLDDNLVAYLSDFGIAK 640
            DLKP+N+L+D      ++DFG AK
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK 189

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 9/148 (6%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            IG G FG +Y    +  G EVA+K+  ++         +E ++ K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             E    +++      SLE      +    +   L +   + S +EY+H       IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRD 128

Query: 618 LKPDNVL---LDDNLVAYLSDFGIAKLL 642
           +KPDN L        + Y+ DFG+AK  
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-24
 Identities = 31/157 (19%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
           ++G G  G V +        + A+K+    C +A +   +     ++ +  ++++++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 558 ----SNEEFKALVLEYKPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCLAP 612
               +  +   +V+E    G L   +    +      +   IM  +  A++YLH      
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 613 VIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGED 646
           + H D+KP+N+L      N +  L+DFG AK     +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 35/148 (23%), Positives = 69/148 (46%), Gaps = 7/148 (4%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVI 554
             IG G +G+V+KA+       VA+K   L         S   E  ++K ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 555 SSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVI 614
               +++   LV E+      + +   +  + D     + +  +   L + H      V+
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---VL 123

Query: 615 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
           H DLKP N+L++ N    L++FG+A+  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF 151

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 2e-24
 Identities = 36/154 (23%), Positives = 61/154 (39%), Gaps = 13/154 (8%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAF------KSFAVECEMMKSIR--HRN 549
           L+G GGFGSVY    + D + VA+K         +          +E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 550 LIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
           +I+++      +   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128

Query: 610 LAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLL 642
              V+H D+K +N+L+D +     L DFG   LL
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 3e-24
 Identities = 38/177 (21%), Positives = 65/177 (36%), Gaps = 27/177 (15%)

Query: 494 FSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-FKSFAVECEMMKSIR 546
                 +GRG FG V +A             VAVK+       +  ++   E +++  I 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 547 HRNLIKVISSCSNEEFKAL--VLEYKPHGSLEKYLYSSNC---------------ILDIF 589
           H   +  +     +    L  ++E+   G+L  YL S                   L + 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 590 QRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
             +     VA  +E+L        IH DL   N+LL +  V  + DFG+A+ +  + 
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 5e-24
 Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 15/167 (8%)

Query: 487 LCRATNGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRAFKSFAVECEMMK 543
            C   + + +   IG+G FG V+KAR    G +VA+K   ++        +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 544 SIRHRNLIKVISSCSNEEFKA--------LVLEYKPHGSLEKYLYSSNCILDIFQRLNIM 595
            ++H N++ +I  C  +            LV ++  H               + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 596 IDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 642
             + + L Y+H      ++H D+K  NVL+  + V  L+DFG+A+  
Sbjct: 124 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 167

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 1e-23
 Identities = 38/158 (24%), Positives = 69/158 (43%), Gaps = 13/158 (8%)

Query: 498 NLIGRGGFGSVYKARL----GDGMEVAVKVFN----LQCGRAFKSFAVECEMMKSIRHR- 548
            ++G G +G V+  R       G   A+KV      +Q  +  +    E ++++ IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 549 NLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 608
            L+ +  +   E    L+L+Y   G L  +L         F    + I V   +  L   
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 609 CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 646
               +I+ D+K +N+LLD N    L+DFG++K  + ++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 2e-23
 Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 15/155 (9%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRAFKSFAVECEMMKSIRHRNLI 551
            +G G F  V K R    G++ A K          + G + +    E  ++K I+H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 552 KVISSCSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLA 611
            +     N+    L+LE    G L  +  +    L   +    +  + + + YLH     
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 133

Query: 612 PVIHCDLKPDNVLLDDN----LVAYLSDFGIAKLL 642
            + H DLKP+N++L D         + DFG+A  +
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.0 bits (243), Expect = 3e-23
 Identities = 29/150 (19%), Positives = 55/150 (36%), Gaps = 11/150 (7%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            IG G FG +++   L +  +VA+K    +          E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 558 SNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCD 617
             E    +++      SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRD 126

Query: 618 LKPDNVLLDDNL-----VAYLSDFGIAKLL 642
           +KPDN L+         + Y+ DFG+ K  
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 94.9 bits (235), Expect = 7e-22
 Identities = 34/150 (22%), Positives = 72/150 (48%), Gaps = 15/150 (10%)

Query: 498 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVIS 555
             +GRG +  V++A  + +  +V VK+      +  K    E ++++++R   N+I +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 556 SCSNEEFK--ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPV 613
              +   +  ALV E+  +   ++   +    L  +     M ++  AL+Y H      +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG---I 150

Query: 614 IHCDLKPDNVLLD-DNLVAYLSDFGIAKLL 642
           +H D+KP NV++D ++    L D+G+A+  
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 1e-21
 Identities = 21/154 (13%), Positives = 51/154 (33%), Gaps = 20/154 (12%)

Query: 498 NLIGRGGFGSVYKARLGDGMEVAVKVFNL----------QCGRAFKSFAVECEMMKSIRH 547
            L+G G   +V+        E  VK   +          +       F+V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 548 RNLIKVISSCSNEEFKALVLEYKPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLH 606
           R L K+      + +      ++ +  L + + +     + +     ++  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 607 FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
                 ++H DL   NVL+ +  + ++ DF  + 
Sbjct: 121 HRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 1e-21
 Identities = 56/313 (17%), Positives = 98/313 (31%), Gaps = 31/313 (9%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
           L  +     P+   L L  N  +        N   L  L L  N  S   P  F  L  L
Sbjct: 22  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
           E L L  N L     ++         K+L  + + +N +  +      G     + +   
Sbjct: 82  ERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDS 229
           +    SG        +     I +    +          L +L    LD NK+      S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITKVDAAS 190

Query: 230 ICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFS 289
           +  L  L +L L  N +        +N   LR L L++N+L  +P    + K I  +   
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250

Query: 290 SNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGS--IPD 347
           +N ++                  ++ +     P       +   + L  N ++     P 
Sbjct: 251 NNNIS------------------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 348 SFGDLISLKFLNL 360
           +F  +     + L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.3 bits (207), Expect = 2e-18
 Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 12/261 (4%)

Query: 136 KSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGG 195
                + L +N +  I       NL + L    + N  +S   P     L     + L  
Sbjct: 31  PDTALLDLQNNKITEIKD-GDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88

Query: 196 NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFS 255
           N+L          LQ+L+    +  K+  S+ + + ++  +  L     K  G     F 
Sbjct: 89  NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQ 147

Query: 256 NLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN 315
            +  L  + ++   +T+IP        + +L+   N +T      +  L  L  +  S N
Sbjct: 148 GMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG------AI 369
           + S+V    +    +L  L L  N+L   +P    D   ++ + L NNN+S         
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 370 PTSLEKLSYLEDLNLSFNKLE 390
           P    K +    ++L  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.4 bits (202), Expect = 7e-18
 Identities = 50/235 (21%), Positives = 88/235 (37%), Gaps = 5/235 (2%)

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
           +P+++    ++  +DL  NK+          L+ L  L L +NK+    P +   L +L 
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 238 ELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL 297
            L L  N+L          L  LR+      ++        N   +++L  +    +G  
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142

Query: 298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKF 357
                 +K L  I  +  N +++     G   +L  L L  N++      S   L +L  
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199

Query: 358 LNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNEL 412
           L LS N++S     SL    +L +L+L+ NKL                    N +
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.0 bits (201), Expect = 1e-17
 Identities = 50/228 (21%), Positives = 81/228 (35%), Gaps = 6/228 (2%)

Query: 190 TIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS 249
            +      L   +P  L        L L +NK+          L  L+ L L  NK+   
Sbjct: 14  VVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 250 IPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIG 309
            P  F+ L  L  L LS N+L  +P         L+++ +             N  +++ 
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 310 IDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAI 369
           +  +    S +      G+K L Y+ +    +  +IP       SL  L+L  N ++   
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187

Query: 370 PTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP 417
             SL+ L+ L  L LSFN +        +      E    N  L   P
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 6e-17
 Identities = 58/281 (20%), Positives = 105/281 (37%), Gaps = 21/281 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           ++P ++    +   LDL++NK+         N+  L  L L NN +       A   L  
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-AFAPLVK 80

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           LE L L  N       +      +L +    +N  +    + F  L  +  + L  N L 
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
           SS  E     +    K L++I ++D  +  I        L  SL + ++    ++     
Sbjct: 138 SSGIE---NGAFQGMKKLSYIRIADTNITTIPQ-----GLPPSLTELHLDGNKITKVDAA 189

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
            +  L N   + L  N ++     +L+    L+ L L++NKL   +P  +     +  + 
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248

Query: 241 LGGNKLFG------SIPACFSNLASLRILSLSSNELTSIPL 275
           L  N +          P   +  AS   +SL SN +    +
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.2 bits (186), Expect = 8e-16
 Identities = 55/275 (20%), Positives = 102/275 (37%), Gaps = 27/275 (9%)

Query: 2   IPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNL 61
              +  NL+NL  L L +NK+    P A   +  L+ L+L  N L      +     P  
Sbjct: 47  KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM-----PKT 101

Query: 62  EALLLWGNNFSGTIPRFIFNASKLSI---LELSQNSFSGFIPNTFGNLRNLEWLNLRDNY 118
              L    N    + + +FN     I   L  +    SG     F  ++ L ++ + D  
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161

Query: 119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI 178
           +T+    L          SLT +HL  N +  + + +  G   ++L    +S  ++S   
Sbjct: 162 ITTIPQGL--------PPSLTELHLDGNKITKVDAASLKGL--NNLAKLGLSFNSISAVD 211

Query: 179 PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSIC------R 232
              + N  +   + L  NKL   +P  L+  + +Q + L +N +     +  C      +
Sbjct: 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270

Query: 233 LTELYELELGGNKL--FGSIPACFSNLASLRILSL 265
                 + L  N +  +   P+ F  +     + L
Sbjct: 271 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 2e-21
 Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 15/170 (8%)

Query: 482 FSYLELCRATNGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFKS 534
           F   E+ +              +G G +G+V  A     G +VA+K      Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 535 FAVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYKPHGSLEKYLYSSNCILDIFQ 590
              E  ++K +RH N+I ++   + +E    F    L     G+    L      L   +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDR 122

Query: 591 RLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 640
              ++  +   L Y+H      +IH DLKP N+ ++++    + DFG+A+
Sbjct: 123 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 8e-21
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)

Query: 481 TFSYLELCRATNGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFK 533
           TF   EL +      E     + +G G +GSV  A     G+ VAVK  +   Q     K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 534 SFAVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYKPHGSLEKYLYSSNCILDIF 589
               E  ++K ++H N+I ++   +      EF  + L     G+    +      L   
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDD 121

Query: 590 QRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 639
               ++  +   L+Y+H      +IH DLKP N+ ++++    + DFG+A
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 9e-20
 Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 16/152 (10%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRAFKSFAVECEMMKSIRHRNLIKVIS 555
            IG G  G V  A        VA+K  +   Q     K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 556 SCSNEEFK------ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 609
             + ++         LV+E       +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139

Query: 610 LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 641
              +IH DLKP N+++  +    + DFG+A+ 
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLART 168

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.4 bits (207), Expect = 2e-18
 Identities = 69/289 (23%), Positives = 111/289 (38%), Gaps = 25/289 (8%)

Query: 130 SSLSNCKSLTFIHLSDNPLDGILS-KTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNS 188
            + +    +  + LS   L       +S+ NL +    +     N+ G IP  I  LT  
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 189 ITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG 248
             + +    ++G+IP  LS+++ L  L    N L G++P SI  L  L  +   GN++ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLI 308
           +IP  + + + L      S    +  +        L     S  +       +       
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 309 GIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA 368
                  N  +    ++G  KNL  L L  NR+ G++P     L  L  LN+S NNL   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-- 281

Query: 369 IPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP 417
                                 GEIP+GG+   F   ++  N+ LCGSP
Sbjct: 282 ----------------------GEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.3 bits (186), Expect = 1e-15
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 12/272 (4%)

Query: 7   SNLQNLEELDLRHNKLVG--TVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL 64
           +    +  LDL    L     +P+++ N+  L  L++   + L      A  +L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 65  LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTP 124
            +   N SG IP F+     L  L+ S N+ SG +P +  +L NL  +    N ++ + P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 125 ELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITN 184
           +    S  S  K  T + +S N L G +  T        +          +  +     N
Sbjct: 167 D----SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 185 LTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN 244
                          G + ++ +         L +N++ G++P  + +L  L+ L +  N
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLD----LRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 245 KLFGSIPACFSNLASLRILSLSSN-ELTSIPL 275
            L G IP    NL    + + ++N  L   PL
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.3 bits (173), Expect = 5e-14
 Identities = 55/292 (18%), Positives = 100/292 (34%), Gaps = 33/292 (11%)

Query: 81  NASKLSILELSQNSFSGF--IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSL 138
              +++ L+LS  +      IP++  NL  L +L +                +++    L
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP----IPPAIAKLTQL 103

Query: 139 TFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKL 198
            +++++   + G        +   +L     S   +SG +P  I++L N + I   GN++
Sbjct: 104 HYLYITHTNVSGA--IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161

Query: 199 NGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLA 258
           +                        G+IPDS    ++L+                     
Sbjct: 162 S------------------------GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
           +L  + LS N L       +      Q    +         ++G  K L G+D   N   
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257

Query: 319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIP 370
             +P  +  LK L  L + +N L G IP   G+L        +NN      P
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 68.6 bits (166), Expect = 4e-13
 Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 13/256 (5%)

Query: 1   EIPLEISNLQNLEELDLRHN-KLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLP 59
            IP  ++NL  L  L +     LVG +P AI  ++ L  L++ + ++ G +         
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI-K 125

Query: 60  NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
            L  L    N  SGT+P  I +   L  +    N  SG IP+++G+   L          
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN- 184

Query: 120 TSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIP 179
                       +    +   +   D   + +    S+   S           N      
Sbjct: 185 -------RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237

Query: 180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL 239
            ++    N   +DL  N++ G++P  L++L+ L  L +  N L G IP     L      
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296

Query: 240 ELGGNKLF--GSIPAC 253
               NK      +PAC
Sbjct: 297 AYANNKCLCGSPLPAC 312

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.3 bits (207), Expect = 4e-18
 Identities = 33/160 (20%), Positives = 63/160 (39%), Gaps = 20/160 (12%)

Query: 499 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSC 557
            +G G F +V+ A+ + +   VA+K+         ++   E ++++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 558 SNEEFK---------------ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 602
           +N   K                +V E      L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 603 EYLHFGCLAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKL 641
           +Y+H  C   +IH D+KP+NVL++  +    L    IA L
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL 176

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 3e-17
 Identities = 54/257 (21%), Positives = 87/257 (33%), Gaps = 6/257 (2%)

Query: 136 KSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGG 195
            +   I L  N +  +    S     +    +  SN                        
Sbjct: 32  AASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 196 NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFS 255
            +L    P T   L +L  L LD   L+   P     L  L  L L  N L       F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 256 NLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSM 314
           +L +L  L L  N ++S+P   F  L  + +L    N +    P    +L  L+ +    
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 315 NNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLE 374
           NN S++    +  L+ L+YL L  N        +      L+    S++ +  ++P  L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 375 KLSYLEDLNLSFNKLEG 391
                    L+ N L+G
Sbjct: 270 GRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (178), Expect = 6e-15
 Identities = 55/271 (20%), Positives = 100/271 (36%), Gaps = 13/271 (4%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
            +P+ I      + + L  N++     A+      L +L L +N L    ++        
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
            +  L          P       +L  L L +       P  F  L  L++L L+DN L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
           +   +     +  +  +LT + L  N +  +  +   G   HSL    +    V+   P 
Sbjct: 143 ALPDD-----TFRDLGNLTHLFLHGNRISSVPERAFRG--LHSLDRLLLHQNRVAHVHPH 195

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
              +L   +T+ L  N L+      L+ L+ LQ L L+DN        +      L +  
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFR 254

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELT 271
              +++  S+P     LA   +  L++N+L 
Sbjct: 255 GSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (177), Expect = 8e-15
 Identities = 53/269 (19%), Positives = 90/269 (33%), Gaps = 9/269 (3%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
           L ++        + + L GN  S            L+IL L  N  +      F  L  L
Sbjct: 23  LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
           E L+L DN    S    +F         L  +HL    L  +     +     +L+  Y+
Sbjct: 83  EQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQYLYL 136

Query: 170 SNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDS 229
            +  +     +   +L N   + L GN+++         L  L  L L  N++    P +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 230 ICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFS 289
              L  L  L L  N L        + L +L+ L L+ N              + +   S
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256

Query: 290 SNFLTGPLPLEIGNLKVLIGIDFSMNNFS 318
           S+ +   LP  +    +      + N+  
Sbjct: 257 SSEVPCSLPQRLAGRDLK---RLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (164), Expect = 4e-13
 Identities = 63/242 (26%), Positives = 89/242 (36%), Gaps = 4/242 (1%)

Query: 178 IPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELY 237
           +P  I     S  I L GN+++     +    + L  L L  N L      +   L  L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 238 ELELGGNKLFGSI-PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNF-SSNFLTG 295
           +L+L  N    S+ PA F  L  L  L L    L  +    +     LQ  +   N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 296 PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISL 355
                  +L  L  +    N  SSV      GL +L+ L L  NR+    P +F DL  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 356 KFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCG 415
             L L  NNLS     +L  L  L+ L L+ N    +      +          +E+ C 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 416 SP 417
            P
Sbjct: 264 LP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 29/170 (17%), Positives = 48/170 (28%), Gaps = 27/170 (15%)

Query: 251 PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGI 310
            AC          S     L ++P+         ++    N ++          + L  +
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 311 DFSMNNFSSVI-------------------------PTEIGGLKNLEYLFLGYNRLEGSI 345
               N  + +                          P    GL  L  L L    L+   
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 346 PDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR 395
           P  F  L +L++L L +N L      +   L  L  L L  N++     R
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.0 bits (162), Expect = 6e-13
 Identities = 51/209 (24%), Positives = 76/209 (36%), Gaps = 6/209 (2%)

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
           E++ + + + ++     L  ++P  L K      L L +N L      ++   T L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE 300
           L   +L          L  L  L LS N+L S+PL    L  +  L+ S N LT      
Sbjct: 62  LDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNL 360
           +  L  L  +    N   ++ P  +     LE L L  N L          L +L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 361 SNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
             N+L   IP        L    L  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 1e-09
 Identities = 45/195 (23%), Positives = 67/195 (34%), Gaps = 13/195 (6%)

Query: 74  TIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLS 133
            +P  +      +IL LS+N    F   T      L  LNL    LT             
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ---------- 71

Query: 134 NCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDL 193
              +L  +   D   + + S   +G    +L    +S   ++      +  L     + L
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131

Query: 194 GGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPAC 253
            GN+L    P  L+   KL+ L L +N L       +  L  L  L L  N L+ +IP  
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 254 FSNLASLRILSLSSN 268
           F     L    L  N
Sbjct: 191 FFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (127), Expect = 2e-08
 Identities = 37/185 (20%), Positives = 64/185 (34%), Gaps = 10/185 (5%)

Query: 107 RNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKD 166
           ++   L+L +N L + +      ++L     LT ++L    L  +    ++  L      
Sbjct: 31  KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS 85

Query: 167 FYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSI 226
                     G       + +        N+L       L  L +LQ L L  N+L+   
Sbjct: 86  HNQLQSLPLLGQTLPALTVLDVSF-----NRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 227 PDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQL 286
           P  +    +L +L L  N L        + L +L  L L  N L +IP  F+    +   
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFA 200

Query: 287 NFSSN 291
               N
Sbjct: 201 FLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 3e-08
 Identities = 36/193 (18%), Positives = 53/193 (27%), Gaps = 52/193 (26%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNS--------------- 45
            +P ++   ++   L L  N L     A +   + L  L+L                   
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 46  -----------------------------LLGCLSSIADVRLPNLEALLLWGNNFSGTIP 76
                                         L  L   A   L  L+ L L GN      P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 77  RFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCK 136
             +    KL  L L+ N+ +         L NL+ L L++N L       +         
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY------TIPKGFFGSH 195

Query: 137 SLTFIHLSDNPLD 149
            L F  L  NP  
Sbjct: 196 LLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 4e-06
 Identities = 37/198 (18%), Positives = 59/198 (29%), Gaps = 13/198 (6%)

Query: 50  LSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNL 109
           L+++      +   L L  N         +   ++L+ L L             G L  L
Sbjct: 22  LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD--RAELTKLQVDGTLPVL 79

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYM 169
             L+L  N L S              ++L  + + D   + + S                
Sbjct: 80  GTLDLSHNQLQSLPL---------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 170 SNCNVSGGI-PEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPD 228
              N    + P  +T       + L  N L       L+ L+ L  L L +N L  +IP 
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 229 SICRLTELYELELGGNKL 246
                  L    L GN  
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 1/90 (1%)

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
             NN +      +     L  L L +NS    IP  F     L +  L  N    +   L
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTS 156
            F   L +     ++      +  + S  +
Sbjct: 215 YFRRWLQDNAENVYVWKQGVDVKAMTSNVA 244

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 6e-09
 Identities = 44/308 (14%), Positives = 83/308 (26%), Gaps = 37/308 (12%)

Query: 7   SNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLL 66
               +LE L    N L   +P    ++  L + +    +L      +  + + N +   L
Sbjct: 55  ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL 113

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
                S  +     + + L  L     S               E  NL       +    
Sbjct: 114 PELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNS 173

Query: 127 SFL---------------------------SSLSNCKSLTFIHLSDNPLDGILSKTSIGN 159
                                           L+   +   +  +   L   L   ++ +
Sbjct: 174 LKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRD 233

Query: 160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDD 219
              +       +           + L+         N  +  I         L+ L + +
Sbjct: 234 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 293

Query: 220 NKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWN 279
           NKL   +P    RL  L       N L   +P    N   L+ L +  N L   P    +
Sbjct: 294 NKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQN---LKQLHVEYNPLREFPDIPES 345

Query: 280 LKDILQLN 287
           ++D L++N
Sbjct: 346 VED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 47/331 (14%), Positives = 85/331 (25%), Gaps = 30/331 (9%)

Query: 11  NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEAL------ 64
              EL+L +  L  ++P    +   L+ L    NSL         ++   ++        
Sbjct: 39  QAHELELNNLGL-SSLPELPPH---LESLVASCNSLTELPELPQSLKSLLVDNNNLKALS 94

Query: 65  ----LLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
               LL     S      +      S L++     +                   +    
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
               +     +     + +   L D PL           L    +   +           
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL-------- 206

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE 240
                 N++   L     +                            +    L+EL    
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266

Query: 241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLE 300
              N     I +      SL  L++S+N+L  +P     L+   +L  S N L   +P  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPEL 322

Query: 301 IGNLKVLIGIDFSMNNFSSVIPTEIGGLKNL 331
             NLK L       N      P     +++L
Sbjct: 323 PQNLKQL---HVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.7 bits (114), Expect = 1e-06
 Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 10/103 (9%)

Query: 276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
            F  L ++    +  N  +  +         L  ++ S N     +P        LE L 
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLI 310

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG--AIPTSLEKL 376
             +N L   +P+      +LK L++  N L     IP S+E L
Sbjct: 311 ASFNHLA-EVPELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.9 bits (112), Expect = 2e-06
 Identities = 19/80 (23%), Positives = 35/80 (43%), Gaps = 8/80 (10%)

Query: 312 FSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPT 371
           + +N  S+ I +      +LE L +  N+L   +P        L+ L  S N+L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 372 SLEKLSYLEDLNLSFNKLEG 391
             + L  L   ++ +N L  
Sbjct: 322 LPQNLKQL---HVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 17/51 (33%), Positives = 22/51 (43%), Gaps = 4/51 (7%)

Query: 231 CRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLK 281
           C   + +ELEL    L  S+P        L  L  S N LT +P    +LK
Sbjct: 35  CLDRQAHELELNNLGL-SSLP---ELPPHLESLVASCNSLTELPELPQSLK 81

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.0 bits (124), Expect = 7e-09
 Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 5/124 (4%)

Query: 261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV 320
           R+L L+  +LT +      L  +  L+ S N L    P  +  L+ L  +  S N   +V
Sbjct: 1   RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 321 IPTEIGGLKNLEYLFLGYNRLEG-SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYL 379
                     L+ L L  NRL+  +          L  LNL  N+L             L
Sbjct: 59  DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 380 EDLN 383
             ++
Sbjct: 117 PSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 7e-07
 Identities = 26/119 (21%), Positives = 38/119 (31%), Gaps = 7/119 (5%)

Query: 15  LDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGT 74
           L L H  L  TV   +  + ++  L L +N L     ++A   L  LE L    N     
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALA--ALRCLEVLQASDNALENV 58

Query: 75  IPRFIFNASKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSL 132
                    +   L L  N            +   L  LNL+ N L         L+ +
Sbjct: 59  DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 5e-05
 Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 11/129 (8%)

Query: 87  ILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
           +L L+    +  +      L  +  L+L  N L +  P L+ L  L   +       +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ---ASDNALE 56

Query: 147 PLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITL 206
            +DG+ +   +  L         +N        + + +    + ++L GN L     I  
Sbjct: 57  NVDGVANLPRLQELLLC------NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110

Query: 207 SKLQKLQGL 215
              + L  +
Sbjct: 111 RLAEMLPSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 1e-04
 Identities = 27/118 (22%), Positives = 49/118 (41%), Gaps = 6/118 (5%)

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP 227
           ++++ +++  +   +  L     +DL  N+L    P  L+ L+ L+ L   DN       
Sbjct: 4   HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENV 58

Query: 228 DSICRLTELYELELGGNKLFG-SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDIL 284
           D +  L  L EL L  N+L   +      +   L +L+L  N L         L ++L
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 2e-04
 Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 8/125 (6%)

Query: 215 LGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP 274
           L L    L  ++   + +L  +  L+L  N+L    P   + L  L +L  S N L ++ 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 275 LTFWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFS---SVIPTEIGGLKN 330
               NL  + +L   +N L        + +   L+ ++   N+      +       L +
Sbjct: 60  -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 331 LEYLF 335
           +  + 
Sbjct: 119 VSSIL 123

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 3e-08
 Identities = 46/219 (21%), Positives = 73/219 (33%), Gaps = 27/219 (12%)

Query: 184 NLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGG 243
            L N+I I  G + +     +T + L  +  L      +     + +  L  L  LEL  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 244 NKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGN 303
           N++     A   NL  +  L LS N L ++               S+          + N
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 304 LKVLIGIDF-----------------SMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP 346
           L+VL                      S+ N      T +  L  L  L    N++    P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 347 DSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS 385
                L +L  ++L NN +S   P  L   S L  + L+
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 5e-07
 Identities = 27/221 (12%), Positives = 71/221 (32%), Gaps = 24/221 (10%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
             +    +   +++ +  +  T  +L  +  L+     +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG 200
           + L DN +  +    ++  ++             +    + I  L  + T       L G
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 201 S------------IPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFG 248
                        I              L     + S    +  L++L  L+   NK+  
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFS 289
             P   ++L +L  + L +N+++ +     N  ++  +  +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 4e-04
 Identities = 38/235 (16%), Positives = 72/235 (30%), Gaps = 28/235 (11%)

Query: 8   NLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVR-LPNLEALLL 66
            L N  ++    + +  TV  A  ++  +  L      +    ++I  V+ L NL  L L
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV----TTIEGVQYLNNLIGLEL 70

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPEL 126
             N  +   P           L  +       I                           
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQI----------- 119

Query: 127 SFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLT 186
                 ++   L  +         +   T+I  L+      Y+S  N        + NL+
Sbjct: 120 ------TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS 173

Query: 187 NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL 241
              T+    NK++   P  L+ L  L  + L +N++    P  +   + L+ + L
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 7e-08
 Identities = 38/203 (18%), Positives = 72/203 (35%), Gaps = 15/203 (7%)

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
                +I  +L    +     +T ++L  +  +  +++ ++      I  L  + +L L 
Sbjct: 21  DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
           GNKL          LA+L+ L     +   +             + S           + 
Sbjct: 77  GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN 362
           +L  L  +    N  + +       L  L+ L L  N++   +P     L  L+ L LS 
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 363 NNLSGAIPTSLEKLSYLEDLNLS 385
           N++S     +L  L  L+ L L 
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 29/200 (14%), Positives = 68/200 (34%), Gaps = 25/200 (12%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
             ++     L + S +  +      L +++ +   ++ + S       +  +    ++T 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 141 IHLSDNPLDG-------------ILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTN 187
           + L+ N L                L +  + +LS       + + ++      +I  L +
Sbjct: 73  LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132

Query: 188 SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLF 247
              ++      N    IT+            ++     I   +  LT+L  L L  N + 
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI- 190

Query: 248 GSIPACFSNLASLRILSLSS 267
             + A  + L +L +L L S
Sbjct: 191 SDLRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 19/177 (10%), Positives = 60/177 (33%), Gaps = 14/177 (7%)

Query: 3   PLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLG--CLSSIADVRLPN 60
            +  + L +++++   ++ +       I  +  +  L L  N L     L+++ ++    
Sbjct: 39  AVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLF 96

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L+   +   +    + +    + + + +             +     N        + LT
Sbjct: 97  LDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLT 156

Query: 121 SST------PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSN 171
                     ++S +  L+    L  ++LS N +  +    ++  L  +L    + +
Sbjct: 157 KLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL---RALAGLK-NLDVLELFS 209

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 48.6 bits (114), Expect = 4e-07
 Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 3/161 (1%)

Query: 259 SLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEI-GNLKVLIGIDFSMNNF 317
               +  +   L  IP          +L  + N L       + G L  L+ ++   N  
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66

Query: 318 SSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLS 377
           + + P    G  +++ L LG N+++      F  L  LK LNL +N +S  +P S E L+
Sbjct: 67  TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126

Query: 378 YLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPT 418
            L  LNL+ N                 +S  G    CG+P+
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.7 bits (109), Expect = 2e-06
 Identities = 44/186 (23%), Positives = 71/186 (38%), Gaps = 14/186 (7%)

Query: 14  ELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSG 73
            +D     L   +P  I        L L +N L    S     RLP+L  L L  N  +G
Sbjct: 12  TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 74  TIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLS 133
             P     AS +  L+L +N         F  L  L+ LNL DN ++   P      S  
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFE 123

Query: 134 NCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDL 193
           +  SLT ++L+ NP +       +   +  L+   ++      G P ++ ++      DL
Sbjct: 124 HLNSLTSLNLASNPFNCN---CHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDL 177

Query: 194 GGNKLN 199
             ++  
Sbjct: 178 PHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)

Query: 224 GSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDI 283
                    L +L  L L  N++   +P  F +L SL  L+L+SN         W  + +
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151

Query: 284 LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNF 317
            + + +        P ++ ++++    D   + F
Sbjct: 152 RKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 4e-06
 Identities = 13/71 (18%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 330 NLEYLFLGYNRL-EGSIPDSFGDLISLKFLNLSNNNLSG----AIPTSLEKLSYLEDLNL 384
           +++ L +    L +    +    L   + + L +  L+      I ++L     L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 385 SFNKLEGEIPR 395
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 5/93 (5%)

Query: 85  LSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHL 143
           +  L++     S          L+  + + L D  LT +  +    S+L    +L  ++L
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNL 62

Query: 144 SDNPLDGILSKT---SIGNLSHSLKDFYMSNCN 173
             N L  +        +   S  ++   + NC 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 19/76 (25%), Positives = 27/76 (35%), Gaps = 9/76 (11%)

Query: 329 KNLEYLFLGYNRLEG----SIPDSFGDLISLKFLNLSNNNLSGAIPTSL-----EKLSYL 379
             L  L+L    +      S+  +     SL+ L+LSNN L  A    L     +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 380 EDLNLSFNKLEGEIPR 395
           E L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 13/93 (13%)

Query: 303 NLKVLIGIDFSMNNFSSVIPTEI-GGLKNLEYLFLGYNRLEG----SIPDSFGDLISLKF 357
           +++ L   D      S     E+   L+  + + L    L       I  +     +L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 358 LNLSNNNLSGAIPTSL-----EKLSYLEDLNLS 385
           LNL +N L       +          ++ L+L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 7e-05
 Identities = 15/92 (16%), Positives = 24/92 (26%), Gaps = 4/92 (4%)

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSG----FIPNTFGNLRNLEWLNLRDNYLTSS 122
                           S L +L L+    S      +  T     +L  L+L +N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 123 TPELSFLSSLSNCKSLTFIHLSDNPLDGILSK 154
                  S       L  + L D      +  
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 9e-05
 Identities = 12/92 (13%), Positives = 27/92 (29%), Gaps = 5/92 (5%)

Query: 60  NLEALLLWGNNFSGT-IPRFIFNASKLSILELSQNSFSG----FIPNTFGNLRNLEWLNL 114
           ++++L +     S       +    +  ++ L     +      I +       L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 115 RDNYLTSSTPELSFLSSLSNCKSLTFIHLSDN 146
           R N L             +    +  + L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 9e-05
 Identities = 13/97 (13%), Positives = 31/97 (31%), Gaps = 4/97 (4%)

Query: 11  NLEELDLRHNKLVGTVPAAIF-NMSMLKLLHLQNNSLLG-CLSSIADV--RLPNLEALLL 66
           +++ LD++  +L     A +   +   +++ L +  L       I+      P L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 67  WGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTF 103
             N         +    +    ++ + S         
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 15/83 (18%), Positives = 28/83 (33%), Gaps = 9/83 (10%)

Query: 303 NLKVLIGIDFSMNNFS----SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLI----- 353
              VL  +  +  + S    S +   +    +L  L L  N L  +      + +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 354 SLKFLNLSNNNLSGAIPTSLEKL 376
            L+ L L +   S  +   L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 5e-04
 Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 10/89 (11%)

Query: 190 TIDLGGNKLNGS-IPITLSKLQKLQGLGLDDNKLEG----SIPDSICRLTELYELELGGN 244
           ++D+   +L+ +     L  LQ+ Q + LDD  L       I  ++     L EL L  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 245 KLFGSIPACF-----SNLASLRILSLSSN 268
           +L      C      +    ++ LSL + 
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 7e-04
 Identities = 16/89 (17%), Positives = 28/89 (31%), Gaps = 8/89 (8%)

Query: 27  PAAIFNMSMLKLLHLQNNSLLG-CLSSIADV--RLPNLEALLLWGNNFSGTIPRFIFNA- 82
                  S+L++L L +  +     SS+A       +L  L L  N         +  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 83  ----SKLSILELSQNSFSGFIPNTFGNLR 107
                 L  L L    +S  + +    L 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 12/91 (13%), Positives = 23/91 (25%), Gaps = 5/91 (5%)

Query: 282 DILQLNFSSNFLT-GPLPLEIGNLKVLIGIDFSMNNFS----SVIPTEIGGLKNLEYLFL 336
           DI  L+     L+       +  L+    +       +      I + +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 337 GYNRLEGSIPDSFGDLISLKFLNLSNNNLSG 367
             N L           +      +   +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 16/81 (19%), Positives = 27/81 (33%), Gaps = 8/81 (9%)

Query: 7   SNLQNLEELDLRHNKL----VGTVPAAIFNMSMLKLLHLQNNSL----LGCLSSIADVRL 58
                L  L L    +      ++ A +     L+ L L NN L    +  L        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 59  PNLEALLLWGNNFSGTIPRFI 79
             LE L+L+   +S  +   +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 18/92 (19%), Positives = 26/92 (28%), Gaps = 10/92 (10%)

Query: 59  PNLEALLLWGNNFSGTIPRFIFNA----SKLSILELSQNSFSGFIPNTFG-----NLRNL 109
             L  L L   + S +    +         L  L+LS N                    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 110 EWLNLRDNYLTSSTPELSFLSSLSNCKSLTFI 141
           E L L D Y +    +    +   +  SL  I
Sbjct: 429 EQLVLYDIYWSEEMEDR-LQALEKDKPSLRVI 459

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 6e-06
 Identities = 37/200 (18%), Positives = 76/200 (38%), Gaps = 15/200 (7%)

Query: 183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG 242
           T L   +   LG   +     ++ + L ++  L  D   ++ SI D +  L  L ++   
Sbjct: 15  TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70

Query: 243 GNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIG 302
            N+L         NL  L  + +++N++  I              F++          + 
Sbjct: 71  NNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 303 NLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSN 362
           NL  L     ++++ S++         N     +       +      +L +L+ L++S+
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQV-------TDLKPLANLTTLERLDISS 181

Query: 363 NNLSGAIPTSLEKLSYLEDL 382
           N +S    + L KL+ LE L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.3 bits (90), Expect = 6e-04
 Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 21/194 (10%)

Query: 81  NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTF 140
             ++     L + + +  +  +  +L  +  L      + S       +  +    +LT 
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66

Query: 141 IHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG 200
           I+ S+N L  I   T + NL+  +     +N          +TNLT              
Sbjct: 67  INFSNNQLTDI---TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL-----FNNQI 118

Query: 201 SIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASL 260
           +    L  L  L  L L  N +      S     +        N++    P   +NL +L
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFS--SNQVTDLKP--LANLTTL 174

Query: 261 RILSLSSNELTSIP 274
             L +SSN+++ I 
Sbjct: 175 ERLDISSNKVSDIS 188

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.4 bits (108), Expect = 6e-06
 Identities = 38/328 (11%), Positives = 81/328 (24%), Gaps = 24/328 (7%)

Query: 77  RFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCK 136
           RF      L +  ++       +        +++ + L  N + +         ++++ K
Sbjct: 2   RFSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKK 59

Query: 137 SLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSN-CNVSGGIPEEITNLTNSITIDLGG 195
            L     SD     +  +                    V              +   L  
Sbjct: 60  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 196 NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFS 255
           +     + +  + L    G  +     E ++         L  +  G N+L       ++
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 256 NLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN 315
                  L  +   + +          +L+       L      +     +         
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239

Query: 316 NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGD------LISLKFLNLSNNNLSGAI 369
                +            L L    L      +  D       I L+ L L  N +    
Sbjct: 240 KSWPNLR----------ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 289

Query: 370 PTSL-----EKLSYLEDLNLSFNKLEGE 392
             +L     EK+  L  L L+ N+   E
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 36/316 (11%), Positives = 80/316 (25%), Gaps = 25/316 (7%)

Query: 1   EIPLEISNLQNLEELDLRHNKL----VGTVPAAIFNMSMLKLLHLQNNSLLGCLSSI--- 53
            +   +    +++E+ L  N +       +   I +   L++    +         I   
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 54  ------ADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLR 107
                 A ++ P L  + L  N F  T    + +              +  +    G   
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 108 NLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDF 167
                 L  N    + P L  +    N                         +  +    
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLE-NGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200

Query: 168 YMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIP 227
                 +  G+          +  +   +  + ++ I L     L+ LGL+D  L     
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260

Query: 228 DSI------CRLTELYELELGGNKLFGSIP-----ACFSNLASLRILSLSSNELTSIPLT 276
            ++           L  L L  N++               +  L  L L+ N  +     
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320

Query: 277 FWNLKDILQLNFSSNF 292
              ++++         
Sbjct: 321 VDEIREVFSTRGRGEL 336

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 40/233 (17%), Positives = 79/233 (33%), Gaps = 13/233 (5%)

Query: 160 LSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNG-SIPITLSKLQKLQGLGLD 218
           LS  +  F      +   + E  +       +DL  + +   ++   LS+  KLQ L L+
Sbjct: 21  LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79

Query: 219 DNKLEGSIPDSICRLTELYELELGGNKLF--GSIPACFSNLASLRILSLSSNELTSIPLT 276
             +L   I +++ + + L  L L G   F   ++    S+ + L  L+LS     +    
Sbjct: 80  GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 139

Query: 277 FWNLKD--------ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGL 328
              +           L     +   +    L      ++           +    E   L
Sbjct: 140 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199

Query: 329 KNLEYLFLGY-NRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLE 380
             L++L L     +        G++ +LK L +      G +    E L +L+
Sbjct: 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 2/100 (2%)

Query: 261 RILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS-S 319
           + L L+   L          + ++      +F+  PL       + +  +D S +    S
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61

Query: 320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLN 359
            +   +     L+ L L   RL   I ++     +L  LN
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 1e-05
 Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 4/146 (2%)

Query: 249 SIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLI 308
            +    S        +L    L S P         + LN  S+     L +   N+  L+
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAAT-LRIIEENIPELL 68

Query: 309 GIDFSMNNFSSV--IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS 366
            ++ S N    +  + + +    NL+ L L  N L+          + L+ L L  N+LS
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 367 GAIPTSLEKLSYLEDLNLSFNKLEGE 392
                    +S + +      +L+G 
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 32/156 (20%), Positives = 49/156 (31%), Gaps = 7/156 (4%)

Query: 265 LSSNELTSIPLTFWNLKDILQLNFS-SNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 323
           L   ++  + L      D  Q         + P  +      VL       ++ ++ +  
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVL----NRRSSMAATLRI 59

Query: 324 EIGGLKNLEYLFLGYNRLEG--SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLED 381
               +  L  L L  NRL     +        +LK LNLS N L         K   LE+
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 382 LNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSP 417
           L L  N L        ++ +   E F     L G  
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 3e-05
 Identities = 31/222 (13%), Positives = 60/222 (27%), Gaps = 25/222 (11%)

Query: 74  TIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSST---------- 123
            IP  +        L              F    +LE + +  N +              
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 124 -----------PELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNC 172
                             +  N  +L ++ +S+  +  +     I +L   L D   +  
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 173 NVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICR 232
             +      +     S+ + L  N +        +  Q  +    D+N LE    D    
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIP 274
            +    L++   ++         NL  LR  S     L  +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 8/57 (14%), Positives = 14/57 (24%)

Query: 307 LIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNN 363
                   NN   +      G      L +   R+         +L  L+  +  N 
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 9/44 (20%), Positives = 13/44 (29%)

Query: 345 IPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK 388
             D F        L++S   +       LE L  L   +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 12/50 (24%), Positives = 19/50 (38%), Gaps = 1/50 (2%)

Query: 67  WGNNFSGTIPRFIF-NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR 115
             NN    +P  +F  AS   IL++S+            NL+ L   +  
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 6e-04
 Identities = 31/221 (14%), Positives = 66/221 (29%), Gaps = 6/221 (2%)

Query: 1   EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPN 60
           EIP ++   +N  EL     KL      A      L+ + +  N +L  + +     LP 
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 61  LEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLT 120
           L                +I   +  ++  L     S        ++  +  L      + 
Sbjct: 80  LH----EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 121 SSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPE 180
            +    +   +     S   + L  N            N +   +     N N+     +
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 181 EITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNK 221
                +  + +D+   +++      L  L+KL+     + K
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.002
 Identities = 9/57 (15%), Positives = 16/57 (28%), Gaps = 11/57 (19%)

Query: 6   ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLE 62
                    LD+   ++       + N+  L+     N             +LP LE
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-----------KLPTLE 242

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 5e-05
 Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 6/136 (4%)

Query: 254 FSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFS 313
           ++N    R L L   ++  I      L     ++FS N +          L+ L  +  +
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVN 71

Query: 314 MNNFSSVIPTEIGGLKNLEYLFLGYNRLEG-SIPDSFGDLISLKFLNLSNNN---LSGAI 369
            N    +       L +L  L L  N L      D    L SL +L +  N         
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 370 PTSLEKLSYLEDLNLS 385
              + K+  +  L+  
Sbjct: 132 LYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 9e-05
 Identities = 24/139 (17%), Positives = 49/139 (35%), Gaps = 7/139 (5%)

Query: 4   LEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEA 63
            + +N     ELDLR  K+   +      +     +   +N  +  L       L  L+ 
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-IRKLDGFP--LLRRLKT 67

Query: 64  LLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGF-IPNTFGNLRNLEWLNLRDNYLTSS 122
           LL+  N               L+ L L+ NS       +   +L++L +L +  N +T+ 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 123 TPELSFLSSLSNCKSLTFI 141
                ++  +     +  +
Sbjct: 128 KHYRLYV--IYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 1e-04
 Identities = 21/143 (14%), Positives = 46/143 (32%), Gaps = 10/143 (6%)

Query: 80  FNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLT 139
            NA +   L+L        I N    L   + ++  DN +         L      + L 
Sbjct: 15  TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPLLRRLK 66

Query: 140 FIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLN 199
            + +++N +  I           +      ++     G  + + +L +   + +  N + 
Sbjct: 67  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125

Query: 200 GSIPITLSKLQKLQGLG-LDDNK 221
                 L  + K+  +  LD  K
Sbjct: 126 NKKHYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 4e-04
 Identities = 23/133 (17%), Positives = 46/133 (34%), Gaps = 6/133 (4%)

Query: 233 LTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNF 292
                EL+L G K+   I    + L     +  S NE+  +   F  L+ +  L  ++N 
Sbjct: 17  AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNR 74

Query: 293 LTGPLPLEIGNLKVLIGIDFSMNNFSSV-IPTEIGGLKNLEYLFLG---YNRLEGSIPDS 348
           +          L  L  +  + N+   +     +  LK+L YL +        +      
Sbjct: 75  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134

Query: 349 FGDLISLKFLNLS 361
              +  ++ L+  
Sbjct: 135 IYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.002
 Identities = 6/42 (14%), Positives = 17/42 (40%), Gaps = 1/42 (2%)

Query: 348 SFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKL 389
            + + +  + L+L    +   I      L   + ++ S N++
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (92), Expect = 2e-04
 Identities = 22/110 (20%), Positives = 34/110 (30%), Gaps = 2/110 (1%)

Query: 10  QNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGN 69
                L    +  +      +     L  L+++N   L  L       L  L  L +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 70  NFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYL 119
                 P       +LS L LS N+       T     +L+ L L  N L
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPL 115

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.5 bits (88), Expect = 9e-04
 Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 12/175 (6%)

Query: 225 SIPDSICRLTELYE---LELGGNKLFGSIP------ACFSNLASLRILSLSSNELTSIPL 275
           +I D+I    E       E    +L G IP      A  S L + + L+LS+N +  I  
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS- 64

Query: 276 TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF 335
           +   ++++  L+   N +     L+   +   +   +   N  + +      +       
Sbjct: 65  SLSGMENLRILSLGRNLIKKIENLD--AVADTLEELWISYNQIASLSGIEKLVNLRVLYM 122

Query: 336 LGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLE 390
                      D    L  L+ L L+ N L      +     Y  ++      L+
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	646
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.98
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.94
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.81
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.65
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.65
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.61
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.61
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.5
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.49
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.64
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.64
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.44
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.63
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.44
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.83
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.82
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.62
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.76
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.71

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.1e-33  Score=285.20  Aligned_cols=255  Identities=31%  Similarity=0.533  Sum_probs=236.7

Q ss_pred             cCcEEEeecccccc--cCCcccccCCCCCEEEccC-CccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEE
Q 046544          163 SLKDFYMSNCNVSG--GIPEEITNLTNSITIDLGG-NKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYEL  239 (646)
Q Consensus       163 ~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  239 (646)
                      .++.|+|++|++++  .+|+.++++++|++|||++ |++.+.+|..|+++++|++|+|++|++.+..+..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            57788888888877  4789999999999999997 89999999999999999999999999999999999999999999


Q ss_pred             EecCCcccccCCccccCCCCCceeecCCCccc-cccccccccccc-ccccCCCCcccCCCCCccCccccceEEEcccccc
Q 046544          240 ELGGNKLFGSIPACFSNLASLRILSLSSNELT-SIPLTFWNLKDI-LQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNF  317 (646)
Q Consensus       240 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l  317 (646)
                      ++++|.+.+..|..++++++|+.+++++|.++ .+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            99999999999999999999999999999998 789888888776 789999999999999988888765 699999999


Q ss_pred             cccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCC
Q 046544          318 SSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGG  397 (646)
Q Consensus       318 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  397 (646)
                      .+..|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999996554 78999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCccccccCCccccCCCCc
Q 046544          398 SFGNFAAESFEGNELLCGSPTL  419 (646)
Q Consensus       398 ~~~~~~~~~~~~N~~~c~~~~~  419 (646)
                      .++.++.+++.+|+.+|+.|+.
T Consensus       289 ~L~~L~~l~l~~N~~l~g~plp  310 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSS
T ss_pred             cCCCCCHHHhCCCccccCCCCC
Confidence            8999999999999999998863

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.1e-31  Score=278.25  Aligned_cols=339  Identities=26%  Similarity=0.393  Sum_probs=198.3

Q ss_pred             ECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCcc
Q 046544           16 DLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSF   95 (646)
Q Consensus        16 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l   95 (646)
                      +++.+.+++.++  ...+.+|++|++++|.|+. +..+.  .+++|++|+|++|+|++..|  +.++++|++|++++|+|
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l~gl~--~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVE--YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-CTTGG--GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-ccccc--cCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccc
Confidence            344444444332  2345566666666666654 23333  26666666666666664332  66666666666666666


Q ss_pred             ccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhc-----------------
Q 046544           96 SGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIG-----------------  158 (646)
Q Consensus        96 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----------------  158 (646)
                      .++.|  ++++++|+.|++++|.++....       ......+..+....|.+..+.......                 
T Consensus       101 ~~i~~--l~~l~~L~~L~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (384)
T d2omza2         101 ADITP--LANLTNLTGLTLFNNQITDIDP-------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPL  171 (384)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCCGG-------GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGG
T ss_pred             ccccc--cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            65432  5666666666666666665432       233345555555555443332111000                 


Q ss_pred             cccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcE
Q 046544          159 NLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYE  238 (646)
Q Consensus       159 ~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  238 (646)
                      .............|...  .+..+..++++..+++++|.+++..|  +...++|++|++++|++++.  +.+..+++|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~  245 (384)
T d2omza2         172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTD  245 (384)
T ss_dssp             TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred             ccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccch
Confidence            00112222233333322  34556666777777777777765544  34456777777777777642  35666777777


Q ss_pred             EEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEccccccc
Q 046544          239 LELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFS  318 (646)
Q Consensus       239 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  318 (646)
                      |++++|++++..+  +..+++|++|++++|.++.++ .+..++.++.++++.|.+++.  ..+..++.++.|++++|+++
T Consensus       246 L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~  320 (384)
T d2omza2         246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNIS  320 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCS
T ss_pred             hccccCccCCCCc--ccccccCCEeeccCcccCCCC-ccccccccccccccccccccc--cccchhcccCeEECCCCCCC
Confidence            7777777765432  666677777777777777665 355666667777777776642  34566667777777777776


Q ss_pred             ccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCC
Q 046544          319 SVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFN  387 (646)
Q Consensus       319 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  387 (646)
                      ++.  .+..+++|++|++++|++++ ++ .++++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       321 ~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         321 DIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            653  26666777777777777764 22 46667777777777777765443  666777777777766

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.8e-32  Score=270.84  Aligned_cols=148  Identities=30%  Similarity=0.389  Sum_probs=136.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999864 79999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++...  .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.+
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999988764  5899999999999999999999   88999999999999999999999999999997643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-32  Score=272.15  Aligned_cols=148  Identities=26%  Similarity=0.380  Sum_probs=138.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      +.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999965 68999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      +||+|.+++.+....+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            999999998776667999999999999999999999   889999999999999999999999999999765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-32  Score=271.05  Aligned_cols=149  Identities=24%  Similarity=0.342  Sum_probs=133.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357899999999999999999975 69999999997653 2334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+||+|.+++... ..+++.++..++.|+++|++|||   +++|+||||||+|||+++++.+||+|||+|+.+.
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            99999999998654 47899999999999999999999   8899999999999999999999999999998764

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1e-30  Score=272.99  Aligned_cols=339  Identities=23%  Similarity=0.328  Sum_probs=273.4

Q ss_pred             EECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCC
Q 046544           39 LHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNY  118 (646)
Q Consensus        39 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  118 (646)
                      ..++.+.+++.++.   ..+.+|++|++++|.|+..  +.+..+++|++|+|++|+|+++.|  |+++++|++|++++|+
T Consensus        27 ~~l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          27 TVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHTTCSSTTSEECH---HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHhCCCCCCCccCH---HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence            46777777654332   2477999999999999853  457889999999999999998754  9999999999999999


Q ss_pred             CCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccC-------------------C
Q 046544          119 LTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGI-------------------P  179 (646)
Q Consensus       119 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-------------------p  179 (646)
                      ++.++       .++++++|+.|++++|.+.++.....    ...+.......|.+....                   .
T Consensus       100 i~~i~-------~l~~l~~L~~L~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  168 (384)
T d2omza2         100 IADIT-------PLANLTNLTGLTLFNNQITDIDPLKN----LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL  168 (384)
T ss_dssp             CCCCG-------GGTTCTTCCEEECCSSCCCCCGGGTT----CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC
T ss_pred             ccccc-------cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccchh
Confidence            98763       37899999999999999987754322    234556666666554321                   2


Q ss_pred             cccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCC
Q 046544          180 EEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLAS  259 (646)
Q Consensus       180 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  259 (646)
                      ..+...+.........|...  ....+..+++++.+++++|.+++..|  +...++|++|++++|+++..  +.+..+++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~  242 (384)
T d2omza2         169 KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTN  242 (384)
T ss_dssp             GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred             hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccc
Confidence            23344445555556665553  35567888999999999999997655  56678999999999999753  46889999


Q ss_pred             CceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCc
Q 046544          260 LRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYN  339 (646)
Q Consensus       260 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  339 (646)
                      |+.|++++|.++.++. +..+++|+.|++++|.+++..  .+..++.++.++++.|.+++.  ..+..+++++.|++++|
T Consensus       243 L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n  317 (384)
T d2omza2         243 LTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFN  317 (384)
T ss_dssp             CSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSS
T ss_pred             cchhccccCccCCCCc-ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCC
Confidence            9999999999998874 778899999999999998654  477899999999999999864  45888999999999999


Q ss_pred             cCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCc
Q 046544          340 RLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNE  411 (646)
Q Consensus       340 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~  411 (646)
                      ++++..+  +..+++|++|++++|+|++ ++ .+..+++|++|++++|++++.+| ...++.++.+++++|.
T Consensus       318 ~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         318 NISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCEE
T ss_pred             CCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCCc
Confidence            9997643  8899999999999999984 44 69999999999999999998665 5668899999998883

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-32  Score=267.58  Aligned_cols=149  Identities=29%  Similarity=0.456  Sum_probs=132.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||++++++..++..++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999888999999987543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +|+|.+++......+++..+..++.|+++||+|+|   .++|+||||||+||++++++.+||+|||+|+.+.+
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccC
Confidence            99999999887778899999999999999999999   88999999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.5e-32  Score=273.70  Aligned_cols=150  Identities=28%  Similarity=0.498  Sum_probs=136.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999975 68999999987543 3457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          570 KPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       570 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |++|++.+++... ...+++..+..++.||+.||+|||   .++|+||||||+|||+++++.+||+|||+|+...+
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999998754 457899999999999999999999   88999999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=4.4e-32  Score=272.00  Aligned_cols=148  Identities=26%  Similarity=0.481  Sum_probs=126.1

Q ss_pred             CCCcceeecccccceEEEEEeC-CC---cEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      +|+..+.||+|+||+||+|+++ ++   ..||||.+.... ....++|.+|++++++++|||||++++++..++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4556789999999999999864 33   358899876543 344568999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999887778999999999999999999999   8899999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=262.88  Aligned_cols=149  Identities=28%  Similarity=0.421  Sum_probs=135.3

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||+|++....   ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999975 68999999987432   334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |||++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...+
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999997654 6899999999999999999999   88999999999999999999999999999987644

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=3e-31  Score=271.42  Aligned_cols=150  Identities=21%  Similarity=0.329  Sum_probs=137.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56899999999999999999964 79999999998766555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--CCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++...+..+++.++..|+.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+.+..
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999988777667999999999999999999999   89999999999999997  678999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-31  Score=259.38  Aligned_cols=149  Identities=26%  Similarity=0.443  Sum_probs=138.0

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++++|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            67899999999999999999998899999999986543 44789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          572 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       572 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +|++.+++......+++..+.+++.|+++||+|||   +++|+||||||+||++++++.+||+|||+|+.+.+
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            99999998777677899999999999999999999   88999999999999999999999999999987643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-31  Score=263.79  Aligned_cols=147  Identities=27%  Similarity=0.490  Sum_probs=131.2

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEecc--CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999864  35999998754  34456789999999999999999999998754 56899999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++|+|.+++...+..+++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+...
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            99999999999877778999999999999999999999   8899999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=263.28  Aligned_cols=149  Identities=26%  Similarity=0.471  Sum_probs=132.7

Q ss_pred             hCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      .++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.. +..++|||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35788899999999999999999888999999997543 345789999999999999999999998754 5679999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ++|+|.+++.... ..+++..+..|+.||++||+|||   .++|+||||||+|||+++++.+||+|||+|+.+.+
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence            9999999875433 35899999999999999999999   88999999999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=4.4e-31  Score=269.97  Aligned_cols=150  Identities=21%  Similarity=0.317  Sum_probs=137.6

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  570 (646)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999964 79999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc--CCCcEEEEeecCcccccC
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~--~~~~~ki~DfGla~~~~~  644 (646)
                      +||+|.+++......+++..+..++.||+.||+|||   +++||||||||+|||++  .++.+||+|||+|+.+.+
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999776667999999999999999999999   89999999999999995  467899999999997654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-31  Score=264.32  Aligned_cols=148  Identities=30%  Similarity=0.452  Sum_probs=135.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56899999999999999999974 79999999997532   334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+||+|.+++...+ .+++..+..++.|++.|++|+|   +++||||||||+||++++++.+||+|||+|+.+.
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence            9999999999987654 6899999999999999999999   8899999999999999999999999999999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=271.19  Aligned_cols=148  Identities=22%  Similarity=0.326  Sum_probs=134.9

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999965 78999999998653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCL-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      ||+||+|.+++...+ .+++..+..++.|++.|++|||   + ++|+||||||+|||+++++.+||+|||+|+.+
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999997654 6899999999999999999999   5 48999999999999999999999999999865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.9e-31  Score=259.83  Aligned_cols=149  Identities=26%  Similarity=0.425  Sum_probs=131.0

Q ss_pred             CCCCcce-eecccccceEEEEEeC---CCcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENN-LIGRGGFGSVYKARLG---DGMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|...+ +||+|+||+||+|.++   ++..||||+++.... ...++|.+|++++++++|||||++++++..+ ..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            3455566 4999999999999764   356799999976543 3457899999999999999999999998754 57999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||||++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999998877778999999999999999999999   88999999999999999999999999999997643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=8e-31  Score=263.49  Aligned_cols=147  Identities=28%  Similarity=0.370  Sum_probs=132.6

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .|+..+.||+|+||+||+|+.. +|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999864 789999999986542   234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||++|++..+.... ..+++.++..++.||+.||.|||   .++||||||||+|||+++++.+||+|||+|+...
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999987766554 47899999999999999999999   8899999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=260.78  Aligned_cols=152  Identities=26%  Similarity=0.388  Sum_probs=124.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec--CCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN--EEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv  566 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++....  +...+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999865 79999999997653  2345678899999999999999999999865  4568999


Q ss_pred             EEecCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          567 LEYKPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGC--LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ||||+||+|.+++..   .+..+++..+..++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2357899999999999999999999421  23599999999999999999999999999987


Q ss_pred             cc
Q 046544          642 LI  643 (646)
Q Consensus       642 ~~  643 (646)
                      +.
T Consensus       164 ~~  165 (269)
T d2java1         164 LN  165 (269)
T ss_dssp             C-
T ss_pred             cc
Confidence            64

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.5e-30  Score=262.19  Aligned_cols=227  Identities=32%  Similarity=0.475  Sum_probs=200.5

Q ss_pred             cCcEEEeec-ccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEe
Q 046544          163 SLKDFYMSN-CNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELEL  241 (646)
Q Consensus       163 ~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  241 (646)
                      +|++|+|++ |+++|.+|..++++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+..++.|+.+++
T Consensus        77 ~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l  156 (313)
T d1ogqa_          77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF  156 (313)
T ss_dssp             TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeec
Confidence            455566654 5667778899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCccccCCCCC-ceeecCCCccccc-ccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccc
Q 046544          242 GGNKLFGSIPACFSNLASL-RILSLSSNELTSI-PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS  319 (646)
Q Consensus       242 ~~N~i~~~~~~~~~~l~~L-~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  319 (646)
                      ++|.+.+.+|..+..+.++ +.+++++|+++.. |..+..+ ....++++++...+.+|..+..+++++.+++++|.+++
T Consensus       157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~  235 (313)
T d1ogqa_         157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF  235 (313)
T ss_dssp             CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999988888776 8899999999855 4455554 45579999999999999999999999999999999987


Q ss_pred             cCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCc-ceee
Q 046544          320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNK-LEGE  392 (646)
Q Consensus       320 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~  392 (646)
                      .+ ..++.+++|+.|+|++|++++.+|+.|+.+++|++|||++|+|+|.+|. +..+++|+.+++++|+ +.|.
T Consensus       236 ~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         236 DL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             BG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             cc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            65 4689999999999999999999999999999999999999999999985 6889999999999998 5553

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-30  Score=263.87  Aligned_cols=149  Identities=27%  Similarity=0.364  Sum_probs=135.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999964 79999999997542   334577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |||+||+|.+++...+ .+++..+..+++|++.|++|+|   +++|+||||||+|||++.+|.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999987755 6889999999999999999999   89999999999999999999999999999997643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=2.9e-30  Score=255.39  Aligned_cols=149  Identities=27%  Similarity=0.417  Sum_probs=134.9

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCc---------hHHHHHHHHHHHHhCC-CCCceeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR---------AFKSFAVECEMMKSIR-HRNLIKVISSCSNE  560 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~  560 (646)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67899999999999999999964 7999999999765321         2246888999999996 99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      +..|+|||||+||+|.+++...+ .+++.++..++.||++||+|||   .++|+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997754 6899999999999999999999   8899999999999999999999999999998


Q ss_pred             cccC
Q 046544          641 LLIG  644 (646)
Q Consensus       641 ~~~~  644 (646)
                      .+.+
T Consensus       159 ~~~~  162 (277)
T d1phka_         159 QLDP  162 (277)
T ss_dssp             ECCT
T ss_pred             EccC
Confidence            7643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=3.1e-30  Score=260.23  Aligned_cols=149  Identities=28%  Similarity=0.367  Sum_probs=135.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999974 69999999997532   334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      |||+||++.+++.... .+++..+..++.||+.|++|+|   +++|+||||||+|||++.++.+||+|||+|+.+.+
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999999887765 6788888999999999999999   89999999999999999999999999999997643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.7e-30  Score=260.97  Aligned_cols=149  Identities=22%  Similarity=0.337  Sum_probs=124.0

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      .+.|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999975 68999999997654 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~  643 (646)
                      ||+||+|.+++...+ .+++.++..++.|++.|++|||   +++|+||||||+||++.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999997654 7899999999999999999999   88999999999999994   57899999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=258.10  Aligned_cols=149  Identities=28%  Similarity=0.506  Sum_probs=130.6

Q ss_pred             CCCCcceeecccccceEEEEEeCC-C----cEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD-G----MEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      +.|+..+.||+|+||+||+|.++. +    ..||||++..... ...++|.+|++++++++|||||++++++...+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            567888999999999999998653 2    4699999875433 344578999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||||.+|++.+++......+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999887778999999999999999999999   8899999999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.9e-30  Score=260.23  Aligned_cols=150  Identities=20%  Similarity=0.296  Sum_probs=135.4

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367899999999999999999875 68999999997653 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC--CCcEEEEeecCcccccC
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~--~~~~ki~DfGla~~~~~  644 (646)
                      |+||+|.+++...+..+++.++..++.||+.|++|||   +++|+||||||+|||++.  ...+||+|||+|+....
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999877667999999999999999999999   889999999999999974  45899999999987643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.4e-30  Score=253.07  Aligned_cols=145  Identities=28%  Similarity=0.396  Sum_probs=127.0

Q ss_pred             CcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEec----CCeeEEEE
Q 046544          495 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSN----EEFKALVL  567 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~  567 (646)
                      +..+.||+|+||+||+|++. +++.||+|.+....  ....+.+.+|++++++++|||||++++++..    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999965 68899999987553  3345678999999999999999999999865    34689999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEEc-CCCcEEEEeecCccccc
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nil~~-~~~~~ki~DfGla~~~~  643 (646)
                      |||++|+|.+++.... .+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999997654 6899999999999999999999   666  99999999999996 57899999999998654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.8e-28  Score=247.49  Aligned_cols=286  Identities=20%  Similarity=0.172  Sum_probs=168.9

Q ss_pred             CCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEcc
Q 046544           36 LKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLR  115 (646)
Q Consensus        36 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  115 (646)
                      ++.++=++++++..|+.+    .+++++|+|++|+|+...+..|.++++|++|++++|.+..+.|.+|.++++|++|+++
T Consensus        12 ~~~~~C~~~~L~~lP~~l----~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLEKVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCCSCCCSC----CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCCccCCCC----CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            445555555565543333    2456677777777765555567777777777777777777767777777777777777


Q ss_pred             CCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccc--cccCCcccccCCCCCEEEc
Q 046544          116 DNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNV--SGGIPEEITNLTNSITIDL  193 (646)
Q Consensus       116 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l--~~~~p~~~~~l~~L~~L~L  193 (646)
                      +|+|+.++..        ....++.|++++|.+..+....+.  .......++...|..  ....+..+..+++|+.+++
T Consensus        88 ~n~l~~l~~~--------~~~~l~~L~~~~n~l~~l~~~~~~--~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l  157 (305)
T d1xkua_          88 KNQLKELPEK--------MPKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  157 (305)
T ss_dssp             SSCCSBCCSS--------CCTTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             CCccCcCccc--------hhhhhhhhhccccchhhhhhhhhh--ccccccccccccccccccCCCccccccccccCcccc
Confidence            7777766532        124566777777776655332211  122344455554432  2234455666666777777


Q ss_pred             cCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccc
Q 046544          194 GGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSI  273 (646)
Q Consensus       194 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l  273 (646)
                      ++|.+... |..+  .++|++|++++|.+....+.+|.+++.+++|++++|++.+..+..|.++++|++|+|++|.|+++
T Consensus       158 ~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l  234 (305)
T d1xkua_         158 ADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV  234 (305)
T ss_dssp             CSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred             ccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc
Confidence            77766643 2221  35666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             ccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC--CcccccccC
Q 046544          274 PLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE--GSIPDSFGD  351 (646)
Q Consensus       274 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~  351 (646)
                      |.++..+++|++|++++|+|+.+....|..                  +..+..+.+|+.|+|++|+++  .+.|.+|..
T Consensus       235 p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~  296 (305)
T d1xkua_         235 PGGLADHKYIQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC  296 (305)
T ss_dssp             CTTTTTCSSCCEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred             ccccccccCCCEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCccCcCCHhHhcc
Confidence            655555566666666655555332222211                  223344566777777777664  344555555


Q ss_pred             CCCCC
Q 046544          352 LISLK  356 (646)
Q Consensus       352 l~~L~  356 (646)
                      +....
T Consensus       297 ~~~~~  301 (305)
T d1xkua_         297 VYVRA  301 (305)
T ss_dssp             CCCGG
T ss_pred             cccCc
Confidence            44333

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.1e-30  Score=255.61  Aligned_cols=148  Identities=26%  Similarity=0.402  Sum_probs=134.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC------CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++....      ....+.+.+|++++++++|||||++++++.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999974 79999999997542      223578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC----cEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~----~~ki~DfGla~  640 (646)
                      +|||||+||+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+|++|||+|+
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999997654 6899999999999999999999   88999999999999998766    59999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       166 ~~~  168 (293)
T d1jksa_         166 KID  168 (293)
T ss_dssp             ECT
T ss_pred             hcC
Confidence            764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.3e-30  Score=253.82  Aligned_cols=141  Identities=28%  Similarity=0.427  Sum_probs=124.3

Q ss_pred             eeecccccceEEEEEeC---CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecCC
Q 046544          498 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKPH  572 (646)
Q Consensus       498 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  572 (646)
                      ++||+|+||+||+|.++   +++.||||+++...  ....++|.+|++++++++|||||+++++|..+ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999854   35789999986542  33456899999999999999999999999754 57899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          573 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       573 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            99999998754 6899999999999999999999   8899999999999999999999999999998764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-30  Score=255.46  Aligned_cols=147  Identities=29%  Similarity=0.495  Sum_probs=130.6

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEecC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYKP  571 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  571 (646)
                      ++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. ++..++|||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5789999999999999999999888899999987543 34578999999999999999999999985 456899999999


Q ss_pred             CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          572 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       572 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|++..++... ...+++.++..++.||+.|++|||   .++|+||||||+|||+++++.+||+|||+|+.+.
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            99999888653 246899999999999999999999   8899999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.4e-30  Score=258.76  Aligned_cols=149  Identities=28%  Similarity=0.479  Sum_probs=129.0

Q ss_pred             CCCCcceeecccccceEEEEEeCC------CcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCee
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  563 (646)
                      ++|+..+.||+|+||+||+|++..      ...||+|.+.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578889999999999999998542      2369999886543 33456789999999998 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 046544          564 ALVLEYKPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPD  621 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~  621 (646)
                      |+|||||++|+|.+++....                      ..+++..+..++.||++||+|||   +++||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            99999999999999997653                      24788899999999999999999   889999999999


Q ss_pred             CEEEcCCCcEEEEeecCccccc
Q 046544          622 NVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       622 Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||+++.++.+||+|||+|+...
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~  215 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIM  215 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGG
T ss_pred             ccccccCCeEEEeecccccccc
Confidence            9999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=1.3e-29  Score=259.18  Aligned_cols=149  Identities=25%  Similarity=0.352  Sum_probs=135.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  567 (646)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....   ....+.+.+|+++++.++|||||++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47899999999999999999975 79999999997532   334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ||+.||++.+++...+ .+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+.+.+
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999987654 6899999999999999999999   88999999999999999999999999999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=253.92  Aligned_cols=149  Identities=27%  Similarity=0.371  Sum_probs=129.4

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...  +...+++.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999996 479999999996543  2235688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |+.++.+..........+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceecc
Confidence            99765444444444567999999999999999999999   8899999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=3.8e-29  Score=257.13  Aligned_cols=149  Identities=24%  Similarity=0.318  Sum_probs=130.0

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHH---HHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFA---VECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ......+.   +|+++++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999965 69999999987432   11122333   3467778889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +|||||+||+|.+++.... .+++..+..++.||+.||+|||   .++||||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999997654 6789999999999999999999   89999999999999999999999999999997643

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=2.5e-27  Score=239.07  Aligned_cols=284  Identities=21%  Similarity=0.307  Sum_probs=199.8

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCC
Q 046544           60 NLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLT  139 (646)
Q Consensus        60 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  139 (646)
                      .++++|-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..++++     .|.++++|+
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~-----~f~~l~~L~   82 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFAPLVKLE   82 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-----TTTTCTTCC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh-----hhhCCCccC
Confidence            5678999999999 5566553  6899999999999988888999999999999999999987553     588999999


Q ss_pred             EEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccc--cccCccccCCCCCCeEEe
Q 046544          140 FIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLN--GSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       140 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L  217 (646)
                      +|++++|+++.++...     ...+..|++.+|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++
T Consensus        83 ~L~l~~n~l~~l~~~~-----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l  157 (305)
T d1xkua_          83 RLYLSKNQLKELPEKM-----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  157 (305)
T ss_dssp             EEECCSSCCSBCCSSC-----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             EecccCCccCcCccch-----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccc
Confidence            9999999998875432     245777777777777766666667777777777776543  233455666667777777


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      ++|.+.. +|..+  .++|+.|++++|.+....+..|.+++.+++|++++|.++.+                       .
T Consensus       158 ~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~-----------------------~  211 (305)
T d1xkua_         158 ADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-----------------------D  211 (305)
T ss_dssp             CSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE-----------------------C
T ss_pred             ccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccc-----------------------c
Confidence            7776663 33322  45666666666666666666666666666666666666554                       3


Q ss_pred             CCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccc------cCCCCCCEEEccCCcCc--ccC
Q 046544          298 PLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSF------GDLISLKFLNLSNNNLS--GAI  369 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~Ls~N~l~--~~~  369 (646)
                      +..+.++++|++|+|++|++++ +|.+|..+++|++|+|++|+|+.+....|      ..+.+|+.|+|++|.++  ...
T Consensus       212 ~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~  290 (305)
T d1xkua_         212 NGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ  290 (305)
T ss_dssp             TTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred             cccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence            4445555666666666666664 35667777777888887777775544444      34567778888888765  355


Q ss_pred             CccccCCCCCCcee
Q 046544          370 PTSLEKLSYLEDLN  383 (646)
Q Consensus       370 p~~~~~l~~L~~L~  383 (646)
                      |.+|..+.....++
T Consensus       291 ~~~f~~~~~~~~~~  304 (305)
T d1xkua_         291 PSTFRCVYVRAAVQ  304 (305)
T ss_dssp             GGGGTTCCCGGGEE
T ss_pred             HhHhcccccCcccc
Confidence            66666555544443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.7e-29  Score=251.96  Aligned_cols=148  Identities=24%  Similarity=0.382  Sum_probs=132.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC---CchHHHHHHHHHHHH-hCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRAFKSFAVECEMMK-SIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|...+.||+|+||+||+|+.. +|+.||||++++..   ....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999865 79999999997542   334456777777765 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||+||+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+|++|||+|+...
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999997654 6889999999999999999999   8899999999999999999999999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2e-29  Score=253.42  Aligned_cols=156  Identities=29%  Similarity=0.454  Sum_probs=137.0

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccCCc-hHHHHHHHHHHHHhCCCCCceeEEEEE
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-AFKSFAVECEMMKSIRHRNLIKVISSC  557 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~  557 (646)
                      .+++...++|+..+.||+|+||+||+|+++      +++.||||+++..... ..++|.+|++++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344445678999999999999999999853      3578999998765433 356799999999999999999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 046544          558 SNEEFKALVLEYKPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGCLAPVI  614 (646)
Q Consensus       558 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii  614 (646)
                      ...+..++||||+++|+|.+++....                       ..+++..+..|+.|++.||+|+|   .++||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999996532                       24788899999999999999999   88999


Q ss_pred             ecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          615 HCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       615 Hrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ||||||+|||++.++.+||+|||+|+.+.
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~  191 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIY  191 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred             eeEEcccceEECCCCcEEEccchhheecc
Confidence            99999999999999999999999998653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.8e-29  Score=247.67  Aligned_cols=148  Identities=24%  Similarity=0.379  Sum_probs=125.1

Q ss_pred             CCCCcceeecccccceEEEEEeCC----CcEEEEEEEeccCC-chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCG-RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||+||+|++..    +..||||.++.... ...+.+.+|++++++++|||||++++++. ++..|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578899999999999999998642    45688988865433 34567999999999999999999999985 5678999


Q ss_pred             EEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          567 LEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      |||+++|++.+++......+++..+..++.||++||+|+|   +++|+||||||+||++++++.+||+|||+|+.+.
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998887778999999999999999999999   8899999999999999999999999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.95  E-value=4.5e-29  Score=249.18  Aligned_cols=148  Identities=24%  Similarity=0.352  Sum_probs=132.8

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||+||+|++++|+.||||++....  +...+++.+|+.++++++|||||++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999999899999999997653  23357889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +.++.+..+. .....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+|++|||.|....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            9876555554 44457999999999999999999999   8899999999999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.1e-29  Score=246.77  Aligned_cols=148  Identities=28%  Similarity=0.392  Sum_probs=124.3

Q ss_pred             CCCCcceeecccccceEEEEEeC--CC--cEEEEEEEecc---CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQ---CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKA  564 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  564 (646)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||++...   .....++|.+|++++++++|||||++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999853  23  47899988654   23445789999999999999999999999965 4678


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      +|||||++|++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999999998877667999999999999999999999   8899999999999999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=249.41  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=129.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc----EEEEEEEecc-CCchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  565 (646)
                      .+|+..+.||+|+||+||+|++. +|+    +||+|.++.. ..+..+++.+|++++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999864 444    5888887643 344567899999999999999999999999865 5678


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      +|||+.+|+|.+++......+++..+..++.||++||+|||   .++||||||||+||+++.++.+||+|||+|+.+..
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999999888888999999999999999999999   88999999999999999999999999999987643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.3e-29  Score=249.72  Aligned_cols=145  Identities=29%  Similarity=0.419  Sum_probs=124.2

Q ss_pred             cceeecccccceEEEEEeC-CCcEEEEEEEeccCC-----chHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEEe
Q 046544          496 ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       496 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ..++||+|+||+||+|+.+ +|+.||||+++....     ...+.+.+|++++++++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999964 699999999865432     1235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ++++++..+. ..+..+++..+..+++||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...+
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCC
Confidence            9887666554 44457888899999999999999999   89999999999999999999999999999987654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-28  Score=243.75  Aligned_cols=231  Identities=26%  Similarity=0.244  Sum_probs=157.2

Q ss_pred             CCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEec-CCcccccCCccccCCCCCceee
Q 046544          186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELG-GNKLFGSIPACFSNLASLRILS  264 (646)
Q Consensus       186 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~  264 (646)
                      +++++|+|++|+|+.+++.+|.++++|++|++++|++..+.+..+..++.++.++.. .|.++...+..|+++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            345566666666665555566666666666666666666666666666666666543 4455555566666666666666


Q ss_pred             cCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCC
Q 046544          265 LSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEG  343 (646)
Q Consensus       265 L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  343 (646)
                      +++|.+..++. .+...++|+.+++++|.++++.+..|..++.|+.|++++|+++++.+.+|.++++|+++++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            66666665543 34455666666666666666666677777778888888888887777888888888888888888887


Q ss_pred             cccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCC
Q 046544          344 SIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGS  416 (646)
Q Consensus       344 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~  416 (646)
                      ..|..|..+++|++||+++|++++..|..|..+++|++|++++|++.|.++.......++......+...|..
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~  264 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL  264 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence            7788888888888888888888877777888888888888888888877664332333444445555566643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.8e-28  Score=245.36  Aligned_cols=144  Identities=29%  Similarity=0.498  Sum_probs=128.2

Q ss_pred             ceeecccccceEEEEEeCC----CcEEEEEEEecc-CCchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCeeEEEEEec
Q 046544          497 NNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYK  570 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~  570 (646)
                      .++||+|+||+||+|++..    +..||||+++.. .....++|.+|++++++++||||+++++++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998643    236899998753 34456789999999999999999999999875 56899999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|++.+++.......++..+.+++.|++.|+.|+|   .++|+||||||+|||+++++.+||+|||+|+.+.
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            999999999887777889999999999999999999   8899999999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=2.1e-28  Score=242.90  Aligned_cols=147  Identities=24%  Similarity=0.405  Sum_probs=131.6

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCC---chHHHHHHHHHHHHhCCCCCceeEEEEEecCC----ee
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----FK  563 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----~~  563 (646)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....   ...+.+.+|+++++.++|||||++++++..++    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            6799999999999999999986 4799999999975532   33457899999999999999999999987653    47


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      |+|||||+||+|.+++...+ .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.++++|||.++..
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            89999999999999887654 6899999999999999999999   889999999999999999999999999998765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-28  Score=246.31  Aligned_cols=148  Identities=34%  Similarity=0.611  Sum_probs=129.2

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCc--EEEEEEEecc-CCchHHHHHHHHHHHHhC-CCCCceeEEEEEecCCeeEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CGRAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEFKALV  566 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  566 (646)
                      ++|+..+.||+|+||+||+|+++ +|.  .||||.+... .....+.+.+|+++++++ +|||||++++++..++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999865 454  4778877643 334556899999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcE
Q 046544          567 LEYKPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVA  631 (646)
Q Consensus       567 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~  631 (646)
                      |||+++|+|.+++...               ...+++..+..++.||+.|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999654               256899999999999999999999   8899999999999999999999


Q ss_pred             EEEeecCcccc
Q 046544          632 YLSDFGIAKLL  642 (646)
Q Consensus       632 ki~DfGla~~~  642 (646)
                      ||+|||+|+..
T Consensus       167 kl~DfG~a~~~  177 (309)
T d1fvra_         167 KIADFGLSRGQ  177 (309)
T ss_dssp             EECCTTCEESS
T ss_pred             EEccccccccc
Confidence            99999999865

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8e-29  Score=242.83  Aligned_cols=146  Identities=33%  Similarity=0.471  Sum_probs=124.7

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEec-CCeeEEEEEec
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYK  570 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~  570 (646)
                      ++|+..+.||+|+||.||+|++ .|+.||||+++..  ...+++.+|++++++++||||+++++++.. ++..|+||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577889999999999999998 4788999998643  345789999999999999999999999865 46689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          571 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       571 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|.+++.... ..+++..+++++.||+.|++|||   +++|+||||||+||+++.++.+|++|||+++...
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999996543 35889999999999999999999   8899999999999999999999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.9e-28  Score=247.70  Aligned_cols=145  Identities=22%  Similarity=0.322  Sum_probs=125.6

Q ss_pred             CCCCcc-eeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHh-CCCCCceeEEEEEec----CCeeE
Q 046544          492 NGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKS-IRHRNLIKVISSCSN----EEFKA  564 (646)
Q Consensus       492 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~----~~~~~  564 (646)
                      ++|.+. +.||+|+||+||+|+. .+|+.||||+++..     +.+.+|++++.+ .+|||||++++++.+    +...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578776 4699999999999986 47999999998632     456789998765 589999999999865    35689


Q ss_pred             EEEEecCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecCcc
Q 046544          565 LVLEYKPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAK  640 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~---~~~~ki~DfGla~  640 (646)
                      +|||||+||+|.+++...+ ..+++.++..++.|++.|++|||   .++|+||||||+|||+++   .+.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceee
Confidence            9999999999999998653 46899999999999999999999   889999999999999975   5679999999998


Q ss_pred             cccC
Q 046544          641 LLIG  644 (646)
Q Consensus       641 ~~~~  644 (646)
                      ....
T Consensus       163 ~~~~  166 (335)
T d2ozaa1         163 ETTS  166 (335)
T ss_dssp             ECCC
T ss_pred             eccC
Confidence            7643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.5e-28  Score=244.03  Aligned_cols=146  Identities=29%  Similarity=0.439  Sum_probs=124.2

Q ss_pred             CCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHH--HHHHHHhCCCCCceeEEEEEecCC----eeEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAV--ECEMMKSIRHRNLIKVISSCSNEE----FKAL  565 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~H~niv~~~~~~~~~~----~~~l  565 (646)
                      ++|...+.||+|+||.||+|++ +|+.||||+++...   .+++.+  |+..++.++|||||++++++.+++    ..|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4567789999999999999997 68899999986442   233444  455556789999999999998654    5799


Q ss_pred             EEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          566 VLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----CLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       566 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      |||||++|+|.++++..  .+++..+.+++.|++.|++|+|+.     +.++||||||||+|||+++++.+||+|||+|+
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999875  488999999999999999999943     24799999999999999999999999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      .+.
T Consensus       157 ~~~  159 (303)
T d1vjya_         157 RHD  159 (303)
T ss_dssp             EEE
T ss_pred             ccc
Confidence            764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.9e-28  Score=246.73  Aligned_cols=150  Identities=21%  Similarity=0.404  Sum_probs=132.2

Q ss_pred             hCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCee
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFK  563 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  563 (646)
                      .++|+..+.||+|+||+||+|++.      +++.||||+++... ......|.+|++++++++|||||++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888999999999999999753      35789999987543 23445789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 046544          564 ALVLEYKPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLS  634 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~  634 (646)
                      ++|||||++|+|.+++....         ..+++..+..++.|+++||.|||   .++|+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986431         34688899999999999999999   8899999999999999999999999


Q ss_pred             eecCccccc
Q 046544          635 DFGIAKLLI  643 (646)
Q Consensus       635 DfGla~~~~  643 (646)
                      |||+|+.+.
T Consensus       176 DFGla~~~~  184 (308)
T d1p4oa_         176 DFGMTRDIY  184 (308)
T ss_dssp             CTTCCCGGG
T ss_pred             ecccceecc
Confidence            999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.2e-28  Score=245.77  Aligned_cols=151  Identities=26%  Similarity=0.437  Sum_probs=121.3

Q ss_pred             HhCCCCcceeecccccceEEEEEeC------CCcEEEEEEEeccC-CchHHHHHHHHHHHHhC-CCCCceeEEEEEecC-
Q 046544          490 ATNGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRAFKSFAVECEMMKSI-RHRNLIKVISSCSNE-  560 (646)
Q Consensus       490 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-  560 (646)
                      ..++|+..+.||+|+||+||+|++.      +++.||||+++... ....+.+.+|.+++.++ +|+||+.+++++..+ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3467999999999999999999853      35689999987543 23456788888888776 789999999988765 


Q ss_pred             CeeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          561 EFKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       561 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      +..++|||||++|+|.+++....               ..+++.++..++.||++||+|||   +++||||||||+|||+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence            46899999999999999997542               34789999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCccccc
Q 046544          626 DDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~  643 (646)
                      ++++.+||+|||+|+...
T Consensus       168 ~~~~~~Kl~DFGla~~~~  185 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIY  185 (299)
T ss_dssp             CGGGCEEECC------CC
T ss_pred             CCCCcEEEccCcchhhcc
Confidence            999999999999998754

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.6e-27  Score=236.28  Aligned_cols=234  Identities=21%  Similarity=0.255  Sum_probs=200.0

Q ss_pred             ccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEee-cccccCcCchhhcCCCCCcEEE
Q 046544          162 HSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLD-DNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       162 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                      ..+++|+|++|+|+.+.+.+|.++++|++||+++|++..+.+..+.++..++.++.. .|.++...+.+|.++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            345666666666666667788999999999999999999989999999999998765 6678878888999999999999


Q ss_pred             ecCCcccccCCccccCCCCCceeecCCCccccccc-ccccccccccccCCCCcccCCCCCccCccccceEEEcccccccc
Q 046544          241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPL-TFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSS  319 (646)
Q Consensus       241 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  319 (646)
                      +++|.+....+..+....+|+.+++++|.|+.+|. .|..+++|+.|++++|.+++..+..|.++++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            99999988888889999999999999999999875 56788899999999999998888999999999999999999999


Q ss_pred             cCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccCC
Q 046544          320 VIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPRG  396 (646)
Q Consensus       320 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  396 (646)
                      +.|..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+...-+ ...-...++.+....+++.|..|..
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~  267 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR  267 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGG
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchH
Confidence            999999999999999999999999999999999999999999999985432 1111234566777788888877765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.5e-28  Score=243.81  Aligned_cols=151  Identities=26%  Similarity=0.424  Sum_probs=134.0

Q ss_pred             hCCCCcceeecccccceEEEEEe------CCCcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecCCe
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNEEF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  562 (646)
                      .++|+..+.||+|+||.||+|++      .+++.||||+++.... .....+.+|+.+++++ +|||||++++++..++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36788899999999999999975      2467899999976543 3455789999999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEE
Q 046544          563 KALVLEYKPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLL  625 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~  625 (646)
                      .++|||||++|+|.+++....                 ..+++..+..++.||++|++|||   .++||||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999997543                 25888999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeecCcccccC
Q 046544          626 DDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       626 ~~~~~~ki~DfGla~~~~~  644 (646)
                      +.++.+|++|||+|+.+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~  197 (311)
T d1t46a_         179 THGRITKICDFGLARDIKN  197 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTS
T ss_pred             cccCcccccccchheeccC
Confidence            9999999999999997653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.9e-28  Score=240.11  Aligned_cols=148  Identities=25%  Similarity=0.329  Sum_probs=128.7

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC------chHHHHHHHHHHHHhCC--CCCceeEEEEEecCCe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RAFKSFAVECEMMKSIR--HRNLIKVISSCSNEEF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~  562 (646)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....      ...+++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999964 799999999875421      11234668999999986  8999999999999999


Q ss_pred             eEEEEEecCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-CCcEEEEeecCcc
Q 046544          563 KALVLEYKPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAK  640 (646)
Q Consensus       563 ~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-~~~~ki~DfGla~  640 (646)
                      .++||||+.+ +++.+++.... .+++.++..++.|++.|++|||   +++|+||||||+||+++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999986 57888876543 6899999999999999999999   899999999999999984 5799999999998


Q ss_pred             ccc
Q 046544          641 LLI  643 (646)
Q Consensus       641 ~~~  643 (646)
                      ...
T Consensus       160 ~~~  162 (273)
T d1xwsa_         160 LLK  162 (273)
T ss_dssp             ECC
T ss_pred             ecc
Confidence            754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.9e-27  Score=238.24  Aligned_cols=149  Identities=24%  Similarity=0.339  Sum_probs=134.4

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCCeeEEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEEFKALVLE  568 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  568 (646)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999964 78999999997553  3446788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccccC
Q 046544          569 YKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       569 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~~  644 (646)
                      ++.++++..+.... +.+++..+..++.|++.||+|||   .++|+||||||+|||++.++.+|++|||.|+....
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            99998888776554 47889999999999999999999   88999999999999999999999999999987643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.9e-27  Score=231.65  Aligned_cols=203  Identities=24%  Similarity=0.194  Sum_probs=133.6

Q ss_pred             ccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCce
Q 046544          183 TNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRI  262 (646)
Q Consensus       183 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  262 (646)
                      .+...+.++|.+++.++.+ |..+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.  .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence            4456667778888888754 44443  46788888888887766677788888888888888876443  3566777888


Q ss_pred             eecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCC
Q 046544          263 LSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       263 L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      |+|++|+++.+|..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++++.+..+..+++|+.+++++|+++
T Consensus        82 L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            88888777777766666666777776666666655666666666666666666666555555666666666666666666


Q ss_pred             CcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCccee
Q 046544          343 GSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       343 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  391 (646)
                      +..++.|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|++.|
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            555555666666666666666665 455555555555555555554444

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=240.06  Aligned_cols=150  Identities=29%  Similarity=0.480  Sum_probs=127.5

Q ss_pred             CCCCcceeecccccceEEEEEeCC--------CcEEEEEEEeccCC-chHHHHHHHHHHHHhC-CCCCceeEEEEEecCC
Q 046544          492 NGFSENNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCG-RAFKSFAVECEMMKSI-RHRNLIKVISSCSNEE  561 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  561 (646)
                      ++|...+.||+|+||.||+|+..+        +..||||+++.... .....+.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            578889999999999999997422        34799999876543 3456788899999888 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD  626 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~  626 (646)
                      ..++|||||++|++.+++....               ..+++.++..++.|++.||+|||   +++||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997553               35899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCcccccC
Q 046544          627 DNLVAYLSDFGIAKLLIG  644 (646)
Q Consensus       627 ~~~~~ki~DfGla~~~~~  644 (646)
                      .++.+||+|||+++...+
T Consensus       170 ~~~~~kl~dfg~~~~~~~  187 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHH  187 (299)
T ss_dssp             TTCCEEECSTTCCCCGGG
T ss_pred             CCCCeEeccchhhccccc
Confidence            999999999999987643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.8e-27  Score=243.75  Aligned_cols=148  Identities=24%  Similarity=0.308  Sum_probs=125.9

Q ss_pred             hCCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccC-CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC----eeE
Q 046544          491 TNGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE----FKA  564 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----~~~  564 (646)
                      +.+|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999986 479999999997543 334567889999999999999999999987653    234


Q ss_pred             EEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccccc
Q 046544          565 LVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       565 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~~  643 (646)
                      ++|+|+.+|+|.+++...  .+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            556667799999999765  5899999999999999999999   8899999999999999999999999999998653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.8e-27  Score=241.88  Aligned_cols=145  Identities=30%  Similarity=0.448  Sum_probs=121.4

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCceeEEEEEecC------CeeEE
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------EFKAL  565 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~~~l  565 (646)
                      +|+..++||+|+||+||+|++. +|+.||||++......    ..+|++++++++||||+++++++...      .+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5778899999999999999975 6999999999765322    24699999999999999999998543      35789


Q ss_pred             EEEecCCCCHHHHH--hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecCcccc
Q 046544          566 VLEYKPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLL  642 (646)
Q Consensus       566 v~e~~~~g~L~~~l--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~-~~ki~DfGla~~~  642 (646)
                      |||||+++....+.  ......+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99999875433332  234457899999999999999999999   89999999999999999764 8999999999876


Q ss_pred             cC
Q 046544          643 IG  644 (646)
Q Consensus       643 ~~  644 (646)
                      ..
T Consensus       174 ~~  175 (350)
T d1q5ka_         174 VR  175 (350)
T ss_dssp             CT
T ss_pred             cC
Confidence            43

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3e-26  Score=225.93  Aligned_cols=208  Identities=27%  Similarity=0.269  Sum_probs=175.4

Q ss_pred             cCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccc
Q 046544          207 SKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQL  286 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  286 (646)
                      .+...+.+.+.+++.++. +|..+.  +++++|+|++|+|+++.+..|.++++|++|+|++|+|+++|. +..+++|+.|
T Consensus         7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L   82 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL   82 (266)
T ss_dssp             ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred             cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence            455677778889999984 565553  478999999999988888889999999999999999998874 5678899999


Q ss_pred             cCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          287 NFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       287 ~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      ++++|++++ .+..+..+++|+.|++++|.+.++.+..+..+.++++|++++|.++...+..+..+++|+.+++++|+++
T Consensus        83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             ccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            999999884 5667888999999999999999888888889999999999999999888888888999999999999999


Q ss_pred             ccCCccccCCCCCCceeCcCCcceeeccCCCCCCCCccccccCCccccCCCCc
Q 046544          367 GAIPTSLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFAAESFEGNELLCGSPTL  419 (646)
Q Consensus       367 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~~  419 (646)
                      +..+..|..+++|++|+|++|+|+..++.......++.++++||||.|+|...
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~  214 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEIL  214 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred             ccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence            88888889999999999999999854344456788888999999999988654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=8.2e-27  Score=237.49  Aligned_cols=143  Identities=24%  Similarity=0.390  Sum_probs=125.6

Q ss_pred             CCCCcceeecccccceEEEEEe-CCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecC--CeeEEEE
Q 046544          492 NGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNE--EFKALVL  567 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~  567 (646)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..   ..+++.+|+++++.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 47999999998643   3467889999999995 99999999998754  5689999


Q ss_pred             EecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecCcccccC
Q 046544          568 EYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIG  644 (646)
Q Consensus       568 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~-~~~ki~DfGla~~~~~  644 (646)
                      |||++|+|..+.    ..+++.++..+++||+.||+|||   +++|+||||||+|||++.+ +.+|++|||+|+....
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987764    35899999999999999999999   8999999999999999865 4699999999987643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.5e-27  Score=240.55  Aligned_cols=148  Identities=26%  Similarity=0.369  Sum_probs=124.8

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecCC------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNEE------  561 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  561 (646)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            368999999999999999999964 69999999997543  234567889999999999999999999998664      


Q ss_pred             eeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          562 FKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       562 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                      ..|+||||+ ++++..+.+..  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            469999999 66888877654  5899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccC
Q 046544          642 LIG  644 (646)
Q Consensus       642 ~~~  644 (646)
                      ..+
T Consensus       171 ~~~  173 (346)
T d1cm8a_         171 ADS  173 (346)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.5e-27  Score=236.75  Aligned_cols=149  Identities=26%  Similarity=0.406  Sum_probs=126.3

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC-------
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE-------  560 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  560 (646)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  +...+++.+|++++++++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999964 79999999986542  33456788999999999999999999988653       


Q ss_pred             -CeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCc
Q 046544          561 -EFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIA  639 (646)
Q Consensus       561 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla  639 (646)
                       +..|+||||++++.+.. .......+++..+..+++|++.||+|||   +++|+||||||+|||++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence             45799999998765554 4444557889999999999999999999   889999999999999999999999999999


Q ss_pred             cccc
Q 046544          640 KLLI  643 (646)
Q Consensus       640 ~~~~  643 (646)
                      +.+.
T Consensus       165 ~~~~  168 (318)
T d3blha1         165 RAFS  168 (318)
T ss_dssp             EECC
T ss_pred             eecc
Confidence            8654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.4e-27  Score=239.73  Aligned_cols=148  Identities=26%  Similarity=0.374  Sum_probs=131.5

Q ss_pred             CCCCcceeecccccceEEEEEe----CCCcEEEEEEEeccC----CchHHHHHHHHHHHHhCCC-CCceeEEEEEecCCe
Q 046544          492 NGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRAFKSFAVECEMMKSIRH-RNLIKVISSCSNEEF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~  562 (646)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999974    258899999986432    2234567889999999966 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .++||||+.+|+|.+++...+ ..++..+..++.|++.|++|+|   +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999997765 5678889999999999999999   889999999999999999999999999999876


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       180 ~  180 (322)
T d1vzoa_         180 V  180 (322)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=4.4e-26  Score=227.64  Aligned_cols=146  Identities=20%  Similarity=0.269  Sum_probs=130.1

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCC-CCceeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+.+|+++++.++| +||+.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999965 689999999865432  2456789999999965 8999999999999999999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~-----~~~~ki~DfGla~~~~  643 (646)
                      + +|+|.+++...+..+++.++..++.|++.|++|+|   +++|+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 68999999887778999999999999999999999   899999999999999964     5789999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.2e-27  Score=235.94  Aligned_cols=153  Identities=27%  Similarity=0.401  Sum_probs=127.7

Q ss_pred             HHHhCCCCcceeecccccceEEEEEeC-C-CcEEEEEEEeccC--CchHHHHHHHHHHHHhC---CCCCceeEEEEEec-
Q 046544          488 CRATNGFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQC--GRAFKSFAVECEMMKSI---RHRNLIKVISSCSN-  559 (646)
Q Consensus       488 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~-  559 (646)
                      |+..++|++.+.||+|+||+||+|++. + ++.||||+++...  ......+.+|+++++.+   +||||+++++++.. 
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            345578999999999999999999863 4 6779999987543  22234566788777655   89999999999853 


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 046544          560 ----EEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSD  635 (646)
Q Consensus       560 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~D  635 (646)
                          ....+++|||++++.+..........+++..+..++.|++.||+|||   .++||||||||+|||+++++.+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence                34689999999988776666666667899999999999999999999   88999999999999999999999999


Q ss_pred             ecCccccc
Q 046544          636 FGIAKLLI  643 (646)
Q Consensus       636 fGla~~~~  643 (646)
                      ||+++...
T Consensus       160 fg~~~~~~  167 (305)
T d1blxa_         160 FGLARIYS  167 (305)
T ss_dssp             CCSCCCCC
T ss_pred             hhhhhhhc
Confidence            99998653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.6e-26  Score=235.89  Aligned_cols=148  Identities=23%  Similarity=0.325  Sum_probs=125.9

Q ss_pred             hCCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCC--chHHHHHHHHHHHHhCCCCCceeEEEEEecC-----Ce
Q 046544          491 TNGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RAFKSFAVECEMMKSIRHRNLIKVISSCSNE-----EF  562 (646)
Q Consensus       491 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  562 (646)
                      +++|+..+.||+|+||+||+|+.. +|+.||||+++....  ...+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999964 799999999975532  3445788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .+++|||+.||+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46777888899999998654  5899999999999999999999   889999999999999999999999999998765


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       172 ~  172 (348)
T d2gfsa1         172 D  172 (348)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=1.8e-25  Score=224.26  Aligned_cols=146  Identities=26%  Similarity=0.390  Sum_probs=124.5

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCc-eeEEEEEecCCeeEEEEEe
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEY  569 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~  569 (646)
                      ++|+..+.||+|+||+||+|++. +|+.||||++.....  .+++.+|+++++.++|+++ +.+.+++...+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999864 689999999876532  2457889999999977665 5555666777889999999


Q ss_pred             cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecCccccc
Q 046544          570 KPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLI  643 (646)
Q Consensus       570 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~---~~~~~ki~DfGla~~~~  643 (646)
                      + +|++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+|++|||+|+.+.
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 56788887777778999999999999999999999   88999999999999985   35579999999999764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.8e-25  Score=228.26  Aligned_cols=145  Identities=25%  Similarity=0.317  Sum_probs=120.8

Q ss_pred             CCCCcceeecccccceEEEEEeC-CCcEEEEEEEeccC--CchHHHHHHHHHHHHhCCCCCceeEEEEEecC------Ce
Q 046544          492 NGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRAFKSFAVECEMMKSIRHRNLIKVISSCSNE------EF  562 (646)
Q Consensus       492 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~  562 (646)
                      ++|++.++||+|+||+||+|++. +|+.||||++....  ....+++.+|+.+++.++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999975 69999999998553  23345788999999999999999999998643      57


Q ss_pred             eEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcccc
Q 046544          563 KALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL  642 (646)
Q Consensus       563 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~~  642 (646)
                      .|+|||||.++ +.+.+.   ..+++..+..+++|++.|++|||   .++|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765 444443   25789999999999999999999   889999999999999999999999999998765


Q ss_pred             c
Q 046544          643 I  643 (646)
Q Consensus       643 ~  643 (646)
                      .
T Consensus       170 ~  170 (355)
T d2b1pa1         170 G  170 (355)
T ss_dssp             -
T ss_pred             c
Confidence            3

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.90  E-value=2.6e-21  Score=198.24  Aligned_cols=303  Identities=26%  Similarity=0.279  Sum_probs=167.6

Q ss_pred             CCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEc
Q 046544           11 NLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILEL   90 (646)
Q Consensus        11 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L   90 (646)
                      ++++|||++|+|+. +|+.   .++|++|+|++|+|+.. |..    +.+|+.|++++|+++ .++..   .+.|++|++
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~l-p~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTEL-PEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSC-CCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCccc-ccc----hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            46666666666663 3432   34566666666666542 211    345666666666665 22221   134666666


Q ss_pred             ccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEee
Q 046544           91 SQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS  170 (646)
Q Consensus        91 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~  170 (646)
                      ++|.+..+ | .++.+++|++|++++|.++..+.         ....+..+.+.++..                      
T Consensus       106 ~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~---------~~~~l~~l~~~~~~~----------------------  152 (353)
T d1jl5a_         106 SNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD---------LPPSLEFIAAGNNQL----------------------  152 (353)
T ss_dssp             CSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCC----------------------
T ss_pred             cccccccc-c-chhhhccceeecccccccccccc---------ccccccchhhccccc----------------------
Confidence            66666543 2 24555566666666655554322         123344444444333                      


Q ss_pred             cccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccC
Q 046544          171 NCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI  250 (646)
Q Consensus       171 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  250 (646)
                          .  .+..+..++.++.+++++|.+.....    .....+.+...++.+. ..+ .+..++.|+.+++++|.... .
T Consensus       153 ----~--~~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~  219 (353)
T d1jl5a_         153 ----E--ELPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-L  219 (353)
T ss_dssp             ----S--SCCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred             ----c--ccccccccccceeccccccccccccc----cccccccccccccccc-ccc-cccccccccccccccccccc-c
Confidence                2  22345566677777777777653221    1123455666665555 233 35567777777777777653 2


Q ss_pred             CccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCC
Q 046544          251 PACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKN  330 (646)
Q Consensus       251 ~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  330 (646)
                      +.   ...++..+.+.++.+...+....   .+...++..+.+.+.. ..   .......++..|.+.+.    ...+++
T Consensus       220 ~~---~~~~l~~~~~~~~~~~~~~~~~~---~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~~----~~~~~~  285 (353)
T d1jl5a_         220 PD---LPPSLEALNVRDNYLTDLPELPQ---SLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL----CDLPPS  285 (353)
T ss_dssp             CS---CCTTCCEEECCSSCCSCCCCCCT---TCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE----CCCCTT
T ss_pred             cc---ccccccccccccccccccccccc---cccccccccccccccc-cc---cchhcccccccCccccc----cccCCC
Confidence            22   23566777777777766554322   3333444444333211 00   12234455666655533    334578


Q ss_pred             CCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeeccC
Q 046544          331 LEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEIPR  395 (646)
Q Consensus       331 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  395 (646)
                      |++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|++|++++|+++. +|.
T Consensus       286 L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~  341 (353)
T d1jl5a_         286 LEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPD  341 (353)
T ss_dssp             CCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCC
T ss_pred             CCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCc
Confidence            888888888887 45543   567888888888887 55643   4578888888888874 443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=3.4e-22  Score=186.10  Aligned_cols=133  Identities=17%  Similarity=0.178  Sum_probs=105.8

Q ss_pred             CcceeecccccceEEEEEeCCCcEEEEEEEeccCC------------------chHHHHHHHHHHHHhCCCCCceeEEEE
Q 046544          495 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RAFKSFAVECEMMKSIRHRNLIKVISS  556 (646)
Q Consensus       495 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~~~~~  556 (646)
                      .+.++||+|+||.||+|+..+|++||||+++....                  .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988899999998753210                  011234568889999999999988765


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 046544          557 CSNEEFKALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNLVAYLSDF  636 (646)
Q Consensus       557 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~~~ki~Df  636 (646)
                      ..    .+++|||++++...++        +......++.|++.|++|||   .++|+||||||+|||+++++ ++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             cC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEEC
Confidence            32    3799999988655432        23345679999999999999   88999999999999999764 889999


Q ss_pred             cCccccc
Q 046544          637 GIAKLLI  643 (646)
Q Consensus       637 Gla~~~~  643 (646)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998764

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=2.8e-19  Score=182.79  Aligned_cols=301  Identities=28%  Similarity=0.316  Sum_probs=180.8

Q ss_pred             CCCccccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCcccc
Q 046544            1 EIPLEISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIF   80 (646)
Q Consensus         1 ~ip~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   80 (646)
                      ++|+.   +++|++|+|++|+|+. +|..   ..+|++|++++|+++. ++.+    .+.|++|++++|.++. +|. ++
T Consensus        52 ~lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~l----p~~L~~L~L~~n~l~~-lp~-~~  117 (353)
T d1jl5a_          52 SLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQLEK-LPE-LQ  117 (353)
T ss_dssp             CCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCCSS-CCC-CT
T ss_pred             CCCCC---CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccch-hhhh----cccccccccccccccc-ccc-hh
Confidence            35643   4689999999999994 5655   4679999999999975 3332    2479999999999994 554 57


Q ss_pred             CCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccc
Q 046544           81 NASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNL  160 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  160 (646)
                      .+++|++|++++|.+....    .....+..+.+..+.....       ..+..++.++.+++++|.+.......     
T Consensus       118 ~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~~~-------~~l~~l~~l~~L~l~~n~~~~~~~~~-----  181 (353)
T d1jl5a_         118 NSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLEEL-------PELQNLPFLTAIYADNNSLKKLPDLP-----  181 (353)
T ss_dssp             TCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSSC-------CCCTTCTTCCEEECCSSCCSSCCCCC-----
T ss_pred             hhccceeeccccccccccc----cccccccchhhcccccccc-------ccccccccceeccccccccccccccc-----
Confidence            8999999999999998543    2356788899888877653       24678899999999999887653221     


Q ss_pred             cccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEE
Q 046544          161 SHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELE  240 (646)
Q Consensus       161 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  240 (646)
                       ...+.+...++.+.. . ..+..++.++.+++++|....                         .+.   ...++..+.
T Consensus       182 -~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~~-------------------------~~~---~~~~l~~~~  230 (353)
T d1jl5a_         182 -LSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLKT-------------------------LPD---LPPSLEALN  230 (353)
T ss_dssp             -TTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCSS-------------------------CCS---CCTTCCEEE
T ss_pred             -ccccccccccccccc-c-ccccccccccccccccccccc-------------------------ccc---ccccccccc
Confidence             223444444444432 1 123444555555555554432                         111   122344444


Q ss_pred             ecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEccccccccc
Q 046544          241 LGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSV  320 (646)
Q Consensus       241 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  320 (646)
                      +.+|.+... +.   ...++...++..+.+..++...   ......++..+.+.+    ....+++|++|++++|+++. 
T Consensus       231 ~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~~l~---~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~~-  298 (353)
T d1jl5a_         231 VRDNYLTDL-PE---LPQSLTFLDVSENIFSGLSELP---PNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLIE-  298 (353)
T ss_dssp             CCSSCCSCC-CC---CCTTCCEEECCSSCCSEESCCC---TTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCSC-
T ss_pred             ccccccccc-cc---cccccccccccccccccccccc---chhcccccccCcccc----ccccCCCCCEEECCCCccCc-
Confidence            444444321 11   1223344444444333322110   112223334443332    12234567777777777774 


Q ss_pred             CccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCc
Q 046544          321 IPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS  385 (646)
Q Consensus       321 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  385 (646)
                      +|.   .+++|+.|+|++|+|+ .+|+.   +++|++|+|++|+|+ .+|...   .+|+.|.+.
T Consensus       299 lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~  352 (353)
T d1jl5a_         299 LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN  352 (353)
T ss_dssp             CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred             ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence            343   3567888888888887 44543   457888888888887 556532   345666553

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=3.2e-21  Score=186.84  Aligned_cols=219  Identities=17%  Similarity=0.133  Sum_probs=102.6

Q ss_pred             CEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCccccc-CCccccCCCCCcEEEcc
Q 046544           13 EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGT-IPRFIFNASKLSILELS   91 (646)
Q Consensus        13 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls   91 (646)
                      +.++.++++++. +|..+.  +++++|+|++|+|+. ++...+.++++|++|+|++|.+.+. .+..|.+++++++|++.
T Consensus        11 ~~i~c~~~~l~~-iP~~l~--~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCSS-CCSCSC--SCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCCC-cCCCCC--CCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            455555555553 232221  345555555555543 2222333455555555555555432 23344555555555544


Q ss_pred             -cCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEee
Q 046544           92 -QNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMS  170 (646)
Q Consensus        92 -~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~  170 (646)
                       .|.+....+..|.++++|++|++++|.++..++.    ..+..++.+..                          +...
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~----~~~~~l~~l~~--------------------------~~~~  136 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV----HKIHSLQKVLL--------------------------DIQD  136 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC----TTTCBSSCEEE--------------------------EEES
T ss_pred             ccccccccccccccccccccccccchhhhcccccc----ccccccccccc--------------------------cccc
Confidence             2445545555555555555555555555443221    11122222222                          2333


Q ss_pred             cccccccCCcccccCC-CCCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCccccc
Q 046544          171 NCNVSGGIPEEITNLT-NSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGS  249 (646)
Q Consensus       171 ~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  249 (646)
                      ++.+....+..|..++ .++.|++++|+++.+.+..|.....++.+++++|+|+.+.+..|.++++|++|+|++|+|+.+
T Consensus       137 n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l  216 (242)
T d1xwdc1         137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL  216 (242)
T ss_dssp             CTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred             ccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCcc
Confidence            3333333334444432 455566666666544444443322222234455555544444555566666666666666554


Q ss_pred             CCccccCCCCCceeec
Q 046544          250 IPACFSNLASLRILSL  265 (646)
Q Consensus       250 ~~~~~~~l~~L~~L~L  265 (646)
                      .+..|.++++|+++++
T Consensus       217 ~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         217 PSYGLENLKKLRARST  232 (242)
T ss_dssp             CSSSCTTCCEEESSSE
T ss_pred             CHHHHcCCcccccCcC
Confidence            4555555555555544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=6e-21  Score=184.85  Aligned_cols=200  Identities=19%  Similarity=0.179  Sum_probs=121.8

Q ss_pred             CCCCEEEccCCccccccCccccCCCCCCeEEeecccccCc-CchhhcCCCCCcEEEecC-CcccccCCccccCCCCCcee
Q 046544          186 TNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGS-IPDSICRLTELYELELGG-NKLFGSIPACFSNLASLRIL  263 (646)
Q Consensus       186 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L  263 (646)
                      +++++||+++|+|+.+.+.+|.++++|++|++++|.+... .+.+|.++++++++++.. |.+....+..|.++++|+.+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            3566666666666655555666666666666666666543 344566666666666543 55655666666666666666


Q ss_pred             ecCCCccccccc--ccccccccccccCCCCcccCCCCCccCccc-cceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          264 SLSSNELTSIPL--TFWNLKDILQLNFSSNFLTGPLPLEIGNLK-VLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       264 ~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      ++++|.++..+.  .+..+..+..+..+++.+....+..|..++ .++.|++++|+++++.+..|....-++.+++++|+
T Consensus       109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTT
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccc
Confidence            666666665543  122344445555555555554555555543 56777777777776555555433223334566777


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCc
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLS  385 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  385 (646)
                      ++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            775555667777777777777777775555566776666666554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=3.2e-20  Score=177.74  Aligned_cols=204  Identities=21%  Similarity=0.328  Sum_probs=116.5

Q ss_pred             CEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccC
Q 046544           37 KLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRD  116 (646)
Q Consensus        37 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  116 (646)
                      ..++++.+++++.+   ....+.+|++|++++|.|+.. + .+..+++|++|++++|.|+++.|  |.++++|+++++++
T Consensus        22 ~~~~l~~~~~~d~~---~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEE---CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcC---CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            34455555554322   112255666666666666632 2 35667777777777777765433  66777777777777


Q ss_pred             CCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCC
Q 046544          117 NYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGN  196 (646)
Q Consensus       117 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  196 (646)
                      |.++.++       .+.++++|++++++++...++.+.    ...+.+..+.++++.+...  ..+...++|+.|++++|
T Consensus        95 n~~~~i~-------~l~~l~~L~~l~l~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n  161 (227)
T d1h6ua2          95 NPLKNVS-------AIAGLQSIKTLDLTSTQITDVTPL----AGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNA  161 (227)
T ss_dssp             CCCSCCG-------GGTTCTTCCEEECTTSCCCCCGGG----TTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred             ccccccc-------cccccccccccccccccccccchh----ccccchhhhhchhhhhchh--hhhcccccccccccccc
Confidence            7766542       356677777777777766544221    1123455555555555432  23555566666666666


Q ss_pred             ccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecC
Q 046544          197 KLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       197 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      ++.+..  .+.++++|+.|+|++|++++. + .|.++++|++|+|++|+++++.|  ++++++|++|+++
T Consensus       162 ~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         162 QVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             ccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            665332  255666666666666666643 2 25666666666666666654332  5566666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=2.6e-20  Score=178.40  Aligned_cols=209  Identities=24%  Similarity=0.327  Sum_probs=145.9

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      +.++..++++.+++++..  .+.++.+|++|++++|.|+.+  ..+..+++|++|++++|+++.+.       .+.++++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~-------~l~~l~~   86 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA-------PLKNLTK   86 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-------GGTTCCS
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc-------ccccccc
Confidence            344455678888888654  456788999999999999976  35899999999999999998763       3788999


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |+++++++|.++.+.                            .+..+++|+.++++++...+.  ..+...+.++.+.+
T Consensus        87 l~~l~~~~n~~~~i~----------------------------~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~  136 (227)
T d1h6ua2          87 ITELELSGNPLKNVS----------------------------AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYL  136 (227)
T ss_dssp             CCEEECCSCCCSCCG----------------------------GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             ccccccccccccccc----------------------------ccccccccccccccccccccc--chhccccchhhhhc
Confidence            999999999887542                            244556666666666665433  23455566666666


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPL  297 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  297 (646)
                      +++.+...  ..+...++|++|++++|.+.+..  .|+++++|+.|++++|+++.+|. +.++++|++|++++|++++..
T Consensus       137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~  211 (227)
T d1h6ua2         137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS  211 (227)
T ss_dssp             CSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred             hhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCc
Confidence            66666532  23556666777777777665332  36667777777777777776653 566677777777777776543


Q ss_pred             CCccCccccceEEEccc
Q 046544          298 PLEIGNLKVLIGIDFSM  314 (646)
Q Consensus       298 ~~~~~~l~~L~~L~ls~  314 (646)
                      |  ++++++|+.|++++
T Consensus       212 ~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         212 P--LANTSNLFIVTLTN  226 (227)
T ss_dssp             G--GTTCTTCCEEEEEE
T ss_pred             c--cccCCCCCEEEeeC
Confidence            2  66777777777763

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5.8e-23  Score=218.41  Aligned_cols=381  Identities=20%  Similarity=0.173  Sum_probs=177.3

Q ss_pred             CCCCEEECCCCcccccC-CcCccCCCCCCEEECcCCcCcccC-CccC--cCCCCCCCEEEccCCccccc----CCcccc-
Q 046544           10 QNLEELDLRHNKLVGTV-PAAIFNMSMLKLLHLQNNSLLGCL-SSIA--DVRLPNLEALLLWGNNFSGT----IPRFIF-   80 (646)
Q Consensus        10 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~~--~~~l~~L~~L~L~~N~l~~~----~~~~~~-   80 (646)
                      .+|++||+++|+|++.. ...+..++++++|+|++|.|+..- ..++  ....++|++|||++|.|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36788899988887532 344556788888888888875210 0111  12367888888888887632    222232 


Q ss_pred             CCCCCcEEEcccCccccc----cCccccCcCCCCEEEccCCCCCCCCCcccccccC-CCCCCCCEEECCCCCCCCcCCcc
Q 046544           81 NASKLSILELSQNSFSGF----IPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSL-SNCKSLTFIHLSDNPLDGILSKT  155 (646)
Q Consensus        81 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~~~  155 (646)
                      ...+|++|+|++|+|++.    .+..+..+++|++|+|++|.++...... +...+ ...............+.......
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~  160 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASCEP  160 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh-hhhcccccccccccccccccccchhhhcc
Confidence            234688888888887643    2445667788888888888775422111 01111 11222333333333332110000


Q ss_pred             hh--ccccccCcEEEeecccccccC----Cccc-ccCCCCCEEEccCCccccc----cCccccCCCCCCeEEeecccccC
Q 046544          156 SI--GNLSHSLKDFYMSNCNVSGGI----PEEI-TNLTNSITIDLGGNKLNGS----IPITLSKLQKLQGLGLDDNKLEG  224 (646)
Q Consensus       156 ~~--~~~~~~L~~L~L~~n~l~~~~----p~~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~  224 (646)
                      ..  ......++.++++++.+....    ...+ ..-.....+++..+.+...    ....+...+.++.+++++|.+..
T Consensus       161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~  240 (460)
T d1z7xw1         161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  240 (460)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence            00  001123455555554443210    0011 1112334455555444311    11122334455555555555431


Q ss_pred             -----cCchhhcCCCCCcEEEecCCcccccC----CccccCCCCCceeecCCCcccccc-----ccc-ccccccccccCC
Q 046544          225 -----SIPDSICRLTELYELELGGNKLFGSI----PACFSNLASLRILSLSSNELTSIP-----LTF-WNLKDILQLNFS  289 (646)
Q Consensus       225 -----~~~~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~lp-----~~~-~~l~~L~~L~l~  289 (646)
                           ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.++...     ..+ .....|+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~  320 (460)
T d1z7xw1         241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  320 (460)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence                 11222333445555555555553221    112333455555555555554211     001 112345555555


Q ss_pred             CCcccCCCCCc----cCccccceEEEccccccccc----CccccC-CCCCCCEEEccCccCCCc----ccccccCCCCCC
Q 046544          290 SNFLTGPLPLE----IGNLKVLIGIDFSMNNFSSV----IPTEIG-GLKNLEYLFLGYNRLEGS----IPDSFGDLISLK  356 (646)
Q Consensus       290 ~N~l~~~~~~~----~~~l~~L~~L~ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~  356 (646)
                      +|.++......    +...++|++|+|++|+++..    .+..+. ..+.|++|+|++|+|++.    +++.+..+++|+
T Consensus       321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~  400 (460)
T d1z7xw1         321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR  400 (460)
T ss_dssp             TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred             ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence            55544322111    12233455555555555432    112221 234566666666665432    233344455566


Q ss_pred             EEEccCCcCcccCCccc----c-CCCCCCceeCcCCccee
Q 046544          357 FLNLSNNNLSGAIPTSL----E-KLSYLEDLNLSFNKLEG  391 (646)
Q Consensus       357 ~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~L~~N~l~~  391 (646)
                      +|||++|+|+......+    . ....|+.|++++|.+..
T Consensus       401 ~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             EEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            66666666553222211    1 22345556665555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=1.2e-20  Score=175.71  Aligned_cols=176  Identities=22%  Similarity=0.232  Sum_probs=122.2

Q ss_pred             CcEEEecCCcccccCCccccCCCCCceeecCCCcccc-cc-cccccccccccccCCCCcccCCCCCccCccccceEEEcc
Q 046544          236 LYELELGGNKLFGSIPACFSNLASLRILSLSSNELTS-IP-LTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFS  313 (646)
Q Consensus       236 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls  313 (646)
                      .++++.++|+++.+ |..+.  +++++|+|++|+|+. ++ ..|.++++|+.|++++|.+....+..|..+++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcCcc-CCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            35677888887743 43332  577788888888864 33 356677788888888888877777777778888888888


Q ss_pred             cccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceeec
Q 046544          314 MNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGEI  393 (646)
Q Consensus       314 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  393 (646)
                      +|+++++.|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence            8888877777788888888888888888777777777788888888888877643221 111233556667777777655


Q ss_pred             cCCCCCCCCccccccCCccccCCC
Q 046544          394 PRGGSFGNFAAESFEGNELLCGSP  417 (646)
Q Consensus       394 p~~~~~~~~~~~~~~~N~~~c~~~  417 (646)
                      |..  +......+++.|.+.|.++
T Consensus       166 p~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         166 PSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             STT--TTTSBGGGSCTTTCCCCCC
T ss_pred             Chh--hcCCEeeecCHhhCcCCCC
Confidence            543  4555666777787777554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=1.4e-20  Score=193.93  Aligned_cols=148  Identities=18%  Similarity=0.242  Sum_probs=116.6

Q ss_pred             CCCcceeecccccceEEEEEeC-CCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-----------CCCceeEEEEEecC
Q 046544          493 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-----------HRNLIKVISSCSNE  560 (646)
Q Consensus       493 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~~~~~~~~~  560 (646)
                      +|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5999999999999999999964 79999999997542 23456778998888775           57899999887653


Q ss_pred             --CeeEEEEEecCCCCHH-HH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEEcCCC------c
Q 046544          561 --EFKALVLEYKPHGSLE-KY-LYSSNCILDIFQRLNIMIDVASALEYLHFGCLAPVIHCDLKPDNVLLDDNL------V  630 (646)
Q Consensus       561 --~~~~lv~e~~~~g~L~-~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil~~~~~------~  630 (646)
                        ...+++|+++..+... .. ........++..+..++.|++.|++|||+  ..+|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              5567777776554332 22 22334568889999999999999999993  27899999999999997654      4


Q ss_pred             EEEEeecCccccc
Q 046544          631 AYLSDFGIAKLLI  643 (646)
Q Consensus       631 ~ki~DfGla~~~~  643 (646)
                      +|++|||.|+...
T Consensus       171 ~kl~dfg~s~~~~  183 (362)
T d1q8ya_         171 IKIADLGNACWYD  183 (362)
T ss_dssp             EEECCCTTCEETT
T ss_pred             eeEeecccccccc
Confidence            9999999998654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=3.8e-20  Score=172.15  Aligned_cols=129  Identities=26%  Similarity=0.352  Sum_probs=61.1

Q ss_pred             eeecCCCcccccccccccccccccccCCCCcccC-CCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCcc
Q 046544          262 ILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNR  340 (646)
Q Consensus       262 ~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  340 (646)
                      .++.++++++++|..+.  +++++|+|++|.|++ ..+..|.++++|+.|++++|.++++.+..|..+++|++|+|++|+
T Consensus        12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~   89 (192)
T d1w8aa_          12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence            44444444444444332  344444445444443 223344444444445554444444444444444444555555554


Q ss_pred             CCCcccccccCCCCCCEEEccCCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          341 LEGSIPDSFGDLISLKFLNLSNNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       341 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      |+++.|++|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++.+.
T Consensus        90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            4444444444444455555555544444444444444444455544444443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=1.3e-22  Score=215.71  Aligned_cols=378  Identities=18%  Similarity=0.139  Sum_probs=253.8

Q ss_pred             CCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccc----cCCccccCCCCCcEEEcccCcccccc----Ccccc-C
Q 046544           35 MLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSG----TIPRFIFNASKLSILELSQNSFSGFI----PNTFG-N  105 (646)
Q Consensus        35 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~  105 (646)
                      +|++||+++|++++..-.-....++++++|+|++|.|+.    .+...+..+++|++|||++|.|+...    ...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            589999999999752111111247899999999999984    34556788999999999999997432    22232 2


Q ss_pred             cCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEECCCCCCCCcCCcchhcc---ccccCcEEEeeccccccc----C
Q 046544          106 LRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIHLSDNPLDGILSKTSIGN---LSHSLKDFYMSNCNVSGG----I  178 (646)
Q Consensus       106 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~---~~~~L~~L~L~~n~l~~~----~  178 (646)
                      ..+|++|+|++|+++...... +...+..+++|++|++++|++...........   ..............+...    .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~-l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGV-LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHH-HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCEEECCCCCcccccccc-ccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            357999999999997643221 34568889999999999999864321111111   111233344433333221    1


Q ss_pred             CcccccCCCCCEEEccCCccccccC----ccc-cCCCCCCeEEeecccccCc----CchhhcCCCCCcEEEecCCcccc-
Q 046544          179 PEEITNLTNSITIDLGGNKLNGSIP----ITL-SKLQKLQGLGLDDNKLEGS----IPDSICRLTELYELELGGNKLFG-  248 (646)
Q Consensus       179 p~~~~~l~~L~~L~L~~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~-  248 (646)
                      ...+.....++.++++++......-    ..+ ..-.....+++..+.+...    ....+...+.++.+++++|++.. 
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence            1234456788999999988753211    111 2234567888888876532    22345567889999999998743 


Q ss_pred             ----cCCccccCCCCCceeecCCCcccccc-----cccccccccccccCCCCcccCCCCCc-----cCccccceEEEccc
Q 046544          249 ----SIPACFSNLASLRILSLSSNELTSIP-----LTFWNLKDILQLNFSSNFLTGPLPLE-----IGNLKVLIGIDFSM  314 (646)
Q Consensus       249 ----~~~~~~~~l~~L~~L~L~~N~l~~lp-----~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~l~~L~~L~ls~  314 (646)
                          ..+..+.....++.+++++|.+...+     ..+...+.++.+++++|.+.......     ......|+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~  321 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  321 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence                22344556788999999999987443     23456788999999999986322211     12346799999999


Q ss_pred             ccccccCccc----cCCCCCCCEEEccCccCCCc----cccccc-CCCCCCEEEccCCcCccc----CCccccCCCCCCc
Q 046544          315 NNFSSVIPTE----IGGLKNLEYLFLGYNRLEGS----IPDSFG-DLISLKFLNLSNNNLSGA----IPTSLEKLSYLED  381 (646)
Q Consensus       315 N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~  381 (646)
                      |.++......    +...++|++|+|++|++++.    +++.+. ..+.|++|+|++|.|+..    ++..+..+++|++
T Consensus       322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~  401 (460)
T d1z7xw1         322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  401 (460)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence            9988654333    34567899999999999753    333343 467899999999999853    4556777899999


Q ss_pred             eeCcCCcceeeccCC------CCCCCCccccccCCccc
Q 046544          382 LNLSFNKLEGEIPRG------GSFGNFAAESFEGNELL  413 (646)
Q Consensus       382 L~L~~N~l~~~~p~~------~~~~~~~~~~~~~N~~~  413 (646)
                      |+|++|+++..-...      .....++.+++.+|.+.
T Consensus       402 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            999999997532111      11235777888877764

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=2.2e-19  Score=169.37  Aligned_cols=164  Identities=27%  Similarity=0.428  Sum_probs=81.3

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      +.+|++|++++|.++...  .+..+++|++|+|++|+|+++.+  ++.+++|++|++++|+|+.++       .+.++++
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~l~-------~l~~l~~  113 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS-------SLKDLKK  113 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG-------GGTTCTT
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccccc-------ccccccc
Confidence            445556666666555322  24556666666666666665432  456666666666666665432       2555666


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |+.|++++|.+..+                            ..+..+++++.+++++|.+++  +..+..+++|+++++
T Consensus       114 L~~L~l~~~~~~~~----------------------------~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l  163 (210)
T d1h6ta2         114 LKSLSLEHNGISDI----------------------------NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSL  163 (210)
T ss_dssp             CCEEECTTSCCCCC----------------------------GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEEC
T ss_pred             cccccccccccccc----------------------------ccccccccccccccccccccc--ccccccccccccccc
Confidence            66666666655432                            123333444444444444432  122334444444444


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecC
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLS  266 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  266 (646)
                      ++|++++..  .+.++++|++|+|++|+|+.+ + .|.++++|++|+|+
T Consensus       164 ~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         164 EDNQISDIV--PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             ccccccccc--cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            444444321  144455555555555555432 2 34455555555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=1.3e-19  Score=170.95  Aligned_cols=165  Identities=25%  Similarity=0.335  Sum_probs=96.6

Q ss_pred             CCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccC
Q 046544          209 LQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNF  288 (646)
Q Consensus       209 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l  288 (646)
                      +.+|++|++++|.++...  .+..+++|++|+|++|+|++..  .++.+++|++|++++|+++.+| .+..+++|+.|++
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-ccccccccccccc
Confidence            334555555555555321  2445555555555555555332  2445555555555555555554 3455555556666


Q ss_pred             CCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCccc
Q 046544          289 SSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSGA  368 (646)
Q Consensus       289 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  368 (646)
                      ++|.+..  ...+..++.++.+++++|.+++.  ..+..+++|+.+++++|++++..+  ++++++|++|+|++|+|+. 
T Consensus       120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-  192 (210)
T d1h6ta2         120 EHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-  192 (210)
T ss_dssp             TTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-
T ss_pred             ccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-
Confidence            5555542  22455566666666666666542  345566777777777777765332  6777777777777777763 


Q ss_pred             CCccccCCCCCCceeCcC
Q 046544          369 IPTSLEKLSYLEDLNLSF  386 (646)
Q Consensus       369 ~p~~~~~l~~L~~L~L~~  386 (646)
                      +| .+..+++|++|+|++
T Consensus       193 l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CG-GGTTCTTCSEEEEEE
T ss_pred             Ch-hhcCCCCCCEEEccC
Confidence            33 477777777777653

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=4.4e-19  Score=165.84  Aligned_cols=161  Identities=25%  Similarity=0.337  Sum_probs=88.9

Q ss_pred             CCCCCEEEccCCcccccCCccccCCCCCcEEEcccCccccccCccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCC
Q 046544           58 LPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQNSFSGFIPNTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKS  137 (646)
Q Consensus        58 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  137 (646)
                      ++++++|++++|.++..  +.+..+++|++|++++|+|+++.|  |+++++|++|++++|.+..++       .++++++
T Consensus        39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~-------~l~~l~~  107 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT-------PLANLTN  107 (199)
T ss_dssp             HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-------GGTTCTT
T ss_pred             hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc-------ccccccc
Confidence            45566666666666532  235556666666666666665433  666666777777666665542       2556666


Q ss_pred             CCEEECCCCCCCCcCCcchhccccccCcEEEeecccccccCCcccccCCCCCEEEccCCccccccCccccCCCCCCeEEe
Q 046544          138 LTFIHLSDNPLDGILSKTSIGNLSHSLKDFYMSNCNVSGGIPEEITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGL  217 (646)
Q Consensus       138 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  217 (646)
                      |++|++++|.+..+                            ..+..+++|+.|++++|++...  ..+..+++|++|++
T Consensus       108 L~~L~l~~~~~~~~----------------------------~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l  157 (199)
T d2omxa2         108 LTGLTLFNNQITDI----------------------------DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNF  157 (199)
T ss_dssp             CSEEECCSSCCCCC----------------------------GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred             cccccccccccccc----------------------------cccchhhhhHHhhhhhhhhccc--cccccccccccccc
Confidence            66666666655432                            1233445555555555555422  23455555555555


Q ss_pred             ecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCcee
Q 046544          218 DDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRIL  263 (646)
Q Consensus       218 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  263 (646)
                      ++|++++..  .+.++++|++|++++|+++++ + .++++++|+.|
T Consensus       158 ~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         158 SSNQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             ccccccCCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            555555332  255566666666666665532 2 35555555543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=5.6e-19  Score=165.13  Aligned_cols=162  Identities=27%  Similarity=0.404  Sum_probs=100.0

Q ss_pred             CCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCccccccccccccccccccc
Q 046544          208 KLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLN  287 (646)
Q Consensus       208 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~  287 (646)
                      .+.++++|++++|.|+..  +.+..+++|++|++++|++++..+  ++++++|++|++++|.+..+| .+.+++.|+.|+
T Consensus        38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~  112 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLT  112 (199)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred             HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc-cccccccccccc
Confidence            345555566666655532  235556666666666666654332  566666666666666666555 255556666666


Q ss_pred             CCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCcc
Q 046544          288 FSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLSG  367 (646)
Q Consensus       288 l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  367 (646)
                      +++|.+...  ..+..+++|+.|++++|++...  ..+..+++|++|++++|++++..  .++++++|++|++++|++++
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence            666655532  2355666777777777776643  34677777777777777777543  37777777777777777764


Q ss_pred             cCCccccCCCCCCce
Q 046544          368 AIPTSLEKLSYLEDL  382 (646)
Q Consensus       368 ~~p~~~~~l~~L~~L  382 (646)
                       ++ .+..+++|++|
T Consensus       187 -i~-~l~~L~~L~~L  199 (199)
T d2omxa2         187 -IS-VLAKLTNLESL  199 (199)
T ss_dssp             -CG-GGGGCTTCSEE
T ss_pred             -Cc-cccCCCCCCcC
Confidence             33 46677777654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=3.4e-17  Score=161.80  Aligned_cols=225  Identities=19%  Similarity=0.186  Sum_probs=133.4

Q ss_pred             CEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCccccc-CCccccCCCCCcEEEcc
Q 046544           13 EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGT-IPRFIFNASKLSILELS   91 (646)
Q Consensus        13 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls   91 (646)
                      ++|||+++.+.......+.. ..+..+.+++..+.......  ....+|++|||++|.++.. ++..+..+++|++|+|+
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~--~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSC--CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhh--ccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            47899988764221111111 24567777777664322222  2366899999999988743 45567788999999999


Q ss_pred             cCccccccCccccCcCCCCEEEccCC-CCCCCCCcccccccCCCCCCCCEEECCCCC-CCCcCCcchhccccccCcEEEe
Q 046544           92 QNSFSGFIPNTFGNLRNLEWLNLRDN-YLTSSTPELSFLSSLSNCKSLTFIHLSDNP-LDGILSKTSIGNLSHSLKDFYM  169 (646)
Q Consensus        92 ~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~~~~L~~L~L  169 (646)
                      +|.+.+..+..++.+++|++|+|+++ .++...    +..-+.++++|++|+++++. ++.......+....+.|+.|++
T Consensus        80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~----l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l  155 (284)
T d2astb2          80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA----LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL  155 (284)
T ss_dssp             TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH----HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred             ccCCCcHHHHHHhcCCCCcCccccccccccccc----cchhhHHHHhccccccccccccccccchhhhcccccccchhhh
Confidence            99998777788888999999999985 454311    11123567899999998853 4321111122233456677776


Q ss_pred             ecc--ccccc-CCcccccCCCCCEEEccCC-ccccccCccccCCCCCCeEEeecc-cccCcCchhhcCCCCCcEEEecCC
Q 046544          170 SNC--NVSGG-IPEEITNLTNSITIDLGGN-KLNGSIPITLSKLQKLQGLGLDDN-KLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       170 ~~n--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                      +++  .++.. +...+.++++|++|++++| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++
T Consensus       156 ~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            654  23221 2222344566666666553 344444445555555555555553 344444444555555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=8e-17  Score=144.35  Aligned_cols=131  Identities=18%  Similarity=0.190  Sum_probs=71.1

Q ss_pred             ccCCCCCCEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCC
Q 046544            6 ISNLQNLEELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKL   85 (646)
Q Consensus         6 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L   85 (646)
                      +.+..++++|||++|+|+.+ +..+..+++|++|+|++|.|+.. +.+.  .+++|++|++++|+++...+..+..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~~~~--~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCC--CCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-CCcc--cCcchhhhhcccccccCCCcccccccccc
Confidence            44555666666666666643 44555666666666666666542 2222  35566666666666665544445556666


Q ss_pred             cEEEcccCccccccC-ccccCcCCCCEEEccCCCCCCCCCcccccccCCCCCCCCEEE
Q 046544           86 SILELSQNSFSGFIP-NTFGNLRNLEWLNLRDNYLTSSTPELSFLSSLSNCKSLTFIH  142 (646)
Q Consensus        86 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~  142 (646)
                      ++|++++|+|+.+.. ..+..+++|++|++++|+++..+..  ....+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~--r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY--RLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTH--HHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccccch--HHHHHHHCCCcCeeC
Confidence            666666666654322 3455566666666666665544321  011234455555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.61  E-value=2.3e-17  Score=168.13  Aligned_cols=193  Identities=21%  Similarity=0.212  Sum_probs=84.5

Q ss_pred             cCCCCCcEEEcccCcccccc----CccccCcCCCCEEEccCCCCCCCCCcc--------cccccCCCCCCCCEEECCCCC
Q 046544           80 FNASKLSILELSQNSFSGFI----PNTFGNLRNLEWLNLRDNYLTSSTPEL--------SFLSSLSNCKSLTFIHLSDNP  147 (646)
Q Consensus        80 ~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~--------~~~~~l~~l~~L~~L~Ls~N~  147 (646)
                      ...++|++|+|++|.+....    ...+...++|++|++++|.+.......        .........+.|+.+++++|.
T Consensus        90 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~  169 (344)
T d2ca6a1          90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  169 (344)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccc
Confidence            34455666666666555321    122334455666666666543210000        000011234566666666666


Q ss_pred             CCCcCCcchh--ccccccCcEEEeeccccccc-----CCcccccCCCCCEEEccCCccccc----cCccccCCCCCCeEE
Q 046544          148 LDGILSKTSI--GNLSHSLKDFYMSNCNVSGG-----IPEEITNLTNSITIDLGGNKLNGS----IPITLSKLQKLQGLG  216 (646)
Q Consensus       148 l~~~~~~~~~--~~~~~~L~~L~L~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~  216 (646)
                      +.........  ......+++|+|++|.+...     +...+...++|+.|+|++|.++..    +...+...++|++|+
T Consensus       170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~  249 (344)
T d2ca6a1         170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  249 (344)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             ccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhh
Confidence            5422110000  00112344444444443321     123344556666666666665422    223344555666666


Q ss_pred             eecccccCcCchh----hcC--CCCCcEEEecCCcccccC----Cccc-cCCCCCceeecCCCcccc
Q 046544          217 LDDNKLEGSIPDS----ICR--LTELYELELGGNKLFGSI----PACF-SNLASLRILSLSSNELTS  272 (646)
Q Consensus       217 L~~N~l~~~~~~~----~~~--l~~L~~L~L~~N~i~~~~----~~~~-~~l~~L~~L~L~~N~l~~  272 (646)
                      |++|.|.+.....    +..  .+.|++|++++|+|....    ...+ .++++|+.|+|++|.+..
T Consensus       250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            6666655322222    221  234556666666554321    1112 134455555555555543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=3e-16  Score=140.54  Aligned_cols=125  Identities=21%  Similarity=0.148  Sum_probs=70.7

Q ss_pred             CCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEE
Q 046544          256 NLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLF  335 (646)
Q Consensus       256 ~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  335 (646)
                      +..+++.|+|++|+|+.+|..+..+++|+.|++++|.++..  ..|..+++|+.|++++|.++++.+..+..+++|+.|+
T Consensus        16 n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          16 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             CTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccce
Confidence            33344444444444444433333344444444444444321  1245556666666666666665555566677777777


Q ss_pred             ccCccCCCccc-ccccCCCCCCEEEccCCcCcccCCc----cccCCCCCCcee
Q 046544          336 LGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIPT----SLEKLSYLEDLN  383 (646)
Q Consensus       336 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~  383 (646)
                      +++|+++.... ..+..+++|++|++++|.++. .|.    .+..+++|+.||
T Consensus        94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             eccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            77777764322 456777777777777777763 332    466677777766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=1.6e-15  Score=129.06  Aligned_cols=103  Identities=24%  Similarity=0.233  Sum_probs=55.3

Q ss_pred             CEEECCCCcccccCCcCccCCCCCCEEECcCCcCcccCCccCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEccc
Q 046544           13 EELDLRHNKLVGTVPAAIFNMSMLKLLHLQNNSLLGCLSSIADVRLPNLEALLLWGNNFSGTIPRFIFNASKLSILELSQ   92 (646)
Q Consensus        13 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~   92 (646)
                      ++|||++|+|+.. + .+.++++|++|++++|.|+..++.+.  .+++|++|++++|+|++. | .+..+++|++|++++
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~lp~~~~--~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRALPPALA--ALRCLEVLQASDNALENV-D-GVANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCCCCGGGG--GCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCcchhhhh--hhhccccccccccccccc-C-ccccccccCeEECCC
Confidence            3566666666633 2 35666666666666666654332222  355555666655555532 2 245555555555555


Q ss_pred             CccccccC-ccccCcCCCCEEEccCCCCCC
Q 046544           93 NSFSGFIP-NTFGNLRNLEWLNLRDNYLTS  121 (646)
Q Consensus        93 N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  121 (646)
                      |+|+++.. ..+..+++|++|++++|+++.
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            55554332 345555555555555555543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.58  E-value=2.8e-15  Score=127.53  Aligned_cols=101  Identities=30%  Similarity=0.379  Sum_probs=44.6

Q ss_pred             eeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccccccccCccccCCCCCCCEEEccCccC
Q 046544          262 ILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMNNFSSVIPTEIGGLKNLEYLFLGYNRL  341 (646)
Q Consensus       262 ~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  341 (646)
                      +|+|++|+|+.+| .+..++.|++|++++|.++. +|..++.+++|+.|++++|.+++. | .++.+++|++|++++|++
T Consensus         2 ~L~Ls~n~l~~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           2 VLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EEECTTSCCSSCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCC
T ss_pred             EEEcCCCCCCCCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCcc
Confidence            3444444444333 13333333333333333331 222333344444444444444432 1 245555555555555555


Q ss_pred             CCccc-ccccCCCCCCEEEccCCcCc
Q 046544          342 EGSIP-DSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       342 ~~~~p-~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      ++... ..+..+++|+.|++++|+++
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCC
Confidence            53321 34555555555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.57  E-value=8.5e-17  Score=163.84  Aligned_cols=74  Identities=20%  Similarity=0.328  Sum_probs=39.9

Q ss_pred             CccccCCCCCcEEEcccCcccccc----CccccCcCCCCEEEccCCCCCCCCCcc-----cccccCCCCCCCCEEECCCC
Q 046544           76 PRFIFNASKLSILELSQNSFSGFI----PNTFGNLRNLEWLNLRDNYLTSSTPEL-----SFLSSLSNCKSLTFIHLSDN  146 (646)
Q Consensus        76 ~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~~~l~~l~~L~~L~Ls~N  146 (646)
                      ...+.....|++|+|++|.|....    ...+...++|+.|+++++.........     .+...+..+++|++|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            344555677777777777775322    223455666777777666554332110     01223445555666666555


Q ss_pred             CCC
Q 046544          147 PLD  149 (646)
Q Consensus       147 ~l~  149 (646)
                      .+.
T Consensus       104 ~i~  106 (344)
T d2ca6a1         104 AFG  106 (344)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=8e-16  Score=151.76  Aligned_cols=185  Identities=18%  Similarity=0.173  Sum_probs=88.4

Q ss_pred             cccCCCCCEEEccCCccccccCccccCCCCCCeEEeecc-cccCc-CchhhcCCCCCcEEEecCCc-cccc-CCcccc-C
Q 046544          182 ITNLTNSITIDLGGNKLNGSIPITLSKLQKLQGLGLDDN-KLEGS-IPDSICRLTELYELELGGNK-LFGS-IPACFS-N  256 (646)
Q Consensus       182 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N~-i~~~-~~~~~~-~  256 (646)
                      +..+++|++|+++++.+.+..+..+..+++|++|+++++ .+++. ....+.++++|++|+++++. ++.. ....+. .
T Consensus        67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~  146 (284)
T d2astb2          67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV  146 (284)
T ss_dssp             HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred             HHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccc
Confidence            444555555555555554444444555555555555553 33321 11122345556666665532 2211 111111 1


Q ss_pred             CCCCceeecCCCc--ccccccccccccccccccCCCCcccCCCCCccCccccceEEEcccc-cccccCccccCCCCCCCE
Q 046544          257 LASLRILSLSSNE--LTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN-NFSSVIPTEIGGLKNLEY  333 (646)
Q Consensus       257 l~~L~~L~L~~N~--l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~  333 (646)
                      .++|+.|+++++.  ++.-.                      +...+..+++|+.|++++| .+++.....+..+++|++
T Consensus       147 ~~~L~~L~l~~~~~~i~~~~----------------------l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~  204 (284)
T d2astb2         147 SETITQLNLSGYRKNLQKSD----------------------LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH  204 (284)
T ss_dssp             CTTCCEEECCSCGGGSCHHH----------------------HHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             ccccchhhhccccccccccc----------------------ccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence            2455555555431  22100                      0011123445555555553 344445555666677777


Q ss_pred             EEccCc-cCCCcccccccCCCCCCEEEccCCcCcc-cCCccccCCCCCCceeCcCCcceee
Q 046544          334 LFLGYN-RLEGSIPDSFGDLISLKFLNLSNNNLSG-AIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       334 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      |+++++ .+++.....++.+++|+.|+++++ ++. .++.....+++   |.+..++++..
T Consensus       205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~  261 (284)
T d2astb2         205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTI  261 (284)
T ss_dssp             EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCT
T ss_pred             EECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCC
Confidence            777763 566555556667777777777776 321 11111223333   44566666643

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=3e-14  Score=126.37  Aligned_cols=108  Identities=22%  Similarity=0.154  Sum_probs=60.0

Q ss_pred             cccccCCCCcccCCCCCccCccccceEEEcccc-cccccCccccCCCCCCCEEEccCccCCCcccccccCCCCCCEEEcc
Q 046544          283 ILQLNFSSNFLTGPLPLEIGNLKVLIGIDFSMN-NFSSVIPTEIGGLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLS  361 (646)
Q Consensus       283 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  361 (646)
                      .+.++.+++.+. ..|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            344555555554 24455555566666666544 3555555556666666666666666665555556666666666666


Q ss_pred             CCcCcccCCccccCCCCCCceeCcCCcceee
Q 046544          362 NNNLSGAIPTSLEKLSYLEDLNLSFNKLEGE  392 (646)
Q Consensus       362 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  392 (646)
                      +|+|+...+..|..+ .|+.|+|++|++.+.
T Consensus        89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          89 FNALESLSWKTVQGL-SLQELVLSGNPLHCS  118 (156)
T ss_dssp             SSCCSCCCSTTTCSC-CCCEEECCSSCCCCC
T ss_pred             CCCCcccChhhhccc-cccccccCCCcccCC
Confidence            666654333334333 455555555555543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.49  E-value=4.4e-16  Score=144.50  Aligned_cols=114  Identities=25%  Similarity=0.213  Sum_probs=66.7

Q ss_pred             cCchhhcCCCCCcEEEecCCcccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCcc
Q 046544          225 SIPDSICRLTELYELELGGNKLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNL  304 (646)
Q Consensus       225 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  304 (646)
                      .+|.++..+++|++|+|++|+|+.+ + .+.++++|+.|+|++|.|+++|..+..+++|+.|++++|.++..  ..+..+
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccccccccccc--cccccc
Confidence            3456677777777777777777643 2 36777777777777777777765444445566666666665532  124445


Q ss_pred             ccceEEEcccccccccCc-cccCCCCCCCEEEccCccCC
Q 046544          305 KVLIGIDFSMNNFSSVIP-TEIGGLKNLEYLFLGYNRLE  342 (646)
Q Consensus       305 ~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  342 (646)
                      ++|+.|++++|++++... ..++.+++|+.|+|++|++.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555555543321 34455555555555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.46  E-value=8.6e-16  Score=142.53  Aligned_cols=143  Identities=23%  Similarity=0.307  Sum_probs=92.4

Q ss_pred             CcEEEecCC--cccccCCccccCCCCCceeecCCCcccccccccccccccccccCCCCcccCCCCCccCccccceEEEcc
Q 046544          236 LYELELGGN--KLFGSIPACFSNLASLRILSLSSNELTSIPLTFWNLKDILQLNFSSNFLTGPLPLEIGNLKVLIGIDFS  313 (646)
Q Consensus       236 L~~L~L~~N--~i~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ls  313 (646)
                      ++.++++++  .+. ..+..+..+++|++|+|++|.|+.++ .+.++++|+.|++++|.++. +|..+..++.|+.|+++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~  101 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWIS  101 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECS
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCCcc-cccCCccccChhhccccccc-ccccccccccccccccc
Confidence            444455443  222 34456777888888888888888775 46777778888888887763 44445555667777777


Q ss_pred             cccccccCccccCCCCCCCEEEccCccCCCccc-ccccCCCCCCEEEccCCcCcccCCcc----------ccCCCCCCce
Q 046544          314 MNNFSSVIPTEIGGLKNLEYLFLGYNRLEGSIP-DSFGDLISLKFLNLSNNNLSGAIPTS----------LEKLSYLEDL  382 (646)
Q Consensus       314 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L  382 (646)
                      +|.++.+  ..+..+++|+.|++++|+++.... ..+..+++|+.|+|++|+++...+..          +..+++|+.|
T Consensus       102 ~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~L  179 (198)
T d1m9la_         102 YNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL  179 (198)
T ss_dssp             EEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEE
T ss_pred             ccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEe
Confidence            7777754  336666777777777777764322 45677777777777777776443332          4456666665


Q ss_pred             e
Q 046544          383 N  383 (646)
Q Consensus       383 ~  383 (646)
                      |
T Consensus       180 D  180 (198)
T d1m9la_         180 D  180 (198)
T ss_dssp             S
T ss_pred             C
Confidence            5

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=6.5e-14  Score=124.19  Aligned_cols=103  Identities=21%  Similarity=0.142  Sum_probs=48.1

Q ss_pred             EEEeecccccccCCcccccCCCCCEEEccCC-ccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCC
Q 046544          166 DFYMSNCNVSGGIPEEITNLTNSITIDLGGN-KLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGN  244 (646)
Q Consensus       166 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  244 (646)
                      .++.+++++.. .|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            34444444442 2344444455555555433 244444444555555555555555554444444555555555555555


Q ss_pred             cccccCCccccCCCCCceeecCCCcc
Q 046544          245 KLFGSIPACFSNLASLRILSLSSNEL  270 (646)
Q Consensus       245 ~i~~~~~~~~~~l~~L~~L~L~~N~l  270 (646)
                      +|+.+.+..|..+ +|+.|+|++|.+
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CCcccChhhhccc-cccccccCCCcc
Confidence            5544333334332 344444444444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=1.3e-09  Score=96.66  Aligned_cols=104  Identities=22%  Similarity=0.189  Sum_probs=66.3

Q ss_pred             CCEEEccCCccccccCccccCCCCCCeEEeecccccCcCchhhcCCCCCcEEEecCCcccccC--CccccCCCCCceeec
Q 046544          188 SITIDLGGNKLNGSIPITLSKLQKLQGLGLDDNKLEGSIPDSICRLTELYELELGGNKLFGSI--PACFSNLASLRILSL  265 (646)
Q Consensus       188 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L  265 (646)
                      .+.||++++...    ..+..+..+..++..++... .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|
T Consensus        24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L   98 (162)
T d1koha1          24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL   98 (162)
T ss_dssp             SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred             hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence            344555554422    12334444555555555444 45556667888888888888887543  345667888888888


Q ss_pred             CCCccccccc-ccccccccccccCCCCcccCC
Q 046544          266 SSNELTSIPL-TFWNLKDILQLNFSSNFLTGP  296 (646)
Q Consensus       266 ~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~  296 (646)
                      ++|.|++++. .+.....|+.|++++|.+...
T Consensus        99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          99 SGNELKSERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             ccCccccchhhhhhhccccceeecCCCCcCcC
Confidence            8888888765 333445677888888877643

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=8.8e-10  Score=97.71  Aligned_cols=40  Identities=30%  Similarity=0.160  Sum_probs=16.2

Q ss_pred             CCCCCCEEEccCccCCCcccccccCCCCCCEEEccCCcCc
Q 046544          327 GLKNLEYLFLGYNRLEGSIPDSFGDLISLKFLNLSNNNLS  366 (646)
Q Consensus       327 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  366 (646)
                      .+++|+.|+|++|+|+...+-.+.....|+.|++++|.++
T Consensus        89 ~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          89 KAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             hCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            3344444444444444322222222334444444444444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.44  E-value=9.4e-07  Score=84.37  Aligned_cols=150  Identities=15%  Similarity=0.081  Sum_probs=100.5

Q ss_pred             HHHHHHhCCCCcceeecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCee
Q 046544          485 LELCRATNGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFK  563 (646)
Q Consensus       485 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~  563 (646)
                      .++....+.|+..+..+-++-+.||+... +++.+++|+...........+.+|...+..++ +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34555556676555433344468998864 55667888876554434445677888877663 44467788888888899


Q ss_pred             EEEEEecCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 046544          564 ALVLEYKPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC----------------------------------  609 (646)
Q Consensus       564 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------  609 (646)
                      ++||++++|.++.+......      ....++.++++.++.+|...                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988866542211      12234555566666666210                                  


Q ss_pred             ----------------------CCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          610 ----------------------LAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       610 ----------------------~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                                            ...++|+|+.|.||++++++.+.++||+.|..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  11378999999999999887778999987753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.90  E-value=1.2e-06  Score=77.22  Aligned_cols=92  Identities=15%  Similarity=0.161  Sum_probs=53.0

Q ss_pred             CCCCEEEccCC-ccccc----CCccccCCCCCcEEEcccCccccccCc----cccCcCCCCEEEccCCCCCCCCCccccc
Q 046544           59 PNLEALLLWGN-NFSGT----IPRFIFNASKLSILELSQNSFSGFIPN----TFGNLRNLEWLNLRDNYLTSSTPELSFL  129 (646)
Q Consensus        59 ~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~  129 (646)
                      ++|++|+|+++ .++..    +-..+...++|++|+|++|.+......    .+...+.|++|+|++|.|+..... .+.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~-~l~   93 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA-RLL   93 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH-HHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH-HHH
Confidence            44555555542 33321    223345556677777777777643222    234456778888888777643211 134


Q ss_pred             ccCCCCCCCCEEECCCCCCCCc
Q 046544          130 SSLSNCKSLTFIHLSDNPLDGI  151 (646)
Q Consensus       130 ~~l~~l~~L~~L~Ls~N~l~~~  151 (646)
                      ..+...++|++|++++|.+..+
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHhCCcCCEEECCCCcCCCc
Confidence            4567777888888888776544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=2.8e-05  Score=73.26  Aligned_cols=131  Identities=17%  Similarity=0.073  Sum_probs=84.9

Q ss_pred             eeccccc-ceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCC--CCCceeEEEEEecCCeeEEEEEecCCCCH
Q 046544          499 LIGRGGF-GSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYKPHGSL  575 (646)
Q Consensus       499 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g~L  575 (646)
                      .+..|.. +.||+....+|..+++|.......   ..+..|++.++.+.  .--+.+++.+...++..++|||+++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4556654 578999887788889997654432   34566777777663  33466788888888889999999988654


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 046544          576 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF------------------------------------------------  607 (646)
Q Consensus       576 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~------------------------------------------------  607 (646)
                      .+..      ...   ...+.++++.+.-||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3210      111   0111222233333331                                                


Q ss_pred             -------CCCCCeEecCCCCCCEEEcCCCcEEEEeecCccc
Q 046544          608 -------GCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL  641 (646)
Q Consensus       608 -------~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~~  641 (646)
                             .....++|+|+.|.||+++++..+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   0012379999999999999887788999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.63  E-value=6.4e-06  Score=72.43  Aligned_cols=17  Identities=18%  Similarity=0.333  Sum_probs=7.5

Q ss_pred             CCCCCCCCEEECCCCCC
Q 046544          132 LSNCKSLTFIHLSDNPL  148 (646)
Q Consensus       132 l~~l~~L~~L~Ls~N~l  148 (646)
                      +...++|++|+|++|.+
T Consensus        40 L~~n~~L~~L~Ls~n~l   56 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAI   56 (167)
T ss_dssp             HTTCSCCCEEECTTSCC
T ss_pred             HhhCCccceeecccccc
Confidence            33344444444444443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.44  E-value=0.0002  Score=71.88  Aligned_cols=76  Identities=17%  Similarity=0.151  Sum_probs=49.0

Q ss_pred             ceeecccccceEEEEEeC-CCcEEEEEEEecc-------CCchHHHHHHHHHHHHhC-CC--CCceeEEEEEecCCeeEE
Q 046544          497 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-------CGRAFKSFAVECEMMKSI-RH--RNLIKVISSCSNEEFKAL  565 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~H--~niv~~~~~~~~~~~~~l  565 (646)
                      .+.||.|....||+.+.. +++.|++|.....       .+....+...|.+.++.+ .+  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457899999999999865 4678999975421       112234456688877765 22  346666655  3445678


Q ss_pred             EEEecCCCC
Q 046544          566 VLEYKPHGS  574 (646)
Q Consensus       566 v~e~~~~g~  574 (646)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.83  E-value=3.5e-05  Score=67.49  Aligned_cols=16  Identities=0%  Similarity=-0.085  Sum_probs=7.1

Q ss_pred             CCCCCCCEEECCCCCC
Q 046544          133 SNCKSLTFIHLSDNPL  148 (646)
Q Consensus       133 ~~l~~L~~L~Ls~N~l  148 (646)
                      ...++|++|++++|.+
T Consensus        43 ~~n~~L~~L~Ls~n~l   58 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRS   58 (166)
T ss_dssp             TTCCSCCEEECTTSCC
T ss_pred             hcCCccCeeeccCCcc
Confidence            3344444444444443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.82  E-value=9e-05  Score=64.72  Aligned_cols=41  Identities=7%  Similarity=0.091  Sum_probs=19.2

Q ss_pred             cCCCCCCeEEeecccccCc----CchhhcCCCCCcEEEecCCccc
Q 046544          207 SKLQKLQGLGLDDNKLEGS----IPDSICRLTELYELELGGNKLF  247 (646)
Q Consensus       207 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~  247 (646)
                      ...++|++|++++|.+...    +...+...++++.+++++|.+.
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            3445555555555554422    1122333455555555555543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.62  E-value=0.0031  Score=61.13  Aligned_cols=67  Identities=12%  Similarity=0.101  Sum_probs=45.0

Q ss_pred             ceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCce--eEE-----EEEecCCeeEEEEEecCCC
Q 046544          506 GSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI--KVI-----SSCSNEEFKALVLEYKPHG  573 (646)
Q Consensus       506 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv--~~~-----~~~~~~~~~~lv~e~~~~g  573 (646)
                      -.||+++..+|+.|++|+.+... ...+++..|...+..+....+.  ...     ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47999999899999999986542 2346677788887776432221  111     1233456788999999774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.76  E-value=0.027  Score=53.76  Aligned_cols=156  Identities=17%  Similarity=0.098  Sum_probs=80.7

Q ss_pred             ccHHHHHHHhCCCCccee-----ecccccceEEEEEeCCCcEEEEEEEeccCCchHHHHHHHHHHHHhCCCCCce--eEE
Q 046544          482 FSYLELCRATNGFSENNL-----IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAFKSFAVECEMMKSIRHRNLI--KVI  554 (646)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv--~~~  554 (646)
                      .+-+|+.....+|..++.     |..|---+.|+.+..+|+ +++|++....  ..++...|.+.+..+...++.  ...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            345667777777876533     335555678988876665 8899886432  223344466666655322221  111


Q ss_pred             E------EEecCCeeEEEEEecCCCCHHH-----------HH---h----hCC----CCCCH------------------
Q 046544          555 S------SCSNEEFKALVLEYKPHGSLEK-----------YL---Y----SSN----CILDI------------------  588 (646)
Q Consensus       555 ~------~~~~~~~~~lv~e~~~~g~L~~-----------~l---~----~~~----~~l~~------------------  588 (646)
                      .      +....+....++.+..+.....           .+   +    ...    .....                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1222345667777776632210           00   0    000    00000                  


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCEEEcCCCcEEEEeecCcc
Q 046544          589 FQRLNIMIDVASALEYLH-FGCLAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK  640 (646)
Q Consensus       589 ~~~~~i~~~i~~~l~~lH-~~~~~~iiHrdlk~~Nil~~~~~~~ki~DfGla~  640 (646)
                      ......+......+.-.+ .....++||+|+.++||+++.+...-|.||+.|.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            001111222222222222 1224689999999999999998888899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.71  E-value=0.016  Score=57.53  Aligned_cols=73  Identities=18%  Similarity=0.177  Sum_probs=48.4

Q ss_pred             ceeecccccceEEEEEeCC--------CcEEEEEEEeccCCchHHHHHHHHHHHHhCC-CCCceeEEEEEecCCeeEEEE
Q 046544          497 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRAFKSFAVECEMMKSIR-HRNLIKVISSCSNEEFKALVL  567 (646)
Q Consensus       497 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  567 (646)
                      .+.++-|-.-.+|++...+        .+.|.+++.. .... .-...+|..+++.+. +.-.+++++++..    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3567778888999998543        3567777765 3222 234567888888774 4334577777642    5899


Q ss_pred             EecCCCCH
Q 046544          568 EYKPHGSL  575 (646)
Q Consensus       568 e~~~~g~L  575 (646)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543